[
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/1",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/V600E",
		"source": "oncokb",
		"description": "FDA-approved biomarker and drug in this indication",
		"drug_labels": "DABRAFENIB,TRAMETINIB",
		"variant_name": "V600E",
		"source_link": "http://oncokb.org/#/gene/BRAF/variant/V600E",
		"evidence_label": "A",
		"response_type": "NA",
		"evidence_level": "1",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/1",
				"source": "MEDDRA",
				"term": "Anaplastic Thyroid Cancer",
				"pheno_id": "MEDDRA:10002240",
				"family": null,
				"description": "Anaplastic Thyroid Cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/1"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/1",
				"type": "Predictive",
				"description": "1",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/29072975"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Anaplastic Thyroid Cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/1"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/2",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/1"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/1",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/1"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/2",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/2",
			"name": "V600",
			"description": "BRAF V600",
			"biomarker_type": "NA",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580"
			],
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453137,
			"end_pos": 140453137,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453137C>T",
			"hgvs_c": "NM_004333.4:c.1798G>A",
			"hgvs_p": "NP_004324.2:p.Val600Met",
			"dbsnp_ids": [
				"121913378"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453137C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/V600",
		"source": "oncokb",
		"description": "FDA-approved biomarker and drug in this indication",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600",
		"source_link": "http://oncokb.org/#/gene/BRAF/variant/V600",
		"evidence_label": "A",
		"response_type": "NA",
		"evidence_level": "1",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/2",
				"source": "http://purl.obolibrary.org/obo/DOID_4329",
				"term": "Erdheim-Chester disease",
				"pheno_id": "DOID:4329",
				"family": "histiocytosis",
				"description": "Erdheim-Chester disease",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/2"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/2",
				"type": "Predictive",
				"description": "1",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26287849",
					"http://www.ncbi.nlm.nih.gov/pubmed/29188284"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Erdheim-Chester Disease",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/2"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/3",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/2"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/3",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/V600E",
		"source": "oncokb",
		"description": "FDA-approved biomarker and drug in this indication",
		"drug_labels": "VEMURAFENIB,DABRAFENIB,DABRAFENIB,TRAMETINIB,VEMURAFENIB,COBIMETINIB,TRAMETINIB,ENCORAFENIB,BINIMETINIB",
		"variant_name": "V600E",
		"source_link": "http://oncokb.org/#/gene/BRAF/variant/V600E",
		"evidence_label": "A",
		"response_type": "NA",
		"evidence_level": "1",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/3",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/3"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/3",
				"type": "Predictive",
				"description": "1",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/29573941",
					"http://www.ncbi.nlm.nih.gov/pubmed/22735384",
					"http://www.ncbi.nlm.nih.gov/pubmed/28961848",
					"http://www.ncbi.nlm.nih.gov/pubmed/25265494",
					"http://www.ncbi.nlm.nih.gov/pubmed/25287827",
					"http://www.ncbi.nlm.nih.gov/pubmed/25399551",
					"http://www.ncbi.nlm.nih.gov/pubmed/22608338",
					"http://www.ncbi.nlm.nih.gov/pubmed/23051966",
					"http://www.ncbi.nlm.nih.gov/pubmed/28891408",
					"http://www.ncbi.nlm.nih.gov/pubmed/27480103",
					"http://www.ncbi.nlm.nih.gov/pubmed/22663011",
					"http://www.ncbi.nlm.nih.gov/pubmed/25265492",
					"http://www.ncbi.nlm.nih.gov/pubmed/24508103",
					"http://www.ncbi.nlm.nih.gov/pubmed/29361468",
					"http://www.ncbi.nlm.nih.gov/pubmed/28991513",
					"http://www.ncbi.nlm.nih.gov/pubmed/23020132"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/3"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/4",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/3"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/5",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/3"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/6",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/3"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/7",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/3"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/8",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/3"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/9",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "COBIMETINIB",
				"envcontext_id": "16222096",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "COBIMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/3"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/10",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/3"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/11",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "ENCORAFENIB",
				"envcontext_id": "50922675",
				"usan_stem": "raf kinase inhibitors",
				"description": "ENCORAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/3"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/12",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "BINIMETINIB",
				"envcontext_id": "10288191",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "BINIMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/3"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/4",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/3",
			"name": "V600K",
			"description": "BRAF V600K",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453137,
			"ref": "AC",
			"alt": "TT",
			"hgvs_g": "NC_000007.13:g.140453136_140453137delinsTT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"121913227"
			],
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/V600K",
		"source": "oncokb",
		"description": "FDA-approved biomarker and drug in this indication",
		"drug_labels": "DABRAFENIB,TRAMETINIB,VEMURAFENIB,COBIMETINIB,TRAMETINIB,ENCORAFENIB,BINIMETINIB",
		"variant_name": "V600K",
		"source_link": "http://oncokb.org/#/gene/BRAF/variant/V600K",
		"evidence_label": "A",
		"response_type": "NA",
		"evidence_level": "1",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/4",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/4"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/4",
				"type": "Predictive",
				"description": "1",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/29573941",
					"http://www.ncbi.nlm.nih.gov/pubmed/28891408",
					"http://www.ncbi.nlm.nih.gov/pubmed/27480103",
					"http://www.ncbi.nlm.nih.gov/pubmed/22663011",
					"http://www.ncbi.nlm.nih.gov/pubmed/25265492",
					"http://www.ncbi.nlm.nih.gov/pubmed/25265494",
					"http://www.ncbi.nlm.nih.gov/pubmed/25287827",
					"http://www.ncbi.nlm.nih.gov/pubmed/29361468",
					"http://www.ncbi.nlm.nih.gov/pubmed/28991513",
					"http://www.ncbi.nlm.nih.gov/pubmed/23020132",
					"http://www.ncbi.nlm.nih.gov/pubmed/25399551"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/4"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/19",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "BINIMETINIB",
				"envcontext_id": "10288191",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "BINIMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/4"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/18",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "ENCORAFENIB",
				"envcontext_id": "50922675",
				"usan_stem": "raf kinase inhibitors",
				"description": "ENCORAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/4"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/17",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/4"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/16",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "COBIMETINIB",
				"envcontext_id": "16222096",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "COBIMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/4"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/15",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/4"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/14",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/4"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/13",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/4"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/5",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/V600E",
		"source": "oncokb",
		"description": "FDA-approved biomarker and drug in this indication",
		"drug_labels": "DABRAFENIB,TRAMETINIB",
		"variant_name": "V600E",
		"source_link": "http://oncokb.org/#/gene/BRAF/variant/V600E",
		"evidence_label": "A",
		"response_type": "NA",
		"evidence_level": "1",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/5",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/5"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/5",
				"type": "Predictive",
				"description": "1",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27283860",
					"http://www.ncbi.nlm.nih.gov/pubmed/28919011"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Non-Small Cell Lung Cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/5"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/21",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/5"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/20",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/5"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/6",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/2",
			"name": "V600",
			"description": "BRAF V600",
			"biomarker_type": "NA",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580"
			],
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453137,
			"end_pos": 140453137,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453137C>T",
			"hgvs_c": "NM_004333.4:c.1798G>A",
			"hgvs_p": "NP_004324.2:p.Val600Met",
			"dbsnp_ids": [
				"121913378"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453137C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/V600",
		"source": "oncokb",
		"description": "Compelling clinical evidence supports the biomarker as being predictive of response to a drug in this indication but neither biomarker and drug are standard of care",
		"drug_labels": "PANITUMUMAB,DABRAFENIB,TRAMETINIB",
		"variant_name": "V600",
		"source_link": "http://oncokb.org/#/gene/BRAF/variant/V600",
		"evidence_label": "C",
		"response_type": "sensitive",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/6",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/6"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/6",
				"type": "Predictive",
				"description": "3A",
				"publications": [
					"http://ascopubs.org/doi/abs/10.1200/jco.2014.32.15_suppl.3515",
					"http://ascopubs.org/doi/abs/10.1200/jco.2010.28.15_suppl.3534",
					"http://www.ncbi.nlm.nih.gov/pubmed/19884556",
					"http://www.ncbi.nlm.nih.gov/pubmed/29431699",
					"http://www.ncbi.nlm.nih.gov/pubmed/20619739",
					"http://www.ncbi.nlm.nih.gov/pubmed/25589621",
					"http://www.ncbi.nlm.nih.gov/pubmed/19001320",
					"http://www.ncbi.nlm.nih.gov/pubmed/22448344"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Colorectal Cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/6"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/24",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/6"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/23",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/6"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/22",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "PANITUMUMAB",
				"envcontext_id": "CHEMBL1201827",
				"usan_stem": "monoclonal antibodies",
				"description": "PANITUMUMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/6"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/7",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/4",
			"name": "Fusions",
			"description": "BRAF Fusions",
			"biomarker_type": "NA",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": null,
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/Fusions",
		"source": "oncokb",
		"description": "Compelling clinical evidence supports the biomarker as being predictive of response to a drug in this indication but neither biomarker and drug are standard of care",
		"drug_labels": "COBIMETINIB,TRAMETINIB",
		"variant_name": "Fusions",
		"source_link": "http://oncokb.org/#/gene/BRAF/variant/Fusions",
		"evidence_label": "C",
		"response_type": "sensitive",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/7",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/7"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/7",
				"type": "Predictive",
				"description": "3A",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26314551",
					"http://www.ncbi.nlm.nih.gov/pubmed/23890088",
					"http://www.ncbi.nlm.nih.gov/pubmed/24345920",
					"http://www.ncbi.nlm.nih.gov/pubmed/26072686"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/7"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/26",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/7"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/25",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "COBIMETINIB",
				"envcontext_id": "16222096",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "COBIMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/7"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/8",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/5",
			"name": "K601",
			"description": "BRAF K601",
			"biomarker_type": "NA",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453134,
			"end_pos": 140453134,
			"ref": "T",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.140453134T>C",
			"hgvs_c": "NM_004333.4:c.1801A>G",
			"hgvs_p": "NP_004324.2:p.Lys601Glu",
			"dbsnp_ids": [
				"121913364"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453134T>C?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/K601",
		"source": "oncokb",
		"description": "Compelling clinical evidence supports the biomarker as being predictive of response to a drug in this indication but neither biomarker and drug are standard of care",
		"drug_labels": "TRAMETINIB",
		"variant_name": "K601",
		"source_link": "http://oncokb.org/#/gene/BRAF/variant/K601",
		"evidence_label": "C",
		"response_type": "sensitive",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/8",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/8"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/8",
				"type": "Predictive",
				"description": "3A",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22798288",
					"http://www.ncbi.nlm.nih.gov/pubmed/28344857",
					"http://www.ncbi.nlm.nih.gov/pubmed/24933606",
					"http://www.ncbi.nlm.nih.gov/pubmed/23248257"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/8"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/27",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/8"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/9",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/6",
			"name": "L597",
			"description": "BRAF L597",
			"biomarker_type": "NA",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453146,
			"end_pos": 140453146,
			"ref": "G",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.140453146G>C",
			"hgvs_c": "NM_004333.4:c.1789C>G",
			"hgvs_p": "NP_004324.2:p.Leu597Val",
			"dbsnp_ids": [
				"121913369"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453146G>C?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/L597",
		"source": "oncokb",
		"description": "Compelling clinical evidence supports the biomarker as being predictive of response to a drug in this indication but neither biomarker and drug are standard of care",
		"drug_labels": "TRAMETINIB",
		"variant_name": "L597",
		"source_link": "http://oncokb.org/#/gene/BRAF/variant/L597",
		"evidence_label": "C",
		"response_type": "sensitive",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/9",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/9"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/9",
				"type": "Predictive",
				"description": "3A",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22798288",
					"http://www.ncbi.nlm.nih.gov/pubmed/24933606"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/9"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/28",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/9"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/10",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/4",
			"name": "Fusions",
			"description": "BRAF Fusions",
			"biomarker_type": "NA",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": null,
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/Fusions",
		"source": "oncokb",
		"description": "Compelling clinical evidence supports the biomarker as being predictive of response to a drug in this indication but neither biomarker and drug are standard of care",
		"drug_labels": "COBIMETINIB,TRAMETINIB",
		"variant_name": "Fusions",
		"source_link": "http://oncokb.org/#/gene/BRAF/variant/Fusions",
		"evidence_label": "C",
		"response_type": "sensitive",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/10",
				"source": "http://purl.obolibrary.org/obo/DOID_2394",
				"term": "ovarian cancer",
				"pheno_id": "DOID:2394",
				"family": "reproductive organ cancer",
				"description": "ovarian cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/10"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/10",
				"type": "Predictive",
				"description": "3A",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23890088",
					"http://www.ncbi.nlm.nih.gov/pubmed/26324360",
					"http://www.ncbi.nlm.nih.gov/pubmed/24345920"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Ovarian Cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/10"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/30",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/10"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/29",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "COBIMETINIB",
				"envcontext_id": "16222096",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "COBIMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/10"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/11",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/7",
			"name": "D287H",
			"description": "BRAF D287H",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140501213,
			"end_pos": 140501213,
			"ref": "C",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.140501213C>G",
			"hgvs_c": "NM_004333.4:c.859G>C",
			"hgvs_p": "NP_004324.2:p.Asp287His",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140501213C>G?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/D287H",
		"source": "oncokb",
		"description": "Compelling biological evidence supports the biomarker as being predictive of response to a drug but neither biomarker and drug are standard of care",
		"drug_labels": "PLX8394",
		"variant_name": "D287H",
		"source_link": "http://oncokb.org/#/gene/BRAF/variant/D287H",
		"evidence_label": "D",
		"response_type": "sensitive",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/11",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/11"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/11",
				"type": "Predictive",
				"description": "4",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26466569",
					"http://www.ncbi.nlm.nih.gov/pubmed/28659148",
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-All Tumors",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/11"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/31",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "PLX8394",
				"envcontext_id": "CID90116675",
				"usan_stem": null,
				"description": "PLX8394",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/11"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/12",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/8",
			"name": "D594",
			"description": "BRAF D594",
			"biomarker_type": "NA",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453155,
			"end_pos": 140453155,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453155C>T",
			"hgvs_c": "NM_004333.4:c.1780G>A",
			"hgvs_p": "NP_004324.2:p.Asp594Asn",
			"dbsnp_ids": [
				"397516896"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453155C>T?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/D594",
		"source": "oncokb",
		"description": "Compelling biological evidence supports the biomarker as being predictive of response to a drug but neither biomarker and drug are standard of care",
		"drug_labels": "PLX8394",
		"variant_name": "D594",
		"source_link": "http://oncokb.org/#/gene/BRAF/variant/D594",
		"evidence_label": "D",
		"response_type": "sensitive",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/12",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/12"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/12",
				"type": "Predictive",
				"description": "4",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26466569",
					"http://www.ncbi.nlm.nih.gov/pubmed/28659148",
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-All Tumors",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/12"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/32",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "PLX8394",
				"envcontext_id": "CID90116675",
				"usan_stem": null,
				"description": "PLX8394",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/12"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/13",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/9",
			"name": "F595L",
			"description": "BRAF F595L",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453152,
			"end_pos": 140453152,
			"ref": "A",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.140453152A>G",
			"hgvs_c": "NM_004333.4:c.1783T>C",
			"hgvs_p": "NP_004324.2:p.Phe595Leu",
			"dbsnp_ids": [
				"794729219"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453152A>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/F595L",
		"source": "oncokb",
		"description": "Compelling biological evidence supports the biomarker as being predictive of response to a drug but neither biomarker and drug are standard of care",
		"drug_labels": "PLX8394",
		"variant_name": "F595L",
		"source_link": "http://oncokb.org/#/gene/BRAF/variant/F595L",
		"evidence_label": "D",
		"response_type": "sensitive",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/13",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/13"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/13",
				"type": "Predictive",
				"description": "4",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26466569",
					"http://www.ncbi.nlm.nih.gov/pubmed/28659148",
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-All Tumors",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/13"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/33",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "PLX8394",
				"envcontext_id": "CID90116675",
				"usan_stem": null,
				"description": "PLX8394",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/13"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/14",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/10",
			"name": "G464",
			"description": "BRAF G464",
			"biomarker_type": "NA",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140481418,
			"end_pos": 140481418,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140481418C>T",
			"hgvs_c": "NM_004333.4:c.1390G>A",
			"hgvs_p": "NP_004324.2:p.Gly464Arg",
			"dbsnp_ids": [
				"121913349"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140481418C>T?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/G464",
		"source": "oncokb",
		"description": "Compelling biological evidence supports the biomarker as being predictive of response to a drug but neither biomarker and drug are standard of care",
		"drug_labels": "PLX8394",
		"variant_name": "G464",
		"source_link": "http://oncokb.org/#/gene/BRAF/variant/G464",
		"evidence_label": "D",
		"response_type": "sensitive",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/14",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/14"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/14",
				"type": "Predictive",
				"description": "4",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26466569",
					"http://www.ncbi.nlm.nih.gov/pubmed/28659148",
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-All Tumors",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/14"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/34",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "PLX8394",
				"envcontext_id": "CID90116675",
				"usan_stem": null,
				"description": "PLX8394",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/14"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/15",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/11",
			"name": "G466",
			"description": "BRAF G466",
			"biomarker_type": "NA",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140481412,
			"end_pos": 140481412,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140481412C>T",
			"hgvs_c": "NM_004333.4:c.1396G>A",
			"hgvs_p": "NP_004324.2:p.Gly466Arg",
			"dbsnp_ids": [
				"121913353"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140481412C>T?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/G466",
		"source": "oncokb",
		"description": "Compelling biological evidence supports the biomarker as being predictive of response to a drug but neither biomarker and drug are standard of care",
		"drug_labels": "PLX8394",
		"variant_name": "G466",
		"source_link": "http://oncokb.org/#/gene/BRAF/variant/G466",
		"evidence_label": "D",
		"response_type": "sensitive",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/15",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/15"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/15",
				"type": "Predictive",
				"description": "4",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26466569",
					"http://www.ncbi.nlm.nih.gov/pubmed/28659148",
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-All Tumors",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/15"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/35",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "PLX8394",
				"envcontext_id": "CID90116675",
				"usan_stem": null,
				"description": "PLX8394",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/15"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/16",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/12",
			"name": "G469",
			"description": "BRAF G469",
			"biomarker_type": "NA",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140481403,
			"end_pos": 140481403,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140481403C>T",
			"hgvs_c": "NM_004333.4:c.1405G>A",
			"hgvs_p": "NP_004324.2:p.Gly469Arg",
			"dbsnp_ids": [
				"121913357"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140481403C>T?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/G469",
		"source": "oncokb",
		"description": "Compelling biological evidence supports the biomarker as being predictive of response to a drug but neither biomarker and drug are standard of care",
		"drug_labels": "PLX8394",
		"variant_name": "G469",
		"source_link": "http://oncokb.org/#/gene/BRAF/variant/G469",
		"evidence_label": "D",
		"response_type": "sensitive",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/16",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/16"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/16",
				"type": "Predictive",
				"description": "4",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26466569",
					"http://www.ncbi.nlm.nih.gov/pubmed/28659148",
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-All Tumors",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/16"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/36",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "PLX8394",
				"envcontext_id": "CID90116675",
				"usan_stem": null,
				"description": "PLX8394",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/16"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/17",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/13",
			"name": "G596",
			"description": "BRAF G596",
			"biomarker_type": "NA",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453149,
			"end_pos": 140453149,
			"ref": "C",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.140453149C>G",
			"hgvs_c": "NM_004333.4:c.1786G>C",
			"hgvs_p": "NP_004324.2:p.Gly596Arg",
			"dbsnp_ids": [
				"121913361"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453149C>G?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/G596",
		"source": "oncokb",
		"description": "Compelling biological evidence supports the biomarker as being predictive of response to a drug but neither biomarker and drug are standard of care",
		"drug_labels": "PLX8394",
		"variant_name": "G596",
		"source_link": "http://oncokb.org/#/gene/BRAF/variant/G596",
		"evidence_label": "D",
		"response_type": "sensitive",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/17",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/17"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/17",
				"type": "Predictive",
				"description": "4",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26466569",
					"http://www.ncbi.nlm.nih.gov/pubmed/28659148",
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-All Tumors",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/17"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/37",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "PLX8394",
				"envcontext_id": "CID90116675",
				"usan_stem": null,
				"description": "PLX8394",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/17"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/18",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/5",
			"name": "K601",
			"description": "BRAF K601",
			"biomarker_type": "NA",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453134,
			"end_pos": 140453134,
			"ref": "T",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.140453134T>C",
			"hgvs_c": "NM_004333.4:c.1801A>G",
			"hgvs_p": "NP_004324.2:p.Lys601Glu",
			"dbsnp_ids": [
				"121913364"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453134T>C?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/K601",
		"source": "oncokb",
		"description": "Compelling biological evidence supports the biomarker as being predictive of response to a drug but neither biomarker and drug are standard of care",
		"drug_labels": "PLX8394",
		"variant_name": "K601",
		"source_link": "http://oncokb.org/#/gene/BRAF/variant/K601",
		"evidence_label": "D",
		"response_type": "sensitive",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/18",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/18"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/18",
				"type": "Predictive",
				"description": "4",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26466569",
					"http://www.ncbi.nlm.nih.gov/pubmed/28659148",
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-All Tumors",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/18"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/38",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "PLX8394",
				"envcontext_id": "CID90116675",
				"usan_stem": null,
				"description": "PLX8394",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/18"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/19",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/6",
			"name": "L597",
			"description": "BRAF L597",
			"biomarker_type": "NA",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453146,
			"end_pos": 140453146,
			"ref": "G",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.140453146G>C",
			"hgvs_c": "NM_004333.4:c.1789C>G",
			"hgvs_p": "NP_004324.2:p.Leu597Val",
			"dbsnp_ids": [
				"121913369"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453146G>C?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/L597",
		"source": "oncokb",
		"description": "Compelling biological evidence supports the biomarker as being predictive of response to a drug but neither biomarker and drug are standard of care",
		"drug_labels": "PLX8394",
		"variant_name": "L597",
		"source_link": "http://oncokb.org/#/gene/BRAF/variant/L597",
		"evidence_label": "D",
		"response_type": "sensitive",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/19",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/19"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/19",
				"type": "Predictive",
				"description": "4",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26466569",
					"http://www.ncbi.nlm.nih.gov/pubmed/28659148",
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-All Tumors",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/19"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/39",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "PLX8394",
				"envcontext_id": "CID90116675",
				"usan_stem": null,
				"description": "PLX8394",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/19"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/20",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/14",
			"name": "N581",
			"description": "BRAF N581",
			"biomarker_type": "NA",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453987,
			"end_pos": 140453987,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.140453987T>G",
			"hgvs_c": "NM_004333.4:c.1741A>C",
			"hgvs_p": "NP_004324.2:p.Asn581His",
			"dbsnp_ids": [
				"180177040"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453987T>G?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/N581",
		"source": "oncokb",
		"description": "Compelling biological evidence supports the biomarker as being predictive of response to a drug but neither biomarker and drug are standard of care",
		"drug_labels": "PLX8394",
		"variant_name": "N581",
		"source_link": "http://oncokb.org/#/gene/BRAF/variant/N581",
		"evidence_label": "D",
		"response_type": "sensitive",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/20",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/20"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/20",
				"type": "Predictive",
				"description": "4",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26466569",
					"http://www.ncbi.nlm.nih.gov/pubmed/28659148",
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-All Tumors",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/20"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/40",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "PLX8394",
				"envcontext_id": "CID90116675",
				"usan_stem": null,
				"description": "PLX8394",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/20"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/21",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/15",
			"name": "S467L",
			"description": "BRAF S467L",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140481408,
			"end_pos": 140481408,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140481408G>A",
			"hgvs_c": "NM_004333.4:c.1400C>T",
			"hgvs_p": "NP_004324.2:p.Ser467Leu",
			"dbsnp_ids": [
				"867748453"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140481408G>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/S467L",
		"source": "oncokb",
		"description": "Compelling biological evidence supports the biomarker as being predictive of response to a drug but neither biomarker and drug are standard of care",
		"drug_labels": "PLX8394",
		"variant_name": "S467L",
		"source_link": "http://oncokb.org/#/gene/BRAF/variant/S467L",
		"evidence_label": "D",
		"response_type": "sensitive",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/21",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/21"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/21",
				"type": "Predictive",
				"description": "4",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26466569",
					"http://www.ncbi.nlm.nih.gov/pubmed/28659148",
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-All Tumors",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/21"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/41",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "PLX8394",
				"envcontext_id": "CID90116675",
				"usan_stem": null,
				"description": "PLX8394",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/21"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/22",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/16",
			"name": "V459L",
			"description": "BRAF V459L",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140481433,
			"end_pos": 140481433,
			"ref": "C",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.140481433C>G",
			"hgvs_c": "NM_004333.4:c.1375G>C",
			"hgvs_p": "NP_004324.2:p.Val459Leu",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140481433C>G?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/V459L",
		"source": "oncokb",
		"description": "Compelling biological evidence supports the biomarker as being predictive of response to a drug but neither biomarker and drug are standard of care",
		"drug_labels": "PLX8394",
		"variant_name": "V459L",
		"source_link": "http://oncokb.org/#/gene/BRAF/variant/V459L",
		"evidence_label": "D",
		"response_type": "sensitive",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/22",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/22"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/22",
				"type": "Predictive",
				"description": "4",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26466569",
					"http://www.ncbi.nlm.nih.gov/pubmed/28659148",
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-All Tumors",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/22"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/42",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "PLX8394",
				"envcontext_id": "CID90116675",
				"usan_stem": null,
				"description": "PLX8394",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/22"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/23",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/17",
			"name": "A246P",
			"description": "BRAF A246P",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140501336,
			"end_pos": 140501336,
			"ref": "C",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.140501336C>G",
			"hgvs_c": "NM_004333.4:c.736G>C",
			"hgvs_p": "NP_004324.2:p.Ala246Pro",
			"dbsnp_ids": [
				"180177034"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140501336C>G?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/A246P",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "A246P",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/23",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/23"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/23",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/16474404"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/23"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/24",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/18",
			"name": "A598T",
			"description": "BRAF A598T",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453143,
			"end_pos": 140453143,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453143C>T",
			"hgvs_c": "NM_004333.4:c.1792G>A",
			"hgvs_p": "NP_004324.2:p.Ala598Thr",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453143C>T?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/A598T",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "A598T",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [

		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/24",
				"type": "Predisposing",
				"description": "Loss-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26619011",
					"http://www.ncbi.nlm.nih.gov/pubmed/22926515"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Neutral",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/24"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/25",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/19",
			"name": "A598V",
			"description": "BRAF A598V",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453142,
			"end_pos": 140453142,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140453142G>A",
			"hgvs_c": "NM_004333.4:c.1793C>T",
			"hgvs_p": "NP_004324.2:p.Ala598Val",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453142G>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/A598V",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "A598V",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/24",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/25"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/25",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19200582"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/25"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/26",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/20",
			"name": "A728V",
			"description": "BRAF A728V",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140434515,
			"end_pos": 140434515,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140434515G>A",
			"hgvs_c": "NM_004333.4:c.2183C>T",
			"hgvs_p": "NP_004324.2:p.Ala728Val",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140434515G>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/A728V",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "A728V",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/25",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/26"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/26",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15035987"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/26"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/27",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/21",
			"name": "AGAP3–BRAF Fusion",
			"description": "BRAF AGAP3–BRAF Fusion",
			"biomarker_type": "NA",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453155,
			"end_pos": 140453155,
			"ref": "C",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140453155C>A",
			"hgvs_c": "NM_004333.4:c.1780G>T",
			"hgvs_p": "NP_004324.2:p.Asp594Tyr",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453155C>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/AGAP3–BRAF Fusion",
		"source": "oncokb",
		"description": "NA",
		"drug_labels": null,
		"variant_name": "AGAP3–BRAF Fusion",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/26",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/27"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/27",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28539463"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/27"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/28",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/22",
			"name": "AGK-BRAF Fusion",
			"description": "BRAF AGK-BRAF Fusion",
			"biomarker_type": "NA",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453155,
			"end_pos": 140453155,
			"ref": "C",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140453155C>A",
			"hgvs_c": "NM_004333.4:c.1780G>T",
			"hgvs_p": "NP_004324.2:p.Asp594Tyr",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453155C>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/AGK-BRAF Fusion",
		"source": "oncokb",
		"description": "NA",
		"drug_labels": null,
		"variant_name": "AGK-BRAF Fusion",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/27",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/28"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/28",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26314551",
					"http://www.ncbi.nlm.nih.gov/pubmed/23890088",
					"http://www.ncbi.nlm.nih.gov/pubmed/24135138"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/28"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/29",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/23",
			"name": "AKAP9-BRAF Fusion",
			"description": "BRAF AKAP9-BRAF Fusion",
			"biomarker_type": "NA",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453155,
			"end_pos": 140453155,
			"ref": "C",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140453155C>A",
			"hgvs_c": "NM_004333.4:c.1780G>T",
			"hgvs_p": "NP_004324.2:p.Asp594Tyr",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453155C>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/AKAP9-BRAF Fusion",
		"source": "oncokb",
		"description": "NA",
		"drug_labels": null,
		"variant_name": "AKAP9-BRAF Fusion",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/28",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/29"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/29",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15630448"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/29"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/30",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/24",
			"name": "Amplification",
			"description": "BRAF Amplification",
			"biomarker_type": "NA",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140419127,
			"end_pos": 140624564,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/Amplification",
		"source": "oncokb",
		"description": "NA",
		"drug_labels": null,
		"variant_name": "Amplification",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/29",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/30"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/30",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15467732",
					"http://www.ncbi.nlm.nih.gov/pubmed/24055054",
					"http://www.ncbi.nlm.nih.gov/pubmed/25618114",
					"http://www.ncbi.nlm.nih.gov/pubmed/22395615",
					"http://www.ncbi.nlm.nih.gov/pubmed/21098728"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/30"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/31",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/25",
			"name": "CUL1-BRAF Fusion",
			"description": "BRAF CUL1-BRAF Fusion",
			"biomarker_type": "NA",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453155,
			"end_pos": 140453155,
			"ref": "C",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140453155C>A",
			"hgvs_c": "NM_004333.4:c.1780G>T",
			"hgvs_p": "NP_004324.2:p.Asp594Tyr",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453155C>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/CUL1-BRAF Fusion",
		"source": "oncokb",
		"description": "NA",
		"drug_labels": null,
		"variant_name": "CUL1-BRAF Fusion",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/30",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/31"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/31",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25985019",
					"http://www.ncbi.nlm.nih.gov/pubmed/22745804",
					"http://www.ncbi.nlm.nih.gov/pubmed/15630448",
					"http://www.ncbi.nlm.nih.gov/pubmed/26324360"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/31"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/32",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/7",
			"name": "D287H",
			"description": "BRAF D287H",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140501213,
			"end_pos": 140501213,
			"ref": "C",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.140501213C>G",
			"hgvs_c": "NM_004333.4:c.859G>C",
			"hgvs_p": "NP_004324.2:p.Asp287His",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140501213C>G?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/D287H",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "D287H",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/31",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/32"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/32",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26343582",
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/32"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/33",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/26",
			"name": "D594A",
			"description": "BRAF D594A",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453154,
			"end_pos": 140453154,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.140453154T>G",
			"hgvs_c": "NM_004333.4:c.1781A>C",
			"hgvs_p": "NP_004324.2:p.Asp594Ala",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453154T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/D594A",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "D594A",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/32",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/33"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/33",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719",
					"http://www.ncbi.nlm.nih.gov/pubmed/20141835",
					"http://www.ncbi.nlm.nih.gov/pubmed/28481359"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/33"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/34",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/27",
			"name": "D594E",
			"description": "BRAF D594E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453153,
			"end_pos": 140453153,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453153A>T",
			"hgvs_c": "NM_004333.4:c.1782T>A",
			"hgvs_p": "NP_004324.2:p.Asp594Glu",
			"dbsnp_ids": [
				"121913337"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453153A>T?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/D594E",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "D594E",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/33",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/34"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/34",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20978199"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/34"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/35",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/28",
			"name": "D594G",
			"description": "BRAF D594G",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453154,
			"end_pos": 140453154,
			"ref": "T",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.140453154T>C",
			"hgvs_c": "NM_004333.4:c.1781A>G",
			"hgvs_p": "NP_004324.2:p.Asp594Gly",
			"dbsnp_ids": [
				"121913338"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453154T>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/D594G",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "D594G",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/34",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/35"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/35",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26498038",
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719",
					"http://www.ncbi.nlm.nih.gov/pubmed/20141835",
					"http://www.ncbi.nlm.nih.gov/pubmed/28481359"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/35"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/36",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/29",
			"name": "D594H",
			"description": "BRAF D594H",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453155,
			"end_pos": 140453155,
			"ref": "C",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.140453155C>G",
			"hgvs_c": "NM_004333.4:c.1780G>C",
			"hgvs_p": "NP_004324.2:p.Asp594His",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453155C>G?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/D594H",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "D594H",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/35",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/36"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/36",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719",
					"http://www.ncbi.nlm.nih.gov/pubmed/28481359"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/36"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/37",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/30",
			"name": "D594N",
			"description": "BRAF D594N",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453155,
			"end_pos": 140453155,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453155C>T",
			"hgvs_c": "NM_004333.4:c.1780G>A",
			"hgvs_p": "NP_004324.2:p.Asp594Asn",
			"dbsnp_ids": [
				"397516896"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453155C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/D594N",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "D594N",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/36",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/37"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/37",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23833300",
					"http://www.ncbi.nlm.nih.gov/pubmed/26498038",
					"http://www.ncbi.nlm.nih.gov/pubmed/22798288",
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/37"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/38",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/31",
			"name": "D594V",
			"description": "BRAF D594V",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453154,
			"end_pos": 140453154,
			"ref": "T",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140453154T>A",
			"hgvs_c": "NM_004333.4:c.1781A>T",
			"hgvs_p": "NP_004324.2:p.Asp594Val",
			"dbsnp_ids": [
				"121913338"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453154T>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/D594V",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "D594V",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/37",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/38"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/38",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/14678966",
					"http://www.ncbi.nlm.nih.gov/pubmed/19376813",
					"http://www.ncbi.nlm.nih.gov/pubmed/15035987",
					"http://www.ncbi.nlm.nih.gov/pubmed/16439621"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/38"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/39",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/32",
			"name": "D594Y",
			"description": "BRAF D594Y",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453155,
			"end_pos": 140453155,
			"ref": "C",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140453155C>A",
			"hgvs_c": "NM_004333.4:c.1780G>T",
			"hgvs_p": "NP_004324.2:p.Asp594Tyr",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453155C>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/D594Y",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "D594Y",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/38",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/39"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/39",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23833300",
					"http://www.ncbi.nlm.nih.gov/pubmed/20141835",
					"http://www.ncbi.nlm.nih.gov/pubmed/16439621"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/39"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/40",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/33",
			"name": "E275K",
			"description": "BRAF E275K",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140501249,
			"end_pos": 140501249,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140501249C>T",
			"hgvs_c": "NM_004333.4:c.823G>A",
			"hgvs_p": "NP_004324.2:p.Glu275Lys",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140501249C>T?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/E275K",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "E275K",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/39",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/40"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/40",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19206169"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/40"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/41",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/34",
			"name": "E501G",
			"description": "BRAF E501G",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140477806,
			"end_pos": 140477806,
			"ref": "T",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.140477806T>C",
			"hgvs_c": "NM_004333.4:c.1502A>G",
			"hgvs_p": "NP_004324.2:p.Glu501Gly",
			"dbsnp_ids": [
				"180177039"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140477806T>C?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/E501G",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "E501G",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [

		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/41",
				"type": "Predisposing",
				"description": "Likely Neutral",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/16474404",
					"http://www.ncbi.nlm.nih.gov/pubmed/16439621"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Neutral",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/41"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/42",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/35",
			"name": "E501K",
			"description": "BRAF E501K",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140477807,
			"end_pos": 140477807,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140477807C>T",
			"hgvs_c": "NM_004333.4:c.1501G>A",
			"hgvs_p": "NP_004324.2:p.Glu501Lys",
			"dbsnp_ids": [
				"180177038"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140477807C>T?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/E501K",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "E501K",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [

		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/42",
				"type": "Predisposing",
				"description": "Inconclusive",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/17603482",
					"http://www.ncbi.nlm.nih.gov/pubmed/16474404"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Inconclusive",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/42"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/43",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/36",
			"name": "E586K",
			"description": "BRAF E586K",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453179,
			"end_pos": 140453179,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453179C>T",
			"hgvs_c": "NM_004333.4:c.1756G>A",
			"hgvs_p": "NP_004324.2:p.Glu586Lys",
			"dbsnp_ids": [
				"121913340"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453179C>T?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/E586K",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "E586K",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/40",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/43"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/43",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15035987"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/43"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/44",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/37",
			"name": "F247L",
			"description": "BRAF F247L",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140501331,
			"end_pos": 140501331,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140501331A>T",
			"hgvs_c": "NM_004333.4:c.741T>A",
			"hgvs_p": "NP_004324.2:p.Phe247Leu",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140501331A>T?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/F247L",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "F247L",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/41",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/44"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/44",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28512244",
					"http://www.ncbi.nlm.nih.gov/pubmed/29533785"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/44"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/45",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/38",
			"name": "F468C",
			"description": "BRAF F468C",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140481405,
			"end_pos": 140481405,
			"ref": "A",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.140481405A>C",
			"hgvs_c": "NM_004333.4:c.1403T>G",
			"hgvs_p": "NP_004324.2:p.Phe468Cys",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140481405A>C?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/F468C",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "F468C",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/42",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/45"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/45",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15150094"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/45"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/46",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/9",
			"name": "F595L",
			"description": "BRAF F595L",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453152,
			"end_pos": 140453152,
			"ref": "A",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.140453152A>G",
			"hgvs_c": "NM_004333.4:c.1783T>C",
			"hgvs_p": "NP_004324.2:p.Phe595Leu",
			"dbsnp_ids": [
				"794729219"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453152A>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/F595L",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "F595L",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/43",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/46"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/46",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15150094",
					"http://www.ncbi.nlm.nih.gov/pubmed/26150740",
					"http://www.ncbi.nlm.nih.gov/pubmed/26582644",
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719",
					"http://www.ncbi.nlm.nih.gov/pubmed/15035987"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/46"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/47",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/39",
			"name": "FAM131B-BRAF Fusion",
			"description": "BRAF FAM131B-BRAF Fusion",
			"biomarker_type": "NA",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453155,
			"end_pos": 140453155,
			"ref": "C",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140453155C>A",
			"hgvs_c": "NM_004333.4:c.1780G>T",
			"hgvs_p": "NP_004324.2:p.Asp594Tyr",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453155C>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/FAM131B-BRAF Fusion",
		"source": "oncokb",
		"description": "NA",
		"drug_labels": null,
		"variant_name": "FAM131B-BRAF Fusion",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/44",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/47"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/47",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25040262",
					"http://www.ncbi.nlm.nih.gov/pubmed/15630448",
					"http://www.ncbi.nlm.nih.gov/pubmed/21424530"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/47"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/48",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/4",
			"name": "Fusions",
			"description": "BRAF Fusions",
			"biomarker_type": "NA",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": null,
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/Fusions",
		"source": "oncokb",
		"description": "NA",
		"drug_labels": null,
		"variant_name": "Fusions",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/45",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/48"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/48",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/18974108",
					"http://www.ncbi.nlm.nih.gov/pubmed/26314551",
					"http://www.ncbi.nlm.nih.gov/pubmed/25985019",
					"http://www.ncbi.nlm.nih.gov/pubmed/26343582",
					"http://www.ncbi.nlm.nih.gov/pubmed/22745804",
					"http://www.ncbi.nlm.nih.gov/pubmed/15630448",
					"http://www.ncbi.nlm.nih.gov/pubmed/26324360",
					"http://www.ncbi.nlm.nih.gov/pubmed/21424530",
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719",
					"http://www.ncbi.nlm.nih.gov/pubmed/20526349",
					"http://www.ncbi.nlm.nih.gov/pubmed/24345920"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/48"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/49",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/40",
			"name": "G464E",
			"description": "BRAF G464E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140481417,
			"end_pos": 140481417,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140481417C>T",
			"hgvs_c": "NM_004333.4:c.1391G>A",
			"hgvs_p": "NP_004324.2:p.Gly464Glu",
			"dbsnp_ids": [
				"121913348"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140481417C>T?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/G464E",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "G464E",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/46",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/49"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/49",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15150094",
					"http://www.ncbi.nlm.nih.gov/pubmed/20179705",
					"http://www.ncbi.nlm.nih.gov/pubmed/26343582",
					"http://www.ncbi.nlm.nih.gov/pubmed/16364920",
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719",
					"http://www.ncbi.nlm.nih.gov/pubmed/18794803",
					"http://www.ncbi.nlm.nih.gov/pubmed/15035987",
					"http://www.ncbi.nlm.nih.gov/pubmed/23680146"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/49"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/50",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/41",
			"name": "G464R",
			"description": "BRAF G464R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140481418,
			"end_pos": 140481418,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140481418C>T",
			"hgvs_c": "NM_004333.4:c.1390G>A",
			"hgvs_p": "NP_004324.2:p.Gly464Arg",
			"dbsnp_ids": [
				"121913349"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140481418C>T?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/G464R",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "G464R",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/47",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/50"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/50",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15046639"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/50"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/51",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/42",
			"name": "G464V",
			"description": "BRAF G464V",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140481417,
			"end_pos": 140481417,
			"ref": "C",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140481417C>A",
			"hgvs_c": "NM_004333.4:c.1391G>T",
			"hgvs_p": "NP_004324.2:p.Gly464Val",
			"dbsnp_ids": [
				"121913348"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140481417C>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/G464V",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "G464V",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/48",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/51"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/51",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15150094",
					"http://www.ncbi.nlm.nih.gov/pubmed/20179705",
					"http://www.ncbi.nlm.nih.gov/pubmed/17314276",
					"http://www.ncbi.nlm.nih.gov/pubmed/26343582",
					"http://www.ncbi.nlm.nih.gov/pubmed/12068308",
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719",
					"http://www.ncbi.nlm.nih.gov/pubmed/18794803",
					"http://www.ncbi.nlm.nih.gov/pubmed/15035987"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/51"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/52",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/43",
			"name": "G466A",
			"description": "BRAF G466A",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140481411,
			"end_pos": 140481411,
			"ref": "C",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.140481411C>G",
			"hgvs_c": "NM_004333.4:c.1397G>C",
			"hgvs_p": "NP_004324.2:p.Gly466Ala",
			"dbsnp_ids": [
				"121913351"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140481411C>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/G466A",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "G466A",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/49",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/52"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/52",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719",
					"http://www.ncbi.nlm.nih.gov/pubmed/15035987",
					"http://www.ncbi.nlm.nih.gov/pubmed/28481359"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/52"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/53",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/44",
			"name": "G466E",
			"description": "BRAF G466E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140481411,
			"end_pos": 140481411,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140481411C>T",
			"hgvs_c": "NM_004333.4:c.1397G>A",
			"hgvs_p": "NP_004324.2:p.Gly466Glu",
			"dbsnp_ids": [
				"121913351"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140481411C>T?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/G466E",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "G466E",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/50",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/53"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/53",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27790118",
					"http://www.ncbi.nlm.nih.gov/pubmed/15046639",
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719",
					"http://www.ncbi.nlm.nih.gov/pubmed/15035987",
					"http://www.ncbi.nlm.nih.gov/pubmed/24446311",
					"http://www.ncbi.nlm.nih.gov/pubmed/28481359"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/53"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/54",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/45",
			"name": "G466R",
			"description": "BRAF G466R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140481412,
			"end_pos": 140481412,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140481412C>T",
			"hgvs_c": "NM_004333.4:c.1396G>A",
			"hgvs_p": "NP_004324.2:p.Gly466Arg",
			"dbsnp_ids": [
				"121913353"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140481412C>T?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/G466R",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "G466R",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/51",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/54"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/54",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/16364920",
					"http://www.ncbi.nlm.nih.gov/pubmed/15046639",
					"http://www.ncbi.nlm.nih.gov/pubmed/15035987"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/54"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/55",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/46",
			"name": "G466V",
			"description": "BRAF G466V",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140481411,
			"end_pos": 140481411,
			"ref": "C",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140481411C>A",
			"hgvs_c": "NM_004333.4:c.1397G>T",
			"hgvs_p": "NP_004324.2:p.Gly466Val",
			"dbsnp_ids": [
				"121913351"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140481411C>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/G466V",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "G466V",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/52",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/55"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/55",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22649091",
					"http://www.ncbi.nlm.nih.gov/pubmed/26498038",
					"http://www.ncbi.nlm.nih.gov/pubmed/24202393",
					"http://www.ncbi.nlm.nih.gov/pubmed/16364920",
					"http://www.ncbi.nlm.nih.gov/pubmed/15046639",
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719",
					"http://www.ncbi.nlm.nih.gov/pubmed/15035987",
					"http://www.ncbi.nlm.nih.gov/pubmed/28481359",
					"http://www.ncbi.nlm.nih.gov/pubmed/16439621"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/55"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/56",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/47",
			"name": "G469A",
			"description": "BRAF G469A",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140481402,
			"end_pos": 140481402,
			"ref": "C",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.140481402C>G",
			"hgvs_c": "NM_004333.4:c.1406G>C",
			"hgvs_p": "NP_004324.2:p.Gly469Ala",
			"dbsnp_ids": [
				"121913355"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140481402C>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/G469A",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "G469A",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/53",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/56"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/56",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20179705",
					"http://www.ncbi.nlm.nih.gov/pubmed/23833300",
					"http://www.ncbi.nlm.nih.gov/pubmed/26343582",
					"http://www.ncbi.nlm.nih.gov/pubmed/12068308",
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719",
					"http://www.ncbi.nlm.nih.gov/pubmed/18794803",
					"http://www.ncbi.nlm.nih.gov/pubmed/22510884",
					"http://www.ncbi.nlm.nih.gov/pubmed/22773810",
					"http://www.ncbi.nlm.nih.gov/pubmed/16439621"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/56"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/57",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/48",
			"name": "G469E",
			"description": "BRAF G469E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140481402,
			"end_pos": 140481402,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140481402C>T",
			"hgvs_c": "NM_004333.4:c.1406G>A",
			"hgvs_p": "NP_004324.2:p.Gly469Glu",
			"dbsnp_ids": [
				"121913355"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140481402C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/G469E",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "G469E",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/54",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/57"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/57",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15150094",
					"http://www.ncbi.nlm.nih.gov/pubmed/26498038",
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719",
					"http://www.ncbi.nlm.nih.gov/pubmed/18794803",
					"http://www.ncbi.nlm.nih.gov/pubmed/22510884",
					"http://www.ncbi.nlm.nih.gov/pubmed/15035987",
					"http://www.ncbi.nlm.nih.gov/pubmed/16439621"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/57"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/58",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/49",
			"name": "G469L",
			"description": "BRAF G469L",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": null,
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/G469L",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "G469L",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/55",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/58"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/58",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24920063",
					"http://www.ncbi.nlm.nih.gov/pubmed/24035431"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/58"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/59",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/50",
			"name": "G469R",
			"description": "BRAF G469R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140481403,
			"end_pos": 140481403,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140481403C>T",
			"hgvs_c": "NM_004333.4:c.1405G>A",
			"hgvs_p": "NP_004324.2:p.Gly469Arg",
			"dbsnp_ids": [
				"121913357"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140481403C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/G469R",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "G469R",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/56",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/59"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/59",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26150740",
					"http://www.ncbi.nlm.nih.gov/pubmed/24920063",
					"http://www.ncbi.nlm.nih.gov/pubmed/20179705",
					"http://www.ncbi.nlm.nih.gov/pubmed/26498038",
					"http://www.ncbi.nlm.nih.gov/pubmed/16096377",
					"http://www.ncbi.nlm.nih.gov/pubmed/26343582",
					"http://www.ncbi.nlm.nih.gov/pubmed/26619011",
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719",
					"http://www.ncbi.nlm.nih.gov/pubmed/18794803"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/59"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/60",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/51",
			"name": "G469V",
			"description": "BRAF G469V",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140481402,
			"end_pos": 140481402,
			"ref": "C",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140481402C>A",
			"hgvs_c": "NM_004333.4:c.1406G>T",
			"hgvs_p": "NP_004324.2:p.Gly469Val",
			"dbsnp_ids": [
				"121913355"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140481402C>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/G469V",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "G469V",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/57",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/60"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/60",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27388325",
					"http://www.ncbi.nlm.nih.gov/pubmed/20179705",
					"http://www.ncbi.nlm.nih.gov/pubmed/25870796",
					"http://www.ncbi.nlm.nih.gov/pubmed/23401075",
					"http://www.ncbi.nlm.nih.gov/pubmed/26343582",
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719",
					"http://www.ncbi.nlm.nih.gov/pubmed/18794803"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/60"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/61",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/52",
			"name": "G469del",
			"description": "BRAF G469del",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140481401,
			"end_pos": 140481403,
			"ref": "TTCC",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140481401_140481403delinsT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/G469del",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that deletes bases from the coding sequence",
		"drug_labels": null,
		"variant_name": "G469del",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/58",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/61"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/61",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23833300"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/61"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/62",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/53",
			"name": "G478C",
			"description": "BRAF G478C",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140481376,
			"end_pos": 140481376,
			"ref": "C",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140481376C>A",
			"hgvs_c": "NM_004333.4:c.1432G>T",
			"hgvs_p": "NP_004324.2:p.Gly478Cys",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140481376C>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/G478C",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "G478C",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [

		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/62",
				"type": "Predisposing",
				"description": "Loss-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22926515"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Neutral",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/62"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/63",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/54",
			"name": "G596C",
			"description": "BRAF G596C",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453149,
			"end_pos": 140453149,
			"ref": "C",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140453149C>A",
			"hgvs_c": "NM_004333.4:c.1786G>T",
			"hgvs_p": "NP_004324.2:p.Gly596Cys",
			"dbsnp_ids": [
				"121913361"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453149C>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/G596C",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "G596C",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/59",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/63"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/63",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/63"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/64",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/55",
			"name": "G596D",
			"description": "BRAF G596D",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453148,
			"end_pos": 140453148,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453148C>T",
			"hgvs_c": "NM_004333.4:c.1787G>A",
			"hgvs_p": "NP_004324.2:p.Gly596Asp",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453148C>T?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/G596D",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "G596D",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/60",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/64"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/64",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/17360030",
					"http://www.ncbi.nlm.nih.gov/pubmed/23481512",
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/64"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/65",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/56",
			"name": "G596R",
			"description": "BRAF G596R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453149,
			"end_pos": 140453149,
			"ref": "C",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.140453149C>G",
			"hgvs_c": "NM_004333.4:c.1786G>C",
			"hgvs_p": "NP_004324.2:p.Gly596Arg",
			"dbsnp_ids": [
				"121913361"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453149C>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/G596R",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "G596R",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/61",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/65"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/65",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/14678966",
					"http://www.ncbi.nlm.nih.gov/pubmed/26498038",
					"http://www.ncbi.nlm.nih.gov/pubmed/16364920",
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719",
					"http://www.ncbi.nlm.nih.gov/pubmed/15035987"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/65"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/66",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/57",
			"name": "G596V",
			"description": "BRAF G596V",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453148,
			"end_pos": 140453148,
			"ref": "C",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140453148C>A",
			"hgvs_c": "NM_004333.4:c.1787G>T",
			"hgvs_p": "NP_004324.2:p.Gly596Val",
			"dbsnp_ids": [
				"397507483"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453148C>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/G596V",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "G596V",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/62",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/66"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/66",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19376813",
					"http://www.ncbi.nlm.nih.gov/pubmed/16439621"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/66"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/67",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/58",
			"name": "GTF2I-BRAF Fusion",
			"description": "BRAF GTF2I-BRAF Fusion",
			"biomarker_type": "NA",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453155,
			"end_pos": 140453155,
			"ref": "C",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140453155C>A",
			"hgvs_c": "NM_004333.4:c.1780G>T",
			"hgvs_p": "NP_004324.2:p.Asp594Tyr",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453155C>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/GTF2I-BRAF Fusion",
		"source": "oncokb",
		"description": "NA",
		"drug_labels": null,
		"variant_name": "GTF2I-BRAF Fusion",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/63",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/67"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/67",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26314551",
					"http://www.ncbi.nlm.nih.gov/pubmed/28448514"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/67"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/68",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/59",
			"name": "H574Q",
			"description": "BRAF H574Q",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140454006,
			"end_pos": 140454006,
			"ref": "G",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140454006G>T",
			"hgvs_c": "NM_004333.4:c.1722C>A",
			"hgvs_p": "NP_004324.2:p.His574Gln",
			"dbsnp_ids": [
				"397507481"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140454006G>T?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/H574Q",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "H574Q",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/64",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/68"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/68",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27478040"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/68"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/69",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/60",
			"name": "I326V",
			"description": "BRAF I326V",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140500166,
			"end_pos": 140500166,
			"ref": "T",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.140500166T>C",
			"hgvs_c": "NM_004333.4:c.976A>G",
			"hgvs_p": "NP_004324.2:p.Ile326Val",
			"dbsnp_ids": [
				"775040765"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140500166T>C?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/I326V",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "I326V",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [

		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/69",
				"type": "Predisposing",
				"description": "Likely Neutral",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/17603482"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Neutral",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/69"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/70",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/61",
			"name": "I463S",
			"description": "BRAF I463S",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140481420,
			"end_pos": 140481420,
			"ref": "A",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.140481420A>C",
			"hgvs_c": "NM_004333.4:c.1388T>G",
			"hgvs_p": "NP_004324.2:p.Ile463Ser",
			"dbsnp_ids": [
				"180177033"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140481420A>C?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/I463S",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "I463S",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [

		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/70",
				"type": "Predisposing",
				"description": "Likely Neutral",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15150094",
					"http://www.ncbi.nlm.nih.gov/pubmed/15035987"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Neutral",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/70"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/71",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/62",
			"name": "K483E",
			"description": "BRAF K483E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140477861,
			"end_pos": 140477861,
			"ref": "T",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.140477861T>C",
			"hgvs_c": "NM_004333.4:c.1447A>G",
			"hgvs_p": "NP_004324.2:p.Lys483Glu",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140477861T>C?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/K483E",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "K483E",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/65",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/71"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/71",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27799065",
					"http://www.ncbi.nlm.nih.gov/pubmed/23533272",
					"http://www.ncbi.nlm.nih.gov/pubmed/15035987"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/71"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/72",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/63",
			"name": "K483M",
			"description": "BRAF K483M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140477859,
			"end_pos": 140477860,
			"ref": "TT",
			"alt": "CA",
			"hgvs_g": "NC_000007.13:g.140477859_140477860delinsCA",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/K483M",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "K483M",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/66",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/72"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/72",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19376813",
					"http://www.ncbi.nlm.nih.gov/pubmed/23533272",
					"http://www.ncbi.nlm.nih.gov/pubmed/15035987",
					"http://www.ncbi.nlm.nih.gov/pubmed/27025703"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/72"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/73",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/64",
			"name": "K499E",
			"description": "BRAF K499E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140477813,
			"end_pos": 140477813,
			"ref": "T",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.140477813T>C",
			"hgvs_c": "NM_004333.4:c.1495A>G",
			"hgvs_p": "NP_004324.2:p.Lys499Glu",
			"dbsnp_ids": [
				"180177037"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140477813T>C?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/K499E",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "K499E",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/67",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/73"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/73",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/16474404",
					"http://www.ncbi.nlm.nih.gov/pubmed/16439621"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/73"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/74",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/65",
			"name": "K601E",
			"description": "BRAF K601E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453134,
			"end_pos": 140453134,
			"ref": "T",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.140453134T>C",
			"hgvs_c": "NM_004333.4:c.1801A>G",
			"hgvs_p": "NP_004324.2:p.Lys601Glu",
			"dbsnp_ids": [
				"121913364"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453134T>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/K601E",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "K601E",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/68",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/74"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/74",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20179705",
					"http://www.ncbi.nlm.nih.gov/pubmed/26343582",
					"http://www.ncbi.nlm.nih.gov/pubmed/22798288",
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719",
					"http://www.ncbi.nlm.nih.gov/pubmed/18794803",
					"http://www.ncbi.nlm.nih.gov/pubmed/26643848"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/74"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/75",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/66",
			"name": "K601N",
			"description": "BRAF K601N",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453132,
			"end_pos": 140453132,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.140453132T>G",
			"hgvs_c": "NM_004333.4:c.1803A>C",
			"hgvs_p": "NP_004324.2:p.Lys601Asn",
			"dbsnp_ids": [
				"121913365"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453132T>G?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/K601N",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "K601N",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/69",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/75"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/75",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20179705",
					"http://www.ncbi.nlm.nih.gov/pubmed/24270325",
					"http://www.ncbi.nlm.nih.gov/pubmed/26343582",
					"http://www.ncbi.nlm.nih.gov/pubmed/12068308",
					"http://www.ncbi.nlm.nih.gov/pubmed/22798288",
					"http://www.ncbi.nlm.nih.gov/pubmed/23273605",
					"http://www.ncbi.nlm.nih.gov/pubmed/25178945",
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719",
					"http://www.ncbi.nlm.nih.gov/pubmed/18794803",
					"http://www.ncbi.nlm.nih.gov/pubmed/15035987"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/75"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/76",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/67",
			"name": "K601Q",
			"description": "BRAF K601Q",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453134,
			"end_pos": 140453134,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.140453134T>G",
			"hgvs_c": "NM_004333.4:c.1801A>C",
			"hgvs_p": "NP_004324.2:p.Lys601Gln",
			"dbsnp_ids": [
				"121913364"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453134T>G?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/K601Q",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "K601Q",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/70",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/76"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/76",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19206169"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/76"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/77",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/68",
			"name": "K601T",
			"description": "BRAF K601T",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453133,
			"end_pos": 140453133,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.140453133T>G",
			"hgvs_c": "NM_004333.4:c.1802A>C",
			"hgvs_p": "NP_004324.2:p.Lys601Thr",
			"dbsnp_ids": [
				"397507484"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453133T>G?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/K601T",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "K601T",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/71",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/77"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/77",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26090869",
					"http://www.ncbi.nlm.nih.gov/pubmed/26343582",
					"http://www.ncbi.nlm.nih.gov/pubmed/22798288",
					"http://www.ncbi.nlm.nih.gov/pubmed/25938346",
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/77"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/78",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/69",
			"name": "KIAA1549-BRAF Fusion",
			"description": "BRAF KIAA1549-BRAF Fusion",
			"biomarker_type": "NA",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453155,
			"end_pos": 140453155,
			"ref": "C",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140453155C>A",
			"hgvs_c": "NM_004333.4:c.1780G>T",
			"hgvs_p": "NP_004324.2:p.Asp594Tyr",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453155C>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/KIAA1549-BRAF Fusion",
		"source": "oncokb",
		"description": "NA",
		"drug_labels": null,
		"variant_name": "KIAA1549-BRAF Fusion",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/72",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/78"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/78",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/18974108",
					"http://www.ncbi.nlm.nih.gov/pubmed/23533272",
					"http://www.ncbi.nlm.nih.gov/pubmed/24345920",
					"http://www.ncbi.nlm.nih.gov/pubmed/26072686"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/78"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/79",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/70",
			"name": "L485F",
			"description": "BRAF L485F",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140477853,
			"end_pos": 140477853,
			"ref": "C",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140477853C>A",
			"hgvs_c": "NM_004333.4:c.1455G>T",
			"hgvs_p": "NP_004324.2:p.Leu485Phe",
			"dbsnp_ids": [
				"180177036"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140477853C>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/L485F",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "L485F",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/73",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/79"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/79",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/16474404",
					"http://www.ncbi.nlm.nih.gov/pubmed/16439621"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/79"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/80",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/71",
			"name": "L485_P490del",
			"description": "BRAF L485_P490del",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": null,
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/L485_P490del",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that deletes bases from the coding sequence",
		"drug_labels": null,
		"variant_name": "L485_P490del",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/74",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/80"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/80",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26732095"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/80"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/81",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/72",
			"name": "L485_P490delinsF",
			"description": "BRAF L485_P490delinsF",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": null,
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/L485_P490delinsF",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that deletes bases from the coding sequence",
		"drug_labels": null,
		"variant_name": "L485_P490delinsF",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/75",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/81"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/81",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26732095"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/81"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/82",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/73",
			"name": "L485_P490delinsY",
			"description": "BRAF L485_P490delinsY",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": null,
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/L485_P490delinsY",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that deletes bases from the coding sequence",
		"drug_labels": null,
		"variant_name": "L485_P490delinsY",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/76",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/82"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/82",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26732095"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/82"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/83",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/74",
			"name": "L485_Q494del",
			"description": "BRAF L485_Q494del",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": null,
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/L485_Q494del",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that deletes bases from the coding sequence",
		"drug_labels": null,
		"variant_name": "L485_Q494del",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/77",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/83"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/83",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26732095"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/83"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/84",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/75",
			"name": "L505H",
			"description": "BRAF L505H",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140477794,
			"end_pos": 140477794,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140477794A>T",
			"hgvs_c": "NM_004333.4:c.1514T>A",
			"hgvs_p": "NP_004324.2:p.Leu505His",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140477794A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/L505H",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "L505H",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/78",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/84"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/84",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25515853",
					"http://www.ncbi.nlm.nih.gov/pubmed/24112705",
					"http://www.ncbi.nlm.nih.gov/pubmed/24283590"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/84"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/85",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/76",
			"name": "L514V",
			"description": "BRAF L514V",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140476866,
			"end_pos": 140476866,
			"ref": "G",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.140476866G>C",
			"hgvs_c": "NM_004333.4:c.1540C>G",
			"hgvs_p": "NP_004324.2:p.Leu514Val",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140476866G>C?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/L514V",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "L514V",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/79",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/85"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/85",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/29880583"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/85"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/86",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/77",
			"name": "L584F",
			"description": "BRAF L584F",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453185,
			"end_pos": 140453185,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140453185G>A",
			"hgvs_c": "NM_004333.4:c.1750C>T",
			"hgvs_p": "NP_004324.2:p.Leu584Phe",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453185G>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/L584F",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "L584F",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [

		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/86",
				"type": "Predisposing",
				"description": "Inconclusive",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23658559"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Inconclusive",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/86"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/87",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/78",
			"name": "L597Q",
			"description": "BRAF L597Q",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453145,
			"end_pos": 140453145,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453145A>T",
			"hgvs_c": "NM_004333.4:c.1790T>A",
			"hgvs_p": "NP_004324.2:p.Leu597Gln",
			"dbsnp_ids": [
				"121913366"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453145A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/L597Q",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "L597Q",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/80",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/87"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/87",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20179705",
					"http://www.ncbi.nlm.nih.gov/pubmed/26343582",
					"http://www.ncbi.nlm.nih.gov/pubmed/12068308",
					"http://www.ncbi.nlm.nih.gov/pubmed/22798288",
					"http://www.ncbi.nlm.nih.gov/pubmed/24933606",
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719",
					"http://www.ncbi.nlm.nih.gov/pubmed/18794803",
					"http://www.ncbi.nlm.nih.gov/pubmed/26643848",
					"http://www.ncbi.nlm.nih.gov/pubmed/15035987"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/87"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/88",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/79",
			"name": "L597R",
			"description": "BRAF L597R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453145,
			"end_pos": 140453145,
			"ref": "A",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.140453145A>C",
			"hgvs_c": "NM_004333.4:c.1790T>G",
			"hgvs_p": "NP_004324.2:p.Leu597Arg",
			"dbsnp_ids": [
				"121913366"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453145A>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/L597R",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "L597R",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/81",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/88"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/88",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22798288",
					"http://www.ncbi.nlm.nih.gov/pubmed/24933606",
					"http://www.ncbi.nlm.nih.gov/pubmed/26643848"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/88"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/89",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/80",
			"name": "L597S",
			"description": "BRAF L597S",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453145,
			"end_pos": 140453146,
			"ref": "AG",
			"alt": "GA",
			"hgvs_g": "NC_000007.13:g.140453145_140453146delinsGA",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"121913368"
			],
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/L597S",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "L597S",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/82",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/89"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/89",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22798288",
					"http://www.ncbi.nlm.nih.gov/pubmed/24933606",
					"http://www.ncbi.nlm.nih.gov/pubmed/26643848"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/89"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/90",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/81",
			"name": "L597V",
			"description": "BRAF L597V",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453146,
			"end_pos": 140453146,
			"ref": "G",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.140453146G>C",
			"hgvs_c": "NM_004333.4:c.1789C>G",
			"hgvs_p": "NP_004324.2:p.Leu597Val",
			"dbsnp_ids": [
				"121913369"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453146G>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/L597V",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "L597V",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/83",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/90"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/90",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20179705",
					"http://www.ncbi.nlm.nih.gov/pubmed/26343582",
					"http://www.ncbi.nlm.nih.gov/pubmed/12068308",
					"http://www.ncbi.nlm.nih.gov/pubmed/22798288",
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719",
					"http://www.ncbi.nlm.nih.gov/pubmed/18794803",
					"http://www.ncbi.nlm.nih.gov/pubmed/26643848",
					"http://www.ncbi.nlm.nih.gov/pubmed/15035987"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/90"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/91",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/82",
			"name": "MKRN1-BRAF Fusion",
			"description": "BRAF MKRN1-BRAF Fusion",
			"biomarker_type": "NA",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453155,
			"end_pos": 140453155,
			"ref": "C",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140453155C>A",
			"hgvs_c": "NM_004333.4:c.1780G>T",
			"hgvs_p": "NP_004324.2:p.Asp594Tyr",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453155C>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/MKRN1-BRAF Fusion",
		"source": "oncokb",
		"description": "NA",
		"drug_labels": null,
		"variant_name": "MKRN1-BRAF Fusion",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/84",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/91"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/91",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/18974108",
					"http://www.ncbi.nlm.nih.gov/pubmed/26314551",
					"http://www.ncbi.nlm.nih.gov/pubmed/15630448",
					"http://www.ncbi.nlm.nih.gov/pubmed/26324360",
					"http://www.ncbi.nlm.nih.gov/pubmed/23817572"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/91"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/92",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/83",
			"name": "N486_P490del",
			"description": "BRAF N486_P490del",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": null,
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/N486_P490del",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that deletes bases from the coding sequence",
		"drug_labels": null,
		"variant_name": "N486_P490del",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/85",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/92"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/92",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26732095",
					"http://www.ncbi.nlm.nih.gov/pubmed/18060073"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/92"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/93",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/84",
			"name": "N581D",
			"description": "BRAF N581D",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453987,
			"end_pos": 140453987,
			"ref": "T",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.140453987T>C",
			"hgvs_c": "NM_004333.4:c.1741A>G",
			"hgvs_p": "NP_004324.2:p.Asn581Asp",
			"dbsnp_ids": [
				"180177040"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453987T>C?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/N581D",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "N581D",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/86",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/93"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/93",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/16474404"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/93"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/94",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/85",
			"name": "N581I",
			"description": "BRAF N581I",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453193,
			"end_pos": 140453193,
			"ref": "T",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140453193T>A",
			"hgvs_c": "NM_004333.4:c.1742A>T",
			"hgvs_p": "NP_004324.2:p.Asn581Ile",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453193T>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/N581I",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "N581I",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/87",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/94"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/94",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15917418",
					"http://www.ncbi.nlm.nih.gov/pubmed/22969966",
					"http://www.ncbi.nlm.nih.gov/pubmed/26202550",
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/94"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/95",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/86",
			"name": "N581S",
			"description": "BRAF N581S",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453193,
			"end_pos": 140453193,
			"ref": "T",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.140453193T>C",
			"hgvs_c": "NM_004333.4:c.1742A>G",
			"hgvs_p": "NP_004324.2:p.Asn581Ser",
			"dbsnp_ids": [
				"121913370"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453193T>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/N581S",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "N581S",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/88",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/95"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/95",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26498038",
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719",
					"http://www.ncbi.nlm.nih.gov/pubmed/15035987"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/95"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/96",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/87",
			"name": "N581Y",
			"description": "BRAF N581Y",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453987,
			"end_pos": 140453987,
			"ref": "T",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140453987T>A",
			"hgvs_c": "NM_004333.4:c.1741A>T",
			"hgvs_p": "NP_004324.2:p.Asn581Tyr",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453987T>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/N581Y",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "N581Y",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/89",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/96"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/96",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19474002",
					"http://www.ncbi.nlm.nih.gov/pubmed/26084293",
					"http://www.ncbi.nlm.nih.gov/pubmed/19276360",
					"http://www.ncbi.nlm.nih.gov/pubmed/15035987"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/96"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/97",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/88",
			"name": "P367R",
			"description": "BRAF P367R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140494148,
			"end_pos": 140494148,
			"ref": "G",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.140494148G>C",
			"hgvs_c": "NM_004333.4:c.1100C>G",
			"hgvs_p": "NP_004324.2:p.Pro367Arg",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140494148G>C?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/P367R",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "P367R",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/90",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/97"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/97",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27478040"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/97"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/98",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/89",
			"name": "P490_Q494del",
			"description": "BRAF P490_Q494del",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": null,
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/P490_Q494del",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that deletes bases from the coding sequence",
		"drug_labels": null,
		"variant_name": "P490_Q494del",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/91",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/98"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/98",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26732095"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/98"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/99",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/90",
			"name": "PAPSS1-BRAF Fusion",
			"description": "BRAF PAPSS1-BRAF Fusion",
			"biomarker_type": "NA",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453155,
			"end_pos": 140453155,
			"ref": "C",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140453155C>A",
			"hgvs_c": "NM_004333.4:c.1780G>T",
			"hgvs_p": "NP_004324.2:p.Asp594Tyr",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453155C>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/PAPSS1-BRAF Fusion",
		"source": "oncokb",
		"description": "NA",
		"drug_labels": null,
		"variant_name": "PAPSS1-BRAF Fusion",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/92",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/99"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/99",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15630448",
					"http://www.ncbi.nlm.nih.gov/pubmed/24345920"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/99"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/100",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/91",
			"name": "PPFIBP2-BRAF Fusion",
			"description": "BRAF PPFIBP2-BRAF Fusion",
			"biomarker_type": "NA",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453155,
			"end_pos": 140453155,
			"ref": "C",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140453155C>A",
			"hgvs_c": "NM_004333.4:c.1780G>T",
			"hgvs_p": "NP_004324.2:p.Asp594Tyr",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453155C>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/PPFIBP2-BRAF Fusion",
		"source": "oncokb",
		"description": "NA",
		"drug_labels": null,
		"variant_name": "PPFIBP2-BRAF Fusion",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/93",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/100"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/100",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26072686"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/100"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/101",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/92",
			"name": "Q201H",
			"description": "BRAF Q201H",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140508697,
			"end_pos": 140508697,
			"ref": "C",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140508697C>A",
			"hgvs_c": "NM_004333.4:c.603G>T",
			"hgvs_p": "NP_004324.2:p.Gln201His",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140508697C>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/Q201H",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "Q201H",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [

		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/101",
				"type": "Predisposing",
				"description": "Inconclusive",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/18060073"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Inconclusive",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/101"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/102",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/93",
			"name": "Q257R",
			"description": "BRAF Q257R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140501302,
			"end_pos": 140501302,
			"ref": "T",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.140501302T>C",
			"hgvs_c": "NM_004333.4:c.770A>G",
			"hgvs_p": "NP_004324.2:p.Gln257Arg",
			"dbsnp_ids": [
				"180177035"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140501302T>C?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/Q257R",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "Q257R",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/94",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/102"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/102",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19376813",
					"http://www.ncbi.nlm.nih.gov/pubmed/16474404",
					"http://www.ncbi.nlm.nih.gov/pubmed/16439621"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/102"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/103",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/94",
			"name": "R462E",
			"description": "BRAF R462E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": null,
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/R462E",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "R462E",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/95",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/103"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/103",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25155755"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/103"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/104",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/95",
			"name": "R462I",
			"description": "BRAF R462I",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140481423,
			"end_pos": 140481423,
			"ref": "C",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140481423C>A",
			"hgvs_c": "NM_004333.4:c.1385G>T",
			"hgvs_p": "NP_004324.2:p.Arg462Ile",
			"dbsnp_ids": [
				"180177032"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140481423C>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/R462I",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "R462I",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [

		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/104",
				"type": "Predisposing",
				"description": "Neutral",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15150094",
					"http://www.ncbi.nlm.nih.gov/pubmed/15035987"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Neutral",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/104"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/105",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/96",
			"name": "R506_K507insVLR",
			"description": "BRAF R506_K507insVLR",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": null,
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/R506_K507insVLR",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that inserts bases into in the coding sequence",
		"drug_labels": null,
		"variant_name": "R506_K507insVLR",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/96",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/105"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/105",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23817572"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/105"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/106",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/97",
			"name": "R509H",
			"description": "BRAF R509H",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": null,
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/R509H",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "R509H",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [

		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/106",
				"type": "Predisposing",
				"description": "Loss-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20179705"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Neutral",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/106"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/107",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/98",
			"name": "R671Q",
			"description": "BRAF R671Q",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140439727,
			"end_pos": 140439727,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140439727C>T",
			"hgvs_c": "NM_004333.4:c.2012G>A",
			"hgvs_p": "NP_004324.2:p.Arg671Gln",
			"dbsnp_ids": [
				"397507485"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140439727C>T?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/R671Q",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "R671Q",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/97",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/107"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/107",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28174173"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/107"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/108",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/99",
			"name": "S151A",
			"description": "BRAF S151A",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140534462,
			"end_pos": 140534462,
			"ref": "A",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.140534462A>C",
			"hgvs_c": "NM_004333.4:c.451T>G",
			"hgvs_p": "NP_004324.2:p.Ser151Ala",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140534462A>C?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/S151A",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "S151A",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/98",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/108"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/108",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21478863"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/108"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/109",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/100",
			"name": "S467A",
			"description": "BRAF S467A",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140481409,
			"end_pos": 140481409,
			"ref": "A",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.140481409A>C",
			"hgvs_c": "NM_004333.4:c.1399T>G",
			"hgvs_p": "NP_004324.2:p.Ser467Ala",
			"dbsnp_ids": [
				"869025606"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140481409A>C?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/S467A",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "S467A",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/99",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/109"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/109",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19376813",
					"http://www.ncbi.nlm.nih.gov/pubmed/16439621"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/109"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/110",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/15",
			"name": "S467L",
			"description": "BRAF S467L",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140481408,
			"end_pos": 140481408,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140481408G>A",
			"hgvs_c": "NM_004333.4:c.1400C>T",
			"hgvs_p": "NP_004324.2:p.Ser467Leu",
			"dbsnp_ids": [
				"867748453"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140481408G>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/S467L",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "S467L",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/100",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/110"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/110",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26498038",
					"http://www.ncbi.nlm.nih.gov/pubmed/25651238",
					"http://www.ncbi.nlm.nih.gov/pubmed/24710085",
					"http://www.ncbi.nlm.nih.gov/pubmed/26559571",
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/110"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/111",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/101",
			"name": "SND1-BRAF Fusion",
			"description": "BRAF SND1-BRAF Fusion",
			"biomarker_type": "NA",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453155,
			"end_pos": 140453155,
			"ref": "C",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140453155C>A",
			"hgvs_c": "NM_004333.4:c.1780G>T",
			"hgvs_p": "NP_004324.2:p.Asp594Tyr",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453155C>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/SND1-BRAF Fusion",
		"source": "oncokb",
		"description": "NA",
		"drug_labels": null,
		"variant_name": "SND1-BRAF Fusion",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/101",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/111"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/111",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25266736",
					"http://www.ncbi.nlm.nih.gov/pubmed/25985019",
					"http://www.ncbi.nlm.nih.gov/pubmed/22745804",
					"http://www.ncbi.nlm.nih.gov/pubmed/24345920"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/111"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/112",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/102",
			"name": "T241P",
			"description": "BRAF T241P",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140501351,
			"end_pos": 140501351,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.140501351T>G",
			"hgvs_c": "NM_004333.4:c.721A>C",
			"hgvs_p": "NP_004324.2:p.Thr241Pro",
			"dbsnp_ids": [
				"387906661"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140501351T>G?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/T241P",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "T241P",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/102",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/112"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/112",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19206169"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/112"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/113",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/103",
			"name": "T488_P492del",
			"description": "BRAF T488_P492del",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": null,
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/T488_P492del",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that deletes bases from the coding sequence",
		"drug_labels": null,
		"variant_name": "T488_P492del",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/103",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/113"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/113",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26732095"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/113"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/114",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/104",
			"name": "T529I",
			"description": "BRAF T529I",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140476820,
			"end_pos": 140476820,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140476820G>A",
			"hgvs_c": "NM_004333.4:c.1586C>T",
			"hgvs_p": "NP_004324.2:p.Thr529Ile",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140476820G>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/T529I",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "T529I",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [

		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/114",
				"type": "Predisposing",
				"description": "Likely Neutral",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15573099",
					"http://www.ncbi.nlm.nih.gov/pubmed/20538618"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Neutral",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/114"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/115",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/105",
			"name": "T529M",
			"description": "BRAF T529M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": null,
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/T529M",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "T529M",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [

		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/115",
				"type": "Predisposing",
				"description": "Likely Neutral",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15573099",
					"http://www.ncbi.nlm.nih.gov/pubmed/20538618"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Neutral",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/115"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/116",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/106",
			"name": "T529N",
			"description": "BRAF T529N",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140476820,
			"end_pos": 140476820,
			"ref": "G",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140476820G>T",
			"hgvs_c": "NM_004333.4:c.1586C>A",
			"hgvs_p": "NP_004324.2:p.Thr529Asn",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140476820G>T?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/T529N",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "T529N",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [

		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/116",
				"type": "Predisposing",
				"description": "Likely Neutral",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15573099",
					"http://www.ncbi.nlm.nih.gov/pubmed/20538618"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Neutral",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/116"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/117",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/107",
			"name": "T599I",
			"description": "BRAF T599I",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453139,
			"end_pos": 140453139,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140453139G>A",
			"hgvs_c": "NM_004333.4:c.1796C>T",
			"hgvs_p": "NP_004324.2:p.Thr599Ile",
			"dbsnp_ids": [
				"121913375"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453139G>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/T599I",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "T599I",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/104",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/117"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/117",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15035987"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/117"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/118",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/108",
			"name": "T599R",
			"description": "BRAF T599R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453139,
			"end_pos": 140453139,
			"ref": "G",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.140453139G>C",
			"hgvs_c": "NM_004333.4:c.1796C>G",
			"hgvs_p": "NP_004324.2:p.Thr599Arg",
			"dbsnp_ids": [
				"121913375"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453139G>C?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/T599R",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "T599R",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/105",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/118"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/118",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25120313",
					"http://www.ncbi.nlm.nih.gov/pubmed/19206169"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/118"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/119",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/109",
			"name": "T599_V600insEAT",
			"description": "BRAF T599_V600insEAT",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": null,
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/T599_V600insEAT",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that inserts bases into in the coding sequence",
		"drug_labels": null,
		"variant_name": "T599_V600insEAT",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/106",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/119"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/119",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/16501605"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/119"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/120",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/110",
			"name": "T599_V600insETT",
			"description": "BRAF T599_V600insETT",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": null,
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/T599_V600insETT",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that inserts bases into in the coding sequence",
		"drug_labels": null,
		"variant_name": "T599_V600insETT",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/107",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/120"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/120",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/16501605"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/120"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/121",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/111",
			"name": "T599_V600insV",
			"description": "BRAF T599_V600insV",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": null,
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/T599_V600insV",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that inserts bases into in the coding sequence",
		"drug_labels": null,
		"variant_name": "T599_V600insV",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/108",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/121"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/121",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/16501605"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/121"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/122",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/112",
			"name": "T599dup",
			"description": "BRAF T599dup",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453138,
			"end_pos": 140453139,
			"ref": "T",
			"alt": "TGTA",
			"hgvs_g": "NC_000007.13:g.140453138_140453139delinsTGTA",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/T599dup",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that inserts bases into in the coding sequence",
		"drug_labels": null,
		"variant_name": "T599dup",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/109",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/122"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/122",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23833300",
					"http://www.ncbi.nlm.nih.gov/pubmed/21190184",
					"http://www.ncbi.nlm.nih.gov/pubmed/19363522"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/122"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/123",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/113",
			"name": "T599insTT",
			"description": "BRAF T599insTT",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": null,
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/T599insTT",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that inserts bases into in the coding sequence",
		"drug_labels": null,
		"variant_name": "T599insTT",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/110",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/123"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/123",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21190184"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/123"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/124",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/114",
			"name": "TRIM24-BRAF Fusion",
			"description": "BRAF TRIM24-BRAF Fusion",
			"biomarker_type": "NA",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453155,
			"end_pos": 140453155,
			"ref": "C",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140453155C>A",
			"hgvs_c": "NM_004333.4:c.1780G>T",
			"hgvs_p": "NP_004324.2:p.Asp594Tyr",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453155C>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/TRIM24-BRAF Fusion",
		"source": "oncokb",
		"description": "NA",
		"drug_labels": null,
		"variant_name": "TRIM24-BRAF Fusion",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/111",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/124"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/124",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15630448",
					"http://www.ncbi.nlm.nih.gov/pubmed/24345920"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/124"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/125",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/16",
			"name": "V459L",
			"description": "BRAF V459L",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140481433,
			"end_pos": 140481433,
			"ref": "C",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.140481433C>G",
			"hgvs_c": "NM_004333.4:c.1375G>C",
			"hgvs_p": "NP_004324.2:p.Val459Leu",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140481433C>G?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/V459L",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "V459L",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/112",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/125"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/125",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719",
					"http://www.ncbi.nlm.nih.gov/pubmed/12460918"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/125"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/126",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/115",
			"name": "V471F",
			"description": "BRAF V471F",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140481397,
			"end_pos": 140481397,
			"ref": "C",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140481397C>A",
			"hgvs_c": "NM_004333.4:c.1411G>T",
			"hgvs_p": "NP_004324.2:p.Val471Phe",
			"dbsnp_ids": [
				"121913376"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140481397C>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/V471F",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "V471F",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/113",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/126"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/126",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25348715"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/126"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/127",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/116",
			"name": "V487_P492delinsA",
			"description": "BRAF V487_P492delinsA",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": null,
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/V487_P492delinsA",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that deletes bases from the coding sequence",
		"drug_labels": null,
		"variant_name": "V487_P492delinsA",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/114",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/127"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/127",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26732095"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/127"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/128",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/117",
			"name": "V600D",
			"description": "BRAF V600D",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453135,
			"end_pos": 140453136,
			"ref": "CA",
			"alt": "AT",
			"hgvs_g": "NC_000007.13:g.140453135_140453136delinsAT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"121913377"
			],
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/V600D",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "V600D",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/115",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/128"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/128",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25417114",
					"http://www.ncbi.nlm.nih.gov/pubmed/23579220",
					"http://www.ncbi.nlm.nih.gov/pubmed/22614978",
					"http://www.ncbi.nlm.nih.gov/pubmed/20179705",
					"http://www.ncbi.nlm.nih.gov/pubmed/23833300",
					"http://www.ncbi.nlm.nih.gov/pubmed/26091043",
					"http://www.ncbi.nlm.nih.gov/pubmed/26343582",
					"http://www.ncbi.nlm.nih.gov/pubmed/12068308",
					"http://www.ncbi.nlm.nih.gov/pubmed/25079552",
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719",
					"http://www.ncbi.nlm.nih.gov/pubmed/19251651",
					"http://www.ncbi.nlm.nih.gov/pubmed/15035987"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/128"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/129",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/118",
			"name": "V600D_K601insFGLAT",
			"description": "BRAF V600D_K601insFGLAT",
			"biomarker_type": "NA",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": null,
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/V600D_K601insFGLAT",
		"source": "oncokb",
		"description": "NA",
		"drug_labels": null,
		"variant_name": "V600D_K601insFGLAT",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/116",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/129"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/129",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/17297294"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/129"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/130",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/V600E",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "V600E",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/117",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/130"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/130",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25417114",
					"http://www.ncbi.nlm.nih.gov/pubmed/20179705",
					"http://www.ncbi.nlm.nih.gov/pubmed/23833300",
					"http://www.ncbi.nlm.nih.gov/pubmed/26091043",
					"http://www.ncbi.nlm.nih.gov/pubmed/26343582",
					"http://www.ncbi.nlm.nih.gov/pubmed/12068308",
					"http://www.ncbi.nlm.nih.gov/pubmed/25079552",
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719",
					"http://www.ncbi.nlm.nih.gov/pubmed/19251651",
					"http://www.ncbi.nlm.nih.gov/pubmed/15035987"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/130"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/131",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/119",
			"name": "V600G",
			"description": "BRAF V600G",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.140453136A>C",
			"hgvs_c": "NM_004333.4:c.1799T>G",
			"hgvs_p": "NP_004324.2:p.Val600Gly",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>C?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/V600G",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "V600G",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/118",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/131"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/131",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20735442",
					"http://www.ncbi.nlm.nih.gov/pubmed/16273091",
					"http://www.ncbi.nlm.nih.gov/pubmed/12068308",
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719",
					"http://www.ncbi.nlm.nih.gov/pubmed/26287849",
					"http://www.ncbi.nlm.nih.gov/pubmed/15035987"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/131"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/132",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/3",
			"name": "V600K",
			"description": "BRAF V600K",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453137,
			"ref": "AC",
			"alt": "TT",
			"hgvs_g": "NC_000007.13:g.140453136_140453137delinsTT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"121913227"
			],
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/V600K",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "V600K",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/119",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/132"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/132",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25417114",
					"http://www.ncbi.nlm.nih.gov/pubmed/20179705",
					"http://www.ncbi.nlm.nih.gov/pubmed/23833300",
					"http://www.ncbi.nlm.nih.gov/pubmed/22535154",
					"http://www.ncbi.nlm.nih.gov/pubmed/26091043",
					"http://www.ncbi.nlm.nih.gov/pubmed/26343582",
					"http://www.ncbi.nlm.nih.gov/pubmed/23922205",
					"http://www.ncbi.nlm.nih.gov/pubmed/25079552",
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719",
					"http://www.ncbi.nlm.nih.gov/pubmed/19251651",
					"http://www.ncbi.nlm.nih.gov/pubmed/15035987"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/132"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/133",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/120",
			"name": "V600M",
			"description": "BRAF V600M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453137,
			"end_pos": 140453137,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453137C>T",
			"hgvs_c": "NM_004333.4:c.1798G>A",
			"hgvs_p": "NP_004324.2:p.Val600Met",
			"dbsnp_ids": [
				"121913378"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453137C>T?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/V600M",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "V600M",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [

		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/133",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23579220",
					"http://www.ncbi.nlm.nih.gov/pubmed/20179705",
					"http://www.ncbi.nlm.nih.gov/pubmed/26343582",
					"http://www.ncbi.nlm.nih.gov/pubmed/26382582",
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719",
					"http://www.ncbi.nlm.nih.gov/pubmed/22536370",
					"http://www.ncbi.nlm.nih.gov/pubmed/25382067"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Inconclusive",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/133"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/134",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/121",
			"name": "V600R",
			"description": "BRAF V600R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453137,
			"ref": "AC",
			"alt": "CT",
			"hgvs_g": "NC_000007.13:g.140453136_140453137delinsCT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"121913227"
			],
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/V600R",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "V600R",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/120",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/134"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/134",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25417114",
					"http://www.ncbi.nlm.nih.gov/pubmed/22614978",
					"http://www.ncbi.nlm.nih.gov/pubmed/20179705",
					"http://www.ncbi.nlm.nih.gov/pubmed/23833300",
					"http://www.ncbi.nlm.nih.gov/pubmed/26343582",
					"http://www.ncbi.nlm.nih.gov/pubmed/23473613",
					"http://www.ncbi.nlm.nih.gov/pubmed/25079552",
					"http://www.ncbi.nlm.nih.gov/pubmed/28783719",
					"http://www.ncbi.nlm.nih.gov/pubmed/23237741",
					"http://www.ncbi.nlm.nih.gov/pubmed/15035987",
					"http://www.ncbi.nlm.nih.gov/pubmed/22536370",
					"http://www.ncbi.nlm.nih.gov/pubmed/23490649"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/134"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/135",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/122",
			"name": "V600_K601delinsE",
			"description": "BRAF V600_K601delinsE",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453134,
			"end_pos": 140453136,
			"ref": "TTCA",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453134_140453136delinsT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/V600_K601delinsE",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that deletes bases from the coding sequence",
		"drug_labels": null,
		"variant_name": "V600_K601delinsE",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/121",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/135"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/135",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26045855",
					"http://www.ncbi.nlm.nih.gov/pubmed/23833300"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/135"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/136",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/123",
			"name": "V600delinsYM",
			"description": "BRAF V600delinsYM",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": null,
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/V600delinsYM",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that inserts bases into in the coding sequence",
		"drug_labels": null,
		"variant_name": "V600delinsYM",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/122",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/136"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/136",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22752848"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/136"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/137",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/124",
			"name": "W450L",
			"description": "BRAF W450L",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140481459,
			"end_pos": 140481459,
			"ref": "C",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140481459C>A",
			"hgvs_c": "NM_004333.4:c.1349G>T",
			"hgvs_p": "NP_004324.2:p.Trp450Leu",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140481459C>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/W450L",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "W450L",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [

		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/137",
				"type": "Predisposing",
				"description": "Likely Neutral",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27478040"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Neutral",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/137"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/138",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/125",
			"name": "W531C",
			"description": "BRAF W531C",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140476813,
			"end_pos": 140476813,
			"ref": "C",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140476813C>A",
			"hgvs_c": "NM_004333.4:c.1593G>T",
			"hgvs_p": "NP_004324.2:p.Trp531Cys",
			"dbsnp_ids": [
				"606231228"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140476813C>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/W531C",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "W531C",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [

		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/138",
				"type": "Predisposing",
				"description": "Likely Neutral",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19206169"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Neutral",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/138"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/139",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/126",
			"name": "Y472C",
			"description": "BRAF Y472C",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140481393,
			"end_pos": 140481393,
			"ref": "T",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.140481393T>C",
			"hgvs_c": "NM_004333.4:c.1415A>G",
			"hgvs_p": "NP_004324.2:p.Tyr472Cys",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140481393T>C?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/Y472C",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "Y472C",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/123",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/139"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/139",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22649091"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/139"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/140",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/127",
			"name": "ZKSCAN1-BRAF Fusion",
			"description": "BRAF ZKSCAN1-BRAF Fusion",
			"biomarker_type": "NA",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453155,
			"end_pos": 140453155,
			"ref": "C",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140453155C>A",
			"hgvs_c": "NM_004333.4:c.1780G>T",
			"hgvs_p": "NP_004324.2:p.Asp594Tyr",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453155C>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/ZKSCAN1-BRAF Fusion",
		"source": "oncokb",
		"description": "NA",
		"drug_labels": null,
		"variant_name": "ZKSCAN1-BRAF Fusion",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/124",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/140"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/140",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26314551"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/140"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/141",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/128",
			"name": "p61BRAF-V600E",
			"description": "BRAF p61BRAF-V600E",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": null,
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "http://oncokb.org/#/gene/BRAF/variant/p61BRAF-V600E",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that deletes bases from the coding sequence",
		"drug_labels": null,
		"variant_name": "p61BRAF-V600E",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/125",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/141"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/141",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22113612"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "BRAF-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/141"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/142",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/129",
			"name": "Exon 20 insertion",
			"description": "EGFR Exon 20 insertion",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": null,
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/Exon 20 insertion",
		"source": "oncokb",
		"description": "Standard of care biomarker predictive of resistance to an FDA-approved drug in this indication",
		"drug_labels": "AFATINIB,Erlotinib,GEFITINIB",
		"variant_name": "Exon 20 insertion",
		"source_link": "http://oncokb.org/#/gene/EGFR/variant/Exon+20+insertion",
		"evidence_label": "A",
		"response_type": "resistant",
		"evidence_level": "1",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/126",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/142"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/142",
				"type": "Predictive",
				"description": "R1",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23371856",
					"http://www.ncbi.nlm.nih.gov/pubmed/24065731",
					"http://www.ncbi.nlm.nih.gov/pubmed/19536777",
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160",
					"http://www.ncbi.nlm.nih.gov/pubmed/21764376",
					"http://www.ncbi.nlm.nih.gov/pubmed/18676761",
					"http://www.ncbi.nlm.nih.gov/pubmed/24893891",
					"http://www.ncbi.nlm.nih.gov/pubmed/23328547",
					"http://www.ncbi.nlm.nih.gov/pubmed/1867676",
					"http://www.ncbi.nlm.nih.gov/pubmed/15897572",
					"http://www.ncbi.nlm.nih.gov/pubmed/17686547"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Non-Small Cell Lung Cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/142"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/45",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/142"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/44",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/142"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/43",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/142"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/143",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/130",
			"name": "T790M",
			"description": "EGFR T790M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249071,
			"end_pos": 55249071,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249071C>T",
			"hgvs_c": "NM_005228.3:c.2369C>T",
			"hgvs_p": "NP_005219.2:p.Thr790Met",
			"dbsnp_ids": [
				"121434569"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249071C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/T790M",
		"source": "oncokb",
		"description": "Standard of care biomarker predictive of resistance to an FDA-approved drug in this indication",
		"drug_labels": "AFATINIB,Erlotinib,GEFITINIB",
		"variant_name": "T790M",
		"source_link": "http://oncokb.org/#/gene/EGFR/variant/T790M",
		"evidence_label": "A",
		"response_type": "resistant",
		"evidence_level": "1",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/127",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/143"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/143",
				"type": "Predictive",
				"description": "R1",
				"publications": [
					"http://library.iaslc.org/search-speaker?search_speaker=17991",
					"http://www.ncbi.nlm.nih.gov/pubmed/24478319",
					"http://www.ncbi.nlm.nih.gov/pubmed/26051236",
					"http://www.ncbi.nlm.nih.gov/pubmed/23816963"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Non-Small Cell Lung Cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/143"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/48",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/143"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/47",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/143"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/46",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/143"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/144",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/131",
			"name": "A750P",
			"description": "EGFR A750P",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242478,
			"end_pos": 55242478,
			"ref": "G",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.55242478G>C",
			"hgvs_c": "NM_005228.3:c.2248G>C",
			"hgvs_p": "NP_005219.2:p.Ala750Pro",
			"dbsnp_ids": [
				"121913229"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55242478G>C?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/A750P",
		"source": "oncokb",
		"description": "FDA-approved biomarker and drug in this indication",
		"drug_labels": "Erlotinib,AFATINIB,GEFITINIB",
		"variant_name": "A750P",
		"source_link": "http://oncokb.org/#/gene/EGFR/variant/A750P",
		"evidence_label": "A",
		"response_type": "NA",
		"evidence_level": "1",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/128",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/144"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/144",
				"type": "Predictive",
				"description": "1",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28336552",
					"http://www.ncbi.nlm.nih.gov/pubmed/19625781",
					"http://www.ncbi.nlm.nih.gov/pubmed/25179728",
					"http://www.ncbi.nlm.nih.gov/pubmed/15737014"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Non-Small Cell Lung Cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/144"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/51",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/144"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/50",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/144"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/49",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/144"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/145",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/132",
			"name": "A763_Y764insFQEA",
			"description": "EGFR A763_Y764insFQEA",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55248992,
			"end_pos": 55248993,
			"ref": "T",
			"alt": "TTCCAGGAAGCCT",
			"hgvs_g": "NC_000007.13:g.55248992_55248993delinsTTCCAGGAAGCCT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/A763_Y764insFQEA",
		"source": "oncokb",
		"description": "FDA-approved biomarker and drug in this indication",
		"drug_labels": "Erlotinib,AFATINIB,GEFITINIB",
		"variant_name": "A763_Y764insFQEA",
		"source_link": "http://oncokb.org/#/gene/EGFR/variant/A763_Y764insFQEA",
		"evidence_label": "A",
		"response_type": "NA",
		"evidence_level": "1",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/129",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/145"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/145",
				"type": "Predictive",
				"description": "1",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23371856",
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160",
					"http://www.ncbi.nlm.nih.gov/pubmed/23969006"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Non-Small Cell Lung Cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/145"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/54",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/145"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/53",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/145"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/52",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/145"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/146",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/133",
			"name": "E709K",
			"description": "EGFR E709K",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55241677,
			"end_pos": 55241677,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55241677G>A",
			"hgvs_c": "NM_005228.3:c.2125G>A",
			"hgvs_p": "NP_005219.2:p.Glu709Lys",
			"dbsnp_ids": [
				"727504256"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55241677G>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/E709K",
		"source": "oncokb",
		"description": "FDA-approved biomarker and drug in this indication",
		"drug_labels": "AFATINIB,Erlotinib,GEFITINIB",
		"variant_name": "E709K",
		"source_link": "http://oncokb.org/#/gene/EGFR/variant/E709K",
		"evidence_label": "A",
		"response_type": "NA",
		"evidence_level": "1",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/130",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/146"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/146",
				"type": "Predictive",
				"description": "1",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28336552",
					"http://www.ncbi.nlm.nih.gov/pubmed/23566546",
					"http://www.ncbi.nlm.nih.gov/pubmed/18000506",
					"http://www.ncbi.nlm.nih.gov/pubmed/25179728",
					"http://www.ncbi.nlm.nih.gov/pubmed/25130612",
					"http://www.ncbi.nlm.nih.gov/pubmed/23749122",
					"http://www.ncbi.nlm.nih.gov/pubmed/15710947"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Non-Small Cell Lung Cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/146"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/57",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/146"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/56",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/146"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/55",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/146"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/147",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/134",
			"name": "E709_T710delinsD",
			"description": "EGFR E709_T710delinsD",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55241679,
			"end_pos": 55241681,
			"ref": "AAAC",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55241679_55241681delinsA",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/E709_T710delinsD",
		"source": "oncokb",
		"description": "FDA-approved biomarker and drug in this indication",
		"drug_labels": "AFATINIB,Erlotinib,GEFITINIB",
		"variant_name": "E709_T710delinsD",
		"source_link": "http://oncokb.org/#/gene/EGFR/variant/E709_T710delinsD",
		"evidence_label": "A",
		"response_type": "NA",
		"evidence_level": "1",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/131",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/147"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/147",
				"type": "Predictive",
				"description": "1",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21531810",
					"http://www.ncbi.nlm.nih.gov/pubmed/28336552",
					"http://www.ncbi.nlm.nih.gov/pubmed/26206867"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Non-Small Cell Lung Cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/147"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/60",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/147"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/59",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/147"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/58",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/147"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/148",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/135",
			"name": "Exon 19 deletion",
			"description": "EGFR Exon 19 deletion",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55086714,
			"end_pos": 55324313,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/Exon 19 deletion",
		"source": "oncokb",
		"description": "FDA-approved biomarker and drug in this indication",
		"drug_labels": "Erlotinib,AFATINIB,OSIMERTINIB,DACOMITINIB,GEFITINIB",
		"variant_name": "Exon 19 deletion",
		"source_link": "http://oncokb.org/#/gene/EGFR/variant/Exon+19+deletion",
		"evidence_label": "A",
		"response_type": "NA",
		"evidence_level": "1",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/132",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/148"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/148",
				"type": "Predictive",
				"description": "1",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28958502",
					"http://www.ncbi.nlm.nih.gov/pubmed/23816960",
					"http://www.ncbi.nlm.nih.gov/pubmed/20022809",
					"http://www.ncbi.nlm.nih.gov/pubmed/21670455",
					"http://www.ncbi.nlm.nih.gov/pubmed/29151359",
					"http://www.ncbi.nlm.nih.gov/pubmed/22452895",
					"http://www.ncbi.nlm.nih.gov/pubmed/25589191",
					"http://www.ncbi.nlm.nih.gov/pubmed/22285168",
					"http://www.ncbi.nlm.nih.gov/pubmed/29864379",
					"http://www.ncbi.nlm.nih.gov/pubmed/19692680",
					"http://www.ncbi.nlm.nih.gov/pubmed/27987585",
					"http://www.ncbi.nlm.nih.gov/pubmed/22370314",
					"http://www.ncbi.nlm.nih.gov/pubmed/20573926"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Non-Small Cell Lung Cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/148"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/65",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/148"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/64",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DACOMITINIB",
				"envcontext_id": "11511120",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "DACOMITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/148"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/63",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "OSIMERTINIB",
				"envcontext_id": "71496458",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "OSIMERTINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/148"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/62",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/148"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/61",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/148"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/149",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/136",
			"name": "Exon 19 deletion/insertion",
			"description": "EGFR Exon 19 deletion/insertion",
			"biomarker_type": "NA",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55086714,
			"end_pos": 55324313,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/Exon 19 deletion/insertion",
		"source": "oncokb",
		"description": "FDA-approved biomarker and drug in this indication",
		"drug_labels": "Erlotinib,AFATINIB,OSIMERTINIB,DACOMITINIB,GEFITINIB",
		"variant_name": "Exon 19 deletion/insertion",
		"source_link": "http://oncokb.org/#/gene/EGFR/variant/Exon+19+deletion%2Finsertion",
		"evidence_label": "A",
		"response_type": "NA",
		"evidence_level": "1",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/133",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/149"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/149",
				"type": "Predictive",
				"description": "1",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28958502",
					"http://www.ncbi.nlm.nih.gov/pubmed/23816960",
					"http://www.ncbi.nlm.nih.gov/pubmed/20022809",
					"http://www.ncbi.nlm.nih.gov/pubmed/21670455",
					"http://www.ncbi.nlm.nih.gov/pubmed/29151359",
					"http://www.ncbi.nlm.nih.gov/pubmed/22452895",
					"http://www.ncbi.nlm.nih.gov/pubmed/25589191",
					"http://www.ncbi.nlm.nih.gov/pubmed/22285168",
					"http://www.ncbi.nlm.nih.gov/pubmed/29864379",
					"http://www.ncbi.nlm.nih.gov/pubmed/19692680",
					"http://www.ncbi.nlm.nih.gov/pubmed/27987585",
					"http://www.ncbi.nlm.nih.gov/pubmed/22370314",
					"http://www.ncbi.nlm.nih.gov/pubmed/20573926"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Non-Small Cell Lung Cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/149"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/70",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/149"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/69",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DACOMITINIB",
				"envcontext_id": "11511120",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "DACOMITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/149"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/68",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "OSIMERTINIB",
				"envcontext_id": "71496458",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "OSIMERTINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/149"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/67",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/149"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/66",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/149"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/150",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/137",
			"name": "Exon 19 insertion",
			"description": "EGFR Exon 19 insertion",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": null,
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/Exon 19 insertion",
		"source": "oncokb",
		"description": "FDA-approved biomarker and drug in this indication",
		"drug_labels": "AFATINIB,Erlotinib,GEFITINIB",
		"variant_name": "Exon 19 insertion",
		"source_link": "http://oncokb.org/#/gene/EGFR/variant/Exon+19+insertion",
		"evidence_label": "A",
		"response_type": "NA",
		"evidence_level": "1",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/134",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/150"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/150",
				"type": "Predictive",
				"description": "1",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28336552",
					"http://www.ncbi.nlm.nih.gov/pubmed/22190593"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Non-Small Cell Lung Cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/150"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/73",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/150"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/72",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/150"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/71",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/150"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/151",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/138",
			"name": "G719",
			"description": "EGFR G719",
			"biomarker_type": "NA",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580"
			],
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55241707,
			"end_pos": 55241707,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55241707G>A",
			"hgvs_c": "NM_005228.3:c.2155G>A",
			"hgvs_p": "NP_005219.2:p.Gly719Ser",
			"dbsnp_ids": [
				"28929495"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55241707G>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/G719",
		"source": "oncokb",
		"description": "FDA-approved biomarker and drug in this indication",
		"drug_labels": "Erlotinib,AFATINIB,GEFITINIB",
		"variant_name": "G719",
		"source_link": "http://oncokb.org/#/gene/EGFR/variant/G719",
		"evidence_label": "A",
		"response_type": "NA",
		"evidence_level": "1",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/135",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/151"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/151",
				"type": "Predictive",
				"description": "1",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21531810",
					"http://www.ncbi.nlm.nih.gov/pubmed/28336552",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118073",
					"http://www.ncbi.nlm.nih.gov/pubmed/26051236",
					"http://www.ncbi.nlm.nih.gov/pubmed/21670455",
					"http://www.ncbi.nlm.nih.gov/pubmed/16011858",
					"http://www.ncbi.nlm.nih.gov/pubmed/24285021",
					"http://www.ncbi.nlm.nih.gov/pubmed/20573926"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Non-Small Cell Lung Cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/151"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/76",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/151"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/75",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/151"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/74",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/151"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/152",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/139",
			"name": "Kinase Domain Duplication",
			"description": "EGFR Kinase Domain Duplication",
			"biomarker_type": "NA",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": null,
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/Kinase Domain Duplication",
		"source": "oncokb",
		"description": "FDA-approved biomarker and drug in this indication",
		"drug_labels": "AFATINIB,Erlotinib,GEFITINIB",
		"variant_name": "Kinase Domain Duplication",
		"source_link": "http://oncokb.org/#/gene/EGFR/variant/Kinase+Domain+Duplication",
		"evidence_label": "A",
		"response_type": "NA",
		"evidence_level": "1",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/136",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/152"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/152",
				"type": "Predictive",
				"description": "1",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28336552",
					"http://www.ncbi.nlm.nih.gov/pubmed/26286086"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Non-Small Cell Lung Cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/152"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/79",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/152"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/78",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/152"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/77",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/152"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/153",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/140",
			"name": "L747P",
			"description": "EGFR L747P",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": null,
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": "",
			"alt": "",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/L747P",
		"source": "oncokb",
		"description": "FDA-approved biomarker and drug in this indication",
		"drug_labels": "Erlotinib,AFATINIB,GEFITINIB",
		"variant_name": "L747P",
		"source_link": "http://oncokb.org/#/gene/EGFR/variant/L747P",
		"evidence_label": "A",
		"response_type": "NA",
		"evidence_level": "1",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/137",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/153"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/153",
				"type": "Predictive",
				"description": "1",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28336552",
					"http://www.ncbi.nlm.nih.gov/pubmed/22190593"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Non-Small Cell Lung Cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/153"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/82",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/153"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/81",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/153"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/80",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/153"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/154",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/141",
			"name": "L833V",
			"description": "EGFR L833V",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259439,
			"end_pos": 55259439,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259439T>G",
			"hgvs_c": "NM_005228.3:c.2497T>G",
			"hgvs_p": "NP_005219.2:p.Leu833Val",
			"dbsnp_ids": [
				"397517126"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259439T>G?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/L833V",
		"source": "oncokb",
		"description": "FDA-approved biomarker and drug in this indication",
		"drug_labels": "AFATINIB,Erlotinib,GEFITINIB",
		"variant_name": "L833V",
		"source_link": "http://oncokb.org/#/gene/EGFR/variant/L833V",
		"evidence_label": "A",
		"response_type": "NA",
		"evidence_level": "1",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/138",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/154"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/154",
				"type": "Predictive",
				"description": "1",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21949883",
					"http://www.ncbi.nlm.nih.gov/pubmed/23912954",
					"http://www.ncbi.nlm.nih.gov/pubmed/25130612",
					"http://www.ncbi.nlm.nih.gov/pubmed/20808254",
					"http://www.ncbi.nlm.nih.gov/pubmed/21422421"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Non-Small Cell Lung Cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/154"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/85",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/154"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/84",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/154"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/83",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/154"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/155",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/142",
			"name": "L858R",
			"description": "EGFR L858R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259515T>G",
			"hgvs_c": "NM_005228.3:c.2573T>G",
			"hgvs_p": "NP_005219.2:p.Leu858Arg",
			"dbsnp_ids": [
				"121434568"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/L858R",
		"source": "oncokb",
		"description": "FDA-approved biomarker and drug in this indication",
		"drug_labels": "Erlotinib,AFATINIB,OSIMERTINIB,DACOMITINIB,GEFITINIB",
		"variant_name": "L858R",
		"source_link": "http://oncokb.org/#/gene/EGFR/variant/L858R",
		"evidence_label": "A",
		"response_type": "NA",
		"evidence_level": "1",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/139",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/155"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/155",
				"type": "Predictive",
				"description": "1",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28958502",
					"http://www.ncbi.nlm.nih.gov/pubmed/23816960",
					"http://www.ncbi.nlm.nih.gov/pubmed/20022809",
					"http://www.ncbi.nlm.nih.gov/pubmed/21670455",
					"http://www.ncbi.nlm.nih.gov/pubmed/29151359",
					"http://www.ncbi.nlm.nih.gov/pubmed/22452895",
					"http://www.ncbi.nlm.nih.gov/pubmed/25589191",
					"http://www.ncbi.nlm.nih.gov/pubmed/22285168",
					"http://www.ncbi.nlm.nih.gov/pubmed/29864379",
					"http://www.ncbi.nlm.nih.gov/pubmed/19692680",
					"http://www.ncbi.nlm.nih.gov/pubmed/27987585",
					"http://www.ncbi.nlm.nih.gov/pubmed/22370314",
					"http://www.ncbi.nlm.nih.gov/pubmed/20573926"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Non-Small Cell Lung Cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/155"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/90",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/155"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/89",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DACOMITINIB",
				"envcontext_id": "11511120",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "DACOMITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/155"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/88",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "OSIMERTINIB",
				"envcontext_id": "71496458",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "OSIMERTINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/155"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/87",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/155"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/86",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/155"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/156",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/143",
			"name": "L861",
			"description": "EGFR L861",
			"biomarker_type": "NA",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259523,
			"end_pos": 55259523,
			"ref": "C",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259523C>G",
			"hgvs_c": "NM_005228.3:c.2581C>G",
			"hgvs_p": "NP_005219.2:p.Leu861Val",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259523C>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/L861",
		"source": "oncokb",
		"description": "FDA-approved biomarker and drug in this indication",
		"drug_labels": "AFATINIB,Erlotinib,GEFITINIB",
		"variant_name": "L861",
		"source_link": "http://oncokb.org/#/gene/EGFR/variant/L861",
		"evidence_label": "A",
		"response_type": "NA",
		"evidence_level": "1",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/140",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/156"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/156",
				"type": "Predictive",
				"description": "1",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21531810",
					"http://www.ncbi.nlm.nih.gov/pubmed/28336552",
					"http://www.ncbi.nlm.nih.gov/pubmed/26051236"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Non-Small Cell Lung Cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/156"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/93",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/156"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/92",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/156"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/91",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/156"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/157",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/144",
			"name": "M277E",
			"description": "EGFR M277E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": null,
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/M277E",
		"source": "oncokb",
		"description": "FDA-approved biomarker and drug in this indication",
		"drug_labels": "Erlotinib,AFATINIB,GEFITINIB",
		"variant_name": "M277E",
		"source_link": "http://oncokb.org/#/gene/EGFR/variant/M277E",
		"evidence_label": "A",
		"response_type": "NA",
		"evidence_level": "1",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/141",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/157"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/157",
				"type": "Predictive",
				"description": "1",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28979142"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Non-Small Cell Lung Cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/157"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/96",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/157"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/95",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/157"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/94",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/157"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/158",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/145",
			"name": "S768I",
			"description": "EGFR S768I",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249005,
			"end_pos": 55249005,
			"ref": "G",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249005G>T",
			"hgvs_c": "NM_005228.3:c.2303G>T",
			"hgvs_p": "NP_005219.2:p.Ser768Ile",
			"dbsnp_ids": [
				"121913465"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249005G>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/S768I",
		"source": "oncokb",
		"description": "FDA-approved biomarker and drug in this indication",
		"drug_labels": "AFATINIB,Erlotinib,GEFITINIB",
		"variant_name": "S768I",
		"source_link": "http://oncokb.org/#/gene/EGFR/variant/S768I",
		"evidence_label": "A",
		"response_type": "NA",
		"evidence_level": "1",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/142",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/158"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/158",
				"type": "Predictive",
				"description": "1",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/17285735",
					"http://www.ncbi.nlm.nih.gov/pubmed/28336552",
					"http://www.ncbi.nlm.nih.gov/pubmed/25521405",
					"http://www.ncbi.nlm.nih.gov/pubmed/26051236"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Non-Small Cell Lung Cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/158"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/99",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/158"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/98",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/158"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/97",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/158"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/159",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/130",
			"name": "T790M",
			"description": "EGFR T790M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249071,
			"end_pos": 55249071,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249071C>T",
			"hgvs_c": "NM_005228.3:c.2369C>T",
			"hgvs_p": "NP_005219.2:p.Thr790Met",
			"dbsnp_ids": [
				"121434569"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249071C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/T790M",
		"source": "oncokb",
		"description": "FDA-approved biomarker and drug in this indication",
		"drug_labels": "OSIMERTINIB",
		"variant_name": "T790M",
		"source_link": "http://oncokb.org/#/gene/EGFR/variant/T790M",
		"evidence_label": "A",
		"response_type": "NA",
		"evidence_level": "1",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/143",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/159"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/159",
				"type": "Predictive",
				"description": "1",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25923549",
					"http://www.ncbi.nlm.nih.gov/pubmed/27751847",
					"http://www.ncbi.nlm.nih.gov/pubmed/29151359"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Non-Small Cell Lung Cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/159"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/100",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "OSIMERTINIB",
				"envcontext_id": "71496458",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "OSIMERTINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/159"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/160",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/129",
			"name": "Exon 20 insertion",
			"description": "EGFR Exon 20 insertion",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": null,
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/Exon 20 insertion",
		"source": "oncokb",
		"description": "Compelling clinical evidence supports the biomarker as being predictive of response to a drug in this indication but neither biomarker and drug are standard of care",
		"drug_labels": "Poziotinib",
		"variant_name": "Exon 20 insertion",
		"source_link": "http://oncokb.org/#/gene/EGFR/variant/Exon+20+insertion",
		"evidence_label": "C",
		"response_type": "sensitive",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/144",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/160"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/160",
				"type": "Predictive",
				"description": "3A",
				"publications": [
					"https://wclc2018.iaslc.org/wp-content/uploads/2018/09/WCLC2018-Abstract-Book_vF-LR-REV-SEPT-25-2018.pdf",
					"http://www.ncbi.nlm.nih.gov/pubmed/27188206",
					"http://www.ncbi.nlm.nih.gov/pubmed/29686424"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Non-Small Cell Lung Cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/160"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/101",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Poziotinib",
				"envcontext_id": "25127713",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Poziotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/160"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/161",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/146",
			"name": "A289V",
			"description": "EGFR A289V",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55221822,
			"end_pos": 55221822,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55221822C>T",
			"hgvs_c": "NM_005228.3:c.866C>T",
			"hgvs_p": "NP_005219.2:p.Ala289Val",
			"dbsnp_ids": [
				"149840192"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55221822C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/A289V",
		"source": "oncokb",
		"description": "Compelling biological evidence supports the biomarker as being predictive of response to a drug but neither biomarker and drug are standard of care",
		"drug_labels": "Lapatinib",
		"variant_name": "A289V",
		"source_link": "http://oncokb.org/#/gene/EGFR/variant/A289V",
		"evidence_label": "D",
		"response_type": "sensitive",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/145",
				"source": "http://purl.obolibrary.org/obo/DOID_3070",
				"term": "malignant glioma",
				"pheno_id": "DOID:3070",
				"family": "cell type cancer",
				"description": "malignant glioma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/161"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/161",
				"type": "Predictive",
				"description": "4",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/18334972",
					"http://www.ncbi.nlm.nih.gov/pubmed/20459769",
					"http://www.ncbi.nlm.nih.gov/pubmed/22588883"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Glioma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/161"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/102",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Lapatinib",
				"envcontext_id": "208908",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Lapatinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/161"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/162",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/147",
			"name": "Amplification",
			"description": "EGFR Amplification",
			"biomarker_type": "NA",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55086714,
			"end_pos": 55324313,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/Amplification",
		"source": "oncokb",
		"description": "Compelling biological evidence supports the biomarker as being predictive of response to a drug but neither biomarker and drug are standard of care",
		"drug_labels": "Lapatinib",
		"variant_name": "Amplification",
		"source_link": "http://oncokb.org/#/gene/EGFR/variant/Amplification",
		"evidence_label": "D",
		"response_type": "sensitive",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/146",
				"source": "http://purl.obolibrary.org/obo/DOID_3070",
				"term": "malignant glioma",
				"pheno_id": "DOID:3070",
				"family": "cell type cancer",
				"description": "malignant glioma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/162"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/162",
				"type": "Predictive",
				"description": "4",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/18334972",
					"http://www.ncbi.nlm.nih.gov/pubmed/20459769",
					"http://www.ncbi.nlm.nih.gov/pubmed/22588883"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Glioma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/162"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/103",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Lapatinib",
				"envcontext_id": "208908",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Lapatinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/162"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/163",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/148",
			"name": "R108K",
			"description": "EGFR R108K",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55211080,
			"end_pos": 55211080,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55211080G>A",
			"hgvs_c": "NM_005228.3:c.323G>A",
			"hgvs_p": "NP_005219.2:p.Arg108Lys",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55211080G>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/R108K",
		"source": "oncokb",
		"description": "Compelling biological evidence supports the biomarker as being predictive of response to a drug but neither biomarker and drug are standard of care",
		"drug_labels": "Lapatinib",
		"variant_name": "R108K",
		"source_link": "http://oncokb.org/#/gene/EGFR/variant/R108K",
		"evidence_label": "D",
		"response_type": "sensitive",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/147",
				"source": "http://purl.obolibrary.org/obo/DOID_3070",
				"term": "malignant glioma",
				"pheno_id": "DOID:3070",
				"family": "cell type cancer",
				"description": "malignant glioma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/163"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/163",
				"type": "Predictive",
				"description": "4",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/18334972",
					"http://www.ncbi.nlm.nih.gov/pubmed/20459769",
					"http://www.ncbi.nlm.nih.gov/pubmed/22588883"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Glioma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/163"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/104",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Lapatinib",
				"envcontext_id": "208908",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Lapatinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/163"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/164",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/149",
			"name": "T263P",
			"description": "EGFR T263P",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55221743,
			"end_pos": 55221743,
			"ref": "A",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.55221743A>C",
			"hgvs_c": "NM_005228.3:c.787A>C",
			"hgvs_p": "NP_005219.2:p.Thr263Pro",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55221743A>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/T263P",
		"source": "oncokb",
		"description": "Compelling biological evidence supports the biomarker as being predictive of response to a drug but neither biomarker and drug are standard of care",
		"drug_labels": "Lapatinib",
		"variant_name": "T263P",
		"source_link": "http://oncokb.org/#/gene/EGFR/variant/T263P",
		"evidence_label": "D",
		"response_type": "sensitive",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/148",
				"source": "http://purl.obolibrary.org/obo/DOID_3070",
				"term": "malignant glioma",
				"pheno_id": "DOID:3070",
				"family": "cell type cancer",
				"description": "malignant glioma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/164"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/164",
				"type": "Predictive",
				"description": "4",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/18334972",
					"http://www.ncbi.nlm.nih.gov/pubmed/20459769",
					"http://www.ncbi.nlm.nih.gov/pubmed/22588883"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Glioma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/164"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/105",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Lapatinib",
				"envcontext_id": "208908",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Lapatinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/164"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/165",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/150",
			"name": "D761Y",
			"description": "EGFR D761Y",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242511,
			"end_pos": 55242511,
			"ref": "G",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55242511G>T",
			"hgvs_c": "NM_005228.3:c.2281G>T",
			"hgvs_p": "NP_005219.2:p.Asp761Tyr",
			"dbsnp_ids": [
				"121913418"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55242511G>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/D761Y",
		"source": "oncokb",
		"description": "Compelling biological evidence supports the biomarker as being predictive of response to a drug but neither biomarker and drug are standard of care",
		"drug_labels": "OSIMERTINIB",
		"variant_name": "D761Y",
		"source_link": "http://oncokb.org/#/gene/EGFR/variant/D761Y",
		"evidence_label": "D",
		"response_type": "sensitive",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/149",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/165"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/165",
				"type": "Predictive",
				"description": "4",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28424065",
					"http://www.ncbi.nlm.nih.gov/pubmed/17085664"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Non-Small Cell Lung Cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/165"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/106",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "OSIMERTINIB",
				"envcontext_id": "71496458",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "OSIMERTINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/165"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/166",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/151",
			"name": "C797G",
			"description": "EGFR C797G",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249091,
			"end_pos": 55249091,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55249091T>G",
			"hgvs_c": "NM_005228.3:c.2389T>G",
			"hgvs_p": "NP_005219.2:p.Cys797Gly",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249091T>G?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/C797G",
		"source": "oncokb",
		"description": "Compelling clinical evidence supports the biomarker as being predictive of resistance to a drug, but neither biomarker nor drug are standard care",
		"drug_labels": "OSIMERTINIB",
		"variant_name": "C797G",
		"source_link": "http://oncokb.org/#/gene/EGFR/variant/C797G",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/150",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/166"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/166",
				"type": "Predictive",
				"description": "R2",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/29713646",
					"http://www.ncbi.nlm.nih.gov/pubmed/27086175"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Non-Small Cell Lung Cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/166"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/107",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "OSIMERTINIB",
				"envcontext_id": "71496458",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "OSIMERTINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/166"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/167",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/152",
			"name": "C797S",
			"description": "EGFR C797S",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249091,
			"end_pos": 55249091,
			"ref": "T",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55249091T>A",
			"hgvs_c": "NM_005228.3:c.2389T>A",
			"hgvs_p": "NP_005219.2:p.Cys797Ser",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249091T>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/C797S",
		"source": "oncokb",
		"description": "Compelling clinical evidence supports the biomarker as being predictive of resistance to a drug, but neither biomarker nor drug are standard care",
		"drug_labels": "OSIMERTINIB",
		"variant_name": "C797S",
		"source_link": "http://oncokb.org/#/gene/EGFR/variant/C797S",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/151",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/167"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/167",
				"type": "Predictive",
				"description": "R2",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26749488",
					"http://www.ncbi.nlm.nih.gov/pubmed/28625641",
					"http://www.ncbi.nlm.nih.gov/pubmed/26181354",
					"http://www.ncbi.nlm.nih.gov/pubmed/25939061"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Non-Small Cell Lung Cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/167"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/108",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "OSIMERTINIB",
				"envcontext_id": "71496458",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "OSIMERTINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/167"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/168",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/150",
			"name": "D761Y",
			"description": "EGFR D761Y",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242511,
			"end_pos": 55242511,
			"ref": "G",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55242511G>T",
			"hgvs_c": "NM_005228.3:c.2281G>T",
			"hgvs_p": "NP_005219.2:p.Asp761Tyr",
			"dbsnp_ids": [
				"121913418"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55242511G>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/D761Y",
		"source": "oncokb",
		"description": "Compelling clinical evidence supports the biomarker as being predictive of resistance to a drug, but neither biomarker nor drug are standard care",
		"drug_labels": "GEFITINIB",
		"variant_name": "D761Y",
		"source_link": "http://oncokb.org/#/gene/EGFR/variant/D761Y",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/152",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/168"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/168",
				"type": "Predictive",
				"description": "R2",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28424065",
					"http://www.ncbi.nlm.nih.gov/pubmed/17085664",
					"http://www.ncbi.nlm.nih.gov/pubmed/17192902",
					"http://www.ncbi.nlm.nih.gov/pubmed/22052230"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Non-Small Cell Lung Cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/168"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/109",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/168"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/169",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/153",
			"name": "A289D",
			"description": "EGFR A289D",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55221822,
			"end_pos": 55221822,
			"ref": "C",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55221822C>A",
			"hgvs_c": "NM_005228.3:c.866C>A",
			"hgvs_p": "NP_005219.2:p.Ala289Asp",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55221822C>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/A289D",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "A289D",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/153",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/169"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/169",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/17177598",
					"http://www.ncbi.nlm.nih.gov/pubmed/26619011",
					"http://www.ncbi.nlm.nih.gov/pubmed/22588883"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/169"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/170",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/146",
			"name": "A289V",
			"description": "EGFR A289V",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55221822,
			"end_pos": 55221822,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55221822C>T",
			"hgvs_c": "NM_005228.3:c.866C>T",
			"hgvs_p": "NP_005219.2:p.Ala289Val",
			"dbsnp_ids": [
				"149840192"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55221822C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/A289V",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "A289V",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/154",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/170"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/170",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24120142",
					"http://www.ncbi.nlm.nih.gov/pubmed/29141884",
					"http://www.ncbi.nlm.nih.gov/pubmed/17177598",
					"http://www.ncbi.nlm.nih.gov/pubmed/22588883"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/170"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/171",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/154",
			"name": "A508V",
			"description": "EGFR A508V",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55229216,
			"end_pos": 55229216,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55229216C>T",
			"hgvs_c": "NM_005228.3:c.1523C>T",
			"hgvs_p": "NP_005219.2:p.Ala508Val",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55229216C>T?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/A508V",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "A508V",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [

		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/171",
				"type": "Predisposing",
				"description": "Likely Neutral",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28979142"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Neutral",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/171"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/172",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/155",
			"name": "A743T",
			"description": "EGFR A743T",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242457,
			"end_pos": 55242457,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55242457G>A",
			"hgvs_c": "NM_005228.3:c.2227G>A",
			"hgvs_p": "NP_005219.2:p.Ala743Thr",
			"dbsnp_ids": [
				"759256622"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55242457G>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/A743T",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "A743T",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [

		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/172",
				"type": "Predisposing",
				"description": "Neutral",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24891042"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Neutral",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/172"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/173",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/131",
			"name": "A750P",
			"description": "EGFR A750P",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242478,
			"end_pos": 55242478,
			"ref": "G",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.55242478G>C",
			"hgvs_c": "NM_005228.3:c.2248G>C",
			"hgvs_p": "NP_005219.2:p.Ala750Pro",
			"dbsnp_ids": [
				"121913229"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55242478G>C?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/A750P",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "A750P",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/155",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/173"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/173",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19625781",
					"http://www.ncbi.nlm.nih.gov/pubmed/25179728",
					"http://www.ncbi.nlm.nih.gov/pubmed/15737014",
					"http://www.ncbi.nlm.nih.gov/pubmed/16187797"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/173"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/174",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/156",
			"name": "A750_E758del",
			"description": "EGFR A750_E758del",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": null,
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/A750_E758del",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that deletes bases from the coding sequence",
		"drug_labels": null,
		"variant_name": "A750_E758del",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/156",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/174"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/174",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/18325048",
					"http://www.ncbi.nlm.nih.gov/pubmed/15329413",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118073",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118125"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/174"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/175",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/157",
			"name": "A750_E758delinsP",
			"description": "EGFR A750_E758delinsP",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": null,
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/A750_E758delinsP",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that deletes bases from the coding sequence",
		"drug_labels": null,
		"variant_name": "A750_E758delinsP",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/157",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/175"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/175",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15329413",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118073",
					"http://www.ncbi.nlm.nih.gov/pubmed/18261621",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118125"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/175"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/176",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/158",
			"name": "A755G",
			"description": "EGFR A755G",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242494,
			"end_pos": 55242494,
			"ref": "C",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55242494C>G",
			"hgvs_c": "NM_005228.3:c.2264C>G",
			"hgvs_p": "NP_005219.2:p.Ala755Gly",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55242494C>G?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/A755G",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "A755G",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/158",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/176"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/176",
				"type": "Predisposing",
				"description": "Inconclusive",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28336552",
					"http://www.ncbi.nlm.nih.gov/pubmed/16467085"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/176"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/177",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/132",
			"name": "A763_Y764insFQEA",
			"description": "EGFR A763_Y764insFQEA",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55248992,
			"end_pos": 55248993,
			"ref": "T",
			"alt": "TTCCAGGAAGCCT",
			"hgvs_g": "NC_000007.13:g.55248992_55248993delinsTTCCAGGAAGCCT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/A763_Y764insFQEA",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that inserts bases into in the coding sequence",
		"drug_labels": null,
		"variant_name": "A763_Y764insFQEA",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/159",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/177"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/177",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/29533785",
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/177"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/178",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/159",
			"name": "A767_V769del",
			"description": "EGFR A767_V769del",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": null,
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/A767_V769del",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that deletes bases from the coding sequence",
		"drug_labels": null,
		"variant_name": "A767_V769del",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/160",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/178"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/178",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23371856",
					"http://www.ncbi.nlm.nih.gov/pubmed/19536777",
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160",
					"http://www.ncbi.nlm.nih.gov/pubmed/21764376",
					"http://www.ncbi.nlm.nih.gov/pubmed/18676761",
					"http://www.ncbi.nlm.nih.gov/pubmed/15897572",
					"http://www.ncbi.nlm.nih.gov/pubmed/17686547"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/178"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/179",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/160",
			"name": "A767_V769dup",
			"description": "EGFR A767_V769dup",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249010,
			"end_pos": 55249011,
			"ref": "G",
			"alt": "GCCAGCGTGG",
			"hgvs_g": "NC_000007.13:g.55249010_55249011dupGCCAGCGTGG",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/A767_V769dup",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that inserts bases into in the coding sequence",
		"drug_labels": null,
		"variant_name": "A767_V769dup",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/161",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/179"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/179",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23371856",
					"http://www.ncbi.nlm.nih.gov/pubmed/19536777",
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160",
					"http://www.ncbi.nlm.nih.gov/pubmed/21764376",
					"http://www.ncbi.nlm.nih.gov/pubmed/18676761",
					"http://www.ncbi.nlm.nih.gov/pubmed/23912954",
					"http://www.ncbi.nlm.nih.gov/pubmed/23749122",
					"http://www.ncbi.nlm.nih.gov/pubmed/15897572",
					"http://www.ncbi.nlm.nih.gov/pubmed/17686547"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/179"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/180",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/161",
			"name": "A859T",
			"description": "EGFR A859T",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259517,
			"end_pos": 55259517,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55259517G>A",
			"hgvs_c": "NM_005228.3:c.2575G>A",
			"hgvs_p": "NP_005219.2:p.Ala859Thr",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259517G>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/A859T",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "A859T",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [

		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/180",
				"type": "Predisposing",
				"description": "Likely Neutral",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21317745",
					"http://www.ncbi.nlm.nih.gov/pubmed/23912954",
					"http://www.ncbi.nlm.nih.gov/pubmed/17877814",
					"http://www.ncbi.nlm.nih.gov/pubmed/15710947"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Neutral",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/180"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/181",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/162",
			"name": "A864T",
			"description": "EGFR A864T",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259532,
			"end_pos": 55259532,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55259532G>A",
			"hgvs_c": "NM_005228.3:c.2590G>A",
			"hgvs_p": "NP_005219.2:p.Ala864Thr",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259532G>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/A864T",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "A864T",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/162",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/181"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/181",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23585556",
					"http://www.ncbi.nlm.nih.gov/pubmed/19147750",
					"http://www.ncbi.nlm.nih.gov/pubmed/21761100",
					"http://www.ncbi.nlm.nih.gov/pubmed/22722798",
					"http://www.ncbi.nlm.nih.gov/pubmed/16551849"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/181"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/182",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/147",
			"name": "Amplification",
			"description": "EGFR Amplification",
			"biomarker_type": "NA",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55086714,
			"end_pos": 55324313,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/Amplification",
		"source": "oncokb",
		"description": "NA",
		"drug_labels": null,
		"variant_name": "Amplification",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/163",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/182"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/182",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24120142",
					"http://www.ncbi.nlm.nih.gov/pubmed/10728703"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/182"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/183",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/163",
			"name": "C-terminal domain",
			"description": "EGFR C-terminal domain",
			"biomarker_type": "NA",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55224556,
			"end_pos": 55224556,
			"ref": "T",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.55224556T>C",
			"hgvs_c": "NM_005228.3:c.1207+31T>C",
			"hgvs_p": null,
			"dbsnp_ids": [
				"375700897"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55224556T>C?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/C-terminal domain",
		"source": "oncokb",
		"description": "NA",
		"drug_labels": null,
		"variant_name": "C-terminal domain",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/164",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/183"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/183",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24120142",
					"http://www.ncbi.nlm.nih.gov/pubmed/22001862",
					"http://www.ncbi.nlm.nih.gov/pubmed/24292886",
					"http://www.ncbi.nlm.nih.gov/pubmed/20676128",
					"http://www.ncbi.nlm.nih.gov/pubmed/23007009"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/183"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/184",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/164",
			"name": "C620Y",
			"description": "EGFR C620Y",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55233109,
			"end_pos": 55233109,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55233109G>A",
			"hgvs_c": "NM_005228.3:c.1859G>A",
			"hgvs_p": "NP_005219.2:p.Cys620Tyr",
			"dbsnp_ids": [
				"150899403"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55233109G>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/C620Y",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "C620Y",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/165",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/184"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/184",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24747966"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/184"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/185",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/165",
			"name": "C628Y",
			"description": "EGFR C628Y",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55238870,
			"end_pos": 55238870,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55238870G>A",
			"hgvs_c": "NM_005228.3:c.1883G>A",
			"hgvs_p": "NP_005219.2:p.Cys628Tyr",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55238870G>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/C628Y",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "C628Y",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [

		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/185",
				"type": "Predisposing",
				"description": "Neutral",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24747966"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Neutral",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/185"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/186",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/151",
			"name": "C797G",
			"description": "EGFR C797G",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249091,
			"end_pos": 55249091,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55249091T>G",
			"hgvs_c": "NM_005228.3:c.2389T>G",
			"hgvs_p": "NP_005219.2:p.Cys797Gly",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249091T>G?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/C797G",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "C797G",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/166",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/186"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/186",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/29713646",
					"http://www.ncbi.nlm.nih.gov/pubmed/26378037",
					"http://www.ncbi.nlm.nih.gov/pubmed/27086175"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/186"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/187",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/152",
			"name": "C797S",
			"description": "EGFR C797S",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249091,
			"end_pos": 55249091,
			"ref": "T",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55249091T>A",
			"hgvs_c": "NM_005228.3:c.2389T>A",
			"hgvs_p": "NP_005219.2:p.Cys797Ser",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249091T>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/C797S",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "C797S",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/167",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/187"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/187",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26749488",
					"http://www.ncbi.nlm.nih.gov/pubmed/27251290",
					"http://www.ncbi.nlm.nih.gov/pubmed/28625641",
					"http://www.ncbi.nlm.nih.gov/pubmed/25964297",
					"http://www.ncbi.nlm.nih.gov/pubmed/26378037",
					"http://www.ncbi.nlm.nih.gov/pubmed/26181354",
					"http://www.ncbi.nlm.nih.gov/pubmed/25939061"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/187"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/188",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/166",
			"name": "C797Y",
			"description": "EGFR C797Y",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249092,
			"end_pos": 55249092,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55249092G>A",
			"hgvs_c": "NM_005228.3:c.2390G>A",
			"hgvs_p": "NP_005219.2:p.Cys797Tyr",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249092G>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/C797Y",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "C797Y",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/168",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/188"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/188",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20942962"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/188"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/189",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/167",
			"name": "D587H",
			"description": "EGFR D587H",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55233009,
			"end_pos": 55233009,
			"ref": "G",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.55233009G>C",
			"hgvs_c": "NM_005228.3:c.1759G>C",
			"hgvs_p": "NP_005219.2:p.Asp587His",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55233009G>C?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/D587H",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "D587H",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/169",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/189"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/189",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26571394",
					"http://www.ncbi.nlm.nih.gov/pubmed/27245685"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/189"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/190",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/168",
			"name": "D761N",
			"description": "EGFR D761N",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242511,
			"end_pos": 55242511,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55242511G>A",
			"hgvs_c": "NM_005228.3:c.2281G>A",
			"hgvs_p": "NP_005219.2:p.Asp761Asn",
			"dbsnp_ids": [
				"121913418"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55242511G>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/D761N",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "D761N",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/170",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/190"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/190",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19147750",
					"http://www.ncbi.nlm.nih.gov/pubmed/26870223"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/190"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/191",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/150",
			"name": "D761Y",
			"description": "EGFR D761Y",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242511,
			"end_pos": 55242511,
			"ref": "G",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55242511G>T",
			"hgvs_c": "NM_005228.3:c.2281G>T",
			"hgvs_p": "NP_005219.2:p.Asp761Tyr",
			"dbsnp_ids": [
				"121913418"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55242511G>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/D761Y",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "D761Y",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/171",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/191"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/191",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/17973572",
					"http://www.ncbi.nlm.nih.gov/pubmed/28424065",
					"http://www.ncbi.nlm.nih.gov/pubmed/17545553",
					"http://www.ncbi.nlm.nih.gov/pubmed/19632948",
					"http://www.ncbi.nlm.nih.gov/pubmed/17085664",
					"http://www.ncbi.nlm.nih.gov/pubmed/17192902",
					"http://www.ncbi.nlm.nih.gov/pubmed/22052230"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/191"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/192",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/169",
			"name": "D770_N771insD",
			"description": "EGFR D770_N771insD",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": null,
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/D770_N771insD",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that inserts bases into in the coding sequence",
		"drug_labels": null,
		"variant_name": "D770_N771insD",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/172",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/192"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/192",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23371856",
					"http://www.ncbi.nlm.nih.gov/pubmed/19536777",
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160",
					"http://www.ncbi.nlm.nih.gov/pubmed/21764376",
					"http://www.ncbi.nlm.nih.gov/pubmed/18676761",
					"http://www.ncbi.nlm.nih.gov/pubmed/15897572",
					"http://www.ncbi.nlm.nih.gov/pubmed/17686547"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/192"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/193",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/170",
			"name": "D770_N771insNPG",
			"description": "EGFR D770_N771insNPG",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/D770_N771insNPG",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that inserts bases into in the coding sequence",
		"drug_labels": null,
		"variant_name": "D770_N771insNPG",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/173",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/193"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/193",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23371856",
					"http://www.ncbi.nlm.nih.gov/pubmed/19536777",
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160",
					"http://www.ncbi.nlm.nih.gov/pubmed/21764376",
					"http://www.ncbi.nlm.nih.gov/pubmed/18676761",
					"http://www.ncbi.nlm.nih.gov/pubmed/15897572",
					"http://www.ncbi.nlm.nih.gov/pubmed/17686547"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/193"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/194",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/171",
			"name": "D770_N771insSVD",
			"description": "EGFR D770_N771insSVD",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249013,
			"end_pos": 55249014,
			"ref": null,
			"alt": "GCGTGGACA",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/D770_N771insSVD",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that inserts bases into in the coding sequence",
		"drug_labels": null,
		"variant_name": "D770_N771insSVD",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/174",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/194"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/194",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23371856",
					"http://www.ncbi.nlm.nih.gov/pubmed/19536777",
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160",
					"http://www.ncbi.nlm.nih.gov/pubmed/21764376",
					"http://www.ncbi.nlm.nih.gov/pubmed/18676761",
					"http://www.ncbi.nlm.nih.gov/pubmed/15897572",
					"http://www.ncbi.nlm.nih.gov/pubmed/17686547"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/194"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/195",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/172",
			"name": "D770_N771insVDSVDNP",
			"description": "EGFR D770_N771insVDSVDNP",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": null,
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/D770_N771insVDSVDNP",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that inserts bases into in the coding sequence",
		"drug_labels": null,
		"variant_name": "D770_N771insVDSVDNP",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/175",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/195"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/195",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23371856",
					"http://www.ncbi.nlm.nih.gov/pubmed/19536777",
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160",
					"http://www.ncbi.nlm.nih.gov/pubmed/21764376",
					"http://www.ncbi.nlm.nih.gov/pubmed/18676761",
					"http://www.ncbi.nlm.nih.gov/pubmed/15897572",
					"http://www.ncbi.nlm.nih.gov/pubmed/21841502",
					"http://www.ncbi.nlm.nih.gov/pubmed/17686547"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/195"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/196",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/173",
			"name": "D770_P772dup",
			"description": "EGFR D770_P772dup",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": null,
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/D770_P772dup",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that inserts bases into in the coding sequence",
		"drug_labels": null,
		"variant_name": "D770_P772dup",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/176",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/196"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/196",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23371856",
					"http://www.ncbi.nlm.nih.gov/pubmed/19536777",
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160",
					"http://www.ncbi.nlm.nih.gov/pubmed/21764376",
					"http://www.ncbi.nlm.nih.gov/pubmed/18676761",
					"http://www.ncbi.nlm.nih.gov/pubmed/23749122",
					"http://www.ncbi.nlm.nih.gov/pubmed/15897572",
					"http://www.ncbi.nlm.nih.gov/pubmed/17686547"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/196"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/197",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/174",
			"name": "E330K",
			"description": "EGFR E330K",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55223621,
			"end_pos": 55223621,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55223621G>A",
			"hgvs_c": "NM_005228.3:c.988G>A",
			"hgvs_p": "NP_005219.2:p.Glu330Lys",
			"dbsnp_ids": [
				"139429793"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55223621G>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/E330K",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "E330K",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/177",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/197"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/197",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24212795"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/197"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/198",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/175",
			"name": "E709A",
			"description": "EGFR E709A",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55241678,
			"end_pos": 55241678,
			"ref": "A",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.55241678A>C",
			"hgvs_c": "NM_005228.3:c.2126A>C",
			"hgvs_p": "NP_005219.2:p.Glu709Ala",
			"dbsnp_ids": [
				"397517085"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55241678A>C?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/E709A",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "E709A",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/178",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/198"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/198",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21531810",
					"http://www.ncbi.nlm.nih.gov/pubmed/29141884",
					"http://www.ncbi.nlm.nih.gov/pubmed/19671738",
					"http://www.ncbi.nlm.nih.gov/pubmed/23242437",
					"http://www.ncbi.nlm.nih.gov/pubmed/18261621",
					"http://www.ncbi.nlm.nih.gov/pubmed/23566546",
					"http://www.ncbi.nlm.nih.gov/pubmed/22483783",
					"http://www.ncbi.nlm.nih.gov/pubmed/23749122",
					"http://www.ncbi.nlm.nih.gov/pubmed/20479403",
					"http://www.ncbi.nlm.nih.gov/pubmed/15710947",
					"http://www.ncbi.nlm.nih.gov/pubmed/18372921",
					"http://www.ncbi.nlm.nih.gov/pubmed/21841502"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/198"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/199",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/133",
			"name": "E709K",
			"description": "EGFR E709K",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55241677,
			"end_pos": 55241677,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55241677G>A",
			"hgvs_c": "NM_005228.3:c.2125G>A",
			"hgvs_p": "NP_005219.2:p.Glu709Lys",
			"dbsnp_ids": [
				"727504256"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55241677G>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/E709K",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "E709K",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/179",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/199"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/199",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19726454",
					"http://www.ncbi.nlm.nih.gov/pubmed/29141884",
					"http://www.ncbi.nlm.nih.gov/pubmed/23566546",
					"http://www.ncbi.nlm.nih.gov/pubmed/18000506",
					"http://www.ncbi.nlm.nih.gov/pubmed/25179728",
					"http://www.ncbi.nlm.nih.gov/pubmed/25130612",
					"http://www.ncbi.nlm.nih.gov/pubmed/23749122",
					"http://www.ncbi.nlm.nih.gov/pubmed/15710947",
					"http://www.ncbi.nlm.nih.gov/pubmed/26206867"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/199"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/200",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/134",
			"name": "E709_T710delinsD",
			"description": "EGFR E709_T710delinsD",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55241679,
			"end_pos": 55241681,
			"ref": "AAAC",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55241679_55241681delinsA",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/E709_T710delinsD",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that deletes bases from the coding sequence",
		"drug_labels": null,
		"variant_name": "E709_T710delinsD",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/180",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/200"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/200",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21531810",
					"http://www.ncbi.nlm.nih.gov/pubmed/26206867"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/200"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/201",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/176",
			"name": "E734Q",
			"description": "EGFR E734Q",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242430,
			"end_pos": 55242430,
			"ref": "G",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.55242430G>C",
			"hgvs_c": "NM_005228.3:c.2200G>C",
			"hgvs_p": "NP_005219.2:p.Glu734Gln",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55242430G>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/E734Q",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "E734Q",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/181",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/201"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/201",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20942962"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/201"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/202",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/177",
			"name": "E746_A750del",
			"description": "EGFR E746_A750del",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242465,
			"end_pos": 55242479,
			"ref": "AGGAATTAAGAGAAGC",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55242465_55242479delinsA",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/E746_A750del",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that deletes bases from the coding sequence",
		"drug_labels": null,
		"variant_name": "E746_A750del",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/182",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/202"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/202",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/18508816",
					"http://www.ncbi.nlm.nih.gov/pubmed/29141884",
					"http://www.ncbi.nlm.nih.gov/pubmed/16467085",
					"http://www.ncbi.nlm.nih.gov/pubmed/15329413",
					"http://www.ncbi.nlm.nih.gov/pubmed/25179728",
					"http://www.ncbi.nlm.nih.gov/pubmed/15710947",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118125",
					"http://www.ncbi.nlm.nih.gov/pubmed/15897572",
					"http://www.ncbi.nlm.nih.gov/pubmed/18325048",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118073",
					"http://www.ncbi.nlm.nih.gov/pubmed/18261621",
					"http://www.ncbi.nlm.nih.gov/pubmed/22483783",
					"http://www.ncbi.nlm.nih.gov/pubmed/16373402"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/202"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/203",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/178",
			"name": "E746_A750delinsQ",
			"description": "EGFR E746_A750delinsQ",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": null,
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/E746_A750delinsQ",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that deletes bases from the coding sequence",
		"drug_labels": null,
		"variant_name": "E746_A750delinsQ",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/183",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/203"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/203",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15329413",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118073",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118125",
					"http://www.ncbi.nlm.nih.gov/pubmed/17192902"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/203"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/204",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/179",
			"name": "E746_S752delinsA",
			"description": "EGFR E746_S752delinsA",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242467,
			"end_pos": 55242484,
			"ref": "GAATTAAGAGAAGCAACAT",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55242467_55242484delinsG",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/E746_S752delinsA",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that deletes bases from the coding sequence",
		"drug_labels": null,
		"variant_name": "E746_S752delinsA",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/184",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/204"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/204",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15329413",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118073",
					"http://www.ncbi.nlm.nih.gov/pubmed/15710947",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118125"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/204"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/205",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/180",
			"name": "E746_S752delinsI",
			"description": "EGFR E746_S752delinsI",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": null,
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/E746_S752delinsI",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that deletes bases from the coding sequence",
		"drug_labels": null,
		"variant_name": "E746_S752delinsI",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/185",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/205"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/205",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15329413",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118073",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118125",
					"http://www.ncbi.nlm.nih.gov/pubmed/17192902"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/205"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/206",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/181",
			"name": "E746_S752delinsV",
			"description": "EGFR E746_S752delinsV",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": null,
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/E746_S752delinsV",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that deletes bases from the coding sequence",
		"drug_labels": null,
		"variant_name": "E746_S752delinsV",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/186",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/206"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/206",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15329413",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118073",
					"http://www.ncbi.nlm.nih.gov/pubmed/22483783",
					"http://www.ncbi.nlm.nih.gov/pubmed/25179728",
					"http://www.ncbi.nlm.nih.gov/pubmed/15710947",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118125"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/206"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/207",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/182",
			"name": "E746_T751delinsA",
			"description": "EGFR E746_T751delinsA",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242467,
			"end_pos": 55242481,
			"ref": "GAATTAAGAGAAGCAA",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55242467_55242481delinsG",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"121913425"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55242467_55242481del?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/E746_T751delinsA",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that deletes bases from the coding sequence",
		"drug_labels": null,
		"variant_name": "E746_T751delinsA",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/187",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/207"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/207",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15329413",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118073",
					"http://www.ncbi.nlm.nih.gov/pubmed/15710947",
					"http://www.ncbi.nlm.nih.gov/pubmed/15897572",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118125"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/207"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/208",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/183",
			"name": "E746_T751delinsL",
			"description": "EGFR E746_T751delinsL",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": null,
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/E746_T751delinsL",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that deletes bases from the coding sequence",
		"drug_labels": null,
		"variant_name": "E746_T751delinsL",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/188",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/208"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/208",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15329413",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118073",
					"http://www.ncbi.nlm.nih.gov/pubmed/18261621",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118125"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/208"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/209",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/184",
			"name": "E746_T751delinsVA",
			"description": "EGFR E746_T751delinsVA",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242467,
			"end_pos": 55242483,
			"ref": "AATTAAGAGAAGCAACA",
			"alt": "TTGCT",
			"hgvs_g": "NC_000007.13:g.55242467_55242483delinsTTGCT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/E746_T751delinsVA",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that deletes bases from the coding sequence",
		"drug_labels": null,
		"variant_name": "E746_T751delinsVA",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/189",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/209"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/209",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/18508816",
					"http://www.ncbi.nlm.nih.gov/pubmed/15329413",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118073",
					"http://www.ncbi.nlm.nih.gov/pubmed/15897572",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118125"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/209"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/210",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/185",
			"name": "E746_T751insIP",
			"description": "EGFR E746_T751insIP",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": null,
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/E746_T751insIP",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that inserts bases into in the coding sequence",
		"drug_labels": null,
		"variant_name": "E746_T751insIP",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/190",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/210"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/210",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/18325048",
					"http://www.ncbi.nlm.nih.gov/pubmed/22190593"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/210"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/211",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/186",
			"name": "E804G",
			"description": "EGFR E804G",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249113,
			"end_pos": 55249113,
			"ref": "A",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55249113A>G",
			"hgvs_c": "NM_005228.3:c.2411A>G",
			"hgvs_p": "NP_005219.2:p.Glu804Gly",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249113A>G?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/E804G",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "E804G",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/191",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/211"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/211",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/18193092"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/211"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/212",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/187",
			"name": "E865K",
			"description": "EGFR E865K",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259535,
			"end_pos": 55259535,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55259535G>A",
			"hgvs_c": "NM_005228.3:c.2593G>A",
			"hgvs_p": "NP_005219.2:p.Glu865Lys",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259535G>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/E865K",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "E865K",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/192",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/212"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/212",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/29141884"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/212"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/213",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/188",
			"name": "E866K",
			"description": "EGFR E866K",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259538,
			"end_pos": 55259538,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55259538G>A",
			"hgvs_c": "NM_005228.3:c.2596G>A",
			"hgvs_p": "NP_005219.2:p.Glu866Lys",
			"dbsnp_ids": [
				"756703787"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259538G>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/E866K",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "E866K",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [

		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/213",
				"type": "Predisposing",
				"description": "Loss-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19147750"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Neutral",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/213"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/214",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/189",
			"name": "E868G",
			"description": "EGFR E868G",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259545,
			"end_pos": 55259545,
			"ref": "A",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259545A>G",
			"hgvs_c": "NM_005228.3:c.2603A>G",
			"hgvs_p": "NP_005219.2:p.Glu868Gly",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259545A>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/E868G",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "E868G",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/193",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/214"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/214",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20942962",
					"http://www.ncbi.nlm.nih.gov/pubmed/16870303"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/214"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/215",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/190",
			"name": "E884K",
			"description": "EGFR E884K",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55260483,
			"end_pos": 55260483,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55260483G>A",
			"hgvs_c": "NM_005228.3:c.2650G>A",
			"hgvs_p": "NP_005219.2:p.Glu884Lys",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55260483G>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/E884K",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "E884K",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/194",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/215"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/215",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/16407879",
					"http://www.ncbi.nlm.nih.gov/pubmed/19015641"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/215"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/216",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/191",
			"name": "E931G",
			"description": "EGFR E931G",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55266500,
			"end_pos": 55266500,
			"ref": "A",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55266500A>G",
			"hgvs_c": "NM_005228.3:c.2792A>G",
			"hgvs_p": "NP_005219.2:p.Glu931Gly",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55266500A>G?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/E931G",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "E931G",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/195",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/216"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/216",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/17974985"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/216"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/217",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/192",
			"name": "EGFR-RAD51 Fusion",
			"description": "EGFR EGFR-RAD51 Fusion",
			"biomarker_type": "NA",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242467,
			"end_pos": 55242467,
			"ref": "A",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55242467A>G",
			"hgvs_c": "NM_005228.3:c.2237A>G",
			"hgvs_p": "NP_005219.2:p.Glu746Gly",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55242467A>G?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/EGFR-RAD51 Fusion",
		"source": "oncokb",
		"description": "NA",
		"drug_labels": null,
		"variant_name": "EGFR-RAD51 Fusion",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/196",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/217"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/217",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27102076"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/217"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/218",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/193",
			"name": "EGFR-SEPT14 Fusion",
			"description": "EGFR EGFR-SEPT14 Fusion",
			"biomarker_type": "NA",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242467,
			"end_pos": 55242467,
			"ref": "A",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55242467A>G",
			"hgvs_c": "NM_005228.3:c.2237A>G",
			"hgvs_p": "NP_005219.2:p.Glu746Gly",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55242467A>G?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/EGFR-SEPT14 Fusion",
		"source": "oncokb",
		"description": "NA",
		"drug_labels": null,
		"variant_name": "EGFR-SEPT14 Fusion",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/197",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/218"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/218",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26762204",
					"http://www.ncbi.nlm.nih.gov/pubmed/23917401"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/218"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/219",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/135",
			"name": "Exon 19 deletion",
			"description": "EGFR Exon 19 deletion",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55086714,
			"end_pos": 55324313,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/Exon 19 deletion",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that deletes bases from the coding sequence",
		"drug_labels": null,
		"variant_name": "Exon 19 deletion",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/198",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/219"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/219",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15329413",
					"http://www.ncbi.nlm.nih.gov/pubmed/18000506",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118125",
					"http://www.ncbi.nlm.nih.gov/pubmed/19536777",
					"http://www.ncbi.nlm.nih.gov/pubmed/18458038",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118073",
					"http://www.ncbi.nlm.nih.gov/pubmed/22019513",
					"http://www.ncbi.nlm.nih.gov/pubmed/23566546",
					"http://www.ncbi.nlm.nih.gov/pubmed/23559152",
					"http://www.ncbi.nlm.nih.gov/pubmed/24457318",
					"http://www.ncbi.nlm.nih.gov/pubmed/22760226",
					"http://www.ncbi.nlm.nih.gov/pubmed/23749122",
					"http://www.ncbi.nlm.nih.gov/pubmed/17192902"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/219"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/220",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/136",
			"name": "Exon 19 deletion/insertion",
			"description": "EGFR Exon 19 deletion/insertion",
			"biomarker_type": "NA",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55086714,
			"end_pos": 55324313,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/Exon 19 deletion/insertion",
		"source": "oncokb",
		"description": "NA",
		"drug_labels": null,
		"variant_name": "Exon 19 deletion/insertion",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/199",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/220"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/220",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15329413",
					"http://www.ncbi.nlm.nih.gov/pubmed/18000506",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118125",
					"http://www.ncbi.nlm.nih.gov/pubmed/19536777",
					"http://www.ncbi.nlm.nih.gov/pubmed/18458038",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118073",
					"http://www.ncbi.nlm.nih.gov/pubmed/22019513",
					"http://www.ncbi.nlm.nih.gov/pubmed/23566546",
					"http://www.ncbi.nlm.nih.gov/pubmed/23559152",
					"http://www.ncbi.nlm.nih.gov/pubmed/24457318",
					"http://www.ncbi.nlm.nih.gov/pubmed/22760226",
					"http://www.ncbi.nlm.nih.gov/pubmed/23749122",
					"http://www.ncbi.nlm.nih.gov/pubmed/17192902"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/220"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/221",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/137",
			"name": "Exon 19 insertion",
			"description": "EGFR Exon 19 insertion",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": null,
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/Exon 19 insertion",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that inserts bases into in the coding sequence",
		"drug_labels": null,
		"variant_name": "Exon 19 insertion",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/200",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/221"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/221",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21422421",
					"http://www.ncbi.nlm.nih.gov/pubmed/22190593"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/221"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/222",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/129",
			"name": "Exon 20 insertion",
			"description": "EGFR Exon 20 insertion",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": null,
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/Exon 20 insertion",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that inserts bases into in the coding sequence",
		"drug_labels": null,
		"variant_name": "Exon 20 insertion",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/201",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/222"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/222",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23371856",
					"http://www.ncbi.nlm.nih.gov/pubmed/19536777",
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160",
					"http://www.ncbi.nlm.nih.gov/pubmed/21764376",
					"http://www.ncbi.nlm.nih.gov/pubmed/18676761",
					"http://www.ncbi.nlm.nih.gov/pubmed/15897572",
					"http://www.ncbi.nlm.nih.gov/pubmed/17686547"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/222"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/223",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/194",
			"name": "Fusions",
			"description": "EGFR Fusions",
			"biomarker_type": "NA",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": null,
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/Fusions",
		"source": "oncokb",
		"description": "NA",
		"drug_labels": null,
		"variant_name": "Fusions",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/202",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/223"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/223",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27102076",
					"http://www.ncbi.nlm.nih.gov/pubmed/23917401"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/223"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/224",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/195",
			"name": "G428D",
			"description": "EGFR G428D",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55225431,
			"end_pos": 55225431,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55225431G>A",
			"hgvs_c": "NM_005228.3:c.1283G>A",
			"hgvs_p": "NP_005219.2:p.Gly428Asp",
			"dbsnp_ids": [
				"606231253"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55225431G>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/G428D",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "G428D",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [

		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/224",
				"type": "Predisposing",
				"description": "Loss-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26436111"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Neutral",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/224"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/225",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/196",
			"name": "G465R",
			"description": "EGFR G465R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55227926,
			"end_pos": 55227926,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55227926G>A",
			"hgvs_c": "NM_005228.3:c.1393G>A",
			"hgvs_p": "NP_005219.2:p.Gly465Arg",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55227926G>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/G465R",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "G465R",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/203",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/225"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/225",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26059438",
					"http://www.ncbi.nlm.nih.gov/pubmed/25623215",
					"http://www.ncbi.nlm.nih.gov/pubmed/26888827"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/225"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/226",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/197",
			"name": "G598V",
			"description": "EGFR G598V",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55233043,
			"end_pos": 55233043,
			"ref": "G",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55233043G>T",
			"hgvs_c": "NM_005228.3:c.1793G>T",
			"hgvs_p": "NP_005219.2:p.Gly598Val",
			"dbsnp_ids": [
				"139236063"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55233043G>T?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/G598V",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "G598V",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/204",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/226"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/226",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24120142",
					"http://www.ncbi.nlm.nih.gov/pubmed/29141884",
					"http://www.ncbi.nlm.nih.gov/pubmed/17177598",
					"http://www.ncbi.nlm.nih.gov/pubmed/22588883"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/226"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/227",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/198",
			"name": "G719A",
			"description": "EGFR G719A",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55241708,
			"end_pos": 55241708,
			"ref": "G",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.55241708G>C",
			"hgvs_c": "NM_005228.3:c.2156G>C",
			"hgvs_p": "NP_005219.2:p.Gly719Ala",
			"dbsnp_ids": [
				"121913428"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55241708G>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/G719A",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "G719A",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/205",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/227"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/227",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21531810",
					"http://www.ncbi.nlm.nih.gov/pubmed/26206867"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/227"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/228",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/199",
			"name": "G719C",
			"description": "EGFR G719C",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55241707,
			"end_pos": 55241707,
			"ref": "G",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55241707G>T",
			"hgvs_c": "NM_005228.3:c.2155G>T",
			"hgvs_p": "NP_005219.2:p.Gly719Cys",
			"dbsnp_ids": [
				"28929495"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55241707G>T?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/G719C",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "G719C",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/206",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/228"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/228",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21531810",
					"http://www.ncbi.nlm.nih.gov/pubmed/29141884",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118073",
					"http://www.ncbi.nlm.nih.gov/pubmed/18261621",
					"http://www.ncbi.nlm.nih.gov/pubmed/26206867",
					"http://www.ncbi.nlm.nih.gov/pubmed/21841502"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/228"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/229",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/200",
			"name": "G719S",
			"description": "EGFR G719S",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55241707,
			"end_pos": 55241707,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55241707G>A",
			"hgvs_c": "NM_005228.3:c.2155G>A",
			"hgvs_p": "NP_005219.2:p.Gly719Ser",
			"dbsnp_ids": [
				"28929495"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55241707G>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/G719S",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "G719S",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/207",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/229"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/229",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21531810",
					"http://www.ncbi.nlm.nih.gov/pubmed/29141884",
					"http://www.ncbi.nlm.nih.gov/pubmed/16187797",
					"http://www.ncbi.nlm.nih.gov/pubmed/26206867"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/229"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/230",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/201",
			"name": "G724S",
			"description": "EGFR G724S",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55241722,
			"end_pos": 55241722,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55241722G>A",
			"hgvs_c": "NM_005228.3:c.2170G>A",
			"hgvs_p": "NP_005219.2:p.Gly724Ser",
			"dbsnp_ids": [
				"1051753269"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55241722G>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/G724S",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "G724S",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/208",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/230"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/230",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/16166444",
					"http://www.ncbi.nlm.nih.gov/pubmed/28838405",
					"http://www.ncbi.nlm.nih.gov/pubmed/24894453",
					"http://www.ncbi.nlm.nih.gov/pubmed/24743239"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/230"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/231",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/202",
			"name": "G735S",
			"description": "EGFR G735S",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242433,
			"end_pos": 55242433,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55242433G>A",
			"hgvs_c": "NM_005228.3:c.2203G>A",
			"hgvs_p": "NP_005219.2:p.Gly735Ser",
			"dbsnp_ids": [
				"121913430"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55242433G>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/G735S",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "G735S",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/209",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/231"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/231",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/18193092",
					"http://www.ncbi.nlm.nih.gov/pubmed/25435280"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/231"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/232",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/203",
			"name": "G796D",
			"description": "EGFR G796D",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249089,
			"end_pos": 55249089,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55249089G>A",
			"hgvs_c": "NM_005228.3:c.2387G>A",
			"hgvs_p": "NP_005219.2:p.Gly796Asp",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249089G>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/G796D",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "G796D",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/210",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/232"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/232",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28572531"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/232"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/233",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/204",
			"name": "G796R",
			"description": "EGFR G796R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249088,
			"end_pos": 55249088,
			"ref": "G",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.55249088G>C",
			"hgvs_c": "NM_005228.3:c.2386G>C",
			"hgvs_p": "NP_005219.2:p.Gly796Arg",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249088G>C?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/G796R",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "G796R",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/211",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/233"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/233",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28625641",
					"http://www.ncbi.nlm.nih.gov/pubmed/29857056"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/233"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/234",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/205",
			"name": "G796S",
			"description": "EGFR G796S",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249088,
			"end_pos": 55249088,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55249088G>A",
			"hgvs_c": "NM_005228.3:c.2386G>A",
			"hgvs_p": "NP_005219.2:p.Gly796Ser",
			"dbsnp_ids": [
				"754426793"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249088G>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/G796S",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "G796S",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/212",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/234"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/234",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/29255376",
					"http://www.ncbi.nlm.nih.gov/pubmed/28625641",
					"http://www.ncbi.nlm.nih.gov/pubmed/18193092"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/234"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/235",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/206",
			"name": "G810S",
			"description": "EGFR G810S",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249130,
			"end_pos": 55249130,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55249130G>A",
			"hgvs_c": "NM_005228.3:c.2428G>A",
			"hgvs_p": "NP_005219.2:p.Gly810Ser",
			"dbsnp_ids": [
				"121913230"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249130G>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/G810S",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "G810S",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/213",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/235"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/235",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19147750"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/235"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/236",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/207",
			"name": "G857E",
			"description": "EGFR G857E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259512,
			"end_pos": 55259512,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55259512G>A",
			"hgvs_c": "NM_005228.3:c.2570G>A",
			"hgvs_p": "NP_005219.2:p.Gly857Glu",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259512G>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/G857E",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "G857E",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/214",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/236"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/236",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23139256",
					"http://www.ncbi.nlm.nih.gov/pubmed/18000506",
					"http://www.ncbi.nlm.nih.gov/pubmed/25435280",
					"http://www.ncbi.nlm.nih.gov/pubmed/19238633"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/236"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/237",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/208",
			"name": "G863D",
			"description": "EGFR G863D",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259530,
			"end_pos": 55259530,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55259530G>A",
			"hgvs_c": "NM_005228.3:c.2588G>A",
			"hgvs_p": "NP_005219.2:p.Gly863Asp",
			"dbsnp_ids": [
				"909797662"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259530G>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/G863D",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "G863D",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/215",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/237"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/237",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/17376509",
					"http://www.ncbi.nlm.nih.gov/pubmed/16204011",
					"http://www.ncbi.nlm.nih.gov/pubmed/15897572"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/237"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/238",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/209",
			"name": "G983R",
			"description": "EGFR G983R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55268881,
			"end_pos": 55268881,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55268881G>A",
			"hgvs_c": "NM_005228.3:c.2947G>A",
			"hgvs_p": "NP_005219.2:p.Gly983Arg",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55268881G>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/G983R",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "G983R",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/216",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/238"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/238",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/29533785"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/238"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/239",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/210",
			"name": "H773L",
			"description": "EGFR H773L",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249020,
			"end_pos": 55249020,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249020A>T",
			"hgvs_c": "NM_005228.3:c.2318A>T",
			"hgvs_p": "NP_005219.2:p.His773Leu",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249020A>T?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/H773L",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "H773L",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/217",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/239"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/239",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/17974985"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/239"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/240",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/211",
			"name": "H773R",
			"description": "EGFR H773R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249020,
			"end_pos": 55249020,
			"ref": "A",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55249020A>G",
			"hgvs_c": "NM_005228.3:c.2318A>G",
			"hgvs_p": "NP_005219.2:p.His773Arg",
			"dbsnp_ids": [
				"121913432"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249020A>G?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/H773R",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "H773R",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/218",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/240"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/240",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/17974985",
					"http://www.ncbi.nlm.nih.gov/pubmed/28336552",
					"http://www.ncbi.nlm.nih.gov/pubmed/18676761",
					"http://www.ncbi.nlm.nih.gov/pubmed/16870303",
					"http://www.ncbi.nlm.nih.gov/pubmed/15623594"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/240"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/241",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/212",
			"name": "H773Y",
			"description": "EGFR H773Y",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249019,
			"end_pos": 55249019,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249019C>T",
			"hgvs_c": "NM_005228.3:c.2317C>T",
			"hgvs_p": "NP_005219.2:p.His773Tyr",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249019C>T?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/H773Y",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "H773Y",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/219",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/241"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/241",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19536777",
					"http://www.ncbi.nlm.nih.gov/pubmed/17974985",
					"http://www.ncbi.nlm.nih.gov/pubmed/18676761"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/241"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/242",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/213",
			"name": "H773_V774insH",
			"description": "EGFR H773_V774insH",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/H773_V774insH",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that inserts bases into in the coding sequence",
		"drug_labels": null,
		"variant_name": "H773_V774insH",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/220",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/242"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/242",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/242"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/243",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/214",
			"name": "H773dup",
			"description": "EGFR H773dup",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249021,
			"end_pos": 55249022,
			"ref": "C",
			"alt": "CCAC",
			"hgvs_g": "NC_000007.13:g.55249021_55249022delinsCCAC",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/H773dup",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that inserts bases into in the coding sequence",
		"drug_labels": null,
		"variant_name": "H773dup",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/221",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/243"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/243",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/243"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/244",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/215",
			"name": "H773insLGNP",
			"description": "EGFR H773insLGNP",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": null,
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/H773insLGNP",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that inserts bases into in the coding sequence",
		"drug_labels": null,
		"variant_name": "H773insLGNP",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/222",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/244"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/244",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23371856",
					"http://www.ncbi.nlm.nih.gov/pubmed/19536777",
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160",
					"http://www.ncbi.nlm.nih.gov/pubmed/21764376",
					"http://www.ncbi.nlm.nih.gov/pubmed/18676761",
					"http://www.ncbi.nlm.nih.gov/pubmed/23749122",
					"http://www.ncbi.nlm.nih.gov/pubmed/15897572",
					"http://www.ncbi.nlm.nih.gov/pubmed/17686547"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/244"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/245",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/216",
			"name": "H870R",
			"description": "EGFR H870R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259551,
			"end_pos": 55259551,
			"ref": "A",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259551A>G",
			"hgvs_c": "NM_005228.3:c.2609A>G",
			"hgvs_p": "NP_005219.2:p.His870Arg",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259551A>G?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/H870R",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "H870R",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [

		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/245",
				"type": "Predisposing",
				"description": "Likely Neutral",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19671738",
					"http://www.ncbi.nlm.nih.gov/pubmed/21841502"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Neutral",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/245"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/246",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/217",
			"name": "I491M",
			"description": "EGFR I491M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55228006,
			"end_pos": 55228006,
			"ref": "A",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55228006A>G",
			"hgvs_c": "NM_005228.3:c.1473A>G",
			"hgvs_p": "NP_005219.2:p.Ile491Met",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55228006A>G?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/I491M",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "I491M",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/223",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/246"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/246",
				"type": "Predisposing",
				"description": "Likely Neutral",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25633215"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/246"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/247",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/218",
			"name": "I744_K745delinsKIPVAI",
			"description": "EGFR I744_K745delinsKIPVAI",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": null,
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/I744_K745delinsKIPVAI",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that inserts bases into in the coding sequence",
		"drug_labels": null,
		"variant_name": "I744_K745delinsKIPVAI",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/224",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/247"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/247",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15329413",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118073",
					"http://www.ncbi.nlm.nih.gov/pubmed/21841502",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118125"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/247"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/248",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/219",
			"name": "I853T",
			"description": "EGFR I853T",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259500,
			"end_pos": 55259500,
			"ref": "T",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.55259500T>C",
			"hgvs_c": "NM_005228.3:c.2558T>C",
			"hgvs_p": "NP_005219.2:p.Ile853Thr",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259500T>C?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/I853T",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "I853T",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [

		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/248",
				"type": "Predisposing",
				"description": "Loss-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19147750"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Neutral",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/248"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/249",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/220",
			"name": "I941R",
			"description": "EGFR I941R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": null,
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/I941R",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "I941R",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [

		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/249",
				"type": "Predisposing",
				"description": "Likely Loss-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24063894"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Neutral",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/249"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/250",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/221",
			"name": "K467T",
			"description": "EGFR K467T",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55227933,
			"end_pos": 55227933,
			"ref": "A",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.55227933A>C",
			"hgvs_c": "NM_005228.3:c.1400A>C",
			"hgvs_p": "NP_005219.2:p.Lys467Thr",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55227933A>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/K467T",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "K467T",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [

		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/250",
				"type": "Predisposing",
				"description": "Likely Neutral",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25633215"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Neutral",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/250"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/251",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/222",
			"name": "K745M",
			"description": "EGFR K745M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242464,
			"end_pos": 55242464,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55242464A>T",
			"hgvs_c": "NM_005228.3:c.2234A>T",
			"hgvs_p": "NP_005219.2:p.Lys745Met",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55242464A>T?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/K745M",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "K745M",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [

		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/251",
				"type": "Predisposing",
				"description": "Loss-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21081186"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Neutral",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/251"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/252",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/223",
			"name": "K745_A750del",
			"description": "EGFR K745_A750del",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": null,
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/K745_A750del",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that deletes bases from the coding sequence",
		"drug_labels": null,
		"variant_name": "K745_A750del",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/225",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/252"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/252",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15329413",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118073",
					"http://www.ncbi.nlm.nih.gov/pubmed/25179728",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118125"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/252"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/253",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/139",
			"name": "Kinase Domain Duplication",
			"description": "EGFR Kinase Domain Duplication",
			"biomarker_type": "NA",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": null,
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/Kinase Domain Duplication",
		"source": "oncokb",
		"description": "NA",
		"drug_labels": null,
		"variant_name": "Kinase Domain Duplication",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/226",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/253"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/253",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26286086"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/253"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/254",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/224",
			"name": "L688P",
			"description": "EGFR L688P",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55241615,
			"end_pos": 55241615,
			"ref": "T",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.55241615T>C",
			"hgvs_c": "NM_005228.3:c.2063T>C",
			"hgvs_p": "NP_005219.2:p.Leu688Pro",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55241615T>C?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/L688P",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "L688P",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [

		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/254",
				"type": "Predisposing",
				"description": "Likely Loss-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19147750"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Neutral",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/254"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/255",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/225",
			"name": "L704N",
			"description": "EGFR L704N",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": null,
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/L704N",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "L704N",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [

		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/255",
				"type": "Predisposing",
				"description": "Loss-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24063894"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Neutral",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/255"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/256",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/226",
			"name": "L718Q",
			"description": "EGFR L718Q",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55241705,
			"end_pos": 55241705,
			"ref": "T",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55241705T>A",
			"hgvs_c": "NM_005228.3:c.2153T>A",
			"hgvs_p": "NP_005219.2:p.Leu718Gln",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55241705T>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/L718Q",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "L718Q",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/227",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/256"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/256",
				"type": "Predisposing",
				"description": "Inconclusive",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27257132",
					"http://www.ncbi.nlm.nih.gov/pubmed/25948633"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/256"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/257",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/140",
			"name": "L747P",
			"description": "EGFR L747P",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": null,
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": "",
			"alt": "",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/L747P",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "L747P",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/228",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/257"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/257",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21531810",
					"http://www.ncbi.nlm.nih.gov/pubmed/18508816",
					"http://www.ncbi.nlm.nih.gov/pubmed/19536777",
					"http://www.ncbi.nlm.nih.gov/pubmed/26339441",
					"http://www.ncbi.nlm.nih.gov/pubmed/26001153",
					"http://www.ncbi.nlm.nih.gov/pubmed/22190593"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/257"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/258",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/227",
			"name": "L747S",
			"description": "EGFR L747S",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242470,
			"end_pos": 55242470,
			"ref": "T",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.55242470T>C",
			"hgvs_c": "NM_005228.3:c.2240T>C",
			"hgvs_p": "NP_005219.2:p.Leu747Ser",
			"dbsnp_ids": [
				"397517097"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55242470T>C?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/L747S",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "L747S",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/229",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/258"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/258",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/17973572",
					"http://www.ncbi.nlm.nih.gov/pubmed/18309959",
					"http://www.ncbi.nlm.nih.gov/pubmed/18645621",
					"http://www.ncbi.nlm.nih.gov/pubmed/19632948",
					"http://www.ncbi.nlm.nih.gov/pubmed/18981003"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/258"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/259",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/228",
			"name": "L747_A750del",
			"description": "EGFR L747_A750del",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": null,
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/L747_A750del",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that deletes bases from the coding sequence",
		"drug_labels": null,
		"variant_name": "L747_A750del",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/230",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/259"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/259",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/16467085",
					"http://www.ncbi.nlm.nih.gov/pubmed/15329413",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118073",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118125"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/259"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/260",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/229",
			"name": "L747_A750delinsP",
			"description": "EGFR L747_A750delinsP",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": null,
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/L747_A750delinsP",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that deletes bases from the coding sequence",
		"drug_labels": null,
		"variant_name": "L747_A750delinsP",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/231",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/260"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/260",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/18508816",
					"http://www.ncbi.nlm.nih.gov/pubmed/15329413",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118073",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118125",
					"http://www.ncbi.nlm.nih.gov/pubmed/17192902"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/260"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/261",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/230",
			"name": "L747_E749del",
			"description": "EGFR L747_E749del",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242469,
			"end_pos": 55242477,
			"ref": "ATTAAGAGAA",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55242469_55242477delinsA",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/L747_E749del",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that deletes bases from the coding sequence",
		"drug_labels": null,
		"variant_name": "L747_E749del",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/232",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/261"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/261",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/16467085",
					"http://www.ncbi.nlm.nih.gov/pubmed/15329413",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118073",
					"http://www.ncbi.nlm.nih.gov/pubmed/25179728",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118125"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/261"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/262",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/231",
			"name": "L747_P753del",
			"description": "EGFR L747_P753del",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": null,
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/L747_P753del",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that deletes bases from the coding sequence",
		"drug_labels": null,
		"variant_name": "L747_P753del",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/233",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/262"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/262",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15329413",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118073",
					"http://www.ncbi.nlm.nih.gov/pubmed/25179728",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118125"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/262"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/263",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/232",
			"name": "L747_P753delinsS",
			"description": "EGFR L747_P753delinsS",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242470,
			"end_pos": 55242487,
			"ref": "TTAAGAGAAGCAACATCTC",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55242470_55242487delinsT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/L747_P753delinsS",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that deletes bases from the coding sequence",
		"drug_labels": null,
		"variant_name": "L747_P753delinsS",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/234",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/263"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/263",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/18508816",
					"http://www.ncbi.nlm.nih.gov/pubmed/15329413",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118073",
					"http://www.ncbi.nlm.nih.gov/pubmed/19147750",
					"http://www.ncbi.nlm.nih.gov/pubmed/25179728",
					"http://www.ncbi.nlm.nih.gov/pubmed/15710947",
					"http://www.ncbi.nlm.nih.gov/pubmed/15897572",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118125"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/263"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/264",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/233",
			"name": "L747_S752del",
			"description": "EGFR L747_S752del",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242469,
			"end_pos": 55242486,
			"ref": "ATTAAGAGAAGCAACATCT",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55242469_55242486delinsA",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/L747_S752del",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that deletes bases from the coding sequence",
		"drug_labels": null,
		"variant_name": "L747_S752del",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/235",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/264"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/264",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/16467085",
					"http://www.ncbi.nlm.nih.gov/pubmed/15329413",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118073",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118125",
					"http://www.ncbi.nlm.nih.gov/pubmed/17192902"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/264"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/265",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/234",
			"name": "L747_T751del",
			"description": "EGFR L747_T751del",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242470,
			"end_pos": 55242484,
			"ref": "TTAAGAGAAGCAACAT",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55242470_55242484delinsT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/L747_T751del",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that deletes bases from the coding sequence",
		"drug_labels": null,
		"variant_name": "L747_T751del",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/236",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/265"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/265",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/18325048",
					"http://www.ncbi.nlm.nih.gov/pubmed/23242437",
					"http://www.ncbi.nlm.nih.gov/pubmed/15329413",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118073",
					"http://www.ncbi.nlm.nih.gov/pubmed/23387505",
					"http://www.ncbi.nlm.nih.gov/pubmed/15897572",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118125"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/265"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/266",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/235",
			"name": "L747_T751delinsP",
			"description": "EGFR L747_T751delinsP",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": null,
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/L747_T751delinsP",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that deletes bases from the coding sequence",
		"drug_labels": null,
		"variant_name": "L747_T751delinsP",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/237",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/266"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/266",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15329413",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118073",
					"http://www.ncbi.nlm.nih.gov/pubmed/15710947",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118125"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/266"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/267",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/236",
			"name": "L792F",
			"description": "EGFR L792F",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249076,
			"end_pos": 55249076,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249076C>T",
			"hgvs_c": "NM_005228.3:c.2374C>T",
			"hgvs_p": "NP_005219.2:p.Leu792Phe",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249076C>T?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/L792F",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "L792F",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/238",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/267"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/267",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27913578",
					"http://www.ncbi.nlm.nih.gov/pubmed/28093244",
					"http://www.ncbi.nlm.nih.gov/pubmed/28625641",
					"http://www.ncbi.nlm.nih.gov/pubmed/29506987"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/267"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/268",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/237",
			"name": "L792H",
			"description": "EGFR L792H",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249077,
			"end_pos": 55249077,
			"ref": "T",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55249077T>A",
			"hgvs_c": "NM_005228.3:c.2375T>A",
			"hgvs_p": "NP_005219.2:p.Leu792His",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249077T>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/L792H",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "L792H",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/239",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/268"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/268",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28093244",
					"http://www.ncbi.nlm.nih.gov/pubmed/28625641",
					"http://www.ncbi.nlm.nih.gov/pubmed/29506987",
					"http://www.ncbi.nlm.nih.gov/pubmed/29857056"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/268"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/269",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/238",
			"name": "L833F",
			"description": "EGFR L833F",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259441,
			"end_pos": 55259441,
			"ref": "G",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55259441G>T",
			"hgvs_c": "NM_005228.3:c.2499G>T",
			"hgvs_p": "NP_005219.2:p.Leu833Phe",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259441G>T?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/L833F",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "L833F",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/240",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/269"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/269",
				"type": "Predisposing",
				"description": "Inconclusive",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26773740",
					"http://www.ncbi.nlm.nih.gov/pubmed/28336552",
					"http://www.ncbi.nlm.nih.gov/pubmed/23922984",
					"http://www.ncbi.nlm.nih.gov/pubmed/25130612"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/269"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/270",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/141",
			"name": "L833V",
			"description": "EGFR L833V",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259439,
			"end_pos": 55259439,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259439T>G",
			"hgvs_c": "NM_005228.3:c.2497T>G",
			"hgvs_p": "NP_005219.2:p.Leu833Val",
			"dbsnp_ids": [
				"397517126"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259439T>G?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/L833V",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "L833V",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/241",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/270"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/270",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28336552",
					"http://www.ncbi.nlm.nih.gov/pubmed/25130612",
					"http://www.ncbi.nlm.nih.gov/pubmed/20808254",
					"http://www.ncbi.nlm.nih.gov/pubmed/21422421"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/270"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/271",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/239",
			"name": "L838P",
			"description": "EGFR L838P",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259455,
			"end_pos": 55259455,
			"ref": "T",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.55259455T>C",
			"hgvs_c": "NM_005228.3:c.2513T>C",
			"hgvs_p": "NP_005219.2:p.Leu838Pro",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259455T>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/L838P",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "L838P",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/242",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/271"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/271",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21531810"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/271"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/272",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/240",
			"name": "L838V",
			"description": "EGFR L838V",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259454,
			"end_pos": 55259454,
			"ref": "C",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259454C>G",
			"hgvs_c": "NM_005228.3:c.2512C>G",
			"hgvs_p": "NP_005219.2:p.Leu838Val",
			"dbsnp_ids": [
				"864621996"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259454C>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/L838V",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "L838V",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/243",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/272"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/272",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19147750"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/272"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/273",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/241",
			"name": "L841V",
			"description": "EGFR L841V",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": null,
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/L841V",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "L841V",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/244",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/273"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/273",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/29533785"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/273"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/274",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/242",
			"name": "L844V",
			"description": "EGFR L844V",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259472,
			"end_pos": 55259472,
			"ref": "C",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259472C>G",
			"hgvs_c": "NM_005228.3:c.2530C>G",
			"hgvs_p": "NP_005219.2:p.Leu844Val",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259472C>G?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/L844V",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "L844V",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/245",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/274"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/274",
				"type": "Predisposing",
				"description": "Inconclusive",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25948633"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/274"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/275",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/243",
			"name": "L858Q",
			"description": "EGFR L858Q",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55259515T>A",
			"hgvs_c": "NM_005228.3:c.2573T>A",
			"hgvs_p": "NP_005219.2:p.Leu858Gln",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/L858Q",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "L858Q",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/246",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/275"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/275",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24743239"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/275"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/276",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/142",
			"name": "L858R",
			"description": "EGFR L858R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259515T>G",
			"hgvs_c": "NM_005228.3:c.2573T>G",
			"hgvs_p": "NP_005219.2:p.Leu858Arg",
			"dbsnp_ids": [
				"121434568"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/L858R",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "L858R",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/247",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/276"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/276",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15329413",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118073",
					"http://www.ncbi.nlm.nih.gov/pubmed/15118125"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/276"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/277",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/244",
			"name": "L861Q",
			"description": "EGFR L861Q",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259524,
			"end_pos": 55259524,
			"ref": "T",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55259524T>A",
			"hgvs_c": "NM_005228.3:c.2582T>A",
			"hgvs_p": "NP_005219.2:p.Leu861Gln",
			"dbsnp_ids": [
				"121913444"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259524T>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/L861Q",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "L861Q",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/248",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/277"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/277",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21531810",
					"http://www.ncbi.nlm.nih.gov/pubmed/18508816",
					"http://www.ncbi.nlm.nih.gov/pubmed/29141884",
					"http://www.ncbi.nlm.nih.gov/pubmed/16467085",
					"http://www.ncbi.nlm.nih.gov/pubmed/17177598",
					"http://www.ncbi.nlm.nih.gov/pubmed/25668120",
					"http://www.ncbi.nlm.nih.gov/pubmed/21841502",
					"http://www.ncbi.nlm.nih.gov/pubmed/15897572",
					"http://www.ncbi.nlm.nih.gov/pubmed/21252719",
					"http://www.ncbi.nlm.nih.gov/pubmed/19536777",
					"http://www.ncbi.nlm.nih.gov/pubmed/18325048",
					"http://www.ncbi.nlm.nih.gov/pubmed/19147750",
					"http://www.ncbi.nlm.nih.gov/pubmed/26051236",
					"http://www.ncbi.nlm.nih.gov/pubmed/18676761",
					"http://www.ncbi.nlm.nih.gov/pubmed/23912954",
					"http://www.ncbi.nlm.nih.gov/pubmed/24457318",
					"http://www.ncbi.nlm.nih.gov/pubmed/22760226",
					"http://www.ncbi.nlm.nih.gov/pubmed/20808254",
					"http://www.ncbi.nlm.nih.gov/pubmed/23749122",
					"http://www.ncbi.nlm.nih.gov/pubmed/24285021"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/277"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/278",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/245",
			"name": "L861R",
			"description": "EGFR L861R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259524,
			"end_pos": 55259524,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259524T>G",
			"hgvs_c": "NM_005228.3:c.2582T>G",
			"hgvs_p": "NP_005219.2:p.Leu861Arg",
			"dbsnp_ids": [
				"121913444"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259524T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/L861R",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "L861R",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/249",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/278"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/278",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21531810",
					"http://www.ncbi.nlm.nih.gov/pubmed/17177598",
					"http://www.ncbi.nlm.nih.gov/pubmed/24743239",
					"http://www.ncbi.nlm.nih.gov/pubmed/21841502",
					"http://www.ncbi.nlm.nih.gov/pubmed/21252719"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/278"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/279",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/144",
			"name": "M277E",
			"description": "EGFR M277E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": null,
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/M277E",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "M277E",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/250",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/279"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/279",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28979142"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/279"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/280",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/246",
			"name": "N528D",
			"description": "EGFR N528D",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55229275,
			"end_pos": 55229275,
			"ref": "A",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55229275A>G",
			"hgvs_c": "NM_005228.3:c.1582A>G",
			"hgvs_p": "NP_005219.2:p.Asn528Asp",
			"dbsnp_ids": [
				"762336338"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55229275A>G?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/N528D",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "N528D",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [

		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/280",
				"type": "Predisposing",
				"description": "Likely Neutral",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28979142"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Neutral",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/280"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/281",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/247",
			"name": "N771_H773dup",
			"description": "EGFR N771_H773dup",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249019,
			"end_pos": 55249020,
			"ref": "C",
			"alt": "CACAACCCCC",
			"hgvs_g": "NC_000007.13:g.55249019_55249020dupCACAACCCCC",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/N771_H773dup",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that inserts bases into in the coding sequence",
		"drug_labels": null,
		"variant_name": "N771_H773dup",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/251",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/281"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/281",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23371856",
					"http://www.ncbi.nlm.nih.gov/pubmed/19536777",
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160",
					"http://www.ncbi.nlm.nih.gov/pubmed/21764376",
					"http://www.ncbi.nlm.nih.gov/pubmed/18676761",
					"http://www.ncbi.nlm.nih.gov/pubmed/23912954",
					"http://www.ncbi.nlm.nih.gov/pubmed/15897572",
					"http://www.ncbi.nlm.nih.gov/pubmed/17686547"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/281"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/282",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/248",
			"name": "N826S",
			"description": "EGFR N826S",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259419,
			"end_pos": 55259419,
			"ref": "A",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259419A>G",
			"hgvs_c": "NM_005228.3:c.2477A>G",
			"hgvs_p": "NP_005219.2:p.Asn826Ser",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259419A>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/N826S",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "N826S",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/252",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/282"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/282",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19147750",
					"http://www.ncbi.nlm.nih.gov/pubmed/15897572"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/282"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/283",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/249",
			"name": "P772R",
			"description": "EGFR P772R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249017,
			"end_pos": 55249017,
			"ref": "C",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55249017C>G",
			"hgvs_c": "NM_005228.3:c.2315C>G",
			"hgvs_p": "NP_005219.2:p.Pro772Arg",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249017C>G?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/P772R",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "P772R",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/253",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/283"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/283",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/29533785"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/283"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/284",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/250",
			"name": "P772_H773insYNP",
			"description": "EGFR P772_H773insYNP",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/P772_H773insYNP",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that inserts bases into in the coding sequence",
		"drug_labels": null,
		"variant_name": "P772_H773insYNP",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/254",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/284"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/284",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23371856",
					"http://www.ncbi.nlm.nih.gov/pubmed/19536777",
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160",
					"http://www.ncbi.nlm.nih.gov/pubmed/21764376",
					"http://www.ncbi.nlm.nih.gov/pubmed/18676761",
					"http://www.ncbi.nlm.nih.gov/pubmed/15897572",
					"http://www.ncbi.nlm.nih.gov/pubmed/17686547"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/284"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/285",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/251",
			"name": "P772_V774dup",
			"description": "EGFR P772_V774dup",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": null,
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/P772_V774dup",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that inserts bases into in the coding sequence",
		"drug_labels": null,
		"variant_name": "P772_V774dup",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/255",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/285"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/285",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23371856",
					"http://www.ncbi.nlm.nih.gov/pubmed/19536777",
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160",
					"http://www.ncbi.nlm.nih.gov/pubmed/21764376",
					"http://www.ncbi.nlm.nih.gov/pubmed/18676761",
					"http://www.ncbi.nlm.nih.gov/pubmed/25179728",
					"http://www.ncbi.nlm.nih.gov/pubmed/15897572",
					"http://www.ncbi.nlm.nih.gov/pubmed/17686547"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/285"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/286",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/252",
			"name": "P848L",
			"description": "EGFR P848L",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259485,
			"end_pos": 55259485,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55259485C>T",
			"hgvs_c": "NM_005228.3:c.2543C>T",
			"hgvs_p": "NP_005219.2:p.Pro848Leu",
			"dbsnp_ids": [
				"148934350"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259485C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/P848L",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "P848L",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [

		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/286",
				"type": "Predisposing",
				"description": "Likely Neutral",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23897956",
					"http://www.ncbi.nlm.nih.gov/pubmed/22848293",
					"http://www.ncbi.nlm.nih.gov/pubmed/25176975",
					"http://www.ncbi.nlm.nih.gov/pubmed/23912954",
					"http://www.ncbi.nlm.nih.gov/pubmed/17877814"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Neutral",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/286"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/287",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/253",
			"name": "Q181H",
			"description": "EGFR Q181H",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55214417,
			"end_pos": 55214417,
			"ref": "G",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.55214417G>C",
			"hgvs_c": "NM_005228.3:c.543G>C",
			"hgvs_p": "NP_005219.2:p.Gln181His",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55214417G>C?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/Q181H",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "Q181H",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [

		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/287",
				"type": "Predisposing",
				"description": "Likely Neutral",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28979142"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Neutral",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/287"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/288",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/254",
			"name": "Q787R",
			"description": "EGFR Q787R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249062,
			"end_pos": 55249062,
			"ref": "A",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55249062A>G",
			"hgvs_c": "NM_005228.3:c.2360A>G",
			"hgvs_p": "NP_005219.2:p.Gln787Arg",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249062A>G?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/Q787R",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "Q787R",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/256",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/288"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/288",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/29533785"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/288"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/289",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/148",
			"name": "R108K",
			"description": "EGFR R108K",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55211080,
			"end_pos": 55211080,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55211080G>A",
			"hgvs_c": "NM_005228.3:c.323G>A",
			"hgvs_p": "NP_005219.2:p.Arg108Lys",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55211080G>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/R108K",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "R108K",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/257",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/289"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/289",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24120142",
					"http://www.ncbi.nlm.nih.gov/pubmed/17177598"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/289"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/290",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/255",
			"name": "R324L",
			"description": "EGFR R324L",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55223604,
			"end_pos": 55223604,
			"ref": "G",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55223604G>T",
			"hgvs_c": "NM_005228.3:c.971G>T",
			"hgvs_p": "NP_005219.2:p.Arg324Leu",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55223604G>T?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/R324L",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "R324L",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/258",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/290"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/290",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/17177598",
					"http://www.ncbi.nlm.nih.gov/pubmed/24212795"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/290"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/291",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/256",
			"name": "R776C",
			"description": "EGFR R776C",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249028,
			"end_pos": 55249028,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249028C>T",
			"hgvs_c": "NM_005228.3:c.2326C>T",
			"hgvs_p": "NP_005219.2:p.Arg776Cys",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249028C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/R776C",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "R776C",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/259",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/291"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/291",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19147750"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/291"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/292",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/257",
			"name": "R776G",
			"description": "EGFR R776G",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249028,
			"end_pos": 55249028,
			"ref": "C",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55249028C>G",
			"hgvs_c": "NM_005228.3:c.2326C>G",
			"hgvs_p": "NP_005219.2:p.Arg776Gly",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249028C>G?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/R776G",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "R776G",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/260",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/292"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/292",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19147750",
					"http://www.ncbi.nlm.nih.gov/pubmed/18676761"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/292"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/293",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/258",
			"name": "R776H",
			"description": "EGFR R776H",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249029,
			"end_pos": 55249029,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55249029G>A",
			"hgvs_c": "NM_005228.3:c.2327G>A",
			"hgvs_p": "NP_005219.2:p.Arg776His",
			"dbsnp_ids": [
				"483352806"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249029G>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/R776H",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "R776H",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/261",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/293"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/293",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23242437",
					"http://www.ncbi.nlm.nih.gov/pubmed/20512075",
					"http://www.ncbi.nlm.nih.gov/pubmed/23358982"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/293"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/294",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/259",
			"name": "R841K",
			"description": "EGFR R841K",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259464,
			"end_pos": 55259464,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55259464G>A",
			"hgvs_c": "NM_005228.3:c.2522G>A",
			"hgvs_p": "NP_005219.2:p.Arg841Lys",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259464G>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/R841K",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "R841K",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [

		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/294",
				"type": "Predisposing",
				"description": "Likely Loss-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/18193092"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Neutral",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/294"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/295",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/260",
			"name": "S229C",
			"description": "EGFR S229C",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55220295,
			"end_pos": 55220295,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55220295A>T",
			"hgvs_c": "NM_005228.3:c.685A>T",
			"hgvs_p": "NP_005219.2:p.Ser229Cys",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55220295A>T?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/S229C",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "S229C",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/262",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/295"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/295",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/29533785"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/295"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/296",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/261",
			"name": "S464L",
			"description": "EGFR S464L",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55227924,
			"end_pos": 55227924,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55227924C>T",
			"hgvs_c": "NM_005228.3:c.1391C>T",
			"hgvs_p": "NP_005219.2:p.Ser464Leu",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55227924C>T?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/S464L",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "S464L",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [

		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/296",
				"type": "Predisposing",
				"description": "Likely Loss-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25633215"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Neutral",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/296"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/297",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/262",
			"name": "S492R",
			"description": "EGFR S492R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55228007,
			"end_pos": 55228007,
			"ref": "A",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.55228007A>C",
			"hgvs_c": "NM_005228.3:c.1474A>C",
			"hgvs_p": "NP_005219.2:p.Ser492Arg",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55228007A>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/S492R",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "S492R",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/263",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/297"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/297",
				"type": "Predisposing",
				"description": "Inconclusive",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24025416",
					"http://www.ncbi.nlm.nih.gov/pubmed/22270724"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/297"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/298",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/263",
			"name": "S645C",
			"description": "EGFR S645C",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55240690,
			"end_pos": 55240690,
			"ref": "C",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55240690C>G",
			"hgvs_c": "NM_005228.3:c.1934C>G",
			"hgvs_p": "NP_005219.2:p.Ser645Cys",
			"dbsnp_ids": [
				"772046081"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55240690C>G?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/S645C",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "S645C",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/264",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/298"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/298",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27478040"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/298"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/299",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/145",
			"name": "S768I",
			"description": "EGFR S768I",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249005,
			"end_pos": 55249005,
			"ref": "G",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249005G>T",
			"hgvs_c": "NM_005228.3:c.2303G>T",
			"hgvs_p": "NP_005219.2:p.Ser768Ile",
			"dbsnp_ids": [
				"121913465"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249005G>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/S768I",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "S768I",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/265",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/299"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/299",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19536777",
					"http://www.ncbi.nlm.nih.gov/pubmed/29141884",
					"http://www.ncbi.nlm.nih.gov/pubmed/16205628",
					"http://www.ncbi.nlm.nih.gov/pubmed/25521406",
					"http://www.ncbi.nlm.nih.gov/pubmed/25521405",
					"http://www.ncbi.nlm.nih.gov/pubmed/23242437",
					"http://www.ncbi.nlm.nih.gov/pubmed/19147750",
					"http://www.ncbi.nlm.nih.gov/pubmed/18676761",
					"http://www.ncbi.nlm.nih.gov/pubmed/23912954",
					"http://www.ncbi.nlm.nih.gov/pubmed/25179728",
					"http://www.ncbi.nlm.nih.gov/pubmed/25130612"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/299"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/300",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/264",
			"name": "S768_D770dup",
			"description": "EGFR S768_D770dup",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249013,
			"end_pos": 55249014,
			"ref": "A",
			"alt": "AGCGTGGACA",
			"hgvs_g": "NC_000007.13:g.55249013_55249014dupAGCGTGGACA",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/S768_D770dup",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that inserts bases into in the coding sequence",
		"drug_labels": null,
		"variant_name": "S768_D770dup",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/266",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/300"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/300",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23371856",
					"http://www.ncbi.nlm.nih.gov/pubmed/19536777",
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160",
					"http://www.ncbi.nlm.nih.gov/pubmed/21764376",
					"http://www.ncbi.nlm.nih.gov/pubmed/18676761",
					"http://www.ncbi.nlm.nih.gov/pubmed/23749122",
					"http://www.ncbi.nlm.nih.gov/pubmed/15897572",
					"http://www.ncbi.nlm.nih.gov/pubmed/17686547"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/300"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/301",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/265",
			"name": "S768_V769insVAS",
			"description": "EGFR S768_V769insVAS",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": null,
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/S768_V769insVAS",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that inserts bases into in the coding sequence",
		"drug_labels": null,
		"variant_name": "S768_V769insVAS",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/267",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/301"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/301",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23371856",
					"http://www.ncbi.nlm.nih.gov/pubmed/19536777",
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160",
					"http://www.ncbi.nlm.nih.gov/pubmed/21764376",
					"http://www.ncbi.nlm.nih.gov/pubmed/18676761",
					"http://www.ncbi.nlm.nih.gov/pubmed/15897572",
					"http://www.ncbi.nlm.nih.gov/pubmed/21841502",
					"http://www.ncbi.nlm.nih.gov/pubmed/17686547"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/301"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/302",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/266",
			"name": "S784F",
			"description": "EGFR S784F",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249053,
			"end_pos": 55249053,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249053C>T",
			"hgvs_c": "NM_005228.3:c.2351C>T",
			"hgvs_p": "NP_005219.2:p.Ser784Phe",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249053C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/S784F",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "S784F",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/268",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/302"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/302",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21531810",
					"http://www.ncbi.nlm.nih.gov/pubmed/20522446",
					"http://www.ncbi.nlm.nih.gov/pubmed/19147750",
					"http://www.ncbi.nlm.nih.gov/pubmed/21841502"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/302"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/303",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/267",
			"name": "T1041A",
			"description": "EGFR T1041A",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55269434,
			"end_pos": 55269434,
			"ref": "A",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55269434A>G",
			"hgvs_c": "NM_005228.3:c.3121A>G",
			"hgvs_p": "NP_005219.2:p.Thr1041Ala",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55269434A>G?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/T1041A",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "T1041A",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/269",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/303"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/303",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24797263"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/303"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/304",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/149",
			"name": "T263P",
			"description": "EGFR T263P",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55221743,
			"end_pos": 55221743,
			"ref": "A",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.55221743A>C",
			"hgvs_c": "NM_005228.3:c.787A>C",
			"hgvs_p": "NP_005219.2:p.Thr263Pro",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55221743A>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/T263P",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "T263P",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/270",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/304"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/304",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/17177598"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/304"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/305",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/268",
			"name": "T34_A289del",
			"description": "EGFR T34_A289del",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": null,
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/T34_A289del",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that deletes bases from the coding sequence",
		"drug_labels": null,
		"variant_name": "T34_A289del",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/271",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/305"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/305",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27216155"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/305"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/306",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/269",
			"name": "T363N",
			"description": "EGFR T363N",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55224307,
			"end_pos": 55224307,
			"ref": "C",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55224307C>A",
			"hgvs_c": "NM_005228.3:c.1088C>A",
			"hgvs_p": "NP_005219.2:p.Thr363Asn",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55224307C>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/T363N",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "T363N",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [

		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/306",
				"type": "Predisposing",
				"description": "Likely Neutral",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28979142"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Neutral",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/306"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/307",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/270",
			"name": "T725M",
			"description": "EGFR T725M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55241726,
			"end_pos": 55241726,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55241726C>T",
			"hgvs_c": "NM_005228.3:c.2174C>T",
			"hgvs_p": "NP_005219.2:p.Thr725Met",
			"dbsnp_ids": [
				"767505234"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55241726C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/T725M",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "T725M",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/272",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/307"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/307",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24743239"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/307"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/308",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/271",
			"name": "T785A",
			"description": "EGFR T785A",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249055,
			"end_pos": 55249055,
			"ref": "A",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55249055A>G",
			"hgvs_c": "NM_005228.3:c.2353A>G",
			"hgvs_p": "NP_005219.2:p.Thr785Ala",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249055A>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/T785A",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "T785A",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/273",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/308"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/308",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20942962"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/308"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/309",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/130",
			"name": "T790M",
			"description": "EGFR T790M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249071,
			"end_pos": 55249071,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249071C>T",
			"hgvs_c": "NM_005228.3:c.2369C>T",
			"hgvs_p": "NP_005219.2:p.Thr790Met",
			"dbsnp_ids": [
				"121434569"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249071C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/T790M",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "T790M",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/274",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/309"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/309",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15728811",
					"http://www.ncbi.nlm.nih.gov/pubmed/18227510",
					"http://www.ncbi.nlm.nih.gov/pubmed/15737014"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/309"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/310",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/272",
			"name": "T854A",
			"description": "EGFR T854A",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259502,
			"end_pos": 55259502,
			"ref": "A",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259502A>G",
			"hgvs_c": "NM_005228.3:c.2560A>G",
			"hgvs_p": "NP_005219.2:p.Thr854Ala",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259502A>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/T854A",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "T854A",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/275",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/310"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/310",
				"type": "Predisposing",
				"description": "Inconclusive",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19010870",
					"http://www.ncbi.nlm.nih.gov/pubmed/26041145"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/310"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/311",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/273",
			"name": "T854S",
			"description": "EGFR T854S",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259502,
			"end_pos": 55259502,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55259502A>T",
			"hgvs_c": "NM_005228.3:c.2560A>T",
			"hgvs_p": "NP_005219.2:p.Thr854Ser",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259502A>T?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/T854S",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "T854S",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/276",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/311"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/311",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28336552",
					"http://www.ncbi.nlm.nih.gov/pubmed/23486275"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/311"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/312",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/274",
			"name": "V159E",
			"description": "EGFR V159E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55214350,
			"end_pos": 55214350,
			"ref": "T",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55214350T>A",
			"hgvs_c": "NM_005228.3:c.476T>A",
			"hgvs_p": "NP_005219.2:p.Val159Glu",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55214350T>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/V159E",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "V159E",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [

		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/312",
				"type": "Predisposing",
				"description": "Likely Neutral",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28979142"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Neutral",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/312"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/313",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/275",
			"name": "V592I",
			"description": "EGFR V592I",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55233024,
			"end_pos": 55233024,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55233024G>A",
			"hgvs_c": "NM_005228.3:c.1774G>A",
			"hgvs_p": "NP_005219.2:p.Val592Ile",
			"dbsnp_ids": [
				"144943614"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55233024G>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/V592I",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "V592I",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [

		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/313",
				"type": "Predisposing",
				"description": "Likely Neutral",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28979142"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Neutral",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/313"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/314",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/276",
			"name": "V689M",
			"description": "EGFR V689M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55241617,
			"end_pos": 55241617,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55241617G>A",
			"hgvs_c": "NM_005228.3:c.2065G>A",
			"hgvs_p": "NP_005219.2:p.Val689Met",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55241617G>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/V689M",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "V689M",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/277",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/314"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/314",
				"type": "Predisposing",
				"description": "Likely Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19560417"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/314"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/315",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/277",
			"name": "V742A",
			"description": "EGFR V742A",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242455,
			"end_pos": 55242455,
			"ref": "T",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.55242455T>C",
			"hgvs_c": "NM_005228.3:c.2225T>C",
			"hgvs_p": "NP_005219.2:p.Val742Ala",
			"dbsnp_ids": [
				"121913466"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55242455T>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/V742A",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "V742A",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/278",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/315"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/315",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21531810",
					"http://www.ncbi.nlm.nih.gov/pubmed/23605641",
					"http://www.ncbi.nlm.nih.gov/pubmed/19147750",
					"http://www.ncbi.nlm.nih.gov/pubmed/16152581"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/315"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/316",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/278",
			"name": "V769M",
			"description": "EGFR V769M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249007,
			"end_pos": 55249007,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55249007G>A",
			"hgvs_c": "NM_005228.3:c.2305G>A",
			"hgvs_p": "NP_005219.2:p.Val769Met",
			"dbsnp_ids": [
				"147149347"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249007G>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/V769M",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "V769M",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/279",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/316"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/316",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21531810",
					"http://www.ncbi.nlm.nih.gov/pubmed/20354512",
					"http://www.ncbi.nlm.nih.gov/pubmed/21764376",
					"http://www.ncbi.nlm.nih.gov/pubmed/23749122"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/316"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/317",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/279",
			"name": "V769_D770insASV",
			"description": "EGFR V769_D770insASV",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": null,
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/V769_D770insASV",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that inserts bases into in the coding sequence",
		"drug_labels": null,
		"variant_name": "V769_D770insASV",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/280",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/317"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/317",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23371856",
					"http://www.ncbi.nlm.nih.gov/pubmed/19536777",
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160",
					"http://www.ncbi.nlm.nih.gov/pubmed/21764376",
					"http://www.ncbi.nlm.nih.gov/pubmed/18676761",
					"http://www.ncbi.nlm.nih.gov/pubmed/15897572",
					"http://www.ncbi.nlm.nih.gov/pubmed/17686547"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/317"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/318",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/280",
			"name": "V769_D770insGVV",
			"description": "EGFR V769_D770insGVV",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": null,
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/V769_D770insGVV",
		"source": "oncokb",
		"description": "An inframe non synonymous variant that inserts bases into in the coding sequence",
		"drug_labels": null,
		"variant_name": "V769_D770insGVV",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/281",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/318"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/318",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23371856",
					"http://www.ncbi.nlm.nih.gov/pubmed/19536777",
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160",
					"http://www.ncbi.nlm.nih.gov/pubmed/21764376",
					"http://www.ncbi.nlm.nih.gov/pubmed/18676761",
					"http://www.ncbi.nlm.nih.gov/pubmed/15897572",
					"http://www.ncbi.nlm.nih.gov/pubmed/17686547",
					"http://www.ncbi.nlm.nih.gov/pubmed/17192902"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/318"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/319",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/281",
			"name": "V843I",
			"description": "EGFR V843I",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259469,
			"end_pos": 55259469,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55259469G>A",
			"hgvs_c": "NM_005228.3:c.2527G>A",
			"hgvs_p": "NP_005219.2:p.Val843Ile",
			"dbsnp_ids": [
				"146795390"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259469G>A?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/V843I",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "V843I",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/282",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/319"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/319",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23380224",
					"http://www.ncbi.nlm.nih.gov/pubmed/21172876",
					"http://www.ncbi.nlm.nih.gov/pubmed/19536777",
					"http://www.ncbi.nlm.nih.gov/pubmed/25057940",
					"http://www.ncbi.nlm.nih.gov/pubmed/18000506",
					"http://www.ncbi.nlm.nih.gov/pubmed/18355544"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/319"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/320",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/282",
			"name": "V851A",
			"description": "EGFR V851A",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259494,
			"end_pos": 55259494,
			"ref": "T",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.55259494T>C",
			"hgvs_c": "NM_005228.3:c.2552T>C",
			"hgvs_p": "NP_005219.2:p.Val851Ala",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259494T>C?assembly=hg19",
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/V851A",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "V851A",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [

		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/320",
				"type": "Predisposing",
				"description": "Loss-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19147750"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Neutral",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/320"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/321",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/283",
			"name": "W731L",
			"description": "EGFR W731L",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242422,
			"end_pos": 55242422,
			"ref": "G",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55242422G>T",
			"hgvs_c": "NM_005228.3:c.2192G>T",
			"hgvs_p": "NP_005219.2:p.Trp731Leu",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55242422G>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/W731L",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "W731L",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/283",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/321"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/321",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20942962"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/321"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/322",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/284",
			"name": "Y801H",
			"description": "EGFR Y801H",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249103,
			"end_pos": 55249103,
			"ref": "T",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.55249103T>C",
			"hgvs_c": "NM_005228.3:c.2401T>C",
			"hgvs_p": "NP_005219.2:p.Tyr801His",
			"dbsnp_ids": [
				"757642107"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249103T>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/Y801H",
		"source": "oncokb",
		"description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved",
		"drug_labels": null,
		"variant_name": "Y801H",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/284",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/322"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/322",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20942962",
					"http://www.ncbi.nlm.nih.gov/pubmed/17224267"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Likely Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/322"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/323",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/285",
			"name": "vII",
			"description": "EGFR vII",
			"biomarker_type": "NA",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": null,
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/vII",
		"source": "oncokb",
		"description": "NA",
		"drug_labels": null,
		"variant_name": "vII",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/285",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/323"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/323",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24893890",
					"http://www.ncbi.nlm.nih.gov/pubmed/17189397"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/323"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/324",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/286",
			"name": "vIII",
			"description": "EGFR vIII",
			"biomarker_type": "NA",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": null,
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/vIII",
		"source": "oncokb",
		"description": "NA",
		"drug_labels": null,
		"variant_name": "vIII",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/286",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/324"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/324",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/8895767",
					"http://www.ncbi.nlm.nih.gov/pubmed/17189397",
					"http://www.ncbi.nlm.nih.gov/pubmed/19324552",
					"http://www.ncbi.nlm.nih.gov/pubmed/8052651",
					"http://www.ncbi.nlm.nih.gov/pubmed/23777544",
					"http://www.ncbi.nlm.nih.gov/pubmed/12438278"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/324"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/325",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/287",
			"name": "vV",
			"description": "EGFR vV",
			"biomarker_type": "NA",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": null,
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "http://oncokb.org/#/gene/EGFR/variant/vV",
		"source": "oncokb",
		"description": "NA",
		"drug_labels": null,
		"variant_name": "vV",
		"source_link": null,
		"evidence_label": null,
		"response_type": null,
		"evidence_level": null,
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/287",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/325"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/325",
				"type": "Predisposing",
				"description": "Gain-of-function",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/17189397",
					"http://www.ncbi.nlm.nih.gov/pubmed/1730638",
					"http://www.ncbi.nlm.nih.gov/pubmed/2790960"
				],
				"evidenceType_sourceName": "oncokb",
				"evidenceType_id": "EGFR-Oncogenic",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/325"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/326",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/288",
			"name": "N771DELinsVH",
			"description": "EGFR N771DELinsVH",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1662/summary/evidence/4796/summary#evidence",
		"source": "civic",
		"description": "In a retrospective study of 46 Caucasian, advanced lung adenocarcinoma patients, a patient harboring EGFR N771insVH mutation was associated with resistance to erlotinib treatment. The patient survived 3.2 months, as compared to the overall 24 months median overall survival of the other patients who were not resistant to erlotinib treatment.",
		"drug_labels": "Erlotinib",
		"variant_name": "N771DELinsVH",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1662/summary",
		"evidence_label": "C",
		"response_type": "resistant",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/288",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/326"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/326",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27032107"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4796",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/326"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/110",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/326"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/327",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/289",
			"name": "Y764_V765insHH",
			"description": "EGFR Y764_V765insHH",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55248992,
			"end_pos": 55248993,
			"ref": "T",
			"alt": "TACCATC",
			"hgvs_g": "NC_000007.13:g.55248992_55248993delinsTACCATC",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1665/summary/evidence/4800/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a Ba/F3 cell line expressing EGFR Y764_V765insHH demonstrated reduced sensitivity to erlotinib treatment (IC50=3.845�M), comparable to Ba/F3 cells expressing EGFR L858R and T790M co-mutation (T790M is a known resistant mutation to 1st and 2nd generations EGFR tyrosine kinase inhibitors; IC50=4.155�M). Resistance was determined by assessing cell proliferation, EGFR, AKT and ERK phosphorylation.",
		"drug_labels": "Erlotinib",
		"variant_name": "Y764_V765insHH",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1665/summary",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/289",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/327"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/327",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4800",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/327"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/111",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/327"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/328",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/289",
			"name": "Y764_V765insHH",
			"description": "EGFR Y764_V765insHH",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55248992,
			"end_pos": 55248993,
			"ref": "T",
			"alt": "TACCATC",
			"hgvs_g": "NC_000007.13:g.55248992_55248993delinsTACCATC",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1665/summary/evidence/5937/summary#evidence",
		"source": "civic",
		"description": "A 66 year old male with 10 pack year smoking history and lung adenocarcinoma with EGFR Y764_V765insHH mutation was given gefitinib as first line treatment, and had stable disease as best response with -7.5% change to target lesions, progression free survival of 9 months, and overall survival of 15 months.",
		"drug_labels": "GEFITINIB",
		"variant_name": "Y764_V765insHH",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1665/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/290",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/328"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/328",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5937",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/328"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/112",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/328"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/329",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/290",
			"name": "E746_S752>D",
			"description": "EGFR E746_S752>D",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242468,
			"end_pos": 55242485,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1009/summary/evidence/2571/summary#evidence",
		"source": "civic",
		"description": "In a phase 2b/3 study of 585 stage IIIB-IV lung adenocarcinoma patients who had a previous round of EGFR-TKI treatment, archival material was available for 141 patients. EGFR mutational analysis revealed that 96 tumors had an EGFR mutation, of which 76 (79%) were positive for either L858R or a deletion in exon 19. These mutations were associated with improved progression-free survival (median 3.3 months  vs 1.0 month ; HR:0.51, 95% CI:0.31-0.85, P<0.009) compared to placebo control.",
		"drug_labels": "AFATINIB",
		"variant_name": "E746_S752>D",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1009/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/291",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/329"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/329",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22452896"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2571",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/329"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/113",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/329"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/330",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/290",
			"name": "E746_S752>D",
			"description": "EGFR E746_S752>D",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242468,
			"end_pos": 55242485,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1009/summary/evidence/2566/summary#evidence",
		"source": "civic",
		"description": "In a phase 3 clinical trial of Japanese NSCLC patients with EGFR mutations (n=230), patients treated with gefitinib were associated with improved progression free survival (10.8 months vs 5.4 months, HR: 0.30, 95% CI: 0.22-0.41, P<0.001), compared to patients treated with carboplatin and paclitaxel combination therapy. The frequency of mutation of exon 19 deletion and L858R was 25.2% (58/230) and 21.3% (49/230), respectively.",
		"drug_labels": "GEFITINIB",
		"variant_name": "E746_S752>D",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1009/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/292",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/330"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/330",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20573926"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2566",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/330"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/114",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/330"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/331",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/290",
			"name": "E746_S752>D",
			"description": "EGFR E746_S752>D",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242468,
			"end_pos": 55242485,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1009/summary/evidence/2567/summary#evidence",
		"source": "civic",
		"description": "In a phase 3 clinical trial of Japanese NSCLC patients with EGFR mutations (n=177), patients treated with gefitinib were associated with improved progression free survival (9.2 months vs 6.3 months, HR:0.49, 95% CI: 0.34-0.71, P<0.0001), compared to cisplatin plus docetaxel treatment. The frequency of mutation in exon 19 deletion and L858R was 50.6% (87/172) and 49.4% (85/172), respectively, in evaluable cases.",
		"drug_labels": "GEFITINIB",
		"variant_name": "E746_S752>D",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1009/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/293",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/331"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/331",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20022809"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2567",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/331"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/115",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/331"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/332",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/290",
			"name": "E746_S752>D",
			"description": "EGFR E746_S752>D",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242468,
			"end_pos": 55242485,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1009/summary/evidence/2572/summary#evidence",
		"source": "civic",
		"description": "A phase 3 study of 345 stage IIIB-IV lung adenocarcinoma patients, reported improved median progression free survival (13.6 months vs. 6.9 months, HR: 0.47, 95% CI: 0.34-0.65, P=0.001) in EGFR mutation positive patients (n=308; exon 19 deletion and L858R mutation) treated with afatinib, as compared to patients treated with standard chemotherapy (cisplatin plus pemetrexed).",
		"drug_labels": "AFATINIB",
		"variant_name": "E746_S752>D",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1009/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/294",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/332"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/332",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23816960"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2572",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/332"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/116",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/332"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/333",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/290",
			"name": "E746_S752>D",
			"description": "EGFR E746_S752>D",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242468,
			"end_pos": 55242485,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1009/summary/evidence/2570/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study using PC9 cells (EGFR exon 19 deletion), inhibition of cell viability was used as an assay to determine sensitivity to EGFR tyrosine kinase inhibitors. PC9 cells demonstrated an increased sensitivity to gefitinib  (IC50: 23.0 nmol/L vs 200.0 nmol/L) compared to NCI-H2073 cells (EGFR wild type).",
		"drug_labels": "GEFITINIB",
		"variant_name": "E746_S752>D",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1009/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/295",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/333"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/333",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24893891"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2570",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/333"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/117",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/333"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/334",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/291",
			"name": "P546S",
			"description": "EGFR P546S",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55231430,
			"end_pos": 55231430,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55231430C>T",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55231430C>T?assembly=hg19",
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1582/summary/evidence/4672/summary#evidence",
		"source": "civic",
		"description": "bp] In an in vitro study, a NIH3T3 cell line expressing EGFR P546S mutation demonstrated increased sensitivity to cetuximab treatment compared to NIH-3T3 cells expressing EGFR wild-type. Sensitivity was determined by assessing cell viability, EGFR auto-phosphorylation, AKT phosphorylation and ERK1/2 phosphorylation.",
		"drug_labels": "CETUXIMAB",
		"variant_name": "P546S",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1582/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/296",
				"source": "http://purl.obolibrary.org/obo/DOID_5520",
				"term": "head and neck squamous cell carcinoma",
				"pheno_id": "DOID:5520",
				"family": "head and neck cancer",
				"description": "head and neck squamous cell carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/334"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/334",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23578570"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4672",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/334"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/118",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/334"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/335",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/292",
			"name": "V834I",
			"description": "EGFR V834I",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": null,
			"refseq": null,
			"isoform": "",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": "",
			"alt": "",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1897/summary/evidence/4248/summary#evidence",
		"source": "civic",
		"description": "In a study, 1 participant with stage IIIB lung adenocarcinoma was sequenced at EGFR exons 18 to 21 and was found to have V834I mutation, and was treated with the 1st generation TKI gefitinib. The patient (F, 79, nonsmoker) had a partial response, progression free survival (PFS) of 5.0 months, overall survival (OS) of 15.0 months and was not alive at study end. As a whole, patients with uncommon EGFR mutations had a response rate of 47.5%, which was between common (del19 and L858R) at 74.1%, and wild type EGFR at 16.5%. Median PFS and OS (months) for the three groups: 5.0 and 15.0 uncommon, 8.5 and 19.6 common, 2.0 and 10.4 wild type.",
		"drug_labels": "GEFITINIB",
		"variant_name": "V834I",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1897/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/297",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/335"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/335",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21531810"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4248",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/335"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/119",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/335"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/336",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/293",
			"name": "EXON 4 DELETION",
			"description": "EGFR EXON 4 DELETION",
			"biomarker_type": "Exon Loss Variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001568"
			],
			"soid": "SO:0001572",
			"so_name": "exon_loss_variant",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55214299,
			"end_pos": 55214433,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/252/summary/evidence/662/summary#evidence",
		"source": "civic",
		"description": "A variant of EGFR with exon 4 deletion (de4 EGFR) enhanced the invasiveness and cisplatin resistance of epithelial ovarian cancer cell lines (SKOV3, CAOV3, ES2) in vitro when compared with wild-type EGFR. The three cell lines were infected with lentivirus for either EGFR or de4 EGFR, and lentivirus-infected cells were used to perform transwell migration assays, invasion assays, and cisplatin sensitivity assays.",
		"drug_labels": "Cisplatin",
		"variant_name": "DELETION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/252/summary",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/298",
				"source": "MEDDRA",
				"term": "Epithelial Ovarian Cancer",
				"pheno_id": "MEDDRA:10033159",
				"family": null,
				"description": "Epithelial Ovarian Cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/336"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/336",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23764753"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "662",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/336"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/120",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "Cisplatin",
				"envcontext_id": "CHEMBL2068237",
				"usan_stem": null,
				"description": "Cisplatin",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/336"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/337",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/270",
			"name": "T725M",
			"description": "EGFR T725M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55241726,
			"end_pos": 55241726,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55241726C>T",
			"hgvs_c": "NM_005228.3:c.2174C>T",
			"hgvs_p": "NP_005219.2:p.Thr725Met",
			"dbsnp_ids": [
				"767505234"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55241726C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/861/summary/evidence/1973/summary#evidence",
		"source": "civic",
		"description": "T725M and L861R are rare cancer-associated mutations and increase EGFR activity in the absence of the activating EGF ligand in cell-based assays",
		"drug_labels": null,
		"variant_name": "T725M",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/861/summary",
		"evidence_label": "D",
		"response_type": "N/A",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/299",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/337"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/337",
				"type": "Predictive",
				"description": "N/A",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24743239"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1973",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/337"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/338",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/149",
			"name": "T263P",
			"description": "EGFR T263P",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55221743,
			"end_pos": 55221743,
			"ref": "A",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.55221743A>C",
			"hgvs_c": "NM_005228.3:c.787A>C",
			"hgvs_p": "NP_005219.2:p.Thr263Pro",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55221743A>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/995/summary/evidence/4187/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a Ba/F3 cell line expressing EGFR T263P demonstrated increased sensitivity to erlotinib treatment, compared to Ba/F3 cells expressing EGFR wild-type. Sensitivity was determined by assessing EGFR auto-phosphorylation.",
		"drug_labels": "Erlotinib",
		"variant_name": "T263P",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/995/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/300",
				"source": "http://purl.obolibrary.org/obo/DOID_3070",
				"term": "malignant glioma",
				"pheno_id": "DOID:3070",
				"family": "cell type cancer",
				"description": "malignant glioma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/338"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/338",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/17177598"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4187",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/338"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/121",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/338"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/339",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/170",
			"name": "D770_N771insNPG",
			"description": "EGFR D770_N771insNPG",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1569/summary/evidence/5947/summary#evidence",
		"source": "civic",
		"description": "Ba/F3 cells transduced with EGFR D770_N771insNPG were IL3 growth independent, suggesting a driver mutation.\n\nGefitinib growth inhibition IC50 in D770_N771insNPG transduced Ba/F3 cells was 3.356 micro molar, which was higher than cells transduced with resistance mutation T790M (IC50=2.752). Similarly, afatinib growth inhibition IC50 was 0.0724 micro molar, which was higher than cells transduced with resistance mutation T790M (IC50=0.0629).",
		"drug_labels": "AFATINIB,GEFITINIB",
		"variant_name": "D770_N771insNPG",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1569/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/301",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/339"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/339",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5947",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/339"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/123",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/339"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/122",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/339"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/340",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/170",
			"name": "D770_N771insNPG",
			"description": "EGFR D770_N771insNPG",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1569/summary/evidence/4651/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a Ba/F3 cell line expressing EGFR D770_N771insNPG demonstrated reduced sensitivity to erlotinib treatment (IC50=2.139�M), comparable to Ba/F3 cells expressing EGFR L858R and T790M co-mutation (T790M is a known resistant mutation to 1st and 2nd generation EGFR tyrosine kinase inhibitors; IC50=4.155�M). Resistance was determined by assessing cell proliferation, EGFR, AKT and ERK phosphorylation.",
		"drug_labels": "Erlotinib",
		"variant_name": "D770_N771insNPG",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1569/summary",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/302",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/340"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/340",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4651",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/340"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/124",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/340"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/341",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/170",
			"name": "D770_N771insNPG",
			"description": "EGFR D770_N771insNPG",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1569/summary/evidence/4491/summary#evidence",
		"source": "civic",
		"description": "EGFR D770_N771insNPG insertion mutation has been associated with resistance to first generation EGFR tyrosine kinase inhibitors, including erlotinib and gefitinib. In an in vitro study, NIH-3T3 cells expressing EGFR D770_N771insNPG demonstrated resistance to gefitinib and erlotinib (100-fold decreased sensitivity) compared to NIH-3T3 cells expressing wild-type EGFR.",
		"drug_labels": "Erlotinib",
		"variant_name": "D770_N771insNPG",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1569/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/303",
				"source": "http://purl.obolibrary.org/obo/DOID_2531",
				"term": "hematologic cancer",
				"pheno_id": "DOID:2531",
				"family": "organ system cancer",
				"description": "hematologic cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/341"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/341",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/16187797"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4491",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/341"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/125",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/341"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/342",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/170",
			"name": "D770_N771insNPG",
			"description": "EGFR D770_N771insNPG",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1569/summary/evidence/4492/summary#evidence",
		"source": "civic",
		"description": "EGFR D770_N771insNPG insertion mutation has been associated with resistance to first generation EGFR tyrosine kinase inhibitors, including erlotinib and gefitinib. In an in vitro study, NIH-3T3 cells expressing EGFR D770_N771insNPG demonstrated resistance to gefitinib and erlotinib (100-fold decreased sensitivity) compared to NIH-3T3 cells expressing wild-type EGFR.",
		"drug_labels": "CETUXIMAB",
		"variant_name": "D770_N771insNPG",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1569/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/304",
				"source": "http://purl.obolibrary.org/obo/DOID_2531",
				"term": "hematologic cancer",
				"pheno_id": "DOID:2531",
				"family": "organ system cancer",
				"description": "hematologic cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/342"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/342",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/16187797"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4492",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/342"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/126",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/342"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/343",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/294",
			"name": "S752_I759delSPKANKEI",
			"description": "EGFR S752_I759delSPKANKEI",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242484,
			"end_pos": 55242507,
			"ref": "ATCTCCGAAAGCCAACAAGGAAATC",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55242484_55242507delinsA",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/891/summary/evidence/3804/summary#evidence",
		"source": "civic",
		"description": "A study of five clinical trials reported that chemotherapy na�ve non-small cell lung cancer patients with EGFR sensitizing mutations (exon 19 deletion, L858R, L861Q, or G719X) treated with erlotinib or gefitinib were associated with improved response rate (59% vs 4%; P<0.0001) and increased median overall survival (24.5 months vs 11.8 months P=0.002) as compared to patients without EGFR sensitizing mutations.",
		"drug_labels": "Erlotinib",
		"variant_name": "S752_I759delSPKANKEI",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/891/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/305",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/343"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/343",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19671843"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3804",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/343"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/127",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/343"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/344",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/150",
			"name": "D761Y",
			"description": "EGFR D761Y",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242511,
			"end_pos": 55242511,
			"ref": "G",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55242511G>T",
			"hgvs_c": "NM_005228.3:c.2281G>T",
			"hgvs_p": "NP_005219.2:p.Asp761Tyr",
			"dbsnp_ids": [
				"121913418"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55242511G>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/712/summary/evidence/1763/summary#evidence",
		"source": "civic",
		"description": "D761Y as a secondary mutation was reported to be associated with resistance to gefitinib and erlotinib in NSCLC cells that contain the L858R-EGFR mutation. This mutation combination was observed in a single patient with lung cancer and specifically in a metastatic brain lesion following gefitinib treatment. Functional validation of its role in drug sensitivity was examined in cell lines (293T and Ba/F3 cells).",
		"drug_labels": "Erlotinib,GEFITINIB",
		"variant_name": "D761Y",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/712/summary",
		"evidence_label": "C",
		"response_type": "resistant",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/306",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/344"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/344",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/17085664"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1763",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/344"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/129",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/344"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/128",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/344"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/345",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/295",
			"name": "K757R",
			"description": "EGFR K757R",
			"biomarker_type": "Missense Variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55242500,
			"end_pos": 55242500,
			"ref": "A",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55242500A>G",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"397517102"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55242500A>G?assembly=hg19",
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/723/summary/evidence/1786/summary#evidence",
		"source": "civic",
		"description": "In a meta-analysis of 7 clinical trials evaluating the efficacy of erlotinib, one patient was described with the exon 19 mutation K757R from the MERIT study. Progression-free (250 days) and overall (435 days) survival suggested sensitivity in this patient. Literature analysis did not identify additional reports of patients harboring this mutation.",
		"drug_labels": "Erlotinib",
		"variant_name": "K757R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/723/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/307",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/345"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/345",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26773740"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1786",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/345"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/130",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/345"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/346",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/138",
			"name": "G719",
			"description": "EGFR G719",
			"biomarker_type": "NA",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580"
			],
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55241707,
			"end_pos": 55241707,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55241707G>A",
			"hgvs_c": "NM_005228.3:c.2155G>A",
			"hgvs_p": "NP_005219.2:p.Gly719Ser",
			"dbsnp_ids": [
				"28929495"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55241707G>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/718/summary/evidence/1780/summary#evidence",
		"source": "civic",
		"description": "In a meta-analysis of 7 clinical trials of erlotinib, 10/24 patients with Exon 18 mutations harbored a G719 variant. These variants were associated with improved progression-free and overall survival. No statistical analysis was reported for this variant and PFS or OS, citing small sample size across the studies.",
		"drug_labels": "Erlotinib",
		"variant_name": "G719",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/718/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/308",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/346"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/346",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26773740"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1780",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/346"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/131",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/346"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/347",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/138",
			"name": "G719",
			"description": "EGFR G719",
			"biomarker_type": "NA",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580"
			],
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55241707,
			"end_pos": 55241707,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55241707G>A",
			"hgvs_c": "NM_005228.3:c.2155G>A",
			"hgvs_p": "NP_005219.2:p.Gly719Ser",
			"dbsnp_ids": [
				"28929495"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55241707G>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/718/summary/evidence/4189/summary#evidence",
		"source": "civic",
		"description": "EGFR G719 mutations have been associated with increased sensitivity to first generation EGFR tyrosine kinase inhibitors, including erlotinib and gefitinib. In a study of patients treated with erlotinib or gefitinib, a subset of patients with EGFR mutation at codons G719 or L861 (n=30) was associated with improved response rate (47.5% vs 16.5%, P<0.001) median progression free survival (5.0 vs 2.0 months, P<0.001), and overall survival (15.0 vs. 10.4 months, P =0.030), compared to patients with wild-type EGFR (n=272).",
		"drug_labels": "GEFITINIB,Erlotinib",
		"variant_name": "G719",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/718/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/309",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/347"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/347",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21531810"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4189",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/347"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/133",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/347"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/132",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/347"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/348",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/284",
			"name": "Y801H",
			"description": "EGFR Y801H",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249103,
			"end_pos": 55249103,
			"ref": "T",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.55249103T>C",
			"hgvs_c": "NM_005228.3:c.2401T>C",
			"hgvs_p": "NP_005219.2:p.Tyr801His",
			"dbsnp_ids": [
				"757642107"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249103T>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1575/summary/evidence/4659/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a COS-7 cell line expressing EGFR Y801H demonstrated increased sensitivity to erlotinib treatment, compared to COS-7 cells expressing EGFR wild-type. Sensitivity was determined by assessing EGFR auto-phosphorylation.",
		"drug_labels": "Erlotinib",
		"variant_name": "Y801H",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1575/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/310",
				"source": "http://purl.obolibrary.org/obo/DOID_1790",
				"term": "malignant mesothelioma",
				"pheno_id": "DOID:1790",
				"family": "cell type cancer",
				"description": "malignant mesothelioma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/348"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/348",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20942962"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4659",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/348"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/134",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/348"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/349",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/296",
			"name": "R831H",
			"description": "EGFR R831H",
			"biomarker_type": "Missense Variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55259434,
			"end_pos": 55259434,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55259434G>A",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"150036236"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259434G>A?assembly=hg19",
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1017/summary/evidence/2620/summary#evidence",
		"source": "civic",
		"description": "Mutations in exon 19 or exon 21 of EGFR were found at higher frequencies in of tumors from patients who had a clinically significant response to gefitinib treatment compared with patients who had no clinical response (89% ,8/9 vs. 8%, 0/7, P=0.001). Biological",
		"drug_labels": "GEFITINIB",
		"variant_name": "R831H",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1017/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/311",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/349"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/349",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15118072"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2620",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/349"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/135",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/349"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/350",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/296",
			"name": "R831H",
			"description": "EGFR R831H",
			"biomarker_type": "Missense Variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55259434,
			"end_pos": 55259434,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55259434G>A",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"150036236"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259434G>A?assembly=hg19",
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1017/summary/evidence/2619/summary#evidence",
		"source": "civic",
		"description": "EGFR belongs to a family of receptor tyrosine kinases that includes EGFR/erbB-1, Her2/erbB-2, Her3/erbB-3, and Her4/erbB-4.",
		"drug_labels": "GEFITINIB",
		"variant_name": "R831H",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1017/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/312",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/350"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/350",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15870435"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2619",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/350"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/136",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/350"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/351",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/296",
			"name": "R831H",
			"description": "EGFR R831H",
			"biomarker_type": "Missense Variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55259434,
			"end_pos": 55259434,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55259434G>A",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"150036236"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259434G>A?assembly=hg19",
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1017/summary/evidence/2618/summary#evidence",
		"source": "civic",
		"description": "EGFR belongs to a family of receptor tyrosine kinases that includes EGFR/erbB-1, Her2/erbB-2, Her3/erbB-3, and Her4/erbB-4. Ligand binding causes receptor homo- or hetero-dimerization, leading to activation of the tyrosine kinase domain.  Kinase activation initiates a cascade of events affecting cell cycle progression, apoptosis, angiogenesis, and metastasis, and is implicated in the development and progression of cancer.. Experimental",
		"drug_labels": "GEFITINIB",
		"variant_name": "R831H",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1017/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/313",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/351"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/351",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20966921"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2618",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/351"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/137",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/351"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/352",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/296",
			"name": "R831H",
			"description": "EGFR R831H",
			"biomarker_type": "Missense Variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55259434,
			"end_pos": 55259434,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55259434G>A",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"150036236"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259434G>A?assembly=hg19",
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1017/summary/evidence/4279/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a COS-7 cell line expressing EGFR R831H demonstrated increased sensitivity to erlotinib treatment, compared to COS-7 cells expressing EGFR wild-type. Sensitivity was determined by assessing EGFR auto-phosphorylation.",
		"drug_labels": "Erlotinib",
		"variant_name": "R831H",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1017/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/314",
				"source": "http://purl.obolibrary.org/obo/DOID_1790",
				"term": "malignant mesothelioma",
				"pheno_id": "DOID:1790",
				"family": "cell type cancer",
				"description": "malignant mesothelioma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/352"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/352",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20942962"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4279",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/352"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/138",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/352"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/353",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/256",
			"name": "R776C",
			"description": "EGFR R776C",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249028,
			"end_pos": 55249028,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249028C>T",
			"hgvs_c": "NM_005228.3:c.2326C>T",
			"hgvs_p": "NP_005219.2:p.Arg776Cys",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249028C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1181/summary/evidence/4468/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a Ba/F3 cell line expressing EGFR R776C demonstrated increased sensitivity to erlotinib treatment comparable to Ba/F3 cells expressing a known sensitizing mutation (EGFR L858R). Sensitivity was determined by assessing cell proliferation, the IC50 of erlotinib for EGFR V742A and EGFR L858R expressing cells were 47 nmol/L and 6 nmol/L, respectively.",
		"drug_labels": "Erlotinib",
		"variant_name": "R776C",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1181/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/315",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/353"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/353",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19147750"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4468",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/353"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/139",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/353"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/354",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/256",
			"name": "R776C",
			"description": "EGFR R776C",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249028,
			"end_pos": 55249028,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249028C>T",
			"hgvs_c": "NM_005228.3:c.2326C>T",
			"hgvs_p": "NP_005219.2:p.Arg776Cys",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249028C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1181/summary/evidence/5818/summary#evidence",
		"source": "civic",
		"description": "EGFR R776C was expressed in Ba/F3 cells which do not contain endogenous EGFR, and conferred growth factor independence to the cells. Cells were plated and treated with 1st generation EGFR inhibitors Gefitinib, Erlotinib, or the the tool compound AEE788, and IC50 values were measured. R776C EGFR cells had moderately high IC50 nmol/L values for gefitinib in comparison to other EGFR constructs, which did not indicate sensitivity. (Gefitinib=110, Erlotinib=47, AEE788=36)",
		"drug_labels": "GEFITINIB",
		"variant_name": "R776C",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1181/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/316",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/354"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/354",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19147750"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5818",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/354"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/140",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/354"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/355",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/240",
			"name": "L838V",
			"description": "EGFR L838V",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259454,
			"end_pos": 55259454,
			"ref": "C",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259454C>G",
			"hgvs_c": "NM_005228.3:c.2512C>G",
			"hgvs_p": "NP_005219.2:p.Leu838Val",
			"dbsnp_ids": [
				"864621996"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259454C>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1018/summary/evidence/4280/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a Ba/F3 cell line expressing EGFR L838V demonstrated reduced sensitivity to erlotinib treatment, compared to Ba/F3 cells expressing a known sensitizing mutation (EGFR L858R). Sensitivity was determined by assessing cell proliferation, the IC50 of erlotinib for EGFR L838V and EGFR L858R expressing cells were 160 nmol/L and 6 nmol/L, respectively.",
		"drug_labels": "Erlotinib",
		"variant_name": "L838V",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1018/summary",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/317",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/355"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/355",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19147750"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4280",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/355"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/141",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/355"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/356",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/297",
			"name": "WILDTYPE",
			"description": "EGFR WILDTYPE",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": null,
			"refseq": null,
			"isoform": "",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": "",
			"alt": "",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/2174/summary/evidence/6185/summary#evidence",
		"source": "civic",
		"description": "In a Japanese Phase III trial, noninferiority of gefitinib in comparison to erlotinib was assessed in lung adenocarcinoma patients with postoperative or recurrent stage IIIb/IV lung adenocarcinoma treated previously with chemotherapy but no tyrosine kinase inhibitor. In the subgroup with wildtype EGFR, 41 and 43 patients were given erlotinib and gefitinib, respectively. Objective response (defined as complete + partial response) was 12.2 and 1 percent with erlotinib and gefitinib (P=0.079). Disease control rate (defined as partial response + stable disease) was 53.7 and 34.9 percent with erlotinib and gefitinib (P=0.083). While planned endpoint of noninferiority was not met, lack of statistically significant differences between erlotinib and gefitinib responses, and less observed adverse responses with gefitinib led the authors to conclude that gefitinib is a viable alternative to erlotinib treatment in these patients.",
		"drug_labels": "GEFITINIB",
		"variant_name": "WILDTYPE",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/2174/summary",
		"evidence_label": "B",
		"response_type": "Reduced Sensitivity",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/318",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/356"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/356",
				"type": "Predictive",
				"description": "Reduced Sensitivity",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27022112"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6185",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/356"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/142",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/356"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/357",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/297",
			"name": "WILDTYPE",
			"description": "EGFR WILDTYPE",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": null,
			"refseq": null,
			"isoform": "",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": "",
			"alt": "",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/2174/summary/evidence/2512/summary#evidence",
		"source": "civic",
		"description": "In a phase 3 clinical trial of East Asian pulmonary adenocarcinoma patients, a subset of patients with EGFR mutations (n=261) treated with gefitinib were associated with improved response (HR:0.48, 95% CI:0.36-0.64, P<0.001), compared to carboplatin plus paclitaxel treatment. The frequency of mutation in exon 19 deletion and L858R was 53.6% (140/261) and 42.5% (111/261), respectively.",
		"drug_labels": "GEFITINIB",
		"variant_name": "WILDTYPE",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/2174/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/319",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/357"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/357",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19692680"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2512",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/357"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/143",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/357"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/358",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/298",
			"name": "VIII",
			"description": "EGFR VIII",
			"biomarker_type": "Disruptive Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820",
				"SO:0001822"
			],
			"soid": "SO:0001826",
			"so_name": "disruptive_inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55087058,
			"end_pos": 55223523,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/312/summary/evidence/4500/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a Ba/F3 cell line expressing EGFR vIII demonstrated increased sensitivity to erlotinib treatment, compared to Ba/F3 cells expressing EGFR wild-type. Sensitivity was determined by assessing EGFR auto-phosphorylation.",
		"drug_labels": "Erlotinib",
		"variant_name": "VIII",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/312/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/320",
				"source": "http://purl.obolibrary.org/obo/DOID_3070",
				"term": "malignant glioma",
				"pheno_id": "DOID:3070",
				"family": "cell type cancer",
				"description": "malignant glioma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/358"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/358",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/17177598"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4500",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/358"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/144",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/358"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/359",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/298",
			"name": "VIII",
			"description": "EGFR VIII",
			"biomarker_type": "Disruptive Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820",
				"SO:0001822"
			],
			"soid": "SO:0001826",
			"so_name": "disruptive_inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55087058,
			"end_pos": 55223523,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/312/summary/evidence/1128/summary#evidence",
		"source": "civic",
		"description": "Expression of EGFRvIII and PTEN was evaluated in 26 patients with glioblastomas treated with erlotinib or gefitinib and no EGFR or Her2/neu kinase domain mutations. 7 patients responded to treatment while 19 progressed rapidly. Coexpression of EGFRvIII and PTEN was associated with clinical response (defined as 25% tumor shrinkage). These results were confirmed using IHC in an independent cohort of 33 patients (8 responders) treated with erlotinib at another institution.",
		"drug_labels": "Erlotinib,GEFITINIB",
		"variant_name": "VIII",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/312/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/321",
				"source": "http://purl.obolibrary.org/obo/DOID_3068",
				"term": "glioblastoma multiforme",
				"pheno_id": "DOID:3068",
				"family": "malignant glioma",
				"description": "glioblastoma multiforme",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/359"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/359",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/16282176"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1128",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/359"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/146",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/359"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/145",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/359"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/360",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/298",
			"name": "VIII",
			"description": "EGFR VIII",
			"biomarker_type": "Disruptive Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820",
				"SO:0001822"
			],
			"soid": "SO:0001826",
			"so_name": "disruptive_inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55087058,
			"end_pos": 55223523,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/312/summary/evidence/971/summary#evidence",
		"source": "civic",
		"description": "In a Phase II clinical trial, patients with Glioblastoma Multiforme (GBM), positive for EGFR VIII deletion mutation (N=65), were treated with the Rindopepimut cancer vaccine,  and standard adjuvant temozolomide chemotherapy.  Median progression free survival (PFS) was 9.2 months, and median overall survival (OS) was 21.8 months.  A pivotal, randomized Phase III trial is currently underway.",
		"drug_labels": "RINDOPEPIMUT",
		"variant_name": "VIII",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/312/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/322",
				"source": "http://purl.obolibrary.org/obo/DOID_3068",
				"term": "glioblastoma multiforme",
				"pheno_id": "DOID:3068",
				"family": "malignant glioma",
				"description": "glioblastoma multiforme",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/360"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/360",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25586468"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "971",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/360"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/147",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "RINDOPEPIMUT",
				"envcontext_id": "CHEMBL2107863",
				"usan_stem": null,
				"description": "RINDOPEPIMUT",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/360"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/361",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/298",
			"name": "VIII",
			"description": "EGFR VIII",
			"biomarker_type": "Disruptive Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820",
				"SO:0001822"
			],
			"soid": "SO:0001826",
			"so_name": "disruptive_inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55087058,
			"end_pos": 55223523,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/312/summary/evidence/848/summary#evidence",
		"source": "civic",
		"description": "47 HNSCC patients treated with cetuximab/docetaxel were retrospectively analyzed for EGFRvIII, EGFR, and AREG expression by IHC. 17% of cases expressed high levels of EGFRvIII. High vIII expression was associated with reduced disease control rate (DCR) and shortened progression free survival (PFS) (HR: 3.3, P = 0.005) but not with OS.",
		"drug_labels": "DOCETAXEL,CETUXIMAB",
		"variant_name": "VIII",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/312/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/323",
				"source": "http://purl.obolibrary.org/obo/DOID_5520",
				"term": "head and neck squamous cell carcinoma",
				"pheno_id": "DOID:5520",
				"family": "head and neck cancer",
				"description": "head and neck squamous cell carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/361"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/361",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21653686"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "848",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/361"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/149",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/361"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/148",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DOCETAXEL",
				"envcontext_id": "148123",
				"usan_stem": "antineoplastics, taxane derivatives",
				"description": "DOCETAXEL",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/361"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/362",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/298",
			"name": "VIII",
			"description": "EGFR VIII",
			"biomarker_type": "Disruptive Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820",
				"SO:0001822"
			],
			"soid": "SO:0001826",
			"so_name": "disruptive_inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55087058,
			"end_pos": 55223523,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/312/summary/evidence/1017/summary#evidence",
		"source": "civic",
		"description": "Two human glioma cell lines (U87MG or LNZ308) overexpressing either wild-type (wt) EGFR or EGFRvIII were treated with nimotuzumab, temozolomide, or both in vitro. Anti-tumor effects of nimotuzumab were greater in EGFRvIII in comparison to EGFRwt (as measured by antitumor effects, growth suppression, survival elongation and EGFR and Akt phosphorylation). Combination of nimotuzumab and temozolomide further increased efficacy.",
		"drug_labels": "Nimotuzumab",
		"variant_name": "VIII",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/312/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/324",
				"source": "http://purl.obolibrary.org/obo/DOID_0060108",
				"term": "brain glioma",
				"pheno_id": "DOID:0060108",
				"family": "central nervous system cancer",
				"description": "brain glioma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/362"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/362",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26778701"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1017",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/362"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/150",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "Nimotuzumab",
				"envcontext_id": "CHEMBL2108359",
				"usan_stem": "monoclonal antibodies",
				"description": "Nimotuzumab",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/362"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/363",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/298",
			"name": "VIII",
			"description": "EGFR VIII",
			"biomarker_type": "Disruptive Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820",
				"SO:0001822"
			],
			"soid": "SO:0001826",
			"so_name": "disruptive_inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55087058,
			"end_pos": 55223523,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/312/summary/evidence/773/summary#evidence",
		"source": "civic",
		"description": "Case report of a 58-year old patient with disease progression after radiotherapy and three temozolomide cycles. Afatinib and temozolomide led to disease regression. At last assessment 63 treatment cycles had been completed and the patient had survived for about 5 years since recurrence. Identified EGFR aberrations included EGFRvIII positivity, EGFR gene amplification and three somatic EGFR mutations.",
		"drug_labels": "AFATINIB",
		"variant_name": "VIII",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/312/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/325",
				"source": "http://purl.obolibrary.org/obo/DOID_3068",
				"term": "glioblastoma multiforme",
				"pheno_id": "DOID:3068",
				"family": "malignant glioma",
				"description": "glioblastoma multiforme",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/363"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/363",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26423602"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "773",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/363"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/151",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/363"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/364",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/298",
			"name": "VIII",
			"description": "EGFR VIII",
			"biomarker_type": "Disruptive Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820",
				"SO:0001822"
			],
			"soid": "SO:0001826",
			"so_name": "disruptive_inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55087058,
			"end_pos": 55223523,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/312/summary/evidence/772/summary#evidence",
		"source": "civic",
		"description": "49 patients (26 pretreatment tissues available for analysis) with recurrent glioblastomas who were treated with EGFR TKIs were analyzed in this study. Results were confirmed in an independent cohort of 33 patients. EGFRvIII and PTEN coexpression were associated with responsiveness to EGFR TKI.",
		"drug_labels": "EGFR",
		"variant_name": "VIII",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/312/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/326",
				"source": "http://purl.obolibrary.org/obo/DOID_3068",
				"term": "glioblastoma multiforme",
				"pheno_id": "DOID:3068",
				"family": "malignant glioma",
				"description": "glioblastoma multiforme",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/364"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/364",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/16282176"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "772",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/364"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/152",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/substance",
				"term": "EGFR",
				"envcontext_id": "SID160769799",
				"usan_stem": null,
				"description": "EGFR",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/364"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/365",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/299",
			"name": "E746V",
			"description": "EGFR E746V",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242467,
			"end_pos": 55242467,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55242467A>T",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55242467A>T?assembly=hg19",
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1005/summary/evidence/4232/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a Ba/F3 cell line expressing EGFR E746_S752insV demonstrated increased sensitivity to erlotinib treatment (IC50=25nM), comparable to Ba/F3 cells expressing EGFR L858R (a known sensitizing mutation to EGFR tyrosine kinase inhibitors; IC50=16nM). Sensitivity was determined by IL-3 independent cell survival.",
		"drug_labels": "Erlotinib",
		"variant_name": "E746V",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1005/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/327",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/365"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/365",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/17877814"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4232",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/365"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/153",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/365"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/366",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/299",
			"name": "E746V",
			"description": "EGFR E746V",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242467,
			"end_pos": 55242467,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55242467A>T",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55242467A>T?assembly=hg19",
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1005/summary/evidence/2535/summary#evidence",
		"source": "civic",
		"description": "In a phase 3 clinical trial of Japanese NSCLC patients with EGFR mutations (n=230), patients treated with gefitinib were associated with improved progression free survival (10.8 months vs 5.4 months, HR: 0.30, 95% CI: 0.22-0.41, P<0.001), compared to patients treated with carboplatin and paclitaxel combination therapy. The frequency of mutation of exon 19 deletion and L858R was 25.2% (58/230) and 21.3% (49/230), respectively.",
		"drug_labels": "GEFITINIB",
		"variant_name": "E746V",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1005/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/328",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/366"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/366",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20573926"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2535",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/366"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/154",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/366"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/367",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/299",
			"name": "E746V",
			"description": "EGFR E746V",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242467,
			"end_pos": 55242467,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55242467A>T",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55242467A>T?assembly=hg19",
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1005/summary/evidence/2536/summary#evidence",
		"source": "civic",
		"description": "In a phase 3 clinical trial of Japanese NSCLC patients with EGFR mutations (n=177), patients treated with gefitinib were associated with improved progression free survival (9.2 months vs 6.3 months, HR:0.49, 95% CI: 0.34-0.71, P<0.0001), compared to cisplatin plus docetaxel treatment. The frequency of mutation in exon 19 deletion and L858R was 50.6% (87/172) and 49.4% (85/172), respectively, in evaluable cases.",
		"drug_labels": "GEFITINIB",
		"variant_name": "E746V",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1005/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/329",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/367"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/367",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20022809"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2536",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/367"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/155",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/367"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/368",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/299",
			"name": "E746V",
			"description": "EGFR E746V",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242467,
			"end_pos": 55242467,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55242467A>T",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55242467A>T?assembly=hg19",
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1005/summary/evidence/2540/summary#evidence",
		"source": "civic",
		"description": "In a study of 585 non-small cell lung cancer patients who had a previous round of EGFR-TKI treatment, archival material was available for 141 patients. EGFR mutational analysis revealed that 96 tumors had an EGFR mutation, of which 76 (79%) were positive for either L858R or a deletion in exon 19. These mutations were associated with improved response to afatinib for progression-free survival (median 3.3 months  vs 1.0 month ; HR:0.51, 95% CI:0.31-0.85, P<0.009) compared to placebo control.",
		"drug_labels": "AFATINIB",
		"variant_name": "E746V",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1005/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/330",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/368"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/368",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22452896"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2540",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/368"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/156",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/368"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/369",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/299",
			"name": "E746V",
			"description": "EGFR E746V",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242467,
			"end_pos": 55242467,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55242467A>T",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55242467A>T?assembly=hg19",
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1005/summary/evidence/2541/summary#evidence",
		"source": "civic",
		"description": "A phase 3 study of 345 stage IIIB-IV lung adenocarcinoma patients, reported improved median progression free survival (13.6 months vs. 6.9 months, HR: 0.47, 95% CI: 0.34-0.65, P=0.001) in EGFR mutation positive patients (n=308; exon 19 deletion and L858R mutation) treated with afatinib, as compared to patients treated with standard chemotherapy (cisplatin plus pemetrexed).",
		"drug_labels": "AFATINIB",
		"variant_name": "E746V",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1005/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/331",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/369"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/369",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23816960"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2541",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/369"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/157",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/369"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/370",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/299",
			"name": "E746V",
			"description": "EGFR E746V",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242467,
			"end_pos": 55242467,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55242467A>T",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55242467A>T?assembly=hg19",
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1005/summary/evidence/2539/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study using PC9 cells (EGFR exon 19 deletion), inhibition of cell viability was used as an assay to determine sensitivity to EGFR tyrosine kinase inhibitors. PC9 cells demonstrated an increased sensitivity to gefitinib  (IC50: 23.0 nmol/L vs 200.0 nmol/L) compared to NCI-H2073 cells (EGFR wild type).",
		"drug_labels": "GEFITINIB",
		"variant_name": "E746V",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1005/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/332",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/370"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/370",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24893891"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2539",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/370"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/158",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/370"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/371",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/300",
			"name": "Y1092 PHOSPHORYLATION",
			"description": "EGFR Y1092 PHOSPHORYLATION",
			"biomarker_type": "N/A",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55272951,
			"end_pos": 55272953,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/390/summary/evidence/923/summary#evidence",
		"source": "civic",
		"description": "While EGFR mutation is a strong predictive factor for EGFR inhibition, some patients with EGFR wild-type also respond.  The authors investigated whether phosphorylated EGFR could be a potential predictive biomarker in patients with wild-type EGFR. Phosphorylation of Y1068 (assessed by IHC) was associated with improved progression free survival (PFS) in 205 patients with stage IIb and IV NSCLC treated with EGFR tyrosine kinase inhibitors (gefitinib or erlotinib) compared to phospho-Y1068 negative patients (median PFS 7.0 months vs. 1.2 months, P < 0.001). In this group, 92 (44.9%) were EGFR mutant. In a subgroup of patients with wild-type EGFR, phospho-Y1068 expression positive patients had a significantly prolonged PFS (4.2 months vs.1.2 months P < 0.001) compared with those without phospho-Y1068 expression.",
		"drug_labels": "Erlotinib,GEFITINIB",
		"variant_name": "PHOSPHORYLATION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/390/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/333",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/371"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/371",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22901364"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "923",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/371"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/160",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/371"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/159",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/371"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/372",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/264",
			"name": "S768_D770dup",
			"description": "EGFR S768_D770dup",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249013,
			"end_pos": 55249014,
			"ref": "A",
			"alt": "AGCGTGGACA",
			"hgvs_g": "NC_000007.13:g.55249013_55249014dupAGCGTGGACA",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1511/summary/evidence/4490/summary#evidence",
		"source": "civic",
		"description": "In a retrospective study of 46 Caucasian, advanced lung adenocarcinoma patients, a patient harboring EGFR S768_D770insSVD mutation was associated with resistance to erlotinib treatment. The patient survived 14 months, as compared to the overall 24 months median overall survival of the other patients who were not resistant to erlotinib treatment.",
		"drug_labels": "Erlotinib",
		"variant_name": "S768_D770dup",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1511/summary",
		"evidence_label": "C",
		"response_type": "resistant",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/334",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/372"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/372",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27032107"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4490",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/372"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/161",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/372"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/373",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/301",
			"name": "E746_S752>A",
			"description": "EGFR E746_S752>A",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242467,
			"end_pos": 55242484,
			"ref": "GAATTAAGAGAAGCAACAT",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55242467_55242484delinsG",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1433/summary/evidence/4227/summary#evidence",
		"source": "civic",
		"description": "A study of five clinical trials reported that chemotherapy na�ve non-small cell lung cancer patients with EGFR sensitizing mutations (exon 19 deletion, L858R, L861Q, or G719X) treated with erlotinib or gefitinib were associated with improved response rate (59% vs 4%; P<0.0001) and increased median overall survival (24.5 months vs 11.8 months P=0.002) as compared to patients without EGFR sensitizing mutations.",
		"drug_labels": "Erlotinib",
		"variant_name": "E746_S752>A",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1433/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/335",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/373"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/373",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19671843"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4227",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/373"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/162",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/373"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/374",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/182",
			"name": "E746_T751delinsA",
			"description": "EGFR E746_T751delinsA",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242467,
			"end_pos": 55242481,
			"ref": "GAATTAAGAGAAGCAA",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55242467_55242481delinsG",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"121913425"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55242467_55242481del?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1004/summary/evidence/4221/summary#evidence",
		"source": "civic",
		"description": "A study of five clinical trials reported that chemotherapy na�ve non-small cell lung cancer patients with EGFR sensitizing mutations (exon 19 deletion, L858R, L861Q, or G719X) treated with erlotinib or gefitinib were associated with improved response rate (59% vs 4%; P<0.0001) and increased median overall survival (24.5 months vs 11.8 months P=0.002) as compared to patients without EGFR sensitizing mutations.",
		"drug_labels": "Erlotinib",
		"variant_name": "E746_T751delinsA",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1004/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/336",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/374"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/374",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19671843"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4221",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/374"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/163",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/374"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/375",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/182",
			"name": "E746_T751delinsA",
			"description": "EGFR E746_T751delinsA",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242467,
			"end_pos": 55242481,
			"ref": "GAATTAAGAGAAGCAA",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55242467_55242481delinsG",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"121913425"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55242467_55242481del?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1004/summary/evidence/4222/summary#evidence",
		"source": "civic",
		"description": "In a lung adenocarcinoma patient with EGFR E746_T751>A mutation EGFR E746_A751>A was associated with improved response to erlotinib treatment. The patient was treated with erlotinib monotherapy and achieved a 10 month response rate.",
		"drug_labels": "Erlotinib",
		"variant_name": "E746_T751delinsA",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1004/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/337",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/375"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/375",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/17085664"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4222",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/375"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/164",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/375"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/376",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/182",
			"name": "E746_T751delinsA",
			"description": "EGFR E746_T751delinsA",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242467,
			"end_pos": 55242481,
			"ref": "GAATTAAGAGAAGCAA",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55242467_55242481delinsG",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"121913425"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55242467_55242481del?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1004/summary/evidence/2533/summary#evidence",
		"source": "civic",
		"description": "Mutations in exon 19 or exon 21 of EGFR were found at higher frequencies in of tumors from patients who had a clinically significant response to gefitinib treatment compared with patients who had no clinical response (89% ,8/9 vs. 8%, 0/7, P=0.001). Biological",
		"drug_labels": "GEFITINIB",
		"variant_name": "E746_T751delinsA",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1004/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/338",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/376"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/376",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15118072"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2533",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/376"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/165",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/376"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/377",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/182",
			"name": "E746_T751delinsA",
			"description": "EGFR E746_T751delinsA",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242467,
			"end_pos": 55242481,
			"ref": "GAATTAAGAGAAGCAA",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55242467_55242481delinsG",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"121913425"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55242467_55242481del?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1004/summary/evidence/2532/summary#evidence",
		"source": "civic",
		"description": "EGFR belongs to a family of receptor tyrosine kinases that includes EGFR/erbB-1, Her2/erbB-2, Her3/erbB-3, and Her4/erbB-4.",
		"drug_labels": "GEFITINIB",
		"variant_name": "E746_T751delinsA",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1004/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/339",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/377"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/377",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15870435"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2532",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/377"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/166",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/377"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/378",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/182",
			"name": "E746_T751delinsA",
			"description": "EGFR E746_T751delinsA",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242467,
			"end_pos": 55242481,
			"ref": "GAATTAAGAGAAGCAA",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55242467_55242481delinsG",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"121913425"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55242467_55242481del?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1004/summary/evidence/2531/summary#evidence",
		"source": "civic",
		"description": "EGFR belongs to a family of receptor tyrosine kinases that includes EGFR/erbB-1, Her2/erbB-2, Her3/erbB-3, and Her4/erbB-4. Ligand binding causes receptor homo- or hetero-dimerization, leading to activation of the tyrosine kinase domain.  Kinase activation initiates a cascade of events affecting cell cycle progression, apoptosis, angiogenesis, and metastasis, and is implicated in the development and progression of cancer.. Experimental",
		"drug_labels": "GEFITINIB",
		"variant_name": "E746_T751delinsA",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1004/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/340",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/378"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/378",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20966921"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2531",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/378"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/167",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/378"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/379",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/302",
			"name": "E746_A750>IP",
			"description": "EGFR E746_A750>IP",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1635/summary/evidence/4754/summary#evidence",
		"source": "civic",
		"description": "A study of five clinical trials reported that chemotherapy na�ve non-small cell lung cancer patients with EGFR sensitizing mutations (exon 19 deletion, L858R, L861Q, or G719X) treated with erlotinib or gefitinib were associated with improved response rate (59% vs 4%; P<0.0001) and increased median overall survival (24.5 months vs 11.8 months P=0.002) as compared to patients without EGFR sensitizing mutations.",
		"drug_labels": "Erlotinib",
		"variant_name": "E746_A750>IP",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1635/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/341",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/379"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/379",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19671843"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4754",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/379"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/168",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/379"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/380",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/200",
			"name": "G719S",
			"description": "EGFR G719S",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55241707,
			"end_pos": 55241707,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55241707G>A",
			"hgvs_c": "NM_005228.3:c.2155G>A",
			"hgvs_p": "NP_005219.2:p.Gly719Ser",
			"dbsnp_ids": [
				"28929495"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55241707G>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/134/summary/evidence/6040/summary#evidence",
		"source": "civic",
		"description": "The G719S mutation was found in a 50-year-old female never smoker with advanced adenocarcinoma of the lung. One month after the end of chemotherapy, , she started erlotinib at 150 mg/d. At the first computer tomography scan evaluation, performed 2 months later, disease reduction of multiple primary lung and nodal lesions was evident. Brain metastases were stable. The patient is still on treatment after 4 months.",
		"drug_labels": "Erlotinib",
		"variant_name": "G719S",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/134/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/342",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/380"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/380",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21841502"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6040",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/380"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/169",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/380"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/381",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/200",
			"name": "G719S",
			"description": "EGFR G719S",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55241707,
			"end_pos": 55241707,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55241707G>A",
			"hgvs_c": "NM_005228.3:c.2155G>A",
			"hgvs_p": "NP_005219.2:p.Gly719Ser",
			"dbsnp_ids": [
				"28929495"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55241707G>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/134/summary/evidence/4192/summary#evidence",
		"source": "civic",
		"description": "In an advanced lung adenocarcinoma patient harboring EGFR G719S mutation, EGFR G719S was reported to be sensitive to erlotinib treatment. The patient was initially treated with standard chemotherapy, and upon appearance of brain and bone metastases was treated with erlotinib monotherapy and achieved disease reduction of the primary lung tumor and stable disease of the brain metastases.",
		"drug_labels": "Erlotinib",
		"variant_name": "G719S",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/134/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/343",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/381"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/381",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21841502"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4192",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/381"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/170",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/381"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/382",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/200",
			"name": "G719S",
			"description": "EGFR G719S",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55241707,
			"end_pos": 55241707,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55241707G>A",
			"hgvs_c": "NM_005228.3:c.2155G>A",
			"hgvs_p": "NP_005219.2:p.Gly719Ser",
			"dbsnp_ids": [
				"28929495"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55241707G>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/134/summary/evidence/4191/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a NIH-3T3 cell line expressing EGFR G719S demonstrated increased sensitivity to erlotinib treatment compared to NIH-3T3 cells expressing EGFR wild-type. Sensitivity was determined by assessing anchorage-independent growth (growth of cells expressing EGFR G719S was inhibited by 100 nM of erlotinib, whereas growth of cells expressing EGFR wild-type was inhibited by >1 �M of erlotinib).",
		"drug_labels": "Erlotinib",
		"variant_name": "G719S",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/134/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/344",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/382"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/382",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/16187797"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4191",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/382"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/171",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/382"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/383",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/200",
			"name": "G719S",
			"description": "EGFR G719S",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55241707,
			"end_pos": 55241707,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55241707G>A",
			"hgvs_c": "NM_005228.3:c.2155G>A",
			"hgvs_p": "NP_005219.2:p.Gly719Ser",
			"dbsnp_ids": [
				"28929495"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55241707G>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/134/summary/evidence/4190/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a Ba/F3 cell line expressing EGFR G719S demonstrated increased sensitivity to erlotinib treatment comparable to Ba/F3 cells expressing a known sensitizing mutation (EGFR L858R). Sensitivity was determined by assessing cell proliferation, the IC50 of erlotinib for EGFR G719S and EGFR L858R expressing cells were 16 nmol/L and 6 nmol/L, respectively.",
		"drug_labels": "Erlotinib",
		"variant_name": "G719S",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/134/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/345",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/383"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/383",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19147750"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4190",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/383"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/172",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/383"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/384",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/200",
			"name": "G719S",
			"description": "EGFR G719S",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55241707,
			"end_pos": 55241707,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55241707G>A",
			"hgvs_c": "NM_005228.3:c.2155G>A",
			"hgvs_p": "NP_005219.2:p.Gly719Ser",
			"dbsnp_ids": [
				"28929495"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55241707G>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/134/summary/evidence/1736/summary#evidence",
		"source": "civic",
		"description": "This small clinical (n=56) study suggests that patients with minor mutations of EGFR, like G719S, are likely to have a moderate response to Tyrosine kinase inhibitors like Gefitinib and Erlotinib. In this study 44 of 56 patients were treated with either gefitinib or erlotinib. 35 patients had a G719 mutation but the majority of these were G719S (20 with G719S, 9 with G719A, 3 with G719C).",
		"drug_labels": "Erlotinib,GEFITINIB",
		"variant_name": "G719S",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/134/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/346",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/384"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/384",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26124334"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1736",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/384"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/174",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/384"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/173",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/384"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/385",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/200",
			"name": "G719S",
			"description": "EGFR G719S",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55241707,
			"end_pos": 55241707,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55241707G>A",
			"hgvs_c": "NM_005228.3:c.2155G>A",
			"hgvs_p": "NP_005219.2:p.Gly719Ser",
			"dbsnp_ids": [
				"28929495"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55241707G>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/134/summary/evidence/2617/summary#evidence",
		"source": "civic",
		"description": "In vitro studies showed that cells with S768I mutation had moderate sensitivity (IC50=90-315nM) to gefitinib , in comparison to the del747-753insS (IC50= 7nM) or L858R (IC50=12-20nM) mutations that confer high gefitinib sensitivity, and to the T790M mutation (IC50>2000nM) which confers gefitinib resistance.",
		"drug_labels": "GEFITINIB",
		"variant_name": "G719S",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/134/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/347",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/385"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/385",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19147750"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2617",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/385"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/175",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/385"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/386",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/200",
			"name": "G719S",
			"description": "EGFR G719S",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55241707,
			"end_pos": 55241707,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55241707G>A",
			"hgvs_c": "NM_005228.3:c.2155G>A",
			"hgvs_p": "NP_005219.2:p.Gly719Ser",
			"dbsnp_ids": [
				"28929495"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55241707G>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/134/summary/evidence/787/summary#evidence",
		"source": "civic",
		"description": "Whole genome sequencing of a case of colon carcinoma revealed a G724S mutation in the EGFR gene. In-vitro, this mutation was shown to be oncogenic and sensitive to Cetuximab, yet relatively insensitive towards small molecules. The same in-vitro results could be reproduced for the G719S mutation.",
		"drug_labels": "CETUXIMAB",
		"variant_name": "G719S",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/134/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/348",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/386"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/386",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24894453"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "787",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/386"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/176",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/386"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/387",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/200",
			"name": "G719S",
			"description": "EGFR G719S",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55241707,
			"end_pos": 55241707,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55241707G>A",
			"hgvs_c": "NM_005228.3:c.2155G>A",
			"hgvs_p": "NP_005219.2:p.Gly719Ser",
			"dbsnp_ids": [
				"28929495"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55241707G>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/134/summary/evidence/274/summary#evidence",
		"source": "civic",
		"description": "Gefinitib has been shown to be effective in treating cell lines with G719S missense mutations.",
		"drug_labels": "GEFITINIB",
		"variant_name": "G719S",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/134/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/349",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/387"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/387",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15118125"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "274",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/387"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/177",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/387"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/388",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/140",
			"name": "L747P",
			"description": "EGFR L747P",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": null,
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": "",
			"alt": "",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1891/summary/evidence/4220/summary#evidence",
		"source": "civic",
		"description": "In a study, 2 participants with stage IV adenocarcinoma were sequenced at EGFR exons 18 to 21.  Both patients were found to have L747P mutation and were treated with the 1st generation TKIs gefitinib or erlotinib. The first patient (M, 62, nonsmoker) was treated with gefitinib and had progressive disease, progression free survival (PFS) of 1.0 months, overall survival (OS) of 7.7 months and was not alive at study end. The second patient (M, 39, nonsmoker) was treated with erlotinib and had progressive disease as response, PFS of 2.3 months, OS of 7.2 months and was alive at study end. As a whole, patients with uncommon EGFR mutations had a response rate of 47.5%, which was between common (del19 and L858R) at 74.1%, and wild type EGFR at 16.5%. Median PFS and OS (months) for the three groups: 5.0 and 15.0 uncommon, 8.5 and 19.6 common, 2.0 and 10.4 wild type.",
		"drug_labels": "Erlotinib",
		"variant_name": "L747P",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1891/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/350",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/388"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/388",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21531810"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4220",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/388"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/178",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/388"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/389",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/303",
			"name": "S720",
			"description": "EGFR S720",
			"biomarker_type": "Protein Altering Variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580"
			],
			"soid": "SO:0001818",
			"so_name": "protein_altering_variant",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55241710,
			"end_pos": 55241711,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/720/summary/evidence/1782/summary#evidence",
		"source": "civic",
		"description": "Efficacy of erlotinib treatment was evaluated by meta-analysis of results from seven trials and literature review. Two patients with p.S270P, and one patient with p.S720F were observed to have poor survival outcomes.",
		"drug_labels": "Erlotinib",
		"variant_name": "S720",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/720/summary",
		"evidence_label": "C",
		"response_type": "resistant",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/351",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/389"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/389",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26773740"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1782",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/389"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/179",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/389"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/390",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/304",
			"name": "D770_N771insGT",
			"description": "EGFR D770_N771insGT",
			"biomarker_type": "Inframe Insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55249012,
			"end_pos": 55249013,
			"ref": null,
			"alt": "GGCACA",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1566/summary/evidence/4643/summary#evidence",
		"source": "civic",
		"description": "In a lung adenocarcinoma patient harboring EGFR D770_N771insGT mutation, EGFR D770_N771insGT was associated with lack of response to treatment with erlotinib monotherapy.",
		"drug_labels": "Erlotinib",
		"variant_name": "D770_N771insGT",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1566/summary",
		"evidence_label": "C",
		"response_type": "resistant",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/352",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/390"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/390",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23371856"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4643",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/390"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/180",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/390"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/391",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/161",
			"name": "A859T",
			"description": "EGFR A859T",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259517,
			"end_pos": 55259517,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55259517G>A",
			"hgvs_c": "NM_005228.3:c.2575G>A",
			"hgvs_p": "NP_005219.2:p.Ala859Thr",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259517G>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1474/summary/evidence/4297/summary#evidence",
		"source": "civic",
		"description": "In a lung adenocarcinoma patient harboring EGFR A859T mutation, EGFR A859T was reported to be sensitive to erlotinib treatment. The patient was initially treated with standard chemotherapy and subsequently achieved a partial response per RECIST criteria at 2 months, and radiographic response at 3 months of erlotinib monotherapy.",
		"drug_labels": "Erlotinib",
		"variant_name": "A859T",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1474/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/353",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/391"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/391",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21317745"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4297",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/391"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/181",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/391"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/392",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/161",
			"name": "A859T",
			"description": "EGFR A859T",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259517,
			"end_pos": 55259517,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55259517G>A",
			"hgvs_c": "NM_005228.3:c.2575G>A",
			"hgvs_p": "NP_005219.2:p.Ala859Thr",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259517G>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1474/summary/evidence/4296/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a MCF-7 cell line expressing EGFR A859T demonstrated reduced sensitivity to erlotinib treatment compared to MCF-7 cells expressing EGFR L858R (a known sensitizing mutation to EGFR tyrosine kinase inhibitors). Sensitivity was determined by assessing AKT phosphorylation.",
		"drug_labels": "Erlotinib",
		"variant_name": "A859T",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1474/summary",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/354",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/392"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/392",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/17877814"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4296",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/392"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/182",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/392"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/393",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/233",
			"name": "L747_S752del",
			"description": "EGFR L747_S752del",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242469,
			"end_pos": 55242486,
			"ref": "ATTAAGAGAAGCAACATCT",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55242469_55242486delinsA",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/890/summary/evidence/2151/summary#evidence",
		"source": "civic",
		"description": "EGFR exon 19 deletion mutations have been associated with increased sensitivity to first generation EGFR tyrosine kinase inhibitors, including erlotinib and gefitinib. In a Phase 2 clinical trial, lung adenocarcinoma patients with EGFR mutations (including exon 19 deletion mutation, n=8) were associated with improved response to erlotinib or gefitinib (P=0.003), compared to patients with wild-type EGFR (n=10).",
		"drug_labels": "GEFITINIB",
		"variant_name": "L747_S752del",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/890/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/355",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/393"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/393",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15329413"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2151",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/393"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/183",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/393"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/394",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/233",
			"name": "L747_S752del",
			"description": "EGFR L747_S752del",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242469,
			"end_pos": 55242486,
			"ref": "ATTAAGAGAAGCAACATCT",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55242469_55242486delinsA",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/890/summary/evidence/3798/summary#evidence",
		"source": "civic",
		"description": "In a stage IV lung adenocarcinoma patient with choroidal metastasis harboring EGFR exon 19 deletion, EGFR exon 19 deletion was associated with sensitivity to erlotinib monotherapy. The patient was treated with erlotinib as first-line treatment and experienced improvement within one week; the patient has remained stable after one year of therapy.",
		"drug_labels": "Erlotinib",
		"variant_name": "L747_S752del",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/890/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/356",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/394"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/394",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27569104"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3798",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/394"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/184",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/394"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/395",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/233",
			"name": "L747_S752del",
			"description": "EGFR L747_S752del",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242469,
			"end_pos": 55242486,
			"ref": "ATTAAGAGAAGCAACATCT",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55242469_55242486delinsA",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/890/summary/evidence/3796/summary#evidence",
		"source": "civic",
		"description": "A study of five clinical trials reported that chemotherapy na�ve non-small cell lung cancer patients with EGFR sensitizing mutations (exon 19 deletion, L858R, L861Q, or G719X) treated with erlotinib or gefitinib were associated with improved response rate (59% vs 4%; P<0.0001) and increased median overall survival (24.5 months vs 11.8 months P=0.002) as compared to patients without EGFR sensitizing mutations.",
		"drug_labels": "Erlotinib",
		"variant_name": "L747_S752del",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/890/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/357",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/395"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/395",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19671843"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3796",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/395"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/185",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/395"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/396",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/233",
			"name": "L747_S752del",
			"description": "EGFR L747_S752del",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242469,
			"end_pos": 55242486,
			"ref": "ATTAAGAGAAGCAACATCT",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55242469_55242486delinsA",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/890/summary/evidence/2149/summary#evidence",
		"source": "civic",
		"description": "In a phase 3 clinical trial of Japanese NSCLC patients with EGFR mutations (n=230), patients treated with gefitinib were associated with improved progression free survival (10.8 months vs 5.4 months, HR: 0.30, 95% CI: 0.22-0.41, P<0.001), compared to patients treated with carboplatin and paclitaxel combination therapy. The frequency of mutation of exon 19 deletion and L858R was 25.2% (58/230) and 21.3% (49/230), respectively.",
		"drug_labels": "GEFITINIB",
		"variant_name": "L747_S752del",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/890/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/358",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/396"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/396",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20573926"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2149",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/396"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/186",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/396"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/397",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/233",
			"name": "L747_S752del",
			"description": "EGFR L747_S752del",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242469,
			"end_pos": 55242486,
			"ref": "ATTAAGAGAAGCAACATCT",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55242469_55242486delinsA",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/890/summary/evidence/2150/summary#evidence",
		"source": "civic",
		"description": "In a phase 3 clinical trial of Japanese NSCLC patients with EGFR mutations (n=177), patients treated with gefitinib were associated with improved progression free survival (9.2 months vs 6.3 months, HR:0.49, 95% CI: 0.34-0.71, P<0.0001), compared to cisplatin plus docetaxel treatment. The frequency of mutation in exon 19 deletion and L858R was 50.6% (87/172) and 49.4% (85/172), respectively, in evaluable cases.",
		"drug_labels": "GEFITINIB",
		"variant_name": "L747_S752del",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/890/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/359",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/397"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/397",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20022809"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2150",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/397"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/187",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/397"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/398",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/233",
			"name": "L747_S752del",
			"description": "EGFR L747_S752del",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242469,
			"end_pos": 55242486,
			"ref": "ATTAAGAGAAGCAACATCT",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55242469_55242486delinsA",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/890/summary/evidence/2154/summary#evidence",
		"source": "civic",
		"description": "A phase 3 study of 345 stage IIIB-IV lung adenocarcinoma patients, reported improved median progression free survival (13.6 months vs. 6.9 months, HR: 0.47, 95% CI: 0.34-0.65, P=0.001) in EGFR mutation positive patients (n=308; exon 19 deletion and L858R mutation) treated with afatinib, as compared to patients treated with standard chemotherapy (cisplatin plus pemetrexed).",
		"drug_labels": "AFATINIB",
		"variant_name": "L747_S752del",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/890/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/360",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/398"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/398",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23816960"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2154",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/398"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/188",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/398"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/399",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/233",
			"name": "L747_S752del",
			"description": "EGFR L747_S752del",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242469,
			"end_pos": 55242486,
			"ref": "ATTAAGAGAAGCAACATCT",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55242469_55242486delinsA",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/890/summary/evidence/2152/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study using PC9 cells (EGFR exon 19 deletion), inhibition of cell viability was used as an assay to determine sensitivity to EGFR tyrosine kinase inhibitors. PC9 cells demonstrated an increased sensitivity to gefitinib  (IC50: 23.0 nmol/L vs 200.0 nmol/L) compared to NCI-H2073 cells (EGFR wild type).",
		"drug_labels": "GEFITINIB",
		"variant_name": "L747_S752del",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/890/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/361",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/399"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/399",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24893891"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2152",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/399"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/189",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/399"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/400",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/232",
			"name": "L747_P753delinsS",
			"description": "EGFR L747_P753delinsS",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242470,
			"end_pos": 55242487,
			"ref": "TTAAGAGAAGCAACATCTC",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55242470_55242487delinsT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1012/summary/evidence/6005/summary#evidence",
		"source": "civic",
		"description": "Patients with recurrent pancreatic adenocarcinoma was treated with gemcitabine + nab-paclitaxel, FOLFIRINOX and docetaxel + irinotecan. After failure of these treatment, a tumor specimen from the pancreaticoduodenectomy was analyzed, which revealed an activating mutation in exon 19 (L747_P753>S) of EGFR. Mutations were also detected in CDKN2A, TP53, and amplifications of PRKCI and TERC. He began erlotinib at 150mg daily. CT imaging revealed a partial response by RECIST at 8, 24 and 32 weeks after starting erlotinib. At 40 weeks CT imaging revealed unequivocal disease progression. After disease progression to erlotinib, a repeat liver biopsy revealed an EGFR T790M mutation. He began treatment with osimertinib at 80mg daily. After 8 weeks of this treatment CT imaging revealed unequivocal disease progression.",
		"drug_labels": "Erlotinib",
		"variant_name": "L747_P753delinsS",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1012/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/362",
				"source": "http://purl.obolibrary.org/obo/DOID_4074",
				"term": "pancreatic adenocarcinoma",
				"pheno_id": "DOID:4074",
				"family": "pancreatic cancer",
				"description": "pancreatic adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/400"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/400",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28874593"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6005",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/400"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/190",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/400"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/401",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/232",
			"name": "L747_P753delinsS",
			"description": "EGFR L747_P753delinsS",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242470,
			"end_pos": 55242487,
			"ref": "TTAAGAGAAGCAACATCTC",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55242470_55242487delinsT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1012/summary/evidence/4270/summary#evidence",
		"source": "civic",
		"description": "In a retrospective study of 46 Caucasian, advanced lung adenocarcinoma patients, a patient harboring EGFR L747_P753insS mutation was associated with resistance to erlotinib treatment. The patient survived 7.4 months, as compared to the overall 24 months median overall survival of the other patients who were not resistant to erlotinib treatment.",
		"drug_labels": "Erlotinib",
		"variant_name": "L747_P753delinsS",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1012/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/363",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/401"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/401",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27032107"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4270",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/401"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/191",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/401"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/402",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/232",
			"name": "L747_P753delinsS",
			"description": "EGFR L747_P753delinsS",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242470,
			"end_pos": 55242487,
			"ref": "TTAAGAGAAGCAACATCTC",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55242470_55242487delinsT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1012/summary/evidence/4266/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a Ba/F3 cell line expressing EGFR L747_P753>S demonstrated increased sensitivity to erlotinib treatment comparable to Ba/F3 cells expressing a known sensitizing mutation (EGFR L858R). Sensitivity was determined by assessing cell proliferation, the IC50 of erlotinib for EGFR L747_P753>S and EGFR L858R expressing cells were 5 nmol/L and 6 nmol/L, respectively.",
		"drug_labels": "Erlotinib",
		"variant_name": "L747_P753delinsS",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1012/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/364",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/402"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/402",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19147750"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4266",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/402"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/192",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/402"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/403",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/232",
			"name": "L747_P753delinsS",
			"description": "EGFR L747_P753delinsS",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242470,
			"end_pos": 55242487,
			"ref": "TTAAGAGAAGCAACATCTC",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55242470_55242487delinsT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1012/summary/evidence/4267/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a Ba/F3 cell line expressing EGFR L747_P753>S demonstrated increased sensitivity to erlotinib treatment (IC50=0.006�M), comparable to Ba/F3 cells expressing EGFR L858R (a known sensitizing mutation to EGFR tyrosine kinase inhibitors; IC50=0.006�M). Sensitivity was determined by assessing cell proliferation, EGFR, AKT and ERK phosphorylation.",
		"drug_labels": "Erlotinib",
		"variant_name": "L747_P753delinsS",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1012/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/365",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/403"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/403",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4267",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/403"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/193",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/403"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/404",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/232",
			"name": "L747_P753delinsS",
			"description": "EGFR L747_P753delinsS",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242470,
			"end_pos": 55242487,
			"ref": "TTAAGAGAAGCAACATCTC",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55242470_55242487delinsT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1012/summary/evidence/2605/summary#evidence",
		"source": "civic",
		"description": "In a phase 3 clinical trial of Japanese NSCLC patients with EGFR mutations (n=230), patients treated with gefitinib were associated with improved progression free survival (10.8 months vs 5.4 months, HR: 0.30, 95% CI: 0.22-0.41, P<0.001), compared to patients treated with carboplatin and paclitaxel combination therapy. The frequency of mutation of exon 19 deletion and L858R was 25.2% (58/230) and 21.3% (49/230), respectively.",
		"drug_labels": "GEFITINIB",
		"variant_name": "L747_P753delinsS",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1012/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/366",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/404"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/404",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20573926"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2605",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/404"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/194",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/404"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/405",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/232",
			"name": "L747_P753delinsS",
			"description": "EGFR L747_P753delinsS",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242470,
			"end_pos": 55242487,
			"ref": "TTAAGAGAAGCAACATCTC",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55242470_55242487delinsT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1012/summary/evidence/2606/summary#evidence",
		"source": "civic",
		"description": "In a phase 3 clinical trial of Japanese NSCLC patients with EGFR mutations (n=177), patients treated with gefitinib were associated with improved progression free survival (9.2 months vs 6.3 months, HR:0.49, 95% CI: 0.34-0.71, P<0.0001), compared to cisplatin plus docetaxel treatment. The frequency of mutation in exon 19 deletion and L858R was 50.6% (87/172) and 49.4% (85/172), respectively, in evaluable cases.",
		"drug_labels": "GEFITINIB",
		"variant_name": "L747_P753delinsS",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1012/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/367",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/405"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/405",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20022809"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2606",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/405"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/195",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/405"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/406",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/232",
			"name": "L747_P753delinsS",
			"description": "EGFR L747_P753delinsS",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242470,
			"end_pos": 55242487,
			"ref": "TTAAGAGAAGCAACATCTC",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55242470_55242487delinsT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1012/summary/evidence/2610/summary#evidence",
		"source": "civic",
		"description": "In a phase 2b/3 study of 585 stage IIIB-IV lung adenocarcinoma patients who had a previous round of EGFR-TKI treatment, archival material was available for 141 patients. EGFR mutational analysis revealed that 96 tumors had an EGFR mutation, of which 76 (79%) were positive for either L858R or a deletion in exon 19. These mutations were associated with improved progression-free survival (median 3.3 months  vs 1.0 month ; HR:0.51, 95% CI:0.31-0.85, P<0.009) compared to placebo control.",
		"drug_labels": "AFATINIB",
		"variant_name": "L747_P753delinsS",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1012/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/368",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/406"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/406",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22452896"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2610",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/406"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/196",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/406"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/407",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/232",
			"name": "L747_P753delinsS",
			"description": "EGFR L747_P753delinsS",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242470,
			"end_pos": 55242487,
			"ref": "TTAAGAGAAGCAACATCTC",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55242470_55242487delinsT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1012/summary/evidence/2611/summary#evidence",
		"source": "civic",
		"description": "A phase 3 study of 345 stage IIIB-IV lung adenocarcinoma patients, reported improved median progression free survival (13.6 months vs. 6.9 months, HR: 0.47, 95% CI: 0.34-0.65, P=0.001) in EGFR mutation positive patients (n=308; exon 19 deletion and L858R mutation) treated with afatinib, as compared to patients treated with standard chemotherapy (cisplatin plus pemetrexed).",
		"drug_labels": "AFATINIB",
		"variant_name": "L747_P753delinsS",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1012/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/369",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/407"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/407",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23816960"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2611",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/407"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/197",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/407"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/408",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/232",
			"name": "L747_P753delinsS",
			"description": "EGFR L747_P753delinsS",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242470,
			"end_pos": 55242487,
			"ref": "TTAAGAGAAGCAACATCTC",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55242470_55242487delinsT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1012/summary/evidence/2609/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study using PC9 cells (EGFR exon 19 deletion), inhibition of cell viability was used as an assay to determine sensitivity to EGFR tyrosine kinase inhibitors. PC9 cells demonstrated an increased sensitivity to gefitinib  (IC50: 23.0 nmol/L vs 200.0 nmol/L) compared to NCI-H2073 cells (EGFR wild type).",
		"drug_labels": "GEFITINIB",
		"variant_name": "L747_P753delinsS",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1012/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/370",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/408"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/408",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24893891"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2609",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/408"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/198",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/408"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/409",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/145",
			"name": "S768I",
			"description": "EGFR S768I",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249005,
			"end_pos": 55249005,
			"ref": "G",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249005G>T",
			"hgvs_c": "NM_005228.3:c.2303G>T",
			"hgvs_p": "NP_005219.2:p.Ser768Ile",
			"dbsnp_ids": [
				"121913465"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249005G>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/562/summary/evidence/4273/summary#evidence",
		"source": "civic",
		"description": "In stage IV lung adenocarcinoma patients (n=2) harboring EGFR S768I mutation, EGFR S768I was associated with progressive disease after 1 month of erlotinib monotherapy; the patient was previously treated with standard chemotherapy.",
		"drug_labels": "Erlotinib",
		"variant_name": "S768I",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/562/summary",
		"evidence_label": "C",
		"response_type": "resistant",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/371",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/409"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/409",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22895145"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4273",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/409"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/199",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/409"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/410",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/145",
			"name": "S768I",
			"description": "EGFR S768I",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249005,
			"end_pos": 55249005,
			"ref": "G",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249005G>T",
			"hgvs_c": "NM_005228.3:c.2303G>T",
			"hgvs_p": "NP_005219.2:p.Ser768Ile",
			"dbsnp_ids": [
				"121913465"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249005G>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/562/summary/evidence/4274/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a Ba/F3 cell line expressing EGFR S768I demonstrated reduced sensitivity to erlotinib treatment, compared to Ba/F3 cells expressing a known sensitizing mutation (EGFR L858R). Sensitivity was determined by assessing cell proliferation, the IC50 of erlotinib for EGFR S768I and EGFR L858R expressing cells were 250 nmol/L and 6 nmol/L, respectively.",
		"drug_labels": "Erlotinib",
		"variant_name": "S768I",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/562/summary",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/372",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/410"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/410",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19147750"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4274",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/410"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/200",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/410"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/411",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/145",
			"name": "S768I",
			"description": "EGFR S768I",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249005,
			"end_pos": 55249005,
			"ref": "G",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249005G>T",
			"hgvs_c": "NM_005228.3:c.2303G>T",
			"hgvs_p": "NP_005219.2:p.Ser768Ile",
			"dbsnp_ids": [
				"121913465"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249005G>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/562/summary/evidence/4185/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a NIH3T3 cell line expressing EGFR R108K demonstrated increased sensitivity to erlotinib treatment comparable to NIH3T3 cells expressing EGFR L858R (a known sensitizing mutation to EGFR tyrosine kinase inhibitors). Sensitivity was determined by assessing EGFR auto-phosphorylation.",
		"drug_labels": "Erlotinib",
		"variant_name": "S768I",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/562/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/373",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/411"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/411",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/17877814"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4185",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/411"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/201",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/411"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/412",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/145",
			"name": "S768I",
			"description": "EGFR S768I",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249005,
			"end_pos": 55249005,
			"ref": "G",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249005G>T",
			"hgvs_c": "NM_005228.3:c.2303G>T",
			"hgvs_p": "NP_005219.2:p.Ser768Ile",
			"dbsnp_ids": [
				"121913465"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249005G>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/562/summary/evidence/2906/summary#evidence",
		"source": "civic",
		"description": "S768I mutations in exon 20 of the EGFR gene are rare and are typically seen in conjunction with sensitizing EGFR mutations. Because of this mutation's rarity and the variability of responses of treated cases, its exact prognostic and predictive role is not fully understood. In our experience, S768I mutations in isolation do not necessarily confer sensitivity to erlotinib, but in conjunction with sensitizing EGFR mutations, S768I mutations do not restrict efficacy.",
		"drug_labels": "Erlotinib",
		"variant_name": "S768I",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/562/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/374",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/412"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/412",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27211795"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2906",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/412"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/202",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/412"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/413",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/145",
			"name": "S768I",
			"description": "EGFR S768I",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249005,
			"end_pos": 55249005,
			"ref": "G",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249005G>T",
			"hgvs_c": "NM_005228.3:c.2303G>T",
			"hgvs_p": "NP_005219.2:p.Ser768Ile",
			"dbsnp_ids": [
				"121913465"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249005G>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/562/summary/evidence/2616/summary#evidence",
		"source": "civic",
		"description": "In vitro studies showed that cells with S768I mutation had moderate sensitivity (IC50=90-315nM) to gefitinib , in comparison to the del747-753insS (IC50= 7nM) or L858R (IC50=12-20nM) mutations that confer high gefitinib sensitivity, and to the T790M mutation (IC50>2000nM) which confers gefitinib resistance.",
		"drug_labels": "GEFITINIB",
		"variant_name": "S768I",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/562/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/375",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/413"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/413",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/16205628"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2616",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/413"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/203",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/413"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/414",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/145",
			"name": "S768I",
			"description": "EGFR S768I",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249005,
			"end_pos": 55249005,
			"ref": "G",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249005G>T",
			"hgvs_c": "NM_005228.3:c.2303G>T",
			"hgvs_p": "NP_005219.2:p.Ser768Ile",
			"dbsnp_ids": [
				"121913465"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249005G>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/562/summary/evidence/2615/summary#evidence",
		"source": "civic",
		"description": "Partial response to gefitinib was achieved in two non-small cell lung cancer patients having a S768I mutation with concomitant G719C mutation.",
		"drug_labels": "GEFITINIB",
		"variant_name": "S768I",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/562/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/376",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/414"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/414",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15998907"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2615",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/414"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/204",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/414"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/415",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/145",
			"name": "S768I",
			"description": "EGFR S768I",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249005,
			"end_pos": 55249005,
			"ref": "G",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249005G>T",
			"hgvs_c": "NM_005228.3:c.2303G>T",
			"hgvs_p": "NP_005219.2:p.Ser768Ile",
			"dbsnp_ids": [
				"121913465"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249005G>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/562/summary/evidence/2614/summary#evidence",
		"source": "civic",
		"description": "In response to gefitinib treatment, lung adenocarcinoma patients with somatic EGFR S768I mutation had longer median progression-free survival when there was a concomitant L858R mutation or in-frame deletion in exon 19, in comparison to those with other concomitant mutations (12.7mo 95%CI 3.4-22.0mo vs. 4.9mo 95%CI 1.5-8.3mo, P=0.048, log-rank test). Partial response to gefitinib was achieved in two non-small cell lung cancer patients having a S768I mutation with concomitant G719C mutation.",
		"drug_labels": "GEFITINIB",
		"variant_name": "S768I",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/562/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/377",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/415"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/415",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19060236"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2614",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/415"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/205",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/415"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/416",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/145",
			"name": "S768I",
			"description": "EGFR S768I",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249005,
			"end_pos": 55249005,
			"ref": "G",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249005G>T",
			"hgvs_c": "NM_005228.3:c.2303G>T",
			"hgvs_p": "NP_005219.2:p.Ser768Ile",
			"dbsnp_ids": [
				"121913465"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249005G>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/562/summary/evidence/1394/summary#evidence",
		"source": "civic",
		"description": "A patient with metastatic lung adenocarcinoma was found to harbor EGFR T790M and S768I mutations when acquired resistance developed after 8 years of erlotinib treatment. Analysis of original tumor samples from 2001 and 2003 were found to also harbor the S768I (but not T790M) mutation. Three-dimensional visualization showed the 768 position to be outside of the erlotinib binding position.",
		"drug_labels": "Erlotinib",
		"variant_name": "S768I",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/562/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/378",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/416"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/416",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25521405"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1394",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/416"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/206",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/416"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/417",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/145",
			"name": "S768I",
			"description": "EGFR S768I",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249005,
			"end_pos": 55249005,
			"ref": "G",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249005G>T",
			"hgvs_c": "NM_005228.3:c.2303G>T",
			"hgvs_p": "NP_005219.2:p.Ser768Ile",
			"dbsnp_ids": [
				"121913465"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249005G>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/562/summary/evidence/1395/summary#evidence",
		"source": "civic",
		"description": "Case report of an 81-year old man with lung adenocarcinoma and EGFR S768I mutation. The patient then received chemotheraoy (vinorelbine) and showed stable disease. Gefitinib was administered when disease progression was noted 4 months later and the patient was followed-up without signs of disease progression for 461 days.",
		"drug_labels": "GEFITINIB",
		"variant_name": "S768I",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/562/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/379",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/417"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/417",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20522446"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1395",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/417"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/207",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/417"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/418",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/152",
			"name": "C797S",
			"description": "EGFR C797S",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249091,
			"end_pos": 55249091,
			"ref": "T",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55249091T>A",
			"hgvs_c": "NM_005228.3:c.2389T>A",
			"hgvs_p": "NP_005219.2:p.Cys797Ser",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249091T>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/415/summary/evidence/4837/summary#evidence",
		"source": "civic",
		"description": "Currently, there are no effective therapeutic strategies to overcome the C797S/T790M/activating-mutation (triple-mutation)-mediated EGFR-TKI resistance to Osimertinib. In the present study, we identify brigatinib to be effective against triple-mutation-harbouring cells in vitro and in vivo. The efficacy of brigatinib is enhanced markedly by combination with anti-EGFR antibodies Ceutximab or Panitumumab because of the decrease of surface and total EGFR expression. Thus, the combination therapy of brigatinib with anti-EGFR antibody is a powerful candidate to overcome triple-mutant EGFR.",
		"drug_labels": "BRIGATINIB,PANITUMUMAB,CETUXIMAB",
		"variant_name": "C797S",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/415/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/380",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/418"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/418",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28287083"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4837",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/418"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/210",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/418"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/209",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "PANITUMUMAB",
				"envcontext_id": "CHEMBL1201827",
				"usan_stem": "monoclonal antibodies",
				"description": "PANITUMUMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/418"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/208",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "BRIGATINIB",
				"envcontext_id": "68165256",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "BRIGATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/418"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/419",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/152",
			"name": "C797S",
			"description": "EGFR C797S",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249091,
			"end_pos": 55249091,
			"ref": "T",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55249091T>A",
			"hgvs_c": "NM_005228.3:c.2389T>A",
			"hgvs_p": "NP_005219.2:p.Cys797Ser",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249091T>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/415/summary/evidence/1396/summary#evidence",
		"source": "civic",
		"description": "Case report of a patient with stage IV lung adenocarcinoma and a 15–base pair deletion in EGFR exon 19. Partial response with erlotinib was achieved for 15 months after initial chemotherapy. After further progression, rebiopsy additionally identified the EGFR T790M mutation and the patient received several cycles of chemotherapy and targeted therapy including afatinib, cetuximab, erlotinib, AZD9291. She was treated with AZD9291 for 9 months until disease progression. Repeat biopsy detected EGFRC797S mutation additionally to both aforementioned EGFR aberrations. In addition, PTEN Y27C and CTNNB1 S37F mutations were present in all 3 samples, and a TSC2 N486I was seen in the third biopsy sample only",
		"drug_labels": "OSIMERTINIB",
		"variant_name": "C797S",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/415/summary",
		"evidence_label": "C",
		"response_type": "resistant",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/381",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/419"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/419",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26181354"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1396",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/419"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/211",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "OSIMERTINIB",
				"envcontext_id": "71496458",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "OSIMERTINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/419"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/420",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/152",
			"name": "C797S",
			"description": "EGFR C797S",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249091,
			"end_pos": 55249091,
			"ref": "T",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55249091T>A",
			"hgvs_c": "NM_005228.3:c.2389T>A",
			"hgvs_p": "NP_005219.2:p.Cys797Ser",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249091T>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/415/summary/evidence/964/summary#evidence",
		"source": "civic",
		"description": "An EGFR resistance mutation, C797S, was discovered by deep sequencing of cell-free plasma DNA (cfDNA) from patients with advanced lung cancer whose tumors had developed resistance to osimertinib. Expression of this mutant EGFR construct in a cell line rendered it resistant to osimertinib. ddPCR on serial cfDNA specimens collected from 15 osimertinib-treated subjects (all positive for T790M before treatment) revealed 6 cases with acquired C797S mutation.",
		"drug_labels": "OSIMERTINIB",
		"variant_name": "C797S",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/415/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/382",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/420"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/420",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25939061"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "964",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/420"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/212",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "OSIMERTINIB",
				"envcontext_id": "71496458",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "OSIMERTINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/420"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/421",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/305",
			"name": "L747_T751>P",
			"description": "EGFR L747_T751>P",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242469,
			"end_pos": 55242481,
			"ref": null,
			"alt": "C",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1010/summary/evidence/2581/summary#evidence",
		"source": "civic",
		"description": "In a phase 2b/3 study of 585 stage IIIB-IV lung adenocarcinoma patients who had a previous round of EGFR-TKI treatment, archival material was available for 141 patients. EGFR mutational analysis revealed that 96 tumors had an EGFR mutation, of which 76 (79%) were positive for either L858R or a deletion in exon 19. These mutations were associated with improved progression-free survival (median 3.3 months  vs 1.0 month ; HR:0.51, 95% CI:0.31-0.85, P<0.009) compared to placebo control.",
		"drug_labels": "AFATINIB",
		"variant_name": "L747_T751>P",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1010/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/383",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/421"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/421",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22452896"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2581",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/421"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/213",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/421"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/422",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/305",
			"name": "L747_T751>P",
			"description": "EGFR L747_T751>P",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242469,
			"end_pos": 55242481,
			"ref": null,
			"alt": "C",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1010/summary/evidence/2576/summary#evidence",
		"source": "civic",
		"description": "In a phase 3 clinical trial of Japanese NSCLC patients with EGFR mutations (n=230), patients treated with gefitinib were associated with improved progression free survival (10.8 months vs 5.4 months, HR: 0.30, 95% CI: 0.22-0.41, P<0.001), compared to patients treated with carboplatin and paclitaxel combination therapy. The frequency of mutation of exon 19 deletion and L858R was 25.2% (58/230) and 21.3% (49/230), respectively.",
		"drug_labels": "GEFITINIB",
		"variant_name": "L747_T751>P",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1010/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/384",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/422"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/422",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20573926"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2576",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/422"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/214",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/422"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/423",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/305",
			"name": "L747_T751>P",
			"description": "EGFR L747_T751>P",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242469,
			"end_pos": 55242481,
			"ref": null,
			"alt": "C",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1010/summary/evidence/2577/summary#evidence",
		"source": "civic",
		"description": "In a phase 3 clinical trial of Japanese NSCLC patients with EGFR mutations (n=177), patients treated with gefitinib were associated with improved progression free survival (9.2 months vs 6.3 months, HR:0.49, 95% CI: 0.34-0.71, P<0.0001), compared to cisplatin plus docetaxel treatment. The frequency of mutation in exon 19 deletion and L858R was 50.6% (87/172) and 49.4% (85/172), respectively, in evaluable cases.",
		"drug_labels": "GEFITINIB",
		"variant_name": "L747_T751>P",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1010/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/385",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/423"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/423",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20022809"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2577",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/423"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/215",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/423"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/424",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/305",
			"name": "L747_T751>P",
			"description": "EGFR L747_T751>P",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242469,
			"end_pos": 55242481,
			"ref": null,
			"alt": "C",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1010/summary/evidence/2578/summary#evidence",
		"source": "civic",
		"description": "In a phase 3 clinical trial of East Asian advanced pulmonary adenocarcinoma patients, a subset of patients with EGFR mutations (n=261) treated with gefitinib were associated with improved response (HR:0.48, 95% CI:0.36-0.64, P<0.001), compared to carboplatin plus paclitaxel treatment. The frequency of mutation in exon 19 deletion and L858R was 53.6% (140/261) and 42.5% (111/261), respectively.",
		"drug_labels": "GEFITINIB",
		"variant_name": "L747_T751>P",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1010/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/386",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/424"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/424",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19692680"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2578",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/424"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/216",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/424"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/425",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/305",
			"name": "L747_T751>P",
			"description": "EGFR L747_T751>P",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242469,
			"end_pos": 55242481,
			"ref": null,
			"alt": "C",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1010/summary/evidence/2582/summary#evidence",
		"source": "civic",
		"description": "A phase 3 study of 345 stage IIIB-IV lung adenocarcinoma patients, reported improved median progression free survival (13.6 months vs. 6.9 months, HR: 0.47, 95% CI: 0.34-0.65, P=0.001) in EGFR mutation positive patients (n=308; exon 19 deletion and L858R mutation) treated with afatinib, as compared to patients treated with standard chemotherapy (cisplatin plus pemetrexed).",
		"drug_labels": "AFATINIB",
		"variant_name": "L747_T751>P",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1010/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/387",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/425"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/425",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23816960"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2582",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/425"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/217",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/425"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/426",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/305",
			"name": "L747_T751>P",
			"description": "EGFR L747_T751>P",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242469,
			"end_pos": 55242481,
			"ref": null,
			"alt": "C",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1010/summary/evidence/2580/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study using PC9 cells (EGFR exon 19 deletion), inhibition of cell viability was used as an assay to determine sensitivity to EGFR tyrosine kinase inhibitors. PC9 cells demonstrated an increased sensitivity to gefitinib  (IC50: 23.0 nmol/L vs 200.0 nmol/L) compared to NCI-H2073 cells (EGFR wild type).",
		"drug_labels": "GEFITINIB",
		"variant_name": "L747_T751>P",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1010/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/388",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/426"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/426",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24893891"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2580",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/426"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/218",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/426"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/427",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/206",
			"name": "G810S",
			"description": "EGFR G810S",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249130,
			"end_pos": 55249130,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55249130G>A",
			"hgvs_c": "NM_005228.3:c.2428G>A",
			"hgvs_p": "NP_005219.2:p.Gly810Ser",
			"dbsnp_ids": [
				"121913230"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249130G>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1016/summary/evidence/5825/summary#evidence",
		"source": "civic",
		"description": "EGFR G810S was expressed in Ba/F3 cells which do not contain endogenous EGFR, and conferred growth factor independance to the cells. Cells were plated and treated with 1st generation EGFR inhibitors \nGefitinib, Erlotinib, or the the tool compound AEE788, and IC50 values were measured. G810S EGFR cells had moderately low IC50 nmol/L values for AEE788 in comparison to other EGFR constructs, suggesting potential sensitivity. (Gefitinib=96, Erlotinib=57, AEE788=30)",
		"drug_labels": "497839-62-0",
		"variant_name": "G810S",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1016/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/389",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/427"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/427",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19147750"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5825",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/427"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/219",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "497839-62-0",
				"envcontext_id": "CID10297043",
				"usan_stem": null,
				"description": "497839-62-0",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/427"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/428",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/206",
			"name": "G810S",
			"description": "EGFR G810S",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249130,
			"end_pos": 55249130,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55249130G>A",
			"hgvs_c": "NM_005228.3:c.2428G>A",
			"hgvs_p": "NP_005219.2:p.Gly810Ser",
			"dbsnp_ids": [
				"121913230"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249130G>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1016/summary/evidence/5824/summary#evidence",
		"source": "civic",
		"description": "EGFR G810S was expressed in Ba/F3 cells which do not contain endogenous EGFR, and conferred growth factor independence to the cells. Cells were plated and treated with 1st generation EGFR inhibitors Gefitinib, Erlotinib, or the the tool compound AEE788, and IC50 values were measured. G819S EGFR cells had moderately high IC50 nmol/L values for gefitinib and erlotinib in comparison to other EGFR constructs, which did not indicate sensitivity. (Gefitinib=96, Erlotinib=57, AEE788=30)",
		"drug_labels": "GEFITINIB,Erlotinib",
		"variant_name": "G810S",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1016/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/390",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/428"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/428",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19147750"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5824",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/428"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/221",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/428"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/220",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/428"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/429",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/306",
			"name": "RARE EGRF MUT",
			"description": "EGFR RARE EGRF MUT",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": null,
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/2334/summary/evidence/6186/summary#evidence",
		"source": "civic",
		"description": "A Japanese Phase III clinical study assessed the noninferiority of gefitinib as compared to erlotinib in 561 advanced stage (IIIB and IV) postoperative lung adenocarcinoma patients. All patients had prior chemotherapy but no treatment with TKIs. 19 patients had unspecified uncommon EGFR mutations, including single mutations other than ex19del and L858R and double mutations. Of those 19 patients, 7 were treated with erlotinib and 12 were treated with gefitinib. Objective response and disease control rate between erlotinib and gefitinib were not significantly different. The study failed to satisfy the primary endpoint of demonstrating statistical noninferiority in PFS of gefitinib.",
		"drug_labels": "GEFITINIB",
		"variant_name": "MUT",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/2334/summary",
		"evidence_label": "C",
		"response_type": "Reduced Sensitivity",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/391",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/429"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/429",
				"type": "Predictive",
				"description": "Reduced Sensitivity",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27022112"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6186",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/429"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/222",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/429"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/430",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/307",
			"name": "Ex19 del L858R",
			"description": "EGFR Ex19 del L858R",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "",
			"chromosome": "7",
			"start_pos": 55086714,
			"end_pos": 55324313,
			"ref": "",
			"alt": "",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1854/summary/evidence/4759/summary#evidence",
		"source": "civic",
		"description": "In a study of 1261 non-small cell lung cancer patients, 49.8% of the analyzed tumors had EGFR mutations including deletions in exon 19 (n=258), L858R (n=260), T790M (n=6) and insertions or duplications in exon 20 (n=25). Patients with EGFR deletions in exon 19 or L858R mutations were associated with an improved response to erlotinib or gefitinib with partial or complete response (74.1% vs. 16.5%, P<0.001) when compared to wildtype EGFR patients. Additionally, tumors with EGFR mutations in L858R or deletions in exon 19 were associated with increased overall survival (19.6mo vs. 10.4mo) compared to wildtype (all patients were treated with either erlotinib or gefitinib). From 61 patients with uncommon EGFR mutations of unknown clinical significance, 47.5% were responders in contrast to the 74.1% responders in the exon 19 deletion/L858R group.",
		"drug_labels": "GEFITINIB,Erlotinib",
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1854/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/392",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/430"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/430",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21531810"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4759",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/430"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/224",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/430"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/223",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/430"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/431",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/307",
			"name": "Ex19 del L858R",
			"description": "EGFR Ex19 del L858R",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "",
			"chromosome": "7",
			"start_pos": 55086714,
			"end_pos": 55324313,
			"ref": "",
			"alt": "",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1854/summary/evidence/2156/summary#evidence",
		"source": "civic",
		"description": "A phase 2 study of 120 stage IIIB-IV lung adenocarcinoma patients reported improved progression free survival in patients with EGFR mutation (defined as exon 19 deletion or exon 21 mutation) when treated (n=13) with gefitinib and pemetrexed/platinum combination therapy (HR: 0.20, 95% CI: 0.05-0.75, P=0.017) as compared to treatment (n=18) with pemtrexed/platinum alone.  In the subgroup of patients without EGFR mutation (defined as all patients without the specific EGFR exon 19 deletion or L858R mutation) a difference in median PFS was not seen between the chemotherapy versus chemotherapy with gefitinib treatment groups.",
		"drug_labels": "GEFITINIB",
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1854/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/393",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/431"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/431",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24755888"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2156",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/431"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/225",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/431"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/432",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/307",
			"name": "Ex19 del L858R",
			"description": "EGFR Ex19 del L858R",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "",
			"chromosome": "7",
			"start_pos": 55086714,
			"end_pos": 55324313,
			"ref": "",
			"alt": "",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1854/summary/evidence/3791/summary#evidence",
		"source": "civic",
		"description": "The phase 3 (EURTAC) study consisted of of 173 non-small cell lung cancer patients who had not had prior chemotherapy for metastatic disease (although adjuvant or neoadjuvant chemotherapy was permitted) and included 160 patients with lung adenocarcinoma subtype. The patients had EGFR mutations (exon 19 deletions or L858R), and improved progression-free survival was reported in the erlotinib treated cohort as compared to the cohort that was treated with standard chemotherapy (9.7mo vs. 5.2mo, HR:0.37, 95%CI:0.25-0.54, P<0.0001, univariate analysis; HR:0.35, 95%CI:0.23-0.52, P<0.0001, multivariate analysis).",
		"drug_labels": "Erlotinib",
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1854/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/394",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/432"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/432",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22285168"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3791",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/432"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/226",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/432"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/433",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/271",
			"name": "T785A",
			"description": "EGFR T785A",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249055,
			"end_pos": 55249055,
			"ref": "A",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55249055A>G",
			"hgvs_c": "NM_005228.3:c.2353A>G",
			"hgvs_p": "NP_005219.2:p.Thr785Ala",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249055A>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1573/summary/evidence/4657/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a COS-7 cell line expressing EGFR T785A demonstrated increased sensitivity to erlotinib treatment, compared to COS-7 cells expressing EGFR wild-type. Sensitivity was determined by assessing EGFR auto-phosphorylation.",
		"drug_labels": "Erlotinib",
		"variant_name": "T785A",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1573/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/395",
				"source": "http://purl.obolibrary.org/obo/DOID_1790",
				"term": "malignant mesothelioma",
				"pheno_id": "DOID:1790",
				"family": "cell type cancer",
				"description": "malignant mesothelioma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/433"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/433",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20942962"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4657",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/433"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/227",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/433"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/434",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/308",
			"name": "N826Y",
			"description": "EGFR N826Y",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "",
			"chromosome": "7",
			"start_pos": 55259418,
			"end_pos": 55259418,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55259418A>T",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259418A>T?assembly=hg19",
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1896/summary/evidence/4244/summary#evidence",
		"source": "civic",
		"description": "In a study, 1 participant with stage IV lung adenocarcinoma was sequenced at EGFR exons 18 to 21 and was found to have N826Y mutation, and was treated with the 1st generation TKI gefitinib. The patient (F, 46, nonsmoker) had progressive disease as response, progression free survival (PFS) of 3.3 months, overall survival (OS) of 13.9 months and was not alive at study end. As a whole, patients with uncommon EGFR mutations had a response rate of 47.5%, which was between common (del19 and L858R) at 74.1%, and wild type EGFR at 16.5%. Median PFS and OS (months) for the three groups: 5.0 and 15.0 uncommon, 8.5 and 19.6 common, 2.0 and 10.4 wild type.",
		"drug_labels": "Erlotinib",
		"variant_name": "N826Y",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1896/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/396",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/434"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/434",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21531810"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4244",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/434"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/228",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/434"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/435",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/309",
			"name": "M766_A767insASV",
			"description": "EGFR M766_A767insASV",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": null,
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/2213/summary/evidence/5938/summary#evidence",
		"source": "civic",
		"description": "A 43 year old female neversmoker lung adenocarcinoma patient with EGFR M766_A767insASV mutation was given erlotinib as first line treatment, and had progressive disease as best response with -3.9% change to target lesions, progression free survival of 1 month.",
		"drug_labels": "Erlotinib",
		"variant_name": "M766_A767insASV",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/2213/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/397",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/435"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/435",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5938",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/435"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/229",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/435"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/436",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/310",
			"name": "MUTATION",
			"description": "EGFR MUTATION",
			"biomarker_type": "Inframe Variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818"
			],
			"soid": "SO:0001650",
			"so_name": "inframe_variant",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/442/summary/evidence/3794/summary#evidence",
		"source": "civic",
		"description": "In a phase II trial for Bronchioloalveolar carcinoma (BAC, or in situ pulmonary adenocarcinoma), EGFR exons 18-24 were analyzed in 7 patients who had shown a partial response to Erlotinib, and 10 patients who did not.  EGFR mutations were seen in 5/7 responders but not in any of the non-responders, which was a significant result (p=0.003).",
		"drug_labels": "Erlotinib",
		"variant_name": "MUTATION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/442/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/398",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/436"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/436",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15329413"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3794",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/436"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/230",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/436"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/437",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/310",
			"name": "MUTATION",
			"description": "EGFR MUTATION",
			"biomarker_type": "Inframe Variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818"
			],
			"soid": "SO:0001650",
			"so_name": "inframe_variant",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/442/summary/evidence/1728/summary#evidence",
		"source": "civic",
		"description": "In the LUX-LUNG 7 trial, (NCT01466660) stage IIIB or IV NSCLC patients with EGFR exon 19 deletion, (n=186) Leu858Arg mutation, (n=132) or both (n=1) were divided into equal groups and treated with first line reversible EGFR inhibitor gefitinib or irreversible pan-ErbB family inhibitor afatinib in order to obtain a direct comparison of these two approved first line treatments. Significant difference was seen in objective response with 70%  of cases with afatinib vs. 56% of cases with gefitinib. Median progression free survival was 11.0 months (10.6-12.9) with afatinib and 10.9 months (9.1-11.5) with gefitinib, HR 0.73 [0.57-0.95] p=0.017.",
		"drug_labels": "AFATINIB",
		"variant_name": "MUTATION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/442/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/399",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/437"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/437",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27083334"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1728",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/437"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/231",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/437"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/438",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/310",
			"name": "MUTATION",
			"description": "EGFR MUTATION",
			"biomarker_type": "Inframe Variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818"
			],
			"soid": "SO:0001650",
			"so_name": "inframe_variant",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/442/summary/evidence/1937/summary#evidence",
		"source": "civic",
		"description": "This open label Phase 3 Trial performed across 36 centers in Japan (WJTOG3405) assessed patients with postoperative recurrent or stage IIIB/IV NSCLC and activating EGFR mutations (Exon 19 deletion and L858R).  88 patients were treated with EGFR inhibitor gefitinib, while 89 were treated with cisplatin/docetaxel. Progression free survival was significantly longer with gefitinib treatment with a median of 9.2 months vs. 6.3 with cisplatin/docetaxel (HR 0.48; 95% CI 0.336-0.710; p<0.0001). Difference in response to gefitinib between the two EGFR mutation types was not observed.",
		"drug_labels": "GEFITINIB",
		"variant_name": "MUTATION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/442/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/400",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/438"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/438",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20022809"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1937",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/438"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/232",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/438"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/439",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/310",
			"name": "MUTATION",
			"description": "EGFR MUTATION",
			"biomarker_type": "Inframe Variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818"
			],
			"soid": "SO:0001650",
			"so_name": "inframe_variant",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/442/summary/evidence/2148/summary#evidence",
		"source": "civic",
		"description": "In a phase 3 clinical trial of East Asian advanced pulmonary adenocarcinoma patients, a subset of patients with EGFR mutations (n=261) treated with gefitinib were associated with improved response (HR:0.48, 95% CI:0.36-0.64, P<0.001), compared to carboplatin plus paclitaxel treatment. The frequency of mutation in exon 19 deletion and L858R was 53.6% (140/261) and 42.5% (111/261), respectively.",
		"drug_labels": "GEFITINIB",
		"variant_name": "MUTATION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/442/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/401",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/439"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/439",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19692680"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2148",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/439"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/233",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/439"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/440",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/310",
			"name": "MUTATION",
			"description": "EGFR MUTATION",
			"biomarker_type": "Inframe Variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818"
			],
			"soid": "SO:0001650",
			"so_name": "inframe_variant",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/442/summary/evidence/2153/summary#evidence",
		"source": "civic",
		"description": "In a phase 2b/3 study of 585 stage IIIB-IV lung adenocarcinoma patients who had a previous round of EGFR-TKI treatment, archival material was available for 141 patients. EGFR mutational analysis revealed that 96 tumors had an EGFR mutation, of which 76 (79%) were positive for either L858R or a deletion in exon 19. These mutations were associated with improved progression-free survival (median 3.3 months  vs 1.0 month ; HR:0.51, 95% CI:0.31-0.85, P<0.009) compared to placebo control.",
		"drug_labels": "AFATINIB",
		"variant_name": "MUTATION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/442/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/402",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/440"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/440",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22452896"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2153",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/440"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/234",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/440"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/441",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/310",
			"name": "MUTATION",
			"description": "EGFR MUTATION",
			"biomarker_type": "Inframe Variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818"
			],
			"soid": "SO:0001650",
			"so_name": "inframe_variant",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/442/summary/evidence/2559/summary#evidence",
		"source": "civic",
		"description": "Mutational profiling was performed on EGFR exons 18-24 from a group of 10 retrospectively chosen patients who had shown partial response or clinical imporvement in response to gefitinib, and in 8 patients who had not shown gefitinib response. 7 of 10 sensitive patients had mutations in EGFR, while none of the 8 gefitinib refractory patients showed EGFR mutation in these exons (p=0.004)",
		"drug_labels": "GEFITINIB",
		"variant_name": "MUTATION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/442/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/403",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/441"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/441",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15329413"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2559",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/441"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/235",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/441"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/442",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/310",
			"name": "MUTATION",
			"description": "EGFR MUTATION",
			"biomarker_type": "Inframe Variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818"
			],
			"soid": "SO:0001650",
			"so_name": "inframe_variant",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/442/summary/evidence/4201/summary#evidence",
		"source": "civic",
		"description": "In the placebo-controlled Phase III study SATURN, using erlotinib maintenance therapy for patients with advanced NSCLC who were selected for response or stable disease after first line chemotherapy, EGFR mutation was assessed. In patients with EGFR mutation, erlotinib maintenance reduced progression and death significantly with median progression free survival (PFS) of 44.6 vs. 13 weeks over placebo. Erlotinib also significantly improved PFS in EGFR wildtype patients, but EGFR mutant tumors treated with erlotinib had significant better PFS than EGFR wildtype. Overall, in the intent to treat population erlotinib significantly improved PFS over placebo (HR, 0.71; 95% CI, 0.62 to 0.82; P<0.001).",
		"drug_labels": "Erlotinib",
		"variant_name": "MUTATION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/442/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/404",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/442"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/442",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21969500"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4201",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/442"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/236",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/442"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/443",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/310",
			"name": "MUTATION",
			"description": "EGFR MUTATION",
			"biomarker_type": "Inframe Variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818"
			],
			"soid": "SO:0001650",
			"so_name": "inframe_variant",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/442/summary/evidence/2939/summary#evidence",
		"source": "civic",
		"description": "In a study of 52 patients with recurrent lung cancer, 27 individuals had EGFR mutation including 2 point mutations in exon 18 (G719A and G1719C), 23 deletions in exon 19, two insertions in exon 19 (I744KIPVAI), on mutation in exon 20 (S768I), and 16 point mutations in exon 21 (L858R and E709H). Patients were treated with the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib, and tumors harboring an EGFR mutation had an increased frequency of partial response (PR) and a lower rate of progressive disease (PD) (PR:22, PD:2 vs. PR:2, PD:17; P<0.0001) compared to wildtype EGFR patients. Patients with KRAS mutations also had a longer overall survival compared to wildtype EGFR patients (HR:2.526, 95% CI:1.314-4.858, P=0.0055).",
		"drug_labels": "GEFITINIB",
		"variant_name": "MUTATION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/442/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/405",
				"source": "http://purl.obolibrary.org/obo/DOID_1324",
				"term": "lung cancer",
				"pheno_id": "DOID:1324",
				"family": "respiratory system cancer",
				"description": "lung cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/443"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/443",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/17409929"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2939",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/443"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/237",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/443"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/444",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/310",
			"name": "MUTATION",
			"description": "EGFR MUTATION",
			"biomarker_type": "Inframe Variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818"
			],
			"soid": "SO:0001650",
			"so_name": "inframe_variant",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/442/summary/evidence/3016/summary#evidence",
		"source": "civic",
		"description": "In a phase 3 clinical trial of non-small cell lung cancer (NSCLC) patients, a subset of patients with EGFR mutations (n=44) treated with gefitinib were associated with improved progression free survival (HR: 0.16, 95% CI: 0.05-0.49, P=0.001), and a higher objective response rate (ORR: 42.1% vs 21.1%, p=0.04) compared to patients treated with docetaxel. Of the 44 patients, 22 had an exon 19 deletion, 16 had an L858R mutation, one patient had an exon 20 T790M mutation, two had an exon G719A mutation and four had other mutations.",
		"drug_labels": "GEFITINIB",
		"variant_name": "MUTATION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/442/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/406",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/444"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/444",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20038723"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3016",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/444"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/238",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/444"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/445",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/310",
			"name": "MUTATION",
			"description": "EGFR MUTATION",
			"biomarker_type": "Inframe Variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818"
			],
			"soid": "SO:0001650",
			"so_name": "inframe_variant",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/442/summary/evidence/5923/summary#evidence",
		"source": "civic",
		"description": "25 patients with metastatic peritoneal mesothelioma were treated with surgical cytoreduction consolidated with intraperitoneal hyperthermic chemotherapy (CRS/IPHC). 8 of the patients carried EGFR mutations in the tyrosine kinase domain. Each mutation was not found in 100 unrelated controls. At study end 10/18 wildtype patients had died with median survival of 14 months, while 2/7 EGFR mutant patients had died and median survival was not yet reached. Median time to progression (TTP) was 12 months in the wildtype group and in the mutant group median TTP was not yet reached. 3 year progression free survival was 71% in the mutant group and 28% in the wildtype group.",
		"drug_labels": "m-cresol",
		"variant_name": "MUTATION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/442/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/407",
				"source": "http://purl.obolibrary.org/obo/DOID_1788",
				"term": "peritoneal mesothelioma",
				"pheno_id": "DOID:1788",
				"family": "malignant mesothelioma",
				"description": "peritoneal mesothelioma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/445"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/445",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20942962"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5923",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/445"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/239",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "m-cresol",
				"envcontext_id": "CID342",
				"usan_stem": null,
				"description": "m-cresol",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/445"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/446",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/310",
			"name": "MUTATION",
			"description": "EGFR MUTATION",
			"biomarker_type": "Inframe Variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818"
			],
			"soid": "SO:0001650",
			"so_name": "inframe_variant",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/442/summary/evidence/6187/summary#evidence",
		"source": "civic",
		"description": "In a Japanese phase III study, lung adenocarcinoma patients with one or more of any mutation in their EGFR gene were treated with either Erlotinib or Gefitinib EGFR tyrosine kinase inhibitors to demonstrate noninferiority of Gefitinib. Eligible patients had postoperative recurrent or stage IIIb/IV cases and had undergone prior chemotherapy but no TKI therapy. Difference between the objective response rate, defined as the sum of the complete and partial responses, was insignificant (P = .476). Difference between the disease control rate, defined as the sum of complete response, partial response, and stable disease, was also insignificant (P = .517). Progression free survival was insignificantly different for Gefitinib and Erlotinib arms at 8.3 and 10.0 months respectively (HR, 1.093; 95% CI, 0.900 to 1.570; P = .221). Additionally, milder adverse affects were observed in the Gefitinib arm; however, these were not statistically significant. The authors are unable to demonstrate an endpoint of Gefitinib noninferiority based of the progression free survival confidence interval. However, given the above data showing insignificance, Gefitinib is likely to be a comparable treatment.",
		"drug_labels": "GEFITINIB",
		"variant_name": "MUTATION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/442/summary",
		"evidence_label": "C",
		"response_type": "Reduced Sensitivity",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/408",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/446"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/446",
				"type": "Predictive",
				"description": "Reduced Sensitivity",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27022112"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6187",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/446"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/240",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/446"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/447",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/310",
			"name": "MUTATION",
			"description": "EGFR MUTATION",
			"biomarker_type": "Inframe Variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818"
			],
			"soid": "SO:0001650",
			"so_name": "inframe_variant",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/442/summary/evidence/6465/summary#evidence",
		"source": "civic",
		"description": "Three major drug resistance mutations, namely  L718Q, L844V, and C797S were identified in EGFR and caused resistance to both WZ4002 and CO-1686. In contrast, only EGFR C797S caused AZD9291 resistance. Cells containing EGFR-sensitizing mutations such as exon 19 deletion or L858R substitution, in conjunction with L718Q, L844V, or C797S retained sensitivity to EGFR inhibitors, gefitinib and afatinib. The C797S mutation, in the presence of exon 19 deletion or L858R substitution and T790M substitution, causes resistance to all current EGFR inhibitors. However, EGFR L858R/T790M/C797S mutations remain partially sensitive to cetuximab which leads to disruption of EGFR dimerization.",
		"drug_labels": "GEFITINIB,AFATINIB",
		"variant_name": "MUTATION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/442/summary",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/409",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/447"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/447",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25948633"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6465",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/447"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/242",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/447"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/241",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/447"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/448",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/310",
			"name": "MUTATION",
			"description": "EGFR MUTATION",
			"biomarker_type": "Inframe Variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818"
			],
			"soid": "SO:0001650",
			"so_name": "inframe_variant",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/442/summary/evidence/1701/summary#evidence",
		"source": "civic",
		"description": "In a study of 1036 patients with lung adenocarcinomas, patients with EGFR mutations (n=275) showed better prognosis (OS: 34 months versus 23 months; HR=0.6; P<0.001).",
		"drug_labels": null,
		"variant_name": "MUTATION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/442/summary",
		"evidence_label": "B",
		"response_type": "Better Outcome",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/410",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/448"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/448",
				"type": "Prognostic",
				"description": "Better Outcome",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22810899"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1701",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/448"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/449",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/310",
			"name": "MUTATION",
			"description": "EGFR MUTATION",
			"biomarker_type": "Inframe Variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818"
			],
			"soid": "SO:0001650",
			"so_name": "inframe_variant",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/442/summary/evidence/3792/summary#evidence",
		"source": "civic",
		"description": "Analysis was performed on the placebo group (n=451) of the Phase III study SATURN using erlotinib maintenance therapy for patients with advanced NSCLC who were selected for response or stable disease after first line chemotherapy. It was found that EGFR Mutant status was a significant positive prognostic factor for overall survival. (HR, 0.33; 95% CI, 0.19 to 0.59; P<0.01)",
		"drug_labels": null,
		"variant_name": "MUTATION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/442/summary",
		"evidence_label": "B",
		"response_type": "Better Outcome",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/411",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/449"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/449",
				"type": "Prognostic",
				"description": "Better Outcome",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21969500"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3792",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/449"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/450",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/311",
			"name": "V774_C775insHV",
			"description": "EGFR V774_C775insHV",
			"biomarker_type": "Inframe Insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1567/summary/evidence/5809/summary#evidence",
		"source": "civic",
		"description": "MCF-7 cells were transduced with YFP tagged EGFR with D770_N771INSSVD mutation, or YFP EGFR wildtype, and stained for ectopic YFP EGFR and phospho-Akt as a readout for EGFR pathway activity. Increased p-Akt stain was seen with ectopic mutant EGFR but not wildtype. Parallel erlotinib incubations of cells with wildtype EGFR induced recompartmentalization of ectopic EGFR protien only at high concentration (10uM). Addition of erlotinib to incubations of mutant EGFR cells did not markedly reduce p-Akt signal below 10uM, and did not induce recompartmentalization of ectopic EGFR protien at any conentration reported (up to 10uM erlotinib), suggesting that the V774_C775INSHV EGFR variant could be a growth pathway driver that is resistant to erlotinib",
		"drug_labels": "Erlotinib",
		"variant_name": "V774_C775insHV",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1567/summary",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/412",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/450"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/450",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/17877814"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5809",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/450"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/243",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/450"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/451",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/311",
			"name": "V774_C775insHV",
			"description": "EGFR V774_C775insHV",
			"biomarker_type": "Inframe Insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1567/summary/evidence/4645/summary#evidence",
		"source": "civic",
		"description": "In a lung adenocarcinoma patient harboring EGFR V774_C775insHV mutation, EGFR V774_C775insHV was associated with lack of response to treatment with erlotinib monotherapy.",
		"drug_labels": "Erlotinib",
		"variant_name": "V774_C775insHV",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1567/summary",
		"evidence_label": "C",
		"response_type": "resistant",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/413",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/451"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/451",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23371856"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4645",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/451"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/244",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/451"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/452",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/312",
			"name": "I744_K745insKIPVAI",
			"description": "EGFR I744_K745insKIPVAI",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": null,
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/2259/summary/evidence/6041/summary#evidence",
		"source": "civic",
		"description": "The del I744_K745insKIPVAI mutation was found in a 36-year-old former female smoker, with an adenocarcinoma of the lung.\nShe received erlotinib at a 150 mg daily dose. A clinical meaningful improvement of symptoms was obtained within a few days, and a tumor assessment after 8 weeks showed a PR.",
		"drug_labels": "Erlotinib",
		"variant_name": "I744_K745insKIPVAI",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/2259/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/414",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/452"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/452",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21841502"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6041",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/452"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/245",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/452"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/453",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/201",
			"name": "G724S",
			"description": "EGFR G724S",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55241722,
			"end_pos": 55241722,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55241722G>A",
			"hgvs_c": "NM_005228.3:c.2170G>A",
			"hgvs_p": "NP_005219.2:p.Gly724Ser",
			"dbsnp_ids": [
				"1051753269"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55241722G>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/317/summary/evidence/786/summary#evidence",
		"source": "civic",
		"description": "Whole genome sequencing of a case of colon carcinoma revealed a G724S mutation in the EGFR gene. In-vitro, this mutation was shown to be oncogenic and sensitive to Cetuximab, yet relatively insensitive towards small molecules.",
		"drug_labels": "CETUXIMAB",
		"variant_name": "G724S",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/317/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/415",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/453"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/453",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24894453"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "786",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/453"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/246",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/453"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/454",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/239",
			"name": "L838P",
			"description": "EGFR L838P",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259455,
			"end_pos": 55259455,
			"ref": "T",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.55259455T>C",
			"hgvs_c": "NM_005228.3:c.2513T>C",
			"hgvs_p": "NP_005219.2:p.Leu838Pro",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259455T>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1457/summary/evidence/4252/summary#evidence",
		"source": "civic",
		"description": "In a study, 1 participant with stage IV lung adenocarcinoma was sequenced at EGFR exons 18 to 21 and was found to have L838P mutation, and was treated with the 1st generation TKI gefitinib. The patient (F, 66, nonsmoker) had a partial response, progression free survival (PFS) of 15.2 months, overall survival (OS) of 29.3 months and was not alive at study end. As a whole, patients with uncommon EGFR mutations had a response rate of 47.5%, which was between common (del19 and L858R) at 74.1%, and wild type EGFR at 16.5%. Median PFS and OS (months) for the three groups: 5.0 and 15.0 uncommon, 8.5 and 19.6 common, 2.0 and 10.4 wild type.",
		"drug_labels": "GEFITINIB",
		"variant_name": "L838P",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1457/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/416",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/454"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/454",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21531810"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4252",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/454"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/247",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/454"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/455",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/245",
			"name": "L861R",
			"description": "EGFR L861R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259524,
			"end_pos": 55259524,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259524T>G",
			"hgvs_c": "NM_005228.3:c.2582T>G",
			"hgvs_p": "NP_005219.2:p.Leu861Arg",
			"dbsnp_ids": [
				"121913444"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259524T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1477/summary/evidence/4669/summary#evidence",
		"source": "civic",
		"description": "In a study, 1 participant with stage IV lung adenocarcinoma was sequenced at EGFR exons 18 to 21 and was found to have L861R mutation, and was treated with the 1st generation TKI gefitinib. The patient (M, 83, nonsmoker) had a partial response, progression free survival (PFS) of 37.5 months, overall survival (OS) of 53.3 months and was alive at study end. As a whole, patients with uncommon EGFR mutations had a response rate of 47.5%, which was between common (del19 and L858R) at 74.1%, and wild type EGFR at 16.5%. Median PFS and OS (months) for the three groups: 5.0 and 15.0 uncommon, 8.5 and 19.6 common, 2.0 and 10.4 wild type.",
		"drug_labels": "GEFITINIB",
		"variant_name": "L861R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1477/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/417",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/455"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/455",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21531810"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4669",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/455"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/248",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/455"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/456",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/245",
			"name": "L861R",
			"description": "EGFR L861R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259524,
			"end_pos": 55259524,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259524T>G",
			"hgvs_c": "NM_005228.3:c.2582T>G",
			"hgvs_p": "NP_005219.2:p.Leu861Arg",
			"dbsnp_ids": [
				"121913444"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259524T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1477/summary/evidence/4300/summary#evidence",
		"source": "civic",
		"description": "In a patient with metastatic adenocarcinoma of the lung harboring EGFR L861R mutation, MET D1028H and EGFR amplification, EGFR L861R was associated with acquired resistance to crizotinib monotherapy. Initially, MDM2 amplification and MET D1028H were identified and the patient was treated with crizotinib. However, disease progression occurred at 10 months of crizotinib treatment, at which time EGFR amplification and EGFR L861R co-mutations were detected.",
		"drug_labels": "CRIZOTINIB",
		"variant_name": "L861R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1477/summary",
		"evidence_label": "C",
		"response_type": "resistant",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/418",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/456"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/456",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26845121"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4300",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/456"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/249",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "CRIZOTINIB",
				"envcontext_id": "11626560",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "CRIZOTINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/456"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/457",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/313",
			"name": "EXON 19 DELETION",
			"description": "EGFR EXON 19 DELETION",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55242415,
			"end_pos": 55242513,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/133/summary/evidence/273/summary#evidence",
		"source": "civic",
		"description": "Exon 19 deletion has been shown to be correlated with gefitinib response.",
		"drug_labels": "GEFITINIB",
		"variant_name": "DELETION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/133/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/419",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/457"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/457",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/16730237"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "273",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/457"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/250",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/457"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/458",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/313",
			"name": "EXON 19 DELETION",
			"description": "EGFR EXON 19 DELETION",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55242415,
			"end_pos": 55242513,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/133/summary/evidence/413/summary#evidence",
		"source": "civic",
		"description": "NSCLC patients with exon 19 deletions in EGFR had longer overall survival than patients with an L858R mutation when treated with gefitinib or erlotinib (38 versus 17 months; P = 0.04).",
		"drug_labels": "GEFITINIB,Erlotinib",
		"variant_name": "DELETION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/133/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/420",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/458"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/458",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/16818686"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "413",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/458"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/252",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/458"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/251",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/458"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/459",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/313",
			"name": "EXON 19 DELETION",
			"description": "EGFR EXON 19 DELETION",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55242415,
			"end_pos": 55242513,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/133/summary/evidence/880/summary#evidence",
		"source": "civic",
		"description": "A phase III clinical trial (NCT00949650) found that median progression free survival among patients with EGFR exon 19 deletion was 13.6 months for afatinib and 6.9 months for chemotherapy (HR, 0.47; 95% CI, 0.34 to 0.65; P = .001). 308 patients had either exon 19 or L858 mutations.",
		"drug_labels": "AFATINIB",
		"variant_name": "DELETION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/133/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/421",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/459"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/459",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23816960"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "880",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/459"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/253",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/459"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/460",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/313",
			"name": "EXON 19 DELETION",
			"description": "EGFR EXON 19 DELETION",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55242415,
			"end_pos": 55242513,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/133/summary/evidence/881/summary#evidence",
		"source": "civic",
		"description": "Stable HEK293 cell lines expressing mutant EGFR cDNAs were created (using a pQCLIN retroviral vector) and their drug sensitivities to afatinib were examined by MTT assay. Phorphorylation of EGFR was assayed by Western blot. The 50% inhibitory concentration (IC50) of afatinib was significantly lower in cells harboring EGFR exon 19 deletion than in cells harboring EGFR L858R.",
		"drug_labels": "AFATINIB",
		"variant_name": "DELETION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/133/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/422",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/460"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/460",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25862853"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "881",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/460"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/254",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/460"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/461",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/313",
			"name": "EXON 19 DELETION",
			"description": "EGFR EXON 19 DELETION",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55242415,
			"end_pos": 55242513,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/133/summary/evidence/882/summary#evidence",
		"source": "civic",
		"description": "In a phase 2 study (NCT00525148), patients with lung adenocarcinoma (stage IIIb with pleural effusion or stage IV) and EGFR mutations, treated with afatinib, were assessed by objective response. In total, 129 patients were treated with afatinib. 66% of the 106 patients with two common activating EGFR mutations (exon 19 deletion or L858R) had an objective response compared to 39% of 23 patients with less common EGFR mutations.",
		"drug_labels": "AFATINIB",
		"variant_name": "DELETION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/133/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/423",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/461"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/461",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22452895"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "882",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/461"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/255",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/461"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/462",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/313",
			"name": "EXON 19 DELETION",
			"description": "EGFR EXON 19 DELETION",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55242415,
			"end_pos": 55242513,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/133/summary/evidence/884/summary#evidence",
		"source": "civic",
		"description": "A randomized phase 3 trial involving 173 NSCLC patients with EGFR mutations (exon 19 deletion or L858R mutation in exon 21) with no history of chemotherapy for metastatic disease. Patients were randomly allocated (1:1) to receive either erlotinib or standard chemotherapy. The primary endpoint was progression-free survival (PFS). Median PFS was 9.7 months in the erlotinib group, compared with 5.2 months in the standard chemotherapy group.",
		"drug_labels": "Erlotinib",
		"variant_name": "DELETION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/133/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/424",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/462"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/462",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22285168"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "884",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/462"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/256",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/462"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/463",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/313",
			"name": "EXON 19 DELETION",
			"description": "EGFR EXON 19 DELETION",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55242415,
			"end_pos": 55242513,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/133/summary/evidence/969/summary#evidence",
		"source": "civic",
		"description": "Cells harboring an exon 19 deletion were sensitive to afatinib. This study performed drug response assays using five human NSCLC cell lines with various combinations of EGFR mutations. In order to directly compare the sensitivity of multiple EGFR mutations to EGFR-TKIs the authors also generated multiple EGFR transduced Ba/F3 stable cell lines and evaluated sensitivity to EGFR-TKIs by MTS assay.",
		"drug_labels": "AFATINIB",
		"variant_name": "DELETION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/133/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/425",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/463"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/463",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26515464"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "969",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/463"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/257",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/463"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/464",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/313",
			"name": "EXON 19 DELETION",
			"description": "EGFR EXON 19 DELETION",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55242415,
			"end_pos": 55242513,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/133/summary/evidence/981/summary#evidence",
		"source": "civic",
		"description": "Afatinib is an irreversible covalent inhibitor of EGFR (second generation). This Phase III clinical trial (LUX-Lung 6; NCT01121393) was performed in Asian patients with EGFR mutant advanced NSCLC. 364 eligible patients with EGFR mutations were assigned to afatinib (n=242) or gemcitabine and cisplatin (n=122) treatment. The trial observed significantly longer median progression-free survival with afatinib vs. gemcitabine and cisplatin treatment (11.0 vs. 5.6 months). Afatinib/Chemotherapy group compositions: 51.2/50.8 % del 19; 38/37.7 % Leu858Arg; 10.8/11.5 % Uncommon.",
		"drug_labels": "AFATINIB",
		"variant_name": "DELETION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/133/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/426",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/464"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/464",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24439929"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "981",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/464"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/258",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/464"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/465",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/313",
			"name": "EXON 19 DELETION",
			"description": "EGFR EXON 19 DELETION",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55242415,
			"end_pos": 55242513,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/133/summary/evidence/983/summary#evidence",
		"source": "civic",
		"description": "In analysis of LUX-Lung 3 and LUX-Lung 6 trials (NCT00949650 and NCT01121393), of EGFR mutant NSCLC, median overall survival with afatinib treatment was seen to be significantly improved over chemotherapy (33.3 vs 21.1 and 31.4 vs 18.4 months in LUX-Lung 3 and LUX-Lung 6 respectively).  This effect was observed in the EGFR exon 19 deletion subgroup, but not in the L858R mutant subgroup.",
		"drug_labels": "AFATINIB",
		"variant_name": "DELETION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/133/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/427",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/465"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/465",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25589191"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "983",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/465"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/259",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/465"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/466",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/313",
			"name": "EXON 19 DELETION",
			"description": "EGFR EXON 19 DELETION",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55242415,
			"end_pos": 55242513,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/133/summary/evidence/1666/summary#evidence",
		"source": "civic",
		"description": "90 NSCLC patients with stage IIIB/IV chemotherapy-resistant tumors were treated with gefitinib, and exon 19 deletion of EGFR was associated with longer time to treatment failure than those with wild-type EGFR (median 8.9 versus 2.1). In multivariate analysis, exon 19 deletion was a significant predictive factor for TTF (HR = 0.0320; P < .0001).",
		"drug_labels": "GEFITINIB",
		"variant_name": "DELETION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/133/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/428",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/466"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/466",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/18509184"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1666",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/466"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/260",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/466"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/467",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/313",
			"name": "EXON 19 DELETION",
			"description": "EGFR EXON 19 DELETION",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55242415,
			"end_pos": 55242513,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/133/summary/evidence/2519/summary#evidence",
		"source": "civic",
		"description": "In a phase 3 clinical trial of Korean, never-smoker, lung adenocarcinoma patients, a subset of patients with EGFR mutations (n=42) treated with gefitinib were associated with improved overall response rate compared to gemcitabine plus cisplatin treatment (84.6%, 22/26, vs. 37.5%, 6/16, P=0.002). By contrast, in EGFR mutation negative cases, the response rate was much lower (25.9%, 7/27). The frequency of mutation in exon 19 deletion and L858R was 64.3% (27/42) and 36.4% (16/42), respectively. Exon 19 and L858R mutations were mutually exclusive in this cohort.",
		"drug_labels": "GEFITINIB",
		"variant_name": "DELETION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/133/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/429",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/467"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/467",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22370314"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2519",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/467"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/261",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/467"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/468",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/313",
			"name": "EXON 19 DELETION",
			"description": "EGFR EXON 19 DELETION",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55242415,
			"end_pos": 55242513,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/133/summary/evidence/2995/summary#evidence",
		"source": "civic",
		"description": "On May 14, 2013, the U.S. Food and Drug Administration approved erlotinib (Tarceva) for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations.",
		"drug_labels": "Erlotinib",
		"variant_name": "DELETION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/133/summary",
		"evidence_label": "A",
		"response_type": "Sensitivity/Response",
		"evidence_level": "1",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/430",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/468"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/468",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24868098"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2995",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/468"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/262",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/468"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/469",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/313",
			"name": "EXON 19 DELETION",
			"description": "EGFR EXON 19 DELETION",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55242415,
			"end_pos": 55242513,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/133/summary/evidence/2996/summary#evidence",
		"source": "civic",
		"description": "Afatinib, an irreversible inhibitor of the ErbB family of tyrosine kinases has been approved in the US for the first-line treatment of patients with metastatic non-small-cell lung cancer (NSCLC) who have tumours with EGFR exon 19 deletions or exon 21 (L858R) substitution mutations as detected by a US FDA-approved test",
		"drug_labels": "AFATINIB",
		"variant_name": "DELETION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/133/summary",
		"evidence_label": "A",
		"response_type": "Sensitivity/Response",
		"evidence_level": "1",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/431",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/469"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/469",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23982599"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2996",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/469"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/263",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/469"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/470",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/313",
			"name": "EXON 19 DELETION",
			"description": "EGFR EXON 19 DELETION",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55242415,
			"end_pos": 55242513,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/133/summary/evidence/4766/summary#evidence",
		"source": "civic",
		"description": "In a stage IV lung adenocarcinoma patient harboring EGFR exon 19 deletion, EGFR exon 19 deletion was associated with sensitivity to erlotinib monotherapy. Prior to identification of the EGFR exon 19 deletion, the patient was underwent complex treatments with standard chemotherapy and experienced disease progression; upon identification of EGFR exon 19 deletion and treatment with erlotinib, the patient achieved a clinical response.",
		"drug_labels": "Erlotinib",
		"variant_name": "DELETION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/133/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/432",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/470"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/470",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27566387"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4766",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/470"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/264",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/470"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/471",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/313",
			"name": "EXON 19 DELETION",
			"description": "EGFR EXON 19 DELETION",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55242415,
			"end_pos": 55242513,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/133/summary/evidence/4859/summary#evidence",
		"source": "civic",
		"description": "Non-small cell cancer patients from two studies [The ARCHER 1009 (NCT01360554) and A7471028 (NCT00769067)] with exon 19 deletion and L858R EGFR (Exon 21) mutations were pooled to compare the efficacy of dacomitinib to erlotinib. 121 patients with any EGFR mutation were enrolled, 101 had activating mutations in exon 19 or 21. Median progression-free survival and median survival were better following dacomitinib treatment (14.6 and 26.6 months, N=53) than erlotinib (9.6 and 23.2, P = 0.146 and P = 0.265, N=48). In exon 19 mutated patients (N=32 and 36) PFS was better for dacomitinib treated patients (HR of 0.585 [95% CI 0.335–1.024], two-sided log-rank, P = 0.058) but did not reach significance.",
		"drug_labels": "DACOMITINIB,Erlotinib",
		"variant_name": "DELETION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/133/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/433",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/471"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/471",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26768165"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4859",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/471"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/266",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/471"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/265",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DACOMITINIB",
				"envcontext_id": "11511120",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "DACOMITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/471"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/472",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/313",
			"name": "EXON 19 DELETION",
			"description": "EGFR EXON 19 DELETION",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55242415,
			"end_pos": 55242513,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/133/summary/evidence/6184/summary#evidence",
		"source": "civic",
		"description": "A Japanese Phase III clinical study assessed the noninferiority of gefitinib in comparison to erlotinib in 561 patients with postoperative or recurrent stage IIIB/IV lung adenocarcinoma. Patients were pretreated with at least one chemotherapy regimen, but no tyrosine kinase inhibitors. In the subgroup of 156 patients with exon 19 deletions as their sole EGFR mutation, 83 and 78 were treated with erlotinib and gefitinib, respectively. Objective response (defined as complete + partial response) was approximately 65 percent for both erlotinib gefitinib and non significantly different  (p= .965). Disease control rate (defined as complete response + partial response + stable disease) was 91.6 and 83.3 percent for erlotinib and gefitinib, respectively (p=.113). The study was unable to demonstrate statistical noninferiority via the planned end point; however, the lack of statistically significant differences between erlotinib and gefitinib responses, and the milder adverse effects experienced by gefitinib treated patients, led the authors to conclude that gefitinib is a feasible alternative to erlotinib in treating patients with ex19del EGFR positive, advanced lung adenocarcinoma.",
		"drug_labels": "GEFITINIB",
		"variant_name": "DELETION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/133/summary",
		"evidence_label": "B",
		"response_type": "Reduced Sensitivity",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/434",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/472"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/472",
				"type": "Predictive",
				"description": "Reduced Sensitivity",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27022112"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6184",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/472"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/267",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/472"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/473",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/176",
			"name": "E734Q",
			"description": "EGFR E734Q",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242430,
			"end_pos": 55242430,
			"ref": "G",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.55242430G>C",
			"hgvs_c": "NM_005228.3:c.2200G>C",
			"hgvs_p": "NP_005219.2:p.Glu734Gln",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55242430G>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1572/summary/evidence/4656/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a COS-7 cell line expressing EGFR E734Q demonstrated increased sensitivity to erlotinib treatment, compared to COS-7 cells expressing EGFR wild-type. Sensitivity was determined by assessing EGFR auto-phosphorylation.",
		"drug_labels": "Erlotinib",
		"variant_name": "E734Q",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1572/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/435",
				"source": "http://purl.obolibrary.org/obo/DOID_1790",
				"term": "malignant mesothelioma",
				"pheno_id": "DOID:1790",
				"family": "cell type cancer",
				"description": "malignant mesothelioma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/473"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/473",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20942962"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4656",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/473"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/268",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/473"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/474",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/314",
			"name": "R451C",
			"description": "EGFR R451C",
			"biomarker_type": "Missense Variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55227884,
			"end_pos": 55227884,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55227884C>T",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"377567759"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55227884C>T?assembly=hg19",
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/454/summary/evidence/1081/summary#evidence",
		"source": "civic",
		"description": "In this preclinical study on the effects of cetuximab, panitumumab or sym004 on various EGFR mutations in colorectal cancer. The R451C mutation showed moderate drug-receptor binding with sym004, cetuximab and panitumumab treatment and inhibition of EGFR phosphorylation.",
		"drug_labels": "PANITUMUMAB,CETUXIMAB",
		"variant_name": "R451C",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/454/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/436",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/474"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/474",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26888827"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1081",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/474"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/270",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/474"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/269",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "PANITUMUMAB",
				"envcontext_id": "CHEMBL1201827",
				"usan_stem": "monoclonal antibodies",
				"description": "PANITUMUMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/474"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/475",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/315",
			"name": "Gain-of-function",
			"description": "EGFR Gain-of-function",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": null,
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1765/summary/evidence/4931/summary#evidence",
		"source": "civic",
		"description": "Study found Somatic EGFR mutations localized to exons 19,21 in 8/9 patients who exhibited a response to Gefitinib treatment. Of these mutations 7/8 were localized near the ATP cleft Gefitinib targets. No EGFR mutations were observed in 7 patients with no response to Gefitinib. An expansion cohort independent of the Gefitinib study showed 2/25 patients harbored EGFR mutations. A second expansion independent of Gefitinib consisting of 95 tumors and 108 cell lines showed no mutations in exons 19,21.",
		"drug_labels": "GEFITINIB",
		"variant_name": null,
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1765/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/437",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/475"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/475",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15118073"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4931",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/475"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/271",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/475"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/476",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/316",
			"name": "P753S",
			"description": "EGFR P753S",
			"biomarker_type": "Missense Variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55242487,
			"end_pos": 55242487,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55242487C>T",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"121913231"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55242487C>T?assembly=hg19",
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/460/summary/evidence/1089/summary#evidence",
		"source": "civic",
		"description": "72-year old male patient presents with SCC with a mutation profile consistent with UV exposure. Sequencing revealed a number of abnormalities including P753S mutation in EGFR. Patient began therapy with cetuximab and sirolimus and continued for 9 months. Disease burden was not measurable by Response Evaluation Criteria in Solid Tumors.",
		"drug_labels": "Rapamycin,SIROLIMUS,CETUXIMAB",
		"variant_name": "P753S",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/460/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/438",
				"source": "http://purl.obolibrary.org/obo/DOID_3151",
				"term": "skin squamous cell carcinoma",
				"pheno_id": "DOID:3151",
				"family": "skin cancer",
				"description": "skin squamous cell carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/476"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/476",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24934779"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1089",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/476"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/274",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/476"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/273",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "SIROLIMUS",
				"envcontext_id": "5284616",
				"usan_stem": "immunosuppressives: immunosuppressant, rapamycin derivatives",
				"description": "SIROLIMUS",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/476"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/272",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Rapamycin",
				"envcontext_id": "53321387",
				"usan_stem": null,
				"description": "Rapamycin",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/476"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/477",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/166",
			"name": "C797Y",
			"description": "EGFR C797Y",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249092,
			"end_pos": 55249092,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55249092G>A",
			"hgvs_c": "NM_005228.3:c.2390G>A",
			"hgvs_p": "NP_005219.2:p.Cys797Tyr",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249092G>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1574/summary/evidence/4658/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a COS-7 cell line expressing EGFR C797Y demonstrated increased sensitivity to erlotinib treatment, compared to COS-7 cells expressing EGFR wild-type. Sensitivity was determined by assessing EGFR auto-phosphorylation.",
		"drug_labels": "Erlotinib",
		"variant_name": "C797Y",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1574/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/439",
				"source": "http://purl.obolibrary.org/obo/DOID_1790",
				"term": "malignant mesothelioma",
				"pheno_id": "DOID:1790",
				"family": "cell type cancer",
				"description": "malignant mesothelioma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/477"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/477",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20942962"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4658",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/477"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/275",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/477"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/478",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/317",
			"name": "M766_A767insAI",
			"description": "EGFR M766_A767insAI",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1664/summary/evidence/4799/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a Ba/F3 cell line expressing EGFR M766_A767insAI demonstrated reduced sensitivity to erlotinib treatment (IC50=3.403�M), comparable to Ba/F3 cells expressing EGFR L858R and T790M co-mutation (T790M is a known resistant mutation to 1st and 2nd generation EGFR tyrosine kinase inhibitors; IC50=4.155�M). Resistance was determined by assessing cell proliferation, EGFR, AKT and ERK phosphorylation.",
		"drug_labels": "Erlotinib",
		"variant_name": "M766_A767insAI",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1664/summary",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/440",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/478"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/478",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4799",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/478"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/276",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/478"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/479",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/318",
			"name": "EXPRESSION",
			"description": "EGFR EXPRESSION",
			"biomarker_type": "N/A",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/354/summary/evidence/4877/summary#evidence",
		"source": "civic",
		"description": "Double blind Phase II clinical trial found an objective response rate of 18.4% and 19% for two groups of patients treated with 250mg/d and 500mg/d respectively. The disease control rate was found to be 54.4% and 51.4% for the two groups.",
		"drug_labels": "GEFITINIB",
		"variant_name": "EXPRESSION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/354/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/441",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/479"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/479",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/12748244"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4877",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/479"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/277",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/479"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/480",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/318",
			"name": "EXPRESSION",
			"description": "EGFR EXPRESSION",
			"biomarker_type": "N/A",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/354/summary/evidence/4213/summary#evidence",
		"source": "civic",
		"description": "A phase 3 study of 889 advanced non-small cell lung cancer patients (with non-progressive disease while on standard chemotherapy treatment), reported that patients harboring EGFR mutation (exon 19 deletion and L858R mutation; n= 493, 46% lung adenocarcinoma, 44% lung squamous cell carcinoma) who were treated with erlotinib had an improved progression free survival (44.6 weeks vs. 13 weeks, HR: 0.10, 95% CI 0.04-0.25, P<0.001) as compared to patients who received placebo.",
		"drug_labels": "Erlotinib",
		"variant_name": "EXPRESSION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/354/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/442",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/480"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/480",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21969500"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4213",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/480"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/278",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/480"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/481",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/318",
			"name": "EXPRESSION",
			"description": "EGFR EXPRESSION",
			"biomarker_type": "N/A",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/354/summary/evidence/1709/summary#evidence",
		"source": "civic",
		"description": "57 patients with chemorefractory colorectal cancer expressing EGFR (IHC staining) were treated with single-agent cetuximab in this phase 2 study. Five patients (9%; 95% CI, 3% to 19%) achieved a partial response. Twenty-one additional patients had stable disease or minor responses. The median survival in these previously treated patients with chemotherapy-refractory colorectal cancer was 6.4 months.",
		"drug_labels": "CETUXIMAB",
		"variant_name": "EXPRESSION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/354/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/443",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/481"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/481",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/14993230"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1709",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/481"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/279",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/481"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/482",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/318",
			"name": "EXPRESSION",
			"description": "EGFR EXPRESSION",
			"biomarker_type": "N/A",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/354/summary/evidence/1708/summary#evidence",
		"source": "civic",
		"description": "463 patients with 1% or more EGFR tumor cell membrane staining, with metastatic CRC progressive after standard chemotherapy were randomized to panitumumab plus best supportive care (BSC, n = 231) or BSC alone (n = 232). Panitumumab significantly prolonged PFS (hazard ratio [HR], 0.54; 95% CI, 0.44 to 0.66, [P < .0001]). Objective response rates favored panitumumab over BSC; after a 12-month minimum follow-up, response rates were 10% for panitumumab and 0% for BSC (P < .0001). No difference was observed in OS (HR, 1.00; 95% CI, 0.82 to 1.22), but 76% of BSC patients entered the cross-over study.",
		"drug_labels": "PANITUMUMAB",
		"variant_name": "EXPRESSION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/354/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/444",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/482"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/482",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/17470858"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1708",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/482"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/280",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "PANITUMUMAB",
				"envcontext_id": "CHEMBL1201827",
				"usan_stem": "monoclonal antibodies",
				"description": "PANITUMUMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/482"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/483",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/318",
			"name": "EXPRESSION",
			"description": "EGFR EXPRESSION",
			"biomarker_type": "N/A",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/354/summary/evidence/1572/summary#evidence",
		"source": "civic",
		"description": "Patients with refractory colorectal cancer expressing immunohistochemically detectable EGFR were randomly assigned to receive treatment with cetuximab (n=287) or receive supportive care alone (n=285). Patients receiving cetuximab had increased overall survival (HR=0.77, 95%CI 0.64-0.92; p=0.005), increased progression-free survival (HR=0.68, 95%CI 0.57-0.80; p<0.001), and improved quality of life at 4 months measured by survey on physical deterioration (-5.9 vs -12.5; p=0.03) and global health status (-3.6 vs. -15.2; p<0.001).",
		"drug_labels": "CETUXIMAB",
		"variant_name": "EXPRESSION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/354/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/445",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/483"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/483",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/18003960"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1572",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/483"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/281",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/483"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/484",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/318",
			"name": "EXPRESSION",
			"description": "EGFR EXPRESSION",
			"biomarker_type": "N/A",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/354/summary/evidence/1984/summary#evidence",
		"source": "civic",
		"description": "18 advanced progressing chordoma patients entered this study (median age: 61 years; disease extent: metastatic 72% and locally advanced 28%). Epidermal growth factor receptor (EGFR) expression and activation were evaluated by immunohistochemistry and/or phospho-arrays, real-time polimerase chain reaction, fluorescence immunostaining. Six (33.3%) patients had PR and 7 (38.9%) SD, as their best Choi responses, corresponding to RECIST SD in all cases. Median PFS by Choi was 6 [interquartile (IQ) range 3-8] months. Median PFS by RECIST was 8 (IQ range 4-12) months, with a 22% CBR. This phase II study showed a modest antitumor activity of lapatinib in chordoma",
		"drug_labels": "Lapatinib",
		"variant_name": "EXPRESSION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/354/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/446",
				"source": "http://purl.obolibrary.org/obo/DOID_3302",
				"term": "chordoma",
				"pheno_id": "DOID:3302",
				"family": "connective tissue cancer",
				"description": "chordoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/484"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/484",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23559153"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1984",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/484"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/282",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Lapatinib",
				"envcontext_id": "208908",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Lapatinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/484"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/485",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/318",
			"name": "EXPRESSION",
			"description": "EGFR EXPRESSION",
			"biomarker_type": "N/A",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/354/summary/evidence/849/summary#evidence",
		"source": "civic",
		"description": "47 HNSCC patients treated with cetuximab/docetaxel were retrospectively analyzed for EGFRvIII, EGFR and AREG expression with IHC. 73 % of cases expressed high level of EGFRvIII. EGFR expression had no impact on PFS or OS.",
		"drug_labels": "DOCETAXEL,CETUXIMAB",
		"variant_name": "EXPRESSION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/354/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/447",
				"source": "http://purl.obolibrary.org/obo/DOID_5520",
				"term": "head and neck squamous cell carcinoma",
				"pheno_id": "DOID:5520",
				"family": "head and neck cancer",
				"description": "head and neck squamous cell carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/485"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/485",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21653686"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "849",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/485"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/284",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/485"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/283",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DOCETAXEL",
				"envcontext_id": "148123",
				"usan_stem": "antineoplastics, taxane derivatives",
				"description": "DOCETAXEL",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/485"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/486",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/184",
			"name": "E746_T751delinsVA",
			"description": "EGFR E746_T751delinsVA",
			"biomarker_type": "inframe_deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242467,
			"end_pos": 55242483,
			"ref": "AATTAAGAGAAGCAACA",
			"alt": "TTGCT",
			"hgvs_g": "NC_000007.13:g.55242467_55242483delinsTTGCT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1214/summary/evidence/2860/summary#evidence",
		"source": "civic",
		"description": "In a study of 585 non-small cell lung cancer patients who had a previous round of EGFR-TKI treatment, archival material was available for 141 patients. EGFR mutational analysis revealed that 96 tumors had an EGFR mutation, of which 76 (79%) were positive for either L858R or a deletion in exon 19. These mutations were associated with improved response to afatinib for progression-free survival (median 3.3 months  vs 1.0 month ; HR:0.51, 95% CI:0.31-0.85, P<0.009) compared to placebo control.",
		"drug_labels": "AFATINIB",
		"variant_name": "E746_T751delinsVA",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1214/summary",
		"evidence_label": "C",
		"response_type": null,
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/448",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/486"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/486",
				"type": "Predictive",
				"description": null,
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22452896"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2860",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/486"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/285",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/486"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/487",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/319",
			"name": "EXON 20 INSERTION",
			"description": "EGFR EXON 20 INSERTION",
			"biomarker_type": "Inframe Insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55248991,
			"end_pos": 55249022,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/726/summary/evidence/4646/summary#evidence",
		"source": "civic",
		"description": "In stage IV lung adenocarcinoma patients (n=2) harboring EGFR inframe exon 20 insertion mutation, EGFR exon 20 insertion was associated with progressive disease after 1 and 3 months of erlotinib monotherapy, respectively; both patients were previously treated with standard chemotherapy.",
		"drug_labels": "Erlotinib",
		"variant_name": "INSERTION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/726/summary",
		"evidence_label": "C",
		"response_type": "resistant",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/449",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/487"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/487",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22895145"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4646",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/487"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/286",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/487"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/488",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/319",
			"name": "EXON 20 INSERTION",
			"description": "EGFR EXON 20 INSERTION",
			"biomarker_type": "Inframe Insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55248991,
			"end_pos": 55249022,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/726/summary/evidence/4650/summary#evidence",
		"source": "civic",
		"description": "In stage IV lung adenocarcinoma patients (n=2) harboring EGFR inframe exon 20 insertion mutation, EGFR exon 20 insertion was associated with progressive disease after 1 and 3 months of erlotinib monotherapy, respectively; both patients were previously treated with standard chemotherapy.",
		"drug_labels": "Erlotinib",
		"variant_name": "INSERTION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/726/summary",
		"evidence_label": "C",
		"response_type": "resistant",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/450",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/488"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/488",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22895145"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4650",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/488"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/287",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/488"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/489",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/319",
			"name": "EXON 20 INSERTION",
			"description": "EGFR EXON 20 INSERTION",
			"biomarker_type": "Inframe Insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55248991,
			"end_pos": 55249022,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/726/summary/evidence/1809/summary#evidence",
		"source": "civic",
		"description": "In retrospective analysis of trials, afatinib conferred limited clinical benefit to patients with EGFR exon 20 insertion mutations (N=23). Only 2 patients had objective responses.",
		"drug_labels": "AFATINIB",
		"variant_name": "INSERTION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/726/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/451",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/489"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/489",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26051236"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1809",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/489"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/288",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/489"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/490",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/319",
			"name": "EXON 20 INSERTION",
			"description": "EGFR EXON 20 INSERTION",
			"biomarker_type": "Inframe Insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55248991,
			"end_pos": 55249022,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/726/summary/evidence/1789/summary#evidence",
		"source": "civic",
		"description": "In retrospective analysis of clinical trials and case studies, most patients with EGFR exon 20 insertion mutations did not benefit from first-generation EGFR kinase inhibitors.",
		"drug_labels": "Erlotinib",
		"variant_name": "INSERTION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/726/summary",
		"evidence_label": "C",
		"response_type": "resistant",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/452",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/490"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/490",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26773740"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1789",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/490"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/289",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/490"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/491",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/320",
			"name": "L747_S752INSQ",
			"description": "EGFR L747_S752INSQ",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1580/summary/evidence/4667/summary#evidence",
		"source": "civic",
		"description": "In adenocarcinoma of the bronchioloalveolar carcinoma patients with EGFR L747_S752insQ, EGFR L747_S752insQ mutation was associated with favorable overall survival (greater than 8 months), as compared to patients without EGFR exon 18-24 mutations who did not achieve a partial response. Partial response was significant in patients with EGFR exon 18-24 mutations (n=7; P=0.003) as compared to patients without EGFR exon 18-24 mutations (n=10).",
		"drug_labels": "Erlotinib",
		"variant_name": "L747_S752INSQ",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1580/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/453",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/491"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/491",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15329413"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4667",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/491"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/290",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/491"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/492",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/321",
			"name": "E 709A and G719C",
			"description": "EGFR E 709A and G719C",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": null,
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/2258/summary/evidence/6039/summary#evidence",
		"source": "civic",
		"description": "The E709A+G719C double mutation was found in an 80-year-old female never smoker with advanced adenocarcinoma of the lung with acinar and BAC characteristics.\nErlotinib was given at the starting dose of 150 mg daily, reduced to 100 and 75 mg due to G3 skin toxicity. The tumor assessment, performed 2 months after the beginning of the treatment, showed a partial response (PR), still maintained after 10 months.",
		"drug_labels": "Erlotinib",
		"variant_name": "G719C",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/2258/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/454",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/492"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/492",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21841502"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6039",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/492"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/291",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/492"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/493",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/322",
			"name": "V774M",
			"description": "EGFR V774M",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "",
			"chromosome": "7",
			"start_pos": 55249022,
			"end_pos": 55249022,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55249022G>A",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"567477136"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249022G>A?assembly=hg19",
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1894/summary/evidence/4231/summary#evidence",
		"source": "civic",
		"description": "In a study, 1 participant with stage IV squamous cell lung carcinoma was sequenced at EGFR exons 18 to 21 and was found to have V774M mutation, and was treated with the 1st generation TKI erlotinib. The patient (M, 80, smoker) had progressive disease as response, progression free survival (PFS) of 1.6 months, overall survival (OS) of 6.7 months and was not alive at study end. As a whole, patients with uncommon EGFR mutations had a response rate of 47.5%, which was between common (del19 and L858R) at 74.1%, and wild type EGFR at 16.5%. Median PFS and OS (months) for the three groups: 5.0 and 15.0 uncommon, 8.5 and 19.6 common, 2.0 and 10.4 wild type.",
		"drug_labels": "Erlotinib",
		"variant_name": "V774M",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1894/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/455",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/493"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/493",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21531810"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4231",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/493"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/292",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/493"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/494",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/323",
			"name": "V851I",
			"description": "EGFR V851I",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55259493,
			"end_pos": 55259493,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55259493G>A",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259493G>A?assembly=hg19",
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1466/summary/evidence/4264/summary#evidence",
		"source": "civic",
		"description": "In a study of 1261 non-small cell lung cancer patients, 49.8% of the analyzed tumors had EGFR mutations including deletions in exon 19 (n=258), L858R (n=260), T790M (n=6) and insertions or duplications in exon 20 (n=25). Patients with EGFR deletions in exon 19 or L858R mutations were associated with an improved response to erlotinib or gefitinib with partial or complete response (74.1% vs. 16.5%, P<0.001) when compared to wildtype EGFR patients. Additionally, tumors with EGFR mutations in L858R or deletions in exon 19 were associated with increased overall survival (19.6mo vs. 10.4mo) compared to wildtype (all patients were treated with either erlotinib or gefitinib).",
		"drug_labels": "Erlotinib",
		"variant_name": "V851I",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1466/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/456",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/494"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/494",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21531810"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4264",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/494"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/293",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/494"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/495",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/262",
			"name": "S492R",
			"description": "EGFR S492R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55228007,
			"end_pos": 55228007,
			"ref": "A",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.55228007A>C",
			"hgvs_c": "NM_005228.3:c.1474A>C",
			"hgvs_p": "NP_005219.2:p.Ser492Arg",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55228007A>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/453/summary/evidence/1080/summary#evidence",
		"source": "civic",
		"description": "In this preclinical study of the effects of cetuximab, panitumumab or sym004 on various EGFR mutations in colorectal cancer. The S492R mutation was sensitive to Sym004 and panitumumab treatment but resistant to cetuximab. Experiments include flow cytometry binding assay, kinase phosphorylation, cell viability, downstream signalling.",
		"drug_labels": "CETUXIMAB",
		"variant_name": "S492R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/453/summary",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/457",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/495"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/495",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26888827"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1080",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/495"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/294",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/495"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/496",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/262",
			"name": "S492R",
			"description": "EGFR S492R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55228007,
			"end_pos": 55228007,
			"ref": "A",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.55228007A>C",
			"hgvs_c": "NM_005228.3:c.1474A>C",
			"hgvs_p": "NP_005219.2:p.Ser492Arg",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55228007A>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/453/summary/evidence/1078/summary#evidence",
		"source": "civic",
		"description": "Tumor sequencing in pre- and post-therapy specimens from ten individuals with mCRC who experienced disease progression after a prior response to cetuximab with chemotherapy was performed. The S492R mutation was identified in two persons. One of them had already died, the other received treatment with panitumumab and had a partial response (50% tumor reduction in all liver lesions) for 5 months.",
		"drug_labels": "PANITUMUMAB",
		"variant_name": "S492R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/453/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/458",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/496"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/496",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22270724"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1078",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/496"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/295",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "PANITUMUMAB",
				"envcontext_id": "CHEMBL1201827",
				"usan_stem": "monoclonal antibodies",
				"description": "PANITUMUMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/496"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/497",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/262",
			"name": "S492R",
			"description": "EGFR S492R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55228007,
			"end_pos": 55228007,
			"ref": "A",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.55228007A>C",
			"hgvs_c": "NM_005228.3:c.1474A>C",
			"hgvs_p": "NP_005219.2:p.Ser492Arg",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55228007A>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/453/summary/evidence/717/summary#evidence",
		"source": "civic",
		"description": "In-vitro studies found this mutation to confer resistance to cetuximab. 2 of 10 patients studied also harbored EGFR S492R and were resistant to cetuximab therapy. Panitumumab was still active in-vitro and in one patient.",
		"drug_labels": "CETUXIMAB",
		"variant_name": "S492R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/453/summary",
		"evidence_label": "C",
		"response_type": "resistant",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/459",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/497"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/497",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22270724"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "717",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/497"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/296",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/497"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/498",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/262",
			"name": "S492R",
			"description": "EGFR S492R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55228007,
			"end_pos": 55228007,
			"ref": "A",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.55228007A>C",
			"hgvs_c": "NM_005228.3:c.1474A>C",
			"hgvs_p": "NP_005219.2:p.Ser492Arg",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55228007A>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/453/summary/evidence/1079/summary#evidence",
		"source": "civic",
		"description": "In this preclinical study of cetuximab, panitumumab or sym004 on various EGFR mutations in colorectal cancer. The S492R mutation was sensitive to Sym004 and panitumumab treatment but resistant to cetuximab. Experiments include flow cytometry binding assay, kinase phosphorylation, cell viability, downstream signalling.",
		"drug_labels": "PANITUMUMAB",
		"variant_name": "S492R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/453/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/460",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/498"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/498",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26888827"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1079",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/498"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/297",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "PANITUMUMAB",
				"envcontext_id": "CHEMBL1201827",
				"usan_stem": "monoclonal antibodies",
				"description": "PANITUMUMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/498"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/499",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/324",
			"name": "H773_V774insNPH",
			"description": "EGFR H773_V774insNPH",
			"biomarker_type": "Inframe Insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55249012,
			"end_pos": 55249013,
			"ref": null,
			"alt": "AACCCCCAC",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1513/summary/evidence/4493/summary#evidence",
		"source": "civic",
		"description": "In a lung adenocarcinoma patient harboring EGFR H773_V774insNPH mutation, EGFR H773_V774insNPH was associated with progressive disease in response to erlotinib monotherapy.",
		"drug_labels": "Erlotinib",
		"variant_name": "H773_V774insNPH",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1513/summary",
		"evidence_label": "C",
		"response_type": "resistant",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/461",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/499"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/499",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4493",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/499"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/298",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/499"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/500",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/221",
			"name": "K467T",
			"description": "EGFR K467T",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55227933,
			"end_pos": 55227933,
			"ref": "A",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.55227933A>C",
			"hgvs_c": "NM_005228.3:c.1400A>C",
			"hgvs_p": "NP_005219.2:p.Lys467Thr",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55227933A>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/455/summary/evidence/1082/summary#evidence",
		"source": "civic",
		"description": "In this preclinical study on the effects of cetuximab, panitumumab or sym004 on various EGFR mutations in colorectal cancer. In NIH3T3 cells expressing EGFR with a K467T mutation, Sym004 and panitumumab bound the mutated receptor and inhibited EGFR phosphorylation in the presence of ligand while cetuximab neither bound to nor inhibited EGFR phosphorylation of the mutated receptor.",
		"drug_labels": "PANITUMUMAB",
		"variant_name": "K467T",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/455/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/462",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/500"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/500",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26888827"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1082",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/500"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/299",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "PANITUMUMAB",
				"envcontext_id": "CHEMBL1201827",
				"usan_stem": "monoclonal antibodies",
				"description": "PANITUMUMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/500"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/501",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/221",
			"name": "K467T",
			"description": "EGFR K467T",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55227933,
			"end_pos": 55227933,
			"ref": "A",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.55227933A>C",
			"hgvs_c": "NM_005228.3:c.1400A>C",
			"hgvs_p": "NP_005219.2:p.Lys467Thr",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55227933A>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/455/summary/evidence/1083/summary#evidence",
		"source": "civic",
		"description": "In this preclinical study on the effects of cetuximab, panitumumab or sym004 on various EGFR mutations in colorectal cancer. In NIH3T3 cells expressing EGFR with a K467T mutation, Sym004 and panitumumab bound the mutated receptor and inhibited EGFR phosphorylation in the presence of ligand while cetuximab neither bound to nor inhibited EGFR phosphorylation of the mutated receptor.",
		"drug_labels": "CETUXIMAB",
		"variant_name": "K467T",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/455/summary",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/463",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/501"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/501",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26888827"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1083",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/501"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/300",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/501"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/502",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/325",
			"name": "G719D",
			"description": "EGFR G719D",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55241708,
			"end_pos": 55241708,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55241708G>A",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"121913428"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55241708G>A?assembly=hg19",
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1420/summary/evidence/4210/summary#evidence",
		"source": "civic",
		"description": "In a study, 2 participants with stage IV lung adenocarcinoma were sequenced at EGFR exons 18 to 21. Both patients were found to have G719D mutation and were treated with the 1st generation TKIs gefitinib or erlotinib. The first patient (M, 81, smoker) was treated with gefitinib and had a partial response, progression free survival (PFS) of 21.7 months, overall survival (OS) of 22.5 months and was alive at study end. The second patient (M, 76, smoker) was treated with erlotinib and had stable disease as response, PFS of 2.6 months, OS of 2.6 months and was alive at study end. As a whole, patients with uncommon EGFR mutations had a response rate of 47.5%, which was between common (del19 and L858R) at 74.1%, and wild type EGFR at 16.5%. Median PFS and OS (months) for the three groups: 5.0 and 15.0 uncommon, 8.5 and 19.6 common, 2.0 and 10.4 wild type.",
		"drug_labels": "GEFITINIB,Erlotinib",
		"variant_name": "G719D",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1420/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/464",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/502"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/502",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21531810"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4210",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/502"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/302",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/502"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/301",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/502"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/503",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/252",
			"name": "P848L",
			"description": "EGFR P848L",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259485,
			"end_pos": 55259485,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55259485C>T",
			"hgvs_c": "NM_005228.3:c.2543C>T",
			"hgvs_p": "NP_005219.2:p.Pro848Leu",
			"dbsnp_ids": [
				"148934350"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259485C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1465/summary/evidence/4281/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a MCF-7 cell line expressing EGFR P848L demonstrated reduced sensitivity to erlotinib treatment compared to MCF-7 cells expressing EGFR L858R (a known sensitizing mutation to EGFR tyrosine kinase inhibitors). Sensitivity was determined by assessing AKT phosphorylation.",
		"drug_labels": "Erlotinib",
		"variant_name": "P848L",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1465/summary",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/465",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/503"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/503",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/17877814"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4281",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/503"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/303",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/503"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/504",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/326",
			"name": "V769A",
			"description": "EGFR V769A",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55249008,
			"end_pos": 55249008,
			"ref": "T",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.55249008T>C",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249008T>C?assembly=hg19",
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1578/summary/evidence/4664/summary#evidence",
		"source": "civic",
		"description": "In an advanced lung adenocarcinoma patient with EGFR V769A mutation, EGFR V769A was reported to be sensitive to erlotinib treatment. The patient was treated with 1st-line standard chemotherapy, radiotherapy, 2nd-line standard chemotherapy, and subsequently 3rd-line erlotinib monotherapy at which time the patient achieved a partial response per RECIST 1.0 criteria and a 9 month progression free survival.",
		"drug_labels": "Erlotinib",
		"variant_name": "V769A",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1578/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/466",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/504"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/504",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24908064"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4664",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/504"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/304",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/504"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/505",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/327",
			"name": "A702S",
			"description": "EGFR A702S",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55241656,
			"end_pos": 55241656,
			"ref": "G",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55241656G>T",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55241656G>T?assembly=hg19",
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/2255/summary/evidence/6035/summary#evidence",
		"source": "civic",
		"description": "A total of 106 Chinese NSCLC patients who had failed at least one chemotherapy regimen received gefitinib 250 mg once daily. Patients with EGFR mutations had a significantly higher overall response rate (ORR), longer time to progression (TTP) and overall survival (OS) compared with those with wild-type receptor. Patient with A702S mutation add a partial response.",
		"drug_labels": "GEFITINIB",
		"variant_name": "A702S",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/2255/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/467",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/505"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/505",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19020901"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6035",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/505"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/305",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/505"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/506",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/142",
			"name": "L858R",
			"description": "EGFR L858R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259515T>G",
			"hgvs_c": "NM_005228.3:c.2573T>G",
			"hgvs_p": "NP_005219.2:p.Leu858Arg",
			"dbsnp_ids": [
				"121434568"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/33/summary/evidence/229/summary#evidence",
		"source": "civic",
		"description": "There is no statistical difference in progression free survival between lung cancer patients treated with gefitinib or erlotinib with EGFR L858R mutations (N=72/242; univariate: P=0.283; multivariate: P=0.250) compared to patients with Exon 19 mutations (N=170).",
		"drug_labels": "GEFITINIB,Erlotinib",
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/33/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/468",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/506"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/506",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24736073"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "229",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/506"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/307",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/506"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/306",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/506"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/507",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/142",
			"name": "L858R",
			"description": "EGFR L858R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259515T>G",
			"hgvs_c": "NM_005228.3:c.2573T>G",
			"hgvs_p": "NP_005219.2:p.Leu858Arg",
			"dbsnp_ids": [
				"121434568"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/33/summary/evidence/276/summary#evidence",
		"source": "civic",
		"description": "Gefinitib has been shown to be effective in treating cell lines with L858R missense mutations.",
		"drug_labels": "GEFITINIB",
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/33/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/469",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/507"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/507",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15118125"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "276",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/507"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/308",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/507"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/508",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/142",
			"name": "L858R",
			"description": "EGFR L858R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259515T>G",
			"hgvs_c": "NM_005228.3:c.2573T>G",
			"hgvs_p": "NP_005219.2:p.Leu858Arg",
			"dbsnp_ids": [
				"121434568"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/33/summary/evidence/879/summary#evidence",
		"source": "civic",
		"description": "A phase III clinical trial (NCT00949650) found that median progression free survival among patients with exon 19 deletions or L858R EGFR mutations (n = 308) was 13.6 months for afatinib and 6.9 months for chemotherapy (HR, 0.47; 95% CI, 0.34 to 0.65; P = 0.001).",
		"drug_labels": "AFATINIB",
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/33/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/470",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/508"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/508",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23816960"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "879",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/508"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/309",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/508"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/509",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/142",
			"name": "L858R",
			"description": "EGFR L858R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259515T>G",
			"hgvs_c": "NM_005228.3:c.2573T>G",
			"hgvs_p": "NP_005219.2:p.Leu858Arg",
			"dbsnp_ids": [
				"121434568"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/33/summary/evidence/883/summary#evidence",
		"source": "civic",
		"description": "In a phase 2 study of patients with lung adenocarcinoma (stage IIIb with pleural effusion or stage IV) and EGFR mutations, treated with afatinib were assessed by objective response. 129 patients were treated with afatinib. 66% of the 106 patients with two common activating EGFR mutations (deletion 19 or L858R) had an objective response compared to 39% of 23 patients with less common mutations.",
		"drug_labels": "AFATINIB",
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/33/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/471",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/509"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/509",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22452895"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "883",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/509"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/310",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/509"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/510",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/142",
			"name": "L858R",
			"description": "EGFR L858R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259515T>G",
			"hgvs_c": "NM_005228.3:c.2573T>G",
			"hgvs_p": "NP_005219.2:p.Leu858Arg",
			"dbsnp_ids": [
				"121434568"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/33/summary/evidence/885/summary#evidence",
		"source": "civic",
		"description": "A randomized phase 3 trial (NCT00446225) involving 173 NSCLC patients with EGFR mutations (exon 19 deletion or L858R mutation in exon 21) with no history of chemotherapy for metastatic disease. Patients were randomly allocated (1:1) to receive either erlotinib or standard chemotherapy. The primary endpoint was progression-free survival (PFS). Median PFS was 9.7 months in the erlotinib group, compared with 5.2 months in the standard chemotherapy group.",
		"drug_labels": "Erlotinib",
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/33/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/472",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/510"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/510",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22285168"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "885",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/510"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/311",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/510"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/511",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/142",
			"name": "L858R",
			"description": "EGFR L858R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259515T>G",
			"hgvs_c": "NM_005228.3:c.2573T>G",
			"hgvs_p": "NP_005219.2:p.Leu858Arg",
			"dbsnp_ids": [
				"121434568"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/33/summary/evidence/968/summary#evidence",
		"source": "civic",
		"description": "Cells harboring L858R were sensitive to afatinib. This study performed drug response assays using five human NSCLC cell lines with various combinations of EGFR mutations. In order to directly compare the sensitivity of multiple EGFR mutations to EGFR-TKIs the authors also generated multiple EGFR transduced Ba/F3 stable cell lines and evaluated sensitivity to EGFR-TKIs by MTS assay.",
		"drug_labels": "AFATINIB",
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/33/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/473",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/511"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/511",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26515464"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "968",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/511"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/312",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/511"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/512",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/142",
			"name": "L858R",
			"description": "EGFR L858R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259515T>G",
			"hgvs_c": "NM_005228.3:c.2573T>G",
			"hgvs_p": "NP_005219.2:p.Leu858Arg",
			"dbsnp_ids": [
				"121434568"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/33/summary/evidence/982/summary#evidence",
		"source": "civic",
		"description": "Afatinib is an irreversible covalent inhibitor of EGFR (second generation). This Phase III clinical trial (LUX-Lung 6; NCT01121393) was performed in Asian patients with EGFR mutant advanced NSCLC. 364 eligible patients with EGFR mutations were assigned to afatinib (n=242) or gemcitabine and cisplatin (n=122) treatment. The trial observed significantly longer median progression-free survival with afatinib vs. gemcitabine and cisplatin treatment (11.0 vs. 5.6 months). Afatinib/Chemotherapy group compositions: 51.2/50.8 % del 19; 38/37.7 % Leu858Arg; 10.8/11.5 % Uncommon.",
		"drug_labels": "AFATINIB",
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/33/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/474",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/512"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/512",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24439929"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "982",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/512"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/313",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/512"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/513",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/142",
			"name": "L858R",
			"description": "EGFR L858R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259515T>G",
			"hgvs_c": "NM_005228.3:c.2573T>G",
			"hgvs_p": "NP_005219.2:p.Leu858Arg",
			"dbsnp_ids": [
				"121434568"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/33/summary/evidence/275/summary#evidence",
		"source": "civic",
		"description": "In NSCLC patients treated with EGFR tyrosine kinase inhibitors, the presence of L858R mutation is prognostic for better progression free survival.",
		"drug_labels": "GEFITINIB,Erlotinib",
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/33/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/475",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/513"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/513",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24457318"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "275",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/513"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/315",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/513"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/314",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/513"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/514",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/142",
			"name": "L858R",
			"description": "EGFR L858R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259515T>G",
			"hgvs_c": "NM_005228.3:c.2573T>G",
			"hgvs_p": "NP_005219.2:p.Leu858Arg",
			"dbsnp_ids": [
				"121434568"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/33/summary/evidence/1665/summary#evidence",
		"source": "civic",
		"description": "90 NSCLC patients with stage IIIB/IV chemotherapy-resistant tumors were  treated with gefitinib, and the L858R EGFR mutation was associated with longer time to treatment failure than those with wild-type EGFR(median 9.1 versus 2.1). In multivariate analysis, L858R mutations plus adenocarcinoma was a significant predictive factor for TTF (HR = 0.1030; P = .0004).",
		"drug_labels": "GEFITINIB",
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/33/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/476",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/514"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/514",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/18509184"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1665",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/514"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/316",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/514"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/515",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/142",
			"name": "L858R",
			"description": "EGFR L858R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259515T>G",
			"hgvs_c": "NM_005228.3:c.2573T>G",
			"hgvs_p": "NP_005219.2:p.Leu858Arg",
			"dbsnp_ids": [
				"121434568"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/33/summary/evidence/2621/summary#evidence",
		"source": "civic",
		"description": "In a phase 3 clinical trial of non-small cell lung cancer (NSCLC) patients, a subset of patients with EGFR mutations (n=44) treated with gefitinib were associated with improved progression free survival (HR: 0.16, 95% CI: 0.05-0.49, P=0.001), and a higher objective response rate (ORR: 42.1% vs 21.1%, p=0.04) compared to patients treated with docetaxel. Of the 44 patients, 22 had an exon 19 deletion, 16 had an L858R mutation, one patient had an exon 20 T790M mutation, two had an exon G719A mutation and four had other mutations.",
		"drug_labels": "GEFITINIB",
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/33/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/477",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/515"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/515",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20038723"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2621",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/515"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/317",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/515"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/516",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/142",
			"name": "L858R",
			"description": "EGFR L858R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259515T>G",
			"hgvs_c": "NM_005228.3:c.2573T>G",
			"hgvs_p": "NP_005219.2:p.Leu858Arg",
			"dbsnp_ids": [
				"121434568"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/33/summary/evidence/2623/summary#evidence",
		"source": "civic",
		"description": "In a phase 3 clinical trial of Japanese NSCLC patients with EGFR mutations (n=230), patients treated with gefitinib were associated with improved progression free survival (10.8 months vs 5.4 months, HR: 0.30, 95% CI: 0.22-0.41, P<0.001), compared to patients treated with carboplatin and paclitaxel combination therapy. The frequency of mutation of exon 19 deletion and L858R was 25.2% (58/230) and 21.3% (49/230), respectively.",
		"drug_labels": "GEFITINIB",
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/33/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/478",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/516"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/516",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20573926"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2623",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/516"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/318",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/516"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/517",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/142",
			"name": "L858R",
			"description": "EGFR L858R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259515T>G",
			"hgvs_c": "NM_005228.3:c.2573T>G",
			"hgvs_p": "NP_005219.2:p.Leu858Arg",
			"dbsnp_ids": [
				"121434568"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/33/summary/evidence/2624/summary#evidence",
		"source": "civic",
		"description": "Mutational profiling was performed on EGFR exons 18-24 from a group of 10 retrospectively chosen patients who had shown partial response or clinical improvement in response to gefitinib. Of 7 tumors with EGFR mutations, 1 was L858R. The patient was a female former smoker who had lung adenocarcinoma histology, and demonstrated response for 5 months, with overall survival 8 months.",
		"drug_labels": "GEFITINIB",
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/33/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/479",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/517"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/517",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15329413"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2624",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/517"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/319",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/517"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/518",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/142",
			"name": "L858R",
			"description": "EGFR L858R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259515T>G",
			"hgvs_c": "NM_005228.3:c.2573T>G",
			"hgvs_p": "NP_005219.2:p.Leu858Arg",
			"dbsnp_ids": [
				"121434568"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/33/summary/evidence/2625/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study using PC9 cells (EGFR exon 19 deletion), inhibition of cell viability was used as an assay to determine sensitivity to EGFR tyrosine kinase inhibitors. PC9 cells demonstrated an increased sensitivity to gefitinib  (IC50: 23.0 nmol/L vs 200.0 nmol/L) compared to NCI-H2073 cells (EGFR wild type).",
		"drug_labels": "GEFITINIB",
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/33/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/480",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/518"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/518",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24893891"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2625",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/518"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/320",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/518"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/519",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/142",
			"name": "L858R",
			"description": "EGFR L858R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259515T>G",
			"hgvs_c": "NM_005228.3:c.2573T>G",
			"hgvs_p": "NP_005219.2:p.Leu858Arg",
			"dbsnp_ids": [
				"121434568"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/33/summary/evidence/2626/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study using NCI-H1666 cells (wildtype EGFR) and NCI-H3255 cells (EGFR-L858R), inhibition of cell growth was used as an assay to determine sensitivity to reversible tyrosine kinase inhibitor drugs. Cells with an EGFR L858R mutation demonstrated an improved response to lapatinib (IC50: 63nM vs. 534nM) compared to wildtype EGFR cells.",
		"drug_labels": "Lapatinib",
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/33/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/481",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/519"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/519",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/18408761"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2626",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/519"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/321",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Lapatinib",
				"envcontext_id": "208908",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Lapatinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/519"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/520",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/142",
			"name": "L858R",
			"description": "EGFR L858R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259515T>G",
			"hgvs_c": "NM_005228.3:c.2573T>G",
			"hgvs_p": "NP_005219.2:p.Leu858Arg",
			"dbsnp_ids": [
				"121434568"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/33/summary/evidence/2627/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study using NCI-H322 cells (wildtype EGFR) and NCI-H3255 cells (EGFR-L858R), inhibition of cell growth was used as an assay to determine sensitivity to irreversible tyrosine kinase inhibitor (TKI) drugs. Cells with an EGFR L858R mutation demonstrated an improved response to PF 00299804  (IC50: 0.007umol/L vs. >10umol/L) compared to wildtype EGFR cells or compared to reversible TKI drug gefitinib (IC50: 0.075umol/L vs. wild-type >10umol/L).",
		"drug_labels": "DACOMITINIB",
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/33/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/482",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/520"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/520",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/18089823"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2627",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/520"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/322",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "DACOMITINIB",
				"envcontext_id": "CHEMBL2105719",
				"usan_stem": null,
				"description": "DACOMITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/520"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/521",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/142",
			"name": "L858R",
			"description": "EGFR L858R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259515T>G",
			"hgvs_c": "NM_005228.3:c.2573T>G",
			"hgvs_p": "NP_005219.2:p.Leu858Arg",
			"dbsnp_ids": [
				"121434568"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/33/summary/evidence/2628/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study using NCI-H1781 cells (EGFR wild-type) and NCI-H3255 cells (EGFR L858R), inhibition of cell growth was used as an assay to determine sensitivity to irreversible tyrosine kinase inhibitor (TKI) drugs. Cells with an EGFR L858R mutation demonstrated an improved response to neratinib (IC50: 0.0049umol/L vs. 0.085umol/L) compared to wildtype EGFR cells or compared to reversible TKI drug erlotinib (IC50: 0.031umol/L vs. wildtype >1umol/L).",
		"drug_labels": "NERATINIB",
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/33/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/483",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/521"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/521",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/16818618"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2628",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/521"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/323",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "NERATINIB",
				"envcontext_id": "9915743",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "NERATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/521"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/522",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/142",
			"name": "L858R",
			"description": "EGFR L858R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259515T>G",
			"hgvs_c": "NM_005228.3:c.2573T>G",
			"hgvs_p": "NP_005219.2:p.Leu858Arg",
			"dbsnp_ids": [
				"121434568"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/33/summary/evidence/2629/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study using NCI-H1666 cells (wildtype EGFR) and NCI-H3255 cells (EGFR-L858R), inhibition of cell growth was used as an assay to determine sensitivity to irreversible tyrosine kinase inhibitor (TKI) drugs. Cells with an EGFR L858R mutation demonstrated an improved response to afatinib (IC50: 0.7nM vs. 60nM) compared to wildtype EGFR cells.",
		"drug_labels": "AFATINIB",
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/33/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/484",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/522"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/522",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/18408761"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2629",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/522"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/324",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/522"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/523",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/142",
			"name": "L858R",
			"description": "EGFR L858R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259515T>G",
			"hgvs_c": "NM_005228.3:c.2573T>G",
			"hgvs_p": "NP_005219.2:p.Leu858Arg",
			"dbsnp_ids": [
				"121434568"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/33/summary/evidence/2630/summary#evidence",
		"source": "civic",
		"description": "In a phase 2b/3 study of 585 stage IIIB-IV lung adenocarcinoma patients who had a previous round of EGFR-TKI treatment, archival material was available for 141 patients. EGFR mutational analysis revealed that 96 tumors had an EGFR mutation, of which 76 (79%) were positive for either L858R or a deletion in exon 19. These mutations were associated with improved progression-free survival (median 3.3 months  vs 1.0 month ; HR:0.51, 95% CI:0.31-0.85, P<0.009) compared to placebo control.",
		"drug_labels": "AFATINIB",
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/33/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/485",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/523"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/523",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22452896"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2630",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/523"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/325",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/523"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/524",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/142",
			"name": "L858R",
			"description": "EGFR L858R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259515T>G",
			"hgvs_c": "NM_005228.3:c.2573T>G",
			"hgvs_p": "NP_005219.2:p.Leu858Arg",
			"dbsnp_ids": [
				"121434568"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/33/summary/evidence/2631/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study using NCI-H1666 cells (wildtype EGFR) and NCI-H3255 cells (EGFR-L858R), inhibition of cell growth was used as an assay to determine sensitivity to irreversible tyrosine kinase inhibitor (TKI) drugs. Cells with an EGFR L858R mutation demonstrated an improved response to canertinib (IC50: 1nM vs. 198nM) compared to wildtype EGFR cells.",
		"drug_labels": "CANERTINIB",
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/33/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/486",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/524"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/524",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/18408761"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2631",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/524"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/326",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "CANERTINIB",
				"envcontext_id": "156414",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "CANERTINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/524"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/525",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/142",
			"name": "L858R",
			"description": "EGFR L858R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259515T>G",
			"hgvs_c": "NM_005228.3:c.2573T>G",
			"hgvs_p": "NP_005219.2:p.Leu858Arg",
			"dbsnp_ids": [
				"121434568"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/33/summary/evidence/2633/summary#evidence",
		"source": "civic",
		"description": "EGFR L858R mutation has been associated with increased sensitivity to first generation EGFR tyrosine kinase inhibitors, including erlotinib and gefitinib.In an in vitro study using PC9 cells (EGFR L858R mutation), inhibition of EGFR phosphorylation was used as an assay to determine sensitivity to EGFR tyrosine kinase inhibitors. PC9 cells demonstrated an increased sensitivity to gefitinib  (IC50: 11.0-12.0 nmol/L vs 61.0 nmol/L) compared to NCI-H2073 cells (EGFR wild type).",
		"drug_labels": "Durvalumab",
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/33/summary",
		"evidence_label": "D",
		"response_type": null,
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/487",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/525"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/525",
				"type": "Predictive",
				"description": null,
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24893891"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2633",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/525"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/327",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/substance",
				"term": "Durvalumab",
				"envcontext_id": "SID249565666",
				"usan_stem": null,
				"description": "Durvalumab",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/525"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/526",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/142",
			"name": "L858R",
			"description": "EGFR L858R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259515T>G",
			"hgvs_c": "NM_005228.3:c.2573T>G",
			"hgvs_p": "NP_005219.2:p.Leu858Arg",
			"dbsnp_ids": [
				"121434568"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/33/summary/evidence/2634/summary#evidence",
		"source": "civic",
		"description": "In a phase 3 clinical trial of Korean, never-smoker, lung adenocarcinoma patients, a subset of patients with EGFR mutations (n=42) treated with gefitinib were associated with improved overall response rate compared to gemcitabine plus cisplatin treatment (84.6%, 22/26, vs. 37.5%, 6/16, P=0.002). By contrast, in EGFR mutation negative cases, the response rate was much lower (25.9%, 7/27). The frequency of mutation in exon 19 deletion and L858R was 64.3% (27/42) and 36.4% (16/42), respectively. Exon 19 and L858R mutations were mutually exclusive in this cohort.",
		"drug_labels": "GEFITINIB",
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/33/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/488",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/526"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/526",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22370314"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2634",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/526"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/328",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/526"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/527",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/142",
			"name": "L858R",
			"description": "EGFR L858R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259515T>G",
			"hgvs_c": "NM_005228.3:c.2573T>G",
			"hgvs_p": "NP_005219.2:p.Leu858Arg",
			"dbsnp_ids": [
				"121434568"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/33/summary/evidence/4265/summary#evidence",
		"source": "civic",
		"description": "MCF-7 cells were transduced with YFP tagged EGFR with E746_A750delELREA mutation, or YFP EGFR wildtype, and stained for ectopic YFP EGFR and phospho-Akt as a readout for EGFR pathway activity. Increased p-Akt stain was seen with ectopic mutant EGFR over wildtype cells. Parallel erlotinib incubations of cells with wildtype EGFR induced recompartmentalization of ectopic EGFR protien only at high concentration (10uM). Addition of erlotinib to mutant EGFR cell incubations reduced p-Akt signal and induced recompartmentalization of ectopic EGFR protien at considerably lower conecntration (100 nM) erlotinib.  These results indicate the EGFR L858R variant as a growth pathway driver targetable by erlotinib.",
		"drug_labels": "Erlotinib",
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/33/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/489",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/527"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/527",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/17877814"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4265",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/527"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/329",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/527"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/528",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/142",
			"name": "L858R",
			"description": "EGFR L858R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259515T>G",
			"hgvs_c": "NM_005228.3:c.2573T>G",
			"hgvs_p": "NP_005219.2:p.Leu858Arg",
			"dbsnp_ids": [
				"121434568"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/33/summary/evidence/4284/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study using NCI-H1666 cells (wildtype EGFR) and NCI-H3255 cells (EGFR-L858R), inhibition of cell growth was used as an assay to determine sensitivity to reversible tyrosine kinase inhibitor drugs. Cells with an EGFR L858R mutation demonstrated an improved response to erlotinib (IC50: 40nM vs. 110nM) compared to EGFR wild type cells.",
		"drug_labels": "Erlotinib",
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/33/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/490",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/528"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/528",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/18408761"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4284",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/528"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/330",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/528"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/529",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/142",
			"name": "L858R",
			"description": "EGFR L858R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259515T>G",
			"hgvs_c": "NM_005228.3:c.2573T>G",
			"hgvs_p": "NP_005219.2:p.Leu858Arg",
			"dbsnp_ids": [
				"121434568"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/33/summary/evidence/4285/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a MCF-7 cell line expressing EGFR L858R mutation demonstrated sensitivity to erlotinib treatment, compared to MCF-7 cells expressing EGFR wild-type. Sensitivity was determined by assessing YFP signal-EGFR relocation.",
		"drug_labels": "Erlotinib",
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/33/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/491",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/529"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/529",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21132006"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4285",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/529"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/331",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/529"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/530",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/142",
			"name": "L858R",
			"description": "EGFR L858R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259515T>G",
			"hgvs_c": "NM_005228.3:c.2573T>G",
			"hgvs_p": "NP_005219.2:p.Leu858Arg",
			"dbsnp_ids": [
				"121434568"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/33/summary/evidence/4286/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, Ba/F3 and NCI-H3255 cell lines expressing EGFR L858R demonstrated increased sensitivity to erlotinib treatment (IC50=0.006�M). Sensitivity was determined by assessing cell proliferation, EGFR, AKT and ERK phosphorylation, levels of BIM (a marker of EGFR TKI-induced cell killing) and cell viability.",
		"drug_labels": "Erlotinib",
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/33/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/492",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/530"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/530",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4286",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/530"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/332",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/530"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/531",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/142",
			"name": "L858R",
			"description": "EGFR L858R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259515T>G",
			"hgvs_c": "NM_005228.3:c.2573T>G",
			"hgvs_p": "NP_005219.2:p.Leu858Arg",
			"dbsnp_ids": [
				"121434568"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/33/summary/evidence/4287/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, CHO and NCI-H3255 cells expressing EGFR L858R mutation were associated with sensitivity to erlotinib treatment. Sensitivity was determined by assessing cell density.",
		"drug_labels": "Erlotinib",
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/33/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/493",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/531"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/531",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27612423"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4287",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/531"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/333",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/531"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/532",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/142",
			"name": "L858R",
			"description": "EGFR L858R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259515T>G",
			"hgvs_c": "NM_005228.3:c.2573T>G",
			"hgvs_p": "NP_005219.2:p.Leu858Arg",
			"dbsnp_ids": [
				"121434568"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/33/summary/evidence/4288/summary#evidence",
		"source": "civic",
		"description": "In a non-small cell lung cancer patient with an EGFR L858R mutation, EGFR L858R was reported to be refractory to 61-day crizotinib treatment.",
		"drug_labels": "CRIZOTINIB",
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/33/summary",
		"evidence_label": "C",
		"response_type": "resistant",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/494",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/532"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/532",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22235099"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4288",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/532"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/334",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "CRIZOTINIB",
				"envcontext_id": "11626560",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "CRIZOTINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/532"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/533",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/142",
			"name": "L858R",
			"description": "EGFR L858R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259515T>G",
			"hgvs_c": "NM_005228.3:c.2573T>G",
			"hgvs_p": "NP_005219.2:p.Leu858Arg",
			"dbsnp_ids": [
				"121434568"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/33/summary/evidence/4290/summary#evidence",
		"source": "civic",
		"description": "In a retrospective study of 46 Caucasian, advanced lung adenocarcinoma patients, a patient harboring EGFR L858R mutation was associated with resistance to erlotinib treatment; the patient survived 3.9 months, as compared to the overall 24 months median overall survival of the other patients who were not resistant to erlotinib treatment.",
		"drug_labels": "Erlotinib",
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/33/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/495",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/533"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/533",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27032107"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4290",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/533"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/335",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/533"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/534",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/142",
			"name": "L858R",
			"description": "EGFR L858R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259515T>G",
			"hgvs_c": "NM_005228.3:c.2573T>G",
			"hgvs_p": "NP_005219.2:p.Leu858Arg",
			"dbsnp_ids": [
				"121434568"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/33/summary/evidence/4291/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, Ba/F3 cell line expressing EGFR L858R was associated with sensitivity to erlotinib treatment. Sensitivity was determined by assessing cell viability, AKT and ERK phosphorylation, and EGFR auto-phosphorylation.",
		"drug_labels": "Erlotinib",
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/33/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/496",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/534"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/534",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27102076"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4291",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/534"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/336",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/534"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/535",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/142",
			"name": "L858R",
			"description": "EGFR L858R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259515T>G",
			"hgvs_c": "NM_005228.3:c.2573T>G",
			"hgvs_p": "NP_005219.2:p.Leu858Arg",
			"dbsnp_ids": [
				"121434568"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/33/summary/evidence/4292/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, Ba/F3 cell line expressing EGFR L858R was associated with sensitivity to cetuximab treatment. Sensitivity was determined by assessing cell viability, AKT and ERK phosphorylation and EGFR auto-phosphorylation.",
		"drug_labels": "CETUXIMAB",
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/33/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/497",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/535"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/535",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27102076"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4292",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/535"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/337",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/535"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/536",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/142",
			"name": "L858R",
			"description": "EGFR L858R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259515T>G",
			"hgvs_c": "NM_005228.3:c.2573T>G",
			"hgvs_p": "NP_005219.2:p.Leu858Arg",
			"dbsnp_ids": [
				"121434568"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/33/summary/evidence/4293/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study using NCI-H3255 cells (EGFR L858R mutation), inhibition of EGFR phosphorylation was used as an assay to determine sensitivity to EGFR tyrosine kinase inhibitors. NCI-H3255 cells demonstrated an sensitivity to erlotinib (IC50: 8.0-11.0 nmol/L vs 108.0 nmol/L) compared to NCI-H2073 cells (EGFR wild type).",
		"drug_labels": "Erlotinib",
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/33/summary",
		"evidence_label": "D",
		"response_type": null,
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/498",
				"source": "http://purl.obolibrary.org/obo/DOID_5409",
				"term": "lung small cell carcinoma",
				"pheno_id": "DOID:5409",
				"family": "lung cancer",
				"description": "lung small cell carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/536"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/536",
				"type": "Predictive",
				"description": null,
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24893891"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4293",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/536"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/338",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/536"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/537",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/142",
			"name": "L858R",
			"description": "EGFR L858R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259515T>G",
			"hgvs_c": "NM_005228.3:c.2573T>G",
			"hgvs_p": "NP_005219.2:p.Leu858Arg",
			"dbsnp_ids": [
				"121434568"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/33/summary/evidence/4294/summary#evidence",
		"source": "civic",
		"description": "EGFR L858R mutation has been associated with increased sensitivity to first generation EGFR tyrosine kinase inhibitors, including erlotinib and gefitinib. In an in vitro study using NCI-H3255 cells (EGFR L858R mutation), inhibition of EGFR phosphorylation was used as an assay to determine sensitivity to EGFR tyrosine kinase inhibitors. NCI-H3255 cells demonstrated increased sensitivity to erlotinib (IC50: 8.0-11.0 nmol/L vs 108.0 nmol/L) compared to NCI-H2073 cells (EGFR wild type).",
		"drug_labels": "CETUXIMAB",
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/33/summary",
		"evidence_label": "D",
		"response_type": null,
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/499",
				"source": "http://purl.obolibrary.org/obo/DOID_2531",
				"term": "hematologic cancer",
				"pheno_id": "DOID:2531",
				"family": "organ system cancer",
				"description": "hematologic cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/537"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/537",
				"type": "Predictive",
				"description": null,
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24893891"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4294",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/537"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/339",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/537"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/538",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/142",
			"name": "L858R",
			"description": "EGFR L858R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259515T>G",
			"hgvs_c": "NM_005228.3:c.2573T>G",
			"hgvs_p": "NP_005219.2:p.Leu858Arg",
			"dbsnp_ids": [
				"121434568"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/33/summary/evidence/4295/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a Ba/F3 cell line expressing EGFR L858R demonstrated increased sensitivity to erlotinib treatment, compared to Ba/F3 cells expressing EGFR wild-type. Sensitivity was determined by assessing EGFR auto-phosphorylation.",
		"drug_labels": "Erlotinib",
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/33/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/500",
				"source": "http://purl.obolibrary.org/obo/DOID_3070",
				"term": "malignant glioma",
				"pheno_id": "DOID:3070",
				"family": "cell type cancer",
				"description": "malignant glioma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/538"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/538",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/17177598"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4295",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/538"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/340",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/538"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/539",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/142",
			"name": "L858R",
			"description": "EGFR L858R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259515T>G",
			"hgvs_c": "NM_005228.3:c.2573T>G",
			"hgvs_p": "NP_005219.2:p.Leu858Arg",
			"dbsnp_ids": [
				"121434568"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/33/summary/evidence/2994/summary#evidence",
		"source": "civic",
		"description": "On May 14, 2013, the U.S. Food and Drug Administration approved erlotinib (Tarceva) for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations.",
		"drug_labels": "Erlotinib",
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/33/summary",
		"evidence_label": "A",
		"response_type": "Sensitivity/Response",
		"evidence_level": "1",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/501",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/539"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/539",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24868098"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2994",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/539"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/341",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/539"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/540",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/142",
			"name": "L858R",
			"description": "EGFR L858R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259515T>G",
			"hgvs_c": "NM_005228.3:c.2573T>G",
			"hgvs_p": "NP_005219.2:p.Leu858Arg",
			"dbsnp_ids": [
				"121434568"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/33/summary/evidence/2997/summary#evidence",
		"source": "civic",
		"description": "Afatinib, an irreversible inhibitor of the ErbB family of tyrosine kinases has been approved in the US for the first-line treatment of patients with metastatic non-small-cell lung cancer (NSCLC) who have tumours with EGFR exon 19 deletions or exon 21 (L858R) substitution mutations as detected by a US FDA-approved test",
		"drug_labels": "AFATINIB",
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/33/summary",
		"evidence_label": "A",
		"response_type": "Sensitivity/Response",
		"evidence_level": "1",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/502",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/540"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/540",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23982599"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2997",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/540"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/342",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/540"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/541",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/142",
			"name": "L858R",
			"description": "EGFR L858R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259515T>G",
			"hgvs_c": "NM_005228.3:c.2573T>G",
			"hgvs_p": "NP_005219.2:p.Leu858Arg",
			"dbsnp_ids": [
				"121434568"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/33/summary/evidence/4860/summary#evidence",
		"source": "civic",
		"description": "The authors pooled patients with exon 19 deletion and L858R EGFR (Exon 21) mutations from both studies (The ARCHER 1009 (NCT01360554) and A7471028 (NCT00769067)) to compare the efficacy of dacomitinib to erlotinib. 121 patients with any EGFR mutation were enrolled, 101 had activating mutations in exon 19 or 21. For those (exon19/21), the median PFS was 14.6 months with dacomitinib and 9.6 months with erlotinib The median survival was 26.6 months with dacomitinib versus 23.2 months with erlotinib.",
		"drug_labels": "DACOMITINIB",
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/33/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/503",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/541"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/541",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26768165"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4860",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/541"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/343",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DACOMITINIB",
				"envcontext_id": "11511120",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "DACOMITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/541"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/542",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/142",
			"name": "L858R",
			"description": "EGFR L858R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259515T>G",
			"hgvs_c": "NM_005228.3:c.2573T>G",
			"hgvs_p": "NP_005219.2:p.Leu858Arg",
			"dbsnp_ids": [
				"121434568"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/33/summary/evidence/2632/summary#evidence",
		"source": "civic",
		"description": "In a phase II trial for bronchioloalveolar carcinoma (BAC, or in situ pulmonary adenocarcinoma), EGFR exons 18-24 were analyzed in 7 patients who had shown a partial response to erlotinib. Two patients had the del L858R mutation. One patient was a male former smoker who demonstrated response for 3 months with overall survival of 3.5 months, and the other patient was a female never smoker who had response for 6 months and overall survival of 17+ months as the patient was alive at study end.",
		"drug_labels": "Erlotinib",
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/33/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/504",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/542"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/542",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15329413"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2632",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/542"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/344",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/542"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/543",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/142",
			"name": "L858R",
			"description": "EGFR L858R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259515T>G",
			"hgvs_c": "NM_005228.3:c.2573T>G",
			"hgvs_p": "NP_005219.2:p.Leu858Arg",
			"dbsnp_ids": [
				"121434568"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/33/summary/evidence/3811/summary#evidence",
		"source": "civic",
		"description": "EGFR L858R was expressed in Ba/F3 cells which do not contain endogenous EGFR, and conferred growth factor independance to the cells. Cells were plated and treated with 1st generation EGFR inhibitors Gefitinib, Erlotinib, or the the tool compound AEE788, and IC50 values were measured. L858R EGFR cells had very low IC50 nmol/L values for all three inhibitors in comparison to other constructs (Gefitinib=12, Erlotinib=6, AEE788=6), indicating sensitivity to all three constructs.",
		"drug_labels": "GEFITINIB,Erlotinib,497839-62-0",
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/33/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/505",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/543"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/543",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19147750"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3811",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/543"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/347",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "497839-62-0",
				"envcontext_id": "CID10297043",
				"usan_stem": null,
				"description": "497839-62-0",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/543"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/346",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/543"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/345",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/543"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/544",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/142",
			"name": "L858R",
			"description": "EGFR L858R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259515T>G",
			"hgvs_c": "NM_005228.3:c.2573T>G",
			"hgvs_p": "NP_005219.2:p.Leu858Arg",
			"dbsnp_ids": [
				"121434568"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/33/summary/evidence/5922/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study performed after identification of the mutation in a malignant peritoneal mesothelioma patient, COS-7 cells expressing EGFR L858R demonstrated increased EGFR phosphotyrosine after EGF treatment over wildtype EGFR \n expressing cells. Cells expressing mutant EGFR also showed increased sensitivity to erlotinib treatment compared to cells expressing EGFR wild-type. Sensitivity was determined by assessing EGFR auto-phosphorylation.",
		"drug_labels": "Erlotinib",
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/33/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/506",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/544"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/544",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20942962"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5922",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/544"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/348",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/544"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/545",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/142",
			"name": "L858R",
			"description": "EGFR L858R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259515T>G",
			"hgvs_c": "NM_005228.3:c.2573T>G",
			"hgvs_p": "NP_005219.2:p.Leu858Arg",
			"dbsnp_ids": [
				"121434568"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/33/summary/evidence/6183/summary#evidence",
		"source": "civic",
		"description": "In a Japanese Phase III clinical trial, noninferiority of Gefitinib as compared to Erlotinib was assessed in 561 postoperative recurrent or stage IIIb/VI patients who had undergone prior chemotherapy treatment but no tyrosine kinase inhibitor therapy. In a subset of patients with sole EGFR L858R, there was an insignificant difference between the objective response and disease control rates for patients treated with erlotinib (N=67) and gefitinib (N=78). Progression free survival was also not significantly different and did not meet the noninferiority endpoint with Gefitinib and Erlotinib arms at 8.1 and 8.5 months, respectively (HR, 0.938; 95% CI, 0.675 to 1.304; P = .704).",
		"drug_labels": "GEFITINIB",
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/33/summary",
		"evidence_label": "B",
		"response_type": "Reduced Sensitivity",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/507",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/545"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/545",
				"type": "Predictive",
				"description": "Reduced Sensitivity",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27022112"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6183",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/545"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/349",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/545"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/546",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/142",
			"name": "L858R",
			"description": "EGFR L858R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259515,
			"end_pos": 55259515,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259515T>G",
			"hgvs_c": "NM_005228.3:c.2573T>G",
			"hgvs_p": "NP_005219.2:p.Leu858Arg",
			"dbsnp_ids": [
				"121434568"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259515T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/33/summary/evidence/347/summary#evidence",
		"source": "civic",
		"description": "Median survival of patients with EGFR L858R mutation is better than those with wild type EGFR.",
		"drug_labels": null,
		"variant_name": "L858R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/33/summary",
		"evidence_label": "B",
		"response_type": "Better Outcome",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/508",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/546"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/546",
				"type": "Prognostic",
				"description": "Better Outcome",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24662454"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "347",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/546"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/547",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/328",
			"name": "E746_T751>I",
			"description": "EGFR E746_T751>I",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1003/summary/evidence/4209/summary#evidence",
		"source": "civic",
		"description": "EGFR exon 19 deletion mutations have been associated with increased sensitivity to first generation EGFR tyrosine kinase inhibitors, including erlotinib and gefitinib. In a Phase 2 clinical trial, lung adenocarcinoma patients with EGFR mutations (including exon 19 deletion mutation, n=8) were associated with increased sensitivity to erlotinib or gefitinib (P=0.003), compared to patients with wild-type EGFR (n=10).",
		"drug_labels": "Erlotinib",
		"variant_name": "E746_T751>I",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1003/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/509",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/547"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/547",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15329413"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4209",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/547"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/350",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/547"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/548",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/328",
			"name": "E746_T751>I",
			"description": "EGFR E746_T751>I",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1003/summary/evidence/4211/summary#evidence",
		"source": "civic",
		"description": "A study of five clinical trials reported that chemotherapy na�ve non-small cell lung cancer patients with EGFR sensitizing mutations (exon 19 deletion, L858R, L861Q, or G719X) treated with erlotinib or gefitinib were associated with improved response rate (59% vs 4%; P<0.0001) and increased median overall survival (24.5 months vs 11.8 months P=0.002) as compared to patients without EGFR sensitizing mutations.",
		"drug_labels": "Erlotinib",
		"variant_name": "E746_T751>I",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1003/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/510",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/548"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/548",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19671843"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4211",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/548"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/351",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/548"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/549",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/328",
			"name": "E746_T751>I",
			"description": "EGFR E746_T751>I",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1003/summary/evidence/2527/summary#evidence",
		"source": "civic",
		"description": "In a study of 585 non-small cell lung cancer patients who had a previous round of EGFR-TKI treatment, archival material was available for 141 patients. EGFR mutational analysis revealed that 96 tumors had an EGFR mutation, of which 76 (79%) were positive for either L858R or a deletion in exon 19. These mutations were associated with improved response to afatinib for progression-free survival (median 3.3 months  vs 1.0 month ; HR:0.51, 95% CI:0.31-0.85, P<0.009) compared to placebo control.",
		"drug_labels": "AFATINIB",
		"variant_name": "E746_T751>I",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1003/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/511",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/549"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/549",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22452896"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2527",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/549"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/352",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/549"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/550",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/328",
			"name": "E746_T751>I",
			"description": "EGFR E746_T751>I",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1003/summary/evidence/2528/summary#evidence",
		"source": "civic",
		"description": "A phase 3 study of 345 stage IIIB-IV lung adenocarcinoma patients, reported improved median progression free survival (13.6 months vs. 6.9 months, HR: 0.47, 95% CI: 0.34-0.65, P=0.001) in EGFR mutation positive patients (n=308; exon 19 deletion and L858R mutation) treated with afatinib, as compared to patients treated with standard chemotherapy (cisplatin plus pemetrexed).",
		"drug_labels": "AFATINIB",
		"variant_name": "E746_T751>I",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1003/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/512",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/550"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/550",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23816960"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2528",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/550"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/353",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/550"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/551",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/328",
			"name": "E746_T751>I",
			"description": "EGFR E746_T751>I",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1003/summary/evidence/2522/summary#evidence",
		"source": "civic",
		"description": "In a phase 3 clinical trial of Japanese NSCLC patients with EGFR mutations (n=230), patients treated with gefitinib were associated with improved progression free survival (10.8 months vs 5.4 months, HR: 0.30, 95% CI: 0.22-0.41, P<0.001), compared to patients treated with carboplatin and paclitaxel combination therapy. The frequency of mutation of exon 19 deletion and L858R was 25.2% (58/230) and 21.3% (49/230), respectively.",
		"drug_labels": "GEFITINIB",
		"variant_name": "E746_T751>I",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1003/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/513",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/551"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/551",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20573926"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2522",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/551"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/354",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/551"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/552",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/328",
			"name": "E746_T751>I",
			"description": "EGFR E746_T751>I",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1003/summary/evidence/2523/summary#evidence",
		"source": "civic",
		"description": "In a phase 3 clinical trial of Japanese NSCLC patients with EGFR mutations (n=177), patients treated with gefitinib were associated with improved progression free survival (9.2 months vs 6.3 months, HR:0.49, 95% CI: 0.34-0.71, P<0.0001), compared to cisplatin plus docetaxel treatment. The frequency of mutation in exon 19 deletion and L858R was 50.6% (87/172) and 49.4% (85/172), respectively, in evaluable cases.",
		"drug_labels": "GEFITINIB",
		"variant_name": "E746_T751>I",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1003/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/514",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/552"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/552",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20022809"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2523",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/552"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/355",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/552"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/553",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/328",
			"name": "E746_T751>I",
			"description": "EGFR E746_T751>I",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1003/summary/evidence/2526/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study using PC9 cells (EGFR exon 19 deletion), inhibition of cell viability was used as an assay to determine sensitivity to EGFR tyrosine kinase inhibitors. PC9 cells demonstrated an increased sensitivity to gefitinib  (IC50: 23.0 nmol/L vs 200.0 nmol/L) compared to NCI-H2073 cells (EGFR wild type).",
		"drug_labels": "GEFITINIB",
		"variant_name": "E746_T751>I",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1003/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/515",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/553"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/553",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24893891"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2526",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/553"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/356",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/553"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/554",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/248",
			"name": "N826S",
			"description": "EGFR N826S",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259419,
			"end_pos": 55259419,
			"ref": "A",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259419A>G",
			"hgvs_c": "NM_005228.3:c.2477A>G",
			"hgvs_p": "NP_005219.2:p.Asn826Ser",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259419A>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1188/summary/evidence/4496/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a Ba/F3 cell line expressing EGFR N826S demonstrated reduced sensitivity to erlotinib treatment, compared to Ba/F3 cells expressing a known sensitizing mutation (EGFR L858R). Sensitivity was determined by assessing cell proliferation, the IC50 of erlotinib for EGFR N826S and EGFR L858R expressing cells were 505 nmol/L and 6 nmol/L, respectively.",
		"drug_labels": "Erlotinib",
		"variant_name": "N826S",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1188/summary",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/516",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/554"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/554",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19147750"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4496",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/554"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/357",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/554"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/555",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/329",
			"name": "OVEREXPRESSION",
			"description": "EGFR OVEREXPRESSION",
			"biomarker_type": "N/A",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/193/summary/evidence/692/summary#evidence",
		"source": "civic",
		"description": "EGFR expression level was not predicitive of response to cetuximab-containing first line regimens in recurrent or metastatic head and neck squamous cell carcinoma and KRAS-wild type colorectal carcinoma.",
		"drug_labels": "CETUXIMAB",
		"variant_name": "OVEREXPRESSION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/193/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/517",
				"source": "http://purl.obolibrary.org/obo/DOID_5520",
				"term": "head and neck squamous cell carcinoma",
				"pheno_id": "DOID:5520",
				"family": "head and neck cancer",
				"description": "head and neck squamous cell carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/555"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/555",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23265711"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "692",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/555"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/358",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/555"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/556",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/329",
			"name": "OVEREXPRESSION",
			"description": "EGFR OVEREXPRESSION",
			"biomarker_type": "N/A",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/193/summary/evidence/3797/summary#evidence",
		"source": "civic",
		"description": "A phase 3 study of 889 advanced non-small cell lung cancer patients (with non-progressive disease while on standard chemotherapy treatment), reported that patients harboring EGFR mutation (exon 19 deletion and L858R mutation; n= 493) who were treated with erlotinib had an improved progression free survival (44.6 weeks vs. 13 weeks, HR: 0.10, 95% CI 0.04-0.25, P<0.001) as compared to patients who received placebo.",
		"drug_labels": "Erlotinib",
		"variant_name": "OVEREXPRESSION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/193/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/518",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/556"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/556",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21969500"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3797",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/556"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/359",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/556"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/557",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/329",
			"name": "OVEREXPRESSION",
			"description": "EGFR OVEREXPRESSION",
			"biomarker_type": "N/A",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/193/summary/evidence/954/summary#evidence",
		"source": "civic",
		"description": "82 patients treated with gefitinib were retrospectively analyzed for EGFR mRNA expression (rt-PCR in 64 patients). Patients with high EGFR mRNA expression (>5.01) had 43% response probability, whereas patients with low EGFR mRNA expression had 8% response probability (P = 0.006). PFS but not OS was also longer in patients with high EGFR mRNA expression.",
		"drug_labels": "GEFITINIB",
		"variant_name": "OVEREXPRESSION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/193/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/519",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/557"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/557",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/16707605"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "954",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/557"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/360",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/557"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/558",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/329",
			"name": "OVEREXPRESSION",
			"description": "EGFR OVEREXPRESSION",
			"biomarker_type": "N/A",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/193/summary/evidence/783/summary#evidence",
		"source": "civic",
		"description": "55 tumor samples were analyzed for EGFR expression using IHC. The objective response rate to anti-EGFR antibody nimotuzumab did not differ significantly between EGFR high- (18 pts) and EGFR low to moderate groups (37 pts).",
		"drug_labels": "Nimotuzumab",
		"variant_name": "OVEREXPRESSION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/193/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/520",
				"source": "http://purl.obolibrary.org/obo/DOID_3748",
				"term": "esophagus squamous cell carcinoma",
				"pheno_id": "DOID:3748",
				"family": "esophageal cancer",
				"description": "esophagus squamous cell carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/558"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/558",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26459251"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "783",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/558"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/361",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "Nimotuzumab",
				"envcontext_id": "CHEMBL2108359",
				"usan_stem": "monoclonal antibodies",
				"description": "Nimotuzumab",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/558"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/559",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/329",
			"name": "OVEREXPRESSION",
			"description": "EGFR OVEREXPRESSION",
			"biomarker_type": "N/A",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/193/summary/evidence/693/summary#evidence",
		"source": "civic",
		"description": "EGFR overexpression was correlated with longer overall survival in patients with advanced NSCLC treated with first line chemotherapy and cetuximab than those treated with first line chemotherapy alone.",
		"drug_labels": "EGFR",
		"variant_name": "OVEREXPRESSION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/193/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/521",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/559"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/559",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22056021"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "693",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/559"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/362",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/substance",
				"term": "EGFR",
				"envcontext_id": "SID160769799",
				"usan_stem": null,
				"description": "EGFR",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/559"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/560",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/329",
			"name": "OVEREXPRESSION",
			"description": "EGFR OVEREXPRESSION",
			"biomarker_type": "N/A",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/193/summary/evidence/737/summary#evidence",
		"source": "civic",
		"description": "In this prospective study in 37 patients of whom 34 were treated with different EGFR inhibitors (gefitinib, erlotinib, afatinib), EGFR mutations and a higher relative expression of EGFR in comparison to MET expression were correlated with longer PFS.",
		"drug_labels": "EGFR",
		"variant_name": "OVEREXPRESSION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/193/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/522",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/560"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/560",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26439803"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "737",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/560"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/363",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/substance",
				"term": "EGFR",
				"envcontext_id": "SID160769799",
				"usan_stem": null,
				"description": "EGFR",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/560"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/561",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/329",
			"name": "OVEREXPRESSION",
			"description": "EGFR OVEREXPRESSION",
			"biomarker_type": "N/A",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/193/summary/evidence/5827/summary#evidence",
		"source": "civic",
		"description": "A total of 57 patients with HER1/EGFR positive non-small cell lung cancer were treated with erlotinib therapy. Two patients achieved a complete response, five had a partial response, and 22/57 patients (39%) had stable disease. Median duration of response was 19.7 weeks, median progression-free survival was 9 weeks (95% CI, 8-15 weeks), median overall survival was 8.4 months (95% CI, 4.8-13.9 months), and 1-year survival rate was 40% (95% CI, 28%-54%).",
		"drug_labels": "Erlotinib",
		"variant_name": "OVEREXPRESSION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/193/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/523",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/561"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/561",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15310767"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5827",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/561"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/364",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/561"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/562",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/329",
			"name": "OVEREXPRESSION",
			"description": "EGFR OVEREXPRESSION",
			"biomarker_type": "N/A",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/193/summary/evidence/474/summary#evidence",
		"source": "civic",
		"description": "In patients with glioblastoma multiforme, those with overespression of wild-type EGFR had shorter overall survival.",
		"drug_labels": null,
		"variant_name": "OVEREXPRESSION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/193/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/524",
				"source": "EVS",
				"term": "Supratentorial Glioblastoma Multiforme",
				"pheno_id": "EVS:Thesaurus.owl#C5149",
				"family": null,
				"description": "Supratentorial Glioblastoma Multiforme",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/562"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/562",
				"type": "Prognostic",
				"description": "Poor Outcome",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/14583498"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "474",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/562"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/563",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/329",
			"name": "OVEREXPRESSION",
			"description": "EGFR OVEREXPRESSION",
			"biomarker_type": "N/A",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/193/summary/evidence/782/summary#evidence",
		"source": "civic",
		"description": "Primary tumors of 91 patients with head and neck squamous cell carcinoma were analyzed for expression of EGFR and TGF-alpha using IHC. Expression of EGFR or TGF-alpha were associated with reduced disease-free and cause-specific survival.",
		"drug_labels": null,
		"variant_name": "OVEREXPRESSION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/193/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/525",
				"source": "http://purl.obolibrary.org/obo/DOID_5520",
				"term": "head and neck squamous cell carcinoma",
				"pheno_id": "DOID:5520",
				"family": "head and neck cancer",
				"description": "head and neck squamous cell carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/563"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/563",
				"type": "Prognostic",
				"description": "Poor Outcome",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/9625170"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "782",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/563"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/564",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/329",
			"name": "OVEREXPRESSION",
			"description": "EGFR OVEREXPRESSION",
			"biomarker_type": "N/A",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/193/summary/evidence/784/summary#evidence",
		"source": "civic",
		"description": "55 tumor samples were analyzed for EGFR expression using IHC.\nPFS and OS was shorter for the EGFR high expressing group (18 pts) than for the low to moderate expression group (37 pts). PFS: 5.8 ± 0.5 vs. 11.0 ± 2.8 months, P = 0.007; OS: 9.7 ± 0.5 vs. 21.5 ± 1.5 months, P = 0.03.",
		"drug_labels": null,
		"variant_name": "OVEREXPRESSION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/193/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/526",
				"source": "http://purl.obolibrary.org/obo/DOID_3748",
				"term": "esophagus squamous cell carcinoma",
				"pheno_id": "DOID:3748",
				"family": "esophageal cancer",
				"description": "esophagus squamous cell carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/564"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/564",
				"type": "Prognostic",
				"description": "Poor Outcome",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26459251"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "784",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/564"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/565",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/330",
			"name": "P772_H773insH",
			"description": "EGFR P772_H773insH",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": null,
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/2217/summary/evidence/5950/summary#evidence",
		"source": "civic",
		"description": "In transduced cos7 cells, P772_H773insH cells showed increased sensitivity to erlotinib in comparison to cells with T790M resistance mutation, but decreased erlotinib sensitivity in comparison to L858R transduced cells.",
		"drug_labels": "Erlotinib",
		"variant_name": "P772_H773insH",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/2217/summary",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/527",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/565"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/565",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5950",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/565"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/365",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/565"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/566",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/331",
			"name": "R705K",
			"description": "EGFR R705K",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55241666,
			"end_pos": 55241666,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55241666G>A",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55241666G>A?assembly=hg19",
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/2333/summary/evidence/6182/summary#evidence",
		"source": "civic",
		"description": "In a large retrospective study, EGFR exons 18-21 were assessed using direct sequencing in 753 French NSCLC cases. Clinical details and patient outcomes were taken, including whether the first generation TKIs erlotinib or gefitinib were administered. One patient was found to have a R705K mutation, was administered a TKI, and an NSCLC progression was observed.",
		"drug_labels": "GEFITINIB,Erlotinib",
		"variant_name": "R705K",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/2333/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/528",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/566"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/566",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23749122"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6182",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/566"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/367",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/566"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/366",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/566"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/567",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/332",
			"name": "T847I",
			"description": "EGFR T847I",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55259482,
			"end_pos": 55259482,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55259482C>T",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259482C>T?assembly=hg19",
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1463/summary/evidence/4260/summary#evidence",
		"source": "civic",
		"description": "In a study, 1 participant with stage IIIB lung adenocarcinoma was sequenced at EGFR exons 18 to 21 and was found to have T847I mutation, and was treated with the 1st generation TKI gefitinib. The patient (M, 77, smoker) progressive disease as response, progression free survival (PFS) of 1.1 months, overall survival (OS) of 1.1 months and was not alive at study end. As a whole, patients with uncommon EGFR mutations had a response rate of 47.5%, which was between common (del19 and L858R) at 74.1%, and wild type EGFR at 16.5%. Median PFS and OS (months) for the three groups: 5.0 and 15.0 uncommon, 8.5 and 19.6 common, 2.0 and 10.4 wild type.",
		"drug_labels": "GEFITINIB",
		"variant_name": "T847I",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1463/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/529",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/567"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/567",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21531810"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4260",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/567"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/368",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/567"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/568",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/333",
			"name": "V774A",
			"description": "EGFR V774A",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "",
			"chromosome": "7",
			"start_pos": 55249023,
			"end_pos": 55249023,
			"ref": "T",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.55249023T>C",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249023T>C?assembly=hg19",
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1892/summary/evidence/4226/summary#evidence",
		"source": "civic",
		"description": "In a study, 1 participant with stage IV adenocarcinoma was sequenced at EGFR exons 18 to 21 and was found to have V774A mutation, and was treated with the 1st generation TKI gefitinib. The patient (F, 51, nonsmoker) had a partial response, progression free survival (PFS) of 6.9 months, overall survival (OS) of 29.7 months and was alive at study end. As a whole, patients with uncommon EGFR mutations had a response rate of 47.5%, which was between common (del19 and L858R) at 74.1%, and wild type EGFR at 16.5%. Median PFS and OS (months) for the three groups: 5.0 and 15.0 uncommon, 8.5 and 19.6 common, 2.0 and 10.4 wild type.",
		"drug_labels": "GEFITINIB",
		"variant_name": "V774A",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1892/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/530",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/568"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/568",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21531810"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4226",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/568"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/369",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/568"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/569",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/334",
			"name": "Y69FS*11",
			"description": "EGFR Y69FS*11",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1672/summary/evidence/4808/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, an esophageal squamous cell carcinoma cell line KYSE70 expressing EGFR Y69fs*11 mutation was associated with insensitivity to erlotinib treatment (IC50=4.31uM). Resistance was determined by assessing cell proliferation.",
		"drug_labels": "Erlotinib",
		"variant_name": "Y69FS*11",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1672/summary",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/531",
				"source": "http://purl.obolibrary.org/obo/DOID_3748",
				"term": "esophagus squamous cell carcinoma",
				"pheno_id": "DOID:3748",
				"family": "esophageal cancer",
				"description": "esophagus squamous cell carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/569"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/569",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27207775"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4808",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/569"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/370",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/569"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/570",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/335",
			"name": "V769_770insASV",
			"description": "EGFR V769_770insASV",
			"biomarker_type": "Direct Tandem Duplication",
			"so_hierarchy": [
				"SO:0000400",
				"SO:0000733",
				"SO:0001508",
				"SO:0001512"
			],
			"soid": "SO:0001513",
			"so_name": "tandem",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55249009,
			"end_pos": 55249010,
			"ref": "",
			"alt": "GCCAGCGTG",
			"hgvs_g": "NC_000007.13:g.55249009_55249010delinsGCCAGCGTG",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/736/summary/evidence/5943/summary#evidence",
		"source": "civic",
		"description": "A 60 year old female former smoker with 2 pack years and EGFR V769_D770insASV lung adenocarcinoma patient was given erlotinib as first line treatment, and had progressive disease as best response with +20% change to target lesions, progression free survival of 0.9 months, and overall survival of 31.6 months.",
		"drug_labels": "Erlotinib",
		"variant_name": "V769_770insASV",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/736/summary",
		"evidence_label": "C",
		"response_type": "resistant",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/532",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/570"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/570",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5943",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/570"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/371",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/570"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/571",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/335",
			"name": "V769_770insASV",
			"description": "EGFR V769_770insASV",
			"biomarker_type": "Direct Tandem Duplication",
			"so_hierarchy": [
				"SO:0000400",
				"SO:0000733",
				"SO:0001508",
				"SO:0001512"
			],
			"soid": "SO:0001513",
			"so_name": "tandem",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55249009,
			"end_pos": 55249010,
			"ref": "",
			"alt": "GCCAGCGTG",
			"hgvs_g": "NC_000007.13:g.55249009_55249010delinsGCCAGCGTG",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/736/summary/evidence/4649/summary#evidence",
		"source": "civic",
		"description": "In stage IV lung adenocarcinoma patients (n=2) harboring EGFR inframe exon 20 insertion mutation, EGFR exon 20 insertion was associated with progressive disease after 1 and 3 months of erlotinib monotherapy, respectively; both patients were previously treated with standard chemotherapy.",
		"drug_labels": "Erlotinib",
		"variant_name": "V769_770insASV",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/736/summary",
		"evidence_label": "C",
		"response_type": "resistant",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/533",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/571"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/571",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22895145"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4649",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/571"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/372",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/571"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/572",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/335",
			"name": "V769_770insASV",
			"description": "EGFR V769_770insASV",
			"biomarker_type": "Direct Tandem Duplication",
			"so_hierarchy": [
				"SO:0000400",
				"SO:0000733",
				"SO:0001508",
				"SO:0001512"
			],
			"soid": "SO:0001513",
			"so_name": "tandem",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55249009,
			"end_pos": 55249010,
			"ref": "",
			"alt": "GCCAGCGTG",
			"hgvs_g": "NC_000007.13:g.55249009_55249010delinsGCCAGCGTG",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/736/summary/evidence/1799/summary#evidence",
		"source": "civic",
		"description": "Although EGFR exon 20 insertions may confer reduced sensitivity to erlotinib, patients with this particular mutation appeared to benefit from therapy.",
		"drug_labels": "Erlotinib",
		"variant_name": "V769_770insASV",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/736/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/534",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/572"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/572",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26773740"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1799",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/572"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/373",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/572"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/573",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/336",
			"name": "L747_A750>P",
			"description": "EGFR L747_A750>P",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242468,
			"end_pos": 55242478,
			"ref": null,
			"alt": "GC",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1006/summary/evidence/2545/summary#evidence",
		"source": "civic",
		"description": "In a phase 3 clinical trial of Japanese NSCLC patients with EGFR mutations (n=230), patients treated with gefitinib were associated with improved progression free survival (10.8 months vs 5.4 months, HR: 0.30, 95% CI: 0.22-0.41, P<0.001), compared to patients treated with carboplatin and paclitaxel combination therapy. The frequency of mutation of exon 19 deletion and L858R was 25.2% (58/230) and 21.3% (49/230), respectively.",
		"drug_labels": "GEFITINIB",
		"variant_name": "L747_A750>P",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1006/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/535",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/573"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/573",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20573926"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2545",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/573"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/374",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/573"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/574",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/336",
			"name": "L747_A750>P",
			"description": "EGFR L747_A750>P",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242468,
			"end_pos": 55242478,
			"ref": null,
			"alt": "GC",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1006/summary/evidence/2546/summary#evidence",
		"source": "civic",
		"description": "In a phase 3 clinical trial of Japanese NSCLC patients with EGFR mutations (n=177), patients treated with gefitinib were associated with improved progression free survival (9.2 months vs 6.3 months, HR:0.49, 95% CI: 0.34-0.71, P<0.0001), compared to cisplatin plus docetaxel treatment. The frequency of mutation in exon 19 deletion and L858R was 50.6% (87/172) and 49.4% (85/172), respectively, in evaluable cases.",
		"drug_labels": "GEFITINIB",
		"variant_name": "L747_A750>P",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1006/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/536",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/574"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/574",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20022809"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2546",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/574"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/375",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/574"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/575",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/336",
			"name": "L747_A750>P",
			"description": "EGFR L747_A750>P",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242468,
			"end_pos": 55242478,
			"ref": null,
			"alt": "GC",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1006/summary/evidence/2550/summary#evidence",
		"source": "civic",
		"description": "In a phase 2b/3 study of 585 stage IIIB-IV lung adenocarcinoma patients who had a previous round of EGFR-TKI treatment, archival material was available for 141 patients. EGFR mutational analysis revealed that 96 tumors had an EGFR mutation, of which 76 (79%) were positive for either L858R or a deletion in exon 19. These mutations were associated with improved progression-free survival (median 3.3 months  vs 1.0 month ; HR:0.51, 95% CI:0.31-0.85, P<0.009) compared to placebo control.",
		"drug_labels": "AFATINIB",
		"variant_name": "L747_A750>P",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1006/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/537",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/575"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/575",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22452896"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2550",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/575"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/376",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/575"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/576",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/336",
			"name": "L747_A750>P",
			"description": "EGFR L747_A750>P",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242468,
			"end_pos": 55242478,
			"ref": null,
			"alt": "GC",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1006/summary/evidence/2551/summary#evidence",
		"source": "civic",
		"description": "A phase 3 study of 345 stage IIIB-IV lung adenocarcinoma patients, reported improved median progression free survival (13.6 months vs. 6.9 months, HR: 0.47, 95% CI: 0.34-0.65, P=0.001) in EGFR mutation positive patients (n=308; exon 19 deletion and L858R mutation) treated with afatinib, as compared to patients treated with standard chemotherapy (cisplatin plus pemetrexed).",
		"drug_labels": "AFATINIB",
		"variant_name": "L747_A750>P",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1006/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/538",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/576"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/576",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23816960"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2551",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/576"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/377",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/576"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/577",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/336",
			"name": "L747_A750>P",
			"description": "EGFR L747_A750>P",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242468,
			"end_pos": 55242478,
			"ref": null,
			"alt": "GC",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1006/summary/evidence/2549/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study using PC9 cells (EGFR exon 19 deletion), inhibition of cell viability was used as an assay to determine sensitivity to EGFR tyrosine kinase inhibitors. PC9 cells demonstrated an increased sensitivity to gefitinib  (IC50: 23.0 nmol/L vs 200.0 nmol/L) compared to NCI-H2073 cells (EGFR wild type).",
		"drug_labels": "GEFITINIB",
		"variant_name": "L747_A750>P",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1006/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/539",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/577"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/577",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24893891"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2549",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/577"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/378",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/577"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/578",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/196",
			"name": "G465R",
			"description": "EGFR G465R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55227926,
			"end_pos": 55227926,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55227926G>A",
			"hgvs_c": "NM_005228.3:c.1393G>A",
			"hgvs_p": "NP_005219.2:p.Gly465Arg",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55227926G>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/443/summary/evidence/1058/summary#evidence",
		"source": "civic",
		"description": "An EGFR G465R mutation (22% of mutant alleles) was detected in a biopsy from one patient which had been previously treated with cetuximab in the analysis of 15 patients with refractory, metastatic CRC after cetuximab/panitumumab, prior to Sym004 treatment. Treatment of this patient with Sym004 yielded disease stabilization lasting 15 weeks. Sym004 is a 1:1 mixture\nof two non-overlapping anti-EGFR monoclonal antibodies. In vitro analysis in the murine fibroblast cell line NIH3T3 with ectopic expression of EGFR mutations S492R, R451C, K467T, and G465R showed that Sym004 effectively bound to all mutants, whereas cetuximab and panitumumab did not effectively bind to all mutants. In-vitro, Sym004 inhibited growth of S492R and G465R EGFR mutant cell lines. In-vivo analysis of S492R and G465R mutant cell lines showed regression of S492R and tumor growth delay of G465R mutant cell lines.\nG465R mutant cell lines were resistant to treatment with panitumumab or cetuximab in-vitro.",
		"drug_labels": "PANITUMUMAB,CETUXIMAB",
		"variant_name": "G465R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/443/summary",
		"evidence_label": "C",
		"response_type": "resistant",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/540",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/578"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/578",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26888827"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1058",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/578"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/380",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/578"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/379",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "PANITUMUMAB",
				"envcontext_id": "CHEMBL1201827",
				"usan_stem": "monoclonal antibodies",
				"description": "PANITUMUMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/578"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/579",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/196",
			"name": "G465R",
			"description": "EGFR G465R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55227926,
			"end_pos": 55227926,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55227926G>A",
			"hgvs_c": "NM_005228.3:c.1393G>A",
			"hgvs_p": "NP_005219.2:p.Gly465Arg",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55227926G>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/443/summary/evidence/1057/summary#evidence",
		"source": "civic",
		"description": "An EGFR G465R mutation (22% of mutant alleles) was detected in a biopsy from one patient which had been previously treated with cetuximab in the analysis of 15 patients with refractory, metastatic CRC after cetuximab/panitumumab, prior to Sym004 treatment. Subsequent treatment of this patient with Sym004 yielded disease stabilization lasting 15 weeks. In vitro analysis in colorectal cancer cell line NIH3T3 with EGFR mutations S492R, R451C, K467T, and G465R showed that antibody mixture Sym004 effectively bound to all mutants, whereas cetuximab and panitumumab did not effectively bind to all mutants. In-vitro, Sym004 inhibited growth of S492R and G465R EGFR mutant cell lines. In-vivo analysis of S492R and G465R mutant cell lines showed regression of S492R and tumor growth delay of G465R mutant cell lines.",
		"drug_labels": "Sym004",
		"variant_name": "G465R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/443/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/541",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/579"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/579",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26888827"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1057",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/579"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/381",
				"source": null,
				"term": "Sym004",
				"envcontext_id": null,
				"usan_stem": "Uncategorized-ENV",
				"description": "Sym004",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/579"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/580",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/337",
			"name": "E746_A750delELREA",
			"description": "EGFR E746_A750delELREA",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242465,
			"end_pos": 55242479,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1002/summary/evidence/2510/summary#evidence",
		"source": "civic",
		"description": "In a phase 3 clinical trial of Japanese NSCLC patients with EGFR mutations (n=230), patients treated with gefitinib were associated with improved progression free survival (10.8 months vs 5.4 months, HR: 0.30, 95% CI: 0.22-0.41, P<0.001), compared to patients treated with carboplatin and paclitaxel combination therapy. The frequency of mutation of exon 19 deletion and L858R was 25.2% (58/230) and 21.3% (49/230), respectively.",
		"drug_labels": "GEFITINIB",
		"variant_name": "E746_A750delELREA",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1002/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/542",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/580"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/580",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20573926"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2510",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/580"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/382",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/580"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/581",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/337",
			"name": "E746_A750delELREA",
			"description": "EGFR E746_A750delELREA",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242465,
			"end_pos": 55242479,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1002/summary/evidence/2511/summary#evidence",
		"source": "civic",
		"description": "In a phase 3 clinical trial of Japanese NSCLC patients with EGFR mutations (n=177), patients treated with gefitinib were associated with improved progression free survival (9.2 months vs 6.3 months, HR:0.49, 95% CI: 0.34-0.71, P<0.0001), compared to cisplatin plus docetaxel treatment. The frequency of mutation in exon 19 deletion and L858R was 50.6% (87/172) and 49.4% (85/172), respectively, in evaluable cases.",
		"drug_labels": "GEFITINIB",
		"variant_name": "E746_A750delELREA",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1002/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/543",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/581"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/581",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20022809"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2511",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/581"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/383",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/581"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/582",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/337",
			"name": "E746_A750delELREA",
			"description": "EGFR E746_A750delELREA",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242465,
			"end_pos": 55242479,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1002/summary/evidence/2513/summary#evidence",
		"source": "civic",
		"description": "EGFR exon 19 deletion mutations have been associated with increased sensitivity to first generation EGFR tyrosine kinase inhibitors, including erlotinib and gefitinib. In a Phase 2 clinical trial, lung adenocarcinoma patients with EGFR mutations (including exon 19 deletion mutation, n=8) were associated with improved response to erlotinib or gefitinib (P=0.003), compared to patients with wild-type EGFR (n=10).",
		"drug_labels": "GEFITINIB",
		"variant_name": "E746_A750delELREA",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1002/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/544",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/582"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/582",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15329413"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2513",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/582"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/384",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/582"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/583",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/337",
			"name": "E746_A750delELREA",
			"description": "EGFR E746_A750delELREA",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242465,
			"end_pos": 55242479,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1002/summary/evidence/2514/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study using PC9 cells (EGFR exon 19 deletion), inhibition of cell viability was used as an assay to determine sensitivity to EGFR tyrosine kinase inhibitors. PC9 cells demonstrated an increased sensitivity to gefitinib  (IC50: 23.0 nmol/L vs 200.0 nmol/L) compared to NCI-H2073 cells (EGFR wild type).",
		"drug_labels": "GEFITINIB",
		"variant_name": "E746_A750delELREA",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1002/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/545",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/583"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/583",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24893891"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2514",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/583"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/385",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/583"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/584",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/337",
			"name": "E746_A750delELREA",
			"description": "EGFR E746_A750delELREA",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242465,
			"end_pos": 55242479,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1002/summary/evidence/2515/summary#evidence",
		"source": "civic",
		"description": "In a phase 2b/3 study of 585 lung adenocarcinoma patients who had a previous round of EGFR-TKI treatment, archival material was available for 141 patients. EGFR mutational analysis revealed that 96 tumors had an EGFR mutation, of which 76 (79%) were positive for either L858R or a deletion in exon 19. These mutations were associated with improved progression-free survival (median 3.3 months  vs 1.0 month ; HR:0.51, 95% CI:0.31-0.85, P<0.009) compared to placebo control.",
		"drug_labels": "AFATINIB",
		"variant_name": "E746_A750delELREA",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1002/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/546",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/584"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/584",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22452896"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2515",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/584"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/386",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/584"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/585",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/337",
			"name": "E746_A750delELREA",
			"description": "EGFR E746_A750delELREA",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242465,
			"end_pos": 55242479,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1002/summary/evidence/2516/summary#evidence",
		"source": "civic",
		"description": "A phase 3 study of 345 stage IIIB-IV lung adenocarcinoma patients, reported improved median progression free survival (13.6 months vs. 6.9 months, HR: 0.47, 95% CI: 0.34-0.65, P=0.001) in EGFR mutation positive patients (n=308; exon 19 deletion and L858R mutation) treated with afatinib, as compared to patients treated with standard chemotherapy (cisplatin plus pemetrexed).",
		"drug_labels": "AFATINIB",
		"variant_name": "E746_A750delELREA",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1002/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/547",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/585"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/585",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23816960"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2516",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/585"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/387",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/585"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/586",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/337",
			"name": "E746_A750delELREA",
			"description": "EGFR E746_A750delELREA",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242465,
			"end_pos": 55242479,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1002/summary/evidence/2518/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study using PC9 cells (EGFR exon 19 deletion), inhibition of cell viability was used as an assay to determine sensitivity to EGFR tyrosine kinase inhibitors. PC9 cells demonstrated an increased sensitivity to gefitinib  (IC50: 23.0 nmol/L vs 200.0 nmol/L) compared to NCI-H2073 cells (EGFR wild type).",
		"drug_labels": "Durvalumab",
		"variant_name": "E746_A750delELREA",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1002/summary",
		"evidence_label": "D",
		"response_type": null,
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/548",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/586"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/586",
				"type": "Predictive",
				"description": null,
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24893891"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2518",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/586"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/388",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/substance",
				"term": "Durvalumab",
				"envcontext_id": "SID249565666",
				"usan_stem": null,
				"description": "Durvalumab",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/586"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/587",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/337",
			"name": "E746_A750delELREA",
			"description": "EGFR E746_A750delELREA",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242465,
			"end_pos": 55242479,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1002/summary/evidence/4198/summary#evidence",
		"source": "civic",
		"description": "EGFR exon 19 deletion mutations have been associated with increased sensitivity to first generation EGFR tyrosine kinase inhibitors, including erlotinib and gefitinib. In a Phase 2 clinical trial, lung adenocarcinoma patients with EGFR mutations (including exon 19 deletion mutation, n=8) were associated with increased sensitivity to erlotinib or gefitinib (P=0.003), compared to patients with wild-type EGFR (n=10).",
		"drug_labels": "Erlotinib",
		"variant_name": "E746_A750delELREA",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1002/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/549",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/587"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/587",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15329413"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4198",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/587"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/389",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/587"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/588",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/337",
			"name": "E746_A750delELREA",
			"description": "EGFR E746_A750delELREA",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242465,
			"end_pos": 55242479,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1002/summary/evidence/4199/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study,  PC9 cells (EGFR E746_A750del) demonstrated increased sensitivity  to erlotinib (IC50:28.0 nmol/L vs 692.0 nmol/L) compared to NCI-H2073 cells (EGFR wild-type).",
		"drug_labels": "Erlotinib",
		"variant_name": "E746_A750delELREA",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1002/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/550",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/588"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/588",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24893891"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4199",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/588"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/390",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/588"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/589",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/337",
			"name": "E746_A750delELREA",
			"description": "EGFR E746_A750delELREA",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242465,
			"end_pos": 55242479,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1002/summary/evidence/4202/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a HCC827 cell line expressing EGFR E746_A750delELREA demonstrated increased sensitivity to erlotinib treatment compared to QG56 cells expressing EGFR wild-type. Sensitivity was determined by assessing cell viability, the mean IC50 of erlotinib EGFR E746_A750delELREA expressing cells was 4 nM vs. 8.9 �M for EGFR wild-type expressing cells (P<0.001).",
		"drug_labels": "Erlotinib",
		"variant_name": "E746_A750delELREA",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1002/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/551",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/589"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/589",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25853010"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4202",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/589"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/391",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/589"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/590",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/337",
			"name": "E746_A750delELREA",
			"description": "EGFR E746_A750delELREA",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242465,
			"end_pos": 55242479,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1002/summary/evidence/4203/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, HCC827 and PC9 cell lines expressing EGFR E746_A750del demonstrated increased sensitivity to erlotinib treatment (IC50=0.017�M and 0.071�M, respectively), comparable to NCI-H3255 cells expressing EGFR L858R (a known sensitizing mutation to EGFR tyrosine kinase inhibitors; IC50=0.068�M). Sensitivity was determined by assessing cell proliferation, EGFR, AKT and ERK phosphorylation, levels of BIM (a marker of EGFR TKI-induced cell killing) and cell viability.",
		"drug_labels": "Erlotinib",
		"variant_name": "E746_A750delELREA",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1002/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/552",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/590"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/590",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4203",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/590"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/392",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/590"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/591",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/337",
			"name": "E746_A750delELREA",
			"description": "EGFR E746_A750delELREA",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242465,
			"end_pos": 55242479,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1002/summary/evidence/4204/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, HCC827 cells expressing EGFR E746_A750del mutation were associated with sensitivity to erlotinib treatment. Sensitivity was determined by assessing cell density and ERK phosphorylation.",
		"drug_labels": "Erlotinib",
		"variant_name": "E746_A750delELREA",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1002/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/553",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/591"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/591",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27612423"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4204",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/591"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/393",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/591"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/592",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/337",
			"name": "E746_A750delELREA",
			"description": "EGFR E746_A750delELREA",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242465,
			"end_pos": 55242479,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1002/summary/evidence/4205/summary#evidence",
		"source": "civic",
		"description": "In a Taiwanese stage IV lung adenocarcinoma patient with brain metastasis harboring EGFR E746_A750del mutation, EGFR E746_A750del was reported to be sensitive to erlotinib treatment. The patient was treated with 6 cycles of 1st-line standard chemotherapy, 2nd-line standard chemotherapy, and 9 months of gefitinib monotherapy when tumor progression occurred, subsequently the patient achieved tumor regression with 2 years of erlotinib monotherapy until the tumor progressed again.",
		"drug_labels": "Erlotinib",
		"variant_name": "E746_A750delELREA",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1002/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/554",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/592"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/592",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/17618013"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4205",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/592"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/394",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/592"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/593",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/337",
			"name": "E746_A750delELREA",
			"description": "EGFR E746_A750delELREA",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242465,
			"end_pos": 55242479,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1002/summary/evidence/4206/summary#evidence",
		"source": "civic",
		"description": "In lung adenocarcinoma patients with EGFR E746_A750del mutation (n=2), EGFR E746_A750del was associated with improved response to erlotinib treatment. The patients were treated with erlotinib monotherapy and achieved 9 and 10 month response rates, respectively.",
		"drug_labels": "Erlotinib",
		"variant_name": "E746_A750delELREA",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1002/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/555",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/593"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/593",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/17085664"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4206",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/593"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/395",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/593"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/594",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/337",
			"name": "E746_A750delELREA",
			"description": "EGFR E746_A750delELREA",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242465,
			"end_pos": 55242479,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1002/summary/evidence/4207/summary#evidence",
		"source": "civic",
		"description": "In a retrospective study of 46 advanced non-small cell lung cancer patients, two patients harboring EGFR E746_A750del mutation were associated with resistance to erlotinib treatment. One patient survived 0.9 months and the other patient survived 3.7 months, as compared to the overall 24 months median overall survival of the other patients.",
		"drug_labels": "Erlotinib",
		"variant_name": "E746_A750delELREA",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1002/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/556",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/594"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/594",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27032107"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4207",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/594"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/396",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/594"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/595",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/337",
			"name": "E746_A750delELREA",
			"description": "EGFR E746_A750delELREA",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242465,
			"end_pos": 55242479,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1002/summary/evidence/4208/summary#evidence",
		"source": "civic",
		"description": "EGFR E746_A750del mutation has been associated with sensitivity to first generation EGFR tyrosine kinase inhibitors, including erlotinib. In an in vitro study, PC9 cells (EGFR E746_A750del) demonstrated increased sensitivity  to erlotinib (IC50:28.0 nmol/L vs 692.0 nmol/L) compared to NCI-H2073 cells (EGFR wild-type).",
		"drug_labels": "CETUXIMAB",
		"variant_name": "E746_A750delELREA",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1002/summary",
		"evidence_label": "D",
		"response_type": null,
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/557",
				"source": "http://purl.obolibrary.org/obo/DOID_2531",
				"term": "hematologic cancer",
				"pheno_id": "DOID:2531",
				"family": "organ system cancer",
				"description": "hematologic cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/595"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/595",
				"type": "Predictive",
				"description": null,
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24893891"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4208",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/595"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/397",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/595"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/596",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/337",
			"name": "E746_A750delELREA",
			"description": "EGFR E746_A750delELREA",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242465,
			"end_pos": 55242479,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1002/summary/evidence/4215/summary#evidence",
		"source": "civic",
		"description": "A study of five clinical trials reported that chemotherapy na�ve non-small cell lung cancer patients with EGFR sensitizing mutations (exon 19 deletion, L858R, L861Q, or G719X) treated with erlotinib or gefitinib were associated with improved response rate (59% vs 4%; P<0.0001) and increased median overall survival (24.5 months vs 11.8 months P=0.002) as compared to patients without EGFR sensitizing mutations.",
		"drug_labels": "Erlotinib",
		"variant_name": "E746_A750delELREA",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1002/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/558",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/596"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/596",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19671843"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4215",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/596"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/398",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/596"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/597",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/337",
			"name": "E746_A750delELREA",
			"description": "EGFR E746_A750delELREA",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242465,
			"end_pos": 55242479,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1002/summary/evidence/4216/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a HCC827 cell line expressing an EGFR exon 19 deletion mutation demonstrated sensitivity to cetuximab treatment, compared to A549, H460, H322 cell lines expressing wild-type EGFR. Sensitivity was determined by assessing cell viability, EGFR-stimulated VEGF production, and EGFR, AKT and ERK phosphorylation. Further, an in vivo an HCC827 xenograft expressing EGFR exon 19 deletion was reportedly sensitive to cetuximab, as assessed by tumor volume.",
		"drug_labels": "CETUXIMAB",
		"variant_name": "E746_A750delELREA",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1002/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/559",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/597"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/597",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27040853"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4216",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/597"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/399",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/597"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/598",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/337",
			"name": "E746_A750delELREA",
			"description": "EGFR E746_A750delELREA",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242465,
			"end_pos": 55242479,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1002/summary/evidence/4642/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a Ba/F3 cell line expressing EGFR L747_A750insP demonstrated increased sensitivity to erlotinib treatment (IC50=5nM), comparable to Ba/F3 cells expressing EGFR L858R (a known sensitizing mutation to EGFR tyrosine kinase inhibitors; IC50=16nM). Sensitivity was determined by IL-3 independent cell survival.",
		"drug_labels": "Erlotinib",
		"variant_name": "E746_A750delELREA",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1002/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/560",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/598"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/598",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/17877814"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4642",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/598"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/400",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/598"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/599",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/338",
			"name": "N771>GY",
			"description": "EGFR N771>GY",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1581/summary/evidence/4671/summary#evidence",
		"source": "civic",
		"description": "In a stage III lung adenocarcinoma patient of African-American descent with EGFR N771>GY mutation, EGFR N771>GY was reported to be resistant to erlotinib treatment. The patient was treated with 4 cycles of standard chemotherapy and subsequently 2 cycles of erlotinib monotherapy; however, after 2 months of treatment the patient experienced progressive disease. In an in vitro study, a MCF-7 cell line expressing EGFR N771>GY mutation demonstrated resistance to erlotinib treatment, compared to MCF-7 cells expressing a known erlotinib sensitizing mutation (EGFR L858R). Sensitivity was determined by assessing YFP signal-EGFR relocation.",
		"drug_labels": "Erlotinib",
		"variant_name": "N771>GY",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1581/summary",
		"evidence_label": "C",
		"response_type": "resistant",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/561",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/599"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/599",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21132006"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4671",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/599"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/401",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/599"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/600",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/339",
			"name": "delD770insGY",
			"description": "EGFR delD770insGY",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55249010,
			"end_pos": 55249011,
			"ref": "G",
			"alt": "GGTT",
			"hgvs_g": "NC_000007.13:g.55249010_55249011delinsGGTT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/2214/summary/evidence/5942/summary#evidence",
		"source": "civic",
		"description": "2 patients with EGFR delD770insGY mutant lung adenocarcinoma were treated with first line erlotinib.\n\nA 76 year old female 6 pack year former smoker had progressive disease as best response with +38.1% change to target lesions, progression free survival of 1 month and overall survival of 12 months. \n\nA 67 year old female 2 pack year former smoker had progressive disease as best response with +6.0% change to target lesions, progression free survival of 1 month and overall survival of 1.5 months.",
		"drug_labels": "Erlotinib",
		"variant_name": "delD770insGY",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/2214/summary",
		"evidence_label": "C",
		"response_type": "resistant",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/562",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/600"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/600",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5942",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/600"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/402",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/600"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/601",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/340",
			"name": "E746G",
			"description": "EGFR E746G",
			"biomarker_type": "Missense Variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55242467,
			"end_pos": 55242467,
			"ref": "A",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55242467A>G",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55242467A>G?assembly=hg19",
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/724/summary/evidence/1787/summary#evidence",
		"source": "civic",
		"description": "In a meta-analysis of 7 clinical trials evaluating the efficacy of erlotinib, one patient was described with the exon 19 mutation E746G from the BeTa study. Progression-free (415 days) and overall (462 days) survival suggested sensitivity in this patient. No statistical analysis was reported for this variant and PFS or OS, citing small sample size across the studies.",
		"drug_labels": "Erlotinib",
		"variant_name": "E746G",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/724/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/563",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/601"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/601",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26773740"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1787",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/601"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/403",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/601"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/602",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/341",
			"name": "L747_T751>Q",
			"description": "EGFR L747_T751>Q",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242468,
			"end_pos": 55242482,
			"ref": null,
			"alt": "GCA",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1008/summary/evidence/2561/summary#evidence",
		"source": "civic",
		"description": "In a phase 2b/3 study of 585 stage IIIB-IV lung adenocarcinoma patients who had a previous round of EGFR-TKI treatment, archival material was available for 141 patients. EGFR mutational analysis revealed that 96 tumors had an EGFR mutation, of which 76 (79%) were positive for either L858R or a deletion in exon 19. These mutations were associated with improved progression-free survival (median 3.3 months  vs 1.0 month ; HR:0.51, 95% CI:0.31-0.85, P<0.009) compared to placebo control.",
		"drug_labels": "AFATINIB",
		"variant_name": "L747_T751>Q",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1008/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/564",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/602"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/602",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22452896"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2561",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/602"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/404",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/602"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/603",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/341",
			"name": "L747_T751>Q",
			"description": "EGFR L747_T751>Q",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242468,
			"end_pos": 55242482,
			"ref": null,
			"alt": "GCA",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1008/summary/evidence/2562/summary#evidence",
		"source": "civic",
		"description": "A phase 3 study of 345 stage IIIB-IV lung adenocarcinoma patients, reported improved median progression free survival (13.6 months vs. 6.9 months, HR: 0.47, 95% CI: 0.34-0.65, P=0.001) in EGFR mutation positive patients (n=308; exon 19 deletion and L858R mutation) treated with afatinib, as compared to patients treated with standard chemotherapy (cisplatin plus pemetrexed).",
		"drug_labels": "AFATINIB",
		"variant_name": "L747_T751>Q",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1008/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/565",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/603"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/603",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23816960"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2562",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/603"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/405",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/603"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/604",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/341",
			"name": "L747_T751>Q",
			"description": "EGFR L747_T751>Q",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242468,
			"end_pos": 55242482,
			"ref": null,
			"alt": "GCA",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1008/summary/evidence/2560/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study using PC9 cells (EGFR exon 19 deletion), inhibition of cell viability was used as an assay to determine sensitivity to EGFR tyrosine kinase inhibitors. PC9 cells demonstrated an increased sensitivity to gefitinib  (IC50: 23.0 nmol/L vs 200.0 nmol/L) compared to NCI-H2073 cells (EGFR wild type).",
		"drug_labels": "GEFITINIB",
		"variant_name": "L747_T751>Q",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1008/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/566",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/604"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/604",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24893891"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2560",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/604"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/406",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/604"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/605",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/341",
			"name": "L747_T751>Q",
			"description": "EGFR L747_T751>Q",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242468,
			"end_pos": 55242482,
			"ref": null,
			"alt": "GCA",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1008/summary/evidence/2556/summary#evidence",
		"source": "civic",
		"description": "In a phase 3 clinical trial of Japanese NSCLC patients with EGFR mutations (n=230), patients treated with gefitinib were associated with improved progression free survival (10.8 months vs 5.4 months, HR: 0.30, 95% CI: 0.22-0.41, P<0.001), compared to patients treated with carboplatin and paclitaxel combination therapy. The frequency of mutation of exon 19 deletion and L858R was 25.2% (58/230) and 21.3% (49/230), respectively.",
		"drug_labels": "GEFITINIB",
		"variant_name": "L747_T751>Q",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1008/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/567",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/605"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/605",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20573926"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2556",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/605"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/407",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/605"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/606",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/341",
			"name": "L747_T751>Q",
			"description": "EGFR L747_T751>Q",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242468,
			"end_pos": 55242482,
			"ref": null,
			"alt": "GCA",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1008/summary/evidence/2557/summary#evidence",
		"source": "civic",
		"description": "In a phase 3 clinical trial of Japanese NSCLC patients with EGFR mutations (n=177), patients treated with gefitinib were associated with improved progression free survival (9.2 months vs 6.3 months, HR:0.49, 95% CI: 0.34-0.71, P<0.0001), compared to cisplatin plus docetaxel treatment. The frequency of mutation in exon 19 deletion and L858R was 50.6% (87/172) and 49.4% (85/172), respectively, in evaluable cases.",
		"drug_labels": "GEFITINIB",
		"variant_name": "L747_T751>Q",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1008/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/568",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/606"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/606",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20022809"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2557",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/606"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/408",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/606"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/607",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/342",
			"name": "E709Q",
			"description": "EGFR E709Q",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55241677,
			"end_pos": 55241677,
			"ref": "G",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.55241677G>C",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55241677G>C?assembly=hg19",
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1413/summary/evidence/6037/summary#evidence",
		"source": "civic",
		"description": "Patient with E709Q add a PR response under Gefinitb treatment.",
		"drug_labels": "GEFITINIB",
		"variant_name": "E709Q",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1413/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/569",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/607"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/607",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15897572"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6037",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/607"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/409",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/607"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/608",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/266",
			"name": "S784F",
			"description": "EGFR S784F",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249053,
			"end_pos": 55249053,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249053C>T",
			"hgvs_c": "NM_005228.3:c.2351C>T",
			"hgvs_p": "NP_005219.2:p.Ser784Phe",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249053C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1182/summary/evidence/4469/summary#evidence",
		"source": "civic",
		"description": "In a pulmonary undifferentiated non-small cell lung cancer patient harboring EGFR S784F mutation, EGFR S784F was reported to be resistant to erlotinib treatment. The patient was initially treated with standard chemotherapy, followed by erlotinib monotherapy, tumor progression was reported after 10 weeks of erlotinib treatment.",
		"drug_labels": "Erlotinib",
		"variant_name": "S784F",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1182/summary",
		"evidence_label": "C",
		"response_type": "resistant",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/570",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/608"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/608",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21841502"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4469",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/608"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/410",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/608"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/609",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/266",
			"name": "S784F",
			"description": "EGFR S784F",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249053,
			"end_pos": 55249053,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249053C>T",
			"hgvs_c": "NM_005228.3:c.2351C>T",
			"hgvs_p": "NP_005219.2:p.Ser784Phe",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249053C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1182/summary/evidence/4235/summary#evidence",
		"source": "civic",
		"description": "In a study, 1 participant with stage IV lung adenocarcinoma was sequenced at EGFR exons 18 to 21 and was found to have S784F mutation, and was treated with the 1st generation TKI gefitinib. The patient (F, 43, nonsmoker) had progressive disease as response, progression free survival (PFS) of 0.4 months, overall survival (OS) of 3.6 months and was not alive at study end. As a whole, patients with uncommon EGFR mutations had a response rate of 47.5%, which was between common (del19 and L858R) at 74.1%, and wild type EGFR at 16.5%. Median PFS and OS (months) for the three groups: 5.0 and 15.0 uncommon, 8.5 and 19.6 common, 2.0 and 10.4 wild type.",
		"drug_labels": "GEFITINIB",
		"variant_name": "S784F",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1182/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/571",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/609"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/609",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21531810"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4235",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/609"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/411",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/609"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/610",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/266",
			"name": "S784F",
			"description": "EGFR S784F",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249053,
			"end_pos": 55249053,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249053C>T",
			"hgvs_c": "NM_005228.3:c.2351C>T",
			"hgvs_p": "NP_005219.2:p.Ser784Phe",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249053C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1182/summary/evidence/5823/summary#evidence",
		"source": "civic",
		"description": "EGFR S784F was expressed in Ba/F3 cells which do not contain endogenous EGFR, and conferred growth factor independance to the cells. Cells were plated and treated with 1st generation EGFR inhibitors Gefitinib, Erlotinib, or the the tool compound AEE788, and IC50 values were measured. S784F EGFR cells had moderately low IC50 nmol/L values for AEE788 in comparison to other EGFR constructs, suggesting potential sensitivity. (Gefitinib=193, Erlotinib=95, AEE788=43)",
		"drug_labels": "497839-62-0",
		"variant_name": "S784F",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1182/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/572",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/610"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/610",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19147750"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5823",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/610"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/412",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "497839-62-0",
				"envcontext_id": "CID10297043",
				"usan_stem": null,
				"description": "497839-62-0",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/610"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/611",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/266",
			"name": "S784F",
			"description": "EGFR S784F",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249053,
			"end_pos": 55249053,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249053C>T",
			"hgvs_c": "NM_005228.3:c.2351C>T",
			"hgvs_p": "NP_005219.2:p.Ser784Phe",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249053C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1182/summary/evidence/5822/summary#evidence",
		"source": "civic",
		"description": "EGFR S784F was expressed in Ba/F3 cells which do not contain endogenous EGFR, and conferred growth factor independance to the cells. Cells were plated and treated with 1st generation EGFR inhibitors Gefitinib, Erlotinib, or the the tool compound AEE788, and IC50 values were measured. S784F EGFR cells had high IC50 nmol/L values for gefitinib and modeerately high for erlotinib in comparison to other EGFR constructs, which did not indicate sensitivity. (Gefitinib=193, Erlotinib=95, AEE788=43)",
		"drug_labels": "GEFITINIB,Erlotinib",
		"variant_name": "S784F",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1182/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/573",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/611"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/611",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19147750"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5822",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/611"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/414",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/611"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/413",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/611"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/612",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/198",
			"name": "G719A",
			"description": "EGFR G719A",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55241708,
			"end_pos": 55241708,
			"ref": "G",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.55241708G>C",
			"hgvs_c": "NM_005228.3:c.2156G>C",
			"hgvs_p": "NP_005219.2:p.Gly719Ala",
			"dbsnp_ids": [
				"121913428"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55241708G>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/999/summary/evidence/6181/summary#evidence",
		"source": "civic",
		"description": "In a large retrospective study, EGFR exons 18-21 were assessed using direct sequencing in 753 French NSCLC cases. Clinical details and patient outcomes were taken, including whether the first generation TKIs erlotinib or gefitinib were administered. One patient was found to have a G719A mutation, was administered a TKI, and an NSCLC progression was observed.",
		"drug_labels": "GEFITINIB,Erlotinib",
		"variant_name": "G719A",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/999/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/574",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/612"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/612",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23749122"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6181",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/612"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/416",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/612"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/415",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/612"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/613",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/198",
			"name": "G719A",
			"description": "EGFR G719A",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55241708,
			"end_pos": 55241708,
			"ref": "G",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.55241708G>C",
			"hgvs_c": "NM_005228.3:c.2156G>C",
			"hgvs_p": "NP_005219.2:p.Gly719Ala",
			"dbsnp_ids": [
				"121913428"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55241708G>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/999/summary/evidence/4193/summary#evidence",
		"source": "civic",
		"description": "3 patients with stage IV non small cell lung adenocarcinoma with G719A mutation were given gefitinib. The study reported progression free survival of 33.2, 5.8 and 0.2 months, and overall survival of 38.4, 2.2 and 1.8 months for the three patients. The patients were not alive at study end. In general G719 mutations were reported as having favorable response to tyrosine kinase inhibition in this study, although it was not as high as among exon 19 deletion and L858R mutations.",
		"drug_labels": "GEFITINIB",
		"variant_name": "G719A",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/999/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/575",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/613"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/613",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21531810"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4193",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/613"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/417",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/613"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/614",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/198",
			"name": "G719A",
			"description": "EGFR G719A",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55241708,
			"end_pos": 55241708,
			"ref": "G",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.55241708G>C",
			"hgvs_c": "NM_005228.3:c.2156G>C",
			"hgvs_p": "NP_005219.2:p.Gly719Ala",
			"dbsnp_ids": [
				"121913428"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55241708G>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/999/summary/evidence/4194/summary#evidence",
		"source": "civic",
		"description": "3 patients with stage IV non small cell lung adenocarcinoma with G719A mutation were given erlotinib. 1 patient was alive at end of study with progression free survival (PFS) of 27.2 months and overall survival (OS) or 42.4 months, and 2 patients had PFS of 1.3 and 2.1 months, and OS of 9.6 and 2.2 months, and were not alive at study end. In general G719 mutations were reported as having favorable response to tyrosine kinase inhibition in this study, although it was not as high as among exon 19 deletion and L858R mutations.",
		"drug_labels": "Erlotinib",
		"variant_name": "G719A",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/999/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/576",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/614"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/614",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21531810"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4194",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/614"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/418",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/614"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/615",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/198",
			"name": "G719A",
			"description": "EGFR G719A",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55241708,
			"end_pos": 55241708,
			"ref": "G",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.55241708G>C",
			"hgvs_c": "NM_005228.3:c.2156G>C",
			"hgvs_p": "NP_005219.2:p.Gly719Ala",
			"dbsnp_ids": [
				"121913428"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55241708G>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/999/summary/evidence/4196/summary#evidence",
		"source": "civic",
		"description": "In a retrospective study of 46, Caucasian, advanced lung adenocarcinoma patients, a patient harboring EGFR G719A mutation was associated with resistance to erlotinib treatment. The patient survived 9.2 months, as compared to the overall 24 months median overall survival of the other patients who were not resistant to erlotinib treatment.",
		"drug_labels": "Erlotinib",
		"variant_name": "G719A",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/999/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/577",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/615"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/615",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27032107"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4196",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/615"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/419",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/615"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/616",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/198",
			"name": "G719A",
			"description": "EGFR G719A",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55241708,
			"end_pos": 55241708,
			"ref": "G",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.55241708G>C",
			"hgvs_c": "NM_005228.3:c.2156G>C",
			"hgvs_p": "NP_005219.2:p.Gly719Ala",
			"dbsnp_ids": [
				"121913428"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55241708G>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/999/summary/evidence/4195/summary#evidence",
		"source": "civic",
		"description": "In a study of 889 non-small cell lung cancer patients, mutations in the EGFR gene was observed in 11.1% of patients (58 of 518 sequenced). Patients with an EGFR mutation were associated with an improved response to erlotinib over placebo treatment (HR:0.10, 95% CI:0.04-0.25, P<0.0001); patients wildtype for EGFR also saw an improved response to erlotinib over placebo treatment (HR:0.78, 95% CI:0.63-0.96, P=0.0185).",
		"drug_labels": "Erlotinib",
		"variant_name": "G719A",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/999/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/578",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/616"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/616",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20493771"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4195",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/616"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/420",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/616"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/617",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/198",
			"name": "G719A",
			"description": "EGFR G719A",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55241708,
			"end_pos": 55241708,
			"ref": "G",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.55241708G>C",
			"hgvs_c": "NM_005228.3:c.2156G>C",
			"hgvs_p": "NP_005219.2:p.Gly719Ala",
			"dbsnp_ids": [
				"121913428"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55241708G>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/999/summary/evidence/2508/summary#evidence",
		"source": "civic",
		"description": "In a study of 297 non-small cell lung cancer patients, 15% of the analyzed tumors had  EGFR mutations including deletions in exon 19 (n=22), L858R (n=16) and G719A (n=2). Patients with EGFR mutations treated with gefitinib were associated with improved response rates (42.1% vs. 6.6%, P=0.04) compared to wildtype EGFR patients.",
		"drug_labels": "GEFITINIB",
		"variant_name": "G719A",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/999/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/579",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/617"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/617",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20038723"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2508",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/617"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/421",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/617"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/618",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/343",
			"name": "A767_V769dupASV",
			"description": "EGFR A767_V769dupASV",
			"biomarker_type": "Inframe Insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55249000,
			"end_pos": 55249001,
			"ref": null,
			"alt": "GCCAGCGTG",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1579/summary/evidence/5949/summary#evidence",
		"source": "civic",
		"description": "Ba/F3 cells transduced with EGFR A767_V769dupASV were IL3 growth independent, suggesting a driver mutation.\n\nGefitinib growth inhibition IC50 in A767_V769dupASV transduced Ba/F3 cells was 2.685 micro molar, which was similar to cells transduced with resistance mutation T790M (IC50=2.752). Afatinib growth inhibition IC50 was 0.0721 micro molar, which was higher than cells transduced with resistance mutation T790M (IC50=0.0629).",
		"drug_labels": "AFATINIB,GEFITINIB",
		"variant_name": "A767_V769dupASV",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1579/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/580",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/618"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/618",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5949",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/618"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/423",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/618"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/422",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/618"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/619",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/343",
			"name": "A767_V769dupASV",
			"description": "EGFR A767_V769dupASV",
			"biomarker_type": "Inframe Insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55249000,
			"end_pos": 55249001,
			"ref": null,
			"alt": "GCCAGCGTG",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1579/summary/evidence/5948/summary#evidence",
		"source": "civic",
		"description": "Ba/F3 cells transduced with EGFR A767_V769dupASV were IL3 growth independent, suggesting a driver mutation, and did not indicate sensitivity to erlotinib treatment (growth inhibition IC50=2.644 micro molar), which was intermediate between Ba/F3 cells with EGFR L858R (IC50=0.006) and cells with L858R + T790M resistance mutation (IC50=4.155). In transduced cos7 cells, A767_V769dupASV cells showed increased sensitivity to erlotinib in comparison to cells with T790M resistance mutation, but decreased erlotinib sensitivity in comparison to L858R transduced cells. Similarly, phospho-EGFR levels in A767_V769dupASV cells decreased with 1 micro molar erlotinib, but did not in T790M cells. In sensitive L858R cells, p-EGFR levels disappeared with 0.01 micro molar erlotinib, but did not disappear in A767_V769dupASV cells at this concentration.",
		"drug_labels": "Erlotinib",
		"variant_name": "A767_V769dupASV",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1579/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/581",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/619"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/619",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5948",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/619"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/424",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/619"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/620",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/343",
			"name": "A767_V769dupASV",
			"description": "EGFR A767_V769dupASV",
			"biomarker_type": "Inframe Insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55249000,
			"end_pos": 55249001,
			"ref": null,
			"alt": "GCCAGCGTG",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1579/summary/evidence/4665/summary#evidence",
		"source": "civic",
		"description": "In a study of 19 non-small cell lung carcinoma patients with EGFR exon 20 insertion mutations and treated with erlotinib monotherapy, patients with EGFR A767_V769dupASV mutation (n=3) experienced progressive disease.",
		"drug_labels": "Erlotinib",
		"variant_name": "A767_V769dupASV",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1579/summary",
		"evidence_label": "C",
		"response_type": "resistant",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/582",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/620"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/620",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4665",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/620"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/425",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/620"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/621",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/343",
			"name": "A767_V769dupASV",
			"description": "EGFR A767_V769dupASV",
			"biomarker_type": "Inframe Insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55249000,
			"end_pos": 55249001,
			"ref": null,
			"alt": "GCCAGCGTG",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1579/summary/evidence/4666/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a MCF-7 cell line expressing EGFR A767_V769dup mutation demonstrated resistance to erlotinib treatment, compared to MCF-7 cells expressing a known erlotinib sensitizing mutation (EGFR L858R). Sensitivity was determined by assessing YFP signal-EGFR relocation.",
		"drug_labels": "Erlotinib",
		"variant_name": "A767_V769dupASV",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1579/summary",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/583",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/621"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/621",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21132006"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4666",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/621"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/426",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/621"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/622",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/171",
			"name": "D770_N771insSVD",
			"description": "EGFR D770_N771insSVD",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249013,
			"end_pos": 55249014,
			"ref": null,
			"alt": "GCGTGGACA",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1445/summary/evidence/5941/summary#evidence",
		"source": "civic",
		"description": "2 patients with EGFR D770_N771insSVD positive lung adenocarcinoma were treated with erlotinib tyrosine kinase inhibitor as first line treatment.\n\nA 66 year old female never smoker had stable disease as best response with +7.1% change to target lesions, progression free survival of 9 months, and overall survival of 59 months.\n\nA 71 year old female never smoker had progressive disease as best response with progression free survival of 0.9 months, and overall survival of 0.9 months.\n\nAlthough the first patient had longer PFS and OS, the authors did not characterize this response as variant sensitivity to erlotinib. This is despite the fact that median PFS of 9 months is longer than the median PFS of 5.5 months for the exon 20 insertion subgroup deemed sensitive by these same authors.",
		"drug_labels": "Erlotinib",
		"variant_name": "D770_N771insSVD",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1445/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/584",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/622"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/622",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5941",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/622"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/427",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/622"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/623",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/171",
			"name": "D770_N771insSVD",
			"description": "EGFR D770_N771insSVD",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249013,
			"end_pos": 55249014,
			"ref": null,
			"alt": "GCGTGGACA",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1445/summary/evidence/4640/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a MCF-7 cell line expressing D770_N771insSVD demonstrated reduced sensitivity to erlotinib treatment similar to MCF-7 cells expressing EGFR T790M (a known resistant mutation to EGFR tyrosine kinase inhibitors). Resistance was determined by assessing AKT phosphorylation.",
		"drug_labels": "Erlotinib",
		"variant_name": "D770_N771insSVD",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1445/summary",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/585",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/623"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/623",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/17877814"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4640",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/623"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/428",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/623"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/624",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/171",
			"name": "D770_N771insSVD",
			"description": "EGFR D770_N771insSVD",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249013,
			"end_pos": 55249014,
			"ref": null,
			"alt": "GCGTGGACA",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1445/summary/evidence/4275/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a Ba/F3 cell line expressing EGFR D770_N771insSVD demonstrated reduced sensitivity to erlotinib treatment (IC50=3.187�M), comparable to Ba/F3 cells expressing EGFR L858R and T790M co-mutation (T790M is a known resistant mutation to 1st and 2nd generation EGFR tyrosine kinase inhibitors; IC50=4.155�M). Resistance was determined by assessing cell proliferation, EGFR, AKT and ERK phosphorylation.",
		"drug_labels": "Erlotinib",
		"variant_name": "D770_N771insSVD",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1445/summary",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/586",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/624"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/624",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4275",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/624"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/429",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/624"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/625",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/344",
			"name": "P772_V774insPHV",
			"description": "EGFR P772_V774insPHV",
			"biomarker_type": "Inframe Insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1668/summary/evidence/4803/summary#evidence",
		"source": "civic",
		"description": "In a lung adenocarcinoma patient harboring EGFR P772_V774insPHV mutation, EGFR P772_V774insPHV was associated with progressive disease in response to erlotinib monotherapy.",
		"drug_labels": "Erlotinib",
		"variant_name": "P772_V774insPHV",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1668/summary",
		"evidence_label": "C",
		"response_type": "resistant",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/587",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/625"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/625",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4803",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/625"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/430",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/625"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/626",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/345",
			"name": "A750T",
			"description": "EGFR A750T",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242478,
			"end_pos": 55242478,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55242478G>A",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55242478G>A?assembly=hg19",
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/2332/summary/evidence/6177/summary#evidence",
		"source": "civic",
		"description": "In a large retrospective study, EGFR exons 18-21 were assessed using direct sequencing in 753 French NSCLC cases. Clinical details and patient outcomes were taken, including wether or not administration of the first generation TKIs erlotinib or gefitinib occurred.  One patient was found to have A750T mutation, was administered TKI, and a partial response was reported.",
		"drug_labels": "Erlotinib,GEFITINIB",
		"variant_name": "A750T",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/2332/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/588",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/626"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/626",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23749122"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6177",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/626"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/432",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/626"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/431",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/626"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/627",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/346",
			"name": "K806E",
			"description": "EGFR K806E",
			"biomarker_type": "Missense Variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55249118,
			"end_pos": 55249118,
			"ref": "A",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55249118A>G",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"754652044"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249118A>G?assembly=hg19",
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1895/summary/evidence/4239/summary#evidence",
		"source": "civic",
		"description": "In a study, 1 participant with stage IIIB lung adenocarcinoma was sequenced at EGFR exons 18 to 21 and was found to have K806E mutation, and was treated with the 1st generation TKI gefitinib. The patient (M, 77, nonsmoker) had progressive disease as response, progression free survival (PFS) of 1.6 months, overall survival (OS) of 28.1 months and was alive at study end. As a whole, patients with uncommon EGFR mutations had a response rate of 47.5%, which was between common (del19 and L858R) at 74.1%, and wild type EGFR at 16.5%. Median PFS and OS (months) for the three groups: 5.0 and 15.0 uncommon, 8.5 and 19.6 common, 2.0 and 10.4 wild type.",
		"drug_labels": "GEFITINIB",
		"variant_name": "K806E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1895/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/589",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/627"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/627",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21531810"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4239",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/627"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/433",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/627"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/628",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/190",
			"name": "E884K",
			"description": "EGFR E884K",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55260483,
			"end_pos": 55260483,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55260483G>A",
			"hgvs_c": "NM_005228.3:c.2650G>A",
			"hgvs_p": "NP_005219.2:p.Glu884Lys",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55260483G>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1390/summary/evidence/3813/summary#evidence",
		"source": "civic",
		"description": "In a lung adenocarcinoma patient harboring EGFR L858R (a known sensitizing mutation to EGFR tyrosine kinase inhibitor) and EGFR E884K co-mutations, EGFR E884K was reported to be refractory to erlotinib treatment. The patient was treated with 6 cycles of erlotinib and chemotherapy, brain metastases developed subsequent to disease stabilization. In an in vitro study, a COS-7 cell line expressing EGFR E884K demonstrated reduced sensitivity to erlotinib treatment, compared to COS-7 cells expressing EGFR wild-type. Resistance was determined by assessing EGFR auto-phosphorylation.",
		"drug_labels": "Erlotinib",
		"variant_name": "E884K",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1390/summary",
		"evidence_label": "C",
		"response_type": "resistant",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/590",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/628"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/628",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/16407879"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3813",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/628"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/434",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/628"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/629",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/143",
			"name": "L861",
			"description": "EGFR L861",
			"biomarker_type": "NA",
			"so_hierarchy": null,
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259523,
			"end_pos": 55259523,
			"ref": "C",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259523C>G",
			"hgvs_c": "NM_005228.3:c.2581C>G",
			"hgvs_p": "NP_005219.2:p.Leu861Val",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259523C>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1866/summary/evidence/4298/summary#evidence",
		"source": "civic",
		"description": "EGFR L861 mutations have been associated with increased sensitivity to first generation EGFR tyrosine kinase inhibitors, including erlotinib and gefitinib. In a study of patients treated with erlotinib or gefitinib, a subset of patients with EGFR mutation at codons G719 or L861 (n=30) was associated with improved response rate (47.5% vs 16.5%, P<0.001) median progression free survival (5.0 vs 2.0 months, P<0.001), and overall survival (15.0 vs. 10.4 months, P =0.030), compared to patients with wild-type EGFR (n=272).",
		"drug_labels": "GEFITINIB,Erlotinib",
		"variant_name": "L861",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1866/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/591",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/629"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/629",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21531810"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4298",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/629"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/436",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/629"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/435",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/629"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/630",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/132",
			"name": "A763_Y764insFQEA",
			"description": "EGFR A763_Y764insFQEA",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55248992,
			"end_pos": 55248993,
			"ref": "T",
			"alt": "TTCCAGGAAGCCT",
			"hgvs_g": "NC_000007.13:g.55248992_55248993delinsTTCCAGGAAGCCT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1515/summary/evidence/5951/summary#evidence",
		"source": "civic",
		"description": "Ba/F3 cells transduced with EGFR A763_Y764insFQEA were IL3 growth independant, suggesting a driver mutation.\n\nGefitinib growth inhibition IC50 in A763_Y764insFQEA transduced Ba/F3 cells was 0.174 micro molar, while cells transduced with sensitive L858R had IC50 0.017, but resistance mutation T790M cells had IC50=2.752. Similarly, afatinib growth inhibition IC50 was 0.0037 micro molar, which was considerably lower than cells transduced with resistance mutation T790M with IC50=0.0629.",
		"drug_labels": "AFATINIB,GEFITINIB",
		"variant_name": "A763_Y764insFQEA",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1515/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/592",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/630"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/630",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5951",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/630"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/438",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/630"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/437",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/630"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/631",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/132",
			"name": "A763_Y764insFQEA",
			"description": "EGFR A763_Y764insFQEA",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55248992,
			"end_pos": 55248993,
			"ref": "T",
			"alt": "TTCCAGGAAGCCT",
			"hgvs_g": "NC_000007.13:g.55248992_55248993delinsTTCCAGGAAGCCT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1515/summary/evidence/4497/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, Ba/F3 and BID007 cell lines expressing EGFR A763_Y764insFQEA demonstrated increased sensitivity to erlotinib treatment (IC50=0.048�M and 0.082�M, respectively), comparable to Ba/F3 and NCI-H3255 cells expressing EGFR L858R (a known sensitizing mutation to EGFR tyrosine kinase inhibitors; IC50=0.006�M and 0.068�M, respectively). Sensitivity was determined by assessing cell proliferation, EGFR, AKT and ERK phosphorylation, levels of BIM (a marker of EGFR TKI-induced cell killing) and cell viability.",
		"drug_labels": "Erlotinib",
		"variant_name": "A763_Y764insFQEA",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1515/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/593",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/631"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/631",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4497",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/631"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/439",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/631"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/632",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/132",
			"name": "A763_Y764insFQEA",
			"description": "EGFR A763_Y764insFQEA",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55248992,
			"end_pos": 55248993,
			"ref": "T",
			"alt": "TTCCAGGAAGCCT",
			"hgvs_g": "NC_000007.13:g.55248992_55248993delinsTTCCAGGAAGCCT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1515/summary/evidence/5939/summary#evidence",
		"source": "civic",
		"description": "Out of a group of 19 EGFR exon 20 insertion NSCLC patients, 3 patients had EGFR M766_A767insASV mutation.\n\nOne patient was 69 year old female neversmoker lung adenocarcinoma patient was given erlotinib as second line treatment, and had partial response with -78.5% change to target lesions, progression free survival of 18 months and overall survival 24 months. \n\nThe next patient was a 38 year old female former smoker with 5 pack years and lung adenocarcinoma who was given erlotinib as first line treatment, and had partial response with -60% change to target lesions, progression free survival of 5.5 months and overall survival 16 months. \n\nThe third patient was a 67 year old female neversmoker lung adenocarcinoma patient who was given erlotinib as third line treatment, and had stable disease as best response with -24% change to target lesions, progressive disease at 3.9 months consisting of brain metastases (not target lesions), and overall survival of 6.7 months. \n\nThe three A763_Y764insFQEA patients had median PFS of 5.5 months in comparison to other EGFR exon 20 insertion patients who had median PFS of 1 month. The response rate of A763_Y764insFQEA was significantly higher (66%) than the other exon 20 muations in this study (0%).",
		"drug_labels": "Erlotinib",
		"variant_name": "A763_Y764insFQEA",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1515/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/594",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/632"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/632",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5939",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/632"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/440",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/632"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/633",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/132",
			"name": "A763_Y764insFQEA",
			"description": "EGFR A763_Y764insFQEA",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55248992,
			"end_pos": 55248993,
			"ref": "T",
			"alt": "TTCCAGGAAGCCT",
			"hgvs_g": "NC_000007.13:g.55248992_55248993delinsTTCCAGGAAGCCT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1515/summary/evidence/4648/summary#evidence",
		"source": "civic",
		"description": "In a metastatic non-small cell lung carcinoma patient harboring EGFR A763_Y764insFQEA mutation, EGFR A763_Y764insFQEA was reported to be sensitive to erlotinib treatment. The patient was initially treated with standard chemotherapy and subsequently achieved a partial response per RECIST criteria after 2 months of erlotinib monotherapy.",
		"drug_labels": "Erlotinib",
		"variant_name": "A763_Y764insFQEA",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1515/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/595",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/633"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/633",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22270724"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4648",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/633"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/441",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/633"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/634",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/132",
			"name": "A763_Y764insFQEA",
			"description": "EGFR A763_Y764insFQEA",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55248992,
			"end_pos": 55248993,
			"ref": "T",
			"alt": "TTCCAGGAAGCCT",
			"hgvs_g": "NC_000007.13:g.55248992_55248993delinsTTCCAGGAAGCCT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1515/summary/evidence/4647/summary#evidence",
		"source": "civic",
		"description": "In a lung adenocarcinoma patient harboring EGFR A763_Y764insFQEA mutation, EGFR A763_Y764insFQEA was associated with partial response to treatment with erlotinib in combination with chemotherapy.",
		"drug_labels": "Erlotinib",
		"variant_name": "A763_Y764insFQEA",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1515/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/596",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/634"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/634",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23371856"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4647",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/634"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/442",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/634"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/635",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/347",
			"name": "EXON 18 OVEREXPRESSION",
			"description": "EGFR EXON 18 OVEREXPRESSION",
			"biomarker_type": "Exon Variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576"
			],
			"soid": "SO:0001791",
			"so_name": "exon_variant",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000344576.2",
			"chromosome": "7",
			"start_pos": 55237999,
			"end_pos": 55238735,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/375/summary/evidence/898/summary#evidence",
		"source": "civic",
		"description": "Overexpression of EGFR exon 18 (Affymetrix Human Exon 1.0 ST) in tumor or blood samples was associated with tumor shrinkage, independently of EGFR mutational status in NSCLC treated with bevacizumab and erlotinib. 76 patients were analyzed for this study.",
		"drug_labels": "Erlotinib,BEVACIZUMAB",
		"variant_name": "OVEREXPRESSION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/375/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/597",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/635"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/635",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24039832"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "898",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/635"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/444",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "BEVACIZUMAB",
				"envcontext_id": "CHEMBL1201583",
				"usan_stem": "monoclonal antibodies",
				"description": "BEVACIZUMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/635"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/443",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/635"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/636",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/189",
			"name": "E868G",
			"description": "EGFR E868G",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259545,
			"end_pos": 55259545,
			"ref": "A",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259545A>G",
			"hgvs_c": "NM_005228.3:c.2603A>G",
			"hgvs_p": "NP_005219.2:p.Glu868Gly",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259545A>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1482/summary/evidence/4301/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a COS-7 cell line expressing EGFR E868G demonstrated increased sensitivity to erlotinib treatment, compared to COS-7 cells expressing EGFR wild-type. Sensitivity was determined by assessing EGFR auto-phosphorylation.",
		"drug_labels": "Erlotinib",
		"variant_name": "E868G",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1482/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/598",
				"source": "http://purl.obolibrary.org/obo/DOID_1790",
				"term": "malignant mesothelioma",
				"pheno_id": "DOID:1790",
				"family": "cell type cancer",
				"description": "malignant mesothelioma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/636"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/636",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20942962"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4301",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/636"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/445",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/636"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/637",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/348",
			"name": "EGFR-RAD51 fusion",
			"description": "EGFR EGFR-RAD51 fusion",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242467,
			"end_pos": 55242467,
			"ref": "A",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55242467A>G",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55242467A>G?assembly=hg19",
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/2203/summary/evidence/5909/summary#evidence",
		"source": "civic",
		"description": "A 48-year-old Chinese man with right lung tumor and multiple brain metastases of a lung adenocarcinoma (T1N2M1, stage IV).  NGS analysis indicated an EGFR-RAD51 fusion rather than the most common kind of EGFR mutations. The patient underwent oral erlotinib treatment and was considered to have a partial response (PR) (according to RECIST). Thus far, after 5 months, the disease is stable and he is continuing treatment with erlotinib.",
		"drug_labels": "Erlotinib",
		"variant_name": "fusion",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/2203/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/599",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/637"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/637",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/29290255"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5909",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/637"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/446",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/637"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/638",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/146",
			"name": "A289V",
			"description": "EGFR A289V",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55221822,
			"end_pos": 55221822,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55221822C>T",
			"hgvs_c": "NM_005228.3:c.866C>T",
			"hgvs_p": "NP_005219.2:p.Ala289Val",
			"dbsnp_ids": [
				"149840192"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55221822C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/996/summary/evidence/4188/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a Ba/F3 cell line expressing EGFR A289V demonstrated increased sensitivity to erlotinib treatment, compared to Ba/F3 cells expressing EGFR wild-type. Variant function was assessed by EGFR auto-phosphorylation. Sensitivity was assessed by cell viability assay using stable transfection of each variant and increasing concentrations of erlotinib (0–10 uM).",
		"drug_labels": "Erlotinib",
		"variant_name": "A289V",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/996/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/600",
				"source": "http://purl.obolibrary.org/obo/DOID_3070",
				"term": "malignant glioma",
				"pheno_id": "DOID:3070",
				"family": "cell type cancer",
				"description": "malignant glioma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/638"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/638",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/17177598"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4188",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/638"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/447",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/638"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/639",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/349",
			"name": "COPY NUMBER VARIATION",
			"description": "EGFR COPY NUMBER VARIATION",
			"biomarker_type": "Copy Number Change",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0002160"
			],
			"soid": "SO:0001563",
			"so_name": "copy_number_change",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/191/summary/evidence/5925/summary#evidence",
		"source": "civic",
		"description": "Among TKI-treated patients, increased EGFR gene copy number appears to be associated with improved survival outcomes.",
		"drug_labels": "GEFITINIB,Erlotinib",
		"variant_name": "VARIATION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/191/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/601",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/639"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/639",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27664271"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5925",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/639"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/449",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/639"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/448",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/639"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/640",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/349",
			"name": "COPY NUMBER VARIATION",
			"description": "EGFR COPY NUMBER VARIATION",
			"biomarker_type": "Copy Number Change",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0002160"
			],
			"soid": "SO:0001563",
			"so_name": "copy_number_change",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/191/summary/evidence/5924/summary#evidence",
		"source": "civic",
		"description": "The result of the analysis found that EGFR gene copy number was associated with increased OS and PFS, supporting the idea that EGFR gene copy number is a biomarker for response to EGFR-TKI therapy in patients with advanced NSCLC.",
		"drug_labels": "GEFITINIB,Erlotinib",
		"variant_name": "VARIATION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/191/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/602",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/640"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/640",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20826716"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5924",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/640"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/451",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/640"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/450",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/640"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/641",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/349",
			"name": "COPY NUMBER VARIATION",
			"description": "EGFR COPY NUMBER VARIATION",
			"biomarker_type": "Copy Number Change",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0002160"
			],
			"soid": "SO:0001563",
			"so_name": "copy_number_change",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/191/summary/evidence/472/summary#evidence",
		"source": "civic",
		"description": "In 134 patients with head and neck squamous cancer 32 had copy number variations. Tumors with variation (either increase or decrease) in copy number of EGFR had worse overall, cancer-specific, and disease-free survival.",
		"drug_labels": null,
		"variant_name": "VARIATION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/191/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/603",
				"source": "http://purl.obolibrary.org/obo/DOID_5520",
				"term": "head and neck squamous cell carcinoma",
				"pheno_id": "DOID:5520",
				"family": "head and neck cancer",
				"description": "head and neck squamous cell carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/641"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/641",
				"type": "Prognostic",
				"description": "Poor Outcome",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/17538160"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "472",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/641"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/642",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/350",
			"name": "delE746_A750",
			"description": "EGFR delE746_A750",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": null,
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/2216/summary/evidence/5946/summary#evidence",
		"source": "civic",
		"description": "HCC827 and PC9 NSCLC cell lines containing delE746_A750 mutation had growth inhibition IC50 with afatinib of 0.0010 and 0.0015 micro molar respectively. In comparison, NCI-H3255 EGFR L858R NSCLC cell line had IC50 0.0007 micro molar, and NCI-H1975 cell line with L858R and T790M resistance mutation had IC50 0.1397 micro molar, suggesting sensitivity to afatinib of delE746_A750.",
		"drug_labels": "AFATINIB",
		"variant_name": "delE746_A750",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/2216/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/604",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/642"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/642",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5946",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/642"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/452",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/642"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/643",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/350",
			"name": "delE746_A750",
			"description": "EGFR delE746_A750",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": null,
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/2216/summary/evidence/5945/summary#evidence",
		"source": "civic",
		"description": "HCC827 and PC9 NSCLC cell lines containing delE746_A750 mutation had growth inhibition IC50 with erlotinib of 0.017 and 0.071 micro molar respectively. In comparison, NCI-H3255 EGFR L858R NSCLC cell line had IC50 0.068 micro molar, and NCI-H1975 cell line with L858R and T790M resistance mutation had IC50 4.282 micro molar, suggesting sensitivity to erlotinib of delE746_A750. Incubation of PC9 and HCC827 cells with 1 micro molar erlotinib reduced phospho-EGFR and phospho-ERK in comparison to controls, and this effect was not seen in a cell line with T790M resistance mutation.",
		"drug_labels": "Erlotinib",
		"variant_name": "delE746_A750",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/2216/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/605",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/643"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/643",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5945",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/643"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/453",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/643"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/644",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/351",
			"name": "N842S",
			"description": "EGFR N842S",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "",
			"chromosome": "7",
			"start_pos": 55259467,
			"end_pos": 55259467,
			"ref": "A",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259467A>G",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259467A>G?assembly=hg19",
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1899/summary/evidence/4256/summary#evidence",
		"source": "civic",
		"description": "In a study, 1 participant with stage IV lung adenocarcinoma was sequenced at EGFR exons 18 to 21 and was found to have N842S mutation, and was treated with the 1st generation TKI gefitinib. The patient (F, 73, nonsmoker) progressive disease as response, progression free survival (PFS) of 0.9 months, overall survival (OS) of 9.7 months and was not alive at study end. As a whole, patients with uncommon EGFR mutations had a response rate of 47.5%, which was between common (del19 and L858R) at 74.1%, and wild type EGFR at 16.5%. Median PFS and OS (months) for the three groups: 5.0 and 15.0 uncommon, 8.5 and 19.6 common, 2.0 and 10.4 wild type.",
		"drug_labels": "GEFITINIB",
		"variant_name": "N842S",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1899/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/606",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/644"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/644",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21531810"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4256",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/644"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/454",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/644"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/645",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/130",
			"name": "T790M",
			"description": "EGFR T790M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249071,
			"end_pos": 55249071,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249071C>T",
			"hgvs_c": "NM_005228.3:c.2369C>T",
			"hgvs_p": "NP_005219.2:p.Thr790Met",
			"dbsnp_ids": [
				"121434569"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249071C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/34/summary/evidence/642/summary#evidence",
		"source": "civic",
		"description": "Lung cancers can accumulate activating mutations in oncogenes such as EGFR. The common L858R EGFR mutation has been shown previously to be sensitive to small molecular tyrosine kinase inhibitors (ie. erlotinib). In response, tumors may accumulate an additional 'gatekeeper' mutation in EGFR, T790M. Authors show that T790M retain low affinity for gefitinib and that introduction of T790M in the presence of L858R mutant increases the ATP affinity of L858R and activates wild-type EGFR, thus showing that increased ATP affinity is the primary mode of resistance in tumors with T790M, though irreversible ATP inhibitors (ie. HKI-272) are able to overcome this resistance via covalent bonding.",
		"drug_labels": "GEFITINIB,497839-62-0",
		"variant_name": "T790M",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/34/summary",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/607",
				"source": "http://purl.obolibrary.org/obo/DOID_1324",
				"term": "lung cancer",
				"pheno_id": "DOID:1324",
				"family": "respiratory system cancer",
				"description": "lung cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/645"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/645",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/18227510"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "642",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/645"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/456",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "497839-62-0",
				"envcontext_id": "CID10297043",
				"usan_stem": null,
				"description": "497839-62-0",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/645"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/455",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/645"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/646",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/130",
			"name": "T790M",
			"description": "EGFR T790M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249071,
			"end_pos": 55249071,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249071C>T",
			"hgvs_c": "NM_005228.3:c.2369C>T",
			"hgvs_p": "NP_005219.2:p.Thr790Met",
			"dbsnp_ids": [
				"121434569"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249071C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/34/summary/evidence/646/summary#evidence",
		"source": "civic",
		"description": "In a phase1-2 study, patients with the T790M mutation were more sensitive to rocelitinib in comparison to patients with T790M-negative NSCLC.",
		"drug_labels": "ROCILETINIB",
		"variant_name": "T790M",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/34/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/608",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/646"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/646",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25923550"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "646",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/646"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/457",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "ROCILETINIB",
				"envcontext_id": "57335384",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "ROCILETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/646"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/647",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/130",
			"name": "T790M",
			"description": "EGFR T790M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249071,
			"end_pos": 55249071,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249071C>T",
			"hgvs_c": "NM_005228.3:c.2369C>T",
			"hgvs_p": "NP_005219.2:p.Thr790Met",
			"dbsnp_ids": [
				"121434569"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249071C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/34/summary/evidence/238/summary#evidence",
		"source": "civic",
		"description": "The T790M mutation in EGFR has been shown to confer resistance to the tyrosine kinase inhibitor erlotinib, and patients harboring this mutation that are placed on the drug are likely to relapse.",
		"drug_labels": "Erlotinib",
		"variant_name": "T790M",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/34/summary",
		"evidence_label": "A",
		"response_type": "resistant",
		"evidence_level": "1",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/609",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/647"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/647",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25668228"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "238",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/647"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/458",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/647"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/648",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/130",
			"name": "T790M",
			"description": "EGFR T790M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249071,
			"end_pos": 55249071,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249071C>T",
			"hgvs_c": "NM_005228.3:c.2369C>T",
			"hgvs_p": "NP_005219.2:p.Thr790Met",
			"dbsnp_ids": [
				"121434569"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249071C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/34/summary/evidence/239/summary#evidence",
		"source": "civic",
		"description": "In non-small cell lung cancer, the appearance of T790M mutation leads to resistance to gefitinib.",
		"drug_labels": "GEFITINIB",
		"variant_name": "T790M",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/34/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/610",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/648"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/648",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15728811"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "239",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/648"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/459",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/648"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/649",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/130",
			"name": "T790M",
			"description": "EGFR T790M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249071,
			"end_pos": 55249071,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249071C>T",
			"hgvs_c": "NM_005228.3:c.2369C>T",
			"hgvs_p": "NP_005219.2:p.Thr790Met",
			"dbsnp_ids": [
				"121434569"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249071C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/34/summary/evidence/240/summary#evidence",
		"source": "civic",
		"description": "In Lung Cancer patients with acquired resistance to Dacomitinib (PF00299804), MET amplification and EGFR T790M were found to be the primary drivers of resistance.",
		"drug_labels": "DACOMITINIB",
		"variant_name": "T790M",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/34/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/611",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/649"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/649",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21430269"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "240",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/649"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/460",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DACOMITINIB",
				"envcontext_id": "11511120",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "DACOMITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/649"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/650",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/130",
			"name": "T790M",
			"description": "EGFR T790M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249071,
			"end_pos": 55249071,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249071C>T",
			"hgvs_c": "NM_005228.3:c.2369C>T",
			"hgvs_p": "NP_005219.2:p.Thr790Met",
			"dbsnp_ids": [
				"121434569"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249071C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/34/summary/evidence/277/summary#evidence",
		"source": "civic",
		"description": "In an NSCLC patient initially with L858R mutation, pemetrexed and cisplatin combination treatment was followed by erlotinib treatment. A slow progression developed which was found to be positive for L858R as well as T790M mutation which confers resistance to tyrosine kinase inhibitors. Due to slow tumor growth erlotinib was continued despite T790M, with re-addition of premetrexed, and this reduced tumor size and resulted in stable disease.",
		"drug_labels": "Erlotinib,Pemetrexed",
		"variant_name": "T790M",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/34/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/612",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/650"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/650",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24636847"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "277",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/650"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/462",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Pemetrexed",
				"envcontext_id": "60843",
				"usan_stem": null,
				"description": "Pemetrexed",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/650"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/461",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/650"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/651",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/130",
			"name": "T790M",
			"description": "EGFR T790M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249071,
			"end_pos": 55249071,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249071C>T",
			"hgvs_c": "NM_005228.3:c.2369C>T",
			"hgvs_p": "NP_005219.2:p.Thr790Met",
			"dbsnp_ids": [
				"121434569"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249071C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/34/summary/evidence/278/summary#evidence",
		"source": "civic",
		"description": "In NSCLC containing a T790M mutation, staurosporine may be inhibitive of EGFR, especially when an L858R mutation is also present.",
		"drug_labels": "Staurosporine",
		"variant_name": "T790M",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/34/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/613",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/651"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/651",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24658966"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "278",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/651"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/463",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Staurosporine",
				"envcontext_id": "44259",
				"usan_stem": null,
				"description": "Staurosporine",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/651"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/652",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/130",
			"name": "T790M",
			"description": "EGFR T790M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249071,
			"end_pos": 55249071,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249071C>T",
			"hgvs_c": "NM_005228.3:c.2369C>T",
			"hgvs_p": "NP_005219.2:p.Thr790Met",
			"dbsnp_ids": [
				"121434569"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249071C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/34/summary/evidence/3801/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a Ba/F3 cell line expressing EGFR S752_I759del demonstrated increased sensitivity to erlotinib treatment (IC50=33nM), comparable to Ba/F3 cells expressing EGFR L858R (a known sensitizing mutation to EGFR tyrosine kinase inhibitors; IC50=16nM). Sensitivity was determined by assessing IL-3 independent cell survival.",
		"drug_labels": "Erlotinib",
		"variant_name": "T790M",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/34/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/614",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/652"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/652",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/17877814"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3801",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/652"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/464",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/652"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/653",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/130",
			"name": "T790M",
			"description": "EGFR T790M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249071,
			"end_pos": 55249071,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249071C>T",
			"hgvs_c": "NM_005228.3:c.2369C>T",
			"hgvs_p": "NP_005219.2:p.Thr790Met",
			"dbsnp_ids": [
				"121434569"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249071C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/34/summary/evidence/3806/summary#evidence",
		"source": "civic",
		"description": "In a lung adenocarcinoma patient with EGFR E746_A751>A (a known erlotinib sensitizing mutation) and EGFR T790M co-mutation treated with erlotinib monotherapy, EGFR T790M was associated with disease progression. The patient was treated with erlotinib monotherapy and achieved a 10 month response rate, but subsequently developed disease progression upon emergence of the EGFR T790M mutation.",
		"drug_labels": "Erlotinib",
		"variant_name": "T790M",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/34/summary",
		"evidence_label": "C",
		"response_type": "resistant",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/615",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/653"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/653",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/17085664"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3806",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/653"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/465",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/653"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/654",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/130",
			"name": "T790M",
			"description": "EGFR T790M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249071,
			"end_pos": 55249071,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249071C>T",
			"hgvs_c": "NM_005228.3:c.2369C>T",
			"hgvs_p": "NP_005219.2:p.Thr790Met",
			"dbsnp_ids": [
				"121434569"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249071C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/34/summary/evidence/3807/summary#evidence",
		"source": "civic",
		"description": "In a study of 6 patients with progressive non-small cell lung cancer during gefitinib or erlotinib therapy,  comparison of DNA sequences from the original diagnostic biopsy specimen and the second biopsy specimen demonstrated that 2 patients acquired a new EGFR-T790M mutation.",
		"drug_labels": "Erlotinib",
		"variant_name": "T790M",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/34/summary",
		"evidence_label": "C",
		"response_type": "resistant",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/616",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/654"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/654",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15737014"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3807",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/654"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/466",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/654"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/655",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/130",
			"name": "T790M",
			"description": "EGFR T790M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249071,
			"end_pos": 55249071,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249071C>T",
			"hgvs_c": "NM_005228.3:c.2369C>T",
			"hgvs_p": "NP_005219.2:p.Thr790Met",
			"dbsnp_ids": [
				"121434569"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249071C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/34/summary/evidence/3808/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a NCI-H1975 cell line expressing EGFR L858R and EGFR T790M co-mutation, EGFR T790M was associated with reduced sensitivity to erlotinib treatment compared to QG56 cells expressing EGFR wild-type. Sensitivity was determined by assessing cell viability (mean IC50 of erlotinib for cells expressing EGFR L858R and EGFR T790M co-mutations was 4.3 �M vs. 8.9 �M for EGFR wild-type expressing cells).",
		"drug_labels": "Erlotinib",
		"variant_name": "T790M",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/34/summary",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/617",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/655"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/655",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25853010"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3808",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/655"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/467",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/655"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/656",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/130",
			"name": "T790M",
			"description": "EGFR T790M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249071,
			"end_pos": 55249071,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249071C>T",
			"hgvs_c": "NM_005228.3:c.2369C>T",
			"hgvs_p": "NP_005219.2:p.Thr790Met",
			"dbsnp_ids": [
				"121434569"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249071C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/34/summary/evidence/963/summary#evidence",
		"source": "civic",
		"description": "Cell line, xenograft, and transgenic models were used to establish Osimertinib as an inhibitor of both EGFR mutation sensitizing (L858M, del exon 19) and T790M resistance mutants. Preclinically, the drug inhibits signaling pathways and cellular growth in both EGFRm(+) and EGFRm(+)/T790M(+) mutant cell lines in vitro, with lower activity against wild-type EGFR lines. Sustained tumor regression was observed in EGFR-mutant tumor xenograft and transgenic models. Treatment of 2 patients with advanced EGFRm(+) T790M(+) NSCLC was reported as proof of principle.",
		"drug_labels": "OSIMERTINIB",
		"variant_name": "T790M",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/34/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/618",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/656"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/656",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24893891"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "963",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/656"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/468",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "OSIMERTINIB",
				"envcontext_id": "71496458",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "OSIMERTINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/656"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/657",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/130",
			"name": "T790M",
			"description": "EGFR T790M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249071,
			"end_pos": 55249071,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249071C>T",
			"hgvs_c": "NM_005228.3:c.2369C>T",
			"hgvs_p": "NP_005219.2:p.Thr790Met",
			"dbsnp_ids": [
				"121434569"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249071C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/34/summary/evidence/965/summary#evidence",
		"source": "civic",
		"description": "This phase I/II trial (NCT01802632) involved 253 non-small cell lung cancer patients with activating EGFR mutations, who had progressed on first generation tyrosine kinase inhibitor treatment, and were subsequently treated with Osimertinib (AZD9291). The overall objective tumor response rate was 51%. Among 127 patients with EGFR T790M who could be evaluated for response, the response rate was 61% (95% CI, 52 to 70). In contrast, among 61 patients without EGFR T790M, the response rate was 21% (95% CI, 12 to 34). The median progression-free survival was 9.6 months in EGFR T790M-positive patients and 2.8 months in EGFR T790M-negative patients.",
		"drug_labels": "OSIMERTINIB",
		"variant_name": "T790M",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/34/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/619",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/657"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/657",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25923549"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "965",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/657"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/469",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "OSIMERTINIB",
				"envcontext_id": "71496458",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "OSIMERTINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/657"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/658",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/130",
			"name": "T790M",
			"description": "EGFR T790M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249071,
			"end_pos": 55249071,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249071C>T",
			"hgvs_c": "NM_005228.3:c.2369C>T",
			"hgvs_p": "NP_005219.2:p.Thr790Met",
			"dbsnp_ids": [
				"121434569"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249071C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/34/summary/evidence/966/summary#evidence",
		"source": "civic",
		"description": "This study summarized 9 EGFR-mutant patients from two clinical trials involving rociletinib (NCT01526928) and subsequent osimertinib (NCT01802632). 8 were T790M-positive prior to treatment with osimertinib. 6 transitioned directly from rociletinib to osimertinib. 3 patients achieved PR and 4 achieved SD. The median PFS was 208 days (95% CI, 41-208 days). Among 6 patients who transitioned directly from rociletinib to osimertinib all derived clinical benefit from osimertinib with either prolonged SD or PR.",
		"drug_labels": "OSIMERTINIB",
		"variant_name": "T790M",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/34/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/620",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/658"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/658",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26720284"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "966",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/658"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/470",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "OSIMERTINIB",
				"envcontext_id": "71496458",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "OSIMERTINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/658"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/659",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/130",
			"name": "T790M",
			"description": "EGFR T790M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249071,
			"end_pos": 55249071,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249071C>T",
			"hgvs_c": "NM_005228.3:c.2369C>T",
			"hgvs_p": "NP_005219.2:p.Thr790Met",
			"dbsnp_ids": [
				"121434569"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249071C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/34/summary/evidence/967/summary#evidence",
		"source": "civic",
		"description": "For cell harboring EGFR T790M mutation, osimertinib and rociletinib showed potent inhibition compared to erlotinib or afatinib. This study performed drug response assays using five human NSCLC cell lines with various combinations of EGFR mutations. In order to directly compare the sensitivity of multiple EGFR mutations to EGFR-TKIs the authors also generated multiple EGFR transduced Ba/F3 stable cell lines and evaluated sensitivity to EGFR-TKIs by MTS assay.",
		"drug_labels": "OSIMERTINIB,ROCILETINIB",
		"variant_name": "T790M",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/34/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/621",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/659"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/659",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26515464"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "967",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/659"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/472",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "ROCILETINIB",
				"envcontext_id": "57335384",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "ROCILETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/659"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/471",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "OSIMERTINIB",
				"envcontext_id": "71496458",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "OSIMERTINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/659"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/660",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/130",
			"name": "T790M",
			"description": "EGFR T790M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249071,
			"end_pos": 55249071,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249071C>T",
			"hgvs_c": "NM_005228.3:c.2369C>T",
			"hgvs_p": "NP_005219.2:p.Thr790Met",
			"dbsnp_ids": [
				"121434569"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249071C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/34/summary/evidence/3809/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a MCF-7 cell line expressing EGFR L858R and T790M co-mutation demonstrated resistance to erlotinib treatment, compared to MCF-7 cells expressing a known erlotinib sensitizing mutation (EGFR L858R). Sensitivity was determined by assessing YFP signal-EGFR relocation.",
		"drug_labels": "Erlotinib",
		"variant_name": "T790M",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/34/summary",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/622",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/660"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/660",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21132006"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3809",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/660"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/473",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/660"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/661",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/130",
			"name": "T790M",
			"description": "EGFR T790M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249071,
			"end_pos": 55249071,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249071C>T",
			"hgvs_c": "NM_005228.3:c.2369C>T",
			"hgvs_p": "NP_005219.2:p.Thr790Met",
			"dbsnp_ids": [
				"121434569"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249071C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/34/summary/evidence/3810/summary#evidence",
		"source": "civic",
		"description": "Experimental - EGFR T790M mutation has been associated with resistance to first generation EGFR tyrosine kinase inhibitors, including erlotinib and gefitinib. In an in vitro study, Ba/F3 cells stably expressing EGFR T790M demonstrated  resistance to gefitinib and erlotinib and the tool construct AEE788. These cells had very high IC50 nmol/L values for all three inhibitors in comparison to other constructs (Gefitinib>2000, Erlotinib>2000, AEE788>2000), indicating resitance to all three inhibitors.",
		"drug_labels": "Erlotinib",
		"variant_name": "T790M",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/34/summary",
		"evidence_label": "D",
		"response_type": null,
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/623",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/661"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/661",
				"type": "Predictive",
				"description": null,
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19147750"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3810",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/661"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/474",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/661"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/662",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/130",
			"name": "T790M",
			"description": "EGFR T790M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249071,
			"end_pos": 55249071,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249071C>T",
			"hgvs_c": "NM_005228.3:c.2369C>T",
			"hgvs_p": "NP_005219.2:p.Thr790Met",
			"dbsnp_ids": [
				"121434569"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249071C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/34/summary/evidence/3812/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, the recombinant EGFR T790M mutation kinase was associated with reduced sensitivity to bosutinib(IC50: 491nM), as compared to wild-type EGFR kinase (IC50: 53nM). Resistance was assessed by analyzing kinase inhibition.",
		"drug_labels": "BOSUTINIB MONOHYDRATE",
		"variant_name": "T790M",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/34/summary",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/624",
				"source": "http://purl.obolibrary.org/obo/DOID_8552",
				"term": "chronic myeloid leukemia",
				"pheno_id": "DOID:8552",
				"family": "leukemia",
				"description": "chronic myeloid leukemia",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/662"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/662",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19039322"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3812",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/662"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/475",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "BOSUTINIB MONOHYDRATE",
				"envcontext_id": "5328940",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "BOSUTINIB MONOHYDRATE",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/662"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/663",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/130",
			"name": "T790M",
			"description": "EGFR T790M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249071,
			"end_pos": 55249071,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249071C>T",
			"hgvs_c": "NM_005228.3:c.2369C>T",
			"hgvs_p": "NP_005219.2:p.Thr790Met",
			"dbsnp_ids": [
				"121434569"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249071C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/34/summary/evidence/1391/summary#evidence",
		"source": "civic",
		"description": "155 patients with lung adenocarcinomas underwent rebiopsy and genotyping (EGFR, AKT1, BRAF, ERBB2, KRAS, MEK1, NRAS, PIK3CA and FISH for MET and HER2) after the development of acquired resistance to EGFR inhibitors (gefitinib or erlotinib). 98 patients were found to have developed EGFR T790M mutations.",
		"drug_labels": "GEFITINIB,Erlotinib",
		"variant_name": "T790M",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/34/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/625",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/663"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/663",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23470965"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1391",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/663"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/477",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/663"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/476",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/663"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/664",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/130",
			"name": "T790M",
			"description": "EGFR T790M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249071,
			"end_pos": 55249071,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249071C>T",
			"hgvs_c": "NM_005228.3:c.2369C>T",
			"hgvs_p": "NP_005219.2:p.Thr790Met",
			"dbsnp_ids": [
				"121434569"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249071C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/34/summary/evidence/762/summary#evidence",
		"source": "civic",
		"description": "CO-1686 (Rociletinib) more effectively induced apoptosis in EGFR mutated (T790M and others) NSCLC cell lines than those harboring wildtype EGFR. CO-1686 also more effectively reduced tumor volume of mouse xenografts harboring the T790M than those with wildtype EGFR.",
		"drug_labels": "ROCILETINIB",
		"variant_name": "T790M",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/34/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/626",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/664"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/664",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24065731"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "762",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/664"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/478",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "ROCILETINIB",
				"envcontext_id": "57335384",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "ROCILETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/664"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/665",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/130",
			"name": "T790M",
			"description": "EGFR T790M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249071,
			"end_pos": 55249071,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249071C>T",
			"hgvs_c": "NM_005228.3:c.2369C>T",
			"hgvs_p": "NP_005219.2:p.Thr790Met",
			"dbsnp_ids": [
				"121434569"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249071C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/34/summary/evidence/1592/summary#evidence",
		"source": "civic",
		"description": "Osimertinib has been approved for the treatment of EGFR T790M mutant NSCLC.",
		"drug_labels": "OSIMERTINIB",
		"variant_name": "T790M",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/34/summary",
		"evidence_label": "A",
		"response_type": "Sensitivity/Response",
		"evidence_level": "1",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/627",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/665"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/665",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26729184"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1592",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/665"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/479",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "OSIMERTINIB",
				"envcontext_id": "71496458",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "OSIMERTINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/665"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/666",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/130",
			"name": "T790M",
			"description": "EGFR T790M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249071,
			"end_pos": 55249071,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249071C>T",
			"hgvs_c": "NM_005228.3:c.2369C>T",
			"hgvs_p": "NP_005219.2:p.Thr790Met",
			"dbsnp_ids": [
				"121434569"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249071C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/34/summary/evidence/1667/summary#evidence",
		"source": "civic",
		"description": "48 tumor samples from 41 patients with EGFR mutant lung adenocarcinoma that were resistant to tyrosine kinase inhibition underwent next generation sequencing (NGS failed in 5 samples leading to a remaining 43 specimens from 39 patients). The prevalence of various mutations post-treatment was analyzed. 79%, or 31 out of the 39 patients,  had the T790M EGFR mutation present, indicating its importance in the development of resistance.",
		"drug_labels": "GEFITINIB,Erlotinib,AFATINIB",
		"variant_name": "T790M",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/34/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/628",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/666"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/666",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27304188"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1667",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/666"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/482",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/666"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/481",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/666"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/480",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/666"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/667",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/130",
			"name": "T790M",
			"description": "EGFR T790M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249071,
			"end_pos": 55249071,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249071C>T",
			"hgvs_c": "NM_005228.3:c.2369C>T",
			"hgvs_p": "NP_005219.2:p.Thr790Met",
			"dbsnp_ids": [
				"121434569"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249071C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/34/summary/evidence/1397/summary#evidence",
		"source": "civic",
		"description": "Case report of a patient with stage IV lung adenocarcinoma and a 15–base pair deletion in EGFR exon 19. Partial response with erlotinib was achieved for 15 months after initial chemotherapy. After further progression, rebiopsy additionally identified the EGFR T790M mutation and the patient received several cycles of chemotherapy and targeted therapy including afatinib, cetuximab, erlotinib, AZD9291. She was treated with AZD9291 for 9 months until disease progression.",
		"drug_labels": "OSIMERTINIB",
		"variant_name": "T790M",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/34/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/629",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/667"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/667",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26181354"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1397",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/667"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/483",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "OSIMERTINIB",
				"envcontext_id": "71496458",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "OSIMERTINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/667"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/668",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/130",
			"name": "T790M",
			"description": "EGFR T790M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249071,
			"end_pos": 55249071,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249071C>T",
			"hgvs_c": "NM_005228.3:c.2369C>T",
			"hgvs_p": "NP_005219.2:p.Thr790Met",
			"dbsnp_ids": [
				"121434569"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249071C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/34/summary/evidence/1863/summary#evidence",
		"source": "civic",
		"description": "Patients with advanced NSCLC and acquired resistance to EGFR TKI (gefitinib or erlotinib) were analyzed for T790M mutations.  Of the 70 patients analyzed, 36 (51%) had the T790M mutation and 34 (49%) were T790M-negative.  There was no significant difference in the median post-progression or overall survival between patients with T790M mutation and without T790M mutation for initial TKI treatment.  However, subsequent treatment with afatinib showed partial response in six patients where 1/21(5%) were in the T790M-positive group and 5/13 (38%) were in the T790M-negative group (P=0.01).",
		"drug_labels": "AFATINIB",
		"variant_name": "T790M",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/34/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/630",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/668"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/668",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24035188"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1863",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/668"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/484",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/668"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/669",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/130",
			"name": "T790M",
			"description": "EGFR T790M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249071,
			"end_pos": 55249071,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249071C>T",
			"hgvs_c": "NM_005228.3:c.2369C>T",
			"hgvs_p": "NP_005219.2:p.Thr790Met",
			"dbsnp_ids": [
				"121434569"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249071C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/34/summary/evidence/1867/summary#evidence",
		"source": "civic",
		"description": "Randomized, international, open-label, phase 3 trial (NCT02151981) in 419 patients with T790M-positive advanced NSCLC and disease progression after first-line EGFR-TKI therapy. Patients were randomized, in a 2:1 ratio, to oral osimertinib or chemotherapy (pemetrexed plus either carboplatin or cisplatin every 3 weeks for up to six cycles, maintenance pemetrexed was allowed). Primary end point was PFS, which was significantly longer with osimertinib than with chemotherapy (10.1 months vs. 4.4 months; HR 0.30; 95% CI: 0.23 to 0.41; P<0.001). Objective response rate was significantly better with osimertinib (71%; 95% CI, 65 to 76) than with chemotherapy (31%; 95% CI, 24 to 40) (odds ratio for objective response, 5.39; 95% CI, 3.47 to 8.48; P<0.001).",
		"drug_labels": "OSIMERTINIB",
		"variant_name": "T790M",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/34/summary",
		"evidence_label": "A",
		"response_type": "Sensitivity/Response",
		"evidence_level": "1",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/631",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/669"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/669",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27959700"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1867",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/669"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/485",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "OSIMERTINIB",
				"envcontext_id": "71496458",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "OSIMERTINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/669"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/670",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/130",
			"name": "T790M",
			"description": "EGFR T790M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249071,
			"end_pos": 55249071,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249071C>T",
			"hgvs_c": "NM_005228.3:c.2369C>T",
			"hgvs_p": "NP_005219.2:p.Thr790Met",
			"dbsnp_ids": [
				"121434569"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249071C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/34/summary/evidence/2157/summary#evidence",
		"source": "civic",
		"description": "In a lung adenocarcinoma patient harboring an EGFR E746_A750 mutation and an acquired EGFR T790M co-mutation, EGFR T790M was associated with sensitivity to osimertinib monotherapy. Prior to the development of the EGFR T790M mutation, the patient was treated with gefitinib and achieved a partial response, but subsequently tumor progression occurred; however, osimertinib treatment resulted a favorable tumor response with the extinguishment of the EGFR T790M mutation. In a stage IV lung adenocarcinoma patient harboring an EGFR L858R mutation and an acquired EGFR T790M co-mutation, EGFR T790M was associated with sensitivity to osimertinib monotherapy. Prior to the development of the EGFR T790M mutation, the patient was treated with erlotinib, followed by gefitinib for 12 months and achieved stable disease, but subsequently metastasis occurred; the EGFR T790M was then identified and subsequent 10 month treatment with osimertinib monotherapy resulted in a 45% disease regression.",
		"drug_labels": "OSIMERTINIB",
		"variant_name": "T790M",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/34/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/632",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/670"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/670",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26269204"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2157",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/670"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/486",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "OSIMERTINIB",
				"envcontext_id": "71496458",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "OSIMERTINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/670"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/671",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/130",
			"name": "T790M",
			"description": "EGFR T790M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249071,
			"end_pos": 55249071,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249071C>T",
			"hgvs_c": "NM_005228.3:c.2369C>T",
			"hgvs_p": "NP_005219.2:p.Thr790Met",
			"dbsnp_ids": [
				"121434569"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249071C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/34/summary/evidence/2158/summary#evidence",
		"source": "civic",
		"description": "In a study of 6 patients with progressive non-small cell lung cancer during gefitinib or erlotinib therapy,  comparison of DNA sequences from the original diagnostic biopsy specimen and the second biopsy specimen demonstrated that 2 patients acquired a new EGFR-T790M mutation.",
		"drug_labels": "GEFITINIB",
		"variant_name": "T790M",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/34/summary",
		"evidence_label": "C",
		"response_type": "resistant",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/633",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/671"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/671",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15737014"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2158",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/671"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/487",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/671"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/672",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/130",
			"name": "T790M",
			"description": "EGFR T790M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249071,
			"end_pos": 55249071,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249071C>T",
			"hgvs_c": "NM_005228.3:c.2369C>T",
			"hgvs_p": "NP_005219.2:p.Thr790Met",
			"dbsnp_ids": [
				"121434569"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249071C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/34/summary/evidence/2159/summary#evidence",
		"source": "civic",
		"description": "In a study of 14 patients with progressive non-small cell lung cancer during gefitinib,  comparison of DNA sequences from the original diagnostic biopsy specimen and the second biopsy specimen demonstrated that 7 patients acquired a new EGFR-T790M mutation.",
		"drug_labels": "GEFITINIB",
		"variant_name": "T790M",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/34/summary",
		"evidence_label": "C",
		"response_type": "resistant",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/634",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/672"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/672",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/17020982"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2159",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/672"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/488",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/672"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/673",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/130",
			"name": "T790M",
			"description": "EGFR T790M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249071,
			"end_pos": 55249071,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249071C>T",
			"hgvs_c": "NM_005228.3:c.2369C>T",
			"hgvs_p": "NP_005219.2:p.Thr790Met",
			"dbsnp_ids": [
				"121434569"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249071C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/34/summary/evidence/2160/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study using NCI-H1666 cells (wildtype EGFR) and NCI-H1975 cells (EGFR-L858R/T790M), inhibition of cell growth was used as an assay to determine sensitivity to reversible tyrosine kinase inhibitor drugs. Cells with an EGFR L858R/T790M mutation demonstrated a reduced response to lapatinib (IC50: >4000nM vs. 534nM) compared to wildtype EGFR cells. Similarly, NIH-3T3 ectopically expression EGFR-L858R/T790M showed reduced sensistivity to lapatinib compared to EGFR wt or L585R mutant cells. These results were further confirmed in a Ba/F3 cell line model",
		"drug_labels": "Lapatinib",
		"variant_name": "T790M",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/34/summary",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/635",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/673"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/673",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/18408761"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2160",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/673"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/489",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Lapatinib",
				"envcontext_id": "208908",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Lapatinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/673"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/674",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/130",
			"name": "T790M",
			"description": "EGFR T790M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249071,
			"end_pos": 55249071,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249071C>T",
			"hgvs_c": "NM_005228.3:c.2369C>T",
			"hgvs_p": "NP_005219.2:p.Thr790Met",
			"dbsnp_ids": [
				"121434569"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249071C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/34/summary/evidence/2161/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study using NCI-H322 cells (wildtype EGFR) and NCI-H1975 cells (EGFR-L858R/T790M), inhibition of cell growth was used as an assay to determine sensitivity to irreversible tyrosine kinase inhibitor (TKI) drugs. PF00299804 inhibited the growth of Ba/F3 cell lines containing the EFGR T790M resistance mutation as well as H1975 and H3255 cell lines that contain both EGFR L858R and T790M mutations and H820 containing an EGFR exon 19 deletion (Del 747_L751, Ins S) and a T790M mutation. All three cell lines were resistant to gefitinib in vitro, but sensitive to PF00299804 (IC50 <1 μmol/L for all three cell lines).",
		"drug_labels": "DACOMITINIB",
		"variant_name": "T790M",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/34/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/636",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/674"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/674",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/18089823"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2161",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/674"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/490",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "DACOMITINIB",
				"envcontext_id": "CHEMBL2105719",
				"usan_stem": null,
				"description": "DACOMITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/674"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/675",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/130",
			"name": "T790M",
			"description": "EGFR T790M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249071,
			"end_pos": 55249071,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249071C>T",
			"hgvs_c": "NM_005228.3:c.2369C>T",
			"hgvs_p": "NP_005219.2:p.Thr790Met",
			"dbsnp_ids": [
				"121434569"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249071C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/34/summary/evidence/2162/summary#evidence",
		"source": "civic",
		"description": "The NSCLC cell line NCI-H1975 carrying the EGFR T790M mutation was resistant to erlotinib but showed increased sensitivity to HKI-272 (neratinib, IC50: 0.29 μmol/L).\nIn an in vitro study Ba/F3 cells transfected with either EGFR-L858R or EGFR-L858R/T790M were used to assay cell growth. Ba/F3 cells require IL-3 in order to proliferate, but cells transfected with an activated oncogene are IL-3 independent. Cells with an EGFR L858R/T790M mutation demonstrated an improved response to neratinib (IC50: 0.185umol/L vs. >10umol/L) compared to the same cells treated with erlotinib.",
		"drug_labels": "NERATINIB",
		"variant_name": "T790M",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/34/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/637",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/675"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/675",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/16818618"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2162",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/675"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/491",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "NERATINIB",
				"envcontext_id": "9915743",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "NERATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/675"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/676",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/130",
			"name": "T790M",
			"description": "EGFR T790M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249071,
			"end_pos": 55249071,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249071C>T",
			"hgvs_c": "NM_005228.3:c.2369C>T",
			"hgvs_p": "NP_005219.2:p.Thr790Met",
			"dbsnp_ids": [
				"121434569"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249071C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/34/summary/evidence/2163/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study using NCI-H1666 cells (wildtype EGFR) and NCI-H1975 cells (EGFR-L858R/T790M), inhibition of cell growth was used as an assay to determine sensitivity to tyrosine kinase inhibitor (TKI) drugs. Cells with an EGFR L858R/T790M mutation demonstrated an improved response to afatinib (IC50: 99nM vs. >4000nM) compared to the same cells treated with erlotinib. In an in vivo mouse xenograft study, the growth of cells with an EGFR-L858R/T790M mutation were more sensitive to treatment of afatinib (concentration: 15-20mg/kg) (median tumor volume = 75-150mm^3 vs. 1000mm^3), compared to reversible TKI lapatinib-treated xenografts. However, no complete responses were observed with afatinib alone.",
		"drug_labels": "AFATINIB",
		"variant_name": "T790M",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/34/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/638",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/676"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/676",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/18408761"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2163",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/676"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/492",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/676"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/677",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/130",
			"name": "T790M",
			"description": "EGFR T790M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249071,
			"end_pos": 55249071,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249071C>T",
			"hgvs_c": "NM_005228.3:c.2369C>T",
			"hgvs_p": "NP_005219.2:p.Thr790Met",
			"dbsnp_ids": [
				"121434569"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249071C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/34/summary/evidence/2164/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study using purified EGFR protein, kinase activity was assayed and compared for wildtype EGFR, EGFR-T790M and EGFR-T790M/L858R using both reversible and irreversible TKI drugs. EFGR proteins with T790M or T790M/L858R mutations were more sensitive to afatinib treatment (IC50: 9.8nM and 24nM, respectively vs. IC50: >1000nM and >1000nM, respectively) compared to treatment with erlotinib or lapatinib treatment. In an in vitro study using NCI-H358 cells (wildtype EGFR) and NCI-H1975 cells (EGFR-L858R/T790M), inhibition of cell growth was used as an assay to determine sensitivity to tyrosine kinase inhibitor drugs. Cells with an EGFR L858R/T790M mutation demonstrated an improved response to afatinib (GI50: 42.0nM vs. >1000nM) compared to the same cells treated with erlotinib. However, IC50s were intermediate compared to a more potent pan-HER inhibitor.",
		"drug_labels": "AFATINIB",
		"variant_name": "T790M",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/34/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/639",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/677"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/677",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21732342"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2164",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/677"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/493",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/677"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/678",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/130",
			"name": "T790M",
			"description": "EGFR T790M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249071,
			"end_pos": 55249071,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249071C>T",
			"hgvs_c": "NM_005228.3:c.2369C>T",
			"hgvs_p": "NP_005219.2:p.Thr790Met",
			"dbsnp_ids": [
				"121434569"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249071C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/34/summary/evidence/2165/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study using NCI-H1666 cells (wildtype EGFR) and NCI-H1975 cells (EGFR-L858R/T790M), inhibition of cell growth was used as an assay to determine sensitivity to tyrosine kinase inhibitor (TKI) drugs. Cells with an EGFR L858R/T790M mutation demonstrated an improved response to canertinib (IC50: 101nM vs. >4000nM) compared to the same cells treated with erlotinib. IC50 values of canertinib were comparable to afatinib.",
		"drug_labels": "CANERTINIB",
		"variant_name": "T790M",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/34/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/640",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/678"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/678",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/18408761"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2165",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/678"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/494",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "CANERTINIB",
				"envcontext_id": "156414",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "CANERTINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/678"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/679",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/130",
			"name": "T790M",
			"description": "EGFR T790M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249071,
			"end_pos": 55249071,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249071C>T",
			"hgvs_c": "NM_005228.3:c.2369C>T",
			"hgvs_p": "NP_005219.2:p.Thr790Met",
			"dbsnp_ids": [
				"121434569"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249071C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/34/summary/evidence/4836/summary#evidence",
		"source": "civic",
		"description": "Currently, there are no effective therapeutic strategies to overcome the C797S/T790M/activating-mutation (triple-mutation)-mediated EGFR-TKI resistance to Osimertinib. In the present study, we identify brigatinib to be effective against triple-mutation-harbouring cells in vitro and in vivo. The efficacy of brigatinib is enhanced markedly by combination with anti-EGFR antibodies Ceutximab or Panitumumab because of the decrease of surface and total EGFR expression. Thus, the combination therapy of brigatinib with anti-EGFR antibody is a powerful candidate to overcome triple-mutant EGFR.",
		"drug_labels": "BRIGATINIB,PANITUMUMAB,CETUXIMAB",
		"variant_name": "T790M",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/34/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/641",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/679"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/679",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28287083"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4836",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/679"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/497",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/679"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/496",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "PANITUMUMAB",
				"envcontext_id": "CHEMBL1201827",
				"usan_stem": "monoclonal antibodies",
				"description": "PANITUMUMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/679"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/495",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "BRIGATINIB",
				"envcontext_id": "68165256",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "BRIGATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/679"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/680",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/130",
			"name": "T790M",
			"description": "EGFR T790M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249071,
			"end_pos": 55249071,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249071C>T",
			"hgvs_c": "NM_005228.3:c.2369C>T",
			"hgvs_p": "NP_005219.2:p.Thr790Met",
			"dbsnp_ids": [
				"121434569"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249071C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/34/summary/evidence/6006/summary#evidence",
		"source": "civic",
		"description": "Patients with recurrent pancreatic adenocarcinoma was treated with gemcitabine + nab-paclitaxel, FOLFIRINOX and docetaxel + irinotecan. After failure of these treatment, a tumor specimen from the pancreaticoduodenectomy was analysed, which revealed an activating mutation in exon 19 (L747_P753>S) of EGFR. Mutations were also detected in CDKN2A, TP53, and amplifications of PRKCI and TERC. He began erlotinib at 150mg daily. CT imaging  revealed a partial response by RECIST at 8, 24 and 32 weeks after starting erlotinib. At 40 weeks CT imaging revealed unequivocal disease progression. After disease progression to erlotinib, a repeat liver biopsy revealed an EGFR T790M mutation. He began treatment with osimertinib at 80mg daily. After 8 weeks of this treatment CT imaging revealed unequivocal disease progression.",
		"drug_labels": "OSIMERTINIB",
		"variant_name": "T790M",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/34/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/642",
				"source": "http://purl.obolibrary.org/obo/DOID_4074",
				"term": "pancreatic adenocarcinoma",
				"pheno_id": "DOID:4074",
				"family": "pancreatic cancer",
				"description": "pancreatic adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/680"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/680",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28874593"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6006",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/680"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/498",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "OSIMERTINIB",
				"envcontext_id": "71496458",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "OSIMERTINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/680"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/681",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/130",
			"name": "T790M",
			"description": "EGFR T790M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249071,
			"end_pos": 55249071,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249071C>T",
			"hgvs_c": "NM_005228.3:c.2369C>T",
			"hgvs_p": "NP_005219.2:p.Thr790Met",
			"dbsnp_ids": [
				"121434569"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249071C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/34/summary/evidence/370/summary#evidence",
		"source": "civic",
		"description": "Patients with NSCLC harboring EGFR T790M mutation have statistically worse overall survival compared to patients with L858R or other exon 19 activating mutations.",
		"drug_labels": null,
		"variant_name": "T790M",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/34/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/643",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/681"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/681",
				"type": "Prognostic",
				"description": "Poor Outcome",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24729716"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "370",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/681"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/682",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/130",
			"name": "T790M",
			"description": "EGFR T790M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55249071,
			"end_pos": 55249071,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55249071C>T",
			"hgvs_c": "NM_005228.3:c.2369C>T",
			"hgvs_p": "NP_005219.2:p.Thr790Met",
			"dbsnp_ids": [
				"121434569"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249071C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/34/summary/evidence/369/summary#evidence",
		"source": "civic",
		"description": "In NSCLC patients with T790M and another activating mutations, their progression free survival is shorter compared to those who do not possess T790M mutation.",
		"drug_labels": null,
		"variant_name": "T790M",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/34/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/644",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/682"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/682",
				"type": "Prognostic",
				"description": "Poor Outcome",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24623981"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "369",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/682"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/683",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/283",
			"name": "W731L",
			"description": "EGFR W731L",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242422,
			"end_pos": 55242422,
			"ref": "G",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55242422G>T",
			"hgvs_c": "NM_005228.3:c.2192G>T",
			"hgvs_p": "NP_005219.2:p.Trp731Leu",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55242422G>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1571/summary/evidence/4655/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a COS-7 cell line expressing EGFR W731L demonstrated increased sensitivity to erlotinib treatment, compared to COS-7 cells expressing EGFR wild-type. Sensitivity was determined by assessing EGFR auto-phosphorylation.",
		"drug_labels": "Erlotinib",
		"variant_name": "W731L",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1571/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/645",
				"source": "http://purl.obolibrary.org/obo/DOID_1790",
				"term": "malignant mesothelioma",
				"pheno_id": "DOID:1790",
				"family": "cell type cancer",
				"description": "malignant mesothelioma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/683"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/683",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20942962"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4655",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/683"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/499",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/683"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/684",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/352",
			"name": "RARE EX 18-21 MUT",
			"description": "EGFR RARE EX 18-21 MUT",
			"biomarker_type": "Exon Variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576"
			],
			"soid": "SO:0001791",
			"so_name": "exon_variant",
			"reference_name": null,
			"refseq": null,
			"isoform": "",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": "",
			"alt": "",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1863/summary/evidence/4762/summary#evidence",
		"source": "civic",
		"description": "In a cohort of NSCLC patients tested for mutation in EGFR exons 18-21 a subset had uncommon mutations of unknown clinical significance (UMUCS). The most commonly occurring UMUCS were G719 and L861 mutations. Among patients that had UMUCS but not G719 or L861, the response rate to tyrosine kinase inhibitors erlotinib or gefitinib, progression free survival, and overall survival were 20%, 1.6 month and 11.1 months, which was similar for wild type EGFR (16.5%, 2.0 months and 10.4 months), which contrasted to higher response for more commonly occurring G719 and L861 mutations (53.3% and 60.0%, respectively).",
		"drug_labels": "GEFITINIB,Erlotinib",
		"variant_name": "MUT",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1863/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/646",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/684"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/684",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21531810"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4762",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/684"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/501",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/684"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/500",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/684"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/685",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/352",
			"name": "RARE EX 18-21 MUT",
			"description": "EGFR RARE EX 18-21 MUT",
			"biomarker_type": "Exon Variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576"
			],
			"soid": "SO:0001791",
			"so_name": "exon_variant",
			"reference_name": null,
			"refseq": null,
			"isoform": "",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": "",
			"alt": "",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1863/summary/evidence/4755/summary#evidence",
		"source": "civic",
		"description": "In a cohort of NSCLC patients treated with tyrosine kinase inhibitors erlotinib or gefitinib, 61 patients with uncommon mutations of unknown clinical significance (UMUCS) in EGFR exons 18-21 responded at a rate of 47.5% (primarily G719 and L861, N=30/61). This was significantly greater (p<0.001) than a response rate of 16.5% in EGFR wild type patients but significantly smaller (p<0.001) than a 74.1% response in EGFR mutant patients with canonical exon 19 deletion or L858R mutation. Uncommon mutations also had greater median PFS (5.0 vs. 2.0 months, P < 0.001) and median overall survival (15.0 vs. 10.4 months, P = 0.030) than in patients with the wild-type EGFR.",
		"drug_labels": "GEFITINIB,Erlotinib",
		"variant_name": "MUT",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1863/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/647",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/685"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/685",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21531810"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4755",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/685"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/503",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/685"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/502",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/685"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/686",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/353",
			"name": "E709K and G719A",
			"description": "EGFR E709K and G719A",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": null,
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/2256/summary/evidence/6036/summary#evidence",
		"source": "civic",
		"description": "Stage IIIB/IV patients with histologically proven NSCLC were enrolled in this study if the tumor cells bore EGFR mutations other than T790M. Patient with E709K and G719A demontrates   PR and an early radiological response to EGFR-TKIs.",
		"drug_labels": "Erlotinib,GEFITINIB",
		"variant_name": "G719A",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/2256/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/648",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/686"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/686",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25179728"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6036",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/686"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/505",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/686"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/504",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/686"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/687",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/354",
			"name": "L747_T751delLREAT",
			"description": "EGFR L747_T751delLREAT",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242468,
			"end_pos": 55242482,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1007/summary/evidence/2588/summary#evidence",
		"source": "civic",
		"description": "In a phase 3 clinical trial of Japanese NSCLC patients with EGFR mutations (n=230), patients treated with gefitinib were associated with improved progression free survival (10.8 months vs 5.4 months, HR: 0.30, 95% CI: 0.22-0.41, P<0.001), compared to patients treated with carboplatin and paclitaxel combination therapy. The frequency of mutation of exon 19 deletion and L858R was 25.2% (58/230) and 21.3% (49/230), respectively.",
		"drug_labels": "GEFITINIB",
		"variant_name": "L747_T751delLREAT",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1007/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/649",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/687"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/687",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20573926"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2588",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/687"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/506",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/687"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/688",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/354",
			"name": "L747_T751delLREAT",
			"description": "EGFR L747_T751delLREAT",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242468,
			"end_pos": 55242482,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1007/summary/evidence/2589/summary#evidence",
		"source": "civic",
		"description": "In a phase 3 clinical trial of Japanese NSCLC patients with EGFR mutations (n=177), patients treated with gefitinib were associated with improved progression free survival (9.2 months vs 6.3 months, HR:0.49, 95% CI: 0.34-0.71, P<0.0001), compared to cisplatin plus docetaxel treatment. The frequency of mutation in exon 19 deletion and L858R was 50.6% (87/172) and 49.4% (85/172), respectively, in evaluable cases.",
		"drug_labels": "GEFITINIB",
		"variant_name": "L747_T751delLREAT",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1007/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/650",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/688"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/688",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20022809"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2589",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/688"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/507",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/688"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/689",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/354",
			"name": "L747_T751delLREAT",
			"description": "EGFR L747_T751delLREAT",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242468,
			"end_pos": 55242482,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1007/summary/evidence/2590/summary#evidence",
		"source": "civic",
		"description": "A phase 3 study of 345 stage IIIB-IV lung adenocarcinoma patients, reported improved median progression free survival (13.6 months vs. 6.9 months, HR: 0.47, 95% CI: 0.34-0.65, P=0.001) in EGFR mutation positive patients (n=308; exon 19 deletion and L858R mutation) treated with afatinib, as compared to patients treated with standard chemotherapy (cisplatin plus pemetrexed).",
		"drug_labels": "AFATINIB",
		"variant_name": "L747_T751delLREAT",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1007/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/651",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/689"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/689",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23816960"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2590",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/689"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/508",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/689"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/690",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/354",
			"name": "L747_T751delLREAT",
			"description": "EGFR L747_T751delLREAT",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242468,
			"end_pos": 55242482,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1007/summary/evidence/2603/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study using PC9 cells (EGFR exon 19 deletion), inhibition of cell viability was used as an assay to determine sensitivity to EGFR tyrosine kinase inhibitors. PC9 cells demonstrated an increased sensitivity to gefitinib  (IC50: 23.0 nmol/L vs 200.0 nmol/L) compared to NCI-H2073 cells (EGFR wild type).",
		"drug_labels": "GEFITINIB",
		"variant_name": "L747_T751delLREAT",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1007/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/652",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/690"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/690",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24893891"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2603",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/690"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/509",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/690"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/691",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/354",
			"name": "L747_T751delLREAT",
			"description": "EGFR L747_T751delLREAT",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242468,
			"end_pos": 55242482,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1007/summary/evidence/2554/summary#evidence",
		"source": "civic",
		"description": "In a study of 585 non-small cell lung cancer patients who had a previous round of EGFR-TKI treatment, archival material was available for 141 patients. EGFR mutational analysis revealed that 96 tumors had an EGFR mutation, of which 76 (79%) were positive for either L858R or a deletion in exon 19. These mutations were associated with improved response to afatinib for progression-free survival (median 3.3 months  vs 1.0 month ; HR:0.51, 95% CI:0.31-0.85, P<0.009) compared to placebo control.",
		"drug_labels": "AFATINIB",
		"variant_name": "L747_T751delLREAT",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1007/summary",
		"evidence_label": "C",
		"response_type": null,
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/653",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/691"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/691",
				"type": "Predictive",
				"description": null,
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22452896"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2554",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/691"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/510",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/691"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/692",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/355",
			"name": "L747_P753>Q",
			"description": "EGFR L747_P753>Q",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242469,
			"end_pos": 55242488,
			"ref": null,
			"alt": "CA",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1011/summary/evidence/2599/summary#evidence",
		"source": "civic",
		"description": "In a phase 2b/3 study of 585 stage IIIB-IV lung adenocarcinoma patients who had a previous round of EGFR-TKI treatment, archival material was available for 141 patients. EGFR mutational analysis revealed that 96 tumors had an EGFR mutation, of which 76 (79%) were positive for either L858R or a deletion in exon 19. These mutations were associated with improved progression-free survival (median 3.3 months  vs 1.0 month ; HR:0.51, 95% CI:0.31-0.85, P<0.009) compared to placebo control.",
		"drug_labels": "AFATINIB",
		"variant_name": "L747_P753>Q",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1011/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/654",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/692"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/692",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22452896"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2599",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/692"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/511",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/692"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/693",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/355",
			"name": "L747_P753>Q",
			"description": "EGFR L747_P753>Q",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242469,
			"end_pos": 55242488,
			"ref": null,
			"alt": "CA",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1011/summary/evidence/2594/summary#evidence",
		"source": "civic",
		"description": "In a phase 3 clinical trial of Japanese NSCLC patients with EGFR mutations (n=230), patients treated with gefitinib were associated with improved progression free survival (10.8 months vs 5.4 months, HR: 0.30, 95% CI: 0.22-0.41, P<0.001), compared to patients treated with carboplatin and paclitaxel combination therapy. The frequency of mutation of exon 19 deletion and L858R was 25.2% (58/230) and 21.3% (49/230), respectively.",
		"drug_labels": "GEFITINIB",
		"variant_name": "L747_P753>Q",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1011/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/655",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/693"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/693",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20573926"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2594",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/693"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/512",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/693"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/694",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/355",
			"name": "L747_P753>Q",
			"description": "EGFR L747_P753>Q",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242469,
			"end_pos": 55242488,
			"ref": null,
			"alt": "CA",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1011/summary/evidence/2595/summary#evidence",
		"source": "civic",
		"description": "In a phase 3 clinical trial of Japanese NSCLC patients with EGFR mutations (n=177), patients treated with gefitinib were associated with improved progression free survival (9.2 months vs 6.3 months, HR:0.49, 95% CI: 0.34-0.71, P<0.0001), compared to cisplatin plus docetaxel treatment. The frequency of mutation in exon 19 deletion and L858R was 50.6% (87/172) and 49.4% (85/172), respectively, in evaluable cases.",
		"drug_labels": "GEFITINIB",
		"variant_name": "L747_P753>Q",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1011/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/656",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/694"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/694",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20022809"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2595",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/694"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/513",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/694"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/695",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/355",
			"name": "L747_P753>Q",
			"description": "EGFR L747_P753>Q",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242469,
			"end_pos": 55242488,
			"ref": null,
			"alt": "CA",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1011/summary/evidence/2600/summary#evidence",
		"source": "civic",
		"description": "A phase 3 study of 345 stage IIIB-IV lung adenocarcinoma patients, reported improved median progression free survival (13.6 months vs. 6.9 months, HR: 0.47, 95% CI: 0.34-0.65, P=0.001) in EGFR mutation positive patients (n=308; exon 19 deletion and L858R mutation) treated with afatinib, as compared to patients treated with standard chemotherapy (cisplatin plus pemetrexed).",
		"drug_labels": "AFATINIB",
		"variant_name": "L747_P753>Q",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1011/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/657",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/695"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/695",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23816960"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2600",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/695"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/514",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/695"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/696",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/355",
			"name": "L747_P753>Q",
			"description": "EGFR L747_P753>Q",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242469,
			"end_pos": 55242488,
			"ref": null,
			"alt": "CA",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1011/summary/evidence/2598/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study using PC9 cells (EGFR exon 19 deletion), inhibition of cell viability was used as an assay to determine sensitivity to EGFR tyrosine kinase inhibitors. PC9 cells demonstrated an increased sensitivity to gefitinib  (IC50: 23.0 nmol/L vs 200.0 nmol/L) compared to NCI-H2073 cells (EGFR wild type).",
		"drug_labels": "GEFITINIB",
		"variant_name": "L747_P753>Q",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1011/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/658",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/696"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/696",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24893891"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2598",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/696"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/515",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/696"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/697",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/148",
			"name": "R108K",
			"description": "EGFR R108K",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55211080,
			"end_pos": 55211080,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55211080G>A",
			"hgvs_c": "NM_005228.3:c.323G>A",
			"hgvs_p": "NP_005219.2:p.Arg108Lys",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55211080G>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/994/summary/evidence/4186/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a Ba/F3 cell line expressing EGFR R108K demonstrated increased sensitivity to erlotinib treatment, compared to Ba/F3 cells expressing EGFR wild-type. Sensitivity was determined by assessing EGFR auto-phosphorylation.",
		"drug_labels": "Erlotinib",
		"variant_name": "R108K",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/994/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/659",
				"source": "http://purl.obolibrary.org/obo/DOID_3070",
				"term": "malignant glioma",
				"pheno_id": "DOID:3070",
				"family": "cell type cancer",
				"description": "malignant glioma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/697"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/697",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/17177598"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4186",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/697"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/516",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/697"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/698",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/277",
			"name": "V742A",
			"description": "EGFR V742A",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242455,
			"end_pos": 55242455,
			"ref": "T",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.55242455T>C",
			"hgvs_c": "NM_005228.3:c.2225T>C",
			"hgvs_p": "NP_005219.2:p.Val742Ala",
			"dbsnp_ids": [
				"121913466"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55242455T>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1001/summary/evidence/4214/summary#evidence",
		"source": "civic",
		"description": "In a study, 1 participant with stage IV adenocarcinoma was sequenced at EGFR exons 18 to 21 and was found to have V742A mutation, and was treated with the 1st generation TKI gefitinib. The patient (M, 72, smoker) had stable disease as response, progression free survival (PFS) of 6.5 months, overall survival (OS) of 7.4 months and was not alive at study end. As a whole, patients with uncommon EGFR mutations had a response rate of 47.5%, which was between common (del19 and L858R) at 74.1%, and wild type EGFR at 16.5%. Median PFS and OS (months) for the three groups: 5.0 and 15.0 uncommon, 8.5 and 19.6 common, 2.0 and 10.4 wild type.",
		"drug_labels": "GEFITINIB",
		"variant_name": "V742A",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1001/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/660",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/698"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/698",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21531810"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4214",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/698"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/517",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/698"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/699",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/277",
			"name": "V742A",
			"description": "EGFR V742A",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242455,
			"end_pos": 55242455,
			"ref": "T",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.55242455T>C",
			"hgvs_c": "NM_005228.3:c.2225T>C",
			"hgvs_p": "NP_005219.2:p.Val742Ala",
			"dbsnp_ids": [
				"121913466"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55242455T>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1001/summary/evidence/4197/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a Ba/F3 cell line expressing EGFR V742A demonstrated increased sensitivity to erlotinib treatment comparable to Ba/F3 cells expressing a known sensitizing mutation (EGFR L858R). Sensitivity was determined by assessing cell proliferation, the IC50 of erlotinib for EGFR V742A and EGFR L858R expressing cells were 21 nmol/L and 6 nmol/L, respectively.",
		"drug_labels": "Erlotinib",
		"variant_name": "V742A",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1001/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/661",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/699"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/699",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19147750"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4197",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/699"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/518",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/699"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/700",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/277",
			"name": "V742A",
			"description": "EGFR V742A",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242455,
			"end_pos": 55242455,
			"ref": "T",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.55242455T>C",
			"hgvs_c": "NM_005228.3:c.2225T>C",
			"hgvs_p": "NP_005219.2:p.Val742Ala",
			"dbsnp_ids": [
				"121913466"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55242455T>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1001/summary/evidence/5819/summary#evidence",
		"source": "civic",
		"description": "EGFR V742A was expressed in Ba/F3 cells which do not contain endogenous EGFR, and conferred growth factor independance to the cells. Cells were plated and treated with 1st generation EGFR inhibitors Gefitinib, Erlotinib, or the the tool compound AEE788, and IC50 values were measured. V742A EGFR cells had moderately high IC50 nmol/L values for gefitinib in comparison to other EGFR constructs, which did not indicate sensitivity. (Gefitinib=65, Erlotinib=21, AEE788=37)",
		"drug_labels": "GEFITINIB",
		"variant_name": "V742A",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1001/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/662",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/700"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/700",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19147750"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5819",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/700"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/519",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/700"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/701",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/356",
			"name": "S768N",
			"description": "EGFR S768N",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55249005,
			"end_pos": 55249005,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55249005G>A",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249005G>A?assembly=hg19",
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1443/summary/evidence/4272/summary#evidence",
		"source": "civic",
		"description": "Cells expressing EGFR harboring the S768N mutation were resistant to erlotinib treatment of up to 3uM, as measured using an in vitro fibril formation assay. This contrasts with cells expressing the L858R mutant conferring erlotinib sensitivity, where fibril formation was observed at concentrations of erlotinib as low as 30nM. In an in vitro study, a MCF-7 cell line expressing EGFR A767_V769dup mutation demonstrated resistance to erlotinib treatment, compared to MCF-7 cells expressing a known erlotinib sensitizing mutation (EGFR L858R). Sensitivity was determined by assessing YFP signal-EGFR relocation.",
		"drug_labels": "Erlotinib",
		"variant_name": "S768N",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1443/summary",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/663",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/701"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/701",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21132006"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4272",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/701"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/520",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/701"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/702",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/356",
			"name": "S768N",
			"description": "EGFR S768N",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55249005,
			"end_pos": 55249005,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55249005G>A",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55249005G>A?assembly=hg19",
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1443/summary/evidence/4271/summary#evidence",
		"source": "civic",
		"description": "The S768N mutation was first reported in a cohort of African American patients with non-small cell lung cancer (NSCLC).  Classical EGFR mutations such as the L858R mutation and exon 19 deletions, found in 10-15% of patients in the general population and 40-50% of East Asian patients, occur at a much lower frequency in African American patients.  For example, in a study of 53 African American NSCLC patients classical EGFR mutations were undetected.",
		"drug_labels": "Erlotinib",
		"variant_name": "S768N",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1443/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/664",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/702"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/702",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19786660"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4271",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/702"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/521",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/702"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/703",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/357",
			"name": "Exon 18 deletion",
			"description": "EGFR Exon 18 deletion",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55086714,
			"end_pos": 55324313,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/2257/summary/evidence/6038/summary#evidence",
		"source": "civic",
		"description": "Among 1,402 EGFR mutations, Del19, L858R, and Ins20 were detected in 40%, 47%, and 4%, respectively. Exon 18 mutations, including G719X, E709X, and Del18, were present in 3.2%. Transfected Ba/F3 cells grew in the absence of IL3, and NIH/3T3 cells formed foci with marked pile-up, indicating their oncogenic abilities. IC90s of 1G and 3G TKIs in G719A, E709K, and Del18 were much higher than those in Del19 (by >11–50-fold), whereas IC90s of afatinib were only 3- to 7-fold greater than those for Del19. Notably, cells transfected with G719A and E709K exhibited higher sensitivity to neratinib (by 5–25-fold) than those expressing Del19. Patients with lung cancers harboring G719X exhibited higher response rate to afatinib or neratinib (∼80%) than to 1G TKIs (35%–56%) by compilation of data in the literature.",
		"drug_labels": "GEFITINIB,Erlotinib",
		"variant_name": "deletion",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/2257/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/665",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/703"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/703",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26206867"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6038",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/703"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/523",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/703"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/522",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/703"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/704",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/244",
			"name": "L861Q",
			"description": "EGFR L861Q",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259524,
			"end_pos": 55259524,
			"ref": "T",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55259524T>A",
			"hgvs_c": "NM_005228.3:c.2582T>A",
			"hgvs_p": "NP_005219.2:p.Leu861Gln",
			"dbsnp_ids": [
				"121913444"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259524T>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1020/summary/evidence/3802/summary#evidence",
		"source": "civic",
		"description": "In a study, a group of 6 participants, 5 with stage IV and one with stage IIIB lung adenocarcinoma, were sequenced at EGFR exons 18 to 21. All patients had L861Q mutation and were treated with the 1st generation TKI gefitinib. 4 patients had partial response with progression free survival (PFS) of 4.3, 19.3, 10.0, 8.7 months; overall survival (OS) of 4.3, 34.9, 15.7, 15.7 months; and all 4 were alive at study end. One patient had stable disease, PFS 6.5 months, OS 15.2 months, and was not alive at study end. One patient had progressive disease as response, with PFS of 2.8 months, OS of 10.7 months, and was not alive at study end. As a whole, patients with uncommon EGFR mutations had a response rate of 47.5%, which was between common (del19 and L858R) at 74.1%, and wild type EGFR at 16.5%. Median PFS and OS (months) for the three groups: 5.0 and 15.0 uncommon, 8.5 and 19.6 common, 2.0 and 10.4 wild type.",
		"drug_labels": "GEFITINIB",
		"variant_name": "L861Q",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1020/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/666",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/704"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/704",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21531810"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3802",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/704"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/524",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/704"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/705",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/244",
			"name": "L861Q",
			"description": "EGFR L861Q",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259524,
			"end_pos": 55259524,
			"ref": "T",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55259524T>A",
			"hgvs_c": "NM_005228.3:c.2582T>A",
			"hgvs_p": "NP_005219.2:p.Leu861Gln",
			"dbsnp_ids": [
				"121913444"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259524T>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1020/summary/evidence/4514/summary#evidence",
		"source": "civic",
		"description": "In a study of 1261 non-small cell lung cancer patients, 49.8% of the analyzed tumors had EGFR mutations including deletions in exon 19 (n=258), L858R (n=260), T790M (n=6) and insertions or duplications in exon 20 (n=25). Patients with EGFR deletions in exon 19 or L858R mutations were associated with an improved response to erlotinib or gefitinib with partial or complete response (74.1% vs. 16.5%, P<0.001) when compared to wildtype EGFR patients. Additionally, tumors with EGFR mutations in L858R or deletions in exon 19 were associated with increased overall survival (19.6mo vs. 10.4mo) compared to wildtype (all patients were treated with either erlotinib or gefitinib).",
		"drug_labels": "Erlotinib",
		"variant_name": "L861Q",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1020/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/667",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/705"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/705",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21531810"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4514",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/705"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/525",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/705"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/706",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/244",
			"name": "L861Q",
			"description": "EGFR L861Q",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259524,
			"end_pos": 55259524,
			"ref": "T",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55259524T>A",
			"hgvs_c": "NM_005228.3:c.2582T>A",
			"hgvs_p": "NP_005219.2:p.Leu861Gln",
			"dbsnp_ids": [
				"121913444"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259524T>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1020/summary/evidence/4299/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a Ba/F3 cell line expressing EGFR L861Q demonstrated increased sensitivity to erlotinib treatment, compared to Ba/F3 cells expressing EGFR wild-type. Sensitivity was determined by assessing EGFR auto-phosphorylation.",
		"drug_labels": "Erlotinib",
		"variant_name": "L861Q",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1020/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/668",
				"source": "http://purl.obolibrary.org/obo/DOID_3070",
				"term": "malignant glioma",
				"pheno_id": "DOID:3070",
				"family": "cell type cancer",
				"description": "malignant glioma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/706"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/706",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/17177598"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4299",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/706"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/526",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/706"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/707",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/244",
			"name": "L861Q",
			"description": "EGFR L861Q",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259524,
			"end_pos": 55259524,
			"ref": "T",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55259524T>A",
			"hgvs_c": "NM_005228.3:c.2582T>A",
			"hgvs_p": "NP_005219.2:p.Leu861Gln",
			"dbsnp_ids": [
				"121913444"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259524T>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1020/summary/evidence/5826/summary#evidence",
		"source": "civic",
		"description": "EGFR L861Q was expressed in Ba/F3 cells which do not contain endogenous EGFR, and conferred growth factor independance to the cells. Cells were plated and treated with 1st generation EGFR inhibitors Gefitinib, Erlotinib, or the the tool compound AEE788, and IC50 values were measured. L861Q EGFR cells had high IC50 nmol/L values for gefitinib and modeerately high for erlotinib in comparison to other EGFR constructs, which did not indicate sensitivity. (Gefitinib=170, Erlotinib=103, AEE788=51)",
		"drug_labels": "497839-62-0,Erlotinib,GEFITINIB",
		"variant_name": "L861Q",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1020/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/669",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/707"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/707",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19147750"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5826",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/707"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/529",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/707"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/528",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/707"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/527",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "497839-62-0",
				"envcontext_id": "CID10297043",
				"usan_stem": null,
				"description": "497839-62-0",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/707"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/708",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/213",
			"name": "H773_V774insH",
			"description": "EGFR H773_V774insH",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1446/summary/evidence/5940/summary#evidence",
		"source": "civic",
		"description": "A 74 year old female former smoker with 8 pack years and EGFR H773_V774insH lung adenocarcinoma patient was given erlotinib as second line treatment, and had progressive disease as best response with +64.8% change to target lesions, progression free survival of 0.8 months, and overall survival of 2 months.",
		"drug_labels": "Erlotinib",
		"variant_name": "H773_V774insH",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1446/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/670",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/708"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/708",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5940",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/708"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/530",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/708"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/709",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/213",
			"name": "H773_V774insH",
			"description": "EGFR H773_V774insH",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1446/summary/evidence/4276/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a Ba/F3 cell line expressing EGFR H773_V774insH demonstrated reduced sensitivity to erlotinib treatment (IC50=3.902�M), comparable to Ba/F3 cells expressing EGFR L858R and T790M co-mutation (T790M is a known resistant mutation to 1st and 2nd generation EGFR tyrosine kinase inhibitors; IC50=4.155�M). Resistance was determined by assessing cell proliferation, EGFR, AKT and ERK phosphorylation.",
		"drug_labels": "Erlotinib",
		"variant_name": "H773_V774insH",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1446/summary",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/671",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/709"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/709",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4276",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/709"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/531",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/709"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/710",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/168",
			"name": "D761N",
			"description": "EGFR D761N",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242511,
			"end_pos": 55242511,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55242511G>A",
			"hgvs_c": "NM_005228.3:c.2281G>A",
			"hgvs_p": "NP_005219.2:p.Asp761Asn",
			"dbsnp_ids": [
				"121913418"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55242511G>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1013/summary/evidence/5821/summary#evidence",
		"source": "civic",
		"description": "EGFR D716N was expressed in Ba/F3 cells which do not contain endogenous EGFR, and conferred growth factor independance to the cells. Cells were plated and treated with 1st generation EGFR inhibitors Gefitinib, Erlotinib, or the the tool compound AEE788, and IC50 values were measured. D716N EGFR cells had moderately low IC50 nmol/L values for AEE788 in comparison to other EGFR constructs, suggesting potential sensitivity. (Gefitinib=104, Erlotinib=75, AEE788=37)",
		"drug_labels": "497839-62-0",
		"variant_name": "D761N",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1013/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/672",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/710"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/710",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19147750"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5821",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/710"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/532",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "497839-62-0",
				"envcontext_id": "CID10297043",
				"usan_stem": null,
				"description": "497839-62-0",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/710"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/711",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/168",
			"name": "D761N",
			"description": "EGFR D761N",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55242511,
			"end_pos": 55242511,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55242511G>A",
			"hgvs_c": "NM_005228.3:c.2281G>A",
			"hgvs_p": "NP_005219.2:p.Asp761Asn",
			"dbsnp_ids": [
				"121913418"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55242511G>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1013/summary/evidence/5820/summary#evidence",
		"source": "civic",
		"description": "EGFR D716N was expressed in Ba/F3 cells which do not contain endogenous EGFR, and conferred growth factor independance to the cells. Cells were plated and treated with 1st generation EGFR inhibitors Gefitinib, Erlotinib, or the the tool compound AEE788, and IC50 values were measured. D716N EGFR cells had relatively high IC50 nmol/L values for gefitinib and erlotinib in comparison to other EGFR constructs, which did not indicate sensitivity. (Gefitinib=104, Erlotinib=75, AEE788=37)",
		"drug_labels": "Erlotinib,GEFITINIB",
		"variant_name": "D761N",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1013/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/673",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/711"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/711",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19147750"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5820",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/711"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/534",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/711"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/533",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/711"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/712",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/272",
			"name": "T854A",
			"description": "EGFR T854A",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259502,
			"end_pos": 55259502,
			"ref": "A",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.55259502A>G",
			"hgvs_c": "NM_005228.3:c.2560A>G",
			"hgvs_p": "NP_005219.2:p.Thr854Ala",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259502A>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1467/summary/evidence/4282/summary#evidence",
		"source": "civic",
		"description": "In a lung adenocarcinoma patient with EGFR L858R (a known sensitizing mutation to EGFR tyrosine kinase inhibitor) and EGFR T854A co-mutation, EGFR T854A was reported to be refractory to erlotinib treatment. The patient was treated with standard chemotherapy, followed by gefitinib monotherapy, and then erlotinib and temozolomide combination therapy, and subsequently succumbed to progressive disease. In an in vitro study, a 293T cell line expressing EGFR T854A demonstrated reduced sensitivity to erlotinib treatment compared to 293T cells expressing EGFR wild-type.",
		"drug_labels": "Erlotinib",
		"variant_name": "T854A",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1467/summary",
		"evidence_label": "C",
		"response_type": "resistant",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/674",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/712"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/712",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19010870"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4282",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/712"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/535",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/712"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/713",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/358",
			"name": "D770_N771insGL",
			"description": "EGFR D770_N771insGL",
			"biomarker_type": "Inframe Insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55249012,
			"end_pos": 55249013,
			"ref": null,
			"alt": "GGGTTA",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1514/summary/evidence/4494/summary#evidence",
		"source": "civic",
		"description": "In a study of 19 non-small cell lung carcinoma patients with EGFR exon 20 insertion mutation and treated with erlotinib monotherapy, patients with EGFR D770_N771insGL mutation (n=3) experienced progressive disease.",
		"drug_labels": "Erlotinib",
		"variant_name": "D770_N771insGL",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1514/summary",
		"evidence_label": "C",
		"response_type": "resistant",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/675",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/713"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/713",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4494",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/713"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/536",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/713"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/714",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/359",
			"name": "AMPLIFICATION",
			"description": "EGFR AMPLIFICATION",
			"biomarker_type": "Transcript Amplification",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001880"
			],
			"soid": "SO:0001889",
			"so_name": "transcript_amplification",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/190/summary/evidence/6927/summary#evidence",
		"source": "civic",
		"description": "This retrospective analysis of a Phase 2 trial shows significant association between increased EGFR gene copy number (≥ 4.0) and OS  in patients with gastric and OGJ cancer treated with cetuximab and chemotherapy, indicating the possibility that patients may be selected for treatment on a genetic basis.",
		"drug_labels": "CETUXIMAB",
		"variant_name": "AMPLIFICATION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/190/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/676",
				"source": "http://purl.obolibrary.org/obo/DOID_3717",
				"term": "gastric adenocarcinoma",
				"pheno_id": "DOID:3717",
				"family": "stomach cancer",
				"description": "gastric adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/714"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/714",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22152101"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6927",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/714"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/537",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/714"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/715",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/359",
			"name": "AMPLIFICATION",
			"description": "EGFR AMPLIFICATION",
			"biomarker_type": "Transcript Amplification",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001880"
			],
			"soid": "SO:0001889",
			"so_name": "transcript_amplification",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/190/summary/evidence/3015/summary#evidence",
		"source": "civic",
		"description": "Evidence of wild-type allele-mediated resistance, a novel concept of acquired resistance in response to mutation-selective inhibitor therapy in cancer treatment. This study reports that the Src-AKT pathway contributes to acquired resistance to third generation EGFR TKIs. In addition, amplification of EGFR wild-type alleles but not mutant alleles was sufficient to confer acquired resistance.",
		"drug_labels": "ROCILETINIB,OSIMERTINIB",
		"variant_name": "AMPLIFICATION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/190/summary",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/677",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/715"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/715",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28202511"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3015",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/715"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/539",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "OSIMERTINIB",
				"envcontext_id": "71496458",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "OSIMERTINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/715"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/538",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "ROCILETINIB",
				"envcontext_id": "57335384",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "ROCILETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/715"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/716",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/359",
			"name": "AMPLIFICATION",
			"description": "EGFR AMPLIFICATION",
			"biomarker_type": "Transcript Amplification",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001880"
			],
			"soid": "SO:0001889",
			"so_name": "transcript_amplification",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/190/summary/evidence/691/summary#evidence",
		"source": "civic",
		"description": "EGFR amplification was not a predictor of response to cetuximab/5-FU/platinum in patients with recurrent or metastatic HNSSC from the EXTREME study.",
		"drug_labels": "FLUOROURACIL,CETUXIMAB,Platinum",
		"variant_name": "AMPLIFICATION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/190/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/678",
				"source": "http://purl.obolibrary.org/obo/DOID_5520",
				"term": "head and neck squamous cell carcinoma",
				"pheno_id": "DOID:5520",
				"family": "head and neck cancer",
				"description": "head and neck squamous cell carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/716"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/716",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21048039"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "691",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/716"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/542",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Platinum",
				"envcontext_id": "CID23939",
				"usan_stem": null,
				"description": "Platinum",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/716"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/541",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/716"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/540",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "FLUOROURACIL",
				"envcontext_id": "3385",
				"usan_stem": "uracil derivatives used as thyroid antagonists and as antineoplastics",
				"description": "FLUOROURACIL",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/716"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/717",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/359",
			"name": "AMPLIFICATION",
			"description": "EGFR AMPLIFICATION",
			"biomarker_type": "Transcript Amplification",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001880"
			],
			"soid": "SO:0001889",
			"so_name": "transcript_amplification",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/190/summary/evidence/977/summary#evidence",
		"source": "civic",
		"description": "In 290 patients with advanced NSCLC, 177 of which were treated with EGFR TKI (erlotinib or gefitinib). EGFR amplification (Multiplex ligation-dependent probe amplification; MLPA) and Mutation (PCR) were analzed. EGFR amplification was associated with EGFR mutation but not independently with patient benefit from EGFR TKI (overall and progression-free survival).",
		"drug_labels": "Erlotinib,GEFITINIB",
		"variant_name": "AMPLIFICATION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/190/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/679",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/717"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/717",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26722081"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "977",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/717"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/544",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/717"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/543",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/717"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/718",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/359",
			"name": "AMPLIFICATION",
			"description": "EGFR AMPLIFICATION",
			"biomarker_type": "Transcript Amplification",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001880"
			],
			"soid": "SO:0001889",
			"so_name": "transcript_amplification",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/190/summary/evidence/948/summary#evidence",
		"source": "civic",
		"description": "A meta-analysis of EGFR gene copy number as a predictive biomarker for patients receiving tyrosine kinase inhibitor treatment was performed. In total, 20 (1689 patients, 594 with increased gene copy number), 10 (822 patients, 290 with increased gene copy number) and 5 studies (294 patients, 129 with increased gene copy number) were analyzed for overall survival (OS), progression-free survival (PFS) and time-to-progression (TTP) meta-analyses respectively. EGFR amplification was associated with increased OS (HR = 0.77; 95% CI 0.66-0.89; P = 0.001), PFS (HR = 0.60; 95% CI 0.46-0.79; P<0.001) and TTP (HR = 0.50; 95% CI 0.28-0.91; P = 0.02). This effect was shown to influence survival in predominantly white patient populations but not patients of Asian descent.",
		"drug_labels": "EGFR",
		"variant_name": "AMPLIFICATION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/190/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/680",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/718"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/718",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20826716"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "948",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/718"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/545",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/substance",
				"term": "EGFR",
				"envcontext_id": "SID160769799",
				"usan_stem": null,
				"description": "EGFR",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/718"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/719",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/359",
			"name": "AMPLIFICATION",
			"description": "EGFR AMPLIFICATION",
			"biomarker_type": "Transcript Amplification",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001880"
			],
			"soid": "SO:0001889",
			"so_name": "transcript_amplification",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/190/summary/evidence/911/summary#evidence",
		"source": "civic",
		"description": "87 patients with metastatic colorectal cancer treated with cetuximab were retrospectively analyzed for EGFR amplifications by FISH. In multivariate analysis, EGFR amplification predicted response and overall survival independent of KRAS status.",
		"drug_labels": "CETUXIMAB",
		"variant_name": "AMPLIFICATION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/190/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/681",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/719"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/719",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/18794099"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "911",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/719"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/546",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/719"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/720",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/359",
			"name": "AMPLIFICATION",
			"description": "EGFR AMPLIFICATION",
			"biomarker_type": "Transcript Amplification",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001880"
			],
			"soid": "SO:0001889",
			"so_name": "transcript_amplification",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/190/summary/evidence/473/summary#evidence",
		"source": "civic",
		"description": "The group of 43 out of 75 tumor samples with increased copy number or amplification of EGFR as determined by FISH (FISH-positive) had worse progression-free and overall survival than FISH-negative tumors.",
		"drug_labels": null,
		"variant_name": "AMPLIFICATION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/190/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/682",
				"source": "http://purl.obolibrary.org/obo/DOID_5520",
				"term": "head and neck squamous cell carcinoma",
				"pheno_id": "DOID:5520",
				"family": "head and neck cancer",
				"description": "head and neck squamous cell carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/720"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/720",
				"type": "Prognostic",
				"description": "Poor Outcome",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/16943533"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "473",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/720"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/721",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/359",
			"name": "AMPLIFICATION",
			"description": "EGFR AMPLIFICATION",
			"biomarker_type": "Transcript Amplification",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001880"
			],
			"soid": "SO:0001889",
			"so_name": "transcript_amplification",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/190/summary/evidence/854/summary#evidence",
		"source": "civic",
		"description": "In this meta-analysis (14 studies, 1021 patients), EGFR gene copy number (GCN) was predictive of improved progression free survival (PFS) and overall survival (OS) with cetuximab or panitumumab regardless of KRAS status. For the pooled analysis, the objective response rate (ORR) was 65.2% (167/256) in patients with high EFGR GCN, while in patients with low EFGR GCN, the pooled ORR was 12.2% (44/361). The odds ratio (OR) was 6.905 (95% CI: 4.489-10.620; Z=8.79, P=0.000). In wild type KRAS patients, the pooled OR was 8.133 (95% CI: 4.316-15.326; Z=6.48, P=0.000).",
		"drug_labels": "PANITUMUMAB,CETUXIMAB",
		"variant_name": "AMPLIFICATION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/190/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/683",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/721"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/721",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24653627"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "854",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/721"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/548",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/721"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/547",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "PANITUMUMAB",
				"envcontext_id": "CHEMBL1201827",
				"usan_stem": "monoclonal antibodies",
				"description": "PANITUMUMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/721"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/722",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/359",
			"name": "AMPLIFICATION",
			"description": "EGFR AMPLIFICATION",
			"biomarker_type": "Transcript Amplification",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001880"
			],
			"soid": "SO:0001889",
			"so_name": "transcript_amplification",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/190/summary/evidence/471/summary#evidence",
		"source": "civic",
		"description": "In patients with cervical squamous cell carcinoma, those with gene amplification of EGFR had worse overall survival.",
		"drug_labels": null,
		"variant_name": "AMPLIFICATION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/190/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/684",
				"source": "http://purl.obolibrary.org/obo/DOID_3744",
				"term": "cervical squamous cell carcinoma",
				"pheno_id": "DOID:3744",
				"family": "female reproductive organ cancer",
				"description": "cervical squamous cell carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/722"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/722",
				"type": "Prognostic",
				"description": "Poor Outcome",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21730982"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "471",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/722"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/723",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/359",
			"name": "AMPLIFICATION",
			"description": "EGFR AMPLIFICATION",
			"biomarker_type": "Transcript Amplification",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001880"
			],
			"soid": "SO:0001889",
			"so_name": "transcript_amplification",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000275493.2",
			"chromosome": "7",
			"start_pos": 55086794,
			"end_pos": 55279321,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/190/summary/evidence/470/summary#evidence",
		"source": "civic",
		"description": "In patients with Barrett's adenocarcinoma, those with amplification of EGFR had shorter disease-specific survial.",
		"drug_labels": null,
		"variant_name": "AMPLIFICATION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/190/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/685",
				"source": "http://purl.obolibrary.org/obo/DOID_7941",
				"term": "Barrett's adenocarcinoma",
				"pheno_id": "DOID:7941",
				"family": "esophageal cancer",
				"description": "Barrett's adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/723"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/723",
				"type": "Prognostic",
				"description": "Poor Outcome",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20840671"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "470",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/723"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/724",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/360",
			"name": "D770_N771insGY",
			"description": "EGFR D770_N771insGY",
			"biomarker_type": "Inframe Insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1666/summary/evidence/4801/summary#evidence",
		"source": "civic",
		"description": "In a study of 19 non-small cell lung carcinoma patients with EGFR exon 20 insertion mutation and treated with erlotinib monotherapy, patients with EGFR delD770insGY mutation (n=2) experienced progressive disease.",
		"drug_labels": "Erlotinib",
		"variant_name": "D770_N771insGY",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1666/summary",
		"evidence_label": "C",
		"response_type": "resistant",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/686",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/724"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/724",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4801",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/724"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/549",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/724"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/725",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/361",
			"name": "E709_T710>D",
			"description": "EGFR E709_T710>D",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55241679,
			"end_pos": 55241681,
			"ref": "AAAC",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55241679_55241681delinsA",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1577/summary/evidence/3793/summary#evidence",
		"source": "civic",
		"description": "In a study, 2 participants with stage IV lung adenocarcinoma were sequenced at EGFR exons 18 to 21.  Both patients were found to have DelE709-T710 insD mutation and were treated with the 1st generation TKI gefitinib. The first patient (F, 61, nonsmoker) had stable disease as response, progression free survival of 5.1 months, overall survival of 22.7 months and was alive at study end. The second patient (M, 65, smoker) had progressive disease as response, progression free survival of 0.9 months, overall survival of 11.1 months and was not alive at study end. As a whole, patients with uncommon EGFR mutations had a response rate of 47.5%, which was between common (del19 and L858R) at 74.1%, and wild type EGFR at 16.5%. Median PFS and OS (months) for the three groups: 5.0 and 15.0 uncommon, 8.5 and 19.6 common, 2.0 and 10.4 wild type.",
		"drug_labels": "GEFITINIB",
		"variant_name": "E709_T710>D",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1577/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/687",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/725"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/725",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21531810"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3793",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/725"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/550",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/725"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/726",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/361",
			"name": "E709_T710>D",
			"description": "EGFR E709_T710>D",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55241679,
			"end_pos": 55241681,
			"ref": "AAAC",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55241679_55241681delinsA",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1577/summary/evidence/4663/summary#evidence",
		"source": "civic",
		"description": "In a stage IV lung adenocarcinoma patient with EGFR E709_T710>D mutation, EGFR E709_T710>D was reported to be sensitive to erlotinib treatment. The patient was treated with erlotinib monotherapy and achieved a best response of 47% reduction of tumor (equivalent to partial response per RECIST criteria), response was sustained for 6 months but subsequently the patient elected to discontinue treatment.",
		"drug_labels": "Erlotinib",
		"variant_name": "E709_T710>D",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1577/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/688",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/726"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/726",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22982663"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4663",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/726"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/551",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/726"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/727",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/362",
			"name": "delL747_P753insS",
			"description": "EGFR delL747_P753insS",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 55242470,
			"end_pos": 55242487,
			"ref": "TTAAGAGAAGCAACATCTC",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.55242470_55242487delinsT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/2215/summary/evidence/5944/summary#evidence",
		"source": "civic",
		"description": "Ba/F3 cells transduced with EGFR delL747_P753insS were IL3 growth independant, suggesting driver mutation, and demonstrated sensitivity to erlotinib treatment (growth inhibition IC50=0.006 micro molar). In comparison Ba/F3 cells with EGFR L858R and cells with L858R + T790M resistnace mutation had IC50 of 0.006 and 4.155 micro molar respectively. Afatanib sensitivity was also reported (IC50 for delL747_P753insS was <0.0001 micro molar, while L858R and L858R + T790M had IC50 of 0.0004 and 0.0629 respectively).",
		"drug_labels": "AFATINIB,Erlotinib",
		"variant_name": "delL747_P753insS",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/2215/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/689",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/727"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/727",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5944",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/727"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/553",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/727"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/552",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "AFATINIB",
				"envcontext_id": "10184653",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "AFATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/727"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/728",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/363",
			"name": "K745_E749delKELRE",
			"description": "EGFR K745_E749delKELRE",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1638/summary/evidence/4764/summary#evidence",
		"source": "civic",
		"description": "In a stage IV lung adenocarcinoma patient with choroidal metastasis harboring EGFR exon 19 deletion, EGFR exon 19 deletion was associated with sensitivity to erlotinib monotherapy. The patient was treated with erlotinib as first-line treatment and experienced improvement within one week; the patient has remained stable after one year of therapy.",
		"drug_labels": "Erlotinib",
		"variant_name": "K745_E749delKELRE",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1638/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/690",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/728"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/728",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27569104"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4764",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/728"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/554",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/728"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/729",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/162",
			"name": "A864T",
			"description": "EGFR A864T",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": 55259532,
			"end_pos": 55259532,
			"ref": "G",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.55259532G>A",
			"hgvs_c": "NM_005228.3:c.2590G>A",
			"hgvs_p": "NP_005219.2:p.Ala864Thr",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.55259532G>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1187/summary/evidence/4495/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a Ba/F3 cell line expressing EGFR A864T demonstrated increased sensitivity to erlotinib treatment comparable to Ba/F3 cells expressing a known sensitizing mutation (EGFR L858R). Sensitivity was determined by assessing cell proliferation, the IC50 of erlotinib for EGFR A864T and EGFR L858R expressing cells were 49 nmol/L and 6 nmol/L, respectively.",
		"drug_labels": "Erlotinib",
		"variant_name": "A864T",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1187/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/691",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/729"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/729",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19147750"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4495",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/729"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/555",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/729"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/730",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2",
			"entrez_id": 1956,
			"ensembl_gene_id": "ENSG00000146648",
			"symbol": "EGFR",
			"uniprot_ids": [
				"P00533"
			],
			"location": "7p11.2",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/250",
			"name": "P772_H773insYNP",
			"description": "EGFR P772_H773insYNP",
			"biomarker_type": "inframe_insertion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001821",
			"so_name": "inframe_insertion",
			"reference_name": "GRCh37",
			"refseq": "NM_005228.3",
			"isoform": "ENST00000275493",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/2"
		},
		"source_url": "https://civicdb.org/events/genes/19/summary/variants/1667/summary/evidence/4802/summary#evidence",
		"source": "civic",
		"description": "In a non-small cell lung cancer patient harboring EGFR P772_H773insYNP mutation, EGFR P772_H773insYNP was associated with progressive disease in response to erlotinib monotherapy.",
		"drug_labels": "Erlotinib",
		"variant_name": "P772_H773insYNP",
		"source_link": "https://civic.genome.wustl.edu/events/genes/19/summary/variants/1667/summary",
		"evidence_label": "C",
		"response_type": "resistant",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/692",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/730"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/730",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24353160"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4802",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/730"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/556",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/730"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/731",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/2",
			"name": "V600",
			"description": "BRAF V600",
			"biomarker_type": "NA",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580"
			],
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453137,
			"end_pos": 140453137,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453137C>T",
			"hgvs_c": "NM_004333.4:c.1798G>A",
			"hgvs_p": "NP_004324.2:p.Val600Met",
			"dbsnp_ids": [
				"121913378"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453137C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/17/summary/evidence/88/summary#evidence",
		"source": "civic",
		"description": "In metastatic colorectal cancer patients with wildtype KRAS, BRAF mutations were associated with poor progression free survival regardless of treatment (panitumumab with best supportive care or best supportive care alone).",
		"drug_labels": "PANITUMUMAB",
		"variant_name": "V600",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/17/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/693",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/731"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/731",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23325582"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "88",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/731"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/557",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "PANITUMUMAB",
				"envcontext_id": "CHEMBL1201827",
				"usan_stem": "monoclonal antibodies",
				"description": "PANITUMUMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/731"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/732",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/2",
			"name": "V600",
			"description": "BRAF V600",
			"biomarker_type": "NA",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580"
			],
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453137,
			"end_pos": 140453137,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453137C>T",
			"hgvs_c": "NM_004333.4:c.1798G>A",
			"hgvs_p": "NP_004324.2:p.Val600Met",
			"dbsnp_ids": [
				"121913378"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453137C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/17/summary/evidence/93/summary#evidence",
		"source": "civic",
		"description": "This was a Phase I and II study (NCT01072175) of dabrafenib and trametinib combination therapy vs. dabrafenib monotherapy in patients with metastatic melanoma.  \n\nCutaneous squamous-cell carcinoma was seen in 7% of patients receiving combination therapy in contrast to 19% in those receiving monotherapy (P = 0.09).\n\nOf 162 patients with V600E or V600K mutation, 108 were given combination therapy and 54 monotherapy.\n\nAfter 1 year, 41% of patients in the combination group were alive and progression free whereas this was 9% in the monotherapy group (P<0.001).\n\n\nMedian progression-free survival was 9.4 months with combination and 5.8 months with monotherapy. Hazard ratio for progression or death was 0.39 (95% CI, 0.25 to 0.62; P<0.001).",
		"drug_labels": "DABRAFENIB,TRAMETINIB",
		"variant_name": "V600",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/17/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/694",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/732"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/732",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23020132"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "93",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/732"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/559",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/732"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/558",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/732"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/733",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/2",
			"name": "V600",
			"description": "BRAF V600",
			"biomarker_type": "NA",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580"
			],
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453137,
			"end_pos": 140453137,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453137C>T",
			"hgvs_c": "NM_004333.4:c.1798G>A",
			"hgvs_p": "NP_004324.2:p.Val600Met",
			"dbsnp_ids": [
				"121913378"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453137C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/17/summary/evidence/994/summary#evidence",
		"source": "civic",
		"description": "Phase I expansion and pharmacodynamic study of oral MEK inhibitor RO4987655. Partial response was observed in 4 of 17 patients with BRAF V600 mutated melanoma. 2 patients with prior vemurafenib treatment progressed under treatment.",
		"drug_labels": "RO4987655",
		"variant_name": "V600",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/17/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/695",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/733"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/733",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24947927"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "994",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/733"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/560",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "RO4987655",
				"envcontext_id": "CID11548630",
				"usan_stem": null,
				"description": "RO4987655",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/733"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/734",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/2",
			"name": "V600",
			"description": "BRAF V600",
			"biomarker_type": "NA",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580"
			],
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453137,
			"end_pos": 140453137,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453137C>T",
			"hgvs_c": "NM_004333.4:c.1798G>A",
			"hgvs_p": "NP_004324.2:p.Val600Met",
			"dbsnp_ids": [
				"121913378"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453137C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/17/summary/evidence/1407/summary#evidence",
		"source": "civic",
		"description": "In the NCT00880321 trial using mutant BRAF inhibitor dabrafenib in solid tumors, 10 cases of melanoma brain metastases were assessed for dabrafenib response. In nine patients a decrease in size of metastases was seen, and in four cases a complete resolution of brain lesions was observed. This subset of patients had median progression free survival of 4.2 months.",
		"drug_labels": "DABRAFENIB",
		"variant_name": "V600",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/17/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/696",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/734"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/734",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22608338"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1407",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/734"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/561",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/734"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/735",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/2",
			"name": "V600",
			"description": "BRAF V600",
			"biomarker_type": "NA",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580"
			],
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453137,
			"end_pos": 140453137,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453137C>T",
			"hgvs_c": "NM_004333.4:c.1798G>A",
			"hgvs_p": "NP_004324.2:p.Val600Met",
			"dbsnp_ids": [
				"121913378"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453137C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/17/summary/evidence/1411/summary#evidence",
		"source": "civic",
		"description": "The Combi-v (NCT01597908) open-label, randomized phase 3 trial had 704 patients with metastatic melanoma with a BRAF V600 mutation. Patients were randomized to receive either a combination of dabrafenib and trametinib or vemurafenib orally as first-line therapy. At preplanned interim analysis the overall survival rate at 12 months was 72% (95% confidence interval [CI], 67 to 77) in the combination-therapy group and 65% (95% CI, 59 to 70) in the vemurafenib group (hazard ratio for death in the combination-therapy group, 0.69; 95% CI, 0.53 to 0.89; P=0.005). Median progression-free survival was 11.4 months in the combination-therapy group and 7.3 months in the vemurafenib group (hazard ratio, 0.56; 95% CI, 0.46 to 0.69; P<0.001). Cutaneous squamous-cell carcinoma and keratoacanthoma occurred at 1% with combination-therapy and 18% in the vemurafenib group.",
		"drug_labels": "TRAMETINIB,DABRAFENIB",
		"variant_name": "V600",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/17/summary",
		"evidence_label": "A",
		"response_type": "Sensitivity/Response",
		"evidence_level": "1",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/697",
				"source": "http://purl.obolibrary.org/obo/DOID_8923",
				"term": "skin melanoma",
				"pheno_id": "DOID:8923",
				"family": "melanoma",
				"description": "skin melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/735"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/735",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25399551"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1411",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/735"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/563",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/735"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/562",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/735"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/736",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/2",
			"name": "V600",
			"description": "BRAF V600",
			"biomarker_type": "NA",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580"
			],
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453137,
			"end_pos": 140453137,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453137C>T",
			"hgvs_c": "NM_004333.4:c.1798G>A",
			"hgvs_p": "NP_004324.2:p.Val600Met",
			"dbsnp_ids": [
				"121913378"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453137C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/17/summary/evidence/1415/summary#evidence",
		"source": "civic",
		"description": "In clinical trial NCT01072175, 43 patients with BRAF V600 metastatic colorectal cancer (CRC) received mutant BRAF inhibitor dabrafenib and MEK inhibitor trametinib. Only 12% of patients showed  partial response or better, with one complete response lasting 36 months and ongoing after data cutoff. 56% of patients achieved stable disease. The median progression free survival (PFS) was 3.5 months, longer than the median PFS (2.5 months) reported for metastatic CRC treated with standard chemotherapy. The authors conclude that MAPK targeting in CRC is a valid approach that can produce meaningful responses but additional work is required to more effectively inhibit the pathway.",
		"drug_labels": "DABRAFENIB,TRAMETINIB",
		"variant_name": "V600",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/17/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/698",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/736"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/736",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26392102"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1415",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/736"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/565",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/736"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/564",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/736"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/737",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/2",
			"name": "V600",
			"description": "BRAF V600",
			"biomarker_type": "NA",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580"
			],
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453137,
			"end_pos": 140453137,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453137C>T",
			"hgvs_c": "NM_004333.4:c.1798G>A",
			"hgvs_p": "NP_004324.2:p.Val600Met",
			"dbsnp_ids": [
				"121913378"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453137C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/17/summary/evidence/1422/summary#evidence",
		"source": "civic",
		"description": "In a randomized phase 3 study, previously untreated advanced or metastatic BRAF V600 mutation-positive melanoma patients treated with combination vemurafenib and cobimetinib showed improved progression free survival (9.9 vs 6.2 months), increased rate of complete or partial response (68% vs 45%), and improved overall survival at 9 months ( 81% vs 73%) compared to the vemurafenib and placebo control group.",
		"drug_labels": "VEMURAFENIB,COBIMETINIB",
		"variant_name": "V600",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/17/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/699",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/737"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/737",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25265494"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1422",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/737"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/567",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "COBIMETINIB",
				"envcontext_id": "16222096",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "COBIMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/737"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/566",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/737"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/738",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/2",
			"name": "V600",
			"description": "BRAF V600",
			"biomarker_type": "NA",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580"
			],
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453137,
			"end_pos": 140453137,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453137C>T",
			"hgvs_c": "NM_004333.4:c.1798G>A",
			"hgvs_p": "NP_004324.2:p.Val600Met",
			"dbsnp_ids": [
				"121913378"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453137C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/17/summary/evidence/1000/summary#evidence",
		"source": "civic",
		"description": "Phase I trial of the mitogen-activated protein kinase 1/2 inhibitor BAY 86-9766. 2 of 2 patients with BRAF mutant melanoma had moderate progressive disease (despite receiving the highest doses administered in the study).",
		"drug_labels": "BAY",
		"variant_name": "V600",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/17/summary",
		"evidence_label": "C",
		"response_type": "resistant",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/700",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/738"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/738",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23434733"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1000",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/738"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/568",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "BAY",
				"envcontext_id": "52949496",
				"usan_stem": null,
				"description": "BAY",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/738"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/739",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/2",
			"name": "V600",
			"description": "BRAF V600",
			"biomarker_type": "NA",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580"
			],
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453137,
			"end_pos": 140453137,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453137C>T",
			"hgvs_c": "NM_004333.4:c.1798G>A",
			"hgvs_p": "NP_004324.2:p.Val600Met",
			"dbsnp_ids": [
				"121913378"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453137C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/17/summary/evidence/1574/summary#evidence",
		"source": "civic",
		"description": "Patients with BRAF-V600 mutated cancers were identified (n=122) and clinical response to vemurafenib was evaluated. Of the 20 patients with non-small-cell-lung cancer (17 with BRAF V600E, one with BRAF V600G and one with BRAF V600 unknown status), 19 were evaluable and the response rate to vemurafenib was 42%, tumor regression was observed in 14/19 patients, progression-free survival was 7.3 months, and 12-month overall survival was 66%.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/17/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/701",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/739"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/739",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26287849"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1574",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/739"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/569",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/739"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/740",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/2",
			"name": "V600",
			"description": "BRAF V600",
			"biomarker_type": "NA",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580"
			],
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453137,
			"end_pos": 140453137,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453137C>T",
			"hgvs_c": "NM_004333.4:c.1798G>A",
			"hgvs_p": "NP_004324.2:p.Val600Met",
			"dbsnp_ids": [
				"121913378"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453137C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/17/summary/evidence/1575/summary#evidence",
		"source": "civic",
		"description": "Patients with BRAF-V600 mutated cancers were identified (n=122) and clinical response to vemurafenib was evaluated.  Of the 14 patients with Langerhans’-cell histiocytosis, 43% of patients had a response to vemurafenib (1 complete and 5 partial responses), disease regression was observed in 12/14 patients, all patients detailed improvement in disease-related symptoms, 0 patients had progressive disease during treatment, 12-month progression free survival was 91%, and overall survival rate was 100%.\nAmong all 18 patients with Erdheim-Chester disease or Langerhans histiocytosis, 94% had BRAF V600E mutations and the remaining 6 percent (1 patient) had an unknown V600 mutation.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/17/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/702",
				"source": "http://purl.obolibrary.org/obo/DOID_2571",
				"term": "Langerhans-cell histiocytosis",
				"pheno_id": "DOID:2571",
				"family": "histiocytosis",
				"description": "Langerhans-cell histiocytosis",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/740"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/740",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26287849"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1575",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/740"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/570",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/740"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/741",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/2",
			"name": "V600",
			"description": "BRAF V600",
			"biomarker_type": "NA",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580"
			],
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453137,
			"end_pos": 140453137,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453137C>T",
			"hgvs_c": "NM_004333.4:c.1798G>A",
			"hgvs_p": "NP_004324.2:p.Val600Met",
			"dbsnp_ids": [
				"121913378"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453137C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/17/summary/evidence/1576/summary#evidence",
		"source": "civic",
		"description": "Patients with BRAF-V600 mutated cancers were identified (n=122) and clinical response to vemurafenib was evaluated.  Of the 10 patients with colorectal cancer (80% BRAF V600E, 20% V600 unknown status), no responses were observed and overall survival was 9.3 months with a median progression-free survival of 4.5 months.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/17/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/703",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/741"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/741",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26287849"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1576",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/741"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/571",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/741"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/742",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/2",
			"name": "V600",
			"description": "BRAF V600",
			"biomarker_type": "NA",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580"
			],
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453137,
			"end_pos": 140453137,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453137C>T",
			"hgvs_c": "NM_004333.4:c.1798G>A",
			"hgvs_p": "NP_004324.2:p.Val600Met",
			"dbsnp_ids": [
				"121913378"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453137C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/17/summary/evidence/1598/summary#evidence",
		"source": "civic",
		"description": "Patients with BRAF-V600 mutated cancers were identified (n=122) and subsequently underwent targeted therapy. 27 patients with colorectal cancer were treated with vemurafenib and cetuximab (N=24 with BRAF V600E mutation, N=3 with V600 unknown status). One response was observed; however, approximately half the patients had tumor regression that did not meet the standard criteria for a partial response. Median progression-free survival and overall survival for patients receiving combination therapy were 3.7 months (95% CI, 1.8 to 5.1) and 7.1 months (95% CI, 4.4 to not reached), respectively. Patients were heavily pretreated, with a median of two lines of previous therapy (range, one to six).",
		"drug_labels": "CETUXIMAB,VEMURAFENIB",
		"variant_name": "V600",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/17/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/704",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/742"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/742",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26287849"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1598",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/742"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/573",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/742"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/572",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/742"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/743",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/2",
			"name": "V600",
			"description": "BRAF V600",
			"biomarker_type": "NA",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580"
			],
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453137,
			"end_pos": 140453137,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453137C>T",
			"hgvs_c": "NM_004333.4:c.1798G>A",
			"hgvs_p": "NP_004324.2:p.Val600Met",
			"dbsnp_ids": [
				"121913378"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453137C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/17/summary/evidence/1750/summary#evidence",
		"source": "civic",
		"description": "Patients who had histologically confirmed, unresectable stage IIIC or IV cutaneous melanoma with a V600E or V600K BRAF mutation were eligible for the study. 322 eligible patients (281 with the V600E mutation, 40 with the V600K mutation, and 1 with both mutations) in a 2:1 ratio to receive oral trametinib (2 mg once daily) or intravenous chemotherapy consisting of either dacarbazine (1000 mg per square meter of body-surface area) or paclitaxel (175 mg per square meter), at the discretion of the investigator, every 3 weeks. The primary end point was progression-free survival; secondary end points included overall survival, overall response rate, duration of response, and safety. Treatment continued until disease progression, death, or withdrawal from the study. In the intention-to-treat population, the median duration of progression-free survival was 4.8 months in the trametinib group as compared with 1.5 months in the chemotherapy group (hazard ratio for progression, 0.45; 95% confidence interval [CI], 0.33 to 0.63; P<0.001).  The 6-month overall survival rate in the intention-to-treat population was 81% in the trametinib group and 67% in the chemotherapy group.",
		"drug_labels": "TRAMETINIB",
		"variant_name": "V600",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/17/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/705",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/743"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/743",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22663011"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1750",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/743"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/574",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/743"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/744",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/2",
			"name": "V600",
			"description": "BRAF V600",
			"biomarker_type": "NA",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580"
			],
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453137,
			"end_pos": 140453137,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453137C>T",
			"hgvs_c": "NM_004333.4:c.1798G>A",
			"hgvs_p": "NP_004324.2:p.Val600Met",
			"dbsnp_ids": [
				"121913378"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453137C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/17/summary/evidence/5905/summary#evidence",
		"source": "civic",
		"description": "Eight patients with BRAF V600 (7 with V600E, 1 with V600 unknown) mutated cholangiocarcinoma received vemurafenib. Only one patients showed partial response and duration of response of this patient was longer than 12 months.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/17/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/706",
				"source": "http://purl.obolibrary.org/obo/DOID_4947",
				"term": "cholangiocarcinoma",
				"pheno_id": "DOID:4947",
				"family": "bile duct cancer",
				"description": "cholangiocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/744"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/744",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26287849"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5905",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/744"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/575",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/744"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/745",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/2",
			"name": "V600",
			"description": "BRAF V600",
			"biomarker_type": "NA",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580"
			],
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453137,
			"end_pos": 140453137,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453137C>T",
			"hgvs_c": "NM_004333.4:c.1798G>A",
			"hgvs_p": "NP_004324.2:p.Val600Met",
			"dbsnp_ids": [
				"121913378"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453137C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/17/summary/evidence/6044/summary#evidence",
		"source": "civic",
		"description": "In this double-blind, randomized, placebo-controlled, multicentre study, adult patients with histologically confirmed BRAF(V600) mutation-positive unresectable stage IIIC or stage IV melanoma were randomly assigned (1:1) to receive cobimetinib or placebo, in combination with oral vemurafenib. Progression-free survival was the primary endpoint.\nBetween Jan 8, 2013, and Jan 31, 2014, 495 eligible adult patients were enrolled and randomly assigned to the cobimetinib plus vemurafenib group (n=247) or placebo plus vemurafenib group (n=248). Investigator-assessed median progression-free survival was 12.3 months for cobimetinib and vemurafenib versus 7.2 months for placebo and vemurafenib (HR 0.58 [95% CI 0.46-0.72], p<0.0001). Median overall survival was 22.3 months for cobimetinib and vemurafenib versus 17.4 months for placebo and vemurafenib (HR 0.70, 95% CI 0.55-0.90; p=0.005). The safety profile for cobimetinib and vemurafenib was tolerable and manageable, and no new safety signals were observed with longer follow-up.",
		"drug_labels": "COBIMETINIB,VEMURAFENIB",
		"variant_name": "V600",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/17/summary",
		"evidence_label": "A",
		"response_type": "Sensitivity/Response",
		"evidence_level": "1",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/707",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/745"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/745",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27480103"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6044",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/745"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/577",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/745"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/576",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "COBIMETINIB",
				"envcontext_id": "16222096",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "COBIMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/745"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/746",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/2",
			"name": "V600",
			"description": "BRAF V600",
			"biomarker_type": "NA",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580"
			],
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453137,
			"end_pos": 140453137,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453137C>T",
			"hgvs_c": "NM_004333.4:c.1798G>A",
			"hgvs_p": "NP_004324.2:p.Val600Met",
			"dbsnp_ids": [
				"121913378"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453137C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/17/summary/evidence/6046/summary#evidence",
		"source": "civic",
		"description": "In a Phase Ib Dose-Escalation Study of Encorafenib and Cetuximab, Twenty-six patients with refractory BRAF V600 mutant metastatic CRC (mCRC) were treated with a selective RAF kinase inhibitor (encorafenib) plus a monoclonal antibody targeting EGFR (cetuximab).  Confirmed overall response rates of 19% were observed and median progression-free survival was 3.7 months.",
		"drug_labels": "ENCORAFENIB,CETUXIMAB",
		"variant_name": "V600",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/17/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/708",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/746"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/746",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28363909"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6046",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/746"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/579",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/746"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/578",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "ENCORAFENIB",
				"envcontext_id": "50922675",
				"usan_stem": "raf kinase inhibitors",
				"description": "ENCORAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/746"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/747",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/2",
			"name": "V600",
			"description": "BRAF V600",
			"biomarker_type": "NA",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580"
			],
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453137,
			"end_pos": 140453137,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453137C>T",
			"hgvs_c": "NM_004333.4:c.1798G>A",
			"hgvs_p": "NP_004324.2:p.Val600Met",
			"dbsnp_ids": [
				"121913378"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453137C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/17/summary/evidence/6047/summary#evidence",
		"source": "civic",
		"description": "In a Phase Ib Dose-Escalation Study of Encorafenib, Cetuximab and Alpelisib, Twenty-eight patients with refractory BRAFV600 mutant metastatic CRC (mCRC) were treated with a selective RAF kinase inhibitor (encorafenib) plus a monoclonal antibody targeting EGFR (cetuximab) with a PI3Kα inhibitor (alpelisib).  Confirmed overall response rates of 18% were observed and median progression-free survival was 4.2 months",
		"drug_labels": "ENCORAFENIB,CETUXIMAB,ALPELISIB",
		"variant_name": "V600",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/17/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/709",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/747"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/747",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28363909"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6047",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/747"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/582",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "ALPELISIB",
				"envcontext_id": "56649450",
				"usan_stem": "phosphatidylinositol 3-kinase inhibitors",
				"description": "ALPELISIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/747"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/581",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/747"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/580",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "ENCORAFENIB",
				"envcontext_id": "50922675",
				"usan_stem": "raf kinase inhibitors",
				"description": "ENCORAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/747"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/748",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/2",
			"name": "V600",
			"description": "BRAF V600",
			"biomarker_type": "NA",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580"
			],
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453137,
			"end_pos": 140453137,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453137C>T",
			"hgvs_c": "NM_004333.4:c.1798G>A",
			"hgvs_p": "NP_004324.2:p.Val600Met",
			"dbsnp_ids": [
				"121913378"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453137C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/17/summary/evidence/6180/summary#evidence",
		"source": "civic",
		"description": "Combination Dabrafenib and Trametinib treatment was assessed for adjuvant treatment of stage III resected BRAF V600 mutant melanoma in the COMBI-AD trial NCT01682083. Patients were treated with combination therapy or placebo for 12 months. The estimated 3-year rate of relapse-free survival was 58% in the treated group and 39% in the placebo group  with hazard ratio for relapse or death of 0.47 (95% CI, 0.39 to 0.58; P<0.001). 3-year overall survival rate for treated group was 86%, and 77% in the placebo group (hazard ratio for death, 0.57; 95% CI, 0.42-0.79; P=0.0006). The level of improvement observed did not cross the prespecified interim analysis boundary of P=0.000019. Distant metastasis-free survival and freedom from relapse was higher in the combination-treated group.",
		"drug_labels": "TRAMETINIB,DABRAFENIB",
		"variant_name": "V600",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/17/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/710",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/748"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/748",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28891408"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6180",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/748"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/584",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/748"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/583",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/748"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/749",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/2",
			"name": "V600",
			"description": "BRAF V600",
			"biomarker_type": "NA",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580"
			],
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453137,
			"end_pos": 140453137,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453137C>T",
			"hgvs_c": "NM_004333.4:c.1798G>A",
			"hgvs_p": "NP_004324.2:p.Val600Met",
			"dbsnp_ids": [
				"121913378"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453137C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/17/summary/evidence/6937/summary#evidence",
		"source": "civic",
		"description": "In this Phase III trial (NCT01584648 COMBI-d), 423 previously untreated patients with unrescectable stage IIIC or IV BRAF V600E or V600K melanoma received dabrafenib and trametinib or dabrafenib alone with primary endpoint of progression free survival with secondary endpoints including disease response. \n\nHazard ratio for progression or death in the dabrafenib–trametinib group, 0.75; (95% confidence interval, 0.57 to 0.99; P=0.03). Of 210 patients in the dabrafenib + trametinib group, 67% of patients had a response, which was 16 percentage points higher than in the dabrafenib group. (95% CI, 6 to 25; P=0.002)",
		"drug_labels": "DABRAFENIB,TRAMETINIB",
		"variant_name": "V600",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/17/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/711",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/749"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/749",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25265492"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6937",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/749"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/586",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/749"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/585",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/749"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/750",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/2",
			"name": "V600",
			"description": "BRAF V600",
			"biomarker_type": "NA",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580"
			],
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453137,
			"end_pos": 140453137,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453137C>T",
			"hgvs_c": "NM_004333.4:c.1798G>A",
			"hgvs_p": "NP_004324.2:p.Val600Met",
			"dbsnp_ids": [
				"121913378"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453137C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/17/summary/evidence/6966/summary#evidence",
		"source": "civic",
		"description": "In this Phase 1b study, 129 patients with unresectable or metastatic melanoma were verified for BRAF V600 mutation using the cobas 4800 mutation test were selected who had progressed on vemurafenib (66 patients) or never received BRAF inhibitor (63 patients). The combination of vemurafenib and cobimetinib was deemed safe and tolerable. Confirmed objective responses were seen in 15% of vemurafenib progressed patients and median progression-free survival was 2.8 months (95% CI 2·6–3·4). Confirmed objective responses were seen in 87% of patients who had never received BRAF inhibitor, including 10% with complete response. Median progression-free survival was 13.7 months (95% CI 10·1–17·5). The majority of patients had BRAF V600E mutation. Post-hoc sequencing of 94 tumor samples indicated seven tumors with a mutation other than BRAF V600E.",
		"drug_labels": "VEMURAFENIB,COBIMETINIB",
		"variant_name": "V600",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/17/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/712",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/750"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/750",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25037139"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6966",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/750"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/588",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "COBIMETINIB",
				"envcontext_id": "16222096",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "COBIMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/750"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/587",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/750"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/751",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/2",
			"name": "V600",
			"description": "BRAF V600",
			"biomarker_type": "NA",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580"
			],
			"soid": "",
			"so_name": "Uncategorized",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453137,
			"end_pos": 140453137,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453137C>T",
			"hgvs_c": "NM_004333.4:c.1798G>A",
			"hgvs_p": "NP_004324.2:p.Val600Met",
			"dbsnp_ids": [
				"121913378"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453137C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/17/summary/evidence/30/summary#evidence",
		"source": "civic",
		"description": "BRAF mutations are associated with melanoma arising in non-chronic sun damaged skin and with superficial spreading melanoma.",
		"drug_labels": null,
		"variant_name": "V600",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/17/summary",
		"evidence_label": "B",
		"response_type": "Positive",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/713",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/751"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/751",
				"type": "Diagnostic",
				"description": "Positive",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21166657"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "30",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/751"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/752",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/364",
			"name": "PPFIBP2-BRAF",
			"description": "BRAF PPFIBP2-BRAF",
			"biomarker_type": "Transcript Fusion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001882"
			],
			"soid": "SO:0001886",
			"so_name": "transcript_fusion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000299492.4",
			"chromosome": "11",
			"start_pos": 7535001,
			"end_pos": 7586998,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/617/summary/evidence/1570/summary#evidence",
		"source": "civic",
		"description": "Case report of a 47year old female patient with metastatic melanoma (BRAF, NRAS, KIT negative). A PPFIBP2-BRAF fusion was identified from DNA from a brain metastasis (inton 3 of PPFIBP2 fused to intron 10 of BRAF). Trametinib was introduced and anemia and ECOG status improved. Imaging revealed a 90% decrease in extracranial and 19% decrease in intracranial metastases with no new metastases and no progressing sites at 6 weeks. Trametinib was stopped and pembrolizumab introduced at this time. Progressive disease was noted after 5 cycles of pembrolizumab but re-introduction of trametinib did not show an effect.",
		"drug_labels": "TRAMETINIB",
		"variant_name": null,
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/617/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/714",
				"source": "http://purl.obolibrary.org/obo/DOID_8923",
				"term": "skin melanoma",
				"pheno_id": "DOID:8923",
				"family": "melanoma",
				"description": "skin melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/752"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/752",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26072686"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1570",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/752"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/589",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/752"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/753",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/54",
			"name": "G596C",
			"description": "BRAF G596C",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453149,
			"end_pos": 140453149,
			"ref": "C",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140453149C>A",
			"hgvs_c": "NM_004333.4:c.1786G>T",
			"hgvs_p": "NP_004324.2:p.Gly596Cys",
			"dbsnp_ids": [
				"121913361"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453149C>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/694/summary/evidence/1738/summary#evidence",
		"source": "civic",
		"description": "non-V600 BRAF mutations can be sensitive to clinically relevant doses of Dabrafenib and Trametinib in HEK293T cells, in lung epithelial cellular model (BEAS-2B) and in human cancer cell lines harboring non-V600 BRAF mutations",
		"drug_labels": "TRAMETINIB,DABRAFENIB",
		"variant_name": "G596C",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/694/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/715",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/753"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/753",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27577079"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1738",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/753"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/591",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/753"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/590",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/753"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/754",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/365",
			"name": "V600E/K AMPLIFICATION",
			"description": "BRAF V600E/K AMPLIFICATION",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 140419127,
			"end_pos": 140624564,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/2361/summary/evidence/6262/summary#evidence",
		"source": "civic",
		"description": "In a retrospective study of 44 relapsed melanoma patients harboring BRAF V600E or V600K (known BRAF inhibitor sensitizing mutations), MAPK pathway reactivation mechanisms were implicated in acquired resistance to BRAF inhibitor (vemurafenib or dabrafenib) monotherapy. The following MAPK pathway variants were found in progressive tumors with patient matched baseline tumors (some patients donated samples from multiple geographically/temporally distinct progressive tumors): NRAS mutations (G12D, G12R, G13R, Q61K, Q61R, Q61L) in 13/71 (18%) of progressive tumors, KRAS mutations (G12C, G12R, Q61H) in 5/71 (7%) of progressive tumors, mutant BRAF amplification (2-15 fold or 4-75 copies) in 11/57 (19%) of progressive tumors, mutant BRAF alternative splice variants (novel exon boundaries between 1/9, 1/11, 3/9) in 6/48 (13%) of progressive tumor RNA.",
		"drug_labels": "DABRAFENIB,VEMURAFENIB",
		"variant_name": "AMPLIFICATION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/2361/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/716",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/754"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/754",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24265155"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6262",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/754"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/593",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/754"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/592",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/754"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/755",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/366",
			"name": "Non-V600",
			"description": "BRAF Non-V600",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": null,
			"refseq": null,
			"isoform": "",
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": "",
			"alt": "",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/2408/summary/evidence/3046/summary#evidence",
		"source": "civic",
		"description": "This study of  9,643 patients characterized clinical implications of non-V600 BRAF mutations in metastatic CRC. Of the patients with metastatic CRC that underwent NGS testing, 208 patients had non-V600 BRAF mutations (22% of BRAF mutations identified and 2.2% of total patients tested ). When compared to V600 BRAF mutations, tumors without V600 BRAF mutations were more prevalent in younger patients (58 v 68 years, respectively) and male patients (65% vs 46%, respectively). Additionally, non-V600 BRAF mutations were less prevalent in high-grade tumors (13% v 64%, respectively) and right-sided primary tumors (36% v 81%, respectively). Median overall survival was significantly longer in patients with non-V600 BRAF-mutant metastatic CRC compared with those with both V600E BRAF-mutant and wild-type BRAF metastatic CRC (60.7 v 11.4 v 43.0 months).",
		"drug_labels": null,
		"variant_name": null,
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/2408/summary",
		"evidence_label": "B",
		"response_type": "Better Outcome",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/717",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/755"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/755",
				"type": "Prognostic",
				"description": "Better Outcome",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28486044"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3046",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/755"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/756",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/31",
			"name": "D594V",
			"description": "BRAF D594V",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453154,
			"end_pos": 140453154,
			"ref": "T",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140453154T>A",
			"hgvs_c": "NM_004333.4:c.1781A>T",
			"hgvs_p": "NP_004324.2:p.Asp594Val",
			"dbsnp_ids": [
				"121913338"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453154T>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/580/summary/evidence/1456/summary#evidence",
		"source": "civic",
		"description": "Preclinical study in melanoma cell lines. Inactivity of BRAF as mediated by specific mutation (D594A, D594V or K483M) or selective pharmacological inhibition leads to MEK hyperactivation through CRAF binding in NRAS mutant D04 cells. Either pan-RAF (e.g. sorafenib in the abscence of CRAF T421N gatekeeper mutation) or MEK inhibitors could instead block ERK pathway hyperactivation in RAS mutated cancers.",
		"drug_labels": "TRAMETINIB,Sorafenib",
		"variant_name": "D594V",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/580/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/718",
				"source": "http://purl.obolibrary.org/obo/DOID_8923",
				"term": "skin melanoma",
				"pheno_id": "DOID:8923",
				"family": "melanoma",
				"description": "skin melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/756"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/756",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20141835"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1456",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/756"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/595",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Sorafenib",
				"envcontext_id": "216239",
				"usan_stem": "raf kinase inhibitors",
				"description": "Sorafenib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/756"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/594",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/756"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/757",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/50",
			"name": "G469R",
			"description": "BRAF G469R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140481403,
			"end_pos": 140481403,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140481403C>T",
			"hgvs_c": "NM_004333.4:c.1405G>A",
			"hgvs_p": "NP_004324.2:p.Gly469Arg",
			"dbsnp_ids": [
				"121913357"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140481403C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/840/summary/evidence/1938/summary#evidence",
		"source": "civic",
		"description": "Case report of a patient with NSCLC and BRAF G469R mutation who showed a dramatic response to sorafenib.",
		"drug_labels": "Sorafenib",
		"variant_name": "G469R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/840/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/719",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/757"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/757",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26237499"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1938",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/757"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/596",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Sorafenib",
				"envcontext_id": "216239",
				"usan_stem": "raf kinase inhibitors",
				"description": "Sorafenib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/757"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/758",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/43",
			"name": "G466A",
			"description": "BRAF G466A",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140481411,
			"end_pos": 140481411,
			"ref": "C",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.140481411C>G",
			"hgvs_c": "NM_004333.4:c.1397G>C",
			"hgvs_p": "NP_004324.2:p.Gly466Ala",
			"dbsnp_ids": [
				"121913351"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140481411C>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/1196/summary/evidence/4499/summary#evidence",
		"source": "civic",
		"description": "In a retrospective study of 53, KRAS exon 2 wild-type, metastatic colorectal cancer patients, patients harboring BRAF G466A (n=1), G469A (n=2), D594G (n=1), or V600E (n=2) mutations were reported to be non-responders to cetuximab in combination with irinotecan, (BRAF mutation positive: responders vs. non-responders = 0 vs. 6; BRAF wild-type: responders vs. non-responders 30 vs. 17; P=0.004), as compared to patients with wild-type BRAF.",
		"drug_labels": "CETUXIMAB",
		"variant_name": "G466A",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/1196/summary",
		"evidence_label": "C",
		"response_type": "resistant",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/720",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/758"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/758",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26989027"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4499",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/758"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/597",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/758"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/759",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/9",
			"name": "F595L",
			"description": "BRAF F595L",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453152,
			"end_pos": 140453152,
			"ref": "A",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.140453152A>G",
			"hgvs_c": "NM_004333.4:c.1783T>C",
			"hgvs_p": "NP_004324.2:p.Phe595Leu",
			"dbsnp_ids": [
				"794729219"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453152A>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/1121/summary/evidence/4426/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a Plat-E cell line expressing a BRAF F595L mutation was associated with resistance to vemurafenib treatment, as compared to Plat-E cells expressing vector, wild-type BRAF or BRAF V600E mutation (a known sensitizing mutation to vemurafenib). Resistance was determined by assessing MEK and ERK phosphorylation.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "F595L",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/1121/summary",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/721",
				"source": "http://purl.obolibrary.org/obo/DOID_4231",
				"term": "histiocytoma",
				"pheno_id": "DOID:4231",
				"family": "musculoskeletal system cancer",
				"description": "histiocytoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/759"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/759",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26582644"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4426",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/759"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/598",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/759"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/760",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/57",
			"name": "G596V",
			"description": "BRAF G596V",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453148,
			"end_pos": 140453148,
			"ref": "C",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140453148C>A",
			"hgvs_c": "NM_004333.4:c.1787G>T",
			"hgvs_p": "NP_004324.2:p.Gly596Val",
			"dbsnp_ids": [
				"397507483"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453148C>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/1650/summary/evidence/4779/summary#evidence",
		"source": "civic",
		"description": "In a retrospective study of 35 lung adenocarcinoma patients (chemotherapy previously administered in 86% of patients), a patient harboring a BRAF G596V mutation was associated with partial response to vemurafenib monotherapy.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "G596V",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/1650/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/722",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/760"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/760",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26200454"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4779",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/760"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/599",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/760"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/761",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/367",
			"name": "ZKSCAN1-BRAF",
			"description": "BRAF ZKSCAN1-BRAF",
			"biomarker_type": "Transcript Fusion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001882"
			],
			"soid": "SO:0001886",
			"so_name": "transcript_fusion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000426572.1",
			"chromosome": "7",
			"start_pos": 99613222,
			"end_pos": 99627575,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/657/summary/evidence/1663/summary#evidence",
		"source": "civic",
		"description": "Analysis of BRAF fusions in 20,573 tumors, across 12 distinct tumor types. BRAF fusions were identified in 55 (0.3%) patients and enriched in spitzoid melanoma, pilocytic astrocytomas, pancreatic acinar and papillary thyroid cancers. Clinical data were available for two patients. Among them one 46-year old woman with spitzoid melanoma that  harbored  a\nZKSCAN1-BRAF fusion responded to treatment with the MEK inhibitor trametinib. Subcutaneous  tumor  nodules  exhibited  clinical responses within 14 days of therapy, and her dominant bulky right lung metastases showed significant response by Day 45. Subsequent robotic-assisted lobectomy was able to remove the previously unresectable tumor with\nclean surgical margins.",
		"drug_labels": "TRAMETINIB",
		"variant_name": null,
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/657/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/723",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/761"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/761",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26314551"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1663",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/761"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/600",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/761"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/762",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/368",
			"name": "AGK-BRAF",
			"description": "BRAF AGK-BRAF",
			"biomarker_type": "Transcript Fusion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001882"
			],
			"soid": "SO:0001886",
			"so_name": "transcript_fusion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000355413.4",
			"chromosome": "7",
			"start_pos": 141250989,
			"end_pos": 141255367,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/285/summary/evidence/723/summary#evidence",
		"source": "civic",
		"description": "BRAF fusion AGK-BRAF was associated with decreased sensitivity to vemurafenib and increased sensitivity to sorafenib in-vitro. A single patient with this fusion showed durable response to sorafenib.",
		"drug_labels": "Sorafenib",
		"variant_name": null,
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/285/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/724",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/762"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/762",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23890088"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "723",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/762"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/601",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Sorafenib",
				"envcontext_id": "216239",
				"usan_stem": "raf kinase inhibitors",
				"description": "Sorafenib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/762"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/763",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/368",
			"name": "AGK-BRAF",
			"description": "BRAF AGK-BRAF",
			"biomarker_type": "Transcript Fusion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001882"
			],
			"soid": "SO:0001886",
			"so_name": "transcript_fusion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000355413.4",
			"chromosome": "7",
			"start_pos": 141250989,
			"end_pos": 141255367,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/285/summary/evidence/724/summary#evidence",
		"source": "civic",
		"description": "A melanoma cell line with AGK-BRAF in-frame fusion showed decreased sensitivity towards Vemurafenib in comparison with BRAF mutated (V600E) cell lines.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": null,
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/285/summary",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/725",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/763"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/763",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23890088"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "724",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/763"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/602",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/763"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/764",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/369",
			"name": "G496A",
			"description": "BRAF G496A",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": null,
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/2221/summary/evidence/5966/summary#evidence",
		"source": "civic",
		"description": "The phase 2a MyPathway study assigned patients with HER2, EGFR, BRAF or SHH alterations to treatment with pertuzumab plus trastuzumab, erlotinib, vemurafenib, or vismodegib, respectively. Of 26 patients with BRAF V600E mutations, objective responses were seen in 12 patients (46%; 95% CI, 27% to 67%). Only one of 23 patients (4%; 95% CI, 0% to 22%) with other non-V600 BRAF mutations had a PR (pancreas cancer with a CUX1-BRAF fusion). Nonresponding BRAF mutations included: K601E (n = 6), G464V (n = 2), G469A (n = 2), G496A (n = 2), N581S (n = 2), and one each for G466V, G596R, G606E, L597Q, P731T, intron 9 rearrangement, intron 10 rearrangement, and MACF1- and WASFL-BRAF fusion.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "G496A",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/2221/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/726",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/764"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/764",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/29320312"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5966",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/764"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/603",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/764"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/765",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/370",
			"name": "CUX1-BRAF",
			"description": "BRAF CUX1-BRAF",
			"biomarker_type": "Transcript Fusion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001882"
			],
			"soid": "SO:0001886",
			"so_name": "transcript_fusion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 140453155,
			"end_pos": 140453155,
			"ref": "C",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140453155C>A",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453155C>A?assembly=hg19",
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/2229/summary/evidence/5977/summary#evidence",
		"source": "civic",
		"description": "The phase 2a MyPathway study assigned patients with HER2, EGFR, BRAF or SHH alterations to treatment with pertuzumab plus trastuzumab, erlotinib, vemurafenib, or vismodegib, respectively. One of 23 patients (4%; 95% CI, 0% to 22%) with other non-V600 BRAF mutations had a PR (pancreas cancer with a CUX1-BRAF fusion).",
		"drug_labels": "VEMURAFENIB",
		"variant_name": null,
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/2229/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/727",
				"source": "http://purl.obolibrary.org/obo/DOID_1793",
				"term": "pancreatic cancer",
				"pheno_id": "DOID:1793",
				"family": "endocrine gland cancer",
				"description": "pancreatic cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/765"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/765",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/29320312"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5977",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/765"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/604",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/765"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/766",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/117",
			"name": "V600D",
			"description": "BRAF V600D",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453135,
			"end_pos": 140453136,
			"ref": "CA",
			"alt": "AT",
			"hgvs_g": "NC_000007.13:g.140453135_140453136delinsAT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"121913377"
			],
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/11/summary/evidence/4488/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, WM2664, a BRAF V600D expressing cell line, demonstrated improved sensitivity to vemurafenib treatment, compared to BRAF wild-type expressing cells. Sensitivity was determined by assessing cell proliferation (WM2664, GI50: 1.5uM; vs. BRAF expressing cells (n=9) GI50: 10-41uM).",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600D",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/11/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/728",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/766"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/766",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/18287029"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4488",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/766"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/605",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/766"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/767",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/117",
			"name": "V600D",
			"description": "BRAF V600D",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453135,
			"end_pos": 140453136,
			"ref": "CA",
			"alt": "AT",
			"hgvs_g": "NC_000007.13:g.140453135_140453136delinsAT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"121913377"
			],
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/11/summary/evidence/4489/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, the WM2664 and WM239A cell lines expressing BRAF V600D were associated with increased sensitivity to vemurafenib treatment, as compared to cell lines expressing BRAF wild-type. Sensitivity was determined by proliferation assay.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600D",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/11/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/729",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/767"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/767",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20551065"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4489",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/767"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/606",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/767"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/768",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/117",
			"name": "V600D",
			"description": "BRAF V600D",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453135,
			"end_pos": 140453136,
			"ref": "CA",
			"alt": "AT",
			"hgvs_g": "NC_000007.13:g.140453135_140453136delinsAT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"121913377"
			],
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/11/summary/evidence/94/summary#evidence",
		"source": "civic",
		"description": "Patients with other BRAF V600 mutations also respond well to the V600E drug dabrafenib.",
		"drug_labels": "DABRAFENIB",
		"variant_name": "V600D",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/11/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/730",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/768"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/768",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23463675"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "94",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/768"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/607",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/768"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/769",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/3",
			"name": "V600K",
			"description": "BRAF V600K",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453137,
			"ref": "AC",
			"alt": "TT",
			"hgvs_g": "NC_000007.13:g.140453136_140453137delinsTT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"121913227"
			],
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/563/summary/evidence/1399/summary#evidence",
		"source": "civic",
		"description": "In the Phase III study of vemurafenib versus dacarbazine BRIM-3 (NCT01006980) in metastatic melanoma, 57 patients were confirmed to have V600K mutation. In this subgroup of treatment-naive patients, significant differences were seen in overall survival (14.5 months with vemurafenib vs. 7.6 months with dacarbazine), as well as median progression free survival (5.9 months with vemurafenib vs. 1.7 months with dacarbazine).",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600K",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/563/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/731",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/769"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/769",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24508103"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1399",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/769"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/608",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/769"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/770",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/3",
			"name": "V600K",
			"description": "BRAF V600K",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453137,
			"ref": "AC",
			"alt": "TT",
			"hgvs_g": "NC_000007.13:g.140453136_140453137delinsTT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"121913227"
			],
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/563/summary/evidence/1400/summary#evidence",
		"source": "civic",
		"description": "A 53 year old male presented with a scalp lesion which was incompletely excised. Metastases were seen in lymph node biopsy and subsequently in CT. BRAF inhibitor vemurafenib was then administered at 960 mg twice daily and later at 720 mg twice daily and reduction in metastases was observed. After 2 years complete radiological response was seen, while treatment was discontinued due to cardiomyopathy. 12 months after stopping vemurafenib patient did not show evidence of metastatic melanoma.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600K",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/563/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/732",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/770"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/770",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26989536"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1400",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/770"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/609",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/770"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/771",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/3",
			"name": "V600K",
			"description": "BRAF V600K",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453137,
			"ref": "AC",
			"alt": "TT",
			"hgvs_g": "NC_000007.13:g.140453136_140453137delinsTT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"121913227"
			],
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/563/summary/evidence/4173/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, cell lines (including YUMAC and YULAC) expressing BRAF V600K were associated with increased sensitivity to vemurafenib (PLX4032) treatment, as compared to cell lines expressing wild-type BRAF. Sensitive was determined by assessing cellular proliferation, and ERK and MEK phosphorylation.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600K",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/563/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/733",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/771"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/771",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20149136"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4173",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/771"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/610",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/771"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/772",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/3",
			"name": "V600K",
			"description": "BRAF V600K",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453137,
			"ref": "AC",
			"alt": "TT",
			"hgvs_g": "NC_000007.13:g.140453136_140453137delinsTT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"121913227"
			],
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/563/summary/evidence/4174/summary#evidence",
		"source": "civic",
		"description": "In a locally advanced, unresectable, melanoma patient harboring BRAF V600K mutation, BRAF V600K was associated with sensitivity to vemurafenib treatment. The patients was initially treated with topical imiquimod and systemic temozolomide, subsequently, the patient was treated with vemurafenib and achieved an outstanding clinical response with substantial tumor burden reduction.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600K",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/563/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/734",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/772"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/772",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20630094"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4174",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/772"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/611",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/772"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/773",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/3",
			"name": "V600K",
			"description": "BRAF V600K",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453137,
			"ref": "AC",
			"alt": "TT",
			"hgvs_g": "NC_000007.13:g.140453136_140453137delinsTT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"121913227"
			],
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/563/summary/evidence/2505/summary#evidence",
		"source": "civic",
		"description": "Patients were treated with a specific RAF inhibitor (dabrafenib), which improved overall survival of patients with BRAF mutations (P<0.003), compared to non-treated patients with BRAF mutations. Patients having BRAF mutations were associated with reduced overall survival (11.1 mo vs. 46.1 mo for wild-type, P=0.006). BRAF mutations were more frequent in tumors with superficially spreading histological sub-type (43%  vs. 19% , P<0.001) compared to BRAF wild-type tumors.",
		"drug_labels": "DABRAFENIB",
		"variant_name": "V600K",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/563/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/735",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/773"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/773",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21343559"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2505",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/773"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/612",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/773"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/774",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/3",
			"name": "V600K",
			"description": "BRAF V600K",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453137,
			"ref": "AC",
			"alt": "TT",
			"hgvs_g": "NC_000007.13:g.140453136_140453137delinsTT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"121913227"
			],
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/563/summary/evidence/2506/summary#evidence",
		"source": "civic",
		"description": "In a study of 322 advanced melanoma patients with BRAF-V600E or BRAF-V600K mutations, treatment with trametinib was associated with improved progression-free survival (4.8mo vs. 1.5mo, <0.001) compared to chemotherapy control group. Additionally, treatment with trametinib was associated with increased 6-month overall survival (HR:0.54, 95% CI:0.32-0.92, P=0.01).",
		"drug_labels": "TRAMETINIB",
		"variant_name": "V600K",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/563/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/736",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/774"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/774",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22663011"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2506",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/774"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/613",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/774"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/775",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/3",
			"name": "V600K",
			"description": "BRAF V600K",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453137,
			"ref": "AC",
			"alt": "TT",
			"hgvs_g": "NC_000007.13:g.140453136_140453137delinsTT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"121913227"
			],
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/563/summary/evidence/2507/summary#evidence",
		"source": "civic",
		"description": "Proposed resistance mechanisms include PDGFRB upregulation or NRAS mutations resulting in MAPK pathway reactivation, but not secondary mutations in BRAF. MEK inhibitors may demonstrate clinical benefit in vemurafenib-resistant melanoma patients.",
		"drug_labels": "DABRAFENIB",
		"variant_name": "V600K",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/563/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/737",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/775"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/775",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21107323"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2507",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/775"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/614",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/775"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/776",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/3",
			"name": "V600K",
			"description": "BRAF V600K",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453137,
			"ref": "AC",
			"alt": "TT",
			"hgvs_g": "NC_000007.13:g.140453136_140453137delinsTT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"121913227"
			],
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/563/summary/evidence/4175/summary#evidence",
		"source": "civic",
		"description": "In a phase 2 clinical trial (NCT00949702) of 344 BRAF V600 mutation, positive advanced melanoma patients, patients with BRAF V600K (n=10) mutation treated with vemurafenib monotherapy were associated with partial response and stable disease (n=4 and n=3, respectively); however; 2 patients did experience progressive disease.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600K",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/563/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/738",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/776"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/776",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22356324"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4175",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/776"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/615",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/776"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/777",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/3",
			"name": "V600K",
			"description": "BRAF V600K",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453137,
			"ref": "AC",
			"alt": "TT",
			"hgvs_g": "NC_000007.13:g.140453136_140453137delinsTT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"121913227"
			],
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/563/summary/evidence/4176/summary#evidence",
		"source": "civic",
		"description": "In a retrospective study of 30 metastatic melanoma patients with progressing metastases, a metastatic melanoma patient harboring BRAF V600K mutation achieved a partial response to vemurafenib treatment.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600K",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/563/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/739",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/777"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/777",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24463458"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4176",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/777"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/616",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/777"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/778",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/3",
			"name": "V600K",
			"description": "BRAF V600K",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453137,
			"ref": "AC",
			"alt": "TT",
			"hgvs_g": "NC_000007.13:g.140453136_140453137delinsTT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"121913227"
			],
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/563/summary/evidence/4177/summary#evidence",
		"source": "civic",
		"description": "In a phase 2 clinical trial (NCT00949702) of 132 BRAF mutation positive metastatic melanoma patients treated with vemurafenib monotherapy, patients harboring BRAF V600E (n=123) or V600K (n=9) mutations were associated with a favorable objective response rate (53% per RECIST v1.1 criteria, 70/132), with 6% (8/132) and 47% (62/132) of patients achieving complete response and partial response, respectively. Specifically, of the patients with BRAF V600K mutation, three achieved partial response, three had stable disease, two progressed and one patients was not evaluable.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600K",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/563/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/740",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/778"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/778",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23569304"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4177",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/778"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/617",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/778"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/779",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/3",
			"name": "V600K",
			"description": "BRAF V600K",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453137,
			"ref": "AC",
			"alt": "TT",
			"hgvs_g": "NC_000007.13:g.140453136_140453137delinsTT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"121913227"
			],
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/563/summary/evidence/4178/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a Hmel-1 cell line expressing BRAF V600K demonstrated improved sensitivity to vemurafenib treatment, compared to LND-1 cells expression BRAF wild-type. Sensitivity was determined by assessing cell proliferation (Hmel-1, IC50: 5.5uM; vs. LND-1, IC50: 32.2uM).",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600K",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/563/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/741",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/779"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/779",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26070258"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4178",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/779"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/618",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/779"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/780",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/3",
			"name": "V600K",
			"description": "BRAF V600K",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453137,
			"ref": "AC",
			"alt": "TT",
			"hgvs_g": "NC_000007.13:g.140453136_140453137delinsTT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"121913227"
			],
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/563/summary/evidence/4179/summary#evidence",
		"source": "civic",
		"description": "In a dermal melanoma patient harboring a BRAF V600K mutation, response to vemurafenib monotherapy was reported. The patient achieved a decrease in the size and number of cerebral metastases at 10 weeks of vemurafenib treatment and survived beyond her pre-vemurafenib treatment prognosis survival of 3 weeks.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600K",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/563/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/742",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/780"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/780",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23677116"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4179",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/780"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/619",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/780"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/781",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/3",
			"name": "V600K",
			"description": "BRAF V600K",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453137,
			"ref": "AC",
			"alt": "TT",
			"hgvs_g": "NC_000007.13:g.140453136_140453137delinsTT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"121913227"
			],
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/563/summary/evidence/4180/summary#evidence",
		"source": "civic",
		"description": "In a retrospective study of 300 stage IV melanoma patients, patients with BRAF V600K mutation (n=18) were associated with a 5.6% (1/18) complete response, a 22.2% (4/18) partial response and stable disease in 44.4% (8/18) of cases; however, 27.8% (5/18) of patients harboring BRAF V600K experienced progressive disease and patients with BRAF V600E mutation achieved a more impressive clinical benefit, as compared to patients with BRAF V600K mutation (P=0.016).",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600K",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/563/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/743",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/781"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/781",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25524477"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4180",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/781"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/620",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/781"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/782",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/3",
			"name": "V600K",
			"description": "BRAF V600K",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453137,
			"ref": "AC",
			"alt": "TT",
			"hgvs_g": "NC_000007.13:g.140453136_140453137delinsTT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"121913227"
			],
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/563/summary/evidence/4181/summary#evidence",
		"source": "civic",
		"description": "In a clinical trial (NCT01597908) of 704 metastatic melanoma patients, patients harboring a BRAF V600K mutation and treated with vemurafenib (n=34) were associated with a 44% response rate, as compared to a 65% response rate in V600E mutation positive patients treated with dabrafenib and trametinib combination therapy (n=34).",
		"drug_labels": "TRAMETINIB,DABRAFENIB",
		"variant_name": "V600K",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/563/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/744",
				"source": "http://purl.obolibrary.org/obo/DOID_8923",
				"term": "skin melanoma",
				"pheno_id": "DOID:8923",
				"family": "melanoma",
				"description": "skin melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/782"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/782",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25399551"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4181",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/782"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/622",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/782"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/621",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/782"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/783",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/3",
			"name": "V600K",
			"description": "BRAF V600K",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453137,
			"ref": "AC",
			"alt": "TT",
			"hgvs_g": "NC_000007.13:g.140453136_140453137delinsTT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"121913227"
			],
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/563/summary/evidence/6179/summary#evidence",
		"source": "civic",
		"description": "Adjuvant dual treatment with BRAF inhibitor dabrafenib and MEK inhibitor trametinib was administered to patients with stage III resected melenoma with V600E or V600K mutation in this stage III trial (COMBO-AD, NCT01682083). 78 (9%) patients had V600K, and were administered dabrafenib and trametinib or placebo for 12 months. In subsequent analysis, relapse or death occurred in 16/41 patients (39%) in the treatment group and 19/37 patients (51%) in the placebo group for a 95% CI Hazard Ratio of 0.54 (0.27-1.06).",
		"drug_labels": "DABRAFENIB,TRAMETINIB",
		"variant_name": "V600K",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/563/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/745",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/783"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/783",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28891408"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6179",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/783"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/624",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/783"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/623",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/783"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/784",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/3",
			"name": "V600K",
			"description": "BRAF V600K",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453137,
			"ref": "AC",
			"alt": "TT",
			"hgvs_g": "NC_000007.13:g.140453136_140453137delinsTT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"121913227"
			],
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/563/summary/evidence/6939/summary#evidence",
		"source": "civic",
		"description": "In this Phase III trial (NCT01584648 COMBI-d), previously untreated patients with unrescectable stage IIIC or IV melanoma with BRAF V600E (360 patients) or V600K (62 patients) received dabrafenib and trametinib or dabrafenib alone with primary endpoint of progression free survival with secondary endpoints including disease response.\n\nHazard ratio for progression or death in the dabrafenib–trametinib group was 0.81; 95% confidence interval. \n\nOf 31 patients in the dabrafenib + trametinib group, 61% of patients had a response, which was 21 percentage points higher than in the dabrafenib group. (95% CI, -3 to 46; P=0.1)",
		"drug_labels": "DABRAFENIB,TRAMETINIB",
		"variant_name": "V600K",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/563/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/746",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/784"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/784",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25265492"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6939",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/784"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/626",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/784"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/625",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/784"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/785",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/3",
			"name": "V600K",
			"description": "BRAF V600K",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453137,
			"ref": "AC",
			"alt": "TT",
			"hgvs_g": "NC_000007.13:g.140453136_140453137delinsTT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"121913227"
			],
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/563/summary/evidence/6941/summary#evidence",
		"source": "civic",
		"description": "In this Phase I and II study (NCT01072175) patients with metastatic melanoma were given dabrafenib and trametinib combination therapy vs. dabrafenib monotherapy. \n\nFrom V600K patients, 9 received monotherapy and 16 combination therapy.\n\nHazard ratio for progression or death was 0.19 (95% CI, 0.05-0.66)\n\nBoth patients with the BRAF V600E and V600K mutation showed significant improvement in progression-free survival.",
		"drug_labels": "DABRAFENIB,TRAMETINIB",
		"variant_name": "V600K",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/563/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/747",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/785"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/785",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23020132"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6941",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/785"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/628",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/785"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/627",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/785"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/786",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/3",
			"name": "V600K",
			"description": "BRAF V600K",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453137,
			"ref": "AC",
			"alt": "TT",
			"hgvs_g": "NC_000007.13:g.140453136_140453137delinsTT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"121913227"
			],
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/563/summary/evidence/6965/summary#evidence",
		"source": "civic",
		"description": "In this Phase III trial (coBRIM, NCT01689519) of 495 V600 mutant melanoma patients, 56 had V600K mutation. 32 patients were treated with vemurafenib and placebo, and 24 were treated with vemurafenib and cobimetinib and tested for progression free survival. 17 of 32 monotherapy group patients had an event with median progression free survival of 5.3 months. In the combination group 4 of 24 patients had an event with median progression-free survival not met, however, when in combination with other V600 mutations median progression-free survival was 9.9 months with combination treatment. Median time to followup for the whole cohort was 7.3 months. Hazard Ratio for progression or death was 0.27 (0.09-0.81).",
		"drug_labels": "DABRAFENIB,TRAMETINIB",
		"variant_name": "V600K",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/563/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/748",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/786"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/786",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25265494"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6965",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/786"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/630",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/786"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/629",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/786"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/787",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/90/summary#evidence",
		"source": "civic",
		"description": "In the setting of BRAF(V600E), NF1 loss resulted in elevated activation of RAS-GTP and resistance to RAF inhibitors.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/749",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/787"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/787",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24576830"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "90",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/787"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/631",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/787"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/788",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/82/summary#evidence",
		"source": "civic",
		"description": "BRAF status does not predict outcome in patients treated with dacarbazine or temozolomide.",
		"drug_labels": "DACARBAZINE,TEMOZOLOMIDE",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "N/A",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/750",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/788"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/788",
				"type": "Predictive",
				"description": "N/A",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24586605"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "82",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/788"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/633",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TEMOZOLOMIDE",
				"envcontext_id": "5394",
				"usan_stem": null,
				"description": "TEMOZOLOMIDE",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/788"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/632",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "DACARBAZINE",
				"envcontext_id": "CHEMBL476",
				"usan_stem": null,
				"description": "DACARBAZINE",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/788"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/789",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/89/summary#evidence",
		"source": "civic",
		"description": "Cetuximab or panitumumab may be ineffective in patients with BRAF mutation unless BRAF inhibitor such as Sorafenib is introduced.",
		"drug_labels": "Sorafenib,PANITUMUMAB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/751",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/789"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/789",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19001320"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "89",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/789"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/635",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "PANITUMUMAB",
				"envcontext_id": "CHEMBL1201827",
				"usan_stem": "monoclonal antibodies",
				"description": "PANITUMUMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/789"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/634",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Sorafenib",
				"envcontext_id": "216239",
				"usan_stem": "raf kinase inhibitors",
				"description": "Sorafenib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/789"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/790",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/91/summary#evidence",
		"source": "civic",
		"description": "In a patient with V600E-positive NSCLC, KRAS G12D seemed to confer resistance to dabrafenib.",
		"drug_labels": "DABRAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "C",
		"response_type": "resistant",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/752",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/790"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/790",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23524406"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "91",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/790"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/636",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/790"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/791",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/95/summary#evidence",
		"source": "civic",
		"description": "Dabrafenib with trametinib provides higher response rate and lower toxicity (as compared to chemotherapy) in patients with melanoma.",
		"drug_labels": "DABRAFENIB,TRAMETINIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/753",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/791"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/791",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24583796"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "95",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/791"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/638",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/791"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/637",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/791"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/792",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/96/summary#evidence",
		"source": "civic",
		"description": "Combined MEK inhibitor GDC0941 and BRAF inhibitor PLX4720 administration to NSG mice subcutanousely injected with colorectal cell lines with a BRAF V600E mutation effectively inhibited tumor growth and reduced cellular proliferation.",
		"drug_labels": "PLX-4720,GDC-0941",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/754",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/792"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/792",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23845441"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "96",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/792"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/640",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GDC-0941",
				"envcontext_id": "CID17755052",
				"usan_stem": null,
				"description": "GDC-0941",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/792"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/639",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "PLX-4720",
				"envcontext_id": "CID24180719",
				"usan_stem": null,
				"description": "PLX-4720",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/792"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/793",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/97/summary#evidence",
		"source": "civic",
		"description": "Combined nutlin-3 and PLX4720 administration to athymic nude mice subcutanousely injected with the A357 colorectal cell line with a BRAF V600E mutation effectively inhibited tumor growth significantly more than single agent therapy.",
		"drug_labels": "PLX-4720,Nutlin",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/755",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/793"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/793",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23812671"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "97",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/793"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/642",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Nutlin",
				"envcontext_id": "71582991",
				"usan_stem": null,
				"description": "Nutlin",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/793"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/641",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "PLX-4720",
				"envcontext_id": "CID24180719",
				"usan_stem": null,
				"description": "PLX-4720",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/793"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/794",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/98/summary#evidence",
		"source": "civic",
		"description": "Mouse xenografts using HT29 cells harboring the BRAF V600E mutation treated with combination therapy (capecitabine, vemurafenib, bevacizumab) showed increased survival and reduced tumor burden compared to single and double agent therapies.",
		"drug_labels": "CAPECITABINE,VEMURAFENIB,BEVACIZUMAB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/756",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/794"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/794",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22180495"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "98",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/794"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/645",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "BEVACIZUMAB",
				"envcontext_id": "CHEMBL1201583",
				"usan_stem": "monoclonal antibodies",
				"description": "BEVACIZUMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/794"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/644",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/794"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/643",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "CAPECITABINE",
				"envcontext_id": "60953",
				"usan_stem": "nucleoside antiviral or antineoplastic agents, cytarabine or azarabine derivatives",
				"description": "CAPECITABINE",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/794"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/795",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/99/summary#evidence",
		"source": "civic",
		"description": "Cell lines expressing the BRAF V600E mutation responded better to vemurafenib treatment than cells wildtype for BRAF as measured by reduced cellular proliferation and inhibition of MET and ERK phosphorylation.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/757",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/795"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/795",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22180495"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "99",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/795"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/646",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/795"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/796",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/126/summary#evidence",
		"source": "civic",
		"description": "Chemotherapy-refractory patients with colorectal cancer harboring BRAF mutations had lower response and disease control rates as well as shorter progression free and overall survival following cetuximab plus chemotherapy than those with wildtype BRAF.",
		"drug_labels": "CETUXIMAB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/758",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/796"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/796",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20619739"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "126",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/796"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/647",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/796"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/797",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/86/summary#evidence",
		"source": "civic",
		"description": "In the setting of BRAF(V600E), NF1 loss resulted in elevated activation of RAS-GTP but does not show resistance to MEK inhibitors.",
		"drug_labels": "TRAMETINIB,391210-10-9",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/759",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/797"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/797",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24576830"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "86",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/797"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/649",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "391210-10-9",
				"envcontext_id": "CID9826528",
				"usan_stem": null,
				"description": "391210-10-9",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/797"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/648",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/797"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/798",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3736/summary#evidence",
		"source": "civic",
		"description": "In metastatic colorectal cancer patients with wildtype KRAS status who received cetuximab therapy, those with a BRAF V600E mutation had reduced progression-free survival (8.0wk vs. 31.4wk, P=0.001, log-rank test, univariate analysis) and reduced overall survival (6.5mo vs. 14.8mo, P=0.001, log-rank test, univariate analysis; HR:6.6, 95%CI:2.4-18.2, P<0.001, multivariate analysis. Similar associations have been found in independent studies.",
		"drug_labels": "CETUXIMAB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/760",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/798"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/798",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19884556"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3736",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/798"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/650",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/798"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/799",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3738/summary#evidence",
		"source": "civic",
		"description": "Among metastatic colorectal cancer patients treated with cetuximab and irinotecan, those with BRAF V600E mutations were less likely to achieve a complete or partial response to therapy (0% , P=0.016, Fisher�s exact test) and had shorter median overall survival (4.1mo vs. 13.9mo, HR:0.51, 95%CI:0.18-0.95, P=0.037) than patients with wildtype BRAF.",
		"drug_labels": "CETUXIMAB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "C",
		"response_type": "resistant",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/761",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/799"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/799",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19603018"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3738",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/799"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/651",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/799"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/800",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3739/summary#evidence",
		"source": "civic",
		"description": "In a retrospective study of 148 treatment naive metastatic colorectal cancer patients, patients with BRAF V600E (n=14) mutation treated with FOLFOX4 plus cetuximab were associated with a decreased progression free survival (7.2mo vs. 9.7mo, HR:0.39, 95% CI:0.21-0.72, P=0.0017), and decreased overall survival (11.7mo vs. 28.5mo, HR:0.23, 95% CI:0.12-0.41, P<0.0001), as compared to patients with wildtype BRAF.",
		"drug_labels": "CETUXIMAB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/762",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/800"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/800",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25666295"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3739",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/800"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/652",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/800"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/801",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3740/summary#evidence",
		"source": "civic",
		"description": "In a retrospective study of 53, KRAS exon 2 wild-type, metastatic colorectal cancer patients, patients harboring BRAF G466A (n=1), G469A (n=2), D594G (n=1), or V600E (n=2) mutations were reported to be non-responders to cetuximab in combination with irinotecan, (BRAF mutation positive: responders vs. non-responders = 0 vs. 6; BRAF wild-type: responders vs. non-responders 30 vs. 17; P=0.004), as compared to patients with wild-type BRAF.",
		"drug_labels": "CETUXIMAB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "C",
		"response_type": "resistant",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/763",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/801"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/801",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26989027"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3740",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/801"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/653",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/801"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/802",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3741/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, WiDr, HT-29, LS411N, and SW1417 cell lines expressing BRAF V600E and treated with vemurafenib and erlotinib, or vemurafenib and gefitinib were associated with a reduction in cell viability (P<0.01), as compared to cells treated solely with vemurafenib or vehicle. WiDr and HT-29 cell lines expressing BRAF V600E were associated with a modest reduction in cell viability. Sensitivity was determined by assessing cell viability after 72h of vemurafenib treatement. In an in vivo study, WiDr and HT-29 xenografts expression BRAF V600E and treated with vemurafenib and erlotinib combination therapy were associated with reduced tumor volume (P<0.05) as compared to xenografts treated with vemurafenib alone, erlotinib alone, or vehicle alone.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/764",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/802"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/802",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22448344"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3741",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/802"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/654",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/802"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/803",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3742/summary#evidence",
		"source": "civic",
		"description": "In a clinical study of 122 cancer patients, including 37 previously treated colorectal cancer patients harboring BRAF V600 (V600E=32; V600 unknown=5) mutations, stable disease and progressive disease were reported in 50% of patients (n=5/10) treated with vemurafenib monotherapy, respectively.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/765",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/803"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/803",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26287849"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3742",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/803"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/655",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/803"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/804",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3743/summary#evidence",
		"source": "civic",
		"description": "An anaplastic thyroid cancer patient harboring BRAF V600E mutation was associated with response to vemurafenib treatment. The patient was initially treated with paclitaxel, but experienced disease progression; subsequently, the patient was treated concurrently with vemurafenib and radiation therapy and achieved regression of metastatic disease.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "C",
		"response_type": null,
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/766",
				"source": "http://purl.obolibrary.org/obo/DOID_3963",
				"term": "thyroid carcinoma",
				"pheno_id": "DOID:3963",
				"family": "endocrine gland cancer",
				"description": "thyroid carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/804"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/804",
				"type": "Predictive",
				"description": null,
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23406047"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3743",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/804"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/656",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/804"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/805",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3744/summary#evidence",
		"source": "civic",
		"description": "In an anaplastic thyroid cancer patient harboring BRAF V600E and TP53 E180K co-mutations, BRAF V600E was associated with response to vemurafenib treatment. Prior to identification of the BRAF V600E mutation, the patient was treated with 6 cycles of standard chemotherapy plus radiation and experienced progressive disease; subsequently, the patient achieved a complete response with 61 weeks of vemurafenib monotherapy followed by disease progression.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "C",
		"response_type": null,
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/767",
				"source": "http://purl.obolibrary.org/obo/DOID_3963",
				"term": "thyroid carcinoma",
				"pheno_id": "DOID:3963",
				"family": "endocrine gland cancer",
				"description": "thyroid carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/805"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/805",
				"type": "Predictive",
				"description": null,
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27532222"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3744",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/805"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/657",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/805"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/806",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3745/summary#evidence",
		"source": "civic",
		"description": "Acquired resistance to vemurafenib in BRAF V600E-positive melanomas frequently confound vemurafenib therapy. Proposed resistance mechanisms include PDGFRB upregulation or NRAS mutations resulting in MAPK pathway reactivation but not secondary mutations in BRAF. MEK inhibitors may demonstrate clinical benefit in vemurafenib resistant melanoma patients.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/768",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/806"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/806",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21107320"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3745",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/806"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/658",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/806"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/807",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3746/summary#evidence",
		"source": "civic",
		"description": "Acquired resistance to vemurafenib in BRAF V600E-positive melanomas frequently confound vemurafenib therapy. Proposed resistance mechanisms include PDGFRB upregulation or NRAS mutations resulting in MAPK pathway reactivation but not secondary mutations in BRAF. MEK inhibitors may demonstrate clinical benefit in vemurafenib resistant melanoma patients.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/769",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/807"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/807",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21107323"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3746",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/807"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/659",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/807"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/808",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3747/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, cell lines (including YUHUY and YUSAC2) expressing BRAF V600E were associated with increased sensitivity to vemurafenib (PLX4032) treatment, as compared to cell lines expressing wild-type BRAF. Sensitive was determined by assessing cellular proliferation, and ERK and MEK phosphorylation.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/770",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/808"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/808",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20149136"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3747",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/808"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/660",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/808"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/809",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3748/summary#evidence",
		"source": "civic",
		"description": "An inducible BRAF-V600E mouse melanoma model shows a tight correlation between activated BRAF and disease progression.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/771",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/809"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/809",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/16424035"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3748",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/809"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/661",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/809"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/810",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3749/summary#evidence",
		"source": "civic",
		"description": "In a retrospective study of 30 metastatic melanoma patients with progressing metastases, patients with BRAF V600E mutation (n=8) treated with vemurafenib monotherapy achieved a partial response (n=5) and stable disease (n=1).",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/772",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/810"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/810",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24463458"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3749",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/810"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/662",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/810"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/811",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/757/summary#evidence",
		"source": "civic",
		"description": "One patient with BRAF V600E mutated melanoma (with no detected PI3K pathway deregulation) had a partial response on treatment with pictilisib, a PI3K inhibitor, for 9.5 months. Study was a phase-1 with 60 patients enrolled.",
		"drug_labels": "PICTILISIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/773",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/811"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/811",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25370471"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "757",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/811"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/663",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "PICTILISIB",
				"envcontext_id": "17755052",
				"usan_stem": "phosphatidylinositol 3-kinase inhibitors",
				"description": "PICTILISIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/811"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/812",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3750/summary#evidence",
		"source": "civic",
		"description": "In a phase 2 clinical trial (NCT00949702) of 132 BRAF mutation positive metastatic melanoma patients treated with vemurafenib monotherapy, patients harboring BRAF V600E (n=123) or V600K (n=9) mutations were associated with a favorable objective response rate (53% per RECIST v1.1 criteria, 70/132), with 6% (8/132) and 47% (62/132) of patients achieving complete response and partial response, respectively.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/774",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/812"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/812",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23569304"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3750",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/812"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/664",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/812"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/813",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3751/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, BRAF V600E expressing cell lines (COLO205, A375 and COLO829) demonstrated improved sensitivity to vemurafenib treatment, compared to BRAF wild-type expressing cells. Sensitivity was determined by assessing cell proliferation (COLO205, GI50: 0.31uM; A375, GI50: 0.50 uM; COLO829, GI50: 1.7 uM vs. BRAF expressing cells (n=9) GI50: 10-41uM) and ERK phosphorylation.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/775",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/813"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/813",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/18287029"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3751",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/813"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/665",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/813"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/814",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3752/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a MBA72 cell line expressing BRAF V600E demonstrated improved sensitivity to vemurafenib treatment, compared to LND-1 cells expression BRAF wild-type. Sensitivity was determined by assessing cell proliferation (MBA72, IC50: 3.2uM; vs. LND-1, IC50: 32.2 uM).",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/776",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/814"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/814",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26070258"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3752",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/814"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/666",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/814"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/815",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3753/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, several cell lines (including MALME-3M, Colo829, Colo38, A375 and SK-MEK28) expressing BRAF V600E were associated with increased sensitivity to vemurafenib (RG7204) treatment, as compared to cell lines expressing BRAF wild-type. Sensitivity was determined by proliferation assay and by assessing MEK1/2 phosphorylation. Further, in an in vivo study, LOX, Colo829 and A375 xenografts were reportedly sensitive to vemurafenib treatment as assessed by tumor volume.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/777",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/815"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/815",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20551065"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3753",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/815"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/667",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/815"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/816",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3754/summary#evidence",
		"source": "civic",
		"description": "In a stage I melanoma patient harboring a BRAF V600E mutation, response to vemurafenib monotherapy was reported. Upon identification of the BRAF V600E mutation, the patient enrolled in a clinical trial and was treated with vemurafenib monotherapy, a partial response was reported. However, novel hypermetabolic nodules developed and the patient enrolled in another clinical trial, undergoing combination therapy of vemurafenib and GDC-0973, but disease progression occurred at 5 months. Subsequently, the patient was treated with vemurafenib and ipilimumab, achieving a confirmed complete response.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/778",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/816"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/816",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24616537"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3754",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/816"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/668",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/816"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/817",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3755/summary#evidence",
		"source": "civic",
		"description": "In a  clinical study of Polish, stage IIIC/IV, melanoma patients with metastases (n=75) harboring BRAF V600 mutation (as detected by cobas 4800 BRAF V600 Mutation Test), patients were associated with a 61.9% (95% CI: 50.1-73.6) median overall survival, a 7.4 months (95% CI: 5.5-9.2) median progression free survival; a median duration response of 7.4 months was reported, with 3% (2/75) and 43% (29/75) of patients achieving a complete and partial response, respectively.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/779",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/817"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/817",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26557775"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3755",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/817"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/669",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/817"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/818",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3756/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study of 27 melanoma cell lines, 18 out of 20 cell lines expressing BRAF V600E mutation were associated with sensitivity to vemurafenib treatment (IC50: 0.01-1�M). Sensitivity was determined by assessing growth inhibition.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/780",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/818"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/818",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22241959"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3756",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/818"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/670",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/818"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/819",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3757/summary#evidence",
		"source": "civic",
		"description": "In a retrospective study of 300 stage IV melanoma patients, patients with BRAF V600E mutation (n=175) were associated with a 4.8% (8/167) complete response, a 58.1% (97/167) partial response and stable disease in 22.2% (37/167) of cases; however, 15% (25/167) of patients harboring BRAF V600E experienced progressive disease.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/781",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/819"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/819",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25524477"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3757",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/819"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/671",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/819"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/820",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3759/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a melanoma cell line, A375, expressing the BRAF V600E mutation was associated with resistance to dasatinib treatment, comparable to melanoma MEWO cells expressing wild-type BRAF. Resistance was determined by assessing cell viability.",
		"drug_labels": "DASATINIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/782",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/820"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/820",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19671763"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3759",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/820"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/672",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DASATINIB",
				"envcontext_id": "3062316",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "DASATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/820"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/821",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3760/summary#evidence",
		"source": "civic",
		"description": "Thyroid cancer cell lines with BRAF V600E mutations were more sensitive to vemurafenib than those with wildtype BRAF (IC50: 0.115� 1.156 uM vs. 56.674�1349.788 uM).",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/783",
				"source": "http://purl.obolibrary.org/obo/DOID_1781",
				"term": "thyroid cancer",
				"pheno_id": "DOID:1781",
				"family": "endocrine gland cancer",
				"description": "thyroid cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/821"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/821",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/18458053"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3760",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/821"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/673",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/821"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/822",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3761/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, the HCC364 cell line expressing a BRAF V600E mutation was associated with sensitivity to vemurafenib treatment. Sensitivity was determined by assessing cell viability, apoptosis and colony formation.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/784",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/822"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/822",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25706985"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3761",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/822"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/674",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/822"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/823",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3762/summary#evidence",
		"source": "civic",
		"description": "In a mouse xenograft model, tumors derived from the glioblastoma cell line AM-38 that were treated with vemurafenib had reduced tumor growth and improved survival compared to control treated mice (P=0.018 and 0.0002, respectively). In contrast, mice with wildtype BRAF xenografts did not respond vemurafenib compared to control treatment as measured by tumor size and survival (P=0.179 and P=0.225, respectively ). A malignant astrocytoma cell line that expressed BRAF V600E was more sensitive to growth inhibition by vemurafenib than a cell line with wildtype BRAF (EC50=1.75 vs. 31.2 umol/L).",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/785",
				"source": "http://purl.obolibrary.org/obo/DOID_3070",
				"term": "malignant glioma",
				"pheno_id": "DOID:3070",
				"family": "cell type cancer",
				"description": "malignant glioma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/823"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/823",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22038996"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3762",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/823"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/675",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/823"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/824",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3766/summary#evidence",
		"source": "civic",
		"description": "In a refractory hairy cell leukemia patient harboring BRAF V600E mutation, BRAF V600E was associated with sensitivity to vemurafenib treatment. The patient was initially treated with conventional treatments and failed to respond; subsequently, the patient was treated with vemurafenib monotherapy and achieved complete remission on day 43 with treatment being terminated at day 56.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/786",
				"source": "http://purl.obolibrary.org/obo/DOID_285",
				"term": "hairy cell leukemia",
				"pheno_id": "DOID:285",
				"family": "leukemia",
				"description": "hairy cell leukemia",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/824"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/824",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22621641"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3766",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/824"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/676",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/824"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/825",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3767/summary#evidence",
		"source": "civic",
		"description": "In a case report, a hairy cell leukemia (HCL) patient harboring BRAF V600E mutation was associated with a complete response to vemurafenib monotherapy after 3 months of treatment, which was sustained after 21 days of therapy. Prior to vemurafenib treatment, the patient had been diagnosed with HCL and achieved a complete hematologic response to splenectomy and interferon treatment, however, the patient subsequently relapsed and was treated with standard chemotherapy with further disease progression. As a follow-up to a previous study (23300174), a hairy cell leukemia patient harboring BRAF V600E mutation was associated with response to vemurafenib monotherapy. The patient was previously treated with vemurafenib and obtained a complete response, but then experienced disease progression. Subsequently, the patient was re-treated with vemurafenib and again achieved a complete hematological response.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/787",
				"source": "http://purl.obolibrary.org/obo/DOID_285",
				"term": "hairy cell leukemia",
				"pheno_id": "DOID:285",
				"family": "leukemia",
				"description": "hairy cell leukemia",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/825"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/825",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23300174"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3767",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/825"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/677",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/825"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/826",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3768/summary#evidence",
		"source": "civic",
		"description": "In a hairy cell leukemia patient harboring BRAF V600E mutation, BRAF V600E mutation was associated with improved response to vemurafenib treatment. The patient was treated with 3 lines of chemotherapy, including 6 cycles of pentostatin and rituximab combination therapy, but experience progressive disease; subsequently, the patient was treated with vemurafenib monotherapy for 58 days and achieved a partial response.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/788",
				"source": "http://purl.obolibrary.org/obo/DOID_285",
				"term": "hairy cell leukemia",
				"pheno_id": "DOID:285",
				"family": "leukemia",
				"description": "hairy cell leukemia",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/826"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/826",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23278307"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3768",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/826"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/678",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/826"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/827",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3769/summary#evidence",
		"source": "civic",
		"description": "As a follow-up to a previous study (23300174), a hairy cell leukemia patient harboring BRAF V600E mutation was associated with response to vemurafenib monotherapy. The patient was previously treated with vemurafenib and obtained a complete response, but then experienced disease progression. Subsequently, the patient was re-treated with vemurafenib and again achieved a complete hematological response.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/789",
				"source": "http://purl.obolibrary.org/obo/DOID_285",
				"term": "hairy cell leukemia",
				"pheno_id": "DOID:285",
				"family": "leukemia",
				"description": "hairy cell leukemia",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/827"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/827",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25815361"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3769",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/827"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/679",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/827"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/828",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3770/summary#evidence",
		"source": "civic",
		"description": "A hairy cell leukemia patient with extensive CNS involvement patient harboring BRAF V600E mutation was associated with complete response to vemurafenib monotherapy. Upon identification of the BRAF V600E mutation, the patient was treated with cytarabine, rituximab and methotrexate but quickly progressed; subsequently, the patient was treated with 2 rounds of vemurafenib and achieved complete response.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/790",
				"source": "http://purl.obolibrary.org/obo/DOID_285",
				"term": "hairy cell leukemia",
				"pheno_id": "DOID:285",
				"family": "leukemia",
				"description": "hairy cell leukemia",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/828"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/828",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27116997"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3770",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/828"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/680",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/828"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/829",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3771/summary#evidence",
		"source": "civic",
		"description": "In a case study, a pediatric grade IV glioblastoma multiforme patient harboring BRAF V600E mutation was associated with a complete response to vemurafenib monotherapy after 4 months of treatment, which was sustained at 6 month of therapy; the patient was undergoing the 7th cycle of therapy at the time of publication of this study.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/791",
				"source": "http://purl.obolibrary.org/obo/DOID_3068",
				"term": "glioblastoma multiforme",
				"pheno_id": "DOID:3068",
				"family": "malignant glioma",
				"description": "glioblastoma multiforme",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/829"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/829",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24725538"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3771",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/829"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/681",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/829"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/830",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3772/summary#evidence",
		"source": "civic",
		"description": "A pediatric pilocytic astrocytoma patient harboring BRAF V600E mutation, BRAF V600E mutation was associated with response to vemurafenib monotherapy. The patient was treated with standard chemotherapy regimens prior to the identification of the BRAF V600E mutation; subsequently, vemurafenib was administered (initially in combination with standard chemotherapy) and an overall regression achieved, with lack of disease progression noted at 15 months of vemurafenib therapy.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/792",
				"source": "http://purl.obolibrary.org/obo/DOID_4851",
				"term": "pilocytic astrocytoma",
				"pheno_id": "DOID:4851",
				"family": "malignant glioma",
				"description": "pilocytic astrocytoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/830"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/830",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24821190"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3772",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/830"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/682",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/830"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/831",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3773/summary#evidence",
		"source": "civic",
		"description": "In a retrospective study of 17 papillary thyroid cancer patients, patients with BRAF V600E mutation (n=6) were associated with a 47% (7/15) partial response rate and a 53% (8/15) stable disease rate.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/793",
				"source": "http://purl.obolibrary.org/obo/DOID_3969",
				"term": "papillary thyroid carcinoma",
				"pheno_id": "DOID:3969",
				"family": "thyroid cancer",
				"description": "papillary thyroid carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/831"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/831",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25353071"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3773",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/831"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/683",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/831"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/832",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3774/summary#evidence",
		"source": "civic",
		"description": "In a clinical trial (NCT01286753) of 55 cancer patients with BRAF V600E mutation, patients with metastatic papillary thyroid cancer (n=3) were associated with sensitivity to vemurafenib treatment. One patient achieved partial response (31% reduction by RECIST) and two patients achieved stable disease (9% and 16% reduction by RECIST criteria), the time to progression for these three patients was 11.7, 13.2 and 11.4 months, and the overall survival was 15 months (patient was subsequently treated with radiation therapy), at least 31.7 months (patient subsequently underwent laryngectomy) and 24.9 months (patient was subsequently treated with sorafenib, followed by sunitinib monotherapy), respectively.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/794",
				"source": "http://purl.obolibrary.org/obo/DOID_3969",
				"term": "papillary thyroid carcinoma",
				"pheno_id": "DOID:3969",
				"family": "thyroid cancer",
				"description": "papillary thyroid carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/832"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/832",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23489023"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3774",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/832"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/684",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/832"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/833",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3775/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, K2, a papillary thyroid carcinoma cell line expressing the BRAFV600E mutation, was associated with sensitivity to dasatinib treatment. Sensitivity was determined by assessing cell growth inhibition. In an in vivo experiment, dasatinib also inhibited the growth of K2 thyroid carcinoma xenografts in 7 of 13 mice.",
		"drug_labels": "DASATINIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/795",
				"source": "http://purl.obolibrary.org/obo/DOID_3969",
				"term": "papillary thyroid carcinoma",
				"pheno_id": "DOID:3969",
				"family": "thyroid cancer",
				"description": "papillary thyroid carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/833"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/833",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23729178"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3775",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/833"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/685",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DASATINIB",
				"envcontext_id": "3062316",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "DASATINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/833"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/834",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3776/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, WiDr, HT-29 and RKO cell lines expressing BRAF V600E mutation was associated with sensitivity to regorafenib treatment, as compared to Caco-2 and KM12SM cells expressing wild-type BRAF. Resistance was determined by assessing cell proliferation and migration.",
		"drug_labels": "REGORAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/796",
				"source": "http://purl.obolibrary.org/obo/DOID_219",
				"term": "colon cancer",
				"pheno_id": "DOID:219",
				"family": "intestinal cancer",
				"description": "colon cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/834"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/834",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26865419"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3776",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/834"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/686",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "REGORAFENIB",
				"envcontext_id": "11167602",
				"usan_stem": "raf kinase inhibitors",
				"description": "REGORAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/834"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/835",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3777/summary#evidence",
		"source": "civic",
		"description": "In a case report, a cervicomedullary ganglioglioma patient harboring BRAF V600E mutation was associated with radiological and clinical response to vemurafenib monotherapy after 3 months of treatment, which was sustained after 6 months of therapy. Prior to vemurafenib treatment, the patient had undergone tracheotomy, was treated with standard chemotherapy and underwent another surgery, but had developed progressive disease.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/797",
				"source": "http://purl.obolibrary.org/obo/DOID_5078",
				"term": "ganglioglioma",
				"pheno_id": "DOID:5078",
				"family": "cell type benign neoplasm",
				"description": "ganglioglioma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/835"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/835",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25524464"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3777",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/835"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/687",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/835"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/836",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3778/summary#evidence",
		"source": "civic",
		"description": "A grade I refractory brainstem ganglioglioma patient harboring BRAF V600E mutation was associated with partial response to vemurafenib monotherapy. The patient experienced significant clinical improvement in response to vemurafenib and maintained a partial response for 12 months; however, disease progression occurred after vemurafenib was discontinued for three months, reintroduction of vemurafenib resulted in a rapid partial response, with continued response noted at time of publication.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/798",
				"source": "http://purl.obolibrary.org/obo/DOID_5078",
				"term": "ganglioglioma",
				"pheno_id": "DOID:5078",
				"family": "cell type benign neoplasm",
				"description": "ganglioglioma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/836"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/836",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26579623"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3778",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/836"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/688",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/836"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/837",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3779/summary#evidence",
		"source": "civic",
		"description": "In a case report, a clear cell sarcoma patient harboring BRAF V600E mutation with distant metastases was associated with a complete response to vemurafenib monotherapy at 8 weeks of treatment. Prior to the administration of vemurafenib, the patient had undergone surgery and was treated with radiation, and standard chemotherapy, but had developed progressive disease.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/799",
				"source": "http://purl.obolibrary.org/obo/DOID_4233",
				"term": "clear cell sarcoma",
				"pheno_id": "DOID:4233",
				"family": "sarcoma",
				"description": "clear cell sarcoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/837"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/837",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26286452"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3779",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/837"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/689",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/837"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/838",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3780/summary#evidence",
		"source": "civic",
		"description": "In a lung adenocarcinoma patient with brain metastases harboring BRAF V600E mutation, BRAF V600E was associated with sensitivity to vemurafenib treatment. Upon treatment with vemurafenib monotherapy, the patient�s metastases demonstrated significant response and pleural right effusion improvement was observed; however, at 4 months the patient�s disease progressed resulting in death.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/800",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/838"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/838",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24888229"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3780",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/838"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/690",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/838"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/839",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3781/summary#evidence",
		"source": "civic",
		"description": "In a stage IV non-small cell lung cancer patient with a BRAF V600E mutation, who developed adenocarcinoma, BRAF V600E was associated with sensitivity to vemurafenib treatment. The patient was initially treated with four cycles of standard chemotherapy (cisplatin and pemetrexed) and achieved a partial response, subsequently a complete radiologic response was observed with 11 cycle of maintenance chemotherapy. However, the patient�s disease eventually progressed and lung adenocarcinoma and hepatic metastases were observed, the patient received radiotherapy, followed by the administration of vemurafenib monotherapy with concurrent radiotherapy, resulting in an excellent partial response followed by complete response.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/801",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/839"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/839",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23733758"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3781",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/839"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/691",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/839"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/840",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3782/summary#evidence",
		"source": "civic",
		"description": "In a retrospective study of 35 lung adenocarcinoma patients (with chemotherapy previously administered in 86% of patients), patients harboring a BRAF V600E mutation and treated with vemurafenib monotherapy (n=29) were associated with an improved response rate; an overall survival (with 1st-line therapy) of 25.63 months, a 54% overall response rate and a 95% disease control rate were reported.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/802",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/840"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/840",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26200454"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3782",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/840"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/692",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/840"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/841",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3783/summary#evidence",
		"source": "civic",
		"description": "A stage IV lung adenocarcinoma patient harboring a BRAF V600E mutation was associated with response to vemurafenib monotherapy. The patient�s prior treatment regimens were complex, including radiotherapy, standard chemotherapy and erlotinib; subsequently, the BRAF V600E mutation was identified and the patient was treated with vemurafenib monotherapy, achieving a favorable response for greater than 24 months.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/803",
				"source": "http://purl.obolibrary.org/obo/DOID_3910",
				"term": "lung adenocarcinoma",
				"pheno_id": "DOID:3910",
				"family": "respiratory system cancer",
				"description": "lung adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/841"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/841",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26776917"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3783",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/841"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/693",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/841"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/842",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3784/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, BRAF V600E expressing cell lines (BCPAP, OCUT1, K1 and SW1736) demonstrated increased sensitivity to vemurafenib treatment, compared to BRAF wild-type expressing cells (FTC133, KAT18, Hth74 and WRO). Sensitivity was determined by assessing cell proliferation (OCUT1, IC50: 0.41uM; SW1736, IC50: 0.12 uM; K1, IC50: 0.83 uM; BCPAP, IC50: 1.16 uM vs. FTC133, IC50: 56.67 uM; KAT18, 541.66 uM; Hth74, IC50: 1349.79 uM; and WRO IC50: 943.73 uM) and ERK phosphorylation.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/804",
				"source": "http://purl.obolibrary.org/obo/DOID_3963",
				"term": "thyroid carcinoma",
				"pheno_id": "DOID:3963",
				"family": "endocrine gland cancer",
				"description": "thyroid carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/842"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/842",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21185263"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3784",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/842"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/694",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/842"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/843",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3785/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, the BCPAP cell line expressing a BRAF V600E mutation was associated with sensitivity to vemurafenib treatment. Sensitivity was determined by assessing cell viability and apoptotic cell death. However, the 8505C cell line expressing a BRAF V600E mutation and high MET protein phosphorylation levels was reported to be insensitive to vemurafenib treatment.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/805",
				"source": "http://purl.obolibrary.org/obo/DOID_3963",
				"term": "thyroid carcinoma",
				"pheno_id": "DOID:3963",
				"family": "endocrine gland cancer",
				"description": "thyroid carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/843"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/843",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26456083"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3785",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/843"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/695",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/843"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/844",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3786/summary#evidence",
		"source": "civic",
		"description": "An anaplastic pleomorphic xanthoastrocytoma patient harboring BRAF V600E mutation was associated with improved response to vemurafenib treatment. The patient was treated with radiation and temozolomide before experiencing disease progression; subsequent treatment with vemurafenib monotherapy, for a 12 week period, resulted in a near complete response.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/806",
				"source": "http://purl.obolibrary.org/obo/DOID_4852",
				"term": "pleomorphic xanthoastrocytoma",
				"pheno_id": "DOID:4852",
				"family": "malignant glioma",
				"description": "pleomorphic xanthoastrocytoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/844"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/844",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25092772"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3786",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/844"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/696",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/844"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/845",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3787/summary#evidence",
		"source": "civic",
		"description": "A stage 4B, low-grade papillary serous ovarian adenocarcinoma patient, harboring a BRAF V600E mutation was associated with response to vemurafenib monotherapy. The patient was treated with standard chemotherapy, hormone therapy and bevacizumab prior to the identification of the BRAF V600E mutation; next, the patient was treated with paclitaxel and an anti-HER3 antibody and finally with vemurafenib, obtaining a partial response of greater than 1 year.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/807",
				"source": "http://purl.obolibrary.org/obo/DOID_3605",
				"term": "ovarian cystadenocarcinoma",
				"pheno_id": "DOID:3605",
				"family": "ovary epithelial cancer",
				"description": "ovarian cystadenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/845"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/845",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26490654"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3787",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/845"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/697",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/845"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/846",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3788/summary#evidence",
		"source": "civic",
		"description": "In a malignant peripheral nerve sheath tumor patient harboring a BRAF V600E mutation, response to vemurafenib monotherapy was reported. Upon identification of the BRAF V600E mutation, the patient was treated with sorafenib monotherapy, but quickly progressed; subsequently, the patient was treated with vemurafenib. 33 days after treatment was initiated, tumor response was reported, as evident by the disappearance of chest and abdominal skin lesions.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/808",
				"source": "http://purl.obolibrary.org/obo/DOID_5940",
				"term": "malignant peripheral nerve sheath tumor",
				"pheno_id": "DOID:5940",
				"family": "peripheral nervous system neoplasm",
				"description": "malignant peripheral nerve sheath tumor",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/846"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/846",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24335681"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3788",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/846"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/698",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/846"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/847",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3789/summary#evidence",
		"source": "civic",
		"description": "A primary central nervous system (CNS)-histiocytic sarcoma patient harboring BRAF V600E mutation was associated with improved response to vemurafenib treatment. The patient was treated with vemurafenib monotherapy and obtained a clinical, biological and radiologic response; subsequently, the patient developed progressive disease and died 6 months after initial treatment with vemurafenib.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/809",
				"source": "http://purl.obolibrary.org/obo/DOID_4231",
				"term": "histiocytoma",
				"pheno_id": "DOID:4231",
				"family": "musculoskeletal system cancer",
				"description": "histiocytoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/847"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/847",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25209580"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3789",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/847"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/699",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/847"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/848",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3790/summary#evidence",
		"source": "civic",
		"description": "In a conjunctival malignant melanoma patient harboring a BRAF V600E mutation, BRAF V600E was associated with response to vemurafenib treatment. Prior to identification of the BRAF V600E mutation, the patient was treated with cryotherapy, standard chemotherapy and whole brain radiotherapy; the patient achieved a 4 month progression free survival with vemurafenib treatment prior to disease progression.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/810",
				"source": "http://purl.obolibrary.org/obo/DOID_1751",
				"term": "malignant conjunctival melanoma",
				"pheno_id": "DOID:1751",
				"family": "sensory system cancer",
				"description": "malignant conjunctival melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/848"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/848",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27520988"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3790",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/848"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/700",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/848"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/849",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/816/summary#evidence",
		"source": "civic",
		"description": "This meta-analysis of 7 randomized control trials evaluating overall survival (OS) (8 for progression free survival) could not definitely state that survival benefit of anti-EGFR monoclonal antibodies is limited to patients with wild type BRAF. In other words, the authors believe that there is insufficient data to justify the exclusion of anti-EGFR monoclonal antibody therapy for patients with mutant BRAF. In these studies, mutant BRAF specifically meant the V600E mutation.",
		"drug_labels": "CETUXIMAB,PANITUMUMAB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/811",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/849"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/849",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25989278"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "816",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/849"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/702",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "PANITUMUMAB",
				"envcontext_id": "CHEMBL1201827",
				"usan_stem": "monoclonal antibodies",
				"description": "PANITUMUMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/849"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/701",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/849"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/850",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/1398/summary#evidence",
		"source": "civic",
		"description": "The BRIM-3 Phase III trial NCT01006980 assessed BRAF inhibitor vemurafenib versus dacarbazine in 598 patients with treatment naive metastatic melanoma and confirmed V600E mutation. Significant differences were seen in overall survival (13.3 months with vemurafenib vs. 10.0 months with dacarbazine) and median progression free survival (6.9 months  with vemurafenib vs. 1.6 months with dacarbazine)",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/812",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/850"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/850",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24508103"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1398",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/850"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/703",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/850"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/851",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/1405/summary#evidence",
		"source": "civic",
		"description": "In this Phase II pilot study (NCT00405587) of BRAF V600 inhibitor vemurafenib in 21 metastatic colorectal cancer (CRC) patients with BRAF V600E, one patient had a durable 21 week partial response, and seven patients had 8 week stable disease as best response. Median progression free survival was 2.1 months and median overall survival was 7.7 months. The authors conclude that single agent vemurafenib did not show meaningful activity in V600E CRC, in contrast to the significant vemurafenib activity against V600 in melanoma.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/813",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/851"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/851",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26460303"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1405",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/851"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/704",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/851"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/852",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/1406/summary#evidence",
		"source": "civic",
		"description": "In trial NCT00880321, dabrafenib was tested in various solid tumor types harboring mutant BRAF after establishing dosage of 150 mg twice daily. In nine colorectal cancer patients with established V600E mutation, 1 confirmed response, 7 instances of stable disease, and 1 case of progressive disease was seen, which contrasted strongly with a 56% confirmed response rate seen in metastatic V600E melanoma patients similarly treated in the same study.",
		"drug_labels": "DABRAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/814",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/852"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/852",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22608338"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1406",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/852"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/705",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/852"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/853",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/1408/summary#evidence",
		"source": "civic",
		"description": "5 of 7 colorectal cancer (CRC) cell lines with BRAF V600E mutation were resistant to treatment with the BRAF inhibitor vemurafenib. An RNAi screen in the WiDr cell line (a V600E CRC line) identified EGFR as an enhancer for survival when exposed to vemurafenib.  Treatment with vemurafenib and EGFR inhibitor (cetuximab or gefitinib) in V600E CRC cells (WiDr, VACO432 and KM20) showed inhibited growth as well as induction of the cleaved PARP apoptotic marker. WiDr and VACO432 cells were injected into immunodeficient mice. Modest response was seen with vemurafenib treatment, while combination treatment showed considerable tumor growth inhibition as compared to control.",
		"drug_labels": "VEMURAFENIB,GEFITINIB,CETUXIMAB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/815",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/853"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/853",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22281684"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1408",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/853"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/708",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/853"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/707",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GEFITINIB",
				"envcontext_id": "123631",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "GEFITINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/853"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/706",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/853"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/854",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/1409/summary#evidence",
		"source": "civic",
		"description": "Phase 3 randomized clinical trial comparing vemurafenib with dacarbazine in 675 patients with previously untreated, metastatic melanoma with the BRAF V600E mutation. At 6 months, overall survival was 84% (95% confidence interval [CI], 78 to 89) in the vemurafenib group and 64% (95% CI, 56 to 73) in the dacarbazine group. A relative reduction of 63% in the risk of death and of 74% in the risk of either death or disease progression was observed with vemurafenib as compared with dacarbazine (P<0.001 for both comparisons).",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "A",
		"response_type": "Sensitivity/Response",
		"evidence_level": "1",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/816",
				"source": "http://purl.obolibrary.org/obo/DOID_8923",
				"term": "skin melanoma",
				"pheno_id": "DOID:8923",
				"family": "melanoma",
				"description": "skin melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/854"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/854",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21639808"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1409",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/854"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/709",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/854"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/855",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/1410/summary#evidence",
		"source": "civic",
		"description": "Phase 2 trial in 132 patients with previously treated metastatic melanoma with BRAF V600E mutation. \nConfirmed overall response rate was 53% (95% confidence interval [CI], 44 to 62; 6% with a complete response and 47% with a partial response), median duration of response was 6.7 months (95% CI, 5.6 to 8.6), and median progression-free survival was 6.8 months (95% CI, 5.6 to 8.1). Median overall survival was 15.9 months (95% CI, 11.6 to 18.3).",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/817",
				"source": "http://purl.obolibrary.org/obo/DOID_8923",
				"term": "skin melanoma",
				"pheno_id": "DOID:8923",
				"family": "melanoma",
				"description": "skin melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/855"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/855",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22356324"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1410",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/855"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/710",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/855"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/856",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/1413/summary#evidence",
		"source": "civic",
		"description": "Treatment response to mutant BRAF inhibitor vemurafenib and EGFR inhibitor panitumumab was assayed in 12 patients with metastatic colorectal cancer (CRC) who had progressed on chemotherapy. Two patients had confirmed partial responses, and 2 showed stable disease over 6 months. The authors conclude that although some efficacy is seen, only a small subset of patients respond to this treatment and the responses are not durable.",
		"drug_labels": "VEMURAFENIB,PANITUMUMAB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/818",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/856"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/856",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25589621"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1413",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/856"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/712",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "PANITUMUMAB",
				"envcontext_id": "CHEMBL1201827",
				"usan_stem": "monoclonal antibodies",
				"description": "PANITUMUMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/856"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/711",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/856"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/857",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/1414/summary#evidence",
		"source": "civic",
		"description": "A 73 year old patient with prior history of breast cancer presented with metastatic papillary thyroid carcinoma. After two treatments of I-131 a comprehensive tumor profile revealed BRAF V600E as the only genetic alteration on a near diploid genome with trisomy 1q. Vemurafenib treatment resulted in improvement of symptoms and considerable reductions in tumor mass, and after 23 months the patient remained on therapy with well controlled disease.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/819",
				"source": "http://purl.obolibrary.org/obo/DOID_3969",
				"term": "papillary thyroid carcinoma",
				"pheno_id": "DOID:3969",
				"family": "thyroid cancer",
				"description": "papillary thyroid carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/857"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/857",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24987354"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1414",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/857"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/713",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/857"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/858",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/1421/summary#evidence",
		"source": "civic",
		"description": "In this Phase III trial (coBRIM, NCT01689519) of 495 V600 mutant melanoma patients, 344 had V600E mutation. 174 patients were treated with vemurafenib and placebo, and 170 were treated with vemurafenib and cobimetinib and tested for progression free survival. 88 of 174 monotherapy group patients had an event with median progression free survival of 6.5 months. In the combination group 58 of 174 patients had an event with median progression-free survival not met, however, when in combination with other V600 mutations median progression-free survival was 9.9 months with combination treatment. Median time to followup for the whole cohort was 7.3 months. Hazard Ratio for progression or death was 0.57 (0.41-0.80).",
		"drug_labels": "VEMURAFENIB,COBIMETINIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/820",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/858"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/858",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25265494"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1421",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/858"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/715",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "COBIMETINIB",
				"envcontext_id": "16222096",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "COBIMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/858"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/714",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/858"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/859",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/1428/summary#evidence",
		"source": "civic",
		"description": "In a mouse model of BRAF V600E colorectal cancer, western blots from tumors in mice treated with BRAF inhibitor GDC-0879 and PI3K/mTOR inhibitor BEZ235 showed stronger reduction in phospho-Akt and phospho-S6 than PI3K/mTOR inhibitor alone, and combination inhibition also resulted in stronger phospho-ERK inhibition in tumors than did BRAF inhibition alone. Increased apoptosis in tumors was seen in dual treatment conditions with increased TUNEL-positive cells. In vehicle treated mice, area of colon covered by tumor increased, while treatment with single agent inhibitors caused growth inhibition resulting in no change in colon area covered by tumors. Administration of dual inhibitors induced tumor regression apparent in a decrease of colonic area covered by tumors over the course of treatment.",
		"drug_labels": "NVP,DACTOLISIB,GDC,0879",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/821",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/859"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/859",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23549875"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1428",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/859"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/719",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "0879",
				"envcontext_id": "11717001",
				"usan_stem": null,
				"description": "0879",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/859"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/718",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GDC",
				"envcontext_id": "11717001",
				"usan_stem": null,
				"description": "GDC",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/859"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/717",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DACTOLISIB",
				"envcontext_id": "11977753",
				"usan_stem": "phosphatidylinositol 3-kinase inhibitors",
				"description": "DACTOLISIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/859"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/716",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "NVP",
				"envcontext_id": "44393931",
				"usan_stem": null,
				"description": "NVP",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/859"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/860",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/1430/summary#evidence",
		"source": "civic",
		"description": "BRAF mutations were identified in 9% of 108 cases of high-grade colorectal neuroendocrine tumors (80% V600E). Two patients were treated with a combination of BRAF and MEK inhibition and exhibited durable response (beyond 7 and 9 months, respectively). Urinary BRAF V600E tumor DNA correlated with disease response in one of the patients. BRAF and MEK inhibition was either dabrafenib+trametinib (case 1) or vemurafenib+trametinib (case 2).",
		"drug_labels": "DABRAFENIB,TRAMETINIB,VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/822",
				"source": "http://purl.obolibrary.org/obo/DOID_0050626",
				"term": "gastrointestinal neuroendocrine tumor",
				"pheno_id": "DOID:0050626",
				"family": "gastrointestinal system cancer",
				"description": "gastrointestinal neuroendocrine tumor",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/860"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/860",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27048246"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1430",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/860"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/722",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/860"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/721",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/860"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/720",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/860"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/861",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/1005/summary#evidence",
		"source": "civic",
		"description": "49 BRAF-mutant melanoma cell lines from patients not previously treated with BRAF inhibition were analyzed. 21 exhibited primary resistance to BRAF inhibition using PLX4720. Inhibition of MEK1/2 (BEZ235) and PI3K/mTOR (AZD6244 [selumetinib]) was the most effective approach to counteract resistance in comparison to inhibition with the PLX4720-BEZ235 (where response was assessed by apoptosis, viability, p-ERK, p-Akt inhibition).",
		"drug_labels": "SELUMETINIB,NVP,DACTOLISIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/823",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/861"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/861",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26678033"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1005",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/861"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/725",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DACTOLISIB",
				"envcontext_id": "11977753",
				"usan_stem": "phosphatidylinositol 3-kinase inhibitors",
				"description": "DACTOLISIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/861"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/724",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "NVP",
				"envcontext_id": "44393931",
				"usan_stem": null,
				"description": "NVP",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/861"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/723",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "SELUMETINIB",
				"envcontext_id": "10127622",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "SELUMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/861"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/862",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/1579/summary#evidence",
		"source": "civic",
		"description": "Two clinical trials evaluated the effects of vemurafenib in 54 patients with BRAF (V600E) positive hairy-cell leukemia.  The overall response rate was 98% with 19/54 having a complete response and 34/54 having a partial response.  In the Italian study (n=25), the median relapse-free survival was 9 months and in the U.S. study (n=24), rate of progression-free survival was 73% with overall survival rate of 91%.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/824",
				"source": "http://purl.obolibrary.org/obo/DOID_285",
				"term": "hairy cell leukemia",
				"pheno_id": "DOID:285",
				"family": "leukemia",
				"description": "hairy cell leukemia",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/862"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/862",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26352686"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1579",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/862"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/726",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/862"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/863",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/1589/summary#evidence",
		"source": "civic",
		"description": "Case report of a patient with BRAF V600E mutant metastatic colorectal cancer. Combined EGFR and BRAF inhibition (panitumumab and vemurafenib) showed an initial partial response for 4 months with subsequent disease progression.",
		"drug_labels": "VEMURAFENIB,PANITUMUMAB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/825",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/863"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/863",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27325282"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1589",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/863"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/728",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "PANITUMUMAB",
				"envcontext_id": "CHEMBL1201827",
				"usan_stem": "monoclonal antibodies",
				"description": "PANITUMUMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/863"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/727",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/863"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/864",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/1591/summary#evidence",
		"source": "civic",
		"description": "Open-label non-randomised phase 2 trial in patients with recurrent or metastatic BRAF V600E mutant papillary thyroid cancer refractory to radioactive iodine. Patients had (cohort 2) or had not (cohort 1) previously been treated with VEGFR inhibitors.\n51 patients were enrolled (26 cohort 1, 25 cohort 2). In cohort 1, partial response was achieved in ten (38.5%) patients. Nine patients achieved stable disease for at least 6 months (35%). Median PFS was 18.2 months and median OS not reached after a median follow-up pf 18.8 months.\nIn cohort 2, six patients (27.3%) achieved a partial response and another six patients achieved stable disease for at least six months. Median PFS was 8.9 months and median OS was 14.4. months.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/826",
				"source": "http://purl.obolibrary.org/obo/DOID_3969",
				"term": "papillary thyroid carcinoma",
				"pheno_id": "DOID:3969",
				"family": "thyroid cancer",
				"description": "papillary thyroid carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/864"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/864",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27460442"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1591",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/864"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/729",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/864"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/865",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/1698/summary#evidence",
		"source": "civic",
		"description": "A 65-year-old man presented with stage II myeloma.  He was initially treated with chemotherapy and he received an autologous stem cell transplant. Sequencing of the recurrent tumor harbored BRAF V600E mutation and he was treated with vemurafenib.  After 7 weeks of treatment, the patient relapsed and died.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/827",
				"source": "http://purl.obolibrary.org/obo/DOID_9538",
				"term": "multiple myeloma",
				"pheno_id": "DOID:9538",
				"family": "bone marrow cancer",
				"description": "multiple myeloma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/865"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/865",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24997557"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1698",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/865"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/730",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/865"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/866",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/1699/summary#evidence",
		"source": "civic",
		"description": "A 54-year-old man presented with stage II myeloma.  He was initially treated with chemotherapy and received an autologous stem cell transplant.  Genomic profiling of the bone biopsy revealed BRAF V600E activating mutation and the patient was treated with vemurafenib.  At 4-months post treatment (time of case study report) the patient maintains near-resolution of hypermetabolic lesions.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/828",
				"source": "http://purl.obolibrary.org/obo/DOID_9538",
				"term": "multiple myeloma",
				"pheno_id": "DOID:9538",
				"family": "bone marrow cancer",
				"description": "multiple myeloma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/866"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/866",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24997557"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1699",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/866"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/731",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/866"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/867",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/1141/summary#evidence",
		"source": "civic",
		"description": "Preclinical study analyzing the differential response to MEK inhibitors in KRAS and BRAF mutant cancer cell lines and mouse xenografts. Inhibition of active, phosphorylated MEK by GDC-0973 (cobimetinib) is required for strong inhibition of the MAPK pathway in BRAF-mutant tumours. This study provides mechanistic rationale for improved efficacy of cobimetinib in BRAF-mutant models compared to MEK inhibitors acting through an alternative mechanism (GDC-0623 and G-573).",
		"drug_labels": "COBIMETINIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/829",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/867"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/867",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23934108"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1141",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/867"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/732",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "COBIMETINIB",
				"envcontext_id": "16222096",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "COBIMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/867"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/868",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/1749/summary#evidence",
		"source": "civic",
		"description": "Multicenter, phase 1, dose-escalation trial of PLX4032 (Vemurafenib). Treatment of metastatic melanoma with PLX4032 in patients with tumors that carry the V600E BRAF mutation resulted in complete or partial tumor regression in the majority of patients. Patients without the V600E mutation had evidence of tumor regression.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/830",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/868"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/868",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20818844"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1749",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/868"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/733",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/868"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/869",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/1902/summary#evidence",
		"source": "civic",
		"description": "Phase 1b study of vemurafenib, cetuximab and irinotecan in 19 patients with colorectal cancer (1 with appendiceal cancer). Six of 17 evaluable patients achieved an objective response, 15 patients total had either stable disease or radiographic response (the patient with appendiceal cancer had disease progression). Estimated median PFS was 7.7 months. Effect of the combined treatment was also observed in xenograft and cell line studies.",
		"drug_labels": "VEMURAFENIB,CETUXIMAB,Irinotecan",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/831",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/869"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/869",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27729313"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1902",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/869"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/736",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Irinotecan",
				"envcontext_id": "60838",
				"usan_stem": "antineoplastics (camptothecine derivatives)",
				"description": "Irinotecan",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/869"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/735",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/869"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/734",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/869"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/870",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/2115/summary#evidence",
		"source": "civic",
		"description": "In metastatic colorectal cancer patients with wildtype KRAS status, those with a BRAF V600E mutation were less likely to respond to treatment with cetuximab or panitumumab than  those with wildtype BRAF (0%  vs. 32% , P=0.029). Regardless of KRAS status, patients with BRAF mutations had reduced progression-free and overall survival (P=0.0107 and P <0.0001, respectively). Transfection of the colorectal cancer cell line DiFi with a BRAF V600E expression vector conferred decreased sensitivity to cetuximab and panitumumab in comparison to cells transfected with empty vector.",
		"drug_labels": "PANITUMUMAB,CETUXIMAB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/832",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/870"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/870",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19001320"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2115",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/870"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/738",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/870"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/737",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "PANITUMUMAB",
				"envcontext_id": "CHEMBL1201827",
				"usan_stem": "monoclonal antibodies",
				"description": "PANITUMUMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/870"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/871",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/2117/summary#evidence",
		"source": "civic",
		"description": "Of 100 metastatic colorectal cancer patients treated with oxaliplatin-based first-line therapy, the 6 patients with either BRAF V600E or D594K had reduced progression-free survival compared to 94 patients with wildtype BRAF (5.0mo vs. 11.7mo, HR:6.4, 95%CI:2.6-15.6, P<0.0001).",
		"drug_labels": "OXALIPLATIN",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/833",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/871"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/871",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19603024"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2117",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/871"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/739",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "OXALIPLATIN",
				"envcontext_id": "CHEMBL414804",
				"usan_stem": "antineoplastics (platinum derivatives)",
				"description": "OXALIPLATIN",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/871"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/872",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/2118/summary#evidence",
		"source": "civic",
		"description": "The presence of BRAF V600E or D594K was associated with reduced progression-free survival in 5 patients with metastatic colorectal cancer treated with irinotecan-based first line therapy (3.5mo vs. 12.8mo, HR:4.1, 95%CI:1.5-11.3, P=0.006) when compared to 39 patients with wildtype BRAF.",
		"drug_labels": "Irinotecan",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/834",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/872"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/872",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19603024"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2118",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/872"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/740",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Irinotecan",
				"envcontext_id": "60838",
				"usan_stem": "antineoplastics (camptothecine derivatives)",
				"description": "Irinotecan",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/872"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/873",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/2119/summary#evidence",
		"source": "civic",
		"description": "Among metastatic colorectal cancer patients treated with cetuximab and irinotecan, those with BRAF V600E mutations were less likely to achieve a complete or partial response to therapy (0% , P=0.016, Fisher�s exact test) and had reduced median overall survival (4.1mo vs. 13.9mo, HR:0.51, 95%CI:0.18-0.95, P=0.037) than patients with wildtype BRAF.",
		"drug_labels": "Irinotecan",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "C",
		"response_type": "resistant",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/835",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/873"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/873",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19603018"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2119",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/873"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/741",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Irinotecan",
				"envcontext_id": "60838",
				"usan_stem": "antineoplastics (camptothecine derivatives)",
				"description": "Irinotecan",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/873"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/874",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/2121/summary#evidence",
		"source": "civic",
		"description": "In a study of metastatic colorectal cancer patients treated with capecitabine, oxaliplatin, and bevacizumab, those with BRAF V600E mutations had reduced progression-free survival (5.9mo vs. 12.2mo, P=0.003) and reduced overall survival (15.0mo vs. 24.6mo, P=0.002) compared to those with wildtype BRAF.",
		"drug_labels": "BEVACIZUMAB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/836",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/874"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/874",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19571295"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2121",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/874"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/742",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "BEVACIZUMAB",
				"envcontext_id": "CHEMBL1201583",
				"usan_stem": "monoclonal antibodies",
				"description": "BEVACIZUMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/874"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/875",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/2122/summary#evidence",
		"source": "civic",
		"description": "In a mouse in vivo study, the dual RAF and VEGF inhibitor sorafenib suppressed the growth of both UACC903 and 1205Lu cell line- generating  xenograft tumors harboring the BRAF-V600E mutation, which had a concomitant reduction of phosphorylated Erk-positive cells (P<0.05).",
		"drug_labels": "Sorafenib",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/837",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/875"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/875",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15781657"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2122",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/875"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/743",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Sorafenib",
				"envcontext_id": "216239",
				"usan_stem": "raf kinase inhibitors",
				"description": "Sorafenib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/875"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/876",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/2123/summary#evidence",
		"source": "civic",
		"description": "An inducible BRAF-V600E mouse melanoma model has shown a tight correlation between activated BRAF and disease progression.",
		"drug_labels": "Sorafenib",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/838",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/876"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/876",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/16424035"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2123",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/876"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/744",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Sorafenib",
				"envcontext_id": "216239",
				"usan_stem": "raf kinase inhibitors",
				"description": "Sorafenib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/876"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/877",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/2124/summary#evidence",
		"source": "civic",
		"description": "In a mouse in vivo study of MEK protein inhibitor, PD-0325901, was able to suppress growth of SKMEL28 BRAF-V600E xenograft tumors (P<0.01). The reduction of growth was associated with loss of D-cyclin expression and induction of p27.",
		"drug_labels": "0325901",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/839",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/877"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/877",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/16273091"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2124",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/877"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/745",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "0325901",
				"envcontext_id": "9826528",
				"usan_stem": null,
				"description": "0325901",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/877"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/878",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/2125/summary#evidence",
		"source": "civic",
		"description": "An inducible BRAF-V600E mouse melanoma model shows a tight correlation between activated BRAF and disease progression.",
		"drug_labels": "0325901",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/840",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/878"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/878",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/16424035"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2125",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/878"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/746",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "0325901",
				"envcontext_id": "9826528",
				"usan_stem": null,
				"description": "0325901",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/878"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/879",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/2126/summary#evidence",
		"source": "civic",
		"description": "Patients with BRAF mutations who were treated with the specific RAF inhibitor dabrafenib had an improved overall survival (P<0.003) compared to untreated patients with BRAF mutations. Patients harboring BRAF mutations were associated with reduced overall survival (11.1mo vs. 46.1mo for wildtype, P=0.006).",
		"drug_labels": "DABRAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/841",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/879"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/879",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21343559"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2126",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/879"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/747",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/879"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/880",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/2127/summary#evidence",
		"source": "civic",
		"description": "Acquired resistance to vemurafenib in BRAF-V600E positive melanomas frequently confound vemurafenib therapy.",
		"drug_labels": "DABRAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/842",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/880"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/880",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20818844"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2127",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/880"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/748",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/880"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/881",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/2128/summary#evidence",
		"source": "civic",
		"description": "An inducible BRAF-V600E mouse melanoma model shows a tight correlation between activated BRAF and disease progression.",
		"drug_labels": "DABRAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/843",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/881"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/881",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/16424035"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2128",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/881"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/749",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/881"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/882",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/2131/summary#evidence",
		"source": "civic",
		"description": "An inducible BRAF-V600E mouse melanoma model shows a tight correlation between activated BRAF and disease progression.",
		"drug_labels": "GSK",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/844",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/882"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/882",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/16424035"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2131",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/882"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/750",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "GSK",
				"envcontext_id": "15983966",
				"usan_stem": null,
				"description": "GSK",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/882"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/883",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/2132/summary#evidence",
		"source": "civic",
		"description": "Proposed resistance mechanisms include PDGFRB upregulation or NRAS mutations resulting in MAPK pathway reactivation, but not secondary mutations in BRAF. MEK inhibitors may demonstrate clinical benefit in vemurafenib-resistant melanoma patients.",
		"drug_labels": "DABRAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/845",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/883"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/883",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21107323"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2132",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/883"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/751",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/883"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/884",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/2133/summary#evidence",
		"source": "civic",
		"description": "Acquired resistance to vemurafenib in BRAF-V600E positive melanomas frequently confound vemurafenib therapy.",
		"drug_labels": "DABRAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/846",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/884"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/884",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21107320"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2133",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/884"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/752",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/884"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/885",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/2134/summary#evidence",
		"source": "civic",
		"description": "An inducible BRAF-V600E mouse melanoma model shows a tight correlation between activated BRAF and disease progression.",
		"drug_labels": "TRAMETINIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/847",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/885"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/885",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/16424035"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2134",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/885"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/753",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/885"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/886",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/2135/summary#evidence",
		"source": "civic",
		"description": "In a study of 322 advanced melanoma patients with BRAF-V600E or BRAF-V600K mutations, treatment with trametinib was associated with improved progression-free survival (4.8mo vs. 1.5mo, <0.001) compared to chemotherapy control group. Additionally, treatment with trametinib was associated with increased 6-month overall survival (HR:0.54, 95% CI:0.32-0.92, P=0.01).",
		"drug_labels": "TRAMETINIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/848",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/886"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/886",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22663011"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2135",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/886"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/754",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/886"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/887",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/2136/summary#evidence",
		"source": "civic",
		"description": "Thyroid cancer cell lines with BRAF V600E mutations were more sensitive to the MAPK inhibitor CI-1040 than those with wildtype BRAF (IC50: 0.031-1.251 uM vs. 44.376-278.286 uM). In a mouse xenograft model, the growth of tumors derived from KAT10 cells, which carries the BRAF V600E mutation, was inhibited following treatment with CI-1040 (P<0.01), but drug treatment had no effect on growth of tumors derived from the MRO cell line, which expresses wildtype BRAF.",
		"drug_labels": "CI-1040",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/849",
				"source": "http://purl.obolibrary.org/obo/DOID_1781",
				"term": "thyroid cancer",
				"pheno_id": "DOID:1781",
				"family": "endocrine gland cancer",
				"description": "thyroid cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/887"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/887",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/17911174"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2136",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/887"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/755",
				"source": null,
				"term": "CI-1040",
				"envcontext_id": "",
				"usan_stem": "Uncategorized-ENV",
				"description": "CI-1040",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/887"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/888",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/2137/summary#evidence",
		"source": "civic",
		"description": "In a study of 102 papillary thyroid cancer patients with a 15 year median follow-up time, those with BRAF V600E mutations had reduced overall survival compared to those with wildtype BRAF (P=0.015, log-rank test). The presence of BRAF V600E was associated with poorer outcome as defined by persistent disease or death (Odds ratio:14.63, 95%CI:1.28-167.29, P=0.03, multivariate analysis.",
		"drug_labels": "CI-1040",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/850",
				"source": "http://purl.obolibrary.org/obo/DOID_1781",
				"term": "thyroid cancer",
				"pheno_id": "DOID:1781",
				"family": "endocrine gland cancer",
				"description": "thyroid cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/888"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/888",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/18682506"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2137",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/888"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/756",
				"source": null,
				"term": "CI-1040",
				"envcontext_id": "",
				"usan_stem": "Uncategorized-ENV",
				"description": "CI-1040",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/888"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/889",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/2139/summary#evidence",
		"source": "civic",
		"description": "Thyroid cancer cell lines with BRAF V600E mutations were more sensitive to the MEK inhibitor RDEA119 than those with wildtype BRAF (IC50: 0.034-0.217 uM vs. 1.413-34.120 uM).",
		"drug_labels": "119",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/851",
				"source": "http://purl.obolibrary.org/obo/DOID_1781",
				"term": "thyroid cancer",
				"pheno_id": "DOID:1781",
				"family": "endocrine gland cancer",
				"description": "thyroid cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/889"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/889",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21351275"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2139",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/889"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/757",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "119",
				"envcontext_id": "9549289",
				"usan_stem": null,
				"description": "119",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/889"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/890",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/2142/summary#evidence",
		"source": "civic",
		"description": "Following treatment with sorafenib, thyroid cancer cell lines with BRAF V600E mutations had severely reduced proliferation rates, but cells with wildtype BRAF were insensitive (P<0.0001).",
		"drug_labels": "Sorafenib",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/852",
				"source": "http://purl.obolibrary.org/obo/DOID_1781",
				"term": "thyroid cancer",
				"pheno_id": "DOID:1781",
				"family": "endocrine gland cancer",
				"description": "thyroid cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/890"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/890",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/16533790"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2142",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/890"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/758",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Sorafenib",
				"envcontext_id": "216239",
				"usan_stem": "raf kinase inhibitors",
				"description": "Sorafenib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/890"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/891",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/2143/summary#evidence",
		"source": "civic",
		"description": "In a genetic screen of 87 lung cancer cell lines, one MEK-dependent cell line HCC364 contained a BRAF-V600E mutation. In growth assays, the MEK inhibitor PD-0325901 reduced proliferation in growth assays of the HCC364 cell line (IC50=3.2 nmol/L). Additionally, cells exposed to PD-0325901 exhibited an increase in apoptosis, as measured by induction of PARP cleavage.",
		"drug_labels": "0325901",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/853",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/891"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/891",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19010912"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2143",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/891"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/759",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "0325901",
				"envcontext_id": "9826528",
				"usan_stem": null,
				"description": "0325901",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/891"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/892",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/2146/summary#evidence",
		"source": "civic",
		"description": "In a phase 2 clinical trial  with 250 metastatic melanoma BRAF-V600E patients, treatment groups were randomly assigned to either dabrafenib, BRAF specific inhibitor, (n=187) or dacarbazine, a standard chemotherapeutic agent (n=63). Patients treated with dabrafenib were associated with improved progression-free survival (5.1mo vs. 2.7mo, HR:0.30, 95% CI:0.18-0.51, P<0.0001) compared with patients undergoing dacarbazine therapy.",
		"drug_labels": "DABRAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/854",
				"source": "http://purl.obolibrary.org/obo/DOID_8923",
				"term": "skin melanoma",
				"pheno_id": "DOID:8923",
				"family": "melanoma",
				"description": "skin melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/892"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/892",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22735384"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2146",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/892"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/760",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/892"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/893",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/2894/summary#evidence",
		"source": "civic",
		"description": "Cetuximab or panitumumab may be ineffective in patients with BRAF mutation unless BRAF inhibitor such as Sorafenib is introduced.",
		"drug_labels": "Sorafenib,CETUXIMAB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/855",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/893"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/893",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19001320"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2894",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/893"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/762",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/893"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/761",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Sorafenib",
				"envcontext_id": "216239",
				"usan_stem": "raf kinase inhibitors",
				"description": "Sorafenib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/893"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/894",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3017/summary#evidence",
		"source": "civic",
		"description": "Patients with BRAF V600E-mutant NSCLC (n=57) were enrolled into a phase 2, multicentre, non-randomised, open-label study, administering dabrafenib plus trametinib. The overall response rate was 36/57 (63.2%, [95% CI 49.3-75.6]) and the median progression-free survival was 9.7 months (95% CI 6.9-19.6). At data cutoff (11.6 months of follow-up), 18/36  (50%) confirmed responses were ongoing and 23/57 (40%) of patients had died.",
		"drug_labels": "DABRAFENIB,TRAMETINIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "A",
		"response_type": "Sensitivity/Response",
		"evidence_level": "1",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/856",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/894"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/894",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27283860"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3017",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/894"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/764",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/894"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/763",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/894"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/895",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/2129/summary#evidence",
		"source": "civic",
		"description": "In a mouse in vivo study, the MEK protein inhibitor selumetinib suppressed the growth of 1205Lu xenograft tumors, which contains the BRAF-V600Emutation (0.91 +/- 0.10-fold volume increase vs. 9.47 +/- 2.14-fold for non-treated mice). These tumors had a concomitant reduction of BrdU positive cells (P=0.009) but no increase in apoptosis. Selumetinib, in combination with docetaxel, a chemotherapeutic agent, produced cycle arrest and elevated apoptosis.",
		"drug_labels": "SELUMETINIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/857",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/895"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/895",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/18172275"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2129",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/895"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/765",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "SELUMETINIB",
				"envcontext_id": "10127622",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "SELUMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/895"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/896",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/2130/summary#evidence",
		"source": "civic",
		"description": "An inducible BRAF-V600E mouse melanoma model has shown a tight correlation between activated BRAF and disease progression.",
		"drug_labels": "SELUMETINIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/858",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/896"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/896",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/16424035"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2130",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/896"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/766",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "SELUMETINIB",
				"envcontext_id": "10127622",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "SELUMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/896"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/897",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/2144/summary#evidence",
		"source": "civic",
		"description": "In a mouse xenograft model, tumors derived from pilocytic astrocytoma cells that expressed BRAF V600E experienced a complete response to treatment with selumetinib, whereas tumors derived from a wildtype BRAF pilocytic astrocytoma cell line were resistant to selumetinib.",
		"drug_labels": "SELUMETINIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/859",
				"source": "http://purl.obolibrary.org/obo/DOID_3070",
				"term": "malignant glioma",
				"pheno_id": "DOID:3070",
				"family": "cell type cancer",
				"description": "malignant glioma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/897"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/897",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20806365"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2144",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/897"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/767",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "SELUMETINIB",
				"envcontext_id": "10127622",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "SELUMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/897"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/898",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/2145/summary#evidence",
		"source": "civic",
		"description": "In a study of pediatric low-grade gliomas, BRAF V600E mutation was associated with a strong trend toward reduced progression free survival (HR:2.39, 95%CI:0.93-6.15, P=0.07, multivariate analysis).",
		"drug_labels": "SELUMETINIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/860",
				"source": "http://purl.obolibrary.org/obo/DOID_3070",
				"term": "malignant glioma",
				"pheno_id": "DOID:3070",
				"family": "cell type cancer",
				"description": "malignant glioma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/898"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/898",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22492957"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2145",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/898"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/768",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "SELUMETINIB",
				"envcontext_id": "10127622",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "SELUMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/898"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/899",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/5902/summary#evidence",
		"source": "civic",
		"description": "Chemotherapy-refractory, metastatic cholangiocarcinoma with BRAF V600E showed dramatically response for Dabrafenib and Trametinib combination.",
		"drug_labels": "DABRAFENIB,TRAMETINIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/861",
				"source": "http://purl.obolibrary.org/obo/DOID_4947",
				"term": "cholangiocarcinoma",
				"pheno_id": "DOID:4947",
				"family": "bile duct cancer",
				"description": "cholangiocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/899"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/899",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28480077"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5902",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/899"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/770",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/899"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/769",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/899"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/900",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/5903/summary#evidence",
		"source": "civic",
		"description": "Two cases of patients with BRAF V600E positive cholangiocarcinoma showed excellent response for Dabrafenib and Trametinib.",
		"drug_labels": "DABRAFENIB,TRAMETINIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/862",
				"source": "http://purl.obolibrary.org/obo/DOID_4947",
				"term": "cholangiocarcinoma",
				"pheno_id": "DOID:4947",
				"family": "bile duct cancer",
				"description": "cholangiocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/900"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/900",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28078132"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5903",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/900"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/772",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/900"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/771",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/900"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/901",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/5904/summary#evidence",
		"source": "civic",
		"description": "Dabrafenib and trametinib combination showed durable response for patients with standard chemotherapy refractory cholangiocarcinoma havoring BRAF V600E.",
		"drug_labels": "DABRAFENIB,TRAMETINIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/863",
				"source": "http://purl.obolibrary.org/obo/DOID_4947",
				"term": "cholangiocarcinoma",
				"pheno_id": "DOID:4947",
				"family": "bile duct cancer",
				"description": "cholangiocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/901"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/901",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25435907"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5904",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/901"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/774",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/901"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/773",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/901"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/902",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/5906/summary#evidence",
		"source": "civic",
		"description": "Patients with metastatic cholangiocarcinoma havoring with BRAF V600E was treated with vemurafenib, panitumumab and irinotecan triplet therapy. Multiple lung metastasis was dramatically regressed and this treatment was continued.",
		"drug_labels": "VEMURAFENIB,PANITUMUMAB,Irinotecan",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/864",
				"source": "http://purl.obolibrary.org/obo/DOID_4947",
				"term": "cholangiocarcinoma",
				"pheno_id": "DOID:4947",
				"family": "bile duct cancer",
				"description": "cholangiocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/902"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/902",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26687137"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5906",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/902"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/777",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Irinotecan",
				"envcontext_id": "60838",
				"usan_stem": "antineoplastics (camptothecine derivatives)",
				"description": "Irinotecan",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/902"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/776",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "PANITUMUMAB",
				"envcontext_id": "CHEMBL1201827",
				"usan_stem": "monoclonal antibodies",
				"description": "PANITUMUMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/902"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/775",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/902"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/903",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/5958/summary#evidence",
		"source": "civic",
		"description": "The phase 2a MyPathway study assigned patients with HER2, EGFR, BRAF or SHH alterations to treatment with pertuzumab plus trastuzumab, erlotinib, vemurafenib, or vismodegib, respectively.\nWithin the BRAF mutant group, fourteen patients had refractory BRAF V600E-mutated NSCLC (adenocarcinoma, n = 13; sarcomatoid, n = 1). Six patients (43%; 95% CI, 18% to 71%) had objective responses (one CR, five PR), and two additional patients had SD > 120 days. The median DOR was 5 months (range, 4 to 14 months).",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/865",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/903"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/903",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/29320312"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5958",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/903"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/778",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/903"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/904",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/5959/summary#evidence",
		"source": "civic",
		"description": "The phase 2a MyPathway study assigned patients with HER2, EGFR, BRAF or SHH alterations to treatment with pertuzumab plus trastuzumab, erlotinib, vemurafenib, or vismodegib, respectively.\nAmong 4 patients with BRAF V600E mutant ovarian cancer, 2 had a partial response and one had stable disease > 120days.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/866",
				"source": "http://purl.obolibrary.org/obo/DOID_2394",
				"term": "ovarian cancer",
				"pheno_id": "DOID:2394",
				"family": "reproductive organ cancer",
				"description": "ovarian cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/904"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/904",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/29320312"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5959",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/904"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/779",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/904"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/905",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/5960/summary#evidence",
		"source": "civic",
		"description": "The phase 2a MyPathway study assigned patients with HER2, EGFR, BRAF or SHH alterations to treatment with pertuzumab plus trastuzumab, erlotinib, vemurafenib, or vismodegib, respectively. Among 2 patients with BRAF V600E mutant colorectal cancer, 1 had a partial response.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/867",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/905"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/905",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/29320312"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5960",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/905"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/780",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/905"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/906",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/5961/summary#evidence",
		"source": "civic",
		"description": "The phase 2a MyPathway study assigned patients with HER2, EGFR, BRAF or SHH alterations to treatment with pertuzumab plus trastuzumab, erlotinib, vemurafenib, or vismodegib, respectively. One patient with BRAF V600E mutant anaplastic thyroid cancer had a complete response.",
		"drug_labels": "VEMURAFENIB,PERTUZUMAB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/868",
				"source": "http://purl.obolibrary.org/obo/DOID_3963",
				"term": "thyroid carcinoma",
				"pheno_id": "DOID:3963",
				"family": "endocrine gland cancer",
				"description": "thyroid carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/906"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/906",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/29320312"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5961",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/906"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/782",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "PERTUZUMAB",
				"envcontext_id": "CHEMBL2007641",
				"usan_stem": "monoclonal antibodies",
				"description": "PERTUZUMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/906"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/781",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/906"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/907",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/5962/summary#evidence",
		"source": "civic",
		"description": "The phase 2a MyPathway study assigned patients with HER2, EGFR, BRAF or SHH alterations to treatment with pertuzumab plus trastuzumab, erlotinib, vemurafenib, or vismodegib, respectively. One patient with BRAF V600E mutant laryngeal cancer had a partial response with vemurafenib.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/869",
				"source": "http://purl.obolibrary.org/obo/DOID_2876",
				"term": "laryngeal squamous cell carcinoma",
				"pheno_id": "DOID:2876",
				"family": "larynx cancer",
				"description": "laryngeal squamous cell carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/907"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/907",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/29320312"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5962",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/907"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/783",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/907"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/908",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/3758/summary#evidence",
		"source": "civic",
		"description": "In a clinical trial (NCT01597908) of 704 metastatic melanoma patients, patients harboring a BRAF V600E mutation and treated with vemurafenib (n=317) were associated with a 51% response rate, as compared to a 64% response rate (p<0.001) in V600E mutation positive patients treated with dabrafenib and trametinib combination therapy (n=312). Median progression-free survival was 11.4 months in the combination-therapy group and 7.3 months in the vemurafenib group (hazard ratio, 0.56; 95% CI, 0.46 to 0.69; P<0.001).",
		"drug_labels": "DABRAFENIB,TRAMETINIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/870",
				"source": "http://purl.obolibrary.org/obo/DOID_8923",
				"term": "skin melanoma",
				"pheno_id": "DOID:8923",
				"family": "melanoma",
				"description": "skin melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/908"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/908",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25399551"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "3758",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/908"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/785",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/908"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/784",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/908"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/909",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/6045/summary#evidence",
		"source": "civic",
		"description": "In a phase 2 “basket” study of vemurafenib in BRAF V600-positive non-melanoma cancers, seven patients with anaplastic thyroid cancer were enrolled. All 7 patients had V600E mutations. One complete response and one partial response was observed, for a response rate of 29%.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/871",
				"source": "MEDDRA",
				"term": "Anaplastic Thyroid Cancer",
				"pheno_id": "MEDDRA:10002240",
				"family": null,
				"description": "Anaplastic Thyroid Cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/909"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/909",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26287849"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6045",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/909"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/786",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/909"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/910",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/6123/summary#evidence",
		"source": "civic",
		"description": "In this trial, 142 patients with metastatic, BRAF V600E mutant colorectal cancer were randomized to receive either BRAF inhibitor dabrafenib (D) + EGFR inhibitor panitumumab (P); or a triple therapy of D + P and MEK inhibition with trametinib (T) or T + P. Confirmed response rates for D+P (n=20), D+T+P (n=91), and T+P (n=31) were 10%, 21%, and 0%, respectively.",
		"drug_labels": "DABRAFENIB,PANITUMUMAB,TRAMETINIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/872",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/910"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/910",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/29431699"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6123",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/910"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/789",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/910"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/788",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "PANITUMUMAB",
				"envcontext_id": "CHEMBL1201827",
				"usan_stem": "monoclonal antibodies",
				"description": "PANITUMUMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/910"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/787",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/910"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/911",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/6124/summary#evidence",
		"source": "civic",
		"description": "In this trial, 142 patients with metastatic, BRAF V600E mutant colorectal cancer were randomized to receive either BRAF inhibitor dabrafenib (D) + EGFR inhibitor panitumumab (P); or a triple therapy of D + P and MEK inhibition with trametinib (T) or T + P. Confirmed response rates for D+P (n=20), D+T+P (n=91), and T+P (n=31) were 10%, 21%, and 0%, respectively.",
		"drug_labels": "TRAMETINIB,PANITUMUMAB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/873",
				"source": "http://purl.obolibrary.org/obo/DOID_0050861",
				"term": "colorectal adenocarcinoma",
				"pheno_id": "DOID:0050861",
				"family": "large intestine cancer",
				"description": "colorectal adenocarcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/911"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/911",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/29431699"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6124",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/911"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/791",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "PANITUMUMAB",
				"envcontext_id": "CHEMBL1201827",
				"usan_stem": "monoclonal antibodies",
				"description": "PANITUMUMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/911"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/790",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/911"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/912",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/6178/summary#evidence",
		"source": "civic",
		"description": "Adjuvant dual treatment with BRAF inhibitor dabrafenib and MEK inhibitor trametinib was administered to patients with stage III resected melenoma with V600E or V600K mutation in this stage III trial (COMBO-AD, NCT01682083). 792 (91%) patients had V600E, and were administered dabrafenib and trametinib or placebo for 12 months. In subsequent analysis, relapse or death occurred in 150/397 patients (38%) in the treatment group and 229/395 patients (58%) in the placebo group for a 95% CI Hazard Ratio of 0.48 (0.39-0.58).",
		"drug_labels": "DABRAFENIB,TRAMETINIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/874",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/912"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/912",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/28891408"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6178",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/912"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/793",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/912"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/792",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/912"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/913",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/6938/summary#evidence",
		"source": "civic",
		"description": "In this Phase III trial (NCT01584648 COMBI-d), previously untreated patients with unresectable stage IIIC or IV melanoma with BRAF V600E (359 patients) or V600K (61 patients) received dabrafenib and trametinib or dabrafenib alone with primary endpoint of progression free survival and secondary endpoints including disease response. The hazard ratio for progression or death in the V600E group was 0.81 for dabrafenib-trametinib vs dabrafenib-alone. Of 179 V600E patients in the dabrafenib-trametinib group, 68% of patients had a response, which was 15 percentage points higher than in the dabrafenib-alone group (95% CI, 4 to 24; P=0.006).",
		"drug_labels": "DABRAFENIB,TRAMETINIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/875",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/913"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/913",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25265492"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6938",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/913"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/795",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/913"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/794",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/913"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/914",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/6940/summary#evidence",
		"source": "civic",
		"description": "In this Phase I and II study (NCT01072175) patients with metastatic melanoma were given dabrafenib and trametinib combination therapy vs. dabrafenib monotherapy. From V600E patients, 45 received monotherapy and 92 received combination therapy. Hazard ratio for progression or death was 0.43 (95% CI, 0.27-0.71). Both patients with the BRAF V600E and V600K mutation showed significant improvement in progression-free survival.",
		"drug_labels": "DABRAFENIB,TRAMETINIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/876",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/914"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/914",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23020132"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6940",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/914"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/797",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/914"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/796",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/914"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/915",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/6975/summary#evidence",
		"source": "civic",
		"description": "Interim analysis of a basket trial evaluating the combination of dabrafenib (BRAF inhibitor) and trametinib (MEK inhibitor) in previously treated V600E-mutated patients showed 11/16 patients with anaplastic thyroid carcinoma responded to treatment (overall response rate 69%; 95% CI, 41% to 89%). Seven patients had ongoing responses.",
		"drug_labels": "DABRAFENIB,TRAMETINIB",
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/877",
				"source": "http://purl.obolibrary.org/obo/DOID_3963",
				"term": "thyroid carcinoma",
				"pheno_id": "DOID:3963",
				"family": "endocrine gland cancer",
				"description": "thyroid carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/915"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/915",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/29072975"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6975",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/915"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/799",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/915"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/798",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/915"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/916",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/106/summary#evidence",
		"source": "civic",
		"description": "BRAF V600E is correlated with poor prognosis in papillary thyroid cancer in a study of 187 patients with PTC and other thyroid diseases.",
		"drug_labels": null,
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/878",
				"source": "http://purl.obolibrary.org/obo/DOID_3969",
				"term": "papillary thyroid carcinoma",
				"pheno_id": "DOID:3969",
				"family": "thyroid cancer",
				"description": "papillary thyroid carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/916"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/916",
				"type": "Prognostic",
				"description": "Poor Outcome",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24396464"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "106",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/916"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/917",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/2503/summary#evidence",
		"source": "civic",
		"description": "In a meta-analysis of 8 studies, papillary thyroid cancer patients with BRAF V600E mutation had a higher frequency of recurrence and persistent disease compared to those with wildtype BRAF (28.5%  vs. 12.8% ,  Risk ratio:2.14, 95%CI:1.67-2.74, P<0.00001).",
		"drug_labels": null,
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/879",
				"source": "http://purl.obolibrary.org/obo/DOID_3969",
				"term": "papillary thyroid carcinoma",
				"pheno_id": "DOID:3969",
				"family": "thyroid cancer",
				"description": "papillary thyroid carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/917"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/917",
				"type": "Prognostic",
				"description": "Poor Outcome",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21882184"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2503",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/917"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/918",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/104/summary#evidence",
		"source": "civic",
		"description": "BRAF V600E is correlated with shorter disease-free and overall Survival in a Spanish cohort of melanoma patients.",
		"drug_labels": null,
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/880",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/918"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/918",
				"type": "Prognostic",
				"description": "Poor Outcome",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24388723"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "104",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/918"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/919",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/102/summary#evidence",
		"source": "civic",
		"description": "Unlike other studies that suggest a poorer outcome, BRAF mutation in this study was not correlated with poorer prognosis in papillary thyroid cancer.",
		"drug_labels": null,
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/881",
				"source": "http://purl.obolibrary.org/obo/DOID_3969",
				"term": "papillary thyroid carcinoma",
				"pheno_id": "DOID:3969",
				"family": "thyroid cancer",
				"description": "papillary thyroid carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/919"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/919",
				"type": "Prognostic",
				"description": "Poor Outcome",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24354346"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "102",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/919"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/920",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/656/summary#evidence",
		"source": "civic",
		"description": "In patients with papillary thyroid cancer harboring both BRAF V600E and the TERT promotor mutation C228T (N=35), recurrence-free survival is worse than in patients harboring one of these mutations (N=159 BRAF, N=26 TERT promoter mutated) or no mutations in either gene (N=287)(P<0.001).",
		"drug_labels": null,
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/882",
				"source": "http://purl.obolibrary.org/obo/DOID_3969",
				"term": "papillary thyroid carcinoma",
				"pheno_id": "DOID:3969",
				"family": "thyroid cancer",
				"description": "papillary thyroid carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/920"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/920",
				"type": "Prognostic",
				"description": "Poor Outcome",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25024077"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "656",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/920"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/921",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/107/summary#evidence",
		"source": "civic",
		"description": "V600E is correlated with disease recurrence in both age cohorts (>65 and <65 yo).",
		"drug_labels": null,
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/883",
				"source": "http://purl.obolibrary.org/obo/DOID_3969",
				"term": "papillary thyroid carcinoma",
				"pheno_id": "DOID:3969",
				"family": "thyroid cancer",
				"description": "papillary thyroid carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/921"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/921",
				"type": "Prognostic",
				"description": "Poor Outcome",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21594703"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "107",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/921"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/922",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/1552/summary#evidence",
		"source": "civic",
		"description": "In a study of 908 patients with colorectal cancer, 45 patients had BRAF V600E mutations and 589 patients were BRAF wild type.  BRAF V600E mutations were more likely to be proximal tumors (68.9%, 20.7%; p<0.0001), they were more likely to be poorly differentiated (17.7%, 1.9%; p<0.0001), they were more likely to be mucinous carcinoma type (20.0%, 4.2%; p=0.0003), they were more likely to have lymphatic invasion (77.6%, 49.9%; p=0.0003), and they had a shorter survival time (31.1 mo, 41.6 mo; p=0.001).  The 3-year survival rate was significantly poorer in the V600E group when compared to the wild type group (63.8%, 87.9%; p<0.0001).",
		"drug_labels": null,
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/884",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/922"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/922",
				"type": "Prognostic",
				"description": "Poor Outcome",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27404270"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1552",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/922"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/923",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/1940/summary#evidence",
		"source": "civic",
		"description": "In a study of 468 colorectal cancer samples, 61 patients had micro-satellite instability and there was a statistically significantly better prognosis for BRAF WT patients relative to BRAF (V600E)-mutated patients (Log-rank P=0.0903).",
		"drug_labels": null,
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "Negative",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/885",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/923"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/923",
				"type": "Prognostic",
				"description": "Negative",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27302369"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1940",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/923"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/924",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/80/summary#evidence",
		"source": "civic",
		"description": "Thyroid nodule with BRAF V600E mutation is highly correlated with papillary thyroid cancer.",
		"drug_labels": null,
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "Positive",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/886",
				"source": "http://purl.obolibrary.org/obo/DOID_3969",
				"term": "papillary thyroid carcinoma",
				"pheno_id": "DOID:3969",
				"family": "thyroid cancer",
				"description": "papillary thyroid carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/924"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/924",
				"type": "Diagnostic",
				"description": "Positive",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24570209"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "80",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/924"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/925",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/79/summary#evidence",
		"source": "civic",
		"description": "BRAF V600E is shown to be associated with the tall-cell variant of papillary thyroid cancer.",
		"drug_labels": null,
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "Positive",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/887",
				"source": "http://purl.obolibrary.org/obo/DOID_1781",
				"term": "thyroid cancer",
				"pheno_id": "DOID:1781",
				"family": "endocrine gland cancer",
				"description": "thyroid cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/925"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/925",
				"type": "Diagnostic",
				"description": "Positive",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21594703"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "79",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/925"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/926",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/463/summary#evidence",
		"source": "civic",
		"description": "In patients with multiple myeloma, those with BRAF V600E had shorter overall survival than wild-type.",
		"drug_labels": null,
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/888",
				"source": "http://purl.obolibrary.org/obo/DOID_0070004",
				"term": "myeloid neoplasm",
				"pheno_id": "DOID:0070004",
				"family": "hematologic cancer",
				"description": "myeloid neoplasm",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/926"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/926",
				"type": "Prognostic",
				"description": "Poor Outcome",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23612012"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "463",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/926"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/927",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/103/summary#evidence",
		"source": "civic",
		"description": "V600E is associated with adverse pathological features of colorectal cancer. This can be concluded as a marker of poor prognosis.",
		"drug_labels": null,
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/889",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/927"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/927",
				"type": "Prognostic",
				"description": "Poor Outcome",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24594804"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "103",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/927"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/928",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/105/summary#evidence",
		"source": "civic",
		"description": "BRAF mutation correlated with poor prognosis in papillary thyroid cancer in both older (>65 yo) and younger (<65 yo) cohorts.",
		"drug_labels": null,
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/890",
				"source": "http://purl.obolibrary.org/obo/DOID_3969",
				"term": "papillary thyroid carcinoma",
				"pheno_id": "DOID:3969",
				"family": "thyroid cancer",
				"description": "papillary thyroid carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/928"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/928",
				"type": "Prognostic",
				"description": "Poor Outcome",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21594703"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "105",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/928"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/929",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/1",
			"name": "V600E",
			"description": "BRAF V600E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453136,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453136A>T",
			"hgvs_c": "NM_004333.4:c.1799T>A",
			"hgvs_p": "NP_004324.2:p.Val600Glu",
			"dbsnp_ids": [
				"113488022"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453136A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/12/summary/evidence/1127/summary#evidence",
		"source": "civic",
		"description": "In 47 patients with Hairy Cell Leukemia, sequencing discovered a V600E mutation in all 47 of the sequenced patients.",
		"drug_labels": null,
		"variant_name": "V600E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/12/summary",
		"evidence_label": "B",
		"response_type": "Positive",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/891",
				"source": "http://purl.obolibrary.org/obo/DOID_285",
				"term": "hairy cell leukemia",
				"pheno_id": "DOID:285",
				"family": "leukemia",
				"description": "hairy cell leukemia",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/929"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/929",
				"type": "Diagnostic",
				"description": "Positive",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21663470"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1127",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/929"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/930",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/371",
			"name": "599INST",
			"description": "BRAF 599INST",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": null,
			"refseq": null,
			"isoform": "ENST00000288602.6",
			"chromosome": "7",
			"start_pos": 140453140,
			"end_pos": 140453141,
			"ref": null,
			"alt": "TGT",
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/1298/summary/evidence/2990/summary#evidence",
		"source": "civic",
		"description": "Pilocytic astrocytoma (PA) is emerging as a tumor entity with dysregulated Ras/Raf/MEK/ERK signaling. The well-known BRAF(V600E) mutation was found in 6/64 (9.38%) of our samples. Furthermore, 2/64 (3.13%) of our samples carried a 3-bp insertion in BRAF resulting in the duplication of threonine 599.Here, we demonstrate that this mutant (B-Raf(insT) ) and another B-Raf mutant, which carries two additional threonine residues at this position, display an in vitro kinase activity and cellular MEK/ERK activation potential comparable to those of B-Raf(V600E) .",
		"drug_labels": null,
		"variant_name": "599INST",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/1298/summary",
		"evidence_label": "C",
		"response_type": "N/A",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/892",
				"source": "http://purl.obolibrary.org/obo/DOID_4851",
				"term": "pilocytic astrocytoma",
				"pheno_id": "DOID:4851",
				"family": "malignant glioma",
				"description": "pilocytic astrocytoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/930"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/930",
				"type": "Predictive",
				"description": "N/A",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21190184"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2990",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/930"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/931",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/51",
			"name": "G469V",
			"description": "BRAF G469V",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140481402,
			"end_pos": 140481402,
			"ref": "C",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140481402C>A",
			"hgvs_c": "NM_004333.4:c.1406G>T",
			"hgvs_p": "NP_004324.2:p.Gly469Val",
			"dbsnp_ids": [
				"121913355"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140481402C>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/841/summary/evidence/1939/summary#evidence",
		"source": "civic",
		"description": "Case report of a patient with HCC and NSCLC (only NSCLC harboring the BRAF G469V mutation). Sorafenib at standard dosage led to a partial response in the primary lesion of the lung, complete response of the metastasis in the contralateral lung, and stability of HCC.",
		"drug_labels": "Sorafenib",
		"variant_name": "G469V",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/841/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/893",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/931"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/931",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27388325"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1939",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/931"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/800",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Sorafenib",
				"envcontext_id": "216239",
				"usan_stem": "raf kinase inhibitors",
				"description": "Sorafenib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/931"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/932",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/372",
			"name": "D594K",
			"description": "BRAF D594K",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": null,
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/2398/summary/evidence/6403/summary#evidence",
		"source": "civic",
		"description": "Of 100 metastatic colorectal cancer patients treated with oxaliplatin-based first-line therapy, the 6 patients with either BRAF V600E or D594K had reduced progression-free survival compared to 94 patients with wildtype BRAF (5.0mo vs. 11.7mo, HR:6.4, 95%CI:2.6-15.6, P<0.0001).",
		"drug_labels": "OXALIPLATIN",
		"variant_name": "D594K",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/2398/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/894",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/932"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/932",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19603024"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6403",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/932"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/801",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "OXALIPLATIN",
				"envcontext_id": "CHEMBL414804",
				"usan_stem": "antineoplastics (platinum derivatives)",
				"description": "OXALIPLATIN",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/932"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/933",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/372",
			"name": "D594K",
			"description": "BRAF D594K",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": null,
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/2398/summary/evidence/6402/summary#evidence",
		"source": "civic",
		"description": "The presence of BRAF V600E or D594K was associated with reduced progression-free survival in 5 patients with metastatic colorectal cancer treated with irinotecan-based first line therapy (3.5mo vs. 12.8mo, HR:4.1, 95%CI:1.5-11.3, P=0.006) when compared to 39 patients with wildtype BRAF.",
		"drug_labels": "Irinotecan",
		"variant_name": "D594K",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/2398/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/895",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/933"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/933",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19603024"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6402",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/933"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/802",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Irinotecan",
				"envcontext_id": "60838",
				"usan_stem": "antineoplastics (camptothecine derivatives)",
				"description": "Irinotecan",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/933"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/934",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/373",
			"name": "BRAF-CUL1",
			"description": "BRAF BRAF-CUL1",
			"biomarker_type": "Transcript Fusion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001882"
			],
			"soid": "SO:0001886",
			"so_name": "transcript_fusion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000288602.6",
			"chromosome": "7",
			"start_pos": 140434279,
			"end_pos": 140487384,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/656/summary/evidence/1662/summary#evidence",
		"source": "civic",
		"description": "One patient with low-grade serous ovarian cancer had an in-frame fusion between the BRAF kinase domain and CUL1 identified by panel sequencing (MSK-IMPACT), with expression confirmed by whole-transcriptome sequencing. This patient with metastatic disease after treatment with carboplatin and paclitaxel, was enrolled onto a study of paclitaxel in combination with an oral MEK inhibitor and achieved a CR. She continued to receive therapy for 7 months, until discontinuation because of the development of pneumonitis. At publication, sustained CR had lasted > 18 months.",
		"drug_labels": "2-Butanone",
		"variant_name": null,
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/656/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/896",
				"source": "http://purl.obolibrary.org/obo/DOID_0050933",
				"term": "ovarian serous carcinoma",
				"pheno_id": "DOID:0050933",
				"family": "ovarian cancer",
				"description": "ovarian serous carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/934"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/934",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26324360"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1662",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/934"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/803",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "2-Butanone",
				"envcontext_id": "CID6569",
				"usan_stem": null,
				"description": "2-Butanone",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/934"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/935",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/63",
			"name": "K483M",
			"description": "BRAF K483M",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140477859,
			"end_pos": 140477860,
			"ref": "TT",
			"alt": "CA",
			"hgvs_g": "NC_000007.13:g.140477859_140477860delinsCA",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/581/summary/evidence/1457/summary#evidence",
		"source": "civic",
		"description": "Preclinical study in melanoma cell lines. Inactivity of BRAF as mediated by specific mutation (D594A, D594V or K483M) or selective pharmacological inhibition leads to MEK hyperactivation through CRAF binding in NRAS mutant D04 cells. Either pan-RAF (e.g. sorafenib in the abscence of CRAF T421N gatekeeper mutation) or MEK inhibitors (e.g., trametinib) could instead block ERK pathway hyperactivation in RAS mutated cancers.",
		"drug_labels": "2-Butanone,Sorafenib",
		"variant_name": "K483M",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/581/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/897",
				"source": "http://purl.obolibrary.org/obo/DOID_8923",
				"term": "skin melanoma",
				"pheno_id": "DOID:8923",
				"family": "melanoma",
				"description": "skin melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/935"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/935",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20141835"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1457",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/935"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/805",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Sorafenib",
				"envcontext_id": "216239",
				"usan_stem": "raf kinase inhibitors",
				"description": "Sorafenib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/935"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/804",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "2-Butanone",
				"envcontext_id": "CID6569",
				"usan_stem": null,
				"description": "2-Butanone",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/935"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/936",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/374",
			"name": "DELNVTAP",
			"description": "BRAF DELNVTAP",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 140477838,
			"end_pos": 140477852,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/1663/summary/evidence/4798/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, 537Mel, OV-90 and H2405 cell lines expressing BRAF N486_P490del mutation demonstrated resistance to vemurafenib treatment, compared to A-375 cell expressing BRAF V600E mutation. Resistance was determined by assessing cell viability, MEK and ERK phosphorylation.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "DELNVTAP",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/1663/summary",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/898",
				"source": "http://purl.obolibrary.org/obo/DOID_1793",
				"term": "pancreatic cancer",
				"pheno_id": "DOID:1793",
				"family": "endocrine gland cancer",
				"description": "pancreatic cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/936"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/936",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26996308"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4798",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/936"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/806",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/936"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/937",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/42",
			"name": "G464V",
			"description": "BRAF G464V",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140481417,
			"end_pos": 140481417,
			"ref": "C",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140481417C>A",
			"hgvs_c": "NM_004333.4:c.1391G>T",
			"hgvs_p": "NP_004324.2:p.Gly464Val",
			"dbsnp_ids": [
				"121913348"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140481417C>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/1106/summary/evidence/5964/summary#evidence",
		"source": "civic",
		"description": "The phase 2a MyPathway study assigned patients with HER2, EGFR, BRAF or SHH alterations to treatment with pertuzumab plus trastuzumab, erlotinib, vemurafenib, or vismodegib, respectively. Of 26 patients with BRAF V600E mutations, objective responses were seen in 12 patients (46%; 95% CI, 27% to 67%). Only one of 23 patients (4%; 95% CI, 0% to 22%) with other non-V600 BRAF mutations had a PR (pancreas cancer with a CUX1-BRAF fusion). Nonresponding BRAF mutations included: K601E (n = 6), G464V (n = 2), G469A (n = 2), G496A (n = 2), N581S (n = 2), and one each for G466V, G596R, G606E, L597Q, P731T, intron 9 rearrangement, intron 10 rearrangement, and MACF1- and WASFL-BRAF fusion.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "G464V",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/1106/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/899",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/937"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/937",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/29320312"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5964",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/937"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/807",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/937"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/938",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/42",
			"name": "G464V",
			"description": "BRAF G464V",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140481417,
			"end_pos": 140481417,
			"ref": "C",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140481417C>A",
			"hgvs_c": "NM_004333.4:c.1391G>T",
			"hgvs_p": "NP_004324.2:p.Gly464Val",
			"dbsnp_ids": [
				"121913348"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140481417C>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/1106/summary/evidence/2811/summary#evidence",
		"source": "civic",
		"description": "In an attempt to block both MAPK and PI3K/Akt pathways, two signaling inhibitors (sorafenib, a BRAF kinase inhibitor, and ceramide, an agent that dephosphorylates Akt) were used in cell culture and mouse cancer models. In combination, sorafenib and ceramide increased apoptosis in MDA-MB-231 breast cells (P<0.05) and also blocked tumor development in mouse xenograft experiments (P<0.05) compared to non-treated or signal treatment animals.",
		"drug_labels": "Sorafenib",
		"variant_name": "G464V",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/1106/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/900",
				"source": "http://purl.obolibrary.org/obo/DOID_1612",
				"term": "breast cancer",
				"pheno_id": "DOID:1612",
				"family": "thoracic cancer",
				"description": "breast cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/938"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/938",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/18519791"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2811",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/938"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/808",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Sorafenib",
				"envcontext_id": "216239",
				"usan_stem": "raf kinase inhibitors",
				"description": "Sorafenib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/938"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/939",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/375",
			"name": "PAPSS1-BRAF",
			"description": "BRAF PAPSS1-BRAF",
			"biomarker_type": "Transcript Fusion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001882"
			],
			"soid": "SO:0001886",
			"so_name": "transcript_fusion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000265174.4",
			"chromosome": "4",
			"start_pos": 108603171,
			"end_pos": 108641608,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/286/summary/evidence/726/summary#evidence",
		"source": "civic",
		"description": "BRAF-fusion in \"pan-negative\" melanomas were identified in TCGA data. Cell-lines with a PAPSS1-BRAF fusion were resistant to treatment with Vemurafenib but sensitive to treatment with Trametinib. This fusion is believed to activate MAPK pathway signaling.",
		"drug_labels": "TRAMETINIB",
		"variant_name": null,
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/286/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/901",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/939"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/939",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24345920"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "726",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/939"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/809",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/939"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/940",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/375",
			"name": "PAPSS1-BRAF",
			"description": "BRAF PAPSS1-BRAF",
			"biomarker_type": "Transcript Fusion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001882"
			],
			"soid": "SO:0001886",
			"so_name": "transcript_fusion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000265174.4",
			"chromosome": "4",
			"start_pos": 108603171,
			"end_pos": 108641608,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/286/summary/evidence/725/summary#evidence",
		"source": "civic",
		"description": "BRAF-fusion in \"pan-negative\" melanomas were identified in TCGA data. Cell-lines with PAPSS1-BRAF fusion were resistant to treatment with Vemurafenib.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": null,
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/286/summary",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/902",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/940"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/940",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24345920"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "725",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/940"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/810",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/940"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/941",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/75",
			"name": "L505H",
			"description": "BRAF L505H",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140477794,
			"end_pos": 140477794,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140477794A>T",
			"hgvs_c": "NM_004333.4:c.1514T>A",
			"hgvs_p": "NP_004324.2:p.Leu505His",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140477794A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/658/summary/evidence/1668/summary#evidence",
		"source": "civic",
		"description": "Using a mutation screen in the BRAFV600E melanoma cell line A375, the L505H variant was identified as conferring resistance to vemurafenib. Analysis of the mutation in T293 cell lines found that the L505H mutant alone or with V600e had greater kinase activity and increased the levels of phospho-MEK. Finally, transduction of Ba/F3 cells with BRAF V600E/L505H IL3 independent proliferation.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "L505H",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/658/summary",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/903",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/941"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/941",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24112705"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1668",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/941"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/811",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/941"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/942",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/75",
			"name": "L505H",
			"description": "BRAF L505H",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140477794,
			"end_pos": 140477794,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140477794A>T",
			"hgvs_c": "NM_004333.4:c.1514T>A",
			"hgvs_p": "NP_004324.2:p.Leu505His",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140477794A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/658/summary/evidence/1669/summary#evidence",
		"source": "civic",
		"description": "In this study, the investigators followed 10 patients treated with vemurafenib, and then they collected biopsies of lesions that progressed. In one of these patients, they identified the L505H mutation.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "L505H",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/658/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/904",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/942"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/942",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25515853"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1669",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/942"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/812",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/942"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/943",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/376",
			"name": "intron 10 rearrangement",
			"description": "BRAF intron 10 rearrangement",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": null,
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/2226/summary/evidence/6400/summary#evidence",
		"source": "civic",
		"description": "In a retrospective study of 44 relapsed melanoma patients harboring BRAF V600E or V600K (known BRAF inhibitor sensitizing mutations), MAPK pathway reactivation mechanisms were implicated in acquired resistance to BRAF inhibitor (vemurafenib or dabrafenib) monotherapy. The following MAPK pathway variants were found in progressive tumors with patient matched baseline tumors (some patients donated samples from multiple geographically/temporally distinct progressive tumors): NRAS mutations (G12D, G12R, G13R, Q61K, Q61R, Q61L) in 13/71 (18%) of progressive tumors, KRAS mutations (G12C, G12R, Q61H) in 5/71 (7%) of progressive tumors, mutant BRAF amplification (2-15 fold or 4-75 copies) in 11/57 (19%) of progressive tumors, mutant BRAF alternative splice variants (novel exon boundaries between 1/9, 1/11, 3/9) in 6/48 (13%) of progressive tumor RNA.",
		"drug_labels": "DABRAFENIB,VEMURAFENIB",
		"variant_name": "rearrangement",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/2226/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/905",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/943"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/943",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24265155"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6400",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/943"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/814",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/943"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/813",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/943"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/944",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/376",
			"name": "intron 10 rearrangement",
			"description": "BRAF intron 10 rearrangement",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": null,
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/2226/summary/evidence/5974/summary#evidence",
		"source": "civic",
		"description": "The phase 2a MyPathway study assigned patients with HER2, EGFR, BRAF or SHH alterations to treatment with pertuzumab plus trastuzumab, erlotinib, vemurafenib, or vismodegib, respectively Of 26 patients with BRAF V600E mutations, objective responses were seen in 12 patients (46%; 95% CI, 27% to 67%). Only one of 23 patients (4%; 95% CI, 0% to 22%) with other non-V600 BRAF mutations had a PR (pancreas cancer with a CUX1-BRAF fusion). Nonresponding BRAF mutations included: K601E (n = 6), G464V (n = 2), G469A (n = 2), G496A (n = 2), N581S (n = 2), and one each for G466V, G596R, G606E, L597Q, P731T, intron 9 rearrangement, intron 10 rearrangement, and MACF1- and WASFL-BRAF fusion.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "rearrangement",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/2226/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/906",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/944"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/944",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/29320312"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5974",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/944"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/815",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/944"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/945",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/377",
			"name": "MACF1-BRAF Fusion",
			"description": "BRAF MACF1-BRAF Fusion",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 140453155,
			"end_pos": 140453155,
			"ref": "C",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140453155C>A",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453155C>A?assembly=hg19",
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/2227/summary/evidence/5975/summary#evidence",
		"source": "civic",
		"description": "The phase 2a MyPathway study assigned patients with HER2, EGFR, BRAF or SHH alterations to treatment with pertuzumab plus trastuzumab, erlotinib, vemurafenib, or vismodegib, respectively Of 26 patients with BRAF V600E mutations, objective responses were seen in 12 patients (46%; 95% CI, 27% to 67%). Only one of 23 patients (4%; 95% CI, 0% to 22%) with other non-V600 BRAF mutations had a PR (pancreas cancer with a CUX1-BRAF fusion). Nonresponding BRAF mutations included: K601E (n = 6), G464V (n = 2), G469A (n = 2), G496A (n = 2), N581S (n = 2), and one each for G466V, G596R, G606E, L597Q, P731T, intron 9 rearrangement, intron 10 rearrangement, and MACF1- and WASFL-BRAF fusion.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "Fusion",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/2227/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/907",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/945"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/945",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/29320312"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5975",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/945"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/816",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/945"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/946",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/378",
			"name": "AMPLIFICATION",
			"description": "BRAF AMPLIFICATION",
			"biomarker_type": "Transcript Amplification",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001880"
			],
			"soid": "SO:0001889",
			"so_name": "transcript_amplification",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000288602.6",
			"chromosome": "7",
			"start_pos": 140434279,
			"end_pos": 140624564,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/1269/summary/evidence/2929/summary#evidence",
		"source": "civic",
		"description": "Paired pre-treatment and post-progression tumor biopsies from BRAF-mutant CRC patients treated with RAF inhibitor combinations were analyzed. Alterations in MAPK pathway genes were found in resistant tumors not present in matched pre-treatment tumors, including KRAS amplification, BRAF amplification, and a MEK1 mutation.",
		"drug_labels": "DABRAFENIB,PANITUMUMAB",
		"variant_name": "AMPLIFICATION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/1269/summary",
		"evidence_label": "C",
		"response_type": "resistant",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/908",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/946"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/946",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25673644"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2929",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/946"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/818",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "PANITUMUMAB",
				"envcontext_id": "CHEMBL1201827",
				"usan_stem": "monoclonal antibodies",
				"description": "PANITUMUMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/946"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/817",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/946"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/947",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/379",
			"name": "WASFL-BRAF Fusion",
			"description": "BRAF WASFL-BRAF Fusion",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 140453155,
			"end_pos": 140453155,
			"ref": "C",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140453155C>A",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453155C>A?assembly=hg19",
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/2228/summary/evidence/5976/summary#evidence",
		"source": "civic",
		"description": "The phase 2a MyPathway study assigned patients with HER2, EGFR, BRAF or SHH alterations to treatment with pertuzumab plus trastuzumab, erlotinib, vemurafenib, or vismodegib, respectively. Of 26 patients with BRAF V600E mutations, objective responses were seen in 12 patients (46%; 95% CI, 27% to 67%). Only one of 23 patients (4%; 95% CI, 0% to 22%) with other non-V600 BRAF mutations had a PR (pancreas cancer with a CUX1-BRAF fusion). Nonresponding BRAF mutations included: K601E (n = 6), G464V (n = 2), G469A (n = 2), G496A (n = 2), N581S (n = 2), and one each for G466V, G596R, G606E, L597Q, P731T, intron 9 rearrangement, intron 10 rearrangement, and MACF1- and WASFL-BRAF fusion.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "Fusion",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/2228/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/909",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/947"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/947",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/29320312"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5976",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/947"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/819",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/947"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/948",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/26",
			"name": "D594A",
			"description": "BRAF D594A",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453154,
			"end_pos": 140453154,
			"ref": "T",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.140453154T>G",
			"hgvs_c": "NM_004333.4:c.1781A>C",
			"hgvs_p": "NP_004324.2:p.Asp594Ala",
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453154T>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/579/summary/evidence/1454/summary#evidence",
		"source": "civic",
		"description": "Preclinical study in melanoma cell lines. Inactivity of BRAF as mediated by specific mutation (D594A, D594V or K483M) or selective pharmacological inhibition leads to MEK hyperactivation through CRAF binding in NRAS mutant D04 cells. Either pan-RAF (e.g. sorafenib in the abscence of CRAF T421N gatekeeper mutation) or MEK inhibitors (e.g., trametinib) could instead block ERK pathway hyperactivation in RAS mutated cancers.",
		"drug_labels": "2-Butanone,Sorafenib",
		"variant_name": "D594A",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/579/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/910",
				"source": "http://purl.obolibrary.org/obo/DOID_8923",
				"term": "skin melanoma",
				"pheno_id": "DOID:8923",
				"family": "melanoma",
				"description": "skin melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/948"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/948",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20141835"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1454",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/948"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/821",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Sorafenib",
				"envcontext_id": "216239",
				"usan_stem": "raf kinase inhibitors",
				"description": "Sorafenib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/948"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/820",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "2-Butanone",
				"envcontext_id": "CID6569",
				"usan_stem": null,
				"description": "2-Butanone",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/948"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/949",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/380",
			"name": "TRIM24-BRAF",
			"description": "BRAF TRIM24-BRAF",
			"biomarker_type": "Transcript Fusion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001882"
			],
			"soid": "SO:0001886",
			"so_name": "transcript_fusion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000343526.4",
			"chromosome": "7",
			"start_pos": 138145079,
			"end_pos": 138239711,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/287/summary/evidence/1416/summary#evidence",
		"source": "civic",
		"description": "Foundation One NGS assay and targeted RNAseq identified PAPSS1-BRAF fusion in a melanoma sample. Further BRAF fusions (TRIM24-BRAF) were identified in TCGA and additional samples. Ectopic expression of engineered cDNA in 293H cells showed that trametinib led to reduced ERK1/2 phosphorylation in fusion positive cells whereas vemurafenib was not effective.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": null,
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/287/summary",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/911",
				"source": "http://purl.obolibrary.org/obo/DOID_8923",
				"term": "skin melanoma",
				"pheno_id": "DOID:8923",
				"family": "melanoma",
				"description": "skin melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/949"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/949",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24345920"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1416",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/949"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/822",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/949"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/950",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/380",
			"name": "TRIM24-BRAF",
			"description": "BRAF TRIM24-BRAF",
			"biomarker_type": "Transcript Fusion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001882"
			],
			"soid": "SO:0001886",
			"so_name": "transcript_fusion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000343526.4",
			"chromosome": "7",
			"start_pos": 138145079,
			"end_pos": 138239711,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/287/summary/evidence/727/summary#evidence",
		"source": "civic",
		"description": "A TRIM24-BRAF fusion was identified in a single patient with metastatic melanoma that was \"pan-negative\" for driver mutations. A cell-line (293H) ectopically expressing the TRIM24-BRAF fusion was found to be sensitive to the MEK-inhibitor Trametinib.",
		"drug_labels": "TRAMETINIB",
		"variant_name": null,
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/287/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/912",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/950"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/950",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24345920"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "727",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/950"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/823",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/950"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/951",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/381",
			"name": "V600_K601DELINSD",
			"description": "BRAF V600_K601DELINSD",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 140453132,
			"end_pos": 140453136,
			"ref": "TTTCA",
			"alt": "AT",
			"hgvs_g": "NC_000007.13:g.140453132_140453136delinsAT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/1658/summary/evidence/4790/summary#evidence",
		"source": "civic",
		"description": "In a stage IIIc melanoma patient harboring BRAF V600_K601delinsD mutation, response to vemurafenib monotherapy was reported. The patient achieved a reduction in the size of axillary and pectoral subcutaneous nodules by the end of the 3rd cycle of vemurafenib treatment; however, 3 months later, the patient experienced brain metastasis and death.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600_K601DELINSD",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/1658/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/913",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/951"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/951",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24108467"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4790",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/951"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/824",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/951"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/952",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/381",
			"name": "V600_K601DELINSD",
			"description": "BRAF V600_K601DELINSD",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": 140453132,
			"end_pos": 140453136,
			"ref": "TTTCA",
			"alt": "AT",
			"hgvs_g": "NC_000007.13:g.140453132_140453136delinsAT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/1658/summary/evidence/4789/summary#evidence",
		"source": "civic",
		"description": "In a stage IV cutaneous nodular thoracic melanoma patient with pulmonary, liver and brain metastases, harboring a BRAF V600_K601delinsD mutation, stable disease to vemurafenib monotherapy was reported. The patient achieved stable disease and a 25% decrease of metastases size with 4 weeks of vemurafenib treatment; however, after administration of vemurafenib for 12 weeks the patient experienced disease progression and death.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600_K601DELINSD",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/1658/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/914",
				"source": "http://purl.obolibrary.org/obo/DOID_8923",
				"term": "skin melanoma",
				"pheno_id": "DOID:8923",
				"family": "melanoma",
				"description": "skin melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/952"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/952",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25265970"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4789",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/952"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/825",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/952"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/953",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/382",
			"name": "AKAP9-BRAF",
			"description": "BRAF AKAP9-BRAF",
			"biomarker_type": "Transcript Fusion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001882"
			],
			"soid": "SO:0001886",
			"so_name": "transcript_fusion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000356239.3",
			"chromosome": "7",
			"start_pos": 91570181,
			"end_pos": 91625114,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/184/summary/evidence/462/summary#evidence",
		"source": "civic",
		"description": "The AKAP9-BRAF fusion gene was found in 3/28 tumor samples of radiation-associated papillary thyroid carcinoma, and no samples of non-radiation associated papillary thyroid carcinoma. This fusion was associated with elevated BRAF kinase activity, similar to the V600E variant.",
		"drug_labels": null,
		"variant_name": null,
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/184/summary",
		"evidence_label": "B",
		"response_type": "Positive",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/915",
				"source": "http://purl.obolibrary.org/obo/DOID_3969",
				"term": "papillary thyroid carcinoma",
				"pheno_id": "DOID:3969",
				"family": "thyroid cancer",
				"description": "papillary thyroid carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/953"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/953",
				"type": "Diagnostic",
				"description": "Positive",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/15630448"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "462",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/953"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/954",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/81",
			"name": "L597V",
			"description": "BRAF L597V",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453146,
			"end_pos": 140453146,
			"ref": "G",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.140453146G>C",
			"hgvs_c": "NM_004333.4:c.1789C>G",
			"hgvs_p": "NP_004324.2:p.Leu597Val",
			"dbsnp_ids": [
				"121913369"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453146G>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/585/summary/evidence/1463/summary#evidence",
		"source": "civic",
		"description": "Case report of a phase 1 study in advanced melanoma patients. 97 patients with melanoma were enrolled and treated with trametinib. One patient with a BRAF Leu597Val had a confirmed partial response with 60% tumour reduction and received study treatment for more than 2 years.",
		"drug_labels": "TRAMETINIB",
		"variant_name": "L597V",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/585/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/916",
				"source": "http://purl.obolibrary.org/obo/DOID_8923",
				"term": "skin melanoma",
				"pheno_id": "DOID:8923",
				"family": "melanoma",
				"description": "skin melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/954"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/954",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22805292"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1463",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/954"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/826",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/954"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/955",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/48",
			"name": "G469E",
			"description": "BRAF G469E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140481402,
			"end_pos": 140481402,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140481402C>T",
			"hgvs_c": "NM_004333.4:c.1406G>A",
			"hgvs_p": "NP_004324.2:p.Gly469Glu",
			"dbsnp_ids": [
				"121913355"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140481402C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/993/summary/evidence/6004/summary#evidence",
		"source": "civic",
		"description": "In this preclinical study, melanoma cell lines harboring the kinase-dead G469E- and D594G mutations were identified. These cell lines were resitant to MEK-Inhibition (U0126) but underwent apoptosis after shRNA-mediated CRAF knowdown or treatment with the pan-RAF inhibitor sorafenib.",
		"drug_labels": "109511-58-2",
		"variant_name": "G469E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/993/summary",
		"evidence_label": "D",
		"response_type": null,
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/917",
				"source": "http://purl.obolibrary.org/obo/DOID_8923",
				"term": "skin melanoma",
				"pheno_id": "DOID:8923",
				"family": "melanoma",
				"description": "skin melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/955"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/955",
				"type": "Predictive",
				"description": null,
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/18794803"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6004",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/955"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/827",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "109511-58-2",
				"envcontext_id": "CID3006531",
				"usan_stem": null,
				"description": "109511-58-2",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/955"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/956",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/48",
			"name": "G469E",
			"description": "BRAF G469E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140481402,
			"end_pos": 140481402,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140481402C>T",
			"hgvs_c": "NM_004333.4:c.1406G>A",
			"hgvs_p": "NP_004324.2:p.Gly469Glu",
			"dbsnp_ids": [
				"121913355"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140481402C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/993/summary/evidence/6003/summary#evidence",
		"source": "civic",
		"description": "In this preclinical study, melanoma cell lines harboring the kinase-dead G469E- and D594G mutations were identified. These cell lines were resitant to MEK-Inhibition but underwent apoptosis after shRNA-mediated CRAF knowdown or Treatment with the pan-RAF Inhibitor sorafenib.",
		"drug_labels": "Sorafenib",
		"variant_name": "G469E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/993/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/918",
				"source": "http://purl.obolibrary.org/obo/DOID_8923",
				"term": "skin melanoma",
				"pheno_id": "DOID:8923",
				"family": "melanoma",
				"description": "skin melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/956"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/956",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/18794803"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6003",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/956"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/828",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Sorafenib",
				"envcontext_id": "216239",
				"usan_stem": "raf kinase inhibitors",
				"description": "Sorafenib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/956"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/957",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/46",
			"name": "G466V",
			"description": "BRAF G466V",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140481411,
			"end_pos": 140481411,
			"ref": "C",
			"alt": "A",
			"hgvs_g": "NC_000007.13:g.140481411C>A",
			"hgvs_c": "NM_004333.4:c.1397G>T",
			"hgvs_p": "NP_004324.2:p.Gly466Val",
			"dbsnp_ids": [
				"121913351"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140481411C>A?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/2222/summary/evidence/5968/summary#evidence",
		"source": "civic",
		"description": "The phase 2a MyPathway study assigned patients with HER2, EGFR, BRAF or SHH alterations to treatment with pertuzumab plus trastuzumab, erlotinib, vemurafenib, or vismodegib, respectively. Of 26 patients with BRAF V600E mutations, objective responses were seen in 12 patients (46%; 95% CI, 27% to 67%). Only one of 23 patients (4%; 95% CI, 0% to 22%) with other non-V600 BRAF mutations had a PR (pancreas cancer with a CUX1-BRAF fusion). Nonresponding BRAF mutations included: K601E (n = 6), G464V (n = 2), G469A (n = 2), G496A (n = 2), N581S (n = 2), and one each for G466V, G596R, G606E, L597Q, P731T, intron 9 rearrangement, intron 10 rearrangement, and MACF1- and WASFL-BRAF fusion.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "G466V",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/2222/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/919",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/957"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/957",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/29320312"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5968",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/957"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/829",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/957"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/958",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/383",
			"name": "KIAA1549-BRAF",
			"description": "BRAF KIAA1549-BRAF",
			"biomarker_type": "Transcript Fusion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001882"
			],
			"soid": "SO:0001886",
			"so_name": "transcript_fusion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000440172.1",
			"chromosome": "7",
			"start_pos": 138545885,
			"end_pos": 138666064,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/618/summary/evidence/1571/summary#evidence",
		"source": "civic",
		"description": "A 65 yr old male patient with metastatic acral lentiginous melanoma (BRAF, NRAS, KIT negative) was found to harbor a KIAA1549-BRAF (intron 15-intron 8) fusion in a subcutaneous metastasis sample after disease progression. Trametinib was started and fatigue and ECOG status improved but imaging revealed slight disease progression after 2 weeks (15 sites measurable, 9 stable, 6 progressive). No new metastases were identified. The patient was switched to pembrolizumab and major disease progression was noted.",
		"drug_labels": "TRAMETINIB",
		"variant_name": null,
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/618/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/920",
				"source": "http://purl.obolibrary.org/obo/DOID_8923",
				"term": "skin melanoma",
				"pheno_id": "DOID:8923",
				"family": "melanoma",
				"description": "skin melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/958"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/958",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26072686"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1571",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/958"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/830",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/958"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/959",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/383",
			"name": "KIAA1549-BRAF",
			"description": "BRAF KIAA1549-BRAF",
			"biomarker_type": "Transcript Fusion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001882"
			],
			"soid": "SO:0001886",
			"so_name": "transcript_fusion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000440172.1",
			"chromosome": "7",
			"start_pos": 138545885,
			"end_pos": 138666064,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/618/summary/evidence/1664/summary#evidence",
		"source": "civic",
		"description": "A patient with a malignant spindle cell tumor of the chest wall treated as a soft tissue sarcoma was identified to harbor a KIAA1549-BRAF fusion. This patient responded to treatment with the pan-kinase inhibitor sorafenib in combination with bevacizumab and temsirolimus, achieving stable disease after 2 cycles extending into 11 cycles at which time she expired due to co-morbidities (acute myocardial infarction, hypotension). Of note, sequencing of 236 cancer-related genes identified CDKN2A A68fs*51, SUFU E283fs*3, MAP3K1 N325fs*3 and homozygous deletion of PTEN as well.",
		"drug_labels": "TEMSIROLIMUS,BEVACIZUMAB,Sorafenib",
		"variant_name": null,
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/618/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/921",
				"source": "http://purl.obolibrary.org/obo/DOID_1115",
				"term": "sarcoma",
				"pheno_id": "DOID:1115",
				"family": "cell type cancer",
				"description": "sarcoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/959"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/959",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24422672"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1664",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/959"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/833",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Sorafenib",
				"envcontext_id": "216239",
				"usan_stem": "raf kinase inhibitors",
				"description": "Sorafenib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/959"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/832",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "BEVACIZUMAB",
				"envcontext_id": "CHEMBL1201583",
				"usan_stem": "monoclonal antibodies",
				"description": "BEVACIZUMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/959"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/831",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TEMSIROLIMUS",
				"envcontext_id": "6918289",
				"usan_stem": "immunosuppressives: immunosuppressant, rapamycin derivatives",
				"description": "TEMSIROLIMUS",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/959"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/960",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/384",
			"name": "MUTATION",
			"description": "BRAF MUTATION",
			"biomarker_type": "Gene Variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878"
			],
			"soid": "SO:0001564",
			"so_name": "gene_variant",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000288602.6",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140481403,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/399/summary/evidence/6307/summary#evidence",
		"source": "civic",
		"description": "This was a retrospective clinical study of 168 metastatic colorectal cancer patients who received first line chemotherapy (made up of 5-fluorouracil (5-FU) only, 5-FU + oxaliplatin, 5-FU + irinotecan, or 5-FU + oxaliplatin + irinotecan) alone or with monoclonal antibodies (bevacizumab or cetuximab). It assessed the relationship between BRAF mutation status in primary tumors and post treatment OS. Of 168 patients, 155 had wildtype BRAF and 13 had mutations in BRAF—including V600E and D594K. The study found that patients harboring a BRAF mutation had a significantly worse outcome than patients expressing wildtype BRAF, regardless of first line chemotherapy regimen or use of monoclonal antibody treatment (Median OS: 10.9 and 40.5 months, respectively; p <.0001).",
		"drug_labels": null,
		"variant_name": "MUTATION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/399/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/922",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/960"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/960",
				"type": "Prognostic",
				"description": "Poor Outcome",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19603024"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6307",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/960"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/961",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/384",
			"name": "MUTATION",
			"description": "BRAF MUTATION",
			"biomarker_type": "Gene Variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878"
			],
			"soid": "SO:0001564",
			"so_name": "gene_variant",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000288602.6",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140481403,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/399/summary/evidence/6306/summary#evidence",
		"source": "civic",
		"description": "This was a retrospective clinical study of 92 metastatic colorectal cancer patients who received cetuximab in conjunction with salvage chemotherapy (refractory to at least one line of treatment). Salvage chemotherapy was composed of 5-fluorouracil (5-FU) only, 5-FU + oxaliplatin, 5-FU + irinotecan, or 5-FU + oxaliplatin + irinotecan. The study assessed the relationship between BRAF mutation status in primary tumors and response to cetuximab-containing salvage chemotherapy, as measured by PFS. Of the 92 patients, 83 had wildtype BRAF and 9 had mutations in BRAF—including V600E and D594K. The study found that patients harboring a BRAF mutation were significantly more resistant to cetuximab-containing salvage chemotherapy than patients with wildtype BRAF (Median PFS: 2.0 and 3.9, respectively; p = .0005).",
		"drug_labels": "CETUXIMAB",
		"variant_name": "MUTATION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/399/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/923",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/961"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/961",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19603024"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6306",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/961"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/834",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/961"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/962",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/384",
			"name": "MUTATION",
			"description": "BRAF MUTATION",
			"biomarker_type": "Gene Variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878"
			],
			"soid": "SO:0001564",
			"so_name": "gene_variant",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000288602.6",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140481403,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/399/summary/evidence/6305/summary#evidence",
		"source": "civic",
		"description": "This was a retrospective clinical study of 97 metastatic colorectal cancer patients who received bevacizumab in conjunction with first-line chemotherapy (composed of 5-fluorouracil (5-FU) only, 5-FU + oxaliplatin, 5-FU + irinotecan, or 5-FU + oxaliplatin + irinotecan). It assessed the relationship between BRAF mutation status in primary tumors and response to bevacizumab-containing first line chemotherapy, as measured by PFS. Of the 97 patients,89 had wildtype BRAF and 8 had mutations in BRAF—including V600E and D594K. The study found that patients harboring a BRAF mutation were significantly more resistant to bevacizumab-containing first-line chemotherapy than patients with wildtype BRAF (Median PFS: 4.2 and 12.5 months, respectively; p < .0001).",
		"drug_labels": "BEVACIZUMAB",
		"variant_name": "MUTATION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/399/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/924",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/962"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/962",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19603024"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6305",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/962"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/835",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "BEVACIZUMAB",
				"envcontext_id": "CHEMBL1201583",
				"usan_stem": "monoclonal antibodies",
				"description": "BEVACIZUMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/962"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/963",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/384",
			"name": "MUTATION",
			"description": "BRAF MUTATION",
			"biomarker_type": "Gene Variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878"
			],
			"soid": "SO:0001564",
			"so_name": "gene_variant",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000288602.6",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140481403,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/399/summary/evidence/6304/summary#evidence",
		"source": "civic",
		"description": "This was a retrospective clinical study of 44 metastatic colorectal cancer patients who received FOLFIRI (5-Fluorouacil + Folinic acid + irinotecan) first-line therapy alone or with bevacizumab. It assessed the relationship between BRAF mutation status in primary tumors and response to irinotecan-based first line therapy, as measured by PFS. Of the 44 patients, 39 had wildtype BRAF and 5 had mutations in BRAF—including V600E and D594K. The study found that patients harboring a BRAF mutation were significantly more resistant to irinotecan-based first-line therapy than patients with wildtype BRAF (Median PFS: 3.5 and 12.8 months, respectively; p = .006).",
		"drug_labels": "Irinotecan",
		"variant_name": "MUTATION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/399/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/925",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/963"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/963",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19603024"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6304",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/963"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/836",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Irinotecan",
				"envcontext_id": "60838",
				"usan_stem": "antineoplastics (camptothecine derivatives)",
				"description": "Irinotecan",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/963"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/964",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/384",
			"name": "MUTATION",
			"description": "BRAF MUTATION",
			"biomarker_type": "Gene Variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878"
			],
			"soid": "SO:0001564",
			"so_name": "gene_variant",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000288602.6",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140481403,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/399/summary/evidence/6303/summary#evidence",
		"source": "civic",
		"description": "This was a retrospective clinical study of 100 metastatic colorectal cancer patients who received FOLFOX (oxaliplatin + 5-fluorouracil + folinic acid) first-line therapy alone or with monoclonal antibodies (bevacizumab or cetuximab). It assessed the relationship between BRAF mutation status in primary tumors and response to oxaliplatin-based first-line therapy, as measured by post treatment PFS. Of 100 patients, 94 had wildtype BRAF and 6 had mutations in BRAF—including V600E and D594K. The study found that patients harboring a BRAF mutation were significantly more resistant to oxaliplatin-based first-line therapy than patients with wildtype BRAF (Median PFS: 5.0 and 11. 7 months, respectively; p < .0001).",
		"drug_labels": "OXALIPLATIN",
		"variant_name": "MUTATION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/399/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/926",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/964"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/964",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19603024"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6303",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/964"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/837",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "OXALIPLATIN",
				"envcontext_id": "CHEMBL414804",
				"usan_stem": "antineoplastics (platinum derivatives)",
				"description": "OXALIPLATIN",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/964"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/965",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/384",
			"name": "MUTATION",
			"description": "BRAF MUTATION",
			"biomarker_type": "Gene Variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878"
			],
			"soid": "SO:0001564",
			"so_name": "gene_variant",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000288602.6",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140481403,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/399/summary/evidence/6302/summary#evidence",
		"source": "civic",
		"description": "This was a retrospective clinical study of 168 metastatic colorectal cancer patients who received first line chemotherapy (made up of 5-fluorouracil (5-FU) only, 5-FU + oxaliplatin, 5-FU + irinotecan, or 5-FU + oxaliplatin + irinotecan) alone or with monoclonal antibodies (bevacizumab or cetuximab). It assessed the relationship between BRAF mutation status in primary tumors and post treatment PFS. Of 168 patients, 155 had wildtype BRAF and 13 had mutations in BRAF—including V600E and D594K. The study found that patients harboring a BRAF mutation had a significantly worse outcome than patients expressing wildtype BRAF, regardless of first line chemotherapy regimen or use of monoclonal antibody treatment (Median PFS: 4.3 and 12.5 months, respectively; p <.0001).",
		"drug_labels": null,
		"variant_name": "MUTATION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/399/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/927",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/965"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/965",
				"type": "Prognostic",
				"description": "Poor Outcome",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/19603024"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6302",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/965"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/966",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/384",
			"name": "MUTATION",
			"description": "BRAF MUTATION",
			"biomarker_type": "Gene Variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878"
			],
			"soid": "SO:0001564",
			"so_name": "gene_variant",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000288602.6",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140481403,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/399/summary/evidence/1704/summary#evidence",
		"source": "civic",
		"description": "A cohort of patient-derived xenografts (PDX) from 85 patients with metastatic colorectal cancer was created. PDX were treated with cetuximab and mechanisms of resistance investigated. None of the xenografts harboring KRAS (N=18), NRAS (N=7) or BRAF (N=3) mutations showed a response to cetuximab whereas 1 out of 4 xenografts with a PIK3CA mutation responded to cetuximab.",
		"drug_labels": "CETUXIMAB",
		"variant_name": "MUTATION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/399/summary",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/928",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/966"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/966",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22586653"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1704",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/966"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/838",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/966"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/967",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/384",
			"name": "MUTATION",
			"description": "BRAF MUTATION",
			"biomarker_type": "Gene Variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878"
			],
			"soid": "SO:0001564",
			"so_name": "gene_variant",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000288602.6",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140481403,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/399/summary/evidence/1404/summary#evidence",
		"source": "civic",
		"description": "A quantitative synthesis was performed on nine studies comparing treatment of metastatic colorectal cancer with cetuximab or panitumumab and chemotherapy, versus chemotherapy alone, or with other targeted inhibitors. It was found that in the patient subgroup with BRAF mutation (V600E in the majority of cases), there were no benefits to overall survival, progression free survival, or overall response rate with addition of cetuximab or panitumumab to treatment. This conclusion held in the first line treatment as well as general treatment setting.",
		"drug_labels": "PANITUMUMAB,CETUXIMAB",
		"variant_name": "MUTATION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/399/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/929",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/967"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/967",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/25673558"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1404",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/967"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/840",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/967"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/839",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "PANITUMUMAB",
				"envcontext_id": "CHEMBL1201827",
				"usan_stem": "monoclonal antibodies",
				"description": "PANITUMUMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/967"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/968",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/384",
			"name": "MUTATION",
			"description": "BRAF MUTATION",
			"biomarker_type": "Gene Variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878"
			],
			"soid": "SO:0001564",
			"so_name": "gene_variant",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000288602.6",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140481403,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/399/summary/evidence/936/summary#evidence",
		"source": "civic",
		"description": "In this screen of 218 solid cancer cell lines, BRAF mutations were predictive of response to the MEK inhibitor GSK1120212. 26 of these cell lines had the BRAF V600E mutation, one cell line had a G469A mutation, one had G596R mutation and one had an unspecified mutation. Also of note, in RAF/RAS mutant colon cancer cell lines, co-occurring PIK3CA/PTEN mutations led to a cytostatic response rather than a cytotoxic response.",
		"drug_labels": "TRAMETINIB",
		"variant_name": "MUTATION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/399/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/930",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/968"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/968",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22169769"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "936",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/968"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/841",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/968"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/969",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/56",
			"name": "G596R",
			"description": "BRAF G596R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453149,
			"end_pos": 140453149,
			"ref": "C",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.140453149C>G",
			"hgvs_c": "NM_004333.4:c.1786G>C",
			"hgvs_p": "NP_004324.2:p.Gly596Arg",
			"dbsnp_ids": [
				"121913361"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453149C>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/1627/summary/evidence/5969/summary#evidence",
		"source": "civic",
		"description": "The phase 2a MyPathway study assigned patients with HER2, EGFR, BRAF or SHH alterations to treatment with pertuzumab plus trastuzumab, erlotinib, vemurafenib, or vismodegib, respectively. Of 26 patients with BRAF V600E mutations, objective responses were seen in 12 patients (46%; 95% CI, 27% to 67%). Only one of 23 patients (4%; 95% CI, 0% to 22%) with other non-V600 BRAF mutations had a PR (pancreas cancer with a CUX1-BRAF fusion). Nonresponding BRAF mutations included: K601E (n = 6), G464V (n = 2), G469A (n = 2), G496A (n = 2), N581S (n = 2), and one each for G466V, G596R, G606E, L597Q, P731T, intron 9 rearrangement, intron 10 rearrangement, and MACF1- and WASFL-BRAF fusion.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "G596R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/1627/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/931",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/969"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/969",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/29320312"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5969",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/969"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/842",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/969"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/970",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/56",
			"name": "G596R",
			"description": "BRAF G596R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453149,
			"end_pos": 140453149,
			"ref": "C",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.140453149C>G",
			"hgvs_c": "NM_004333.4:c.1786G>C",
			"hgvs_p": "NP_004324.2:p.Gly596Arg",
			"dbsnp_ids": [
				"121913361"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453149C>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/1627/summary/evidence/4729/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, an NCI-H508 cell line expressing BRAF G596R demonstrated reduced sensitivity to vemurafenib treatment compared to HT29 cells expressing BRAF V600E (a known vemurafenib sensitizing mutation). Resistance was determined by assessing cellular proliferation.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "G596R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/1627/summary",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/932",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/970"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/970",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22180495"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4729",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/970"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/843",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/970"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/971",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/79",
			"name": "L597R",
			"description": "BRAF L597R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453145,
			"end_pos": 140453145,
			"ref": "A",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.140453145A>C",
			"hgvs_c": "NM_004333.4:c.1790T>G",
			"hgvs_p": "NP_004324.2:p.Leu597Arg",
			"dbsnp_ids": [
				"121913366"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453145A>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/288/summary/evidence/1458/summary#evidence",
		"source": "civic",
		"description": "Preclinical study in 293H cell line. Ectopic expression of V600E, L597R/Q/S, and K601E mutants elevated phospho-MEK and ERK levels. Vemurafenib treatment of all of the BRAF mutant–expressing cells led to a decrease in phospho-MEK and ERK protein levels. Treatment with MEK inhibitor GSK1120212 led to a more dramatic decrease in phospho-ERK signaling.",
		"drug_labels": "TRAMETINIB,VEMURAFENIB",
		"variant_name": "L597R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/288/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/933",
				"source": "http://purl.obolibrary.org/obo/DOID_8923",
				"term": "skin melanoma",
				"pheno_id": "DOID:8923",
				"family": "melanoma",
				"description": "skin melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/971"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/971",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22798288"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1458",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/971"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/845",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/971"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/844",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/971"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/972",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/79",
			"name": "L597R",
			"description": "BRAF L597R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453145,
			"end_pos": 140453145,
			"ref": "A",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.140453145A>C",
			"hgvs_c": "NM_004333.4:c.1790T>G",
			"hgvs_p": "NP_004324.2:p.Leu597Arg",
			"dbsnp_ids": [
				"121913366"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453145A>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/288/summary/evidence/728/summary#evidence",
		"source": "civic",
		"description": "A case report of a patient with BRAF L597R mutation and clinical response to BRAF-inhibition (Vemurafenib) that correlated to in-vitro models.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "L597R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/288/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/934",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/972"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/972",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23715574"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "728",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/972"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/846",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/972"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/973",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/80",
			"name": "L597S",
			"description": "BRAF L597S",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453145,
			"end_pos": 140453146,
			"ref": "AG",
			"alt": "GA",
			"hgvs_g": "NC_000007.13:g.140453145_140453146delinsGA",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"121913368"
			],
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/582/summary/evidence/1460/summary#evidence",
		"source": "civic",
		"description": "Case report of a 69 year old patient with metastatic melanoma treated with MEK inhibitor TAK-733 in a clinical trial. A partial radiographic response with a decrease of 31% in the sum of maximum diameters of target metastatic lesions in the liver and spleen was noted after 2 cycles of therapy and remained progression free at more than 24 weeks. Follow-up sequencing analysis of DNA from the patient's tumor revealed a somatic BRAF L597S mutation.",
		"drug_labels": "TAK,733",
		"variant_name": "L597S",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/582/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/935",
				"source": "http://purl.obolibrary.org/obo/DOID_8923",
				"term": "skin melanoma",
				"pheno_id": "DOID:8923",
				"family": "melanoma",
				"description": "skin melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/973"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/973",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22798288"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1460",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/973"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/848",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "733",
				"envcontext_id": "24963252",
				"usan_stem": null,
				"description": "733",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/973"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/847",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TAK",
				"envcontext_id": "24963252",
				"usan_stem": null,
				"description": "TAK",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/973"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/974",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/80",
			"name": "L597S",
			"description": "BRAF L597S",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453145,
			"end_pos": 140453146,
			"ref": "AG",
			"alt": "GA",
			"hgvs_g": "NC_000007.13:g.140453145_140453146delinsGA",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"121913368"
			],
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/582/summary/evidence/1459/summary#evidence",
		"source": "civic",
		"description": "Preclinical study in 293H cell line. Ectopic expression of V600E, L597R/Q/S, and K601E mutants elevated phospho-MEK and ERK levels. Vemurafenib treatment of all of the BRAF mutant–expressing cells led to a decrease in phospho-MEK and ERK protein levels. Treatment with MEK inhibitor GSK1120212 led to a more dramatic decrease in phospho-ERK signaling.",
		"drug_labels": "TRAMETINIB,VEMURAFENIB",
		"variant_name": "L597S",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/582/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/936",
				"source": "http://purl.obolibrary.org/obo/DOID_8923",
				"term": "skin melanoma",
				"pheno_id": "DOID:8923",
				"family": "melanoma",
				"description": "skin melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/974"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/974",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22798288"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1459",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/974"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/850",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/974"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/849",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/974"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/975",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/385",
			"name": "WILD TYPE",
			"description": "BRAF WILD TYPE",
			"biomarker_type": "Wild Type",
			"so_hierarchy": [
				"SO:0000400",
				"SO:0000733"
			],
			"soid": "SO:0000817",
			"so_name": "wild_type",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000288602.6",
			"chromosome": "7",
			"start_pos": 140434279,
			"end_pos": 140624564,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/426/summary/evidence/995/summary#evidence",
		"source": "civic",
		"description": "Phase I expansion and pharmacodynamic study of the oral MEK inhibitor RO4987655. Among 12 patients with melanoma BRAF wild type and non-NRAS or NRAS unknown status, seven patients experienced partial response or stable disease.",
		"drug_labels": "RO4987655",
		"variant_name": "TYPE",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/426/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/937",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/975"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/975",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24947927"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "995",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/975"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/851",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "RO4987655",
				"envcontext_id": "CID11548630",
				"usan_stem": null,
				"description": "RO4987655",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/975"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/976",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/386",
			"name": "P731T",
			"description": "BRAF P731T",
			"biomarker_type": "Missense Variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000288602.6",
			"chromosome": "7",
			"start_pos": 140434507,
			"end_pos": 140434507,
			"ref": "G",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140434507G>T",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140434507G>T?assembly=hg19",
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/2224/summary/evidence/5972/summary#evidence",
		"source": "civic",
		"description": "The phase 2a MyPathway study assigned patients with HER2, EGFR, BRAF or SHH alterations to treatment with pertuzumab plus trastuzumab, erlotinib, vemurafenib, or vismodegib, respectively. Of 26 patients with BRAF V600E mutations, objective responses were seen in 12 patients (46%; 95% CI, 27% to 67%). Only one of 23 patients (4%; 95% CI, 0% to 22%) with other non-V600 BRAF mutations had a PR (pancreas cancer with a CUX1-BRAF fusion). Nonresponding BRAF mutations included: K601E (n = 6), G464V (n = 2), G469A (n = 2), G496A (n = 2), N581S (n = 2), and one each for G466V, G596R, G606E, L597Q, P731T, intron 9 rearrangement, intron 10 rearrangement, and MACF1- and WASFL-BRAF fusion.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "P731T",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/2224/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/938",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/976"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/976",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/29320312"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5972",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/976"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/852",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/976"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/977",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/387",
			"name": "V600E+V600M",
			"description": "BRAF V600E+V600M",
			"biomarker_type": "Missense Variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000288602.6",
			"chromosome": "7",
			"start_pos": 140453135,
			"end_pos": 140453137,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/13/summary/evidence/73/summary#evidence",
		"source": "civic",
		"description": "A single patient with BRAF V600E/V600M bi-allelic mutation responded to the V600E drug dabrafenib.",
		"drug_labels": "DABRAFENIB",
		"variant_name": "V600E+V600M",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/13/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/939",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/977"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/977",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23031422"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "73",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/977"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/853",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/977"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/978",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/388",
			"name": "G606E",
			"description": "BRAF G606E",
			"biomarker_type": "Missense Variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000288602.6",
			"chromosome": "7",
			"start_pos": 140453118,
			"end_pos": 140453118,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453118C>T",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453118C>T?assembly=hg19",
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/2223/summary/evidence/5970/summary#evidence",
		"source": "civic",
		"description": "The phase 2a MyPathway study assigned patients with HER2, EGFR, BRAF or SHH alterations to treatment with pertuzumab plus trastuzumab, erlotinib, vemurafenib, or vismodegib, respectively. Of 26 patients with BRAF V600E mutations, objective responses were seen in 12 patients (46%; 95% CI, 27% to 67%). Only one of 23 patients (4%; 95% CI, 0% to 22%) with other non-V600 BRAF mutations had a PR (pancreas cancer with a CUX1-BRAF fusion). Nonresponding BRAF mutations included: K601E (n = 6), G464V (n = 2), G469A (n = 2), G496A (n = 2), N581S (n = 2), and one each for G466V, G596R, G606E, L597Q, P731T, intron 9 rearrangement, intron 10 rearrangement, and MACF1- and WASFL-BRAF fusion.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "G606E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/2223/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/940",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/978"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/978",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/29320312"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5970",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/978"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/854",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/978"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/979",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/86",
			"name": "N581S",
			"description": "BRAF N581S",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453193,
			"end_pos": 140453193,
			"ref": "T",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.140453193T>C",
			"hgvs_c": "NM_004333.4:c.1742A>G",
			"hgvs_p": "NP_004324.2:p.Asn581Ser",
			"dbsnp_ids": [
				"121913370"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453193T>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/1186/summary/evidence/5967/summary#evidence",
		"source": "civic",
		"description": "The phase 2a MyPathway study assigned patients with HER2, EGFR, BRAF or SHH alterations to treatment with pertuzumab plus trastuzumab, erlotinib, vemurafenib, or vismodegib, respectively. Of 26 patients with BRAF V600E mutations, objective responses were seen in 12 patients (46%; 95% CI, 27% to 67%). Only one of 23 patients (4%; 95% CI, 0% to 22%) with other non-V600 BRAF mutations had a PR (pancreas cancer with a CUX1-BRAF fusion). Nonresponding BRAF mutations included: K601E (n = 6), G464V (n = 2), G469A (n = 2), G496A (n = 2), N581S (n = 2), and one each for G466V, G596R, G606E, L597Q, P731T, intron 9 rearrangement, intron 10 rearrangement, and MACF1- and WASFL-BRAF fusion.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "N581S",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/1186/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/941",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/979"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/979",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/29320312"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5967",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/979"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/855",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/979"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/980",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/30",
			"name": "D594N",
			"description": "BRAF D594N",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453155,
			"end_pos": 140453155,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453155C>T",
			"hgvs_c": "NM_004333.4:c.1780G>A",
			"hgvs_p": "NP_004324.2:p.Asp594Asn",
			"dbsnp_ids": [
				"397516896"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453155C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/1107/summary/evidence/2817/summary#evidence",
		"source": "civic",
		"description": "Acquired resistance to vemurafenib in BRAF-V600E positive melanomas frequently confound vemurafenib therapy. Proposed resistance mechanisms include PDGFRbeta upregulation or NRAS mutations resulting in MAPK pathway reactivation but not secondary mutations in BRAF. MEK inhibitors may demonstrate clinical benefit in vemurafenib resistant melanoma patients.",
		"drug_labels": "DABRAFENIB",
		"variant_name": "D594N",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/1107/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/942",
				"source": "http://purl.obolibrary.org/obo/DOID_8923",
				"term": "skin melanoma",
				"pheno_id": "DOID:8923",
				"family": "melanoma",
				"description": "skin melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/980"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/980",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21107323"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2817",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/980"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/856",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/980"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/981",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/30",
			"name": "D594N",
			"description": "BRAF D594N",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453155,
			"end_pos": 140453155,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453155C>T",
			"hgvs_c": "NM_004333.4:c.1780G>A",
			"hgvs_p": "NP_004324.2:p.Asp594Asn",
			"dbsnp_ids": [
				"397516896"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453155C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/1107/summary/evidence/2816/summary#evidence",
		"source": "civic",
		"description": "Acquired resistance to vemurafenib in BRAF-V600E positive melanomas frequently confound vemurafenib therapy. Proposed resistance mechanisms include PDGFRbeta upregulation or NRAS mutations resulting in MAPK pathway reactivation but not secondary mutations in BRAF. MEK inhibitors may demonstrate clinical benefit in vemurafenib resistant melanoma patients.",
		"drug_labels": "DABRAFENIB",
		"variant_name": "D594N",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/1107/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/943",
				"source": "http://purl.obolibrary.org/obo/DOID_8923",
				"term": "skin melanoma",
				"pheno_id": "DOID:8923",
				"family": "melanoma",
				"description": "skin melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/981"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/981",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21107320"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2816",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/981"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/857",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/981"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/982",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/30",
			"name": "D594N",
			"description": "BRAF D594N",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453155,
			"end_pos": 140453155,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453155C>T",
			"hgvs_c": "NM_004333.4:c.1780G>A",
			"hgvs_p": "NP_004324.2:p.Asp594Asn",
			"dbsnp_ids": [
				"397516896"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453155C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/1107/summary/evidence/2815/summary#evidence",
		"source": "civic",
		"description": "Acquired resistance to vemurafenib in BRAF-V600E positive melanomas frequently confound vemurafenib therapy. Proposed resistance mechanisms include PDGFRbeta upregulation or NRAS mutations resulting in MAPK pathway reactivation but not secondary mutations in BRAF. MEK inhibitors may demonstrate clinical benefit in vemurafenib resistant melanoma patients.",
		"drug_labels": "DABRAFENIB",
		"variant_name": "D594N",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/1107/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/944",
				"source": "http://purl.obolibrary.org/obo/DOID_8923",
				"term": "skin melanoma",
				"pheno_id": "DOID:8923",
				"family": "melanoma",
				"description": "skin melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/982"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/982",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20818844"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2815",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/982"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/858",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/982"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/983",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/30",
			"name": "D594N",
			"description": "BRAF D594N",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453155,
			"end_pos": 140453155,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453155C>T",
			"hgvs_c": "NM_004333.4:c.1780G>A",
			"hgvs_p": "NP_004324.2:p.Asp594Asn",
			"dbsnp_ids": [
				"397516896"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453155C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/1107/summary/evidence/2814/summary#evidence",
		"source": "civic",
		"description": "An inducible BRAF-V600E mouse melanoma model shows a tight correlation between activated BRAF and disease progression.",
		"drug_labels": "DABRAFENIB",
		"variant_name": "D594N",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/1107/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/945",
				"source": "http://purl.obolibrary.org/obo/DOID_8923",
				"term": "skin melanoma",
				"pheno_id": "DOID:8923",
				"family": "melanoma",
				"description": "skin melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/983"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/983",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/16424035"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2814",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/983"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/859",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/983"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/984",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/30",
			"name": "D594N",
			"description": "BRAF D594N",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453155,
			"end_pos": 140453155,
			"ref": "C",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453155C>T",
			"hgvs_c": "NM_004333.4:c.1780G>A",
			"hgvs_p": "NP_004324.2:p.Asp594Asn",
			"dbsnp_ids": [
				"397516896"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453155C>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/1107/summary/evidence/2813/summary#evidence",
		"source": "civic",
		"description": "Patients were treated with a specific RAF inhibitor (dabrafenib), which improved overall survival of patients with BRAF mutations (P<0.003), compared to non-treated patients with BRAF mutations. Patients having BRAF mutations were associated with reduced overall survival (11.1 mo vs. 46.1 mo for wild-type, P=0.006). BRAF mutations were more frequent in tumors with superficially spreading histological sub-type (43%  vs. 19% , P<0.001) compared to BRAF wild-type tumors.",
		"drug_labels": "DABRAFENIB",
		"variant_name": "D594N",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/1107/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/946",
				"source": "http://purl.obolibrary.org/obo/DOID_8923",
				"term": "skin melanoma",
				"pheno_id": "DOID:8923",
				"family": "melanoma",
				"description": "skin melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/984"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/984",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21343559"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2813",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/984"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/860",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/984"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/985",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/121",
			"name": "V600R",
			"description": "BRAF V600R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453137,
			"ref": "AC",
			"alt": "CT",
			"hgvs_g": "NC_000007.13:g.140453136_140453137delinsCT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"121913227"
			],
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/991/summary/evidence/4172/summary#evidence",
		"source": "civic",
		"description": "In a patient with cutaneous melanoma of the occiput harboring BRAF V600R mutation, BRAF V600R mutation was associated with improved response to vemurafenib treatment. The patient was treated with vemurafenib monotherapy and at 8 weeks obtained a 75% partial response per RECIST criteria; at 19 weeks of treatment, disease progression was observed.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/991/summary",
		"evidence_label": "C",
		"response_type": null,
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/947",
				"source": "http://purl.obolibrary.org/obo/DOID_8923",
				"term": "skin melanoma",
				"pheno_id": "DOID:8923",
				"family": "melanoma",
				"description": "skin melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/985"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/985",
				"type": "Predictive",
				"description": null,
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/23237741"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4172",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/985"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/861",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/985"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/986",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/121",
			"name": "V600R",
			"description": "BRAF V600R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453137,
			"ref": "AC",
			"alt": "CT",
			"hgvs_g": "NC_000007.13:g.140453136_140453137delinsCT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"121913227"
			],
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/991/summary/evidence/4171/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, the WM1341D cell line expressing BRAF V600R was associated with increased sensitivity to vemurafenib treatment, as compared to cell lines expressing BRAF wild-type. Sensitivity was determined by proliferation assay.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/991/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/948",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/986"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/986",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/20551065"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4171",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/986"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/862",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/986"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/987",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/121",
			"name": "V600R",
			"description": "BRAF V600R",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453136,
			"end_pos": 140453137,
			"ref": "AC",
			"alt": "CT",
			"hgvs_g": "NC_000007.13:g.140453136_140453137delinsCT",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": [
				"121913227"
			],
			"myvariant_hg19": null,
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/991/summary/evidence/4170/summary#evidence",
		"source": "civic",
		"description": "In a retrospective study of 30 metastatic melanoma patients with progressing metastases, a metastatic melanoma patient harboring BRAF V600R mutation achieved a favorable response to vemurafenib treatment.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "V600R",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/991/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/949",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/987"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/987",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24463458"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4170",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/987"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/863",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/987"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/988",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/389",
			"name": "intron 9 rearrangement",
			"description": "BRAF intron 9 rearrangement",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": null,
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/2225/summary/evidence/6401/summary#evidence",
		"source": "civic",
		"description": "In a retrospective study of 44 relapsed melanoma patients harboring BRAF V600E or V600K (known BRAF inhibitor sensitizing mutations), MAPK pathway reactivation mechanisms were implicated in acquired resistance to BRAF inhibitor (vemurafenib or dabrafenib) monotherapy. The following MAPK pathway variants were found in progressive tumors with patient matched baseline tumors (some patients donated samples from multiple geographically/temporally distinct progressive tumors): NRAS mutations (G12D, G12R, G13R, Q61K, Q61R, Q61L) in 13/71 (18%) of progressive tumors, KRAS mutations (G12C, G12R, Q61H) in 5/71 (7%) of progressive tumors, mutant BRAF amplification (2-15 fold or 4-75 copies) in 11/57 (19%) of progressive tumors, mutant BRAF alternative splice variants (novel exon boundaries between 1/9, 1/11, 3/9) in 6/48 (13%) of progressive tumor RNA.",
		"drug_labels": "DABRAFENIB,VEMURAFENIB",
		"variant_name": "rearrangement",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/2225/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/950",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/988"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/988",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24265155"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6401",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/988"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/865",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/988"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/864",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/988"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/989",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/389",
			"name": "intron 9 rearrangement",
			"description": "BRAF intron 9 rearrangement",
			"biomarker_type": null,
			"so_hierarchy": null,
			"soid": null,
			"so_name": null,
			"reference_name": null,
			"refseq": null,
			"isoform": null,
			"chromosome": "7",
			"start_pos": null,
			"end_pos": null,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/2225/summary/evidence/5973/summary#evidence",
		"source": "civic",
		"description": "The phase 2a MyPathway study assigned patients with HER2, EGFR, BRAF or SHH alterations to treatment with pertuzumab plus trastuzumab, erlotinib, vemurafenib, or vismodegib, respectively. Of 26 patients with BRAF V600E mutations, objective responses were seen in 12 patients (46%; 95% CI, 27% to 67%). Only one of 23 patients (4%; 95% CI, 0% to 22%) with other non-V600 BRAF mutations had a PR (pancreas cancer with a CUX1-BRAF fusion). Nonresponding BRAF mutations included: K601E (n = 6), G464V (n = 2), G469A (n = 2), G496A (n = 2), N581S (n = 2), and one each for G466V, G596R, G606E, L597Q, P731T, intron 9 rearrangement, intron 10 rearrangement, and MACF1- and WASFL-BRAF fusion.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "rearrangement",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/2225/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/951",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/989"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/989",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/29320312"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5973",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/989"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/866",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/989"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/990",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/47",
			"name": "G469A",
			"description": "BRAF G469A",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140481402,
			"end_pos": 140481402,
			"ref": "C",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.140481402C>G",
			"hgvs_c": "NM_004333.4:c.1406G>C",
			"hgvs_p": "NP_004324.2:p.Gly469Ala",
			"dbsnp_ids": [
				"121913355"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140481402C>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/992/summary/evidence/5965/summary#evidence",
		"source": "civic",
		"description": "The phase 2a MyPathway study assigned patients with HER2, EGFR, BRAF or SHH alterations to treatment with pertuzumab plus trastuzumab, erlotinib, vemurafenib, or vismodegib, respectively. Of 26 patients with BRAF V600E mutations, objective responses were seen in 12 patients (46%; 95% CI, 27% to 67%). Only one of 23 patients (4%; 95% CI, 0% to 22%) with other non-V600 BRAF mutations had a PR (pancreas cancer with a CUX1-BRAF fusion). Nonresponding BRAF mutations included: K601E (n = 6), G464V (n = 2), G469A (n = 2), G496A (n = 2), N581S (n = 2), and one each for G466V, G596R, G606E, L597Q, P731T, intron 9 rearrangement, intron 10 rearrangement, and MACF1- and WASFL-BRAF fusion.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "G469A",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/992/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/952",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/990"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/990",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/29320312"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5965",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/990"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/867",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/990"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/991",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/47",
			"name": "G469A",
			"description": "BRAF G469A",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140481402,
			"end_pos": 140481402,
			"ref": "C",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.140481402C>G",
			"hgvs_c": "NM_004333.4:c.1406G>C",
			"hgvs_p": "NP_004324.2:p.Gly469Ala",
			"dbsnp_ids": [
				"121913355"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140481402C>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/992/summary/evidence/4182/summary#evidence",
		"source": "civic",
		"description": "In a retrospective study of 53, KRAS exon 2 wild-type, metastatic colorectal cancer patients, patients harboring BRAF G466A (n=1), G469A (n=2), D594G (n=1), or V600E (n=2) mutations were reported to be non-responders to cetuximab in combination with irinotecan, (BRAF mutation positive: responders vs. non-responders = 0 vs. 6; BRAF wild-type: responders vs. non-responders 30 vs. 17; P=0.004), as compared to patients with wild-type BRAF.",
		"drug_labels": "CETUXIMAB",
		"variant_name": "G469A",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/992/summary",
		"evidence_label": "C",
		"response_type": "resistant",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/953",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/991"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/991",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26989027"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4182",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/991"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/868",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/991"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/992",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/47",
			"name": "G469A",
			"description": "BRAF G469A",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140481402,
			"end_pos": 140481402,
			"ref": "C",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.140481402C>G",
			"hgvs_c": "NM_004333.4:c.1406G>C",
			"hgvs_p": "NP_004324.2:p.Gly469Ala",
			"dbsnp_ids": [
				"121913355"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140481402C>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/992/summary/evidence/4184/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a PC-9 cell line expressing BRAF G469A mutation demonstrated decreased sensitivity to erlotinib treatment compared to PC-9 cells expressing BRAF wild-type. Sensitivity was determined by performing cell growth-inhibition assays.",
		"drug_labels": "Erlotinib",
		"variant_name": "G469A",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/992/summary",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/954",
				"source": "http://purl.obolibrary.org/obo/DOID_3908",
				"term": "non-small cell lung carcinoma",
				"pheno_id": "DOID:3908",
				"family": "lung cancer",
				"description": "non-small cell lung carcinoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/992"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/992",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22773810"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4184",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/992"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/869",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Erlotinib",
				"envcontext_id": "176870",
				"usan_stem": "tyrosine kinase inhibitors",
				"description": "Erlotinib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/992"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/993",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/47",
			"name": "G469A",
			"description": "BRAF G469A",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140481402,
			"end_pos": 140481402,
			"ref": "C",
			"alt": "G",
			"hgvs_g": "NC_000007.13:g.140481402C>G",
			"hgvs_c": "NM_004333.4:c.1406G>C",
			"hgvs_p": "NP_004324.2:p.Gly469Ala",
			"dbsnp_ids": [
				"121913355"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140481402C>G?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/992/summary/evidence/4183/summary#evidence",
		"source": "civic",
		"description": "In an in vitro study, a MO-1 cell line expressing BRAF G469A demonstrated reduced sensitivity to vemurafenib treatment, similar to LND-1 cells expression BRAF wild-type. Sensitivity was determined by assessing cell proliferation (MO-1, IC50: 15.0uM; vs. LND-1, IC50: 32.2uM).",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "G469A",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/992/summary",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/955",
				"source": "http://purl.obolibrary.org/obo/DOID_1909",
				"term": "melanoma",
				"pheno_id": "DOID:1909",
				"family": "cell type cancer",
				"description": "melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/993"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/993",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26070258"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4183",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/993"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/870",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/993"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/994",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/78",
			"name": "L597Q",
			"description": "BRAF L597Q",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453145,
			"end_pos": 140453145,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453145A>T",
			"hgvs_c": "NM_004333.4:c.1790T>A",
			"hgvs_p": "NP_004324.2:p.Leu597Gln",
			"dbsnp_ids": [
				"121913366"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453145A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/583/summary/evidence/4905/summary#evidence",
		"source": "civic",
		"description": "Case study report including one patient with L597Q mutation-positive metastatic melanoma (M1b disease) treated with the MEK inhibitor trametinib. The L597Q patient achieved a RECIST partial response and showed maximum tumor shrinkage of 33% with trametinib as the first-line treatment and had a partial response for 6.2 months.",
		"drug_labels": "TRAMETINIB",
		"variant_name": "L597Q",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/583/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/956",
				"source": "http://purl.obolibrary.org/obo/DOID_8923",
				"term": "skin melanoma",
				"pheno_id": "DOID:8923",
				"family": "melanoma",
				"description": "skin melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/994"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/994",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/24933606"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4905",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/994"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/871",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/994"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/995",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/78",
			"name": "L597Q",
			"description": "BRAF L597Q",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453145,
			"end_pos": 140453145,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453145A>T",
			"hgvs_c": "NM_004333.4:c.1790T>A",
			"hgvs_p": "NP_004324.2:p.Leu597Gln",
			"dbsnp_ids": [
				"121913366"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453145A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/583/summary/evidence/5971/summary#evidence",
		"source": "civic",
		"description": "The phase 2a MyPathway study assigned patients with HER2, EGFR, BRAF or SHH alterations to treatment with pertuzumab plus trastuzumab, erlotinib, vemurafenib, or vismodegib, respectively. Of 26 patients with BRAF V600E mutations, objective responses were seen in 12 patients (46%; 95% CI, 27% to 67%). Only one of 23 patients (4%; 95% CI, 0% to 22%) with other non-V600 BRAF mutations had a PR (pancreas cancer with a CUX1-BRAF fusion). Nonresponding BRAF mutations included: K601E (n = 6), G464V (n = 2), G469A (n = 2), G496A (n = 2), N581S (n = 2), and one each for G466V, G596R, G606E, L597Q, P731T, intron 9 rearrangement, intron 10 rearrangement, and MACF1- and WASFL-BRAF fusion.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "L597Q",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/583/summary",
		"evidence_label": "C",
		"response_type": "Sensitivity/Response",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/957",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/995"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/995",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/29320312"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5971",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/995"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/872",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/995"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/996",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/78",
			"name": "L597Q",
			"description": "BRAF L597Q",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453145,
			"end_pos": 140453145,
			"ref": "A",
			"alt": "T",
			"hgvs_g": "NC_000007.13:g.140453145A>T",
			"hgvs_c": "NM_004333.4:c.1790T>A",
			"hgvs_p": "NP_004324.2:p.Leu597Gln",
			"dbsnp_ids": [
				"121913366"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453145A>T?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/583/summary/evidence/1461/summary#evidence",
		"source": "civic",
		"description": "Preclinical study in 293H cell line. Ectopic expression of V600E, L597R/Q/S, and K601E mutants elevated phospho-MEK and ERK levels. Vemurafenib treatment of all of the BRAF mutant–expressing cells led to a decrease in phospho-MEK and ERK protein levels. Treatment with MEK inhibitor GSK1120212 led to a more dramatic decrease in phospho-ERK signaling.",
		"drug_labels": "TRAMETINIB,VEMURAFENIB",
		"variant_name": "L597Q",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/583/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/958",
				"source": "http://purl.obolibrary.org/obo/DOID_8923",
				"term": "skin melanoma",
				"pheno_id": "DOID:8923",
				"family": "melanoma",
				"description": "skin melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/996"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/996",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22798288"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1461",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/996"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/874",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/996"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/873",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/996"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/997",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/28",
			"name": "D594G",
			"description": "BRAF D594G",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453154,
			"end_pos": 140453154,
			"ref": "T",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.140453154T>C",
			"hgvs_c": "NM_004333.4:c.1781A>G",
			"hgvs_p": "NP_004324.2:p.Asp594Gly",
			"dbsnp_ids": [
				"121913338"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453154T>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/611/summary/evidence/6002/summary#evidence",
		"source": "civic",
		"description": "In this preclinical study, melanoma cell lines harboring the kinase-dead G469E- and D594G mutations were identified. These cell lines were resitant to MEK-Inhibition but underwent apoptosis after shRNA-mediated CRAF knowdown or Treatment with the pan-RAF Inhibitor sorafenib.",
		"drug_labels": "109511-58-2",
		"variant_name": "D594G",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/611/summary",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/959",
				"source": "http://purl.obolibrary.org/obo/DOID_8923",
				"term": "skin melanoma",
				"pheno_id": "DOID:8923",
				"family": "melanoma",
				"description": "skin melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/997"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/997",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/18794803"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6002",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/997"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/875",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "109511-58-2",
				"envcontext_id": "CID3006531",
				"usan_stem": null,
				"description": "109511-58-2",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/997"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/998",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/28",
			"name": "D594G",
			"description": "BRAF D594G",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453154,
			"end_pos": 140453154,
			"ref": "T",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.140453154T>C",
			"hgvs_c": "NM_004333.4:c.1781A>G",
			"hgvs_p": "NP_004324.2:p.Asp594Gly",
			"dbsnp_ids": [
				"121913338"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453154T>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/611/summary/evidence/6001/summary#evidence",
		"source": "civic",
		"description": "In this preclinical study, melanoma cell lines harboring the kinase-dead G469E- and D594G mutations were identified. These cell lines were resitant to MEK-Inhibition but underwent apoptosis after shRNA-mediated CRAF knowdown or Treatment with the pan-RAF Inhibitor sorafenib.",
		"drug_labels": "Sorafenib",
		"variant_name": "D594G",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/611/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/960",
				"source": "http://purl.obolibrary.org/obo/DOID_8923",
				"term": "skin melanoma",
				"pheno_id": "DOID:8923",
				"family": "melanoma",
				"description": "skin melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/998"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/998",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/18794803"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "6001",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/998"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/876",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "Sorafenib",
				"envcontext_id": "216239",
				"usan_stem": "raf kinase inhibitors",
				"description": "Sorafenib",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/998"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/999",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/28",
			"name": "D594G",
			"description": "BRAF D594G",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453154,
			"end_pos": 140453154,
			"ref": "T",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.140453154T>C",
			"hgvs_c": "NM_004333.4:c.1781A>G",
			"hgvs_p": "NP_004324.2:p.Asp594Gly",
			"dbsnp_ids": [
				"121913338"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453154T>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/611/summary/evidence/4472/summary#evidence",
		"source": "civic",
		"description": "In a retrospective study of 53, KRAS exon 2 wild-type, metastatic colorectal cancer patients, patients harboring BRAF G466A (n=1), G469A (n=2), D594G (n=1), or V600E (n=2) mutations were reported to be non-responders to cetuximab in combination with irinotecan, (BRAF mutation positive: responders vs. non-responders = 0 vs. 6; BRAF wild-type: responders vs. non-responders 30 vs. 17; P=0.004), as compared to patients with wild-type BRAF.",
		"drug_labels": "CETUXIMAB",
		"variant_name": "D594G",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/611/summary",
		"evidence_label": "C",
		"response_type": "resistant",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/961",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/999"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/999",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26989027"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "4472",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/999"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/877",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/999"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/1000",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/28",
			"name": "D594G",
			"description": "BRAF D594G",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453154,
			"end_pos": 140453154,
			"ref": "T",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.140453154T>C",
			"hgvs_c": "NM_004333.4:c.1781A>G",
			"hgvs_p": "NP_004324.2:p.Asp594Gly",
			"dbsnp_ids": [
				"121913338"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453154T>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/611/summary/evidence/1551/summary#evidence",
		"source": "civic",
		"description": "In a study of 908 patients with colorectal cancer, 7 patients had BRAF (D594G) mutations and 45 patients had BRAF (V600E) mutations. Overall clinicopathological implications of BRAF V600E and D594G mutant tumors were similar but BRAF D594G mutations were more likely to be left-sided tumors (85.7% vs. 31.1%; p<0.0098) and they were more likely to present as metastatic tumors (71.4% vs. 28.9%; p<0.04) than BRAF V600E mutant tumors. The overall log-rank was p < 0.001 when all three groups were calculated simultaneously; p < 0.0001 comparing BRAF wild-type and BRAF V600E survival, p = 0.015 comparing BRAF wild-type and BRAF D594G survival, and p = 0.98 comparing BRAF V600E and BRAF D594G.  There was no statistically significant difference in OS between BRAF D594G and BRAF wt but BRAF V600E mutant patients had significantly worse survival when only stage IV patients (BRAF D594G N=5) were analyzed.",
		"drug_labels": null,
		"variant_name": "D594G",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/611/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/962",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/1000"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/1000",
				"type": "Prognostic",
				"description": "Poor Outcome",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27404270"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1551",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/1000"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/1001",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/28",
			"name": "D594G",
			"description": "BRAF D594G",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453154,
			"end_pos": 140453154,
			"ref": "T",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.140453154T>C",
			"hgvs_c": "NM_004333.4:c.1781A>G",
			"hgvs_p": "NP_004324.2:p.Asp594Gly",
			"dbsnp_ids": [
				"121913338"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453154T>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/611/summary/evidence/1553/summary#evidence",
		"source": "civic",
		"description": "In a study of 908 patients with colorectal cancer (CRC), 7 patients had BRAF D595G mutations and 589 patients were BRAF wild type. The survival rate of CRC patients at 3 years was significantly poorer in the BRAF D595G mutations when compared to the wild type group (50%, 87.9%; p<0.00152).",
		"drug_labels": null,
		"variant_name": "D594G",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/611/summary",
		"evidence_label": "B",
		"response_type": "resistant",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/963",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/1001"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/1001",
				"type": "Prognostic",
				"description": "Poor Outcome",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27404270"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1553",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/1001"
			}
		],
		"environmentalcontext_set": [

		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/1002",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/28",
			"name": "D594G",
			"description": "BRAF D594G",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453154,
			"end_pos": 140453154,
			"ref": "T",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.140453154T>C",
			"hgvs_c": "NM_004333.4:c.1781A>G",
			"hgvs_p": "NP_004324.2:p.Asp594Gly",
			"dbsnp_ids": [
				"121913338"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453154T>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/611/summary/evidence/1554/summary#evidence",
		"source": "civic",
		"description": "Two patients with stage IV BRAF (D594G) mutations received anti-EGFR antibody therapy (cetuximab and panitumumab). The first patient was on FOLFOX plus bevacizumab and showed no signs of progression for 10 months. No response was observed after cetuximab was given as a third line therapy. The second patient received panitumumab with FOLFOX and showed no signs of progression for 8 months with reduction of the size of metastases.",
		"drug_labels": "CETUXIMAB,PANITUMUMAB",
		"variant_name": "D594G",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/611/summary",
		"evidence_label": "C",
		"response_type": "resistant",
		"evidence_level": "3",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/964",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/1002"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/1002",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/27404270"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1554",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/1002"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/879",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "PANITUMUMAB",
				"envcontext_id": "CHEMBL1201827",
				"usan_stem": "monoclonal antibodies",
				"description": "PANITUMUMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/1002"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/878",
				"source": "http://rdf.ebi.ac.uk/terms/chembl",
				"term": "CETUXIMAB",
				"envcontext_id": "CHEMBL1201577",
				"usan_stem": "monoclonal antibodies",
				"description": "CETUXIMAB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/1002"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/1003",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/390",
			"name": "DEL 485-490",
			"description": "BRAF DEL 485-490",
			"biomarker_type": "Inframe Deletion",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001820"
			],
			"soid": "SO:0001822",
			"so_name": "inframe_deletion",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000288602.6",
			"chromosome": "7",
			"start_pos": 140477838,
			"end_pos": 140477855,
			"ref": "AGGTGCTGTCACATTCAA",
			"alt": null,
			"hgvs_g": "NC_000007.13:g.140477838_140477855del",
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/522/summary/evidence/1267/summary#evidence",
		"source": "civic",
		"description": "Cells harboring in-frame deletions in BRAF in the L485-P490 amino acid region were found to be sensitive to the RAF dimer inhibitor LY3009120, but not sensitive to the BRAF-selective inhibitors vemurafenib or dabrafenib. These deletions were observed in KRAS wildtype pancreatic, ovarian, NSCLC, and thyroid cancers. In three cell lines H2405 (NSCLC with L485-P490>Y), BxPC-3 (pancreatic with V487-P492>A), and OV-90 (ovarian with N486-P490del), BRAF deletion–mediated MAPK activation was found to be sensitive to LY3009120 as evidenced by dose-dependent inhibition of phospho-MEK and ERK and cell growth inhibition with IC50 values of 0.04, 0.087, and 0.007 μmol/L in these three cell lines. LY3009120, but not vemurafenib, also inhibited tumor growth of both H2405 and BxPC-3 cells xenografted into mice.",
		"drug_labels": "LY3009120",
		"variant_name": "DEL",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/522/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/965",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/1003"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/1003",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/26732095"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1267",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/1003"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/880",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "LY3009120",
				"envcontext_id": "CID71721540",
				"usan_stem": null,
				"description": "LY3009120",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/1003"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/1004",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/391",
			"name": "V600E AMPLIFICATION",
			"description": "BRAF V600E AMPLIFICATION",
			"biomarker_type": "Transcript Amplification",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001880"
			],
			"soid": "SO:0001889",
			"so_name": "transcript_amplification",
			"reference_name": "GRCh37",
			"refseq": null,
			"isoform": "ENST00000288602.6",
			"chromosome": "7",
			"start_pos": 140434279,
			"end_pos": 140624564,
			"ref": null,
			"alt": null,
			"hgvs_g": null,
			"hgvs_c": null,
			"hgvs_p": null,
			"dbsnp_ids": null,
			"myvariant_hg19": null,
			"sources": {
				"civic": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/14/summary/evidence/92/summary#evidence",
		"source": "civic",
		"description": "COLO201 and COLO206F cells harboring BRAF V600E mutations were cloned to be MEK inhibitor (AZD6244 [selumetinib]) resistant. The mechanism of this resistance was shown to be amplification of the BRAF V600E gene.",
		"drug_labels": "SELUMETINIB",
		"variant_name": "AMPLIFICATION",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/14/summary",
		"evidence_label": "D",
		"response_type": "resistant",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/966",
				"source": "http://purl.obolibrary.org/obo/DOID_9256",
				"term": "colorectal cancer",
				"pheno_id": "DOID:9256",
				"family": "intestinal cancer",
				"description": "colorectal cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/1004"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/1004",
				"type": "Predictive",
				"description": "Resistance",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21098728"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "92",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/1004"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/881",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "SELUMETINIB",
				"envcontext_id": "10127622",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "SELUMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/1004"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/1005",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/65",
			"name": "K601E",
			"description": "BRAF K601E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453134,
			"end_pos": 140453134,
			"ref": "T",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.140453134T>C",
			"hgvs_c": "NM_004333.4:c.1801A>G",
			"hgvs_p": "NP_004324.2:p.Lys601Glu",
			"dbsnp_ids": [
				"121913364"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453134T>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/584/summary/evidence/5963/summary#evidence",
		"source": "civic",
		"description": "The phase 2a MyPathway study assigned patients with HER2, EGFR, BRAF or SHH alterations to treatment with pertuzumab plus trastuzumab, erlotinib, vemurafenib, or vismodegib, respectively. Of 26 patients with BRAF V600E mutations, objective responses were seen in 12 patients (46%; 95% CI, 27% to 67%). Only one of 23 patients (4%; 95% CI, 0% to 22%) with other non-V600 BRAF mutations had a PR (pancreas cancer with a CUX1-BRAF fusion). Non-responding BRAF mutations included: K601E (n = 6), G464V (n = 2), G469A (n = 2), G496A (n = 2), N581S (n = 2), and one each for G466V, G596R, G606E, L597Q, P731T, intron 9 rearrangement, intron 10 rearrangement, and MACF1- and WASFL-BRAF fusion.",
		"drug_labels": "VEMURAFENIB",
		"variant_name": "K601E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/584/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/967",
				"source": "http://purl.obolibrary.org/obo/DOID_162",
				"term": "cancer",
				"pheno_id": "DOID:162",
				"family": "cancer",
				"description": "cancer",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/1005"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/1005",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/29320312"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "5963",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/1005"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/882",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/1005"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/1006",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/65",
			"name": "K601E",
			"description": "BRAF K601E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453134,
			"end_pos": 140453134,
			"ref": "T",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.140453134T>C",
			"hgvs_c": "NM_004333.4:c.1801A>G",
			"hgvs_p": "NP_004324.2:p.Lys601Glu",
			"dbsnp_ids": [
				"121913364"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453134T>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/584/summary/evidence/2812/summary#evidence",
		"source": "civic",
		"description": "In a study of 197 metastatic melanoma patients, BRAF mutations were identified in 95 patients including V600E (n=70), V600K (n=19), K601E (n=1) and D594N (n=1). Patients were treated with a specific RAF inhibitor (dabrafenib), which improved overall survival of patients with BRAF mutations (P<0.003), compared to non-treated patients with BRAF mutations. Patients having BRAF mutations without RAF inhibitor treatment were associated with reduced overall survival (11.1 mo vs. 46.1 mo for wild-type, P=0.006).",
		"drug_labels": "DABRAFENIB",
		"variant_name": "K601E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/584/summary",
		"evidence_label": "B",
		"response_type": "Sensitivity/Response",
		"evidence_level": "2",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/968",
				"source": "http://purl.obolibrary.org/obo/DOID_8923",
				"term": "skin melanoma",
				"pheno_id": "DOID:8923",
				"family": "melanoma",
				"description": "skin melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/1006"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/1006",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/21343559"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "2812",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/1006"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/883",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "DABRAFENIB",
				"envcontext_id": "44462760",
				"usan_stem": "raf kinase inhibitors",
				"description": "DABRAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/1006"
			}
		]
	},
	{
		"url": "https://svip-dev.nexus.ethz.ch/api/v1/associations/1007",
		"gene": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1",
			"entrez_id": 673,
			"ensembl_gene_id": "ENSG00000157764",
			"symbol": "BRAF",
			"uniprot_ids": [
				"P15056"
			],
			"location": "7q34",
			"sources": {
				"civic": null,
				"oncokb": null
			}
		},
		"variant": {
			"url": "https://svip-dev.nexus.ethz.ch/api/v1/variants/65",
			"name": "K601E",
			"description": "BRAF K601E",
			"biomarker_type": "missense_variant",
			"so_hierarchy": [
				"SO:0001060",
				"SO:0001537",
				"SO:0001878",
				"SO:0001564",
				"SO:0001576",
				"SO:0001791",
				"SO:0001580",
				"SO:0001818",
				"SO:0001650",
				"SO:0001992"
			],
			"soid": "SO:0001583",
			"so_name": "missense_variant",
			"reference_name": "GRCh37",
			"refseq": "NM_004333.4",
			"isoform": "ENST00000288602",
			"chromosome": "7",
			"start_pos": 140453134,
			"end_pos": 140453134,
			"ref": "T",
			"alt": "C",
			"hgvs_g": "NC_000007.13:g.140453134T>C",
			"hgvs_c": "NM_004333.4:c.1801A>G",
			"hgvs_p": "NP_004324.2:p.Lys601Glu",
			"dbsnp_ids": [
				"121913364"
			],
			"myvariant_hg19": "http://myvariant.info/v1/variant/chr7:g.140453134T>C?assembly=hg19",
			"sources": {
				"civic": null,
				"oncokb": null
			},
			"gene": "https://svip-dev.nexus.ethz.ch/api/v1/genes/1"
		},
		"source_url": "https://civicdb.org/events/genes/5/summary/variants/584/summary/evidence/1462/summary#evidence",
		"source": "civic",
		"description": "Preclinical study in 293H cell line. Ectopic expression of V600E, L597R/Q/S, and K601E mutants elevated phospho-MEK and ERK levels. Vemurafenib treatment of all of the BRAF mutant–expressing cells led to a decrease in phospho-MEK and ERK protein levels. Treatment with MEK inhibitor GSK1120212 led to a more dramatic decrease in phospho-ERK signaling.",
		"drug_labels": "TRAMETINIB,VEMURAFENIB",
		"variant_name": "K601E",
		"source_link": "https://civic.genome.wustl.edu/events/genes/5/summary/variants/584/summary",
		"evidence_label": "D",
		"response_type": "Sensitivity/Response",
		"evidence_level": "4",
		"phenotype_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/phenotypes/969",
				"source": "http://purl.obolibrary.org/obo/DOID_8923",
				"term": "skin melanoma",
				"pheno_id": "DOID:8923",
				"family": "melanoma",
				"description": "skin melanoma",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/1007"
			}
		],
		"evidence_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/evidence_items/1007",
				"type": "Predictive",
				"description": "Sensitivity/Response",
				"publications": [
					"http://www.ncbi.nlm.nih.gov/pubmed/22798288"
				],
				"evidenceType_sourceName": "CIVIC",
				"evidenceType_id": "1462",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/1007"
			}
		],
		"environmentalcontext_set": [
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/885",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "VEMURAFENIB",
				"envcontext_id": "42611257",
				"usan_stem": "raf kinase inhibitors",
				"description": "VEMURAFENIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/1007"
			},
			{
				"url": "https://svip-dev.nexus.ethz.ch/api/v1/environmental_contexts/884",
				"source": "http://rdf.ncbi.nlm.nih.gov/pubchem/compound",
				"term": "TRAMETINIB",
				"envcontext_id": "11707110",
				"usan_stem": "tyrosine kinase inhibitors: mitogen-activated protein (MAP) kinase inhibitors",
				"description": "TRAMETINIB",
				"association": "https://svip-dev.nexus.ethz.ch/api/v1/associations/1007"
			}
		]
	}
]